data_2m86_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m86 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.52 3.039 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 44.61 55.98 5.85 Favored Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.181 1.355 . . . . 0.0 114.903 -162.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -116.38 111.51 20.16 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 120.113 -1.816 . . . . 0.0 111.606 -168.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.28 -147.14 5.55 Favored Glycine 0 C--N 1.349 1.306 0 CA-C-O 122.206 0.892 . . . . 0.0 112.44 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.38 66.0 9.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 120.132 -1.805 . . . . 0.0 113.545 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 m -62.81 -6.26 3.55 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 pttm -89.12 -26.57 21.27 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.298 2.239 . . . . 0.0 113.635 175.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 175.16 87.22 0.08 OUTLIER Pre-proline 0 C--N 1.35 0.622 0 C-N-CA 125.074 1.35 . . . . 0.0 108.738 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.74 127.31 8.66 Favored 'Trans proline' 0 C--N 1.325 -0.702 0 C-N-CA 122.231 1.954 . . . . 0.0 111.65 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.6 t -122.38 -0.38 9.31 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-O 122.71 1.243 . . . . 0.0 110.884 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.9 t -130.39 164.2 25.23 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 124.92 1.288 . . . . 0.0 109.599 -174.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -68.26 -38.13 81.45 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 124.369 1.068 . . . . 0.0 111.105 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.7 -52.9 39.37 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 124.848 1.259 . . . . 0.0 110.803 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.84 -55.25 10.18 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.092 1.757 . . . . 0.0 114.07 169.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.57 -30.81 68.68 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.275 -1.516 . . . . 0.0 113.501 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -58.32 -41.55 84.79 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 119.937 -1.727 . . . . 0.0 112.381 171.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -65.25 -43.2 92.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.769 -1.207 . . . . 0.0 113.454 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -53.26 -29.18 31.51 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 127.072 2.149 . . . . 0.0 115.014 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.49 -19.58 65.67 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.604 1.162 . . . . 0.0 113.94 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.268 42.2 p 54.65 35.59 24.11 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 126.871 2.068 . . . . 0.0 114.299 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.34 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.44 1.896 . . . . 0.0 115.186 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.2 -40.85 1.04 Allowed Glycine 0 CA--C 1.494 -1.225 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -170.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.91 -146.24 17.97 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 124.475 1.036 . . . . 0.0 111.684 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 m -94.53 155.24 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 O-C-N 121.09 -1.241 . . . . 0.0 110.904 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.61 155.52 80.45 Favored Pre-proline 0 N--CA 1.448 -0.559 0 O-C-N 120.601 -1.312 . . . . 0.0 107.592 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.37 6.44 3.55 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 123.113 2.542 . . . . 0.0 113.017 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt 62.63 46.25 5.54 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.705 1.602 . . . . 0.0 114.262 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 pt -59.79 139.24 19.65 Favored 'Isoleucine or valine' 0 C--N 1.348 0.531 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -173.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 mp -86.69 28.1 0.91 Allowed 'General case' 0 C--N 1.346 0.45 0 O-C-N 120.948 -1.095 . . . . 0.0 111.685 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -82.51 138.29 34.36 Favored 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 120.543 -1.348 . . . . 0.0 109.79 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -84.7 127.0 33.88 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.503 0.668 . . . . 0.0 111.019 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.9 p -119.07 -175.95 3.02 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.038 1.335 . . . . 0.0 109.388 -177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -130.67 -12.82 3.8 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 120.696 -1.252 . . . . 0.0 111.116 168.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -157.04 169.99 23.56 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 120.689 -1.257 . . . . 0.0 107.875 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.1 -31.73 71.55 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.579 1.551 . . . . 0.0 113.515 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 m -65.28 -26.64 68.17 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 120.121 -1.612 . . . . 0.0 115.058 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.84 -11.33 59.81 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.308 -0.87 . . . . 0.0 111.987 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -107.4 127.56 27.63 Favored Pre-proline 0 C--N 1.354 0.791 0 O-C-N 120.179 -1.576 . . . . 0.0 112.129 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.07 168.64 23.67 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.195 1.93 . . . . 0.0 114.175 -171.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.32 -85.57 1.13 Allowed Glycine 0 C--N 1.35 1.313 0 C-N-CA 124.626 1.108 . . . . 0.0 112.982 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -161.3 25.59 0.13 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 122.598 1.19 . . . . 0.0 110.169 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 7.1 m -89.63 148.55 23.27 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 119.181 -2.199 . . . . 0.0 109.612 -170.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 pp -115.37 147.42 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 O-C-N 119.882 -1.761 . . . . 0.0 108.821 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.06 117.14 19.08 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.989 1.316 . . . . 0.0 110.158 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -79.9 176.3 9.86 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 120.029 -1.669 . . . . 0.0 110.911 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.89 0.33 2.42 Favored Glycine 0 C--N 1.355 1.59 0 N-CA-C 117.492 1.757 . . . . 0.0 117.492 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.45 -7.49 24.23 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 120.707 -1.466 . . . . 0.0 111.925 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.35 20.18 60.93 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 120.458 -1.401 . . . . 0.0 113.707 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -130.81 145.21 51.91 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 121.133 -1.216 . . . . 0.0 110.593 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 78.8 m -75.39 147.13 40.26 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 123.51 1.624 . . . . 0.0 114.329 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.334 0 CA-C-O 116.19 -2.45 . . . . 0.0 118.186 -174.385 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 57.2 mt . . . . . 0 N--CA 1.504 2.246 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 11.7 m -136.2 166.22 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -115.84 102.14 54.04 Favored Pre-proline 0 C--N 1.345 0.391 0 CA-C-O 117.137 -1.411 . . . . 0.0 110.035 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.49 174.46 9.23 Favored 'Trans proline' 0 C--N 1.325 -0.66 0 C-N-CA 123.3 2.667 . . . . 0.0 114.086 175.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -96.2 154.64 38.73 Favored Pre-proline 0 C--N 1.35 0.617 0 O-C-N 120.914 -1.116 . . . . 0.0 111.617 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.91 -24.32 29.12 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.179 2.586 . . . . 0.0 112.7 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.8 mt -64.59 -52.94 54.94 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 118.686 0.676 . . . . 0.0 111.358 168.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 32.6 tp -58.69 -36.9 74.96 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 124.976 1.311 . . . . 0.0 113.522 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 15.6 tp -47.63 -40.3 19.26 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 125.345 1.458 . . . . 0.0 114.805 170.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -64.47 -36.82 85.44 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 119.645 -1.91 . . . . 0.0 113.723 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 tt -70.45 -50.62 36.34 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 124.037 0.935 . . . . 0.0 110.738 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 88.8 mt -53.59 -46.34 70.33 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.913 1.285 . . . . 0.0 112.287 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -58.95 -25.18 63.3 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.44 -13.57 59.02 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 125.307 1.443 . . . . 0.0 112.025 177.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.62 0.61 10.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 125.07 1.348 . . . . 0.0 109.782 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.2 -15.75 39.19 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 120.084 -1.635 . . . . 0.0 113.155 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -88.14 78.39 8.13 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 120.434 -1.627 . . . . 0.0 113.493 -172.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -85.38 8.1 20.08 Favored 'General case' 0 C--N 1.343 0.318 0 O-C-N 119.895 -1.753 . . . . 0.0 115.466 -176.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.82 149.49 27.14 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 121.339 -0.851 . . . . 0.0 112.508 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -78.74 -27.55 44.79 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.147 1.379 . . . . 0.0 112.527 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 60.4 p -121.58 140.88 51.67 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 120.808 -1.182 . . . . 0.0 112.572 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -139.43 177.31 8.02 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-O 122.439 1.114 . . . . 0.0 110.264 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.48 160.97 17.26 Favored 'General case' 0 C--N 1.346 0.447 0 O-C-N 120.666 -1.271 . . . . 0.0 110.872 175.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.98 -47.68 71.14 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.105 -1.622 . . . . 0.0 114.388 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -59.36 -52.7 64.5 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.978 0.911 . . . . 0.0 112.913 171.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.76 -46.57 50.75 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 174.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 52.1 t -51.88 -48.25 39.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 O-C-N 120.97 -1.081 . . . . 0.0 112.709 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.2 -29.84 38.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.082 -1.012 . . . . 0.0 113.288 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -56.27 -60.34 3.64 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 125.774 1.629 . . . . 0.0 112.193 172.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -59.13 -36.49 75.29 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 120.669 -1.269 . . . . 0.0 112.495 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 5.0 tp -62.56 -51.46 67.26 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.1 1.36 . . . . 0.0 113.902 173.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.23 -51.77 54.27 Favored Glycine 0 C--N 1.35 1.334 0 C-N-CA 125.502 1.525 . . . . 0.0 113.204 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -55.39 -39.15 69.79 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 125.216 1.406 . . . . 0.0 113.399 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -59.11 -56.3 24.02 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 121.149 -0.969 . . . . 0.0 112.74 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.71 -44.97 98.56 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 C-N-CA 124.327 1.051 . . . . 0.0 112.475 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 45.2 ttm -52.43 -44.67 65.58 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 126.268 1.827 . . . . 0.0 112.979 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 11.7 m -85.83 -23.62 27.09 Favored 'General case' 0 C--N 1.346 0.449 0 O-C-N 120.153 -1.592 . . . . 0.0 112.774 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -29.42 55.62 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 118.982 -2.324 . . . . 0.0 113.053 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? 75.15 49.27 0.09 Allowed 'General case' 0 C--N 1.351 0.659 0 C-N-CA 126.496 1.918 . . . . 0.0 110.596 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.6 23.19 12.34 Favored 'General case' 0 C--N 1.349 0.553 0 O-C-N 121.032 -1.042 . . . . 0.0 111.68 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -114.01 144.14 43.59 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.588 -1.32 . . . . 0.0 108.599 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.27 132.59 44.26 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.883 -1.136 . . . . 0.0 110.162 173.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -58.22 -47.77 82.45 Favored 'General case' 0 C--N 1.346 0.424 0 O-C-N 119.705 -1.872 . . . . 0.0 113.681 173.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -75.04 -19.49 60.01 Favored 'General case' 0 C--N 1.347 0.458 0 O-C-N 119.878 -1.764 . . . . 0.0 114.323 176.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.22 58.67 1.58 Allowed 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 119.701 -1.874 . . . . 0.0 110.231 -170.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -62.55 -7.41 4.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.453 1.901 . . . . 0.0 114.903 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -92.7 -3.82 54.22 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.015 2.526 . . . . 0.0 113.551 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 43.8 mm -106.29 139.32 28.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 0 C-N-CA 126.022 1.729 . . . . 0.0 107.643 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 39.9 t -124.7 130.17 73.47 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-O 122.406 1.098 . . . . 0.0 110.324 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.59 109.34 18.47 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.971 -1.08 . . . . 0.0 110.994 172.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 24.1 p -100.38 -14.47 18.34 Favored 'General case' 0 C--N 1.346 0.426 0 O-C-N 121.126 -0.984 . . . . 0.0 112.324 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.89 124.6 20.41 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 120.645 -1.285 . . . . 0.0 113.312 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 79.05 2.75 2.41 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 125.43 1.492 . . . . 0.0 113.554 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -112.12 167.33 10.49 Favored 'General case' 0 C--N 1.35 0.587 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 171.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 tp -64.39 -20.98 66.48 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 128.059 2.543 . . . . 0.0 112.81 -171.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 tp -67.47 -36.55 81.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.785 1.634 . . . . 0.0 112.926 171.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.22 -48.41 31.72 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 120.923 -1.111 . . . . 0.0 112.468 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.33 -42.32 4.48 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 127.823 2.449 . . . . 0.0 114.246 169.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.75 -29.89 15.8 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 120.311 -1.493 . . . . 0.0 114.355 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -74.08 -41.75 61.22 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 120.684 -1.26 . . . . 0.0 111.699 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 84.33 20.82 58.1 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 124.154 0.883 . . . . 0.0 113.14 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.71 153.48 80.12 Favored Pre-proline 0 C--N 1.346 0.421 0 O-C-N 121.155 -1.203 . . . . 0.0 110.561 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.56 -25.18 5.7 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.046 1.83 . . . . 0.0 112.907 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 33.2 p -160.08 164.01 33.42 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 120.016 -1.678 . . . . 0.0 107.427 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -144.56 163.85 32.65 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.593 1.187 . . . . 0.0 110.7 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.57 130.27 54.36 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 120.655 -1.278 . . . . 0.0 111.034 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 48.8 t -62.79 -27.92 43.94 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 O-C-N 119.711 -1.868 . . . . 0.0 111.749 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -25.87 12.67 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 125.854 1.662 . . . . 0.0 114.868 171.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -85.2 55.52 3.53 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 119.968 -1.708 . . . . 0.0 112.185 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -48.58 -44.72 37.08 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 119.229 -2.169 . . . . 0.0 115.519 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -22.81 61.93 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 172.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -87.75 -44.13 11.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.091 1.356 . . . . 0.0 109.734 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 49.6 mm -53.98 -51.9 41.47 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 C-N-CA 125.118 1.367 . . . . 0.0 111.515 174.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -53.84 -45.96 71.07 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 171.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.87 -39.59 93.79 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 119.63 -1.918 . . . . 0.0 113.627 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 24.3 mmt -60.09 -49.25 78.4 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 120.741 -1.224 . . . . 0.0 112.58 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 45.8 mt -59.6 -51.48 72.28 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 C-N-CA 124.826 1.25 . . . . 0.0 112.524 175.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -61.39 -23.4 65.76 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 119.198 -2.189 . . . . 0.0 114.407 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -77.59 -11.87 59.91 Favored 'General case' 0 C--N 1.349 0.57 0 O-C-N 119.499 -2.001 . . . . 0.0 113.503 170.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -95.86 -26.38 15.65 Favored 'General case' 0 CA--C 1.505 -0.764 0 O-C-N 119.985 -1.697 . . . . 0.0 110.403 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 73.3 mt -103.35 174.26 5.95 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 122.023 0.916 . . . . 0.0 110.603 -174.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 97.7 t -116.59 121.66 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 99.2 t . . . . . 0 C--N 1.347 0.46 0 C-N-CA 123.792 0.837 . . . . 0.0 110.331 179.829 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.515 2.808 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 50.15 47.49 41.51 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-N 120.154 1.343 . . . . 0.0 114.874 -165.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 m -114.93 114.03 24.93 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 119.769 -2.018 . . . . 0.0 112.0 -167.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.22 -151.17 5.89 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.84 70.0 4.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.286 -1.126 . . . . 0.0 113.976 -176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 p -69.51 -0.98 7.45 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 119.429 -2.044 . . . . 0.0 114.868 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -92.75 -34.39 13.93 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.619 1.568 . . . . 0.0 113.007 171.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -173.97 85.21 0.36 Allowed Pre-proline 0 C--N 1.347 0.471 0 CA-C-O 118.672 -0.68 . . . . 0.0 109.6 -175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.34 118.86 4.76 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.233 1.955 . . . . 0.0 112.05 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.1 t -107.68 -25.29 11.37 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.954 1.301 . . . . 0.0 110.039 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 t -106.02 165.63 11.08 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.384 -1.447 . . . . 0.0 113.941 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -63.3 -50.44 70.07 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 119.786 -1.822 . . . . 0.0 111.77 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.36 -45.17 72.73 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 125.867 1.667 . . . . 0.0 113.061 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -56.54 -58.43 8.08 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.617 1.567 . . . . 0.0 113.888 171.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -29.52 69.59 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.321 -1.487 . . . . 0.0 113.07 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -35.63 73.81 Favored 'General case' 0 C--N 1.348 0.525 0 O-C-N 119.926 -1.734 . . . . 0.0 112.083 173.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -70.32 -44.33 68.45 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 120.532 -1.355 . . . . 0.0 112.881 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -54.32 -29.55 48.19 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 126.399 1.88 . . . . 0.0 114.862 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.4 tp -61.11 -30.34 70.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.511 1.124 . . . . 0.0 113.81 171.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 t 54.44 53.32 10.96 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 126.536 1.935 . . . . 0.0 113.043 -172.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.84 81.38 1.63 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 123.097 1.427 . . . . 0.0 113.561 -170.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.19 -29.92 0.47 Allowed Glycine 0 C--N 1.342 0.877 0 O-C-N 121.234 -0.916 . . . . 0.0 112.243 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.19 -149.23 18.73 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-N 117.797 0.798 . . . . 0.0 112.44 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.0 t -103.35 138.69 26.72 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 O-C-N 120.972 -1.311 . . . . 0.0 109.012 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.28 157.03 41.13 Favored Pre-proline 0 N--CA 1.447 -0.606 0 O-C-N 120.746 -1.221 . . . . 0.0 109.074 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.73 -1.09 10.27 Favored 'Trans proline' 0 C--N 1.336 -0.123 0 C-N-CA 122.73 2.286 . . . . 0.0 112.757 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt 66.98 53.76 0.81 Allowed 'General case' 0 C--N 1.35 0.609 0 C-N-CA 126.421 1.889 . . . . 0.0 112.704 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 pt -63.35 141.0 18.72 Favored 'Isoleucine or valine' 0 C--N 1.346 0.414 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.2 mt -85.65 29.9 0.67 Allowed 'General case' 0 C--N 1.348 0.503 0 C-N-CA 124.284 1.034 . . . . 0.0 111.825 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -86.32 143.34 27.93 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 120.179 -1.576 . . . . 0.0 109.386 172.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -88.48 133.95 33.99 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.861 0.839 . . . . 0.0 110.456 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.7 p -125.4 -175.88 3.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.001 0.92 . . . . 0.0 108.902 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -129.71 -13.34 4.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.346 -1.471 . . . . 0.0 111.774 167.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -161.89 176.03 11.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -74.2 -27.45 60.81 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.541 -1.349 . . . . 0.0 112.557 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.19 -28.25 67.81 Favored 'General case' 0 C--N 1.348 0.54 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 171.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -84.23 -8.24 59.11 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.347 -0.846 . . . . 0.0 110.701 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -111.29 124.19 33.29 Favored Pre-proline 0 C--N 1.355 0.816 0 O-C-N 120.091 -1.631 . . . . 0.0 111.9 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.28 169.63 22.07 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.147 1.898 . . . . 0.0 114.135 -169.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.69 -87.85 1.14 Allowed Glycine 0 C--N 1.349 1.266 0 C-N-CA 124.319 0.962 . . . . 0.0 112.246 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.39 21.53 0.29 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.992 0.901 . . . . 0.0 110.87 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 4.2 m -83.87 152.34 24.61 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 119.278 -2.139 . . . . 0.0 110.027 -168.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 pp -119.23 146.12 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 O-C-N 120.037 -1.664 . . . . 0.0 108.342 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.51 119.47 21.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.422 1.489 . . . . 0.0 109.298 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -79.53 177.34 8.94 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 119.984 -1.698 . . . . 0.0 110.565 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.34 -18.86 23.12 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 116.598 1.399 . . . . 0.0 116.598 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -82.17 -8.68 59.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.449 -1.03 . . . . 0.0 112.992 174.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.64 14.88 69.48 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 120.659 -1.276 . . . . 0.0 113.905 -175.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -127.56 148.57 50.34 Favored 'General case' 0 C--N 1.347 0.467 0 O-C-N 120.653 -1.498 . . . . 0.0 110.354 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 41.9 m -74.63 147.16 41.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 123.783 1.754 . . . . 0.0 114.35 -175.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.289 0 CA-C-O 116.689 -2.173 . . . . 0.0 117.435 -176.179 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.505 2.275 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 9.8 m -132.88 164.91 33.95 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 119.587 1.085 . . . . 0.0 108.665 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.29 100.49 53.51 Favored Pre-proline 0 C--N 1.344 0.348 0 CA-C-O 117.082 -1.437 . . . . 0.0 110.181 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.37 162.94 39.89 Favored 'Trans proline' 0 C--N 1.331 -0.358 0 C-N-CA 123.232 2.622 . . . . 0.0 114.006 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -89.11 156.28 49.07 Favored Pre-proline 0 C--N 1.347 0.492 0 O-C-N 121.344 -0.847 . . . . 0.0 112.613 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.65 -20.63 30.38 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.232 2.621 . . . . 0.0 113.3 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 81.1 mt -70.32 -61.14 1.89 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.706 0.803 . . . . 0.0 110.186 170.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 31.9 tp -50.74 -37.09 39.9 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 125.422 1.489 . . . . 0.0 114.427 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 8.3 tp -47.66 -40.71 20.6 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 169.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -64.35 -36.84 85.44 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 119.463 -2.023 . . . . 0.0 114.084 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -49.67 60.17 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 121.35 -0.844 . . . . 0.0 111.598 171.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 93.7 mt -52.18 -47.25 65.64 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 124.172 0.989 . . . . 0.0 113.124 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -52.74 -30.03 30.32 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.3 t -77.11 -20.6 55.47 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.602 1.161 . . . . 0.0 111.927 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.12 -9.72 9.49 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 C-N-CA 124.619 1.168 . . . . 0.0 110.606 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.97 -27.31 6.49 Favored Glycine 0 C--N 1.353 1.51 0 O-C-N 120.066 -1.646 . . . . 0.0 111.966 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -78.16 74.27 4.7 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 125.82 1.648 . . . . 0.0 114.718 -171.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -84.8 17.44 2.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 119.248 -2.157 . . . . 0.0 115.158 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.43 143.8 26.54 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 123.36 1.552 . . . . 0.0 113.021 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -20.27 64.03 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 130.093 3.357 . . . . 0.0 112.396 -177.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 31.1 p -140.44 141.27 35.48 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 125.2 1.4 . . . . 0.0 109.87 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -141.51 -173.75 3.85 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.071 -1.018 . . . . 0.0 110.443 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 4.4 p -95.68 168.73 10.49 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.526 -1.358 . . . . 0.0 110.584 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 13.7 mmt -62.48 -49.19 76.37 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.731 -1.231 . . . . 0.0 113.258 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -58.94 -45.51 90.25 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 124.677 1.191 . . . . 0.0 112.206 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -56.34 -47.54 78.59 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 47.2 t -52.81 -46.08 50.97 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 O-C-N 120.135 -1.603 . . . . 0.0 112.958 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.46 -30.79 57.46 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 120.701 -1.249 . . . . 0.0 113.233 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -62.25 -57.24 12.17 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.667 1.587 . . . . 0.0 111.588 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -59.27 -43.03 92.51 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 123.891 0.876 . . . . 0.0 112.495 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.29 -53.7 55.25 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 120.88 -1.138 . . . . 0.0 114.017 170.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.57 -40.99 99.83 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 120.523 -1.36 . . . . 0.0 113.85 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -63.11 -38.12 89.92 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 124.877 1.271 . . . . 0.0 112.718 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -56.46 -56.88 15.71 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 124.288 1.035 . . . . 0.0 112.433 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.01 -42.39 96.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 O-C-N 120.696 -1.253 . . . . 0.0 112.665 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 37.2 ttm -54.76 -41.02 69.95 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 125.911 1.684 . . . . 0.0 113.321 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 17.2 m -87.98 -28.17 21.62 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 120.162 -1.586 . . . . 0.0 112.118 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -35.12 73.63 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 119.658 -1.901 . . . . 0.0 113.562 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? 74.91 59.04 0.07 Allowed 'General case' 0 C--N 1.353 0.725 0 C-N-CA 127.033 2.133 . . . . 0.0 110.516 -169.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mt -110.42 13.79 22.73 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-O 122.065 0.936 . . . . 0.0 111.679 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -100.68 149.87 23.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.901 1.281 . . . . 0.0 108.347 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -85.14 143.42 28.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.146 -0.971 . . . . 0.0 108.548 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -64.08 -33.21 75.23 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 120.73 -1.231 . . . . 0.0 113.067 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -98.06 -35.18 10.5 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.33 -0.856 . . . . 0.0 111.953 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -111.84 63.3 0.62 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.219 1.807 . . . . 0.0 111.912 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -62.29 -9.34 7.73 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.11 1.764 . . . . 0.0 114.764 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -90.07 -6.54 55.38 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.561 1.944 . . . . 0.0 113.695 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 33.1 mm -99.71 134.5 38.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 124.58 1.152 . . . . 0.0 109.273 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 19.8 t -122.74 128.39 75.25 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 O-C-N 120.757 -1.214 . . . . 0.0 109.763 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -89.2 102.72 15.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 120.97 -1.081 . . . . 0.0 109.818 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.56 -1.24 28.62 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 123.77 0.828 . . . . 0.0 111.305 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 1.4 t -71.81 139.41 48.94 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 120.623 -1.298 . . . . 0.0 109.817 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 17.6 m120 71.52 5.38 5.38 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -106.06 169.99 8.17 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 122.526 1.155 . . . . 0.0 109.884 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 13.8 tp -69.63 -21.38 63.57 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 127.193 2.197 . . . . 0.0 112.571 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.39 -32.82 64.67 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 120.565 -1.334 . . . . 0.0 111.89 170.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.57 -40.19 98.82 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 120.617 -1.302 . . . . 0.0 113.091 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.17 -43.14 70.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.688 2.395 . . . . 0.0 112.575 173.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.18 -33.29 20.84 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 119.873 -1.767 . . . . 0.0 114.135 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.3 -41.8 72.86 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 125.713 1.605 . . . . 0.0 111.644 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.89 20.84 72.66 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 123.882 0.754 . . . . 0.0 113.178 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.32 151.86 78.32 Favored Pre-proline 0 C--N 1.345 0.376 0 O-C-N 121.32 -1.106 . . . . 0.0 109.371 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.33 -25.25 11.54 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.207 1.938 . . . . 0.0 111.95 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 53.6 p -161.3 165.52 28.99 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.403 -1.436 . . . . 0.0 108.6 -175.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -143.85 168.82 19.05 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 121.074 -1.016 . . . . 0.0 108.295 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 32.6 t -115.02 140.96 48.62 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.107 -0.996 . . . . 0.0 108.907 172.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 23.9 t -69.51 -22.19 25.22 Favored 'Isoleucine or valine' 0 C--N 1.347 0.493 0 CA-C-O 122.818 1.294 . . . . 0.0 111.564 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -29.62 70.72 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.163 -1.586 . . . . 0.0 112.129 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -80.46 56.98 2.71 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.754 -1.216 . . . . 0.0 112.744 175.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -52.55 -41.91 63.95 Favored 'General case' 0 C--N 1.351 0.639 0 O-C-N 119.624 -1.922 . . . . 0.0 115.555 -176.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -62.51 -33.49 74.99 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 120.54 -1.35 . . . . 0.0 113.337 173.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -78.48 -33.18 48.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.721 -1.237 . . . . 0.0 113.082 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 44.4 mm -50.13 -50.8 19.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 C-N-CA 125.633 1.573 . . . . 0.0 111.344 169.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -51.99 -52.38 50.93 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 125.218 1.407 . . . . 0.0 113.167 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.34 -42.86 82.79 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 119.996 -1.69 . . . . 0.0 115.222 173.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 11.6 mtt -62.99 -38.81 92.67 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 120.638 -1.289 . . . . 0.0 113.174 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 44.3 mt -69.35 -54.09 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.223 -0.923 . . . . 0.0 111.927 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -55.53 -27.6 49.83 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 120.304 -1.497 . . . . 0.0 114.62 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -63.06 -19.53 64.48 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.898 -1.751 . . . . 0.0 115.599 171.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.0 -2.17 17.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.994 0.918 . . . . 0.0 112.169 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 92.6 mt -108.84 151.2 26.57 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 122.693 1.235 . . . . 0.0 110.199 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 16.0 t -95.98 114.29 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 O-C-N 120.315 -1.491 . . . . 0.0 108.914 173.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.35 0.601 0 C-N-CA 124.031 0.932 . . . . 0.0 111.396 179.35 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.262 87.6 p . . . . . 0 N--CA 1.532 3.626 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 55.77 53.05 44.5 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 m -107.68 113.35 26.56 Favored 'General case' 0 CA--C 1.51 -0.573 0 O-C-N 119.884 -1.951 . . . . 0.0 112.38 -173.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.48 -149.87 5.54 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.94 70.72 5.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 121.09 -1.241 . . . . 0.0 113.27 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.0 p -68.65 3.99 1.62 Allowed 'General case' 0 C--N 1.346 0.447 0 O-C-N 119.721 -1.862 . . . . 0.0 115.496 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -100.81 -39.29 7.88 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.538 1.935 . . . . 0.0 111.15 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -167.58 84.79 0.79 Allowed Pre-proline 0 N--CA 1.447 -0.583 0 O-C-N 121.402 -0.812 . . . . 0.0 109.629 -175.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.96 120.22 5.37 Favored 'Trans proline' 0 C--N 1.327 -0.599 0 C-N-CA 121.981 1.787 . . . . 0.0 112.199 -177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -107.33 -37.94 6.1 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.557 1.143 . . . . 0.0 110.109 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 m -94.04 163.67 13.38 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 120.244 -1.535 . . . . 0.0 114.841 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -60.42 -49.81 76.09 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 125.657 1.583 . . . . 0.0 111.295 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.04 -46.82 78.74 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 123.791 0.836 . . . . 0.0 113.155 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -55.09 -58.17 8.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.2 1.4 . . . . 0.0 114.422 171.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -31.98 73.25 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 120.603 -1.311 . . . . 0.0 112.947 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -57.2 -37.85 72.82 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 120.308 -1.495 . . . . 0.0 112.918 170.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -68.28 -40.54 81.79 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.369 -1.457 . . . . 0.0 112.753 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.45 -29.03 61.18 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 126.382 1.873 . . . . 0.0 114.987 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.9 tp -64.98 -18.92 65.7 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 125.286 1.434 . . . . 0.0 113.676 174.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.296 59.8 p 53.85 32.02 14.28 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 126.653 1.981 . . . . 0.0 115.463 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.7 93.71 0.01 OUTLIER 'General case' 0 C--N 1.353 0.72 0 C-N-CA 126.868 2.067 . . . . 0.0 115.784 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.33 -38.03 1.26 Allowed Glycine 0 C--N 1.345 1.078 0 O-C-N 121.341 -0.85 . . . . 0.0 111.892 -169.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.68 -139.6 14.67 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 122.469 1.038 . . . . 0.0 112.528 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -97.68 145.09 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 O-C-N 120.789 -1.418 . . . . 0.0 110.452 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.35 157.7 66.78 Favored Pre-proline 0 N--CA 1.448 -0.541 0 O-C-N 120.531 -1.356 . . . . 0.0 108.168 -175.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.93 -7.82 21.32 Favored 'Trans proline' 0 CA--C 1.52 -0.188 0 C-N-CA 122.579 2.186 . . . . 0.0 112.649 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 mtmt 68.7 53.29 0.53 Allowed 'General case' 0 C--N 1.352 0.688 0 C-N-CA 126.122 1.769 . . . . 0.0 112.066 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.6 pt -64.21 142.03 17.4 Favored 'Isoleucine or valine' 0 C--N 1.347 0.486 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.34 9.94 9.77 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-O 122.545 1.164 . . . . 0.0 112.69 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -70.93 134.65 47.4 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 120.415 -1.428 . . . . 0.0 112.389 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -81.28 124.41 29.3 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 121.71 -0.619 . . . . 0.0 111.797 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.1 p -115.82 -175.86 2.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.34 1.456 . . . . 0.0 109.772 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -122.14 -32.41 3.69 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 120.528 -1.358 . . . . 0.0 110.125 163.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -138.22 176.28 8.84 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 120.613 -1.304 . . . . 0.0 112.427 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -81.03 -5.02 57.11 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 118.898 -2.376 . . . . 0.0 113.262 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.0 t -76.32 -46.76 26.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.457 2.303 . . . . 0.0 109.576 172.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -32.52 67.24 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 128.127 2.571 . . . . 0.0 113.777 177.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.76 120.3 64.9 Favored Pre-proline 0 N--CA 1.447 -0.591 0 O-C-N 120.528 -1.357 . . . . 0.0 112.776 -172.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.78 169.16 23.01 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.487 2.125 . . . . 0.0 114.108 -168.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.15 -89.67 1.1 Allowed Glycine 0 C--N 1.349 1.286 0 C-N-CA 124.195 0.903 . . . . 0.0 111.912 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.17 29.91 0.17 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.74 1.257 . . . . 0.0 109.975 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.9 m -88.66 145.26 25.77 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 119.016 -2.302 . . . . 0.0 109.415 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 pp -111.92 146.04 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 O-C-N 119.766 -1.834 . . . . 0.0 109.564 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -77.92 120.26 22.53 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.737 1.615 . . . . 0.0 110.041 176.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -76.41 174.78 9.83 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 119.846 -1.784 . . . . 0.0 111.077 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.89 -2.89 2.89 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 117.1 1.6 . . . . 0.0 117.1 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.21 -9.0 24.26 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.976 1.31 . . . . 0.0 112.04 172.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.56 25.43 35.83 Favored Glycine 0 C--N 1.35 1.313 0 O-C-N 120.641 -1.287 . . . . 0.0 114.26 -176.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -135.93 150.29 49.25 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 120.724 -1.456 . . . . 0.0 111.465 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.9 m -85.66 116.18 23.78 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 -169.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.263 0 CA-C-O 116.063 -2.521 . . . . 0.0 116.357 175.141 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 N--CA 1.504 2.235 0 CA-C-O 118.288 -0.863 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 12.8 m -139.16 164.97 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 176.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -113.97 103.5 55.19 Favored Pre-proline 0 C--N 1.344 0.368 0 CA-C-O 116.754 -1.593 . . . . 0.0 110.271 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.56 163.93 37.16 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 122.864 2.376 . . . . 0.0 114.196 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -84.66 153.64 61.34 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.151 0.98 . . . . 0.0 113.167 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.98 -17.29 28.68 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.164 2.576 . . . . 0.0 113.34 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -71.54 -57.9 3.99 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 123.992 0.917 . . . . 0.0 109.288 169.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 28.8 tp -54.12 -38.45 65.44 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 125.678 1.591 . . . . 0.0 114.478 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 14.6 tp -46.24 -39.68 10.27 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 125.396 1.479 . . . . 0.0 114.682 168.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -69.04 -37.53 78.64 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 119.193 -2.192 . . . . 0.0 113.05 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.43 -53.32 24.43 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 126.779 2.032 . . . . 0.0 111.942 169.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 76.9 mt -49.89 -45.62 50.93 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.72 1.208 . . . . 0.0 112.513 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . 0.457 ' HZ3' ' HB3' ' B' ' 104' ' ' LYS . 0.0 OUTLIER -63.95 -17.32 63.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 174.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 20.4 t -83.02 -8.66 59.53 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 120.021 -1.674 . . . . 0.0 112.034 171.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.34 -7.67 9.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 C-N-CA 124.766 1.226 . . . . 0.0 110.048 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.58 -16.91 18.87 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 120.459 -1.4 . . . . 0.0 112.558 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.45 79.84 8.85 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.401 -1.647 . . . . 0.0 113.45 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -82.58 5.76 19.88 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.804 -1.81 . . . . 0.0 115.324 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 139.14 31.56 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -174.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.51 -11.67 61.07 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.765 2.026 . . . . 0.0 114.413 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 39.9 p -138.59 137.03 36.58 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.081 1.352 . . . . 0.0 111.297 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -139.35 -172.92 3.46 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 120.798 -1.189 . . . . 0.0 110.092 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.8 p -96.88 173.12 7.45 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.048 -1.657 . . . . 0.0 109.93 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 24.7 mtt -67.15 -43.67 81.72 Favored 'General case' 0 C--N 1.352 0.699 0 O-C-N 120.161 -1.587 . . . . 0.0 113.46 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -58.73 -51.33 70.42 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.237 1.015 . . . . 0.0 111.603 172.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -54.56 -44.1 72.63 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 86.2 t -54.72 -43.53 66.78 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 120.121 -1.612 . . . . 0.0 112.568 176.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.3 -30.91 27.18 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 120.729 -1.232 . . . . 0.0 112.344 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -59.93 -60.86 3.16 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.949 1.7 . . . . 0.0 112.123 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -56.96 -38.23 72.69 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.41 1.084 . . . . 0.0 112.286 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 32.3 tp -64.68 -51.44 62.48 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 172.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.33 -40.29 91.84 Favored Glycine 0 C--N 1.349 1.297 0 O-C-N 119.928 -1.732 . . . . 0.0 114.019 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -30.31 71.33 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 124.724 1.21 . . . . 0.0 112.177 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.44 ' CZ ' ' HD2' ' B' ' 129' ' ' LYS . 7.9 t80 -57.55 -60.95 2.89 Favored 'General case' 0 C--N 1.357 0.91 0 O-C-N 120.833 -1.167 . . . . 0.0 111.669 171.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 45.1 mm -58.41 -40.69 79.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 O-C-N 120.584 -1.322 . . . . 0.0 113.343 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 35.7 ttm -52.55 -43.27 65.08 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 125.077 1.351 . . . . 0.0 113.867 171.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 22.3 m -87.7 -31.88 19.48 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 124.727 1.211 . . . . 0.0 112.534 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . 0.44 ' HD2' ' CZ ' ' B' ' 125' ' ' TYR . 5.2 mmpt? -77.54 -25.42 50.16 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 120.027 -1.671 . . . . 0.0 114.306 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.98 53.67 0.19 Allowed 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.663 1.585 . . . . 0.0 111.38 -176.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.74 19.62 18.44 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.423 1.089 . . . . 0.0 110.627 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -105.09 146.46 29.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.56 -1.338 . . . . 0.0 107.998 173.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.48 139.68 45.92 Favored 'General case' 0 C--N 1.347 0.461 0 O-C-N 120.789 -1.195 . . . . 0.0 110.043 171.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -59.95 -47.16 86.92 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 120.22 -1.55 . . . . 0.0 113.177 174.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -83.09 -19.99 35.73 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.844 1.258 . . . . 0.0 113.973 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -132.83 61.92 1.66 Allowed 'General case' 0 C--N 1.352 0.707 0 O-C-N 120.589 -1.319 . . . . 0.0 109.855 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -64.46 -6.15 6.77 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -89.97 -8.1 52.49 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.586 1.955 . . . . 0.0 113.315 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 47.8 mm -96.44 136.49 27.13 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 124.93 1.292 . . . . 0.0 109.303 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 17.2 t -121.75 123.76 70.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 O-C-N 120.856 -1.152 . . . . 0.0 110.202 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -86.22 113.82 22.54 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.653 1.181 . . . . 0.0 109.183 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 16.0 m -115.11 1.24 13.84 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 120.623 -1.298 . . . . 0.0 111.174 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 34.1 t -73.42 126.8 31.01 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.468 -1.395 . . . . 0.0 110.21 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 75.05 23.9 1.57 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.795 1.238 . . . . 0.0 112.01 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -128.39 165.29 20.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 tp -70.83 -16.89 62.75 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 126.844 2.058 . . . . 0.0 112.143 -170.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.25 -40.95 70.69 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.511 1.524 . . . . 0.0 111.841 169.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.97 -41.81 99.69 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 120.368 -1.458 . . . . 0.0 112.895 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -53.46 -33.64 54.93 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.189 2.196 . . . . 0.0 114.403 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.79 -33.01 11.83 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 120.055 -1.653 . . . . 0.0 113.158 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -78.79 -34.01 45.8 Favored 'General case' 0 C--N 1.35 0.629 0 O-C-N 121.044 -1.035 . . . . 0.0 113.108 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 79.91 15.06 79.9 Favored Glycine 0 C--N 1.35 1.319 0 O-C-N 121.315 -0.866 . . . . 0.0 113.898 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 20.5 m -131.35 151.75 79.33 Favored Pre-proline 0 C--N 1.345 0.38 0 O-C-N 121.055 -1.262 . . . . 0.0 109.844 -174.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.48 -33.11 4.36 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.907 1.738 . . . . 0.0 112.621 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 19.3 m -150.43 161.62 42.14 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -175.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -135.34 163.82 29.14 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.456 -0.777 . . . . 0.0 109.435 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 46.0 t -110.4 129.18 55.82 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 30.6 t -61.31 -28.76 44.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 O-C-N 120.818 -1.176 . . . . 0.0 112.219 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -54.21 -29.26 45.54 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 126.075 1.75 . . . . 0.0 114.795 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.59 54.58 2.41 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 120.575 -1.328 . . . . 0.0 111.75 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -47.97 -46.2 32.2 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 119.96 -1.713 . . . . 0.0 114.428 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -58.47 -38.51 77.71 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 125.365 1.466 . . . . 0.0 114.561 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -72.96 -45.33 58.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.758 0.823 . . . . 0.0 112.038 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 18.9 mt -55.64 -50.55 66.44 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 C-N-CA 125.188 1.395 . . . . 0.0 110.342 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -51.09 -52.14 46.49 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 124.681 1.192 . . . . 0.0 114.122 171.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 1.3 p -58.49 -38.3 77.35 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 119.544 -1.972 . . . . 0.0 115.031 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -42.55 89.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.322 -0.861 . . . . 0.0 112.048 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 31.5 mt -60.67 -52.43 61.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 O-C-N 120.438 -1.413 . . . . 0.0 112.052 173.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -64.31 -4.81 4.13 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -89.22 -27.06 20.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 119.641 -1.912 . . . . 0.0 113.342 168.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -88.06 -20.44 25.74 Favored 'General case' 0 CA--C 1.509 -0.621 0 O-C-N 121.247 -0.908 . . . . 0.0 111.489 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 70.4 mt -108.1 147.24 31.5 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 125.071 1.348 . . . . 0.0 111.705 -174.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 56.2 t -90.78 122.65 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 120.749 -1.219 . . . . 0.0 109.355 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 93.8 t . . . . . 0 C--N 1.35 0.617 0 C-N-CA 124.606 1.162 . . . . 0.0 110.38 176.467 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.518 2.931 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 45.34 60.54 4.07 Favored Glycine 0 C--N 1.355 1.631 0 CA-C-N 120.113 1.324 . . . . 0.0 113.986 -164.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.7 m -123.46 106.22 10.45 Favored 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 120.005 -1.88 . . . . 0.0 112.084 -166.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.33 -155.03 7.62 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.02 68.58 2.52 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.3 t -55.21 -27.92 49.49 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 126.113 1.765 . . . . 0.0 113.583 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -76.32 -29.51 57.34 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -178.6 87.32 0.22 Allowed Pre-proline 0 C--N 1.351 0.643 0 O-C-N 121.146 -0.971 . . . . 0.0 110.434 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -78.61 120.85 4.91 Favored 'Trans proline' 0 C--N 1.327 -0.554 0 C-N-CA 122.319 2.013 . . . . 0.0 112.854 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.9 t -120.57 6.63 10.55 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.248 1.819 . . . . 0.0 110.214 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 m -135.62 156.37 48.97 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 119.507 -1.996 . . . . 0.0 112.92 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -55.83 -45.9 78.24 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 120.352 -1.467 . . . . 0.0 112.919 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.44 94.7 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 125.216 1.406 . . . . 0.0 113.069 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -61.95 -53.91 49.08 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 120.39 -1.444 . . . . 0.0 113.317 172.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.91 -30.46 69.8 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.345 -0.847 . . . . 0.0 113.152 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.4 t90 -54.21 -45.08 72.15 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 120.097 -1.627 . . . . 0.0 113.389 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -62.34 -41.39 98.54 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 120.977 -1.077 . . . . 0.0 113.8 174.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -55.16 -32.52 62.21 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 126.197 1.799 . . . . 0.0 114.629 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.6 tp -56.71 -28.13 60.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.376 1.471 . . . . 0.0 113.803 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p 71.04 17.91 6.04 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.54 2.336 . . . . 0.0 113.951 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.86 93.32 0.01 OUTLIER 'General case' 0 C--N 1.351 0.647 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 -164.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.86 -31.35 1.76 Allowed Glycine 0 C--N 1.345 1.077 0 O-C-N 121.034 -1.041 . . . . 0.0 111.96 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.4 -150.3 16.95 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-O 122.807 1.226 . . . . 0.0 112.407 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 t -97.27 139.89 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 120.913 -1.345 . . . . 0.0 109.458 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.16 156.48 48.51 Favored Pre-proline 0 N--CA 1.45 -0.453 0 O-C-N 120.438 -1.414 . . . . 0.0 108.64 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.69 8.33 2.35 Favored 'Trans proline' 0 N--CA 1.47 0.109 0 C-N-CA 123.058 2.505 . . . . 0.0 113.119 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? 61.45 47.32 6.8 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 125.85 1.66 . . . . 0.0 114.499 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.9 pt -60.78 140.93 17.89 Favored 'Isoleucine or valine' 0 C--N 1.349 0.576 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.5 mt -87.91 24.2 1.84 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-O 122.612 1.196 . . . . 0.0 111.743 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -80.95 138.42 36.1 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 120.428 -1.42 . . . . 0.0 110.49 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -86.85 120.92 28.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.656 -0.652 . . . . 0.0 111.524 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.3 p -109.29 -179.36 3.81 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.082 1.353 . . . . 0.0 110.109 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -119.92 -28.46 5.17 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 120.491 -1.38 . . . . 0.0 110.15 162.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -146.76 173.67 12.16 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 122.931 1.348 . . . . 0.0 113.271 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -73.65 -12.2 60.66 Favored 'General case' 0 C--N 1.346 0.435 0 O-C-N 119.842 -1.786 . . . . 0.0 113.839 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.3 p -78.16 -29.31 48.6 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 126.727 2.011 . . . . 0.0 111.79 173.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.66 -28.75 45.45 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.55 1.54 . . . . 0.0 109.728 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -94.39 119.47 66.4 Favored Pre-proline 0 N--CA 1.445 -0.685 0 O-C-N 120.953 -1.092 . . . . 0.0 113.078 -173.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.71 171.47 17.74 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.526 2.151 . . . . 0.0 114.525 -166.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.23 -84.95 1.14 Allowed Glycine 0 C--N 1.35 1.322 0 C-N-CA 124.345 0.974 . . . . 0.0 112.361 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.69 6.65 0.47 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.9 m -73.82 178.57 4.76 Favored 'General case' 0 C--N 1.347 0.496 0 O-C-N 120.353 -1.467 . . . . 0.0 112.656 -160.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 pp -141.38 149.4 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -86.88 111.68 21.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 126.338 1.855 . . . . 0.0 108.675 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -76.13 172.95 11.95 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 118.91 -2.369 . . . . 0.0 110.827 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.94 -19.36 6.93 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 117.548 1.779 . . . . 0.0 117.548 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -85.8 -8.51 58.07 Favored 'General case' 0 C--N 1.345 0.375 0 O-C-N 121.288 -1.125 . . . . 0.0 113.418 174.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.31 27.55 39.54 Favored Glycine 0 C--N 1.348 1.224 0 O-C-N 120.755 -1.216 . . . . 0.0 114.256 -175.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -137.3 146.69 44.97 Favored 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 120.942 -1.328 . . . . 0.0 110.917 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 83.1 m -78.45 135.95 37.51 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 123.747 1.736 . . . . 0.0 115.232 -170.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.347 0 CA-C-O 115.69 -2.728 . . . . 0.0 116.946 -175.097 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 15.0 m -133.21 170.28 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 119.126 0.876 . . . . 0.0 109.517 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 101.9 51.43 Favored Pre-proline 0 C--N 1.344 0.338 0 CA-C-O 116.849 -1.548 . . . . 0.0 110.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.32 164.23 35.84 Favored 'Trans proline' 0 C--N 1.326 -0.633 0 CA-C-N 123.871 2.418 . . . . 0.0 113.675 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -84.77 153.59 60.94 Favored Pre-proline 0 C--N 1.35 0.616 0 C-N-CA 123.905 0.882 . . . . 0.0 112.605 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.33 -24.27 27.24 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.312 2.675 . . . . 0.0 113.089 -172.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 mt -66.09 -54.48 25.21 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 121.365 -0.834 . . . . 0.0 110.698 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -56.82 -39.26 73.86 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 125.118 1.367 . . . . 0.0 113.663 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 15.8 tp -45.8 -40.62 9.92 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 125.37 1.468 . . . . 0.0 114.925 170.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 29.1 tttp -67.81 -34.79 77.43 Favored 'General case' 0 C--N 1.348 0.514 0 O-C-N 119.889 -1.757 . . . . 0.0 113.375 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.1 -50.25 35.63 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 124.887 1.275 . . . . 0.0 111.247 171.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 91.2 mt -55.17 -42.27 72.95 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 121.146 -0.972 . . . . 0.0 112.302 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.4 -26.05 67.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 175.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 4.0 t -77.93 -13.53 59.85 Favored 'General case' 0 C--N 1.344 0.369 0 O-C-N 120.958 -1.089 . . . . 0.0 112.425 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 5.2 t -97.37 -9.22 9.07 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 C-N-CA 125.154 1.382 . . . . 0.0 109.868 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.65 -20.06 10.27 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 120.465 -1.397 . . . . 0.0 112.514 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -89.28 91.52 8.79 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 120.514 -1.58 . . . . 0.0 112.215 -171.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -95.09 17.87 13.24 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 119.185 -2.197 . . . . 0.0 116.166 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -97.42 143.0 28.58 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.471 1.108 . . . . 0.0 112.937 -171.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.18 9.89 4.11 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 119.769 -1.832 . . . . 0.0 115.677 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.4 p -149.31 131.56 15.52 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 120.381 -1.45 . . . . 0.0 111.186 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -132.74 178.81 6.57 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-O 122.939 1.352 . . . . 0.0 110.814 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.04 163.64 14.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.658 1.583 . . . . 0.0 109.854 170.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 48.4 mtm -62.55 -48.77 78.06 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 119.012 -2.305 . . . . 0.0 113.812 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -60.91 -42.53 98.23 Favored 'General case' 0 C--N 1.349 0.562 0 O-C-N 121.274 -0.892 . . . . 0.0 113.176 173.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -50.94 -48.25 60.92 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.893 1.677 . . . . 0.0 114.804 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -52.45 -49.99 41.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 125.209 1.403 . . . . 0.0 111.884 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.01 -32.17 61.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 120.918 -1.114 . . . . 0.0 113.011 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -62.14 -57.81 10.16 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.557 1.543 . . . . 0.0 111.72 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -57.34 -44.13 84.02 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 123.977 0.911 . . . . 0.0 112.396 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.5 -54.0 50.77 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.41 -44.91 94.64 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 120.126 -1.609 . . . . 0.0 113.657 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -63.77 -32.43 73.93 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 124.139 0.976 . . . . 0.0 112.798 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -57.1 -57.91 10.51 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 120.842 -1.161 . . . . 0.0 112.262 170.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 38.1 mm -63.94 -41.41 92.41 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 O-C-N 120.392 -1.443 . . . . 0.0 112.566 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 46.9 ttm -54.56 -43.9 72.42 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 126.117 1.767 . . . . 0.0 113.705 172.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 20.5 m -86.96 -24.5 24.71 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 120.718 -1.239 . . . . 0.0 112.597 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -75.12 -26.74 59.45 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 119.702 -1.874 . . . . 0.0 113.173 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? 72.04 53.51 0.19 Allowed 'General case' 0 C--N 1.354 0.785 0 C-N-CA 126.113 1.765 . . . . 0.0 110.895 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.54 9.43 33.43 Favored 'General case' 0 C--N 1.348 0.514 0 O-C-N 121.1 -1.0 . . . . 0.0 111.848 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -93.34 146.57 23.63 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.41 160.93 31.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.842 -0.536 . . . . 0.0 110.423 173.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -76.57 -34.92 58.45 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 120.97 -1.081 . . . . 0.0 112.104 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -91.34 -44.87 8.91 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.426 -1.421 . . . . 0.0 110.929 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -107.67 57.12 0.63 Allowed 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.026 1.33 . . . . 0.0 111.721 -173.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -63.09 -11.77 22.16 Favored 'General case' 0 C--N 1.347 0.474 0 O-C-N 120.125 -1.609 . . . . 0.0 114.86 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -86.91 -4.03 59.14 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.343 1.457 . . . . 0.0 113.403 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 47.7 mm -101.55 137.13 30.34 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 C-N-CA 124.988 1.315 . . . . 0.0 108.991 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 16.7 t -123.8 123.34 66.8 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 120.85 -1.156 . . . . 0.0 110.701 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -93.33 113.92 26.22 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 121.192 -0.942 . . . . 0.0 110.101 173.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 16.5 m -115.37 20.92 14.5 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 121.191 -0.943 . . . . 0.0 110.334 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 71.3 p -74.76 140.14 43.85 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 120.11 -1.619 . . . . 0.0 109.862 171.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 3.4 t30 64.75 29.01 12.91 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -138.34 164.47 29.22 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 7.7 tp -70.8 -14.46 62.43 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-O 124.393 2.044 . . . . 0.0 113.536 -165.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.01 -35.71 69.5 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.946 1.699 . . . . 0.0 111.892 170.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.21 -43.22 99.41 Favored Glycine 0 C--N 1.348 1.201 0 O-C-N 120.096 -1.627 . . . . 0.0 113.029 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -53.15 -34.27 56.12 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 126.596 1.958 . . . . 0.0 114.731 172.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 pp -95.89 -31.24 13.23 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 119.538 -1.976 . . . . 0.0 113.402 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -77.9 -42.41 33.35 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.737 1.215 . . . . 0.0 112.513 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 83.82 15.91 69.2 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 121.427 -0.795 . . . . 0.0 113.932 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 32.7 m -131.45 151.55 78.93 Favored Pre-proline 0 C--N 1.343 0.31 0 O-C-N 121.216 -1.167 . . . . 0.0 109.787 -174.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.18 -30.29 5.68 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.811 1.674 . . . . 0.0 112.653 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 87.2 p -154.0 169.4 23.57 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -138.74 165.61 26.54 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.204 1.002 . . . . 0.0 109.289 172.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 26.6 t -109.33 128.76 55.35 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.28 -31.84 51.39 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 O-C-N 120.623 -1.298 . . . . 0.0 111.739 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -58.75 -22.03 56.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.818 2.047 . . . . 0.0 114.463 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -82.4 58.49 4.13 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 120.404 -1.435 . . . . 0.0 112.071 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -49.17 -45.26 43.77 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.027 -1.671 . . . . 0.0 114.132 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -61.33 -33.07 73.01 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 120.64 -1.288 . . . . 0.0 114.234 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -73.95 -46.24 45.36 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 120.326 -1.484 . . . . 0.0 110.955 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 33.0 mm -50.5 -57.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.351 0.671 0 C-N-CA 125.173 1.389 . . . . 0.0 112.44 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -49.2 -46.16 45.26 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 171.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 31.9 m -62.91 -39.58 94.97 Favored 'General case' 0 C--N 1.346 0.429 0 O-C-N 120.543 -1.348 . . . . 0.0 113.379 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -44.94 88.1 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.388 -1.445 . . . . 0.0 111.752 177.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 22.0 mt -57.27 -53.11 48.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 C-N-CA 125.473 1.509 . . . . 0.0 112.291 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -62.74 -11.92 20.66 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.274 -1.516 . . . . 0.0 114.835 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -85.47 -11.65 53.79 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 119.394 -2.066 . . . . 0.0 113.571 169.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -105.04 -21.24 13.31 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 120.194 -1.567 . . . . 0.0 109.883 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 73.2 mt -110.92 151.67 27.64 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 126.111 1.764 . . . . 0.0 110.809 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 61.0 t -96.17 119.63 44.48 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 O-C-N 120.473 -1.392 . . . . 0.0 108.954 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 56.3 t . . . . . 0 C--N 1.348 0.541 0 C-N-CA 124.166 0.986 . . . . 0.0 110.919 177.169 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.519 3.024 0 CA-C-O 116.743 -1.599 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 48.93 39.23 25.24 Favored Glycine 0 C--N 1.357 1.701 0 CA-C-N 120.23 1.377 . . . . 0.0 115.353 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.7 m -118.18 120.06 36.57 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.507 -1.584 . . . . 0.0 111.177 -167.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.05 -148.99 5.91 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.25 78.03 3.78 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 120.996 -1.297 . . . . 0.0 113.239 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.2 t -72.95 3.05 5.76 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 119.435 -2.041 . . . . 0.0 115.457 -175.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -100.74 -44.61 5.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.614 -1.304 . . . . 0.0 110.958 173.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -150.52 85.96 5.18 Favored Pre-proline 0 N--CA 1.443 -0.798 0 O-C-N 121.552 -0.717 . . . . 0.0 109.319 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.84 108.98 2.76 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.273 1.982 . . . . 0.0 110.982 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 t -101.88 -19.89 15.1 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.041 0.936 . . . . 0.0 110.413 -174.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.3 m -120.51 164.64 16.12 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-O 122.797 1.284 . . . . 0.0 113.617 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -61.51 -49.65 75.88 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 126.316 1.846 . . . . 0.0 110.978 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.36 78.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.055 0.942 . . . . 0.0 113.511 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -68.91 -52.71 26.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 121.269 -0.895 . . . . 0.0 112.628 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -29.13 69.79 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 120.695 -1.253 . . . . 0.0 112.574 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -53.05 -38.28 62.32 Favored 'General case' 0 C--N 1.346 0.452 0 O-C-N 120.439 -1.413 . . . . 0.0 113.796 167.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -73.49 -37.23 65.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.416 -1.427 . . . . 0.0 112.726 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.2 -24.02 64.47 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.992 1.317 . . . . 0.0 114.493 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.3 tp -67.84 -23.74 65.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.689 -1.257 . . . . 0.0 112.303 172.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 t 55.26 44.01 28.21 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 127.314 2.246 . . . . 0.0 112.936 -175.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.6 85.25 0.02 OUTLIER 'General case' 0 C--N 1.353 0.748 0 C-N-CA 127.17 2.188 . . . . 0.0 113.92 -172.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.73 -41.82 0.55 Allowed Glycine 0 CA--C 1.492 -1.376 0 O-C-N 121.057 -1.027 . . . . 0.0 112.807 -164.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.77 -142.62 16.09 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.6 p -94.28 135.67 27.93 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 O-C-N 120.562 -1.552 . . . . 0.0 110.445 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.1 t -129.79 145.42 56.98 Favored Pre-proline 0 C--N 1.347 0.486 0 CA-C-O 115.81 -2.043 . . . . 0.0 106.783 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -66.22 -2.36 6.88 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 124.428 3.418 . . . . 0.0 117.47 -164.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.69 52.93 0.41 Allowed 'General case' 0 C--N 1.349 0.582 0 C-N-CA 125.293 1.437 . . . . 0.0 112.48 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.3 pt -70.06 140.59 18.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.466 0 O-C-N 120.299 -1.5 . . . . 0.0 114.093 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.1 mt -88.95 33.76 0.78 Allowed 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.132 -0.98 . . . . 0.0 111.282 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -88.69 131.42 35.02 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 119.945 -1.722 . . . . 0.0 109.394 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.16 108.27 7.8 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 122.238 1.018 . . . . 0.0 111.072 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.0 p -107.3 -161.29 0.77 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.569 1.548 . . . . 0.0 111.391 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -150.45 -37.38 0.14 Allowed 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.619 -1.926 . . . . 0.0 109.47 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -133.51 174.85 9.98 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 171.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -74.15 -2.32 24.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 119.141 -2.225 . . . . 0.0 115.273 -172.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.5 m -90.15 -40.28 12.33 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 125.657 1.583 . . . . 0.0 111.934 -173.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.64 -29.8 68.36 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 123.281 1.515 . . . . 0.0 110.897 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 15.3 t -90.71 109.16 32.56 Favored Pre-proline 0 N--CA 1.443 -0.785 0 C-N-CA 125.429 1.492 . . . . 0.0 111.255 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.87 171.73 17.62 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.449 2.099 . . . . 0.0 115.294 -160.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.83 -93.26 1.58 Allowed Glycine 0 C--N 1.347 1.172 0 C-N-CA 124.271 0.939 . . . . 0.0 112.49 173.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.44 24.88 0.35 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 122.964 1.364 . . . . 0.0 111.096 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 54.4 m -88.57 153.37 21.18 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 119.95 -1.719 . . . . 0.0 108.058 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.4 pp -119.83 154.58 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 170.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.3 m -85.11 134.51 34.19 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.1 mtt85 -82.8 168.89 16.71 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.624 -1.297 . . . . 0.0 108.356 167.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -32.8 -43.48 0.18 Allowed Glycine 0 C--N 1.353 1.508 0 N-CA-C 119.33 2.492 . . . . 0.0 119.33 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -74.07 8.43 2.09 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.92 36.38 90.94 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 119.915 -1.741 . . . . 0.0 114.191 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -135.61 147.27 48.6 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 122.08 0.943 . . . . 0.0 108.609 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.1 m -78.45 130.77 36.45 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 125.212 2.434 . . . . 0.0 113.933 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.274 0 N-CA-C 105.716 -2.954 . . . . 0.0 105.716 -177.87 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 20.7 m -120.72 167.27 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 119.496 1.044 . . . . 0.0 109.217 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -141.54 114.83 6.76 Favored Pre-proline 0 C--N 1.35 0.619 0 CA-C-O 116.694 -1.622 . . . . 0.0 108.181 170.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.73 168.12 25.54 Favored 'Trans proline' 0 C--N 1.328 -0.504 0 CA-C-N 123.822 2.401 . . . . 0.0 112.747 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -84.71 159.54 57.82 Favored Pre-proline 0 C--N 1.346 0.439 0 O-C-N 120.891 -1.13 . . . . 0.0 111.698 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -68.48 -25.16 35.56 Favored 'Trans proline' 0 CA--C 1.521 -0.159 0 C-N-CA 122.781 2.32 . . . . 0.0 114.275 -170.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.05 -42.31 99.68 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.238 0.926 . . . . 0.0 110.526 170.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 17.2 tp -72.45 -34.98 68.14 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 120.191 -1.568 . . . . 0.0 113.11 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 33.0 tp -53.3 -42.07 66.26 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.154 -1.591 . . . . 0.0 113.622 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -62.42 -30.85 71.52 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 120.47 -1.394 . . . . 0.0 113.82 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 24.0 tp -67.66 -61.37 1.92 Allowed 'General case' 0 C--N 1.35 0.619 0 C-N-CA 123.672 0.789 . . . . 0.0 110.335 172.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.29 -49.22 61.69 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 126.39 1.876 . . . . 0.0 113.305 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -14.27 61.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 120.088 -1.632 . . . . 0.0 114.871 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -85.34 -6.92 59.2 Favored 'General case' 0 C--N 1.346 0.413 0 O-C-N 120.047 -1.658 . . . . 0.0 112.234 168.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 15.2 t -94.37 -5.62 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.944 1.298 . . . . 0.0 109.061 163.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.98 -13.36 31.76 Favored Glycine 0 C--N 1.354 1.57 0 O-C-N 119.816 -1.802 . . . . 0.0 113.393 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.11 69.59 10.51 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 120.757 -1.437 . . . . 0.0 113.888 -173.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . 0.25 3.3 pm0 -78.68 76.74 5.18 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 119.61 -1.931 . . . . 0.0 110.959 165.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -151.06 124.5 8.93 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 120.815 -1.178 . . . . 0.0 109.239 168.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.89 -49.43 65.91 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 128.165 2.586 . . . . 0.0 113.475 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 22.6 p -94.48 90.22 6.13 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.139 -1.6 . . . . 0.0 114.755 -169.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -104.32 173.21 6.4 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-O 123.67 1.7 . . . . 0.0 114.522 171.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 32.7 m -96.34 159.52 14.9 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 127.281 2.233 . . . . 0.0 109.985 -173.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 2.4 mmt -53.7 -45.96 70.59 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -63.18 -50.0 72.07 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 120.583 -1.323 . . . . 0.0 112.149 170.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -54.49 -42.36 70.65 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -173.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 47.3 t -58.52 -30.91 42.28 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 O-C-N 120.927 -1.108 . . . . 0.0 111.563 175.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.2 -33.37 14.72 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.261 1.025 . . . . 0.0 112.161 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -56.89 -64.68 0.8 Allowed 'General case' 0 C--N 1.352 0.675 0 O-C-N 119.954 -1.716 . . . . 0.0 113.028 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -56.86 -39.86 75.08 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 124.278 1.031 . . . . 0.0 112.221 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 27.1 tp -63.44 -52.66 60.52 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 120.713 -1.242 . . . . 0.0 113.254 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.77 -41.31 93.73 Favored Glycine 0 C--N 1.349 1.276 0 O-C-N 120.099 -1.625 . . . . 0.0 114.022 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -56.52 -43.46 79.8 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 125.732 1.613 . . . . 0.0 112.85 173.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -54.83 -55.65 27.96 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.585 1.154 . . . . 0.0 112.459 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 3.5 mp -63.95 -43.29 97.65 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 O-C-N 120.35 -1.469 . . . . 0.0 112.215 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 45.9 ttm -57.04 -36.38 70.41 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 125.0 1.32 . . . . 0.0 113.352 175.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 26.1 m -86.06 -34.65 20.64 Favored 'General case' 0 C--N 1.344 0.344 0 O-C-N 120.394 -1.441 . . . . 0.0 112.424 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -68.34 -33.89 75.1 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 120.091 -1.631 . . . . 0.0 114.557 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 77.34 50.92 0.04 OUTLIER 'General case' 0 C--N 1.353 0.719 0 C-N-CA 126.608 1.963 . . . . 0.0 111.017 -171.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 95.1 mt -109.8 34.05 4.05 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 122.713 1.244 . . . . 0.0 110.331 169.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -110.52 148.26 32.47 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 163.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -75.48 161.97 28.74 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.277 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . 0.403 ' CD ' ' HZ2' ' B' ' 135' ' ' LYS 0.264 35.8 mt-10 -62.9 -47.9 81.28 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 119.995 -1.691 . . . . 0.0 111.261 172.02 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' LYS . . . . . 0.403 ' HZ2' ' CD ' ' B' ' 134' ' ' GLU . 0.0 OUTLIER -89.21 -43.92 10.65 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.765 1.626 . . . . 0.0 108.638 -164.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -108.81 63.36 0.6 Allowed 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 125.015 1.326 . . . . 0.0 112.235 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -65.25 -7.24 12.17 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 118.898 -2.376 . . . . 0.0 114.627 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -82.69 -8.95 59.57 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.606 1.562 . . . . 0.0 113.88 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 46.4 mm -99.8 128.86 51.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 O-C-N 120.87 -1.144 . . . . 0.0 109.759 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 48.8 t -116.56 128.38 73.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.481 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -90.78 121.46 32.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 120.902 -1.123 . . . . 0.0 109.071 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 58.5 m -116.35 12.68 15.36 Favored 'General case' 0 CA--C 1.51 -0.584 0 O-C-N 121.131 -0.981 . . . . 0.0 110.837 171.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 33.0 p -71.7 131.97 43.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.112 -1.618 . . . . 0.0 108.994 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 76.55 -27.11 0.18 Allowed 'General case' 0 C--N 1.351 0.647 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -74.99 164.92 26.04 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 119.846 -1.784 . . . . 0.0 111.783 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 33.2 tp -67.94 -18.99 64.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.735 2.014 . . . . 0.0 113.013 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.24 -32.38 71.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.27 -1.519 . . . . 0.0 113.005 167.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.87 -33.25 79.29 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 120.115 -1.616 . . . . 0.0 113.813 -174.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -50.87 -57.31 8.78 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.212 2.605 . . . . 0.0 111.833 170.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 3.9 pp -76.65 -21.75 55.01 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -86.13 -37.1 19.12 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.011 -1.055 . . . . 0.0 112.222 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.12 15.48 78.67 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 121.179 -0.95 . . . . 0.0 114.337 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 29.5 m -125.42 159.38 60.48 Favored Pre-proline 0 C--N 1.344 0.343 0 O-C-N 120.99 -1.3 . . . . 0.0 110.214 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.37 -43.73 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.607 1.538 . . . . 0.0 112.653 172.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 54.6 m -151.76 167.0 29.61 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -126.02 177.69 6.2 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.728 0.775 . . . . 0.0 109.727 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 48.3 t -121.94 123.34 41.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 120.979 -1.076 . . . . 0.0 108.758 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.11 -27.43 43.14 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 O-C-N 120.437 -1.414 . . . . 0.0 112.157 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -55.04 -28.67 53.95 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.182 1.393 . . . . 0.0 114.352 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . 0.583 ' CD ' ' HZ1' ' B' ' 163' ' ' LYS . 34.2 mt-10 -81.83 52.12 1.87 Allowed 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.255 -1.528 . . . . 0.0 112.959 176.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -46.94 -45.58 20.84 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 126.741 2.017 . . . . 0.0 114.844 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -72.16 -1.66 15.84 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 126.709 2.004 . . . . 0.0 115.667 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . 0.583 ' HZ1' ' CD ' ' B' ' 160' ' ' GLU . 36.8 ttmt -105.18 -38.35 6.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.443 -1.411 . . . . 0.0 109.176 167.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 30.4 mm -56.43 -52.53 51.34 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 O-C-N 120.946 -1.096 . . . . 0.0 112.727 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -53.33 -38.36 63.14 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 120.284 -1.51 . . . . 0.0 114.053 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 42.4 m -64.37 -35.9 82.38 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 125.689 1.596 . . . . 0.0 113.585 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 54.6 mtt -65.88 -47.01 76.27 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.334 -1.479 . . . . 0.0 111.281 172.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 50.9 mm -56.09 -50.31 70.93 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 C-N-CA 126.062 1.745 . . . . 0.0 113.201 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -63.38 -12.31 29.56 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 119.473 -2.017 . . . . 0.0 115.931 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -96.9 -12.51 23.38 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 119.468 -2.02 . . . . 0.0 112.839 170.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -84.07 -38.51 20.72 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 119.95 -1.719 . . . . 0.0 109.194 170.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 66.2 mt -93.53 -179.89 5.17 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.944 1.697 . . . . 0.0 113.926 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 94.6 t -111.55 128.54 68.0 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 167.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 C--N 1.349 0.56 0 O-C-N 121.19 -0.944 . . . . 0.0 110.916 176.269 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.276 91.7 p . . . . . 0 N--CA 1.531 3.593 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -5.72 74.92 0.0 OUTLIER Glycine 0 C--N 1.363 2.058 0 C-N-CA 129.423 3.392 . . . . 0.0 119.785 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.3 m -116.07 119.02 34.5 Favored 'General case' 0 CA--C 1.506 -0.746 0 O-C-N 120.978 -1.307 . . . . 0.0 108.492 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.56 -161.23 8.88 Favored Glycine 0 CA--C 1.494 -1.243 0 N-CA-C 105.967 -2.853 . . . . 0.0 105.967 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.49 79.69 0.79 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 119.048 1.424 . . . . 0.0 114.313 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 64.2 p -67.56 -16.86 64.41 Favored 'General case' 0 C--N 1.347 0.473 0 O-C-N 119.685 -1.885 . . . . 0.0 113.907 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -77.05 -31.29 56.09 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.995 1.718 . . . . 0.0 113.386 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -175.78 89.17 0.29 Allowed Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.37 137.23 18.56 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 CA-C-N 121.893 1.712 . . . . 0.0 110.232 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.8 t -127.38 -60.4 1.19 Allowed 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.3 m -68.93 170.93 8.82 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 123.674 1.702 . . . . 0.0 115.559 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -73.75 -35.76 65.07 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 119.945 -1.722 . . . . 0.0 114.489 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.87 -45.9 76.66 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 119.601 -1.937 . . . . 0.0 111.466 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -43.47 -66.98 0.31 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 129.048 2.939 . . . . 0.0 112.933 167.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.29 -6.63 53.9 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 120.383 -1.448 . . . . 0.0 114.461 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -74.09 -51.72 14.83 Favored 'General case' 0 C--N 1.346 0.416 0 O-C-N 119.193 -2.192 . . . . 0.0 110.854 165.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -61.36 -35.71 78.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.094 -1.629 . . . . 0.0 115.19 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.85 -15.42 20.89 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.8 tp -62.03 -26.21 68.11 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 120.326 -1.484 . . . . 0.0 113.214 172.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 t 60.22 49.34 7.31 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-O 123.933 1.825 . . . . 0.0 111.047 -169.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.72 89.16 0.55 Allowed 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.394 1.477 . . . . 0.0 112.629 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.11 -48.17 0.59 Allowed Glycine 0 CA--C 1.496 -1.1 0 O-C-N 121.478 -0.764 . . . . 0.0 114.996 -168.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.17 -144.8 17.03 Favored Glycine 0 C--N 1.345 1.033 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -167.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.5 p -110.94 136.81 45.85 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 O-C-N 120.658 -1.495 . . . . 0.0 111.065 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.2 m -100.04 158.54 31.86 Favored Pre-proline 0 C--N 1.35 0.624 0 O-C-N 120.182 -1.574 . . . . 0.0 110.479 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.52 11.19 1.08 Allowed 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.987 2.458 . . . . 0.0 113.118 164.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt 59.81 49.83 7.6 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 126.008 1.723 . . . . 0.0 115.296 171.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.8 pt -63.51 144.7 14.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 -171.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -85.13 20.22 1.98 Allowed 'General case' 0 C--N 1.347 0.471 0 O-C-N 120.679 -1.263 . . . . 0.0 113.825 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -77.28 126.67 31.3 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 119.364 -2.085 . . . . 0.0 111.21 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -78.55 100.82 7.09 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.988 0.899 . . . . 0.0 112.331 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.2 p -96.13 -175.82 3.49 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.494 1.918 . . . . 0.0 111.666 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -124.11 -41.71 2.19 Favored 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 120.16 -1.588 . . . . 0.0 112.303 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -142.0 168.31 20.04 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 103.784 -2.672 . . . . 0.0 103.784 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -68.95 -26.33 65.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 119.476 -2.015 . . . . 0.0 115.778 -167.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 m -50.93 -45.47 60.51 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 126.593 1.957 . . . . 0.0 114.801 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.85 -22.67 65.71 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 128.131 2.573 . . . . 0.0 113.961 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.6 t -103.63 106.78 53.84 Favored Pre-proline 0 C--N 1.353 0.726 0 O-C-N 119.834 -1.791 . . . . 0.0 112.489 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.11 159.37 53.4 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.804 2.336 . . . . 0.0 114.452 -162.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.7 -96.13 1.92 Allowed Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -161.35 40.61 0.15 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 123.088 1.423 . . . . 0.0 111.116 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.9 m -90.34 178.94 6.0 Favored 'General case' 0 N--CA 1.44 -0.939 0 O-C-N 119.847 -1.783 . . . . 0.0 109.267 -175.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.87 150.71 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 103.211 -2.885 . . . . 0.0 103.211 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.0 m -82.61 127.45 33.38 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.318 1.047 . . . . 0.0 108.368 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -78.36 172.11 14.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.917 -1.114 . . . . 0.0 108.663 170.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.5 -32.61 15.95 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 116.655 1.422 . . . . 0.0 116.655 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -70.03 -9.57 55.73 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.6 20.93 57.47 Favored Glycine 0 C--N 1.349 1.298 0 O-C-N 120.57 -1.331 . . . . 0.0 114.247 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -121.6 146.6 46.81 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 120.607 -1.526 . . . . 0.0 110.616 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.0 m -73.39 133.5 43.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -170.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.714 0 CA-C-O 117.05 -1.972 . . . . 0.0 114.955 173.865 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 94.5 mt . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 19.7 m -121.97 152.31 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 -109.79 117.87 51.34 Favored Pre-proline 0 C--N 1.352 0.679 0 CA-C-O 115.92 -1.99 . . . . 0.0 108.721 172.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.71 167.12 27.02 Favored 'Trans proline' 0 C--N 1.321 -0.897 0 C-N-CA 123.272 2.648 . . . . 0.0 113.19 166.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -78.56 159.04 75.29 Favored Pre-proline 0 C--N 1.351 0.661 0 O-C-N 120.472 -1.393 . . . . 0.0 112.81 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -65.69 -21.68 58.47 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.18 2.586 . . . . 0.0 114.681 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 94.0 mt -70.25 -46.03 65.23 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.131 0.878 . . . . 0.0 111.391 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 18.1 tp -64.68 -33.55 76.22 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 120.993 -1.067 . . . . 0.0 111.809 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 17.9 tp -55.81 -42.07 75.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -65.93 -31.69 72.75 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 119.072 -2.268 . . . . 0.0 113.42 174.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 22.2 tp -66.08 -52.78 45.66 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 121.415 -0.803 . . . . 0.0 111.637 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -54.05 -42.94 69.78 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 124.179 0.992 . . . . 0.0 112.652 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -57.46 -27.18 62.23 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 170.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 21.8 t -78.11 -16.95 57.51 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 120.412 -1.43 . . . . 0.0 112.232 173.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 1.5 t -97.76 4.25 9.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 O-C-N 120.561 -1.337 . . . . 0.0 110.75 172.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.89 -19.39 54.2 Favored Glycine 0 C--N 1.353 1.495 0 O-C-N 119.801 -1.812 . . . . 0.0 113.357 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -76.62 75.12 3.31 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 126.212 1.805 . . . . 0.0 112.848 -174.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -89.22 1.82 55.14 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -170.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.88 160.25 30.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.649 -0.657 . . . . 0.0 110.41 172.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -74.14 -59.84 2.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 123.463 1.602 . . . . 0.0 108.822 161.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 29.9 p -71.5 98.44 1.84 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.352 1.861 . . . . 0.0 115.54 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -112.0 -179.61 3.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 123.354 1.549 . . . . 0.0 111.901 167.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 94.4 m -103.69 155.26 18.71 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.19 1.796 . . . . 0.0 108.683 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 92.7 mtp -54.8 -47.15 74.38 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 119.394 -2.066 . . . . 0.0 115.661 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -57.01 -54.33 48.0 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 120.945 -1.097 . . . . 0.0 112.464 168.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -46.77 -50.15 18.64 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 126.009 1.724 . . . . 0.0 115.079 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.7 t -52.49 -48.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 120.051 -1.655 . . . . 0.0 112.804 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.89 -24.55 44.11 Favored 'General case' 0 C--N 1.347 0.477 0 O-C-N 120.464 -1.398 . . . . 0.0 112.891 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -65.22 -62.82 1.31 Allowed 'General case' 0 C--N 1.345 0.394 0 C-N-CA 125.945 1.698 . . . . 0.0 111.105 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -53.92 -41.11 67.32 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 124.313 1.045 . . . . 0.0 111.953 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 21.5 tp -63.43 -55.54 23.46 Favored 'General case' 0 C--N 1.349 0.547 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.79 -42.21 98.61 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 119.552 -1.968 . . . . 0.0 114.345 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -63.59 -28.78 70.16 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.123 1.369 . . . . 0.0 112.303 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -61.96 -53.17 59.42 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.683 -1.26 . . . . 0.0 112.405 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 2.9 mp -62.58 -43.65 98.66 Favored 'Isoleucine or valine' 0 C--N 1.351 0.65 0 C-N-CA 124.493 1.117 . . . . 0.0 111.306 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 44.5 ttm -50.88 -43.11 59.55 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 125.234 1.413 . . . . 0.0 112.97 172.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 24.4 m -85.25 -30.2 24.01 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 120.496 -1.378 . . . . 0.0 113.334 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.0 -30.0 63.45 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 119.521 -1.987 . . . . 0.0 114.12 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? 76.02 41.53 0.23 Allowed 'General case' 0 C--N 1.352 0.681 0 C-N-CA 125.244 1.418 . . . . 0.0 110.956 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 93.6 mt -104.68 34.0 3.33 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 122.372 1.082 . . . . 0.0 110.845 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -114.96 146.04 41.61 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 165.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.6 151.98 42.04 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 121.189 -0.944 . . . . 0.0 109.264 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.98 -33.52 74.8 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 122.59 1.186 . . . . 0.0 112.004 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -109.92 -28.21 8.86 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 124.345 1.058 . . . . 0.0 112.236 -172.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -109.67 53.79 0.68 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.321 1.848 . . . . 0.0 110.936 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -55.97 -18.38 9.09 Favored 'General case' 0 C--N 1.349 0.56 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -82.84 -5.74 59.12 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.011 1.724 . . . . 0.0 114.877 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 44.1 mm -97.41 123.16 49.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 O-C-N 120.541 -1.349 . . . . 0.0 110.22 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 52.3 t -108.12 129.51 62.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.544 0 O-C-N 120.972 -1.08 . . . . 0.0 108.414 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -95.33 113.79 25.5 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.119 -0.988 . . . . 0.0 109.276 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 63.8 m -118.6 20.85 12.82 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 121.884 0.849 . . . . 0.0 109.986 171.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 34.7 p -76.66 136.65 39.15 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 120.341 -1.474 . . . . 0.0 108.228 170.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 1.2 t30 76.24 -36.06 0.27 Allowed 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -69.26 168.48 14.12 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.64 -1.287 . . . . 0.0 112.661 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 22.9 tp -70.7 -17.54 62.83 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.604 1.562 . . . . 0.0 112.778 -168.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.92 -29.38 66.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.297 -1.502 . . . . 0.0 113.896 168.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.6 -39.0 97.12 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 120.609 -1.307 . . . . 0.0 114.031 -173.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -51.37 -55.3 19.24 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 127.251 2.22 . . . . 0.0 111.816 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 pp -74.62 -27.66 60.55 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 119.867 -1.77 . . . . 0.0 115.098 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -80.81 -40.91 24.19 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 121.387 -0.82 . . . . 0.0 112.114 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.37 22.39 62.76 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 124.162 0.886 . . . . 0.0 113.65 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.74 160.97 66.28 Favored Pre-proline 0 C--N 1.343 0.304 0 O-C-N 121.231 -1.158 . . . . 0.0 108.96 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.04 -51.22 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 121.477 1.563 . . . . 0.0 112.455 170.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 66.8 m -147.93 168.2 22.87 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 119.909 1.232 . . . . 0.0 107.845 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -129.97 173.72 10.44 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.759 0.823 . . . . 0.0 108.864 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 11.4 t -113.74 129.19 56.61 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.18 -1.575 . . . . 0.0 109.859 172.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 35.1 t -60.72 -26.72 39.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.94 0 O-C-N 119.922 -1.736 . . . . 0.0 112.996 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -50.03 -25.2 3.16 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 126.449 1.9 . . . . 0.0 114.694 171.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -91.18 46.7 1.33 Allowed 'General case' 0 N--CA 1.439 -1.007 0 O-C-N 119.502 -1.999 . . . . 0.0 113.687 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' HIS . . . . . 0.422 ' CG ' ' H ' ' B' ' 162' ' ' ARG . 7.5 p80 -32.66 -55.36 0.36 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 128.279 2.632 . . . . 0.0 117.74 176.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . 0.422 ' H ' ' CG ' ' B' ' 161' ' ' HIS . 24.8 ptt180 -59.46 -28.7 67.22 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.037 1.735 . . . . 0.0 115.256 172.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -83.24 -32.57 26.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 119.646 -1.909 . . . . 0.0 112.02 172.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 37.7 mm -54.28 -54.97 17.04 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 O-C-N 120.902 -1.124 . . . . 0.0 110.789 171.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -57.39 -33.61 68.03 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 119.989 -1.694 . . . . 0.0 115.271 171.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 86.4 m -60.65 -35.42 76.17 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.237 -1.54 . . . . 0.0 112.233 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 43.1 mtt -72.85 -48.26 39.11 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.69 -1.257 . . . . 0.0 111.615 172.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 50.9 mm -57.61 -50.39 77.49 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 C-N-CA 124.668 1.187 . . . . 0.0 113.487 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -66.19 -11.08 47.45 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -79.92 -27.13 39.92 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 119.004 -2.31 . . . . 0.0 111.153 170.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -104.69 -2.61 24.74 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 124.298 1.039 . . . . 0.0 110.332 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 43.6 mt -125.93 143.12 51.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.944 2.098 . . . . 0.0 109.567 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 10.7 p -68.86 123.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 O-C-N 119.588 -1.945 . . . . 0.0 113.422 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 54.0 t . . . . . 0 C--N 1.351 0.638 0 C-N-CA 124.667 1.187 . . . . 0.0 110.718 175.58 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.511 2.582 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.71 49.31 77.58 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 119.158 0.89 . . . . 0.0 112.281 -165.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -139.66 96.31 3.06 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 121.356 -1.085 . . . . 0.0 110.046 -167.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.49 -141.1 10.62 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-O 121.882 0.712 . . . . 0.0 113.647 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.99 68.88 6.23 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-O 123.115 1.436 . . . . 0.0 111.614 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 p -69.79 -9.42 54.57 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 126.671 1.988 . . . . 0.0 114.242 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -78.0 -42.86 31.27 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.738 1.215 . . . . 0.0 112.124 171.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -166.83 89.13 0.78 Allowed Pre-proline 0 N--CA 1.448 -0.535 0 O-C-N 121.529 -0.732 . . . . 0.0 110.035 -173.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.44 115.46 2.87 Favored 'Trans proline' 0 C--N 1.329 -0.474 0 C-N-CA 122.32 2.013 . . . . 0.0 112.211 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -116.11 -31.91 5.54 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 119.109 0.868 . . . . 0.0 113.248 -170.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.8 m -105.31 176.96 4.99 Favored 'General case' 0 C--N 1.345 0.387 0 O-C-N 119.472 -2.017 . . . . 0.0 111.397 167.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -63.86 -40.42 96.51 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 119.805 -1.81 . . . . 0.0 113.408 -176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.55 -44.45 85.24 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.571 1.948 . . . . 0.0 113.529 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -55.87 -58.99 5.54 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.033 1.333 . . . . 0.0 114.401 170.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.42 -29.98 69.33 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -37.18 52.93 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 124.933 1.293 . . . . 0.0 113.897 173.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -101.06 18.87 18.62 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 121.025 -1.047 . . . . 0.0 112.22 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.62 -29.04 13.27 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.448 1.099 . . . . 0.0 110.007 165.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.6 -29.13 69.02 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 122.423 1.106 . . . . 0.0 112.38 171.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 m 65.85 43.56 3.06 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 125.797 1.639 . . . . 0.0 112.555 174.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.61 93.49 0.01 OUTLIER 'General case' 0 C--N 1.351 0.646 0 C-N-CA 127.215 2.206 . . . . 0.0 116.778 -170.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.29 -47.34 0.44 Allowed Glycine 0 CA--C 1.491 -1.423 0 C-N-CA 119.796 -1.193 . . . . 0.0 115.019 -171.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.17 -121.14 4.32 Favored Glycine 0 CA--C 1.499 -0.933 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -171.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 p -129.65 143.47 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 O-C-N 121.055 -1.262 . . . . 0.0 108.327 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 62.8 m -104.24 162.19 20.64 Favored Pre-proline 0 C--N 1.346 0.444 0 O-C-N 120.278 -1.514 . . . . 0.0 110.45 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.1 -26.46 57.75 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.576 2.184 . . . . 0.0 112.076 168.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 79.82 78.77 0.05 OUTLIER 'General case' 0 C--N 1.354 0.768 0 C-N-CA 127.605 2.362 . . . . 0.0 110.507 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.8 pt -80.73 140.77 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 O-C-N 120.93 -1.106 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.1 pp -83.33 6.62 19.19 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 122.354 1.073 . . . . 0.0 112.394 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -63.02 132.02 50.57 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 125.112 1.365 . . . . 0.0 111.545 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -74.26 141.14 45.36 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.286 -0.884 . . . . 0.0 111.577 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.0 p -132.7 169.0 17.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 120.777 -1.202 . . . . 0.0 109.563 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -116.56 -37.25 3.74 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 120.012 -1.68 . . . . 0.0 110.683 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -141.61 -171.92 3.42 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.226 1.01 . . . . 0.0 108.622 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.42 -7.1 48.01 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 119.224 -2.172 . . . . 0.0 112.875 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 p -81.38 -40.03 24.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.719 2.008 . . . . 0.0 113.098 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.52 -28.0 68.87 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-O 122.618 1.199 . . . . 0.0 113.042 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.7 t -99.11 108.73 51.21 Favored Pre-proline 0 N--CA 1.443 -0.799 0 C-N-CA 124.107 0.963 . . . . 0.0 112.224 -164.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.77 151.55 57.57 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.113 1.875 . . . . 0.0 113.457 -168.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.09 -120.91 7.01 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.91 41.98 2.47 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.343 1.544 . . . . 0.0 110.149 176.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.1 m -107.85 112.82 25.64 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.014 -1.678 . . . . 0.0 110.736 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.8 pp -76.31 145.51 10.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 O-C-N 120.199 -1.563 . . . . 0.0 112.203 173.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.4 t -80.41 134.95 36.07 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.181 1.392 . . . . 0.0 110.063 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -86.14 167.5 14.87 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 119.56 -1.962 . . . . 0.0 110.869 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -37.34 -45.6 1.3 Allowed Glycine 0 C--N 1.356 1.664 0 C-N-CA 126.898 2.189 . . . . 0.0 118.13 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -62.75 -19.19 63.72 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.2 33.54 8.73 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 120.464 -1.398 . . . . 0.0 112.991 -172.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -139.46 142.37 37.38 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.018 -1.284 . . . . 0.0 107.631 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.95 125.18 27.0 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-O 123.397 1.57 . . . . 0.0 114.272 -173.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.343 0 O-C-N 119.946 -1.721 . . . . 0.0 113.354 -176.336 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.505 2.276 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.18 156.58 40.37 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 mtt-85 -113.73 113.0 47.76 Favored Pre-proline 0 C--N 1.348 0.516 0 CA-C-O 116.526 -1.702 . . . . 0.0 110.578 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.13 166.01 30.57 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 CA-C-N 124.355 2.591 . . . . 0.0 113.09 164.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -82.73 159.05 64.43 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.879 0.872 . . . . 0.0 112.834 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.22 -21.01 36.62 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.881 2.387 . . . . 0.0 114.734 -174.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 93.0 mt -67.37 -43.95 80.18 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 119.799 1.181 . . . . 0.0 111.112 173.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 28.7 tp -64.71 -40.45 95.38 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 124.089 0.956 . . . . 0.0 112.403 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 34.8 tp -49.41 -39.53 33.05 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.38 -32.26 72.21 Favored 'General case' 0 C--N 1.35 0.601 0 O-C-N 119.434 -2.041 . . . . 0.0 113.291 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tt -71.41 -49.88 37.5 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 121.52 -0.737 . . . . 0.0 110.442 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 96.4 mt -52.04 -44.16 64.1 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 124.658 1.183 . . . . 0.0 113.8 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -54.18 -36.15 63.09 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 120.415 -1.428 . . . . 0.0 114.321 169.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.8 t -73.92 -6.74 49.08 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.158 1.383 . . . . 0.0 112.231 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 1.6 t -108.64 7.52 9.28 Favored 'Isoleucine or valine' 0 C--N 1.35 0.616 0 C-N-CA 124.986 1.315 . . . . 0.0 110.718 167.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.82 -23.11 37.41 Favored Glycine 0 C--N 1.351 1.38 0 O-C-N 119.018 -2.301 . . . . 0.0 114.114 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.02 68.48 4.98 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.971 1.708 . . . . 0.0 112.812 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -81.67 4.92 19.99 Favored 'General case' 0 C--N 1.343 0.3 0 O-C-N 120.074 -1.641 . . . . 0.0 114.75 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -83.7 146.98 27.92 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.045 0.938 . . . . 0.0 109.629 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -70.22 -48.41 57.17 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 122.99 1.376 . . . . 0.0 111.058 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 40.7 p -84.05 110.16 18.24 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -128.4 -166.83 1.68 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.687 1.195 . . . . 0.0 110.484 168.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 50.6 p -117.99 175.47 5.66 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 119.595 -1.94 . . . . 0.0 111.362 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 46.0 mtt -57.33 -41.25 79.59 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 120.475 -1.391 . . . . 0.0 113.591 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -52.97 61.1 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.388 1.075 . . . . 0.0 110.618 174.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.73 -31.64 63.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -171.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 67.6 t -55.29 -37.01 42.39 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 O-C-N 120.065 -1.647 . . . . 0.0 111.246 171.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -89.85 -24.76 21.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.733 -1.229 . . . . 0.0 113.635 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -66.77 -56.88 8.51 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.039 -1.663 . . . . 0.0 112.916 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -61.26 -41.96 97.82 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 120.961 -1.087 . . . . 0.0 111.153 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 34.6 tp -57.88 -49.88 75.2 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 120.306 -1.497 . . . . 0.0 113.518 172.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.45 -47.92 79.86 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 120.299 -1.5 . . . . 0.0 114.321 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -58.42 -40.6 82.94 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.184 0.993 . . . . 0.0 113.618 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -58.33 -55.68 31.86 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.735 1.214 . . . . 0.0 113.633 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -68.68 -39.1 79.84 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 O-C-N 120.409 -1.432 . . . . 0.0 111.647 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 55.2 ttm -54.51 -48.33 72.05 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 122.443 1.116 . . . . 0.0 112.37 173.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 38.6 m -70.73 -29.56 65.86 Favored 'General case' 0 C--N 1.344 0.351 0 O-C-N 120.819 -1.176 . . . . 0.0 112.965 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -81.59 -23.15 37.26 Favored 'General case' 0 C--N 1.346 0.433 0 O-C-N 119.022 -2.299 . . . . 0.0 115.61 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? 72.29 49.3 0.22 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 125.343 1.457 . . . . 0.0 112.354 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 2.2 tt -95.85 -27.42 15.21 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 120.326 -1.484 . . . . 0.0 113.029 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -69.01 142.06 54.71 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.021 -1.674 . . . . 0.0 111.756 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.5 137.37 53.44 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.017 0.927 . . . . 0.0 113.302 167.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -64.32 -31.84 73.2 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 120.317 -1.489 . . . . 0.0 113.04 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -96.86 -32.82 11.89 Favored 'General case' 0 C--N 1.347 0.497 0 O-C-N 120.871 -1.143 . . . . 0.0 113.291 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.34 56.59 0.75 Allowed 'General case' 0 C--N 1.351 0.647 0 O-C-N 120.347 -1.471 . . . . 0.0 112.736 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 9.8 pm0 -60.92 5.46 0.05 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 118.655 2.835 . . . . 0.0 118.655 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -102.42 -6.54 22.86 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 119.849 -1.782 . . . . 0.0 111.704 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 49.1 mm -92.34 138.55 19.69 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 C-N-CA 125.27 1.428 . . . . 0.0 109.433 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.33 120.95 30.31 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 O-C-N 120.649 -1.282 . . . . 0.0 108.279 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -105.9 78.6 1.34 Allowed 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 120.535 -1.353 . . . . 0.0 112.795 -171.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 61.5 m -86.34 37.81 0.75 Allowed 'General case' 0 C--N 1.349 0.549 0 O-C-N 119.959 -1.713 . . . . 0.0 114.408 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 11.1 t -88.51 129.64 35.41 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 119.562 -1.961 . . . . 0.0 107.436 165.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 70.08 43.93 0.83 Allowed 'General case' 0 C--N 1.349 0.577 0 CA-C-O 122.878 1.323 . . . . 0.0 111.619 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -141.32 166.12 25.63 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 18.1 tp -83.67 -9.94 58.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.583 1.153 . . . . 0.0 112.651 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 10.1 mp -76.99 -31.23 56.34 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 119.498 -2.001 . . . . 0.0 110.658 164.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.42 -44.05 96.95 Favored Glycine 0 C--N 1.351 1.366 0 C-N-CA 125.279 1.419 . . . . 0.0 114.565 -174.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -46.08 -62.3 1.39 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.036 2.535 . . . . 0.0 112.102 169.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 4.2 pp -78.3 -18.46 55.21 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -172.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -81.22 -48.44 12.06 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.849 -1.157 . . . . 0.0 111.549 168.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.06 29.26 26.11 Favored Glycine 0 C--N 1.352 1.425 0 C-N-CA 124.829 1.204 . . . . 0.0 113.698 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.48 156.26 76.55 Favored Pre-proline 0 C--N 1.346 0.43 0 O-C-N 120.952 -1.322 . . . . 0.0 109.452 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.26 -10.33 13.65 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 CA-C-N 122.363 1.88 . . . . 0.0 112.982 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 10.0 p -178.92 171.36 1.42 Allowed 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -175.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.06 170.65 15.33 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 170.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 40.6 t -114.5 133.93 55.4 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 171.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.92 -39.9 81.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 O-C-N 121.456 -0.778 . . . . 0.0 112.276 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -54.22 -26.39 28.24 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . 0.428 ' CD ' ' HZ2' ' B' ' 163' ' ' LYS . 29.1 mt-10 -81.76 66.2 7.22 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 119.884 -1.76 . . . . 0.0 110.544 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -53.49 -46.23 69.93 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 125.848 1.659 . . . . 0.0 113.05 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 81.3 ttt180 -56.38 -29.45 61.46 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 127.051 2.141 . . . . 0.0 114.252 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . 0.428 ' HZ2' ' CD ' ' B' ' 160' ' ' GLU . 3.6 tppt? -78.17 -42.93 30.09 Favored 'General case' 0 CA--C 1.512 -0.505 0 O-C-N 120.173 -1.579 . . . . 0.0 111.844 173.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 48.1 mm -56.79 -50.11 76.07 Favored 'Isoleucine or valine' 0 C--N 1.347 0.463 0 C-N-CA 124.043 0.937 . . . . 0.0 111.951 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -51.06 -43.73 61.03 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 120.742 -1.224 . . . . 0.0 113.84 168.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 52.9 m -65.45 -33.56 76.23 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 121.083 -1.011 . . . . 0.0 112.893 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -68.22 -48.51 64.97 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 118.88 -2.387 . . . . 0.0 112.697 167.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.7 -50.83 76.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 C-N-CA 124.783 1.233 . . . . 0.0 112.715 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -66.68 -12.07 56.76 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 119.232 -2.168 . . . . 0.0 115.143 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -85.93 -9.04 57.57 Favored 'General case' 0 C--N 1.351 0.663 0 O-C-N 119.596 -1.94 . . . . 0.0 112.215 169.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -96.09 -36.04 11.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 120.3 -1.5 . . . . 0.0 109.36 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 71.4 mt -92.85 161.33 14.54 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.36 1.464 . . . . 0.0 113.653 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.85 126.58 61.25 Favored 'Isoleucine or valine' 0 C--N 1.345 0.389 0 O-C-N 120.7 -1.25 . . . . 0.0 107.733 171.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 C--N 1.346 0.447 0 O-C-N 121.249 -0.907 . . . . 0.0 110.668 178.911 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.517 2.915 0 CA-C-O 117.238 -1.363 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 52.25 45.21 58.02 Favored Glycine 0 C--N 1.357 1.715 0 CA-C-N 120.18 1.354 . . . . 0.0 114.094 -170.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.2 t -152.43 134.39 14.85 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 120.691 -1.476 . . . . 0.0 109.197 -172.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.78 -137.14 3.45 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 122.368 0.982 . . . . 0.0 111.63 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.31 68.14 8.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.04 -1.859 . . . . 0.0 113.173 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 t -59.32 -13.2 7.26 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.613 1.565 . . . . 0.0 114.571 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.6 -30.17 22.02 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.81 1.644 . . . . 0.0 114.337 175.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 174.53 89.6 0.07 OUTLIER Pre-proline 0 C--N 1.35 0.626 0 C-N-CA 124.986 1.314 . . . . 0.0 108.505 -171.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.01 118.57 4.09 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.344 2.03 . . . . 0.0 112.282 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t -113.29 -4.45 13.69 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 122.588 1.185 . . . . 0.0 110.11 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t -126.21 162.62 25.01 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.069 -1.644 . . . . 0.0 113.44 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -61.62 -48.34 81.36 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 120.449 -1.407 . . . . 0.0 111.932 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.81 86.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.553 1.541 . . . . 0.0 112.786 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -63.08 -54.7 33.86 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.783 -1.198 . . . . 0.0 113.656 173.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.63 -31.19 70.17 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.734 0.778 . . . . 0.0 112.239 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -53.63 -49.6 67.52 Favored 'General case' 0 C--N 1.346 0.416 0 O-C-N 119.959 -1.713 . . . . 0.0 113.164 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -67.44 -30.16 69.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.525 -1.359 . . . . 0.0 113.862 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.97 -27.94 65.86 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 125.897 1.679 . . . . 0.0 114.295 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.7 tp -61.9 -25.33 67.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.228 1.011 . . . . 0.0 113.607 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 t 56.43 40.79 29.52 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 124.632 2.158 . . . . 0.0 112.977 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.87 92.6 0.1 Allowed 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.258 1.423 . . . . 0.0 113.526 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.95 -40.66 0.8 Allowed Glycine 0 CA--C 1.496 -1.111 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -173.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.04 -144.62 16.94 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.7 m -93.79 139.84 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 120.211 -1.758 . . . . 0.0 111.102 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.62 156.66 45.87 Favored Pre-proline 0 N--CA 1.45 -0.465 0 O-C-N 120.569 -1.332 . . . . 0.0 109.347 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.59 -10.12 24.83 Favored 'Trans proline' 0 CA--C 1.519 -0.239 0 C-N-CA 122.872 2.382 . . . . 0.0 112.894 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 mptt 64.91 51.82 1.69 Allowed 'General case' 0 C--N 1.349 0.573 0 C-N-CA 126.019 1.728 . . . . 0.0 113.198 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.9 pt -64.89 143.59 15.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 mt -86.24 25.59 1.16 Allowed 'General case' 0 C--N 1.345 0.4 0 C-N-CA 124.877 1.271 . . . . 0.0 111.746 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -80.67 135.19 35.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 120.181 -1.574 . . . . 0.0 110.456 174.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -74.26 126.27 30.27 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 121.83 0.824 . . . . 0.0 111.747 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 p -118.06 -177.53 3.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 120.628 -1.295 . . . . 0.0 110.03 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 -122.05 -21.43 5.97 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 119.85 -1.781 . . . . 0.0 110.968 162.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -157.73 169.2 25.17 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 120.405 -1.434 . . . . 0.0 109.738 -176.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -52.26 -46.13 65.68 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 127.742 2.417 . . . . 0.0 111.656 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.0 m -55.59 -18.26 7.27 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 118.147 2.647 . . . . 0.0 118.147 170.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -93.87 -6.91 44.64 Favored 'General case' 0 C--N 1.345 0.388 0 O-C-N 120.46 -1.4 . . . . 0.0 111.083 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.33 127.47 26.79 Favored Pre-proline 0 C--N 1.349 0.573 0 O-C-N 120.523 -1.36 . . . . 0.0 110.327 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.47 163.33 36.37 Favored 'Trans proline' 0 C--N 1.324 -0.711 0 C-N-CA 122.067 1.845 . . . . 0.0 114.169 -169.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.86 -78.9 1.91 Allowed Glycine 0 C--N 1.348 1.207 0 O-C-N 121.349 -0.844 . . . . 0.0 113.097 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.23 24.82 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 122.377 1.084 . . . . 0.0 111.652 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.1 m -98.16 116.89 31.33 Favored 'General case' 0 C--O 1.215 -0.74 0 O-C-N 119.523 -1.986 . . . . 0.0 112.435 -162.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.57 150.06 6.75 Favored 'Isoleucine or valine' 0 C--N 1.346 0.426 0 O-C-N 118.429 -2.67 . . . . 0.0 113.665 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.29 125.32 29.19 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.804 0.842 . . . . 0.0 108.881 168.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -85.94 179.67 6.96 Favored 'General case' 0 C--N 1.345 0.412 0 O-C-N 120.032 -1.668 . . . . 0.0 110.655 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.24 -5.3 20.47 Favored Glycine 0 C--N 1.353 1.525 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -96.26 -6.15 38.64 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.201 -1.176 . . . . 0.0 112.501 170.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.59 18.28 64.29 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 121.01 -1.056 . . . . 0.0 113.787 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -128.04 146.4 50.69 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 123.083 1.42 . . . . 0.0 110.743 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 80.5 m -67.87 160.71 27.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 123.491 1.615 . . . . 0.0 113.081 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.958 0 O-C-N 119.3 -2.125 . . . . 0.0 116.846 -174.927 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 99.2 mt . . . . . 0 N--CA 1.506 2.329 0 CA-C-O 118.225 -0.893 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 15.2 m -133.47 165.44 32.14 Favored 'Isoleucine or valine' 0 C--N 1.344 0.361 0 CA-C-N 119.274 0.943 . . . . 0.0 109.271 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -114.0 101.82 54.28 Favored Pre-proline 0 C--N 1.345 0.41 0 CA-C-O 116.986 -1.483 . . . . 0.0 110.676 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.95 165.57 29.55 Favored 'Trans proline' 0 C--N 1.326 -0.609 0 C-N-CA 123.228 2.619 . . . . 0.0 114.242 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -87.16 153.2 53.94 Favored Pre-proline 0 C--N 1.351 0.653 0 O-C-N 120.967 -1.083 . . . . 0.0 111.961 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.06 -21.82 42.38 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.536 2.824 . . . . 0.0 113.436 -173.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 89.0 mt -70.14 -47.12 63.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.166 -0.959 . . . . 0.0 110.984 171.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 34.6 tp -65.17 -33.89 77.09 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 124.584 1.154 . . . . 0.0 113.062 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 14.7 tp -48.42 -41.68 29.92 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.326 1.45 . . . . 0.0 113.956 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -65.4 -36.88 85.29 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 119.844 -1.785 . . . . 0.0 114.328 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 tt -70.23 -50.22 42.09 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.656 0.782 . . . . 0.0 111.074 173.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 40.2 mt -52.16 -44.91 64.83 Favored 'General case' 0 C--N 1.35 0.617 0 C-N-CA 124.567 1.147 . . . . 0.0 112.702 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -57.4 -34.57 69.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 55.6 m -71.35 -15.49 62.39 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 124.558 1.143 . . . . 0.0 113.323 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.21 -7.38 9.62 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 124.351 1.06 . . . . 0.0 110.311 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.97 -26.47 7.9 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 120.106 -1.621 . . . . 0.0 112.36 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.41 74.47 7.28 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 126.006 1.723 . . . . 0.0 113.947 -170.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -83.57 12.03 6.3 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 -174.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -99.74 127.06 45.89 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.204 -0.935 . . . . 0.0 112.793 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.44 -9.42 0.3 Allowed 'General case' 0 C--N 1.348 0.515 0 N-CA-C 117.881 2.549 . . . . 0.0 117.881 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 67.4 p -137.11 127.04 25.77 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 119.064 -2.273 . . . . 0.0 111.158 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -129.03 -177.82 4.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 120.46 -1.4 . . . . 0.0 110.462 173.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.8 m -96.85 161.55 13.8 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.156 1.383 . . . . 0.0 108.189 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 1.1 mmm -60.04 -44.96 94.29 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 119.794 -1.816 . . . . 0.0 113.837 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -58.4 -51.87 68.0 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.136 0.974 . . . . 0.0 113.605 170.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -48.66 -49.65 36.5 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 126.504 1.921 . . . . 0.0 114.68 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 40.1 t -54.03 -46.32 65.64 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 O-C-N 120.674 -1.266 . . . . 0.0 112.355 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.11 -38.19 69.37 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.26 1.024 . . . . 0.0 112.325 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -56.25 -59.53 4.8 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.803 1.641 . . . . 0.0 112.79 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -58.02 -41.6 83.49 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 123.903 0.881 . . . . 0.0 112.028 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 26.4 tp -63.17 -52.22 63.26 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 173.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.5 -44.89 95.98 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 119.481 -2.012 . . . . 0.0 113.092 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -60.57 -30.28 69.69 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 124.379 1.071 . . . . 0.0 113.182 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -56.74 -60.25 3.83 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 124.429 1.092 . . . . 0.0 111.613 171.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mt -59.6 -42.87 89.67 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 O-C-N 120.292 -1.505 . . . . 0.0 113.794 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -51.02 -48.24 61.48 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 124.683 1.193 . . . . 0.0 113.556 170.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 40.5 m -78.64 -39.53 36.75 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 120.351 -1.468 . . . . 0.0 112.671 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -74.74 -21.47 59.33 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 126.163 1.785 . . . . 0.0 114.538 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 69.48 50.82 0.5 Allowed 'General case' 0 C--N 1.348 0.541 0 C-N-CA 125.821 1.648 . . . . 0.0 112.394 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 51.8 mt -107.46 18.65 21.28 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 123.782 0.833 . . . . 0.0 111.751 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -105.97 150.04 26.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -81.74 141.65 33.36 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.2 -31.72 72.94 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 121.028 -1.045 . . . . 0.0 113.187 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.76 -29.02 12.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 120.743 -1.223 . . . . 0.0 112.323 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -114.88 69.04 0.71 Allowed 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.097 -1.627 . . . . 0.0 112.641 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -73.41 -2.77 23.68 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 119.896 -1.752 . . . . 0.0 113.992 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -87.15 -10.19 53.35 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.589 1.955 . . . . 0.0 113.033 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 48.3 mm -98.59 134.0 38.89 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 125.497 1.519 . . . . 0.0 109.96 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 48.0 t -117.13 126.89 74.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 O-C-N 120.905 -1.122 . . . . 0.0 111.096 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -82.93 101.6 11.15 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.501 1.12 . . . . 0.0 111.762 173.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 18.3 m -107.14 3.46 25.75 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-O 122.06 0.934 . . . . 0.0 111.69 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 79.0 p -72.91 124.32 25.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 119.744 -1.847 . . . . 0.0 110.897 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 5.3 t30 79.57 18.85 0.72 Allowed 'General case' 0 C--N 1.35 0.621 0 C-N-CA 124.612 1.165 . . . . 0.0 112.478 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -112.06 169.98 8.47 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 124.691 1.196 . . . . 0.0 108.978 172.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 16.5 tp -69.97 -22.9 63.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.601 1.96 . . . . 0.0 112.657 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 2.0 mp -66.46 -34.61 78.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 119.899 -1.751 . . . . 0.0 113.105 167.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.66 -37.77 92.79 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 120.554 -1.341 . . . . 0.0 114.117 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.41 -49.17 70.58 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.722 2.409 . . . . 0.0 112.845 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 1.3 pp -83.51 -28.02 28.96 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 119.35 -2.093 . . . . 0.0 113.918 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -79.6 -41.02 27.99 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 125.141 1.377 . . . . 0.0 112.856 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 78.58 14.4 82.15 Favored Glycine 0 C--N 1.35 1.339 0 C-N-CA 124.189 0.899 . . . . 0.0 114.183 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.15 151.27 78.61 Favored Pre-proline 0 C--N 1.345 0.403 0 O-C-N 120.828 -1.396 . . . . 0.0 110.382 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.92 -26.92 10.61 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 121.965 1.777 . . . . 0.0 112.02 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 27.8 p -159.49 164.54 34.35 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 120.729 -1.232 . . . . 0.0 109.231 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -139.86 160.54 39.67 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 120.241 -1.537 . . . . 0.0 109.182 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 4.5 t -112.17 134.68 53.58 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.44 -33.7 65.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . 0.526 ' HZ1' ' CD ' ' B' ' 160' ' ' GLU . 0.1 OUTLIER -49.72 -25.47 2.99 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 175.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . 0.526 ' CD ' ' HZ1' ' B' ' 159' ' ' LYS . 5.5 mm-40 -80.36 55.88 2.37 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.037 -1.664 . . . . 0.0 111.255 176.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -51.87 -47.39 64.52 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 119.999 -1.688 . . . . 0.0 114.235 -172.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -57.09 -38.46 73.38 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 125.842 1.657 . . . . 0.0 113.271 172.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 18.1 ttpt -66.47 -51.33 57.9 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.235 -1.541 . . . . 0.0 110.598 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 50.9 mm -50.44 -54.65 8.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 C-N-CA 125.566 1.546 . . . . 0.0 112.826 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -51.76 -46.67 64.17 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 9.9 m -59.2 -42.67 91.48 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.627 -1.296 . . . . 0.0 112.453 176.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 3.5 mtp -72.06 -22.88 61.31 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.507 -1.371 . . . . 0.0 113.577 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.45 -52.05 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 O-C-N 121.115 -0.991 . . . . 0.0 110.478 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -57.09 -24.73 56.1 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.25 -12.4 60.0 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.91 -1.744 . . . . 0.0 114.488 173.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -103.05 -13.54 16.8 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 119.945 -1.722 . . . . 0.0 111.381 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 82.6 mt -109.8 155.4 21.68 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.928 1.291 . . . . 0.0 110.541 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 38.8 t -100.58 117.79 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 O-C-N 120.1 -1.625 . . . . 0.0 108.685 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.35 0.591 0 C-N-CA 124.172 0.989 . . . . 0.0 111.022 178.787 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.526 3.336 0 N-CA-C 119.39 3.107 . . . . 0.0 119.39 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.54 15.22 65.89 Favored Glycine 0 C--N 1.355 1.588 0 N-CA-C 115.836 1.094 . . . . 0.0 115.836 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.1 t -140.24 144.04 36.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.51 -129.91 2.51 Favored Glycine 0 C--N 1.346 1.128 0 C-N-CA 125.061 1.315 . . . . 0.0 110.112 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.0 72.53 10.07 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 120.219 -1.753 . . . . 0.0 112.397 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.3 p -68.21 -15.21 63.49 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -173.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -82.39 -38.1 24.61 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.971 1.309 . . . . 0.0 111.91 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -166.79 92.36 0.75 Allowed Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.14 105.69 1.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.078 1.852 . . . . 0.0 111.398 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -103.92 -17.3 15.07 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.74 1.216 . . . . 0.0 112.187 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.4 m -109.76 173.13 6.46 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 123.566 1.65 . . . . 0.0 112.406 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -73.44 -42.23 62.23 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 119.262 -2.149 . . . . 0.0 113.733 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.43 78.46 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 120.315 -1.49 . . . . 0.0 112.878 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -59.16 -58.99 6.22 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 125.975 1.71 . . . . 0.0 113.049 169.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.97 -22.96 65.0 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 120.815 -1.178 . . . . 0.0 113.537 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -62.15 -42.04 98.87 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 119.906 -1.746 . . . . 0.0 112.415 167.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -70.3 -33.73 71.88 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 120.231 -1.543 . . . . 0.0 114.019 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.19 -25.76 61.97 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.98 -14.28 52.74 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.397 1.079 . . . . 0.0 113.431 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.347 94.4 p 56.79 25.67 10.57 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 128.047 2.539 . . . . 0.0 113.913 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.32 91.14 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 128.316 2.647 . . . . 0.0 115.817 -167.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.27 -29.9 1.9 Allowed Glycine 0 C--N 1.344 1.02 0 O-C-N 121.382 -0.824 . . . . 0.0 112.174 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.16 -160.54 17.6 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 122.81 1.228 . . . . 0.0 112.786 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.79 102.89 12.58 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 O-C-N 120.31 -1.7 . . . . 0.0 110.895 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.9 t -80.76 151.79 71.44 Favored Pre-proline 0 C--N 1.348 0.52 0 O-C-N 120.127 -1.608 . . . . 0.0 110.457 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -67.05 -8.86 23.07 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.09 2.527 . . . . 0.0 115.096 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt 70.32 51.88 0.37 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 125.454 1.502 . . . . 0.0 113.341 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.7 pt -67.89 145.66 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 122.872 1.32 . . . . 0.0 113.663 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.1 mp -91.05 28.75 1.52 Allowed 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.475 -1.391 . . . . 0.0 110.661 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -82.03 133.25 35.28 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 120.504 -1.372 . . . . 0.0 110.432 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -80.5 113.87 18.99 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 121.37 -0.832 . . . . 0.0 110.918 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 p -103.91 -141.53 0.36 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.688 1.595 . . . . 0.0 110.817 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -169.61 -39.67 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 120.676 -1.265 . . . . 0.0 107.999 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -125.46 169.29 12.54 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -71.43 -14.81 62.27 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 119.819 -1.801 . . . . 0.0 113.814 173.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.2 m -61.77 -48.0 82.64 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 126.522 1.929 . . . . 0.0 113.876 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.76 -0.56 13.6 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.888 -1.133 . . . . 0.0 113.997 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.7 t -118.7 107.99 41.8 Favored Pre-proline 0 C--N 1.353 0.726 0 O-C-N 119.955 -1.716 . . . . 0.0 111.751 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.35 170.47 19.82 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.767 2.311 . . . . 0.0 115.653 -159.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.11 -90.54 1.67 Allowed Glycine 0 C--N 1.349 1.259 0 C-N-CA 124.181 0.895 . . . . 0.0 113.035 172.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.03 16.06 0.84 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 123.079 1.419 . . . . 0.0 110.54 -177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 32.9 m -76.92 168.36 20.23 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 119.859 -1.776 . . . . 0.0 111.461 -172.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.27 148.38 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 160.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.5 t -77.26 128.38 34.23 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.099 1.759 . . . . 0.0 107.133 171.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -84.79 -179.39 7.09 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 119.973 -1.704 . . . . 0.0 109.249 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.12 -11.03 24.04 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 116.394 1.318 . . . . 0.0 116.394 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -87.06 -7.41 58.11 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 120.704 -1.468 . . . . 0.0 113.374 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.74 13.8 74.55 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 120.71 -1.244 . . . . 0.0 114.259 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -124.18 152.08 43.29 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.134 -1.215 . . . . 0.0 109.765 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 29.2 m -78.91 93.78 5.1 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -166.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.294 0 O-C-N 119.526 -1.984 . . . . 0.0 116.624 -179.694 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.504 2.267 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.8 160.88 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -116.31 117.79 38.31 Favored Pre-proline 0 C--N 1.348 0.53 0 CA-C-O 115.964 -1.97 . . . . 0.0 109.822 170.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.09 -179.28 3.78 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.092 2.528 . . . . 0.0 114.132 169.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.03 159.74 28.65 Favored Pre-proline 0 C--N 1.351 0.634 0 C-N-CA 125.485 1.514 . . . . 0.0 110.609 175.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.99 -26.83 30.86 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.907 2.405 . . . . 0.0 114.098 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.97 -55.54 24.98 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 119.556 1.071 . . . . 0.0 110.942 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 18.5 tp -59.62 -35.62 74.72 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 120.892 -1.13 . . . . 0.0 113.282 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 17.5 tp -56.44 -40.77 75.33 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 120.605 -1.309 . . . . 0.0 114.485 175.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -65.52 -32.33 73.87 Favored 'General case' 0 C--N 1.346 0.442 0 O-C-N 120.002 -1.686 . . . . 0.0 113.613 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 10.2 tt -67.94 -46.26 72.0 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.402 -0.811 . . . . 0.0 110.94 170.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -52.15 -47.62 65.35 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 121.268 -0.895 . . . . 0.0 112.83 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -58.58 -24.99 62.1 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.273 -1.517 . . . . 0.0 114.282 173.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 11.7 t -83.38 -9.64 58.92 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 120.303 -1.498 . . . . 0.0 113.753 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 4.5 t -107.76 16.83 7.05 Favored 'Isoleucine or valine' 0 C--N 1.348 0.509 0 CA-C-O 123.369 1.557 . . . . 0.0 107.903 171.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.1 -20.93 36.97 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 119.262 -2.149 . . . . 0.0 113.96 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.29 69.2 3.53 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.228 1.811 . . . . 0.0 113.473 -172.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -85.39 17.36 3.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 119.467 -2.021 . . . . 0.0 116.204 -173.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . 0.696 ' HE3' ' H ' ' B' ' 111' ' ' ASP . 0.0 OUTLIER -88.21 142.53 27.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 123.874 1.797 . . . . 0.0 110.56 170.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.696 ' H ' ' HE3' ' B' ' 110' ' ' LYS . 2.6 m-20 -78.38 -7.02 56.86 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 130.717 3.607 . . . . 0.0 111.656 -172.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 11.3 p -145.43 135.11 23.4 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 127.087 2.155 . . . . 0.0 109.852 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -139.52 -165.45 1.87 Allowed 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.056 -1.028 . . . . 0.0 110.055 174.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 29.1 p -94.21 -169.63 2.11 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 119.774 -1.829 . . . . 0.0 110.927 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 76.7 mtp -74.56 -53.24 9.79 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 119.367 -2.083 . . . . 0.0 112.001 169.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -58.18 -38.98 77.73 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.211 -0.93 . . . . 0.0 112.927 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.76 -44.31 97.15 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.18 -26.11 39.32 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 O-C-N 119.618 -1.926 . . . . 0.0 111.479 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.68 -27.69 17.93 Favored 'General case' 0 C--N 1.347 0.479 0 O-C-N 120.622 -1.299 . . . . 0.0 113.706 172.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -64.97 -62.53 1.5 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 126.399 1.88 . . . . 0.0 111.612 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -54.96 -36.03 64.89 Favored 'General case' 0 C--N 1.351 0.674 0 O-C-N 120.673 -1.267 . . . . 0.0 112.3 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 33.2 tp -70.48 -49.2 50.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -70.44 -46.37 48.93 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 119.89 -1.756 . . . . 0.0 113.428 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -63.36 -31.29 72.4 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.201 1.4 . . . . 0.0 112.247 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -55.9 -57.85 10.33 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 124.23 1.012 . . . . 0.0 111.861 168.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 89.7 mt -64.12 -43.74 97.49 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 O-C-N 120.534 -1.354 . . . . 0.0 112.888 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 53.5 ttm -57.64 -34.2 69.07 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 125.498 1.519 . . . . 0.0 113.206 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 58.1 m -86.33 -36.27 19.37 Favored 'General case' 0 C--N 1.345 0.37 0 O-C-N 120.621 -1.299 . . . . 0.0 112.623 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -71.66 -22.26 61.7 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 126.769 2.028 . . . . 0.0 114.862 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 71.41 45.12 0.49 Allowed 'General case' 0 C--N 1.351 0.667 0 C-N-CA 125.385 1.474 . . . . 0.0 112.984 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 89.2 mt -100.29 9.32 42.88 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 121.058 -1.026 . . . . 0.0 112.319 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -94.26 141.51 28.48 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.72 -1.237 . . . . 0.0 108.667 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -78.08 147.73 34.56 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.503 1.121 . . . . 0.0 109.277 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -68.98 -31.18 69.84 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.222 1.409 . . . . 0.0 113.3 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -104.17 -24.91 13.11 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 124.813 1.245 . . . . 0.0 112.666 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -116.93 62.55 0.73 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 122.103 0.954 . . . . 0.0 110.822 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.89 -5.04 1.81 Allowed 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.106 -1.621 . . . . 0.0 115.336 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -99.81 -0.51 39.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.261 1.824 . . . . 0.0 112.917 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 51.1 mm -105.26 117.11 50.37 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 C-N-CA 125.216 1.406 . . . . 0.0 108.64 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.49 121.71 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 O-C-N 120.987 -1.071 . . . . 0.0 108.493 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -79.92 108.86 13.83 Favored 'General case' 0 C--N 1.347 0.467 0 O-C-N 120.642 -1.286 . . . . 0.0 111.598 174.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 90.6 m -124.91 24.64 7.56 Favored 'General case' 0 C--N 1.346 0.454 0 O-C-N 121.513 -0.742 . . . . 0.0 111.157 172.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 13.6 p -76.92 142.07 40.24 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 120.315 -1.491 . . . . 0.0 108.704 165.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 28.9 t30 72.97 -31.22 0.22 Allowed 'General case' 0 C--N 1.354 0.774 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -73.77 164.35 26.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.286 -1.509 . . . . 0.0 110.678 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 18.9 tp -73.54 -2.99 25.04 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-O 123.691 1.71 . . . . 0.0 114.174 -162.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 10.0 mp -79.47 -35.9 39.56 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 119.327 -2.108 . . . . 0.0 111.353 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.88 -32.52 82.23 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 120.766 -1.209 . . . . 0.0 113.62 -173.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -47.56 -67.4 0.28 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.355 3.062 . . . . 0.0 112.181 166.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.95 -23.16 48.61 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -78.77 -36.19 43.39 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.139 -1.601 . . . . 0.0 111.66 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.19 19.36 77.12 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 121.266 -0.896 . . . . 0.0 114.839 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 21.9 m -130.91 156.54 79.91 Favored Pre-proline 0 C--N 1.347 0.48 0 O-C-N 120.667 -1.49 . . . . 0.0 110.813 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.01 -26.09 8.17 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 121.923 1.749 . . . . 0.0 112.733 172.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 64.9 p -162.0 165.78 26.92 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 119.701 1.137 . . . . 0.0 109.533 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -138.42 166.12 25.07 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 8.4 t -117.88 143.05 46.65 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.808 -1.182 . . . . 0.0 109.51 169.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 34.6 m -57.95 -34.65 49.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.521 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -52.87 -26.65 15.39 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.34 49.22 0.96 Allowed 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 120.458 -1.401 . . . . 0.0 111.738 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -48.4 -44.32 34.85 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 126.64 1.976 . . . . 0.0 113.333 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -57.59 -35.02 69.85 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 125.692 1.597 . . . . 0.0 114.995 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -81.75 -40.26 22.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.167 -1.583 . . . . 0.0 110.023 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 75.8 mt -59.92 -52.25 63.39 Favored 'Isoleucine or valine' 0 C--N 1.347 0.496 0 C-N-CA 123.929 0.892 . . . . 0.0 111.402 172.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -51.47 -44.04 62.31 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 120.905 -1.122 . . . . 0.0 114.007 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 86.9 m -56.71 -53.77 53.85 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 121.138 -0.976 . . . . 0.0 112.199 174.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 25.9 mmt -61.53 -34.58 75.79 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 120.561 -1.337 . . . . 0.0 114.049 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.83 -55.43 22.47 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 O-C-N 121.106 -0.996 . . . . 0.0 111.39 171.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -68.81 -18.15 64.13 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 119.414 -2.054 . . . . 0.0 115.257 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -64.48 -30.95 71.98 Favored 'General case' 0 C--N 1.349 0.562 0 O-C-N 118.515 -2.615 . . . . 0.0 112.197 165.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -96.56 -15.04 21.82 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 123.899 0.879 . . . . 0.0 113.072 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 69.5 mt -120.64 121.37 38.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.603 1.161 . . . . 0.0 112.489 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.54 119.53 13.35 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 O-C-N 120.276 -1.515 . . . . 0.0 112.399 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 C--N 1.349 0.546 0 C-N-CA 124.825 1.25 . . . . 0.0 110.601 177.46 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' SER . . . . . 0.488 ' HA ' ' H ' ' A' ' 43' ' ' ILE . 34.7 m . . . . . 0 N--CA 1.517 2.888 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.1 55.13 31.95 Favored Glycine 0 C--N 1.357 1.706 0 CA-C-O 121.705 0.614 . . . . 0.0 112.776 -166.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -124.34 105.98 9.88 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 120.315 -1.697 . . . . 0.0 111.429 -168.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.55 -152.11 7.12 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.51 72.6 4.06 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.047 -1.266 . . . . 0.0 113.184 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 p -66.45 -2.11 4.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 126.775 2.03 . . . . 0.0 115.116 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -100.58 -31.79 11.08 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 126.189 1.795 . . . . 0.0 111.474 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -171.27 87.66 0.47 Allowed Pre-proline 0 C--N 1.351 0.656 0 O-C-N 121.382 -0.824 . . . . 0.0 110.53 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.59 98.31 0.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.88 1.72 . . . . 0.0 113.189 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -85.14 -31.97 23.0 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.353 1.061 . . . . 0.0 112.781 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.82 169.03 8.75 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 120.859 -1.15 . . . . 0.0 112.82 -173.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -64.19 -53.46 48.99 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 120.713 -1.242 . . . . 0.0 111.468 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.38 -50.36 67.7 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.183 1.393 . . . . 0.0 113.997 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -45.84 -55.04 7.13 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.915 2.086 . . . . 0.0 115.095 168.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.42 -30.43 60.05 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 120.931 -1.106 . . . . 0.0 112.979 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -54.59 -47.68 73.06 Favored 'General case' 0 C--N 1.349 0.546 0 O-C-N 119.798 -1.814 . . . . 0.0 112.729 173.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -59.51 -40.22 86.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 173.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -60.72 -20.91 62.26 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 125.836 1.654 . . . . 0.0 114.2 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.6 tp -70.53 -17.12 62.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.701 1.2 . . . . 0.0 113.663 174.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.296 91.4 p 50.93 40.89 26.22 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.363 1.865 . . . . 0.0 114.769 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.26 88.97 0.08 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.979 1.712 . . . . 0.0 114.993 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 148.2 -31.63 1.29 Allowed Glycine 0 CA--C 1.496 -1.109 0 O-C-N 120.975 -1.078 . . . . 0.0 111.096 -170.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.8 -132.7 11.02 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-O 122.423 1.013 . . . . 0.0 112.433 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 m -99.77 135.49 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 120.659 -1.495 . . . . 0.0 110.718 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.52 158.15 37.17 Favored Pre-proline 0 N--CA 1.451 -0.385 0 O-C-N 120.354 -1.466 . . . . 0.0 109.513 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.45 -5.9 17.89 Favored 'Trans proline' 0 CA--C 1.521 -0.175 0 C-N-CA 122.754 2.303 . . . . 0.0 112.848 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 mptt 61.74 51.05 4.05 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 126.481 1.912 . . . . 0.0 113.479 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.6 pt -64.11 141.69 17.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -173.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.27 26.3 0.91 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 125.305 1.442 . . . . 0.0 112.088 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -82.29 137.65 34.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.157 -1.59 . . . . 0.0 109.87 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -81.06 125.46 30.23 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 120.973 -1.079 . . . . 0.0 111.36 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.7 p -114.06 -175.22 2.63 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.517 1.151 . . . . 0.0 110.046 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -138.19 -2.95 1.8 Allowed 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 120.994 -1.066 . . . . 0.0 110.586 167.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -169.18 173.43 6.76 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.65 1.18 . . . . 0.0 109.315 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.23 -9.92 58.12 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 128.149 2.58 . . . . 0.0 111.337 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -75.0 -39.12 61.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.753 1.621 . . . . 0.0 110.962 168.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -77.89 -18.41 56.21 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.443 2.297 . . . . 0.0 112.634 -173.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.3 127.94 34.85 Favored Pre-proline 0 CA--C 1.54 0.594 0 O-C-N 120.253 -1.529 . . . . 0.0 111.55 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.76 170.09 21.12 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.649 2.233 . . . . 0.0 113.887 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.09 -96.66 0.99 Allowed Glycine 0 C--N 1.35 1.312 0 C-N-CA 124.238 0.923 . . . . 0.0 112.527 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.62 33.57 0.45 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 122.837 1.303 . . . . 0.0 109.327 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 77.3 m -91.77 136.59 33.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 119.737 -1.852 . . . . 0.0 109.965 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.488 ' H ' ' HA ' ' A' ' 1' ' ' SER . 1.6 pp -103.35 151.16 6.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 O-C-N 120.766 -1.209 . . . . 0.0 110.534 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.3 t -88.47 118.14 27.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.823 1.649 . . . . 0.0 109.154 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -79.05 172.86 13.21 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 118.952 -2.342 . . . . 0.0 110.948 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.58 -27.83 13.53 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 116.836 1.494 . . . . 0.0 116.836 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -83.82 3.49 33.38 Favored 'General case' 0 C--N 1.345 0.386 0 O-C-N 121.205 -1.174 . . . . 0.0 113.472 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.55 22.04 73.62 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 119.949 -1.719 . . . . 0.0 114.252 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -131.71 137.74 48.38 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 120.771 -1.429 . . . . 0.0 111.29 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 66.2 m -66.37 137.65 57.03 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 124.616 2.15 . . . . 0.0 114.288 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.948 0 O-C-N 120.517 -1.365 . . . . 0.0 113.928 173.176 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 N--CA 1.504 2.253 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.4 166.47 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.9 101.42 50.25 Favored Pre-proline 0 C--N 1.346 0.413 0 CA-C-O 116.936 -1.507 . . . . 0.0 110.397 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.99 168.44 23.15 Favored 'Trans proline' 0 C--N 1.329 -0.484 0 C-N-CA 123.104 2.536 . . . . 0.0 114.396 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -86.69 152.98 55.06 Favored Pre-proline 0 C--N 1.349 0.573 0 O-C-N 121.038 -1.038 . . . . 0.0 112.807 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.15 -19.23 29.92 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.145 2.563 . . . . 0.0 112.915 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.6 mt -68.62 -51.55 41.11 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-O 121.579 0.704 . . . . 0.0 110.537 169.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.87 -39.57 81.74 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 124.944 1.298 . . . . 0.0 113.391 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 tp -46.46 -42.19 15.05 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.315 1.446 . . . . 0.0 114.879 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -66.07 -36.05 82.16 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 119.595 -1.94 . . . . 0.0 113.586 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 tt -70.39 -50.82 34.73 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 123.927 0.891 . . . . 0.0 111.062 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 96.5 mt -52.65 -45.69 66.82 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 124.5 1.12 . . . . 0.0 112.412 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -59.14 -28.67 66.78 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 5.9 t -75.72 -13.18 60.3 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 124.559 1.144 . . . . 0.0 112.779 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.73 -4.3 9.37 Favored 'Isoleucine or valine' 0 C--N 1.347 0.486 0 C-N-CA 124.852 1.261 . . . . 0.0 109.987 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.58 -16.57 23.9 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 119.833 -1.792 . . . . 0.0 113.306 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.34 77.61 9.92 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.212 -1.758 . . . . 0.0 113.34 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -81.57 11.83 4.32 Favored 'General case' 0 C--N 1.344 0.351 0 O-C-N 119.747 -1.846 . . . . 0.0 115.758 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 139.94 30.21 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-O 122.132 0.968 . . . . 0.0 113.174 -174.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.05 -15.91 62.57 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.516 2.326 . . . . 0.0 114.087 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 19.6 p -138.81 126.51 22.09 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 120.318 -1.489 . . . . 0.0 110.968 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -128.34 -177.31 4.11 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-O 122.461 1.124 . . . . 0.0 110.879 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 4.2 p -90.76 176.11 6.76 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 120.041 -1.662 . . . . 0.0 110.01 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 8.5 mmt -64.75 -49.23 71.62 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 120.351 -1.468 . . . . 0.0 112.945 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -33.23 74.27 Favored 'General case' 0 C--N 1.349 0.587 0 O-C-N 120.997 -1.064 . . . . 0.0 112.605 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -57.75 -36.74 72.5 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 125.062 1.345 . . . . 0.0 114.134 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.47 -48.86 76.64 Favored 'Isoleucine or valine' 0 C--N 1.356 0.866 0 C-N-CA 123.961 0.905 . . . . 0.0 111.811 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.77 -27.33 40.46 Favored 'General case' 0 C--N 1.346 0.434 0 O-C-N 120.763 -1.211 . . . . 0.0 113.045 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -65.35 -58.84 4.89 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 125.289 1.436 . . . . 0.0 112.033 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -59.79 -41.97 92.32 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 120.992 -1.067 . . . . 0.0 112.236 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 29.6 tp -61.19 -52.45 64.74 Favored 'General case' 0 C--N 1.347 0.485 0 O-C-N 120.569 -1.332 . . . . 0.0 114.017 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.79 -45.54 94.75 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 120.602 -1.311 . . . . 0.0 113.45 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -59.05 -37.21 76.47 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 124.788 1.235 . . . . 0.0 113.157 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -59.93 -57.58 12.25 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 124.636 1.175 . . . . 0.0 112.688 173.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 3.1 mt -63.59 -41.7 93.54 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 O-C-N 119.999 -1.688 . . . . 0.0 112.209 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 52.2 ttm -56.26 -43.45 78.77 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 125.691 1.596 . . . . 0.0 112.681 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 21.6 m -82.56 -30.35 29.7 Favored 'General case' 0 C--N 1.345 0.37 0 O-C-N 119.953 -1.717 . . . . 0.0 112.521 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -75.31 -24.15 57.41 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 119.584 -1.948 . . . . 0.0 114.436 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 71.82 49.84 0.26 Allowed 'General case' 0 C--N 1.352 0.692 0 C-N-CA 125.403 1.481 . . . . 0.0 111.038 -176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 6.1 mt -107.7 17.72 22.25 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 121.054 -1.029 . . . . 0.0 111.961 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -105.83 149.54 26.41 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -77.31 154.81 32.51 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 121.254 -0.904 . . . . 0.0 108.852 172.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -71.53 -37.21 71.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 122.746 1.26 . . . . 0.0 110.794 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -88.63 -51.5 5.65 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 121.035 -1.041 . . . . 0.0 111.884 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -96.13 59.65 1.95 Allowed 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 120.338 -1.476 . . . . 0.0 113.25 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -63.29 -9.33 11.28 Favored 'General case' 0 C--N 1.346 0.436 0 O-C-N 120.098 -1.626 . . . . 0.0 115.03 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -91.07 2.38 56.36 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.293 -1.504 . . . . 0.0 113.315 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 50.1 mm -106.04 143.07 17.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 C-N-CA 125.572 1.549 . . . . 0.0 108.437 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 44.9 t -129.64 130.14 66.82 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 O-C-N 120.778 -1.201 . . . . 0.0 109.114 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -95.26 100.66 12.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.629 1.172 . . . . 0.0 110.404 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 1.2 m -101.43 1.54 38.41 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 121.118 -0.989 . . . . 0.0 112.662 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 26.4 t -65.44 131.18 45.78 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 120.828 -1.17 . . . . 0.0 110.651 173.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 4.9 t30 69.93 25.01 5.01 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.274 1.03 . . . . 0.0 113.226 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -123.26 171.5 9.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 13.8 tp -74.97 -22.19 58.71 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.781 1.632 . . . . 0.0 111.688 -171.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.04 -33.53 70.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 120.799 -1.188 . . . . 0.0 112.715 170.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.67 -38.3 96.21 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 120.065 -1.647 . . . . 0.0 113.812 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -51.91 -50.24 61.48 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.18 2.592 . . . . 0.0 112.456 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' LEU . . . . . 0.469 HD11 HD22 ' B' ' 171' ' ' ASN . 0.9 OUTLIER -78.95 -30.76 44.77 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 120.024 -1.673 . . . . 0.0 113.865 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -75.67 -35.04 60.49 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 120.734 -1.229 . . . . 0.0 112.83 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 73.99 23.2 76.81 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 123.857 0.741 . . . . 0.0 113.696 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.19 152.44 76.95 Favored Pre-proline 0 N--CA 1.451 -0.408 0 O-C-N 121.176 -1.191 . . . . 0.0 108.454 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.71 -38.41 3.2 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 121.797 1.665 . . . . 0.0 111.798 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 31.1 m -144.67 164.31 31.36 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -138.06 178.48 7.09 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 77.5 p -136.78 141.64 42.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.077 -1.639 . . . . 0.0 109.626 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.23 -23.57 23.3 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 CA-C-O 122.62 1.2 . . . . 0.0 113.035 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -60.01 -27.05 66.57 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 120.666 -1.271 . . . . 0.0 113.521 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.87 56.64 1.58 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.838 1.255 . . . . 0.0 112.438 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -53.64 -38.86 64.5 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 119.684 -1.885 . . . . 0.0 114.43 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -67.45 -32.34 73.14 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.903 1.681 . . . . 0.0 113.529 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -74.72 -43.95 52.44 Favored 'General case' 0 C--N 1.348 0.53 0 C-N-CA 125.405 1.482 . . . . 0.0 110.799 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 51.3 mm -50.63 -53.38 13.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.768 1.227 . . . . 0.0 112.012 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -54.25 -43.12 70.66 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 124.243 1.017 . . . . 0.0 113.655 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -36.07 79.88 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 119.7 -1.875 . . . . 0.0 113.664 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.33 -38.38 78.16 Favored 'General case' 0 C--N 1.346 0.44 0 O-C-N 120.434 -1.416 . . . . 0.0 111.845 176.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 67.6 mt -66.54 -50.38 67.24 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 C-N-CA 124.455 1.102 . . . . 0.0 112.313 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -61.1 -14.88 27.37 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 119.735 -1.853 . . . . 0.0 114.918 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -76.31 -12.73 60.12 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.554 -1.966 . . . . 0.0 113.539 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . 0.469 HD22 HD11 ' B' ' 150' ' ' LEU . 2.1 m120 -105.24 -15.91 14.92 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 120.419 -1.426 . . . . 0.0 111.86 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 48.0 mt -111.37 162.93 14.53 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 121.92 0.867 . . . . 0.0 109.804 -174.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.92 126.68 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 O-C-N 120.453 -1.405 . . . . 0.0 108.978 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.348 0.534 0 C-N-CA 123.779 0.832 . . . . 0.0 110.681 -179.226 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.52 3.039 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 44.61 55.98 5.85 Favored Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.181 1.355 . . . . 0.0 114.903 -162.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -116.38 111.51 20.16 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 120.113 -1.816 . . . . 0.0 111.606 -168.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.28 -147.14 5.55 Favored Glycine 0 C--N 1.349 1.306 0 CA-C-O 122.206 0.892 . . . . 0.0 112.44 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.38 66.0 9.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 120.132 -1.805 . . . . 0.0 113.545 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.8 m -62.81 -6.26 3.55 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 pttm -89.12 -26.57 21.27 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.298 2.239 . . . . 0.0 113.635 175.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 175.16 87.22 0.08 OUTLIER Pre-proline 0 C--N 1.35 0.622 0 C-N-CA 125.074 1.35 . . . . 0.0 108.738 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.74 127.31 8.66 Favored 'Trans proline' 0 C--N 1.325 -0.702 0 C-N-CA 122.231 1.954 . . . . 0.0 111.65 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.6 t -122.38 -0.38 9.31 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-O 122.71 1.243 . . . . 0.0 110.884 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.9 t -130.39 164.2 25.23 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 124.92 1.288 . . . . 0.0 109.599 -174.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -68.26 -38.13 81.45 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 124.369 1.068 . . . . 0.0 111.105 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.7 -52.9 39.37 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 124.848 1.259 . . . . 0.0 110.803 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.84 -55.25 10.18 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.092 1.757 . . . . 0.0 114.07 169.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.57 -30.81 68.68 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.275 -1.516 . . . . 0.0 113.501 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -58.32 -41.55 84.79 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 119.937 -1.727 . . . . 0.0 112.381 171.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -65.25 -43.2 92.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.769 -1.207 . . . . 0.0 113.454 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -53.26 -29.18 31.51 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 127.072 2.149 . . . . 0.0 115.014 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.49 -19.58 65.67 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.604 1.162 . . . . 0.0 113.94 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.268 42.2 p 54.65 35.59 24.11 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 126.871 2.068 . . . . 0.0 114.299 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.34 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.44 1.896 . . . . 0.0 115.186 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.2 -40.85 1.04 Allowed Glycine 0 CA--C 1.494 -1.225 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -170.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.91 -146.24 17.97 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 124.475 1.036 . . . . 0.0 111.684 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 m -94.53 155.24 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 O-C-N 121.09 -1.241 . . . . 0.0 110.904 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.61 155.52 80.45 Favored Pre-proline 0 N--CA 1.448 -0.559 0 O-C-N 120.601 -1.312 . . . . 0.0 107.592 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.37 6.44 3.55 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 123.113 2.542 . . . . 0.0 113.017 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt 62.63 46.25 5.54 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.705 1.602 . . . . 0.0 114.262 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 pt -59.79 139.24 19.65 Favored 'Isoleucine or valine' 0 C--N 1.348 0.531 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -173.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 mp -86.69 28.1 0.91 Allowed 'General case' 0 C--N 1.346 0.45 0 O-C-N 120.948 -1.095 . . . . 0.0 111.685 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -82.51 138.29 34.36 Favored 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 120.543 -1.348 . . . . 0.0 109.79 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -84.7 127.0 33.88 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.503 0.668 . . . . 0.0 111.019 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.9 p -119.07 -175.95 3.02 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.038 1.335 . . . . 0.0 109.388 -177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -130.67 -12.82 3.8 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 120.696 -1.252 . . . . 0.0 111.116 168.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -157.04 169.99 23.56 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 120.689 -1.257 . . . . 0.0 107.875 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.1 -31.73 71.55 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.579 1.551 . . . . 0.0 113.515 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 m -65.28 -26.64 68.17 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 120.121 -1.612 . . . . 0.0 115.058 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.84 -11.33 59.81 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.308 -0.87 . . . . 0.0 111.987 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -107.4 127.56 27.63 Favored Pre-proline 0 C--N 1.354 0.791 0 O-C-N 120.179 -1.576 . . . . 0.0 112.129 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.07 168.64 23.67 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.195 1.93 . . . . 0.0 114.175 -171.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.32 -85.57 1.13 Allowed Glycine 0 C--N 1.35 1.313 0 C-N-CA 124.626 1.108 . . . . 0.0 112.982 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -161.3 25.59 0.13 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 122.598 1.19 . . . . 0.0 110.169 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 7.1 m -89.63 148.55 23.27 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 119.181 -2.199 . . . . 0.0 109.612 -170.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 pp -115.37 147.42 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 O-C-N 119.882 -1.761 . . . . 0.0 108.821 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.06 117.14 19.08 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.989 1.316 . . . . 0.0 110.158 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -79.9 176.3 9.86 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 120.029 -1.669 . . . . 0.0 110.911 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.89 0.33 2.42 Favored Glycine 0 C--N 1.355 1.59 0 N-CA-C 117.492 1.757 . . . . 0.0 117.492 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.45 -7.49 24.23 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 120.707 -1.466 . . . . 0.0 111.925 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.35 20.18 60.93 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 120.458 -1.401 . . . . 0.0 113.707 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -130.81 145.21 51.91 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 121.133 -1.216 . . . . 0.0 110.593 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 78.8 m -75.39 147.13 40.26 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 123.51 1.624 . . . . 0.0 114.329 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.334 0 CA-C-O 116.19 -2.45 . . . . 0.0 118.186 -174.385 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 57.2 mt . . . . . 0 N--CA 1.504 2.246 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 11.7 m -136.2 166.22 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -115.84 102.14 54.04 Favored Pre-proline 0 C--N 1.345 0.391 0 CA-C-O 117.137 -1.411 . . . . 0.0 110.035 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.49 174.46 9.23 Favored 'Trans proline' 0 C--N 1.325 -0.66 0 C-N-CA 123.3 2.667 . . . . 0.0 114.086 175.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -96.2 154.64 38.73 Favored Pre-proline 0 C--N 1.35 0.617 0 O-C-N 120.914 -1.116 . . . . 0.0 111.617 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.91 -24.32 29.12 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.179 2.586 . . . . 0.0 112.7 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.8 mt -64.59 -52.94 54.94 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 118.686 0.676 . . . . 0.0 111.358 168.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 32.6 tp -58.69 -36.9 74.96 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 124.976 1.311 . . . . 0.0 113.522 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 15.6 tp -47.63 -40.3 19.26 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 125.345 1.458 . . . . 0.0 114.805 170.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -64.47 -36.82 85.44 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 119.645 -1.91 . . . . 0.0 113.723 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 tt -70.45 -50.62 36.34 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 124.037 0.935 . . . . 0.0 110.738 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 88.8 mt -53.59 -46.34 70.33 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.913 1.285 . . . . 0.0 112.287 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -58.95 -25.18 63.3 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.44 -13.57 59.02 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 125.307 1.443 . . . . 0.0 112.025 177.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.62 0.61 10.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 125.07 1.348 . . . . 0.0 109.782 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.2 -15.75 39.19 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 120.084 -1.635 . . . . 0.0 113.155 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -88.14 78.39 8.13 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 120.434 -1.627 . . . . 0.0 113.493 -172.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -85.38 8.1 20.08 Favored 'General case' 0 C--N 1.343 0.318 0 O-C-N 119.895 -1.753 . . . . 0.0 115.466 -176.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.82 149.49 27.14 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 121.339 -0.851 . . . . 0.0 112.508 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -78.74 -27.55 44.79 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.147 1.379 . . . . 0.0 112.527 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 60.4 p -121.58 140.88 51.67 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 120.808 -1.182 . . . . 0.0 112.572 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -139.43 177.31 8.02 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-O 122.439 1.114 . . . . 0.0 110.264 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.48 160.97 17.26 Favored 'General case' 0 C--N 1.346 0.447 0 O-C-N 120.666 -1.271 . . . . 0.0 110.872 175.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.98 -47.68 71.14 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.105 -1.622 . . . . 0.0 114.388 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -59.36 -52.7 64.5 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.978 0.911 . . . . 0.0 112.913 171.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.76 -46.57 50.75 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 174.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 52.1 t -51.88 -48.25 39.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 O-C-N 120.97 -1.081 . . . . 0.0 112.709 177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.2 -29.84 38.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.082 -1.012 . . . . 0.0 113.288 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -56.27 -60.34 3.64 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 125.774 1.629 . . . . 0.0 112.193 172.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -59.13 -36.49 75.29 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 120.669 -1.269 . . . . 0.0 112.495 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 5.0 tp -62.56 -51.46 67.26 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.1 1.36 . . . . 0.0 113.902 173.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.23 -51.77 54.27 Favored Glycine 0 C--N 1.35 1.334 0 C-N-CA 125.502 1.525 . . . . 0.0 113.204 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -55.39 -39.15 69.79 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 125.216 1.406 . . . . 0.0 113.399 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -59.11 -56.3 24.02 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 121.149 -0.969 . . . . 0.0 112.74 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.71 -44.97 98.56 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 C-N-CA 124.327 1.051 . . . . 0.0 112.475 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 45.2 ttm -52.43 -44.67 65.58 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 126.268 1.827 . . . . 0.0 112.979 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 11.7 m -85.83 -23.62 27.09 Favored 'General case' 0 C--N 1.346 0.449 0 O-C-N 120.153 -1.592 . . . . 0.0 112.774 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -29.42 55.62 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 118.982 -2.324 . . . . 0.0 113.053 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? 75.15 49.27 0.09 Allowed 'General case' 0 C--N 1.351 0.659 0 C-N-CA 126.496 1.918 . . . . 0.0 110.596 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.6 23.19 12.34 Favored 'General case' 0 C--N 1.349 0.553 0 O-C-N 121.032 -1.042 . . . . 0.0 111.68 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -114.01 144.14 43.59 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.588 -1.32 . . . . 0.0 108.599 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.27 132.59 44.26 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.883 -1.136 . . . . 0.0 110.162 173.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -58.22 -47.77 82.45 Favored 'General case' 0 C--N 1.346 0.424 0 O-C-N 119.705 -1.872 . . . . 0.0 113.681 173.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -75.04 -19.49 60.01 Favored 'General case' 0 C--N 1.347 0.458 0 O-C-N 119.878 -1.764 . . . . 0.0 114.323 176.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.22 58.67 1.58 Allowed 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 119.701 -1.874 . . . . 0.0 110.231 -170.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -62.55 -7.41 4.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.453 1.901 . . . . 0.0 114.903 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -92.7 -3.82 54.22 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.015 2.526 . . . . 0.0 113.551 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 43.8 mm -106.29 139.32 28.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 0 C-N-CA 126.022 1.729 . . . . 0.0 107.643 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 39.9 t -124.7 130.17 73.47 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-O 122.406 1.098 . . . . 0.0 110.324 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.59 109.34 18.47 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.971 -1.08 . . . . 0.0 110.994 172.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 24.1 p -100.38 -14.47 18.34 Favored 'General case' 0 C--N 1.346 0.426 0 O-C-N 121.126 -0.984 . . . . 0.0 112.324 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.89 124.6 20.41 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 120.645 -1.285 . . . . 0.0 113.312 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 79.05 2.75 2.41 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 125.43 1.492 . . . . 0.0 113.554 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -112.12 167.33 10.49 Favored 'General case' 0 C--N 1.35 0.587 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 171.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 tp -64.39 -20.98 66.48 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 128.059 2.543 . . . . 0.0 112.81 -171.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 tp -67.47 -36.55 81.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.785 1.634 . . . . 0.0 112.926 171.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.22 -48.41 31.72 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 120.923 -1.111 . . . . 0.0 112.468 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.33 -42.32 4.48 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 127.823 2.449 . . . . 0.0 114.246 169.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.75 -29.89 15.8 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 120.311 -1.493 . . . . 0.0 114.355 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -74.08 -41.75 61.22 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 120.684 -1.26 . . . . 0.0 111.699 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 84.33 20.82 58.1 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 124.154 0.883 . . . . 0.0 113.14 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 35.0 m -133.71 153.48 80.12 Favored Pre-proline 0 C--N 1.346 0.421 0 O-C-N 121.155 -1.203 . . . . 0.0 110.561 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.56 -25.18 5.7 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.046 1.83 . . . . 0.0 112.907 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 33.2 p -160.08 164.01 33.42 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 120.016 -1.678 . . . . 0.0 107.427 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -144.56 163.85 32.65 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.593 1.187 . . . . 0.0 110.7 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.57 130.27 54.36 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 120.655 -1.278 . . . . 0.0 111.034 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 48.8 t -62.79 -27.92 43.94 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 O-C-N 119.711 -1.868 . . . . 0.0 111.749 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -25.87 12.67 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 125.854 1.662 . . . . 0.0 114.868 171.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -85.2 55.52 3.53 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 119.968 -1.708 . . . . 0.0 112.185 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -48.58 -44.72 37.08 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 119.229 -2.169 . . . . 0.0 115.519 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -22.81 61.93 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 172.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -87.75 -44.13 11.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.091 1.356 . . . . 0.0 109.734 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 49.6 mm -53.98 -51.9 41.47 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 C-N-CA 125.118 1.367 . . . . 0.0 111.515 174.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -53.84 -45.96 71.07 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 171.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.87 -39.59 93.79 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 119.63 -1.918 . . . . 0.0 113.627 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 24.3 mmt -60.09 -49.25 78.4 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 120.741 -1.224 . . . . 0.0 112.58 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 45.8 mt -59.6 -51.48 72.28 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 C-N-CA 124.826 1.25 . . . . 0.0 112.524 175.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -61.39 -23.4 65.76 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 119.198 -2.189 . . . . 0.0 114.407 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -77.59 -11.87 59.91 Favored 'General case' 0 C--N 1.349 0.57 0 O-C-N 119.499 -2.001 . . . . 0.0 113.503 170.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -95.86 -26.38 15.65 Favored 'General case' 0 CA--C 1.505 -0.764 0 O-C-N 119.985 -1.697 . . . . 0.0 110.403 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 73.3 mt -103.35 174.26 5.95 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 122.023 0.916 . . . . 0.0 110.603 -174.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 97.7 t -116.59 121.66 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 99.2 t . . . . . 0 C--N 1.347 0.46 0 C-N-CA 123.792 0.837 . . . . 0.0 110.331 179.829 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.515 2.808 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 50.15 47.49 41.51 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-N 120.154 1.343 . . . . 0.0 114.874 -165.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 m -114.93 114.03 24.93 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 119.769 -2.018 . . . . 0.0 112.0 -167.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.22 -151.17 5.89 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.84 70.0 4.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.286 -1.126 . . . . 0.0 113.976 -176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 p -69.51 -0.98 7.45 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 119.429 -2.044 . . . . 0.0 114.868 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -92.75 -34.39 13.93 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.619 1.568 . . . . 0.0 113.007 171.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -173.97 85.21 0.36 Allowed Pre-proline 0 C--N 1.347 0.471 0 CA-C-O 118.672 -0.68 . . . . 0.0 109.6 -175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.34 118.86 4.76 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.233 1.955 . . . . 0.0 112.05 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.1 t -107.68 -25.29 11.37 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.954 1.301 . . . . 0.0 110.039 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 t -106.02 165.63 11.08 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.384 -1.447 . . . . 0.0 113.941 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -63.3 -50.44 70.07 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 119.786 -1.822 . . . . 0.0 111.77 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.36 -45.17 72.73 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 125.867 1.667 . . . . 0.0 113.061 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -56.54 -58.43 8.08 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.617 1.567 . . . . 0.0 113.888 171.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.58 -29.52 69.59 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.321 -1.487 . . . . 0.0 113.07 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -35.63 73.81 Favored 'General case' 0 C--N 1.348 0.525 0 O-C-N 119.926 -1.734 . . . . 0.0 112.083 173.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -70.32 -44.33 68.45 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 120.532 -1.355 . . . . 0.0 112.881 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -54.32 -29.55 48.19 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 126.399 1.88 . . . . 0.0 114.862 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.4 tp -61.11 -30.34 70.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.511 1.124 . . . . 0.0 113.81 171.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 t 54.44 53.32 10.96 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 126.536 1.935 . . . . 0.0 113.043 -172.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.84 81.38 1.63 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 123.097 1.427 . . . . 0.0 113.561 -170.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.19 -29.92 0.47 Allowed Glycine 0 C--N 1.342 0.877 0 O-C-N 121.234 -0.916 . . . . 0.0 112.243 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.19 -149.23 18.73 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-N 117.797 0.798 . . . . 0.0 112.44 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.0 t -103.35 138.69 26.72 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 O-C-N 120.972 -1.311 . . . . 0.0 109.012 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.28 157.03 41.13 Favored Pre-proline 0 N--CA 1.447 -0.606 0 O-C-N 120.746 -1.221 . . . . 0.0 109.074 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.73 -1.09 10.27 Favored 'Trans proline' 0 C--N 1.336 -0.123 0 C-N-CA 122.73 2.286 . . . . 0.0 112.757 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt 66.98 53.76 0.81 Allowed 'General case' 0 C--N 1.35 0.609 0 C-N-CA 126.421 1.889 . . . . 0.0 112.704 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 pt -63.35 141.0 18.72 Favored 'Isoleucine or valine' 0 C--N 1.346 0.414 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.2 mt -85.65 29.9 0.67 Allowed 'General case' 0 C--N 1.348 0.503 0 C-N-CA 124.284 1.034 . . . . 0.0 111.825 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -86.32 143.34 27.93 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 120.179 -1.576 . . . . 0.0 109.386 172.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -88.48 133.95 33.99 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.861 0.839 . . . . 0.0 110.456 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.7 p -125.4 -175.88 3.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.001 0.92 . . . . 0.0 108.902 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -129.71 -13.34 4.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.346 -1.471 . . . . 0.0 111.774 167.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -161.89 176.03 11.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -74.2 -27.45 60.81 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.541 -1.349 . . . . 0.0 112.557 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.19 -28.25 67.81 Favored 'General case' 0 C--N 1.348 0.54 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 171.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -84.23 -8.24 59.11 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.347 -0.846 . . . . 0.0 110.701 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -111.29 124.19 33.29 Favored Pre-proline 0 C--N 1.355 0.816 0 O-C-N 120.091 -1.631 . . . . 0.0 111.9 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.28 169.63 22.07 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.147 1.898 . . . . 0.0 114.135 -169.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.69 -87.85 1.14 Allowed Glycine 0 C--N 1.349 1.266 0 C-N-CA 124.319 0.962 . . . . 0.0 112.246 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.39 21.53 0.29 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.992 0.901 . . . . 0.0 110.87 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 4.2 m -83.87 152.34 24.61 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 119.278 -2.139 . . . . 0.0 110.027 -168.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 pp -119.23 146.12 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 O-C-N 120.037 -1.664 . . . . 0.0 108.342 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.51 119.47 21.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.422 1.489 . . . . 0.0 109.298 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -79.53 177.34 8.94 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 119.984 -1.698 . . . . 0.0 110.565 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.34 -18.86 23.12 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 116.598 1.399 . . . . 0.0 116.598 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -82.17 -8.68 59.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.449 -1.03 . . . . 0.0 112.992 174.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.64 14.88 69.48 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 120.659 -1.276 . . . . 0.0 113.905 -175.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -127.56 148.57 50.34 Favored 'General case' 0 C--N 1.347 0.467 0 O-C-N 120.653 -1.498 . . . . 0.0 110.354 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 41.9 m -74.63 147.16 41.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 123.783 1.754 . . . . 0.0 114.35 -175.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.289 0 CA-C-O 116.689 -2.173 . . . . 0.0 117.435 -176.179 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.505 2.275 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 9.8 m -132.88 164.91 33.95 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 119.587 1.085 . . . . 0.0 108.665 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.29 100.49 53.51 Favored Pre-proline 0 C--N 1.344 0.348 0 CA-C-O 117.082 -1.437 . . . . 0.0 110.181 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.37 162.94 39.89 Favored 'Trans proline' 0 C--N 1.331 -0.358 0 C-N-CA 123.232 2.622 . . . . 0.0 114.006 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -89.11 156.28 49.07 Favored Pre-proline 0 C--N 1.347 0.492 0 O-C-N 121.344 -0.847 . . . . 0.0 112.613 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.65 -20.63 30.38 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.232 2.621 . . . . 0.0 113.3 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 81.1 mt -70.32 -61.14 1.89 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.706 0.803 . . . . 0.0 110.186 170.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 31.9 tp -50.74 -37.09 39.9 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 125.422 1.489 . . . . 0.0 114.427 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 8.3 tp -47.66 -40.71 20.6 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 169.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -64.35 -36.84 85.44 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 119.463 -2.023 . . . . 0.0 114.084 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -49.67 60.17 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 121.35 -0.844 . . . . 0.0 111.598 171.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 93.7 mt -52.18 -47.25 65.64 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 124.172 0.989 . . . . 0.0 113.124 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -52.74 -30.03 30.32 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.3 t -77.11 -20.6 55.47 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.602 1.161 . . . . 0.0 111.927 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.12 -9.72 9.49 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 C-N-CA 124.619 1.168 . . . . 0.0 110.606 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.97 -27.31 6.49 Favored Glycine 0 C--N 1.353 1.51 0 O-C-N 120.066 -1.646 . . . . 0.0 111.966 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -78.16 74.27 4.7 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 125.82 1.648 . . . . 0.0 114.718 -171.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -84.8 17.44 2.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 119.248 -2.157 . . . . 0.0 115.158 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.43 143.8 26.54 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 123.36 1.552 . . . . 0.0 113.021 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -20.27 64.03 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 130.093 3.357 . . . . 0.0 112.396 -177.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 31.1 p -140.44 141.27 35.48 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 125.2 1.4 . . . . 0.0 109.87 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -141.51 -173.75 3.85 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.071 -1.018 . . . . 0.0 110.443 177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 4.4 p -95.68 168.73 10.49 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.526 -1.358 . . . . 0.0 110.584 175.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 13.7 mmt -62.48 -49.19 76.37 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.731 -1.231 . . . . 0.0 113.258 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -58.94 -45.51 90.25 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 124.677 1.191 . . . . 0.0 112.206 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -56.34 -47.54 78.59 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 47.2 t -52.81 -46.08 50.97 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 O-C-N 120.135 -1.603 . . . . 0.0 112.958 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -76.46 -30.79 57.46 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 120.701 -1.249 . . . . 0.0 113.233 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -62.25 -57.24 12.17 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.667 1.587 . . . . 0.0 111.588 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -59.27 -43.03 92.51 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 123.891 0.876 . . . . 0.0 112.495 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.29 -53.7 55.25 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 120.88 -1.138 . . . . 0.0 114.017 170.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.57 -40.99 99.83 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 120.523 -1.36 . . . . 0.0 113.85 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -63.11 -38.12 89.92 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 124.877 1.271 . . . . 0.0 112.718 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -56.46 -56.88 15.71 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 124.288 1.035 . . . . 0.0 112.433 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.01 -42.39 96.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 O-C-N 120.696 -1.253 . . . . 0.0 112.665 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 37.2 ttm -54.76 -41.02 69.95 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 125.911 1.684 . . . . 0.0 113.321 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 17.2 m -87.98 -28.17 21.62 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 120.162 -1.586 . . . . 0.0 112.118 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -35.12 73.63 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 119.658 -1.901 . . . . 0.0 113.562 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? 74.91 59.04 0.07 Allowed 'General case' 0 C--N 1.353 0.725 0 C-N-CA 127.033 2.133 . . . . 0.0 110.516 -169.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mt -110.42 13.79 22.73 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-O 122.065 0.936 . . . . 0.0 111.679 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -100.68 149.87 23.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.901 1.281 . . . . 0.0 108.347 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -85.14 143.42 28.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.146 -0.971 . . . . 0.0 108.548 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -64.08 -33.21 75.23 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 120.73 -1.231 . . . . 0.0 113.067 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -98.06 -35.18 10.5 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.33 -0.856 . . . . 0.0 111.953 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -111.84 63.3 0.62 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.219 1.807 . . . . 0.0 111.912 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -62.29 -9.34 7.73 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.11 1.764 . . . . 0.0 114.764 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -90.07 -6.54 55.38 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.561 1.944 . . . . 0.0 113.695 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 33.1 mm -99.71 134.5 38.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 124.58 1.152 . . . . 0.0 109.273 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 19.8 t -122.74 128.39 75.25 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 O-C-N 120.757 -1.214 . . . . 0.0 109.763 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -89.2 102.72 15.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 120.97 -1.081 . . . . 0.0 109.818 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.56 -1.24 28.62 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 123.77 0.828 . . . . 0.0 111.305 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 1.4 t -71.81 139.41 48.94 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 120.623 -1.298 . . . . 0.0 109.817 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 17.6 m120 71.52 5.38 5.38 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -106.06 169.99 8.17 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 122.526 1.155 . . . . 0.0 109.884 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 13.8 tp -69.63 -21.38 63.57 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 127.193 2.197 . . . . 0.0 112.571 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.39 -32.82 64.67 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 120.565 -1.334 . . . . 0.0 111.89 170.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.57 -40.19 98.82 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 120.617 -1.302 . . . . 0.0 113.091 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.17 -43.14 70.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.688 2.395 . . . . 0.0 112.575 173.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.18 -33.29 20.84 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 119.873 -1.767 . . . . 0.0 114.135 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.3 -41.8 72.86 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 125.713 1.605 . . . . 0.0 111.644 179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.89 20.84 72.66 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 123.882 0.754 . . . . 0.0 113.178 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.32 151.86 78.32 Favored Pre-proline 0 C--N 1.345 0.376 0 O-C-N 121.32 -1.106 . . . . 0.0 109.371 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.33 -25.25 11.54 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.207 1.938 . . . . 0.0 111.95 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 53.6 p -161.3 165.52 28.99 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.403 -1.436 . . . . 0.0 108.6 -175.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -143.85 168.82 19.05 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 121.074 -1.016 . . . . 0.0 108.295 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 32.6 t -115.02 140.96 48.62 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.107 -0.996 . . . . 0.0 108.907 172.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 23.9 t -69.51 -22.19 25.22 Favored 'Isoleucine or valine' 0 C--N 1.347 0.493 0 CA-C-O 122.818 1.294 . . . . 0.0 111.564 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -29.62 70.72 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.163 -1.586 . . . . 0.0 112.129 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -80.46 56.98 2.71 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.754 -1.216 . . . . 0.0 112.744 175.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -52.55 -41.91 63.95 Favored 'General case' 0 C--N 1.351 0.639 0 O-C-N 119.624 -1.922 . . . . 0.0 115.555 -176.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -62.51 -33.49 74.99 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 120.54 -1.35 . . . . 0.0 113.337 173.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -78.48 -33.18 48.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.721 -1.237 . . . . 0.0 113.082 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 44.4 mm -50.13 -50.8 19.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 C-N-CA 125.633 1.573 . . . . 0.0 111.344 169.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -51.99 -52.38 50.93 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 125.218 1.407 . . . . 0.0 113.167 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.34 -42.86 82.79 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 119.996 -1.69 . . . . 0.0 115.222 173.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 11.6 mtt -62.99 -38.81 92.67 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 120.638 -1.289 . . . . 0.0 113.174 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 44.3 mt -69.35 -54.09 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.223 -0.923 . . . . 0.0 111.927 173.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -55.53 -27.6 49.83 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 120.304 -1.497 . . . . 0.0 114.62 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -63.06 -19.53 64.48 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.898 -1.751 . . . . 0.0 115.599 171.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.0 -2.17 17.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.994 0.918 . . . . 0.0 112.169 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 92.6 mt -108.84 151.2 26.57 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 122.693 1.235 . . . . 0.0 110.199 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 16.0 t -95.98 114.29 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 O-C-N 120.315 -1.491 . . . . 0.0 108.914 173.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.35 0.601 0 C-N-CA 124.031 0.932 . . . . 0.0 111.396 179.35 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.262 87.6 p . . . . . 0 N--CA 1.532 3.626 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 55.77 53.05 44.5 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 m -107.68 113.35 26.56 Favored 'General case' 0 CA--C 1.51 -0.573 0 O-C-N 119.884 -1.951 . . . . 0.0 112.38 -173.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.48 -149.87 5.54 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.94 70.72 5.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 121.09 -1.241 . . . . 0.0 113.27 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 11.0 p -68.65 3.99 1.62 Allowed 'General case' 0 C--N 1.346 0.447 0 O-C-N 119.721 -1.862 . . . . 0.0 115.496 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -100.81 -39.29 7.88 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.538 1.935 . . . . 0.0 111.15 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -167.58 84.79 0.79 Allowed Pre-proline 0 N--CA 1.447 -0.583 0 O-C-N 121.402 -0.812 . . . . 0.0 109.629 -175.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.96 120.22 5.37 Favored 'Trans proline' 0 C--N 1.327 -0.599 0 C-N-CA 121.981 1.787 . . . . 0.0 112.199 -177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -107.33 -37.94 6.1 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.557 1.143 . . . . 0.0 110.109 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 m -94.04 163.67 13.38 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 120.244 -1.535 . . . . 0.0 114.841 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -60.42 -49.81 76.09 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 125.657 1.583 . . . . 0.0 111.295 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.04 -46.82 78.74 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 123.791 0.836 . . . . 0.0 113.155 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -55.09 -58.17 8.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.2 1.4 . . . . 0.0 114.422 171.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -31.98 73.25 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 120.603 -1.311 . . . . 0.0 112.947 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -57.2 -37.85 72.82 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 120.308 -1.495 . . . . 0.0 112.918 170.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -68.28 -40.54 81.79 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.369 -1.457 . . . . 0.0 112.753 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -56.45 -29.03 61.18 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 126.382 1.873 . . . . 0.0 114.987 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.9 tp -64.98 -18.92 65.7 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 125.286 1.434 . . . . 0.0 113.676 174.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.296 59.8 p 53.85 32.02 14.28 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 126.653 1.981 . . . . 0.0 115.463 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.7 93.71 0.01 OUTLIER 'General case' 0 C--N 1.353 0.72 0 C-N-CA 126.868 2.067 . . . . 0.0 115.784 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.33 -38.03 1.26 Allowed Glycine 0 C--N 1.345 1.078 0 O-C-N 121.341 -0.85 . . . . 0.0 111.892 -169.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.68 -139.6 14.67 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 122.469 1.038 . . . . 0.0 112.528 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -97.68 145.09 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 O-C-N 120.789 -1.418 . . . . 0.0 110.452 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.35 157.7 66.78 Favored Pre-proline 0 N--CA 1.448 -0.541 0 O-C-N 120.531 -1.356 . . . . 0.0 108.168 -175.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.93 -7.82 21.32 Favored 'Trans proline' 0 CA--C 1.52 -0.188 0 C-N-CA 122.579 2.186 . . . . 0.0 112.649 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 mtmt 68.7 53.29 0.53 Allowed 'General case' 0 C--N 1.352 0.688 0 C-N-CA 126.122 1.769 . . . . 0.0 112.066 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.6 pt -64.21 142.03 17.4 Favored 'Isoleucine or valine' 0 C--N 1.347 0.486 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.34 9.94 9.77 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-O 122.545 1.164 . . . . 0.0 112.69 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -70.93 134.65 47.4 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 120.415 -1.428 . . . . 0.0 112.389 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -81.28 124.41 29.3 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 121.71 -0.619 . . . . 0.0 111.797 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.1 p -115.82 -175.86 2.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.34 1.456 . . . . 0.0 109.772 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -122.14 -32.41 3.69 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 120.528 -1.358 . . . . 0.0 110.125 163.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -138.22 176.28 8.84 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 120.613 -1.304 . . . . 0.0 112.427 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -81.03 -5.02 57.11 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 118.898 -2.376 . . . . 0.0 113.262 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.0 t -76.32 -46.76 26.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.457 2.303 . . . . 0.0 109.576 172.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -32.52 67.24 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 128.127 2.571 . . . . 0.0 113.777 177.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.76 120.3 64.9 Favored Pre-proline 0 N--CA 1.447 -0.591 0 O-C-N 120.528 -1.357 . . . . 0.0 112.776 -172.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.78 169.16 23.01 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.487 2.125 . . . . 0.0 114.108 -168.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.15 -89.67 1.1 Allowed Glycine 0 C--N 1.349 1.286 0 C-N-CA 124.195 0.903 . . . . 0.0 111.912 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.17 29.91 0.17 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.74 1.257 . . . . 0.0 109.975 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.9 m -88.66 145.26 25.77 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 119.016 -2.302 . . . . 0.0 109.415 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 pp -111.92 146.04 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 O-C-N 119.766 -1.834 . . . . 0.0 109.564 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -77.92 120.26 22.53 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.737 1.615 . . . . 0.0 110.041 176.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -76.41 174.78 9.83 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 119.846 -1.784 . . . . 0.0 111.077 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.89 -2.89 2.89 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 117.1 1.6 . . . . 0.0 117.1 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.21 -9.0 24.26 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.976 1.31 . . . . 0.0 112.04 172.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.56 25.43 35.83 Favored Glycine 0 C--N 1.35 1.313 0 O-C-N 120.641 -1.287 . . . . 0.0 114.26 -176.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -135.93 150.29 49.25 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 120.724 -1.456 . . . . 0.0 111.465 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.9 m -85.66 116.18 23.78 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 -169.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.263 0 CA-C-O 116.063 -2.521 . . . . 0.0 116.357 175.141 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 N--CA 1.504 2.235 0 CA-C-O 118.288 -0.863 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 12.8 m -139.16 164.97 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 176.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -113.97 103.5 55.19 Favored Pre-proline 0 C--N 1.344 0.368 0 CA-C-O 116.754 -1.593 . . . . 0.0 110.271 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.56 163.93 37.16 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 122.864 2.376 . . . . 0.0 114.196 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -84.66 153.64 61.34 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.151 0.98 . . . . 0.0 113.167 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.98 -17.29 28.68 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.164 2.576 . . . . 0.0 113.34 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -71.54 -57.9 3.99 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 123.992 0.917 . . . . 0.0 109.288 169.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 28.8 tp -54.12 -38.45 65.44 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 125.678 1.591 . . . . 0.0 114.478 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 14.6 tp -46.24 -39.68 10.27 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 125.396 1.479 . . . . 0.0 114.682 168.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -69.04 -37.53 78.64 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 119.193 -2.192 . . . . 0.0 113.05 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.43 -53.32 24.43 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 126.779 2.032 . . . . 0.0 111.942 169.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 76.9 mt -49.89 -45.62 50.93 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.72 1.208 . . . . 0.0 112.513 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . 0.457 ' HZ3' ' HB3' ' B' ' 104' ' ' LYS . 0.0 OUTLIER -63.95 -17.32 63.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 174.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 20.4 t -83.02 -8.66 59.53 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 120.021 -1.674 . . . . 0.0 112.034 171.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.2 t -105.34 -7.67 9.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 C-N-CA 124.766 1.226 . . . . 0.0 110.048 176.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.58 -16.91 18.87 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 120.459 -1.4 . . . . 0.0 112.558 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.45 79.84 8.85 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.401 -1.647 . . . . 0.0 113.45 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -82.58 5.76 19.88 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.804 -1.81 . . . . 0.0 115.324 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 139.14 31.56 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -174.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.51 -11.67 61.07 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.765 2.026 . . . . 0.0 114.413 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 39.9 p -138.59 137.03 36.58 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.081 1.352 . . . . 0.0 111.297 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -139.35 -172.92 3.46 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 120.798 -1.189 . . . . 0.0 110.092 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 1.8 p -96.88 173.12 7.45 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.048 -1.657 . . . . 0.0 109.93 174.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 24.7 mtt -67.15 -43.67 81.72 Favored 'General case' 0 C--N 1.352 0.699 0 O-C-N 120.161 -1.587 . . . . 0.0 113.46 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -58.73 -51.33 70.42 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.237 1.015 . . . . 0.0 111.603 172.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -54.56 -44.1 72.63 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 86.2 t -54.72 -43.53 66.78 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 120.121 -1.612 . . . . 0.0 112.568 176.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.3 -30.91 27.18 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 120.729 -1.232 . . . . 0.0 112.344 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -59.93 -60.86 3.16 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.949 1.7 . . . . 0.0 112.123 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -56.96 -38.23 72.69 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.41 1.084 . . . . 0.0 112.286 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 32.3 tp -64.68 -51.44 62.48 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 172.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.33 -40.29 91.84 Favored Glycine 0 C--N 1.349 1.297 0 O-C-N 119.928 -1.732 . . . . 0.0 114.019 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -30.31 71.33 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 124.724 1.21 . . . . 0.0 112.177 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.44 ' CZ ' ' HD2' ' B' ' 129' ' ' LYS . 7.9 t80 -57.55 -60.95 2.89 Favored 'General case' 0 C--N 1.357 0.91 0 O-C-N 120.833 -1.167 . . . . 0.0 111.669 171.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 45.1 mm -58.41 -40.69 79.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 O-C-N 120.584 -1.322 . . . . 0.0 113.343 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 35.7 ttm -52.55 -43.27 65.08 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 125.077 1.351 . . . . 0.0 113.867 171.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 22.3 m -87.7 -31.88 19.48 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 124.727 1.211 . . . . 0.0 112.534 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . 0.44 ' HD2' ' CZ ' ' B' ' 125' ' ' TYR . 5.2 mmpt? -77.54 -25.42 50.16 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 120.027 -1.671 . . . . 0.0 114.306 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.98 53.67 0.19 Allowed 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.663 1.585 . . . . 0.0 111.38 -176.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.74 19.62 18.44 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.423 1.089 . . . . 0.0 110.627 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -105.09 146.46 29.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.56 -1.338 . . . . 0.0 107.998 173.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.48 139.68 45.92 Favored 'General case' 0 C--N 1.347 0.461 0 O-C-N 120.789 -1.195 . . . . 0.0 110.043 171.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -59.95 -47.16 86.92 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 120.22 -1.55 . . . . 0.0 113.177 174.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -83.09 -19.99 35.73 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.844 1.258 . . . . 0.0 113.973 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -132.83 61.92 1.66 Allowed 'General case' 0 C--N 1.352 0.707 0 O-C-N 120.589 -1.319 . . . . 0.0 109.855 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -64.46 -6.15 6.77 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -175.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -89.97 -8.1 52.49 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.586 1.955 . . . . 0.0 113.315 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 47.8 mm -96.44 136.49 27.13 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 124.93 1.292 . . . . 0.0 109.303 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 17.2 t -121.75 123.76 70.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 O-C-N 120.856 -1.152 . . . . 0.0 110.202 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -86.22 113.82 22.54 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.653 1.181 . . . . 0.0 109.183 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 16.0 m -115.11 1.24 13.84 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 120.623 -1.298 . . . . 0.0 111.174 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 34.1 t -73.42 126.8 31.01 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.468 -1.395 . . . . 0.0 110.21 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 75.05 23.9 1.57 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.795 1.238 . . . . 0.0 112.01 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -128.39 165.29 20.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 tp -70.83 -16.89 62.75 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 126.844 2.058 . . . . 0.0 112.143 -170.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.25 -40.95 70.69 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.511 1.524 . . . . 0.0 111.841 169.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.97 -41.81 99.69 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 120.368 -1.458 . . . . 0.0 112.895 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -53.46 -33.64 54.93 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.189 2.196 . . . . 0.0 114.403 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.79 -33.01 11.83 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 120.055 -1.653 . . . . 0.0 113.158 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -78.79 -34.01 45.8 Favored 'General case' 0 C--N 1.35 0.629 0 O-C-N 121.044 -1.035 . . . . 0.0 113.108 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 79.91 15.06 79.9 Favored Glycine 0 C--N 1.35 1.319 0 O-C-N 121.315 -0.866 . . . . 0.0 113.898 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 20.5 m -131.35 151.75 79.33 Favored Pre-proline 0 C--N 1.345 0.38 0 O-C-N 121.055 -1.262 . . . . 0.0 109.844 -174.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.48 -33.11 4.36 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.907 1.738 . . . . 0.0 112.621 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 19.3 m -150.43 161.62 42.14 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -175.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -135.34 163.82 29.14 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.456 -0.777 . . . . 0.0 109.435 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 46.0 t -110.4 129.18 55.82 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 30.6 t -61.31 -28.76 44.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 O-C-N 120.818 -1.176 . . . . 0.0 112.219 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -54.21 -29.26 45.54 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 126.075 1.75 . . . . 0.0 114.795 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.59 54.58 2.41 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 120.575 -1.328 . . . . 0.0 111.75 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -47.97 -46.2 32.2 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 119.96 -1.713 . . . . 0.0 114.428 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -58.47 -38.51 77.71 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 125.365 1.466 . . . . 0.0 114.561 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -72.96 -45.33 58.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.758 0.823 . . . . 0.0 112.038 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 18.9 mt -55.64 -50.55 66.44 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 C-N-CA 125.188 1.395 . . . . 0.0 110.342 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -51.09 -52.14 46.49 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 124.681 1.192 . . . . 0.0 114.122 171.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 1.3 p -58.49 -38.3 77.35 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 119.544 -1.972 . . . . 0.0 115.031 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -42.55 89.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.322 -0.861 . . . . 0.0 112.048 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 31.5 mt -60.67 -52.43 61.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 O-C-N 120.438 -1.413 . . . . 0.0 112.052 173.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -64.31 -4.81 4.13 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -89.22 -27.06 20.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 119.641 -1.912 . . . . 0.0 113.342 168.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -88.06 -20.44 25.74 Favored 'General case' 0 CA--C 1.509 -0.621 0 O-C-N 121.247 -0.908 . . . . 0.0 111.489 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 70.4 mt -108.1 147.24 31.5 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 125.071 1.348 . . . . 0.0 111.705 -174.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 56.2 t -90.78 122.65 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 120.749 -1.219 . . . . 0.0 109.355 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 93.8 t . . . . . 0 C--N 1.35 0.617 0 C-N-CA 124.606 1.162 . . . . 0.0 110.38 176.467 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.518 2.931 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 45.34 60.54 4.07 Favored Glycine 0 C--N 1.355 1.631 0 CA-C-N 120.113 1.324 . . . . 0.0 113.986 -164.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.7 m -123.46 106.22 10.45 Favored 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 120.005 -1.88 . . . . 0.0 112.084 -166.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.33 -155.03 7.62 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.02 68.58 2.52 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.3 t -55.21 -27.92 49.49 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 126.113 1.765 . . . . 0.0 113.583 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -76.32 -29.51 57.34 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -178.6 87.32 0.22 Allowed Pre-proline 0 C--N 1.351 0.643 0 O-C-N 121.146 -0.971 . . . . 0.0 110.434 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -78.61 120.85 4.91 Favored 'Trans proline' 0 C--N 1.327 -0.554 0 C-N-CA 122.319 2.013 . . . . 0.0 112.854 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.9 t -120.57 6.63 10.55 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.248 1.819 . . . . 0.0 110.214 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 m -135.62 156.37 48.97 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 119.507 -1.996 . . . . 0.0 112.92 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -55.83 -45.9 78.24 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 120.352 -1.467 . . . . 0.0 112.919 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.44 94.7 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 125.216 1.406 . . . . 0.0 113.069 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -61.95 -53.91 49.08 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 120.39 -1.444 . . . . 0.0 113.317 172.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.91 -30.46 69.8 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.345 -0.847 . . . . 0.0 113.152 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.4 t90 -54.21 -45.08 72.15 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 120.097 -1.627 . . . . 0.0 113.389 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -62.34 -41.39 98.54 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 120.977 -1.077 . . . . 0.0 113.8 174.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -55.16 -32.52 62.21 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 126.197 1.799 . . . . 0.0 114.629 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.6 tp -56.71 -28.13 60.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.376 1.471 . . . . 0.0 113.803 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p 71.04 17.91 6.04 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.54 2.336 . . . . 0.0 113.951 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.86 93.32 0.01 OUTLIER 'General case' 0 C--N 1.351 0.647 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 -164.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.86 -31.35 1.76 Allowed Glycine 0 C--N 1.345 1.077 0 O-C-N 121.034 -1.041 . . . . 0.0 111.96 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.4 -150.3 16.95 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-O 122.807 1.226 . . . . 0.0 112.407 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 t -97.27 139.89 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 120.913 -1.345 . . . . 0.0 109.458 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.16 156.48 48.51 Favored Pre-proline 0 N--CA 1.45 -0.453 0 O-C-N 120.438 -1.414 . . . . 0.0 108.64 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.69 8.33 2.35 Favored 'Trans proline' 0 N--CA 1.47 0.109 0 C-N-CA 123.058 2.505 . . . . 0.0 113.119 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? 61.45 47.32 6.8 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 125.85 1.66 . . . . 0.0 114.499 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.9 pt -60.78 140.93 17.89 Favored 'Isoleucine or valine' 0 C--N 1.349 0.576 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.5 mt -87.91 24.2 1.84 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-O 122.612 1.196 . . . . 0.0 111.743 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -80.95 138.42 36.1 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 120.428 -1.42 . . . . 0.0 110.49 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -86.85 120.92 28.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.656 -0.652 . . . . 0.0 111.524 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.3 p -109.29 -179.36 3.81 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.082 1.353 . . . . 0.0 110.109 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -119.92 -28.46 5.17 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 120.491 -1.38 . . . . 0.0 110.15 162.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -146.76 173.67 12.16 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 122.931 1.348 . . . . 0.0 113.271 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -73.65 -12.2 60.66 Favored 'General case' 0 C--N 1.346 0.435 0 O-C-N 119.842 -1.786 . . . . 0.0 113.839 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.3 p -78.16 -29.31 48.6 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 126.727 2.011 . . . . 0.0 111.79 173.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.66 -28.75 45.45 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.55 1.54 . . . . 0.0 109.728 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -94.39 119.47 66.4 Favored Pre-proline 0 N--CA 1.445 -0.685 0 O-C-N 120.953 -1.092 . . . . 0.0 113.078 -173.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.71 171.47 17.74 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.526 2.151 . . . . 0.0 114.525 -166.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.23 -84.95 1.14 Allowed Glycine 0 C--N 1.35 1.322 0 C-N-CA 124.345 0.974 . . . . 0.0 112.361 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.69 6.65 0.47 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.9 m -73.82 178.57 4.76 Favored 'General case' 0 C--N 1.347 0.496 0 O-C-N 120.353 -1.467 . . . . 0.0 112.656 -160.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 pp -141.38 149.4 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -86.88 111.68 21.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 126.338 1.855 . . . . 0.0 108.675 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -76.13 172.95 11.95 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 118.91 -2.369 . . . . 0.0 110.827 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.94 -19.36 6.93 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 117.548 1.779 . . . . 0.0 117.548 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -85.8 -8.51 58.07 Favored 'General case' 0 C--N 1.345 0.375 0 O-C-N 121.288 -1.125 . . . . 0.0 113.418 174.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.31 27.55 39.54 Favored Glycine 0 C--N 1.348 1.224 0 O-C-N 120.755 -1.216 . . . . 0.0 114.256 -175.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -137.3 146.69 44.97 Favored 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 120.942 -1.328 . . . . 0.0 110.917 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 83.1 m -78.45 135.95 37.51 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 123.747 1.736 . . . . 0.0 115.232 -170.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.347 0 CA-C-O 115.69 -2.728 . . . . 0.0 116.946 -175.097 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 15.0 m -133.21 170.28 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 119.126 0.876 . . . . 0.0 109.517 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 101.9 51.43 Favored Pre-proline 0 C--N 1.344 0.338 0 CA-C-O 116.849 -1.548 . . . . 0.0 110.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.32 164.23 35.84 Favored 'Trans proline' 0 C--N 1.326 -0.633 0 CA-C-N 123.871 2.418 . . . . 0.0 113.675 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -84.77 153.59 60.94 Favored Pre-proline 0 C--N 1.35 0.616 0 C-N-CA 123.905 0.882 . . . . 0.0 112.605 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.33 -24.27 27.24 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.312 2.675 . . . . 0.0 113.089 -172.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 mt -66.09 -54.48 25.21 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 121.365 -0.834 . . . . 0.0 110.698 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -56.82 -39.26 73.86 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 125.118 1.367 . . . . 0.0 113.663 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 15.8 tp -45.8 -40.62 9.92 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 125.37 1.468 . . . . 0.0 114.925 170.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 29.1 tttp -67.81 -34.79 77.43 Favored 'General case' 0 C--N 1.348 0.514 0 O-C-N 119.889 -1.757 . . . . 0.0 113.375 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.1 -50.25 35.63 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 124.887 1.275 . . . . 0.0 111.247 171.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 91.2 mt -55.17 -42.27 72.95 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 121.146 -0.972 . . . . 0.0 112.302 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.4 -26.05 67.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 175.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 4.0 t -77.93 -13.53 59.85 Favored 'General case' 0 C--N 1.344 0.369 0 O-C-N 120.958 -1.089 . . . . 0.0 112.425 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 5.2 t -97.37 -9.22 9.07 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 C-N-CA 125.154 1.382 . . . . 0.0 109.868 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.65 -20.06 10.27 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 120.465 -1.397 . . . . 0.0 112.514 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -89.28 91.52 8.79 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 120.514 -1.58 . . . . 0.0 112.215 -171.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -95.09 17.87 13.24 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 119.185 -2.197 . . . . 0.0 116.166 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -97.42 143.0 28.58 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.471 1.108 . . . . 0.0 112.937 -171.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.18 9.89 4.11 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 119.769 -1.832 . . . . 0.0 115.677 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.4 p -149.31 131.56 15.52 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 120.381 -1.45 . . . . 0.0 111.186 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -132.74 178.81 6.57 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-O 122.939 1.352 . . . . 0.0 110.814 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.04 163.64 14.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.658 1.583 . . . . 0.0 109.854 170.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 48.4 mtm -62.55 -48.77 78.06 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 119.012 -2.305 . . . . 0.0 113.812 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -60.91 -42.53 98.23 Favored 'General case' 0 C--N 1.349 0.562 0 O-C-N 121.274 -0.892 . . . . 0.0 113.176 173.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -50.94 -48.25 60.92 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.893 1.677 . . . . 0.0 114.804 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -52.45 -49.99 41.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 125.209 1.403 . . . . 0.0 111.884 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -75.01 -32.17 61.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 120.918 -1.114 . . . . 0.0 113.011 178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -62.14 -57.81 10.16 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.557 1.543 . . . . 0.0 111.72 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -57.34 -44.13 84.02 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 123.977 0.911 . . . . 0.0 112.396 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.5 -54.0 50.77 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.41 -44.91 94.64 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 120.126 -1.609 . . . . 0.0 113.657 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -63.77 -32.43 73.93 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 124.139 0.976 . . . . 0.0 112.798 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -57.1 -57.91 10.51 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 120.842 -1.161 . . . . 0.0 112.262 170.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 38.1 mm -63.94 -41.41 92.41 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 O-C-N 120.392 -1.443 . . . . 0.0 112.566 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 46.9 ttm -54.56 -43.9 72.42 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 126.117 1.767 . . . . 0.0 113.705 172.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 20.5 m -86.96 -24.5 24.71 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 120.718 -1.239 . . . . 0.0 112.597 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -75.12 -26.74 59.45 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 119.702 -1.874 . . . . 0.0 113.173 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? 72.04 53.51 0.19 Allowed 'General case' 0 C--N 1.354 0.785 0 C-N-CA 126.113 1.765 . . . . 0.0 110.895 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.54 9.43 33.43 Favored 'General case' 0 C--N 1.348 0.514 0 O-C-N 121.1 -1.0 . . . . 0.0 111.848 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -93.34 146.57 23.63 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.41 160.93 31.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.842 -0.536 . . . . 0.0 110.423 173.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -76.57 -34.92 58.45 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 120.97 -1.081 . . . . 0.0 112.104 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -91.34 -44.87 8.91 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.426 -1.421 . . . . 0.0 110.929 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -107.67 57.12 0.63 Allowed 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.026 1.33 . . . . 0.0 111.721 -173.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -63.09 -11.77 22.16 Favored 'General case' 0 C--N 1.347 0.474 0 O-C-N 120.125 -1.609 . . . . 0.0 114.86 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -86.91 -4.03 59.14 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.343 1.457 . . . . 0.0 113.403 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 47.7 mm -101.55 137.13 30.34 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 C-N-CA 124.988 1.315 . . . . 0.0 108.991 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 16.7 t -123.8 123.34 66.8 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 120.85 -1.156 . . . . 0.0 110.701 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -93.33 113.92 26.22 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 121.192 -0.942 . . . . 0.0 110.101 173.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 16.5 m -115.37 20.92 14.5 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 121.191 -0.943 . . . . 0.0 110.334 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 71.3 p -74.76 140.14 43.85 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 120.11 -1.619 . . . . 0.0 109.862 171.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 3.4 t30 64.75 29.01 12.91 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -138.34 164.47 29.22 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 7.7 tp -70.8 -14.46 62.43 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-O 124.393 2.044 . . . . 0.0 113.536 -165.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.01 -35.71 69.5 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.946 1.699 . . . . 0.0 111.892 170.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.21 -43.22 99.41 Favored Glycine 0 C--N 1.348 1.201 0 O-C-N 120.096 -1.627 . . . . 0.0 113.029 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -53.15 -34.27 56.12 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 126.596 1.958 . . . . 0.0 114.731 172.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 pp -95.89 -31.24 13.23 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 119.538 -1.976 . . . . 0.0 113.402 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -77.9 -42.41 33.35 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.737 1.215 . . . . 0.0 112.513 178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 83.82 15.91 69.2 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 121.427 -0.795 . . . . 0.0 113.932 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 32.7 m -131.45 151.55 78.93 Favored Pre-proline 0 C--N 1.343 0.31 0 O-C-N 121.216 -1.167 . . . . 0.0 109.787 -174.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.18 -30.29 5.68 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.811 1.674 . . . . 0.0 112.653 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 87.2 p -154.0 169.4 23.57 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -138.74 165.61 26.54 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.204 1.002 . . . . 0.0 109.289 172.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 26.6 t -109.33 128.76 55.35 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.28 -31.84 51.39 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 O-C-N 120.623 -1.298 . . . . 0.0 111.739 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -58.75 -22.03 56.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.818 2.047 . . . . 0.0 114.463 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -82.4 58.49 4.13 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 120.404 -1.435 . . . . 0.0 112.071 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -49.17 -45.26 43.77 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.027 -1.671 . . . . 0.0 114.132 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -61.33 -33.07 73.01 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 120.64 -1.288 . . . . 0.0 114.234 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -73.95 -46.24 45.36 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 120.326 -1.484 . . . . 0.0 110.955 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 33.0 mm -50.5 -57.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.351 0.671 0 C-N-CA 125.173 1.389 . . . . 0.0 112.44 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -49.2 -46.16 45.26 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 171.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 31.9 m -62.91 -39.58 94.97 Favored 'General case' 0 C--N 1.346 0.429 0 O-C-N 120.543 -1.348 . . . . 0.0 113.379 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -44.94 88.1 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.388 -1.445 . . . . 0.0 111.752 177.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 22.0 mt -57.27 -53.11 48.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 C-N-CA 125.473 1.509 . . . . 0.0 112.291 174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -62.74 -11.92 20.66 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.274 -1.516 . . . . 0.0 114.835 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -85.47 -11.65 53.79 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 119.394 -2.066 . . . . 0.0 113.571 169.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -105.04 -21.24 13.31 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 120.194 -1.567 . . . . 0.0 109.883 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 73.2 mt -110.92 151.67 27.64 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 126.111 1.764 . . . . 0.0 110.809 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 61.0 t -96.17 119.63 44.48 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 O-C-N 120.473 -1.392 . . . . 0.0 108.954 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 56.3 t . . . . . 0 C--N 1.348 0.541 0 C-N-CA 124.166 0.986 . . . . 0.0 110.919 177.169 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.519 3.024 0 CA-C-O 116.743 -1.599 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 48.93 39.23 25.24 Favored Glycine 0 C--N 1.357 1.701 0 CA-C-N 120.23 1.377 . . . . 0.0 115.353 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.7 m -118.18 120.06 36.57 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.507 -1.584 . . . . 0.0 111.177 -167.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.05 -148.99 5.91 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.25 78.03 3.78 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 120.996 -1.297 . . . . 0.0 113.239 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.2 t -72.95 3.05 5.76 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 119.435 -2.041 . . . . 0.0 115.457 -175.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -100.74 -44.61 5.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.614 -1.304 . . . . 0.0 110.958 173.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -150.52 85.96 5.18 Favored Pre-proline 0 N--CA 1.443 -0.798 0 O-C-N 121.552 -0.717 . . . . 0.0 109.319 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.84 108.98 2.76 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.273 1.982 . . . . 0.0 110.982 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 t -101.88 -19.89 15.1 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.041 0.936 . . . . 0.0 110.413 -174.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.3 m -120.51 164.64 16.12 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-O 122.797 1.284 . . . . 0.0 113.617 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -61.51 -49.65 75.88 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 126.316 1.846 . . . . 0.0 110.978 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.36 78.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.055 0.942 . . . . 0.0 113.511 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -68.91 -52.71 26.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 121.269 -0.895 . . . . 0.0 112.628 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -29.13 69.79 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 120.695 -1.253 . . . . 0.0 112.574 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -53.05 -38.28 62.32 Favored 'General case' 0 C--N 1.346 0.452 0 O-C-N 120.439 -1.413 . . . . 0.0 113.796 167.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -73.49 -37.23 65.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.416 -1.427 . . . . 0.0 112.726 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -60.2 -24.02 64.47 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.992 1.317 . . . . 0.0 114.493 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.3 tp -67.84 -23.74 65.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.689 -1.257 . . . . 0.0 112.303 172.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 t 55.26 44.01 28.21 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 127.314 2.246 . . . . 0.0 112.936 -175.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.6 85.25 0.02 OUTLIER 'General case' 0 C--N 1.353 0.748 0 C-N-CA 127.17 2.188 . . . . 0.0 113.92 -172.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.73 -41.82 0.55 Allowed Glycine 0 CA--C 1.492 -1.376 0 O-C-N 121.057 -1.027 . . . . 0.0 112.807 -164.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.77 -142.62 16.09 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.6 p -94.28 135.67 27.93 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 O-C-N 120.562 -1.552 . . . . 0.0 110.445 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.1 t -129.79 145.42 56.98 Favored Pre-proline 0 C--N 1.347 0.486 0 CA-C-O 115.81 -2.043 . . . . 0.0 106.783 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -66.22 -2.36 6.88 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 124.428 3.418 . . . . 0.0 117.47 -164.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.69 52.93 0.41 Allowed 'General case' 0 C--N 1.349 0.582 0 C-N-CA 125.293 1.437 . . . . 0.0 112.48 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.3 pt -70.06 140.59 18.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.466 0 O-C-N 120.299 -1.5 . . . . 0.0 114.093 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.1 mt -88.95 33.76 0.78 Allowed 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.132 -0.98 . . . . 0.0 111.282 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -88.69 131.42 35.02 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 119.945 -1.722 . . . . 0.0 109.394 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.16 108.27 7.8 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 122.238 1.018 . . . . 0.0 111.072 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.0 p -107.3 -161.29 0.77 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.569 1.548 . . . . 0.0 111.391 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -150.45 -37.38 0.14 Allowed 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.619 -1.926 . . . . 0.0 109.47 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -133.51 174.85 9.98 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 171.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -74.15 -2.32 24.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 119.141 -2.225 . . . . 0.0 115.273 -172.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.5 m -90.15 -40.28 12.33 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 125.657 1.583 . . . . 0.0 111.934 -173.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.64 -29.8 68.36 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 123.281 1.515 . . . . 0.0 110.897 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 15.3 t -90.71 109.16 32.56 Favored Pre-proline 0 N--CA 1.443 -0.785 0 C-N-CA 125.429 1.492 . . . . 0.0 111.255 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.87 171.73 17.62 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.449 2.099 . . . . 0.0 115.294 -160.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.83 -93.26 1.58 Allowed Glycine 0 C--N 1.347 1.172 0 C-N-CA 124.271 0.939 . . . . 0.0 112.49 173.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.44 24.88 0.35 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 122.964 1.364 . . . . 0.0 111.096 -176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 54.4 m -88.57 153.37 21.18 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 119.95 -1.719 . . . . 0.0 108.058 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.4 pp -119.83 154.58 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 170.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.3 m -85.11 134.51 34.19 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.1 mtt85 -82.8 168.89 16.71 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.624 -1.297 . . . . 0.0 108.356 167.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -32.8 -43.48 0.18 Allowed Glycine 0 C--N 1.353 1.508 0 N-CA-C 119.33 2.492 . . . . 0.0 119.33 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -74.07 8.43 2.09 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.92 36.38 90.94 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 119.915 -1.741 . . . . 0.0 114.191 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -135.61 147.27 48.6 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 122.08 0.943 . . . . 0.0 108.609 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.1 m -78.45 130.77 36.45 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 125.212 2.434 . . . . 0.0 113.933 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.274 0 N-CA-C 105.716 -2.954 . . . . 0.0 105.716 -177.87 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 20.7 m -120.72 167.27 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 119.496 1.044 . . . . 0.0 109.217 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -141.54 114.83 6.76 Favored Pre-proline 0 C--N 1.35 0.619 0 CA-C-O 116.694 -1.622 . . . . 0.0 108.181 170.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.73 168.12 25.54 Favored 'Trans proline' 0 C--N 1.328 -0.504 0 CA-C-N 123.822 2.401 . . . . 0.0 112.747 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -84.71 159.54 57.82 Favored Pre-proline 0 C--N 1.346 0.439 0 O-C-N 120.891 -1.13 . . . . 0.0 111.698 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -68.48 -25.16 35.56 Favored 'Trans proline' 0 CA--C 1.521 -0.159 0 C-N-CA 122.781 2.32 . . . . 0.0 114.275 -170.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.05 -42.31 99.68 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.238 0.926 . . . . 0.0 110.526 170.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 17.2 tp -72.45 -34.98 68.14 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 120.191 -1.568 . . . . 0.0 113.11 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 33.0 tp -53.3 -42.07 66.26 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.154 -1.591 . . . . 0.0 113.622 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -62.42 -30.85 71.52 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 120.47 -1.394 . . . . 0.0 113.82 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 24.0 tp -67.66 -61.37 1.92 Allowed 'General case' 0 C--N 1.35 0.619 0 C-N-CA 123.672 0.789 . . . . 0.0 110.335 172.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.29 -49.22 61.69 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 126.39 1.876 . . . . 0.0 113.305 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -14.27 61.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 120.088 -1.632 . . . . 0.0 114.871 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -85.34 -6.92 59.2 Favored 'General case' 0 C--N 1.346 0.413 0 O-C-N 120.047 -1.658 . . . . 0.0 112.234 168.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 15.2 t -94.37 -5.62 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.944 1.298 . . . . 0.0 109.061 163.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.98 -13.36 31.76 Favored Glycine 0 C--N 1.354 1.57 0 O-C-N 119.816 -1.802 . . . . 0.0 113.393 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.11 69.59 10.51 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 120.757 -1.437 . . . . 0.0 113.888 -173.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . 0.25 3.3 pm0 -78.68 76.74 5.18 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 119.61 -1.931 . . . . 0.0 110.959 165.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -151.06 124.5 8.93 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 120.815 -1.178 . . . . 0.0 109.239 168.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.89 -49.43 65.91 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 128.165 2.586 . . . . 0.0 113.475 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 22.6 p -94.48 90.22 6.13 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.139 -1.6 . . . . 0.0 114.755 -169.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -104.32 173.21 6.4 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-O 123.67 1.7 . . . . 0.0 114.522 171.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 32.7 m -96.34 159.52 14.9 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 127.281 2.233 . . . . 0.0 109.985 -173.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 2.4 mmt -53.7 -45.96 70.59 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -63.18 -50.0 72.07 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 120.583 -1.323 . . . . 0.0 112.149 170.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -54.49 -42.36 70.65 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -173.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 47.3 t -58.52 -30.91 42.28 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 O-C-N 120.927 -1.108 . . . . 0.0 111.563 175.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.2 -33.37 14.72 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.261 1.025 . . . . 0.0 112.161 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -56.89 -64.68 0.8 Allowed 'General case' 0 C--N 1.352 0.675 0 O-C-N 119.954 -1.716 . . . . 0.0 113.028 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -56.86 -39.86 75.08 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 124.278 1.031 . . . . 0.0 112.221 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 27.1 tp -63.44 -52.66 60.52 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 120.713 -1.242 . . . . 0.0 113.254 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.77 -41.31 93.73 Favored Glycine 0 C--N 1.349 1.276 0 O-C-N 120.099 -1.625 . . . . 0.0 114.022 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -56.52 -43.46 79.8 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 125.732 1.613 . . . . 0.0 112.85 173.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -54.83 -55.65 27.96 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.585 1.154 . . . . 0.0 112.459 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 3.5 mp -63.95 -43.29 97.65 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 O-C-N 120.35 -1.469 . . . . 0.0 112.215 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 45.9 ttm -57.04 -36.38 70.41 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 125.0 1.32 . . . . 0.0 113.352 175.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 26.1 m -86.06 -34.65 20.64 Favored 'General case' 0 C--N 1.344 0.344 0 O-C-N 120.394 -1.441 . . . . 0.0 112.424 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -68.34 -33.89 75.1 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 120.091 -1.631 . . . . 0.0 114.557 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 77.34 50.92 0.04 OUTLIER 'General case' 0 C--N 1.353 0.719 0 C-N-CA 126.608 1.963 . . . . 0.0 111.017 -171.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 95.1 mt -109.8 34.05 4.05 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 122.713 1.244 . . . . 0.0 110.331 169.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -110.52 148.26 32.47 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 163.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -75.48 161.97 28.74 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.277 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . 0.403 ' CD ' ' HZ2' ' B' ' 135' ' ' LYS 0.264 35.8 mt-10 -62.9 -47.9 81.28 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 119.995 -1.691 . . . . 0.0 111.261 172.02 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' LYS . . . . . 0.403 ' HZ2' ' CD ' ' B' ' 134' ' ' GLU . 0.0 OUTLIER -89.21 -43.92 10.65 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.765 1.626 . . . . 0.0 108.638 -164.796 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -108.81 63.36 0.6 Allowed 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 125.015 1.326 . . . . 0.0 112.235 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -65.25 -7.24 12.17 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 118.898 -2.376 . . . . 0.0 114.627 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -82.69 -8.95 59.57 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.606 1.562 . . . . 0.0 113.88 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 46.4 mm -99.8 128.86 51.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 O-C-N 120.87 -1.144 . . . . 0.0 109.759 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 48.8 t -116.56 128.38 73.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.481 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -90.78 121.46 32.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 120.902 -1.123 . . . . 0.0 109.071 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 58.5 m -116.35 12.68 15.36 Favored 'General case' 0 CA--C 1.51 -0.584 0 O-C-N 121.131 -0.981 . . . . 0.0 110.837 171.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 33.0 p -71.7 131.97 43.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.112 -1.618 . . . . 0.0 108.994 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 76.55 -27.11 0.18 Allowed 'General case' 0 C--N 1.351 0.647 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -74.99 164.92 26.04 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 119.846 -1.784 . . . . 0.0 111.783 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 33.2 tp -67.94 -18.99 64.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.735 2.014 . . . . 0.0 113.013 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.24 -32.38 71.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.27 -1.519 . . . . 0.0 113.005 167.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.87 -33.25 79.29 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 120.115 -1.616 . . . . 0.0 113.813 -174.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -50.87 -57.31 8.78 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.212 2.605 . . . . 0.0 111.833 170.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 3.9 pp -76.65 -21.75 55.01 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -86.13 -37.1 19.12 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.011 -1.055 . . . . 0.0 112.222 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.12 15.48 78.67 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 121.179 -0.95 . . . . 0.0 114.337 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 29.5 m -125.42 159.38 60.48 Favored Pre-proline 0 C--N 1.344 0.343 0 O-C-N 120.99 -1.3 . . . . 0.0 110.214 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.37 -43.73 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.607 1.538 . . . . 0.0 112.653 172.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 54.6 m -151.76 167.0 29.61 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -126.02 177.69 6.2 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.728 0.775 . . . . 0.0 109.727 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 48.3 t -121.94 123.34 41.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 120.979 -1.076 . . . . 0.0 108.758 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.11 -27.43 43.14 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 O-C-N 120.437 -1.414 . . . . 0.0 112.157 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -55.04 -28.67 53.95 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.182 1.393 . . . . 0.0 114.352 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . 0.583 ' CD ' ' HZ1' ' B' ' 163' ' ' LYS . 34.2 mt-10 -81.83 52.12 1.87 Allowed 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.255 -1.528 . . . . 0.0 112.959 176.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -46.94 -45.58 20.84 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 126.741 2.017 . . . . 0.0 114.844 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -72.16 -1.66 15.84 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 126.709 2.004 . . . . 0.0 115.667 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.583 ' HZ1' ' CD ' ' B' ' 160' ' ' GLU . 36.8 ttmt -105.18 -38.35 6.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.443 -1.411 . . . . 0.0 109.176 167.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 30.4 mm -56.43 -52.53 51.34 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 O-C-N 120.946 -1.096 . . . . 0.0 112.727 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -53.33 -38.36 63.14 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 120.284 -1.51 . . . . 0.0 114.053 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 42.4 m -64.37 -35.9 82.38 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 125.689 1.596 . . . . 0.0 113.585 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 54.6 mtt -65.88 -47.01 76.27 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.334 -1.479 . . . . 0.0 111.281 172.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 50.9 mm -56.09 -50.31 70.93 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 C-N-CA 126.062 1.745 . . . . 0.0 113.201 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -63.38 -12.31 29.56 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 119.473 -2.017 . . . . 0.0 115.931 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -96.9 -12.51 23.38 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 119.468 -2.02 . . . . 0.0 112.839 170.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -84.07 -38.51 20.72 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 119.95 -1.719 . . . . 0.0 109.194 170.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 66.2 mt -93.53 -179.89 5.17 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.944 1.697 . . . . 0.0 113.926 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 94.6 t -111.55 128.54 68.0 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 167.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 C--N 1.349 0.56 0 O-C-N 121.19 -0.944 . . . . 0.0 110.916 176.269 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.276 91.7 p . . . . . 0 N--CA 1.531 3.593 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -5.72 74.92 0.0 OUTLIER Glycine 0 C--N 1.363 2.058 0 C-N-CA 129.423 3.392 . . . . 0.0 119.785 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.3 m -116.07 119.02 34.5 Favored 'General case' 0 CA--C 1.506 -0.746 0 O-C-N 120.978 -1.307 . . . . 0.0 108.492 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.56 -161.23 8.88 Favored Glycine 0 CA--C 1.494 -1.243 0 N-CA-C 105.967 -2.853 . . . . 0.0 105.967 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.49 79.69 0.79 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 119.048 1.424 . . . . 0.0 114.313 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 64.2 p -67.56 -16.86 64.41 Favored 'General case' 0 C--N 1.347 0.473 0 O-C-N 119.685 -1.885 . . . . 0.0 113.907 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -77.05 -31.29 56.09 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.995 1.718 . . . . 0.0 113.386 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -175.78 89.17 0.29 Allowed Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.37 137.23 18.56 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 CA-C-N 121.893 1.712 . . . . 0.0 110.232 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.8 t -127.38 -60.4 1.19 Allowed 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.3 m -68.93 170.93 8.82 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 123.674 1.702 . . . . 0.0 115.559 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -73.75 -35.76 65.07 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 119.945 -1.722 . . . . 0.0 114.489 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.87 -45.9 76.66 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 119.601 -1.937 . . . . 0.0 111.466 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -43.47 -66.98 0.31 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 129.048 2.939 . . . . 0.0 112.933 167.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.29 -6.63 53.9 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 120.383 -1.448 . . . . 0.0 114.461 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -74.09 -51.72 14.83 Favored 'General case' 0 C--N 1.346 0.416 0 O-C-N 119.193 -2.192 . . . . 0.0 110.854 165.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -61.36 -35.71 78.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.094 -1.629 . . . . 0.0 115.19 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.85 -15.42 20.89 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.8 tp -62.03 -26.21 68.11 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 120.326 -1.484 . . . . 0.0 113.214 172.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 t 60.22 49.34 7.31 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-O 123.933 1.825 . . . . 0.0 111.047 -169.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.72 89.16 0.55 Allowed 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.394 1.477 . . . . 0.0 112.629 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.11 -48.17 0.59 Allowed Glycine 0 CA--C 1.496 -1.1 0 O-C-N 121.478 -0.764 . . . . 0.0 114.996 -168.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.17 -144.8 17.03 Favored Glycine 0 C--N 1.345 1.033 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -167.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.5 p -110.94 136.81 45.85 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 O-C-N 120.658 -1.495 . . . . 0.0 111.065 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.2 m -100.04 158.54 31.86 Favored Pre-proline 0 C--N 1.35 0.624 0 O-C-N 120.182 -1.574 . . . . 0.0 110.479 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.52 11.19 1.08 Allowed 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.987 2.458 . . . . 0.0 113.118 164.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt 59.81 49.83 7.6 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 126.008 1.723 . . . . 0.0 115.296 171.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.8 pt -63.51 144.7 14.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 -171.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -85.13 20.22 1.98 Allowed 'General case' 0 C--N 1.347 0.471 0 O-C-N 120.679 -1.263 . . . . 0.0 113.825 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -77.28 126.67 31.3 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 119.364 -2.085 . . . . 0.0 111.21 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -78.55 100.82 7.09 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.988 0.899 . . . . 0.0 112.331 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.2 p -96.13 -175.82 3.49 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.494 1.918 . . . . 0.0 111.666 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -124.11 -41.71 2.19 Favored 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 120.16 -1.588 . . . . 0.0 112.303 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -142.0 168.31 20.04 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 103.784 -2.672 . . . . 0.0 103.784 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -68.95 -26.33 65.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 119.476 -2.015 . . . . 0.0 115.778 -167.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 m -50.93 -45.47 60.51 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 126.593 1.957 . . . . 0.0 114.801 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.85 -22.67 65.71 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 128.131 2.573 . . . . 0.0 113.961 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.6 t -103.63 106.78 53.84 Favored Pre-proline 0 C--N 1.353 0.726 0 O-C-N 119.834 -1.791 . . . . 0.0 112.489 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.11 159.37 53.4 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.804 2.336 . . . . 0.0 114.452 -162.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.7 -96.13 1.92 Allowed Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -161.35 40.61 0.15 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 123.088 1.423 . . . . 0.0 111.116 177.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.9 m -90.34 178.94 6.0 Favored 'General case' 0 N--CA 1.44 -0.939 0 O-C-N 119.847 -1.783 . . . . 0.0 109.267 -175.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.87 150.71 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 103.211 -2.885 . . . . 0.0 103.211 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.0 m -82.61 127.45 33.38 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.318 1.047 . . . . 0.0 108.368 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -78.36 172.11 14.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.917 -1.114 . . . . 0.0 108.663 170.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.5 -32.61 15.95 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 116.655 1.422 . . . . 0.0 116.655 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -70.03 -9.57 55.73 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.6 20.93 57.47 Favored Glycine 0 C--N 1.349 1.298 0 O-C-N 120.57 -1.331 . . . . 0.0 114.247 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -121.6 146.6 46.81 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 120.607 -1.526 . . . . 0.0 110.616 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.0 m -73.39 133.5 43.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -170.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.714 0 CA-C-O 117.05 -1.972 . . . . 0.0 114.955 173.865 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 94.5 mt . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 19.7 m -121.97 152.31 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 -109.79 117.87 51.34 Favored Pre-proline 0 C--N 1.352 0.679 0 CA-C-O 115.92 -1.99 . . . . 0.0 108.721 172.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.71 167.12 27.02 Favored 'Trans proline' 0 C--N 1.321 -0.897 0 C-N-CA 123.272 2.648 . . . . 0.0 113.19 166.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -78.56 159.04 75.29 Favored Pre-proline 0 C--N 1.351 0.661 0 O-C-N 120.472 -1.393 . . . . 0.0 112.81 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -65.69 -21.68 58.47 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.18 2.586 . . . . 0.0 114.681 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 94.0 mt -70.25 -46.03 65.23 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.131 0.878 . . . . 0.0 111.391 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 18.1 tp -64.68 -33.55 76.22 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 120.993 -1.067 . . . . 0.0 111.809 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 17.9 tp -55.81 -42.07 75.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -65.93 -31.69 72.75 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 119.072 -2.268 . . . . 0.0 113.42 174.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 22.2 tp -66.08 -52.78 45.66 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 121.415 -0.803 . . . . 0.0 111.637 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -54.05 -42.94 69.78 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 124.179 0.992 . . . . 0.0 112.652 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -57.46 -27.18 62.23 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 170.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 21.8 t -78.11 -16.95 57.51 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 120.412 -1.43 . . . . 0.0 112.232 173.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 1.5 t -97.76 4.25 9.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 O-C-N 120.561 -1.337 . . . . 0.0 110.75 172.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.89 -19.39 54.2 Favored Glycine 0 C--N 1.353 1.495 0 O-C-N 119.801 -1.812 . . . . 0.0 113.357 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -76.62 75.12 3.31 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 126.212 1.805 . . . . 0.0 112.848 -174.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -89.22 1.82 55.14 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -170.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.88 160.25 30.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.649 -0.657 . . . . 0.0 110.41 172.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -74.14 -59.84 2.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 123.463 1.602 . . . . 0.0 108.822 161.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 29.9 p -71.5 98.44 1.84 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.352 1.861 . . . . 0.0 115.54 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -112.0 -179.61 3.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 123.354 1.549 . . . . 0.0 111.901 167.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 94.4 m -103.69 155.26 18.71 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.19 1.796 . . . . 0.0 108.683 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 92.7 mtp -54.8 -47.15 74.38 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 119.394 -2.066 . . . . 0.0 115.661 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -57.01 -54.33 48.0 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 120.945 -1.097 . . . . 0.0 112.464 168.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -46.77 -50.15 18.64 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 126.009 1.724 . . . . 0.0 115.079 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.7 t -52.49 -48.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 120.051 -1.655 . . . . 0.0 112.804 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.89 -24.55 44.11 Favored 'General case' 0 C--N 1.347 0.477 0 O-C-N 120.464 -1.398 . . . . 0.0 112.891 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -65.22 -62.82 1.31 Allowed 'General case' 0 C--N 1.345 0.394 0 C-N-CA 125.945 1.698 . . . . 0.0 111.105 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -53.92 -41.11 67.32 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 124.313 1.045 . . . . 0.0 111.953 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 21.5 tp -63.43 -55.54 23.46 Favored 'General case' 0 C--N 1.349 0.547 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.79 -42.21 98.61 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 119.552 -1.968 . . . . 0.0 114.345 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -63.59 -28.78 70.16 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.123 1.369 . . . . 0.0 112.303 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -61.96 -53.17 59.42 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.683 -1.26 . . . . 0.0 112.405 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 2.9 mp -62.58 -43.65 98.66 Favored 'Isoleucine or valine' 0 C--N 1.351 0.65 0 C-N-CA 124.493 1.117 . . . . 0.0 111.306 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 44.5 ttm -50.88 -43.11 59.55 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 125.234 1.413 . . . . 0.0 112.97 172.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 24.4 m -85.25 -30.2 24.01 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 120.496 -1.378 . . . . 0.0 113.334 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.0 -30.0 63.45 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 119.521 -1.987 . . . . 0.0 114.12 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? 76.02 41.53 0.23 Allowed 'General case' 0 C--N 1.352 0.681 0 C-N-CA 125.244 1.418 . . . . 0.0 110.956 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 93.6 mt -104.68 34.0 3.33 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 122.372 1.082 . . . . 0.0 110.845 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -114.96 146.04 41.61 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 165.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.6 151.98 42.04 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 121.189 -0.944 . . . . 0.0 109.264 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.98 -33.52 74.8 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 122.59 1.186 . . . . 0.0 112.004 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -109.92 -28.21 8.86 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 124.345 1.058 . . . . 0.0 112.236 -172.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -109.67 53.79 0.68 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.321 1.848 . . . . 0.0 110.936 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -55.97 -18.38 9.09 Favored 'General case' 0 C--N 1.349 0.56 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -82.84 -5.74 59.12 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.011 1.724 . . . . 0.0 114.877 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 44.1 mm -97.41 123.16 49.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 O-C-N 120.541 -1.349 . . . . 0.0 110.22 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 52.3 t -108.12 129.51 62.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.544 0 O-C-N 120.972 -1.08 . . . . 0.0 108.414 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -95.33 113.79 25.5 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.119 -0.988 . . . . 0.0 109.276 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 63.8 m -118.6 20.85 12.82 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 121.884 0.849 . . . . 0.0 109.986 171.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 34.7 p -76.66 136.65 39.15 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 120.341 -1.474 . . . . 0.0 108.228 170.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 1.2 t30 76.24 -36.06 0.27 Allowed 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -69.26 168.48 14.12 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.64 -1.287 . . . . 0.0 112.661 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 22.9 tp -70.7 -17.54 62.83 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.604 1.562 . . . . 0.0 112.778 -168.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.92 -29.38 66.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.297 -1.502 . . . . 0.0 113.896 168.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.6 -39.0 97.12 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 120.609 -1.307 . . . . 0.0 114.031 -173.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -51.37 -55.3 19.24 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 127.251 2.22 . . . . 0.0 111.816 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 pp -74.62 -27.66 60.55 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 119.867 -1.77 . . . . 0.0 115.098 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -80.81 -40.91 24.19 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 121.387 -0.82 . . . . 0.0 112.114 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.37 22.39 62.76 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 124.162 0.886 . . . . 0.0 113.65 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.74 160.97 66.28 Favored Pre-proline 0 C--N 1.343 0.304 0 O-C-N 121.231 -1.158 . . . . 0.0 108.96 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.04 -51.22 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 121.477 1.563 . . . . 0.0 112.455 170.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 66.8 m -147.93 168.2 22.87 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 119.909 1.232 . . . . 0.0 107.845 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -129.97 173.72 10.44 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.759 0.823 . . . . 0.0 108.864 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 11.4 t -113.74 129.19 56.61 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.18 -1.575 . . . . 0.0 109.859 172.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 35.1 t -60.72 -26.72 39.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.94 0 O-C-N 119.922 -1.736 . . . . 0.0 112.996 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -50.03 -25.2 3.16 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 126.449 1.9 . . . . 0.0 114.694 171.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -91.18 46.7 1.33 Allowed 'General case' 0 N--CA 1.439 -1.007 0 O-C-N 119.502 -1.999 . . . . 0.0 113.687 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' HIS . . . . . 0.422 ' CG ' ' H ' ' B' ' 162' ' ' ARG . 7.5 p80 -32.66 -55.36 0.36 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 128.279 2.632 . . . . 0.0 117.74 176.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . 0.422 ' H ' ' CG ' ' B' ' 161' ' ' HIS . 24.8 ptt180 -59.46 -28.7 67.22 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.037 1.735 . . . . 0.0 115.256 172.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -83.24 -32.57 26.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 119.646 -1.909 . . . . 0.0 112.02 172.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 37.7 mm -54.28 -54.97 17.04 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 O-C-N 120.902 -1.124 . . . . 0.0 110.789 171.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -57.39 -33.61 68.03 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 119.989 -1.694 . . . . 0.0 115.271 171.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 86.4 m -60.65 -35.42 76.17 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.237 -1.54 . . . . 0.0 112.233 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 43.1 mtt -72.85 -48.26 39.11 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.69 -1.257 . . . . 0.0 111.615 172.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 50.9 mm -57.61 -50.39 77.49 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 C-N-CA 124.668 1.187 . . . . 0.0 113.487 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -66.19 -11.08 47.45 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -79.92 -27.13 39.92 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 119.004 -2.31 . . . . 0.0 111.153 170.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -104.69 -2.61 24.74 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 124.298 1.039 . . . . 0.0 110.332 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 43.6 mt -125.93 143.12 51.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.944 2.098 . . . . 0.0 109.567 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 10.7 p -68.86 123.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 O-C-N 119.588 -1.945 . . . . 0.0 113.422 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 54.0 t . . . . . 0 C--N 1.351 0.638 0 C-N-CA 124.667 1.187 . . . . 0.0 110.718 175.58 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.511 2.582 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.71 49.31 77.58 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 119.158 0.89 . . . . 0.0 112.281 -165.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -139.66 96.31 3.06 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 121.356 -1.085 . . . . 0.0 110.046 -167.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.49 -141.1 10.62 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-O 121.882 0.712 . . . . 0.0 113.647 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.99 68.88 6.23 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-O 123.115 1.436 . . . . 0.0 111.614 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 p -69.79 -9.42 54.57 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 126.671 1.988 . . . . 0.0 114.242 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -78.0 -42.86 31.27 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.738 1.215 . . . . 0.0 112.124 171.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -166.83 89.13 0.78 Allowed Pre-proline 0 N--CA 1.448 -0.535 0 O-C-N 121.529 -0.732 . . . . 0.0 110.035 -173.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.44 115.46 2.87 Favored 'Trans proline' 0 C--N 1.329 -0.474 0 C-N-CA 122.32 2.013 . . . . 0.0 112.211 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -116.11 -31.91 5.54 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 119.109 0.868 . . . . 0.0 113.248 -170.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.8 m -105.31 176.96 4.99 Favored 'General case' 0 C--N 1.345 0.387 0 O-C-N 119.472 -2.017 . . . . 0.0 111.397 167.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -63.86 -40.42 96.51 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 119.805 -1.81 . . . . 0.0 113.408 -176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.55 -44.45 85.24 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.571 1.948 . . . . 0.0 113.529 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -55.87 -58.99 5.54 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.033 1.333 . . . . 0.0 114.401 170.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.42 -29.98 69.33 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -37.18 52.93 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 124.933 1.293 . . . . 0.0 113.897 173.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -101.06 18.87 18.62 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 121.025 -1.047 . . . . 0.0 112.22 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.62 -29.04 13.27 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.448 1.099 . . . . 0.0 110.007 165.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.6 -29.13 69.02 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 122.423 1.106 . . . . 0.0 112.38 171.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 m 65.85 43.56 3.06 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 125.797 1.639 . . . . 0.0 112.555 174.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.61 93.49 0.01 OUTLIER 'General case' 0 C--N 1.351 0.646 0 C-N-CA 127.215 2.206 . . . . 0.0 116.778 -170.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.29 -47.34 0.44 Allowed Glycine 0 CA--C 1.491 -1.423 0 C-N-CA 119.796 -1.193 . . . . 0.0 115.019 -171.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.17 -121.14 4.32 Favored Glycine 0 CA--C 1.499 -0.933 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -171.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 p -129.65 143.47 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 O-C-N 121.055 -1.262 . . . . 0.0 108.327 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 62.8 m -104.24 162.19 20.64 Favored Pre-proline 0 C--N 1.346 0.444 0 O-C-N 120.278 -1.514 . . . . 0.0 110.45 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.1 -26.46 57.75 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.576 2.184 . . . . 0.0 112.076 168.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 79.82 78.77 0.05 OUTLIER 'General case' 0 C--N 1.354 0.768 0 C-N-CA 127.605 2.362 . . . . 0.0 110.507 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.8 pt -80.73 140.77 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 O-C-N 120.93 -1.106 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.1 pp -83.33 6.62 19.19 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 122.354 1.073 . . . . 0.0 112.394 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -63.02 132.02 50.57 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 125.112 1.365 . . . . 0.0 111.545 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -74.26 141.14 45.36 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.286 -0.884 . . . . 0.0 111.577 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.0 p -132.7 169.0 17.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 120.777 -1.202 . . . . 0.0 109.563 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -116.56 -37.25 3.74 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 120.012 -1.68 . . . . 0.0 110.683 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -141.61 -171.92 3.42 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.226 1.01 . . . . 0.0 108.622 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.42 -7.1 48.01 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 119.224 -2.172 . . . . 0.0 112.875 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 p -81.38 -40.03 24.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.719 2.008 . . . . 0.0 113.098 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.52 -28.0 68.87 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-O 122.618 1.199 . . . . 0.0 113.042 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.7 t -99.11 108.73 51.21 Favored Pre-proline 0 N--CA 1.443 -0.799 0 C-N-CA 124.107 0.963 . . . . 0.0 112.224 -164.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.77 151.55 57.57 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.113 1.875 . . . . 0.0 113.457 -168.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.09 -120.91 7.01 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.91 41.98 2.47 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.343 1.544 . . . . 0.0 110.149 176.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.1 m -107.85 112.82 25.64 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.014 -1.678 . . . . 0.0 110.736 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.8 pp -76.31 145.51 10.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 O-C-N 120.199 -1.563 . . . . 0.0 112.203 173.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.4 t -80.41 134.95 36.07 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.181 1.392 . . . . 0.0 110.063 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -86.14 167.5 14.87 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 119.56 -1.962 . . . . 0.0 110.869 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -37.34 -45.6 1.3 Allowed Glycine 0 C--N 1.356 1.664 0 C-N-CA 126.898 2.189 . . . . 0.0 118.13 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -62.75 -19.19 63.72 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.2 33.54 8.73 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 120.464 -1.398 . . . . 0.0 112.991 -172.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -139.46 142.37 37.38 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.018 -1.284 . . . . 0.0 107.631 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.95 125.18 27.0 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-O 123.397 1.57 . . . . 0.0 114.272 -173.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.343 0 O-C-N 119.946 -1.721 . . . . 0.0 113.354 -176.336 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.505 2.276 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.18 156.58 40.37 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 mtt-85 -113.73 113.0 47.76 Favored Pre-proline 0 C--N 1.348 0.516 0 CA-C-O 116.526 -1.702 . . . . 0.0 110.578 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.13 166.01 30.57 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 CA-C-N 124.355 2.591 . . . . 0.0 113.09 164.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -82.73 159.05 64.43 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.879 0.872 . . . . 0.0 112.834 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.22 -21.01 36.62 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.881 2.387 . . . . 0.0 114.734 -174.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 93.0 mt -67.37 -43.95 80.18 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 119.799 1.181 . . . . 0.0 111.112 173.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 28.7 tp -64.71 -40.45 95.38 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 124.089 0.956 . . . . 0.0 112.403 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 34.8 tp -49.41 -39.53 33.05 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.38 -32.26 72.21 Favored 'General case' 0 C--N 1.35 0.601 0 O-C-N 119.434 -2.041 . . . . 0.0 113.291 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tt -71.41 -49.88 37.5 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 121.52 -0.737 . . . . 0.0 110.442 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 96.4 mt -52.04 -44.16 64.1 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 124.658 1.183 . . . . 0.0 113.8 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -54.18 -36.15 63.09 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 120.415 -1.428 . . . . 0.0 114.321 169.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.8 t -73.92 -6.74 49.08 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.158 1.383 . . . . 0.0 112.231 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 1.6 t -108.64 7.52 9.28 Favored 'Isoleucine or valine' 0 C--N 1.35 0.616 0 C-N-CA 124.986 1.315 . . . . 0.0 110.718 167.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.82 -23.11 37.41 Favored Glycine 0 C--N 1.351 1.38 0 O-C-N 119.018 -2.301 . . . . 0.0 114.114 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.02 68.48 4.98 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.971 1.708 . . . . 0.0 112.812 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -81.67 4.92 19.99 Favored 'General case' 0 C--N 1.343 0.3 0 O-C-N 120.074 -1.641 . . . . 0.0 114.75 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -83.7 146.98 27.92 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.045 0.938 . . . . 0.0 109.629 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -70.22 -48.41 57.17 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 122.99 1.376 . . . . 0.0 111.058 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 40.7 p -84.05 110.16 18.24 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -128.4 -166.83 1.68 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.687 1.195 . . . . 0.0 110.484 168.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 50.6 p -117.99 175.47 5.66 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 119.595 -1.94 . . . . 0.0 111.362 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 46.0 mtt -57.33 -41.25 79.59 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 120.475 -1.391 . . . . 0.0 113.591 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -52.97 61.1 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.388 1.075 . . . . 0.0 110.618 174.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.73 -31.64 63.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -171.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 67.6 t -55.29 -37.01 42.39 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 O-C-N 120.065 -1.647 . . . . 0.0 111.246 171.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -89.85 -24.76 21.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.733 -1.229 . . . . 0.0 113.635 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -66.77 -56.88 8.51 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.039 -1.663 . . . . 0.0 112.916 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -61.26 -41.96 97.82 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 120.961 -1.087 . . . . 0.0 111.153 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 34.6 tp -57.88 -49.88 75.2 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 120.306 -1.497 . . . . 0.0 113.518 172.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.45 -47.92 79.86 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 120.299 -1.5 . . . . 0.0 114.321 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -58.42 -40.6 82.94 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.184 0.993 . . . . 0.0 113.618 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -58.33 -55.68 31.86 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.735 1.214 . . . . 0.0 113.633 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -68.68 -39.1 79.84 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 O-C-N 120.409 -1.432 . . . . 0.0 111.647 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 55.2 ttm -54.51 -48.33 72.05 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 122.443 1.116 . . . . 0.0 112.37 173.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 38.6 m -70.73 -29.56 65.86 Favored 'General case' 0 C--N 1.344 0.351 0 O-C-N 120.819 -1.176 . . . . 0.0 112.965 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -81.59 -23.15 37.26 Favored 'General case' 0 C--N 1.346 0.433 0 O-C-N 119.022 -2.299 . . . . 0.0 115.61 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? 72.29 49.3 0.22 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 125.343 1.457 . . . . 0.0 112.354 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 2.2 tt -95.85 -27.42 15.21 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 120.326 -1.484 . . . . 0.0 113.029 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -69.01 142.06 54.71 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.021 -1.674 . . . . 0.0 111.756 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.5 137.37 53.44 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.017 0.927 . . . . 0.0 113.302 167.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -64.32 -31.84 73.2 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 120.317 -1.489 . . . . 0.0 113.04 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -96.86 -32.82 11.89 Favored 'General case' 0 C--N 1.347 0.497 0 O-C-N 120.871 -1.143 . . . . 0.0 113.291 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.34 56.59 0.75 Allowed 'General case' 0 C--N 1.351 0.647 0 O-C-N 120.347 -1.471 . . . . 0.0 112.736 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 9.8 pm0 -60.92 5.46 0.05 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 118.655 2.835 . . . . 0.0 118.655 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -102.42 -6.54 22.86 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 119.849 -1.782 . . . . 0.0 111.704 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 49.1 mm -92.34 138.55 19.69 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 C-N-CA 125.27 1.428 . . . . 0.0 109.433 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.33 120.95 30.31 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 O-C-N 120.649 -1.282 . . . . 0.0 108.279 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -105.9 78.6 1.34 Allowed 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 120.535 -1.353 . . . . 0.0 112.795 -171.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 61.5 m -86.34 37.81 0.75 Allowed 'General case' 0 C--N 1.349 0.549 0 O-C-N 119.959 -1.713 . . . . 0.0 114.408 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 11.1 t -88.51 129.64 35.41 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 119.562 -1.961 . . . . 0.0 107.436 165.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 70.08 43.93 0.83 Allowed 'General case' 0 C--N 1.349 0.577 0 CA-C-O 122.878 1.323 . . . . 0.0 111.619 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -141.32 166.12 25.63 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 18.1 tp -83.67 -9.94 58.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.583 1.153 . . . . 0.0 112.651 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 10.1 mp -76.99 -31.23 56.34 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 119.498 -2.001 . . . . 0.0 110.658 164.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.42 -44.05 96.95 Favored Glycine 0 C--N 1.351 1.366 0 C-N-CA 125.279 1.419 . . . . 0.0 114.565 -174.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -46.08 -62.3 1.39 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.036 2.535 . . . . 0.0 112.102 169.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 4.2 pp -78.3 -18.46 55.21 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -172.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -81.22 -48.44 12.06 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.849 -1.157 . . . . 0.0 111.549 168.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.06 29.26 26.11 Favored Glycine 0 C--N 1.352 1.425 0 C-N-CA 124.829 1.204 . . . . 0.0 113.698 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.48 156.26 76.55 Favored Pre-proline 0 C--N 1.346 0.43 0 O-C-N 120.952 -1.322 . . . . 0.0 109.452 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.26 -10.33 13.65 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 CA-C-N 122.363 1.88 . . . . 0.0 112.982 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 10.0 p -178.92 171.36 1.42 Allowed 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -175.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.06 170.65 15.33 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 170.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 40.6 t -114.5 133.93 55.4 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 171.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.92 -39.9 81.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 O-C-N 121.456 -0.778 . . . . 0.0 112.276 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -54.22 -26.39 28.24 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . 0.428 ' CD ' ' HZ2' ' B' ' 163' ' ' LYS . 29.1 mt-10 -81.76 66.2 7.22 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 119.884 -1.76 . . . . 0.0 110.544 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -53.49 -46.23 69.93 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 125.848 1.659 . . . . 0.0 113.05 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 81.3 ttt180 -56.38 -29.45 61.46 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 127.051 2.141 . . . . 0.0 114.252 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . 0.428 ' HZ2' ' CD ' ' B' ' 160' ' ' GLU . 3.6 tppt? -78.17 -42.93 30.09 Favored 'General case' 0 CA--C 1.512 -0.505 0 O-C-N 120.173 -1.579 . . . . 0.0 111.844 173.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 48.1 mm -56.79 -50.11 76.07 Favored 'Isoleucine or valine' 0 C--N 1.347 0.463 0 C-N-CA 124.043 0.937 . . . . 0.0 111.951 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -51.06 -43.73 61.03 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 120.742 -1.224 . . . . 0.0 113.84 168.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 52.9 m -65.45 -33.56 76.23 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 121.083 -1.011 . . . . 0.0 112.893 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -68.22 -48.51 64.97 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 118.88 -2.387 . . . . 0.0 112.697 167.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.7 -50.83 76.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 C-N-CA 124.783 1.233 . . . . 0.0 112.715 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -66.68 -12.07 56.76 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 119.232 -2.168 . . . . 0.0 115.143 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -85.93 -9.04 57.57 Favored 'General case' 0 C--N 1.351 0.663 0 O-C-N 119.596 -1.94 . . . . 0.0 112.215 169.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -96.09 -36.04 11.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 120.3 -1.5 . . . . 0.0 109.36 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 71.4 mt -92.85 161.33 14.54 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.36 1.464 . . . . 0.0 113.653 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.85 126.58 61.25 Favored 'Isoleucine or valine' 0 C--N 1.345 0.389 0 O-C-N 120.7 -1.25 . . . . 0.0 107.733 171.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 C--N 1.346 0.447 0 O-C-N 121.249 -0.907 . . . . 0.0 110.668 178.911 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.517 2.915 0 CA-C-O 117.238 -1.363 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 52.25 45.21 58.02 Favored Glycine 0 C--N 1.357 1.715 0 CA-C-N 120.18 1.354 . . . . 0.0 114.094 -170.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.2 t -152.43 134.39 14.85 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 120.691 -1.476 . . . . 0.0 109.197 -172.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.78 -137.14 3.45 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 122.368 0.982 . . . . 0.0 111.63 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.31 68.14 8.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.04 -1.859 . . . . 0.0 113.173 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 t -59.32 -13.2 7.26 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.613 1.565 . . . . 0.0 114.571 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.6 -30.17 22.02 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.81 1.644 . . . . 0.0 114.337 175.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 174.53 89.6 0.07 OUTLIER Pre-proline 0 C--N 1.35 0.626 0 C-N-CA 124.986 1.314 . . . . 0.0 108.505 -171.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.01 118.57 4.09 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.344 2.03 . . . . 0.0 112.282 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t -113.29 -4.45 13.69 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 122.588 1.185 . . . . 0.0 110.11 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t -126.21 162.62 25.01 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.069 -1.644 . . . . 0.0 113.44 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -61.62 -48.34 81.36 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 120.449 -1.407 . . . . 0.0 111.932 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.81 86.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.553 1.541 . . . . 0.0 112.786 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -63.08 -54.7 33.86 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.783 -1.198 . . . . 0.0 113.656 173.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.63 -31.19 70.17 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.734 0.778 . . . . 0.0 112.239 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -53.63 -49.6 67.52 Favored 'General case' 0 C--N 1.346 0.416 0 O-C-N 119.959 -1.713 . . . . 0.0 113.164 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -67.44 -30.16 69.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.525 -1.359 . . . . 0.0 113.862 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.97 -27.94 65.86 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 125.897 1.679 . . . . 0.0 114.295 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.7 tp -61.9 -25.33 67.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.228 1.011 . . . . 0.0 113.607 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 t 56.43 40.79 29.52 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 124.632 2.158 . . . . 0.0 112.977 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.87 92.6 0.1 Allowed 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.258 1.423 . . . . 0.0 113.526 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.95 -40.66 0.8 Allowed Glycine 0 CA--C 1.496 -1.111 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -173.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.04 -144.62 16.94 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.7 m -93.79 139.84 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 120.211 -1.758 . . . . 0.0 111.102 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.62 156.66 45.87 Favored Pre-proline 0 N--CA 1.45 -0.465 0 O-C-N 120.569 -1.332 . . . . 0.0 109.347 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.59 -10.12 24.83 Favored 'Trans proline' 0 CA--C 1.519 -0.239 0 C-N-CA 122.872 2.382 . . . . 0.0 112.894 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 mptt 64.91 51.82 1.69 Allowed 'General case' 0 C--N 1.349 0.573 0 C-N-CA 126.019 1.728 . . . . 0.0 113.198 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.9 pt -64.89 143.59 15.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 mt -86.24 25.59 1.16 Allowed 'General case' 0 C--N 1.345 0.4 0 C-N-CA 124.877 1.271 . . . . 0.0 111.746 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -80.67 135.19 35.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 120.181 -1.574 . . . . 0.0 110.456 174.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -74.26 126.27 30.27 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 121.83 0.824 . . . . 0.0 111.747 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 p -118.06 -177.53 3.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 120.628 -1.295 . . . . 0.0 110.03 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 -122.05 -21.43 5.97 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 119.85 -1.781 . . . . 0.0 110.968 162.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -157.73 169.2 25.17 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 120.405 -1.434 . . . . 0.0 109.738 -176.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -52.26 -46.13 65.68 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 127.742 2.417 . . . . 0.0 111.656 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.0 m -55.59 -18.26 7.27 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 118.147 2.647 . . . . 0.0 118.147 170.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -93.87 -6.91 44.64 Favored 'General case' 0 C--N 1.345 0.388 0 O-C-N 120.46 -1.4 . . . . 0.0 111.083 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.33 127.47 26.79 Favored Pre-proline 0 C--N 1.349 0.573 0 O-C-N 120.523 -1.36 . . . . 0.0 110.327 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.47 163.33 36.37 Favored 'Trans proline' 0 C--N 1.324 -0.711 0 C-N-CA 122.067 1.845 . . . . 0.0 114.169 -169.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.86 -78.9 1.91 Allowed Glycine 0 C--N 1.348 1.207 0 O-C-N 121.349 -0.844 . . . . 0.0 113.097 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.23 24.82 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 122.377 1.084 . . . . 0.0 111.652 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.1 m -98.16 116.89 31.33 Favored 'General case' 0 C--O 1.215 -0.74 0 O-C-N 119.523 -1.986 . . . . 0.0 112.435 -162.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.57 150.06 6.75 Favored 'Isoleucine or valine' 0 C--N 1.346 0.426 0 O-C-N 118.429 -2.67 . . . . 0.0 113.665 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.29 125.32 29.19 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.804 0.842 . . . . 0.0 108.881 168.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -85.94 179.67 6.96 Favored 'General case' 0 C--N 1.345 0.412 0 O-C-N 120.032 -1.668 . . . . 0.0 110.655 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.24 -5.3 20.47 Favored Glycine 0 C--N 1.353 1.525 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -96.26 -6.15 38.64 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.201 -1.176 . . . . 0.0 112.501 170.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.59 18.28 64.29 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 121.01 -1.056 . . . . 0.0 113.787 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -128.04 146.4 50.69 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 123.083 1.42 . . . . 0.0 110.743 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 80.5 m -67.87 160.71 27.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 123.491 1.615 . . . . 0.0 113.081 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.958 0 O-C-N 119.3 -2.125 . . . . 0.0 116.846 -174.927 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 99.2 mt . . . . . 0 N--CA 1.506 2.329 0 CA-C-O 118.225 -0.893 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 15.2 m -133.47 165.44 32.14 Favored 'Isoleucine or valine' 0 C--N 1.344 0.361 0 CA-C-N 119.274 0.943 . . . . 0.0 109.271 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -114.0 101.82 54.28 Favored Pre-proline 0 C--N 1.345 0.41 0 CA-C-O 116.986 -1.483 . . . . 0.0 110.676 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.95 165.57 29.55 Favored 'Trans proline' 0 C--N 1.326 -0.609 0 C-N-CA 123.228 2.619 . . . . 0.0 114.242 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -87.16 153.2 53.94 Favored Pre-proline 0 C--N 1.351 0.653 0 O-C-N 120.967 -1.083 . . . . 0.0 111.961 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.06 -21.82 42.38 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.536 2.824 . . . . 0.0 113.436 -173.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 89.0 mt -70.14 -47.12 63.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.166 -0.959 . . . . 0.0 110.984 171.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 34.6 tp -65.17 -33.89 77.09 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 124.584 1.154 . . . . 0.0 113.062 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 14.7 tp -48.42 -41.68 29.92 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.326 1.45 . . . . 0.0 113.956 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -65.4 -36.88 85.29 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 119.844 -1.785 . . . . 0.0 114.328 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 tt -70.23 -50.22 42.09 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.656 0.782 . . . . 0.0 111.074 173.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 40.2 mt -52.16 -44.91 64.83 Favored 'General case' 0 C--N 1.35 0.617 0 C-N-CA 124.567 1.147 . . . . 0.0 112.702 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -57.4 -34.57 69.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 55.6 m -71.35 -15.49 62.39 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 124.558 1.143 . . . . 0.0 113.323 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.21 -7.38 9.62 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 124.351 1.06 . . . . 0.0 110.311 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.97 -26.47 7.9 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 120.106 -1.621 . . . . 0.0 112.36 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.41 74.47 7.28 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 126.006 1.723 . . . . 0.0 113.947 -170.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -83.57 12.03 6.3 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 -174.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -99.74 127.06 45.89 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.204 -0.935 . . . . 0.0 112.793 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.44 -9.42 0.3 Allowed 'General case' 0 C--N 1.348 0.515 0 N-CA-C 117.881 2.549 . . . . 0.0 117.881 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 67.4 p -137.11 127.04 25.77 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 119.064 -2.273 . . . . 0.0 111.158 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -129.03 -177.82 4.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 120.46 -1.4 . . . . 0.0 110.462 173.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.8 m -96.85 161.55 13.8 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.156 1.383 . . . . 0.0 108.189 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 1.1 mmm -60.04 -44.96 94.29 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 119.794 -1.816 . . . . 0.0 113.837 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -58.4 -51.87 68.0 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.136 0.974 . . . . 0.0 113.605 170.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -48.66 -49.65 36.5 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 126.504 1.921 . . . . 0.0 114.68 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 40.1 t -54.03 -46.32 65.64 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 O-C-N 120.674 -1.266 . . . . 0.0 112.355 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.11 -38.19 69.37 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.26 1.024 . . . . 0.0 112.325 176.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -56.25 -59.53 4.8 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.803 1.641 . . . . 0.0 112.79 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -58.02 -41.6 83.49 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 123.903 0.881 . . . . 0.0 112.028 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 26.4 tp -63.17 -52.22 63.26 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 173.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.5 -44.89 95.98 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 119.481 -2.012 . . . . 0.0 113.092 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -60.57 -30.28 69.69 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 124.379 1.071 . . . . 0.0 113.182 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -56.74 -60.25 3.83 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 124.429 1.092 . . . . 0.0 111.613 171.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mt -59.6 -42.87 89.67 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 O-C-N 120.292 -1.505 . . . . 0.0 113.794 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -51.02 -48.24 61.48 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 124.683 1.193 . . . . 0.0 113.556 170.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 40.5 m -78.64 -39.53 36.75 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 120.351 -1.468 . . . . 0.0 112.671 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -74.74 -21.47 59.33 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 126.163 1.785 . . . . 0.0 114.538 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 69.48 50.82 0.5 Allowed 'General case' 0 C--N 1.348 0.541 0 C-N-CA 125.821 1.648 . . . . 0.0 112.394 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 51.8 mt -107.46 18.65 21.28 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 123.782 0.833 . . . . 0.0 111.751 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -105.97 150.04 26.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -81.74 141.65 33.36 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.2 -31.72 72.94 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 121.028 -1.045 . . . . 0.0 113.187 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.76 -29.02 12.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 120.743 -1.223 . . . . 0.0 112.323 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -114.88 69.04 0.71 Allowed 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.097 -1.627 . . . . 0.0 112.641 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -73.41 -2.77 23.68 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 119.896 -1.752 . . . . 0.0 113.992 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -87.15 -10.19 53.35 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.589 1.955 . . . . 0.0 113.033 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 48.3 mm -98.59 134.0 38.89 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 125.497 1.519 . . . . 0.0 109.96 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 48.0 t -117.13 126.89 74.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 O-C-N 120.905 -1.122 . . . . 0.0 111.096 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -82.93 101.6 11.15 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.501 1.12 . . . . 0.0 111.762 173.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 18.3 m -107.14 3.46 25.75 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-O 122.06 0.934 . . . . 0.0 111.69 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 79.0 p -72.91 124.32 25.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 119.744 -1.847 . . . . 0.0 110.897 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 5.3 t30 79.57 18.85 0.72 Allowed 'General case' 0 C--N 1.35 0.621 0 C-N-CA 124.612 1.165 . . . . 0.0 112.478 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -112.06 169.98 8.47 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 124.691 1.196 . . . . 0.0 108.978 172.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 16.5 tp -69.97 -22.9 63.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.601 1.96 . . . . 0.0 112.657 178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 2.0 mp -66.46 -34.61 78.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 119.899 -1.751 . . . . 0.0 113.105 167.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.66 -37.77 92.79 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 120.554 -1.341 . . . . 0.0 114.117 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.41 -49.17 70.58 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.722 2.409 . . . . 0.0 112.845 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 1.3 pp -83.51 -28.02 28.96 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 119.35 -2.093 . . . . 0.0 113.918 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -79.6 -41.02 27.99 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 125.141 1.377 . . . . 0.0 112.856 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 78.58 14.4 82.15 Favored Glycine 0 C--N 1.35 1.339 0 C-N-CA 124.189 0.899 . . . . 0.0 114.183 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 33.2 m -131.15 151.27 78.61 Favored Pre-proline 0 C--N 1.345 0.403 0 O-C-N 120.828 -1.396 . . . . 0.0 110.382 -174.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.92 -26.92 10.61 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 121.965 1.777 . . . . 0.0 112.02 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 27.8 p -159.49 164.54 34.35 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 120.729 -1.232 . . . . 0.0 109.231 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -139.86 160.54 39.67 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 120.241 -1.537 . . . . 0.0 109.182 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 4.5 t -112.17 134.68 53.58 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.44 -33.7 65.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . 0.526 ' HZ1' ' CD ' ' B' ' 160' ' ' GLU . 0.1 OUTLIER -49.72 -25.47 2.99 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 175.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . 0.526 ' CD ' ' HZ1' ' B' ' 159' ' ' LYS . 5.5 mm-40 -80.36 55.88 2.37 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.037 -1.664 . . . . 0.0 111.255 176.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -51.87 -47.39 64.52 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 119.999 -1.688 . . . . 0.0 114.235 -172.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -57.09 -38.46 73.38 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 125.842 1.657 . . . . 0.0 113.271 172.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 18.1 ttpt -66.47 -51.33 57.9 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.235 -1.541 . . . . 0.0 110.598 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 50.9 mm -50.44 -54.65 8.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 C-N-CA 125.566 1.546 . . . . 0.0 112.826 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -51.76 -46.67 64.17 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 9.9 m -59.2 -42.67 91.48 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.627 -1.296 . . . . 0.0 112.453 176.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 3.5 mtp -72.06 -22.88 61.31 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.507 -1.371 . . . . 0.0 113.577 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.45 -52.05 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 O-C-N 121.115 -0.991 . . . . 0.0 110.478 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -57.09 -24.73 56.1 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.25 -12.4 60.0 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.91 -1.744 . . . . 0.0 114.488 173.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -103.05 -13.54 16.8 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 119.945 -1.722 . . . . 0.0 111.381 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 82.6 mt -109.8 155.4 21.68 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.928 1.291 . . . . 0.0 110.541 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 38.8 t -100.58 117.79 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 O-C-N 120.1 -1.625 . . . . 0.0 108.685 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.35 0.591 0 C-N-CA 124.172 0.989 . . . . 0.0 111.022 178.787 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.526 3.336 0 N-CA-C 119.39 3.107 . . . . 0.0 119.39 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.54 15.22 65.89 Favored Glycine 0 C--N 1.355 1.588 0 N-CA-C 115.836 1.094 . . . . 0.0 115.836 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.1 t -140.24 144.04 36.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.51 -129.91 2.51 Favored Glycine 0 C--N 1.346 1.128 0 C-N-CA 125.061 1.315 . . . . 0.0 110.112 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.0 72.53 10.07 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 120.219 -1.753 . . . . 0.0 112.397 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.3 p -68.21 -15.21 63.49 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -173.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -82.39 -38.1 24.61 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.971 1.309 . . . . 0.0 111.91 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -166.79 92.36 0.75 Allowed Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.14 105.69 1.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.078 1.852 . . . . 0.0 111.398 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -103.92 -17.3 15.07 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.74 1.216 . . . . 0.0 112.187 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.4 m -109.76 173.13 6.46 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 123.566 1.65 . . . . 0.0 112.406 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -73.44 -42.23 62.23 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 119.262 -2.149 . . . . 0.0 113.733 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.43 78.46 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 120.315 -1.49 . . . . 0.0 112.878 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -59.16 -58.99 6.22 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 125.975 1.71 . . . . 0.0 113.049 169.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.97 -22.96 65.0 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 120.815 -1.178 . . . . 0.0 113.537 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -62.15 -42.04 98.87 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 119.906 -1.746 . . . . 0.0 112.415 167.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -70.3 -33.73 71.88 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 120.231 -1.543 . . . . 0.0 114.019 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.19 -25.76 61.97 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.98 -14.28 52.74 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.397 1.079 . . . . 0.0 113.431 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.347 94.4 p 56.79 25.67 10.57 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 128.047 2.539 . . . . 0.0 113.913 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.32 91.14 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 128.316 2.647 . . . . 0.0 115.817 -167.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.27 -29.9 1.9 Allowed Glycine 0 C--N 1.344 1.02 0 O-C-N 121.382 -0.824 . . . . 0.0 112.174 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.16 -160.54 17.6 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 122.81 1.228 . . . . 0.0 112.786 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.79 102.89 12.58 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 O-C-N 120.31 -1.7 . . . . 0.0 110.895 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.9 t -80.76 151.79 71.44 Favored Pre-proline 0 C--N 1.348 0.52 0 O-C-N 120.127 -1.608 . . . . 0.0 110.457 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -67.05 -8.86 23.07 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.09 2.527 . . . . 0.0 115.096 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt 70.32 51.88 0.37 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 125.454 1.502 . . . . 0.0 113.341 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.7 pt -67.89 145.66 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 122.872 1.32 . . . . 0.0 113.663 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.1 mp -91.05 28.75 1.52 Allowed 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.475 -1.391 . . . . 0.0 110.661 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -82.03 133.25 35.28 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 120.504 -1.372 . . . . 0.0 110.432 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -80.5 113.87 18.99 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 121.37 -0.832 . . . . 0.0 110.918 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.6 p -103.91 -141.53 0.36 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.688 1.595 . . . . 0.0 110.817 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -169.61 -39.67 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 120.676 -1.265 . . . . 0.0 107.999 -178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 12.7 tpp85 -125.46 169.29 12.54 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 172.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -71.43 -14.81 62.27 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 119.819 -1.801 . . . . 0.0 113.814 173.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 18.2 m -61.77 -48.0 82.64 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 126.522 1.929 . . . . 0.0 113.876 173.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.76 -0.56 13.6 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.888 -1.133 . . . . 0.0 113.997 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.7 t -118.7 107.99 41.8 Favored Pre-proline 0 C--N 1.353 0.726 0 O-C-N 119.955 -1.716 . . . . 0.0 111.751 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.35 170.47 19.82 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.767 2.311 . . . . 0.0 115.653 -159.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.11 -90.54 1.67 Allowed Glycine 0 C--N 1.349 1.259 0 C-N-CA 124.181 0.895 . . . . 0.0 113.035 172.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.03 16.06 0.84 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 123.079 1.419 . . . . 0.0 110.54 -177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 32.9 m -76.92 168.36 20.23 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 119.859 -1.776 . . . . 0.0 111.461 -172.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.27 148.38 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 160.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.5 t -77.26 128.38 34.23 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.099 1.759 . . . . 0.0 107.133 171.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -84.79 -179.39 7.09 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 119.973 -1.704 . . . . 0.0 109.249 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.12 -11.03 24.04 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 116.394 1.318 . . . . 0.0 116.394 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -87.06 -7.41 58.11 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 120.704 -1.468 . . . . 0.0 113.374 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.74 13.8 74.55 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 120.71 -1.244 . . . . 0.0 114.259 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -124.18 152.08 43.29 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.134 -1.215 . . . . 0.0 109.765 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 29.2 m -78.91 93.78 5.1 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -166.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.294 0 O-C-N 119.526 -1.984 . . . . 0.0 116.624 -179.694 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.504 2.267 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.8 160.88 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -116.31 117.79 38.31 Favored Pre-proline 0 C--N 1.348 0.53 0 CA-C-O 115.964 -1.97 . . . . 0.0 109.822 170.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.09 -179.28 3.78 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.092 2.528 . . . . 0.0 114.132 169.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.03 159.74 28.65 Favored Pre-proline 0 C--N 1.351 0.634 0 C-N-CA 125.485 1.514 . . . . 0.0 110.609 175.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.99 -26.83 30.86 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.907 2.405 . . . . 0.0 114.098 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.97 -55.54 24.98 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 119.556 1.071 . . . . 0.0 110.942 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 18.5 tp -59.62 -35.62 74.72 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 120.892 -1.13 . . . . 0.0 113.282 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 17.5 tp -56.44 -40.77 75.33 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 120.605 -1.309 . . . . 0.0 114.485 175.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -65.52 -32.33 73.87 Favored 'General case' 0 C--N 1.346 0.442 0 O-C-N 120.002 -1.686 . . . . 0.0 113.613 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 10.2 tt -67.94 -46.26 72.0 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.402 -0.811 . . . . 0.0 110.94 170.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -52.15 -47.62 65.35 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 121.268 -0.895 . . . . 0.0 112.83 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -58.58 -24.99 62.1 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.273 -1.517 . . . . 0.0 114.282 173.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 11.7 t -83.38 -9.64 58.92 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 120.303 -1.498 . . . . 0.0 113.753 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 4.5 t -107.76 16.83 7.05 Favored 'Isoleucine or valine' 0 C--N 1.348 0.509 0 CA-C-O 123.369 1.557 . . . . 0.0 107.903 171.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.1 -20.93 36.97 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 119.262 -2.149 . . . . 0.0 113.96 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.29 69.2 3.53 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.228 1.811 . . . . 0.0 113.473 -172.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -85.39 17.36 3.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 119.467 -2.021 . . . . 0.0 116.204 -173.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . 0.696 ' HE3' ' H ' ' B' ' 111' ' ' ASP . 0.0 OUTLIER -88.21 142.53 27.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 123.874 1.797 . . . . 0.0 110.56 170.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.696 ' H ' ' HE3' ' B' ' 110' ' ' LYS . 2.6 m-20 -78.38 -7.02 56.86 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 130.717 3.607 . . . . 0.0 111.656 -172.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 11.3 p -145.43 135.11 23.4 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 127.087 2.155 . . . . 0.0 109.852 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -139.52 -165.45 1.87 Allowed 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.056 -1.028 . . . . 0.0 110.055 174.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 29.1 p -94.21 -169.63 2.11 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 119.774 -1.829 . . . . 0.0 110.927 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 76.7 mtp -74.56 -53.24 9.79 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 119.367 -2.083 . . . . 0.0 112.001 169.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -58.18 -38.98 77.73 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.211 -0.93 . . . . 0.0 112.927 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.76 -44.31 97.15 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.18 -26.11 39.32 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 O-C-N 119.618 -1.926 . . . . 0.0 111.479 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.68 -27.69 17.93 Favored 'General case' 0 C--N 1.347 0.479 0 O-C-N 120.622 -1.299 . . . . 0.0 113.706 172.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -64.97 -62.53 1.5 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 126.399 1.88 . . . . 0.0 111.612 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -54.96 -36.03 64.89 Favored 'General case' 0 C--N 1.351 0.674 0 O-C-N 120.673 -1.267 . . . . 0.0 112.3 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 33.2 tp -70.48 -49.2 50.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 174.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -70.44 -46.37 48.93 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 119.89 -1.756 . . . . 0.0 113.428 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -63.36 -31.29 72.4 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.201 1.4 . . . . 0.0 112.247 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -55.9 -57.85 10.33 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 124.23 1.012 . . . . 0.0 111.861 168.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 89.7 mt -64.12 -43.74 97.49 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 O-C-N 120.534 -1.354 . . . . 0.0 112.888 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 53.5 ttm -57.64 -34.2 69.07 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 125.498 1.519 . . . . 0.0 113.206 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 58.1 m -86.33 -36.27 19.37 Favored 'General case' 0 C--N 1.345 0.37 0 O-C-N 120.621 -1.299 . . . . 0.0 112.623 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -71.66 -22.26 61.7 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 126.769 2.028 . . . . 0.0 114.862 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 71.41 45.12 0.49 Allowed 'General case' 0 C--N 1.351 0.667 0 C-N-CA 125.385 1.474 . . . . 0.0 112.984 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 89.2 mt -100.29 9.32 42.88 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 121.058 -1.026 . . . . 0.0 112.319 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -94.26 141.51 28.48 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.72 -1.237 . . . . 0.0 108.667 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -78.08 147.73 34.56 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.503 1.121 . . . . 0.0 109.277 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -68.98 -31.18 69.84 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.222 1.409 . . . . 0.0 113.3 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -104.17 -24.91 13.11 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 124.813 1.245 . . . . 0.0 112.666 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -116.93 62.55 0.73 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 122.103 0.954 . . . . 0.0 110.822 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.89 -5.04 1.81 Allowed 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.106 -1.621 . . . . 0.0 115.336 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -99.81 -0.51 39.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.261 1.824 . . . . 0.0 112.917 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 51.1 mm -105.26 117.11 50.37 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 C-N-CA 125.216 1.406 . . . . 0.0 108.64 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.49 121.71 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 O-C-N 120.987 -1.071 . . . . 0.0 108.493 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -79.92 108.86 13.83 Favored 'General case' 0 C--N 1.347 0.467 0 O-C-N 120.642 -1.286 . . . . 0.0 111.598 174.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 90.6 m -124.91 24.64 7.56 Favored 'General case' 0 C--N 1.346 0.454 0 O-C-N 121.513 -0.742 . . . . 0.0 111.157 172.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 13.6 p -76.92 142.07 40.24 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 120.315 -1.491 . . . . 0.0 108.704 165.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 28.9 t30 72.97 -31.22 0.22 Allowed 'General case' 0 C--N 1.354 0.774 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -73.77 164.35 26.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.286 -1.509 . . . . 0.0 110.678 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 18.9 tp -73.54 -2.99 25.04 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-O 123.691 1.71 . . . . 0.0 114.174 -162.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 10.0 mp -79.47 -35.9 39.56 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 119.327 -2.108 . . . . 0.0 111.353 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.88 -32.52 82.23 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 120.766 -1.209 . . . . 0.0 113.62 -173.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -47.56 -67.4 0.28 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.355 3.062 . . . . 0.0 112.181 166.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.95 -23.16 48.61 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -78.77 -36.19 43.39 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.139 -1.601 . . . . 0.0 111.66 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.19 19.36 77.12 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 121.266 -0.896 . . . . 0.0 114.839 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 21.9 m -130.91 156.54 79.91 Favored Pre-proline 0 C--N 1.347 0.48 0 O-C-N 120.667 -1.49 . . . . 0.0 110.813 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.01 -26.09 8.17 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 121.923 1.749 . . . . 0.0 112.733 172.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 64.9 p -162.0 165.78 26.92 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 119.701 1.137 . . . . 0.0 109.533 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -138.42 166.12 25.07 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 8.4 t -117.88 143.05 46.65 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.808 -1.182 . . . . 0.0 109.51 169.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 34.6 m -57.95 -34.65 49.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.521 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -52.87 -26.65 15.39 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.34 49.22 0.96 Allowed 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 120.458 -1.401 . . . . 0.0 111.738 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -48.4 -44.32 34.85 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 126.64 1.976 . . . . 0.0 113.333 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -57.59 -35.02 69.85 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 125.692 1.597 . . . . 0.0 114.995 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -81.75 -40.26 22.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.167 -1.583 . . . . 0.0 110.023 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 75.8 mt -59.92 -52.25 63.39 Favored 'Isoleucine or valine' 0 C--N 1.347 0.496 0 C-N-CA 123.929 0.892 . . . . 0.0 111.402 172.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -51.47 -44.04 62.31 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 120.905 -1.122 . . . . 0.0 114.007 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 86.9 m -56.71 -53.77 53.85 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 121.138 -0.976 . . . . 0.0 112.199 174.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 25.9 mmt -61.53 -34.58 75.79 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 120.561 -1.337 . . . . 0.0 114.049 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.83 -55.43 22.47 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 O-C-N 121.106 -0.996 . . . . 0.0 111.39 171.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -68.81 -18.15 64.13 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 119.414 -2.054 . . . . 0.0 115.257 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -64.48 -30.95 71.98 Favored 'General case' 0 C--N 1.349 0.562 0 O-C-N 118.515 -2.615 . . . . 0.0 112.197 165.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -96.56 -15.04 21.82 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 123.899 0.879 . . . . 0.0 113.072 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 69.5 mt -120.64 121.37 38.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.603 1.161 . . . . 0.0 112.489 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.54 119.53 13.35 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 O-C-N 120.276 -1.515 . . . . 0.0 112.399 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 C--N 1.349 0.546 0 C-N-CA 124.825 1.25 . . . . 0.0 110.601 177.46 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.488 ' HA ' ' H ' ' A' ' 43' ' ' ILE . 34.7 m . . . . . 0 N--CA 1.517 2.888 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.1 55.13 31.95 Favored Glycine 0 C--N 1.357 1.706 0 CA-C-O 121.705 0.614 . . . . 0.0 112.776 -166.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -124.34 105.98 9.88 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 120.315 -1.697 . . . . 0.0 111.429 -168.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.55 -152.11 7.12 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.51 72.6 4.06 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.047 -1.266 . . . . 0.0 113.184 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 p -66.45 -2.11 4.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 126.775 2.03 . . . . 0.0 115.116 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -100.58 -31.79 11.08 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 126.189 1.795 . . . . 0.0 111.474 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -171.27 87.66 0.47 Allowed Pre-proline 0 C--N 1.351 0.656 0 O-C-N 121.382 -0.824 . . . . 0.0 110.53 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.59 98.31 0.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.88 1.72 . . . . 0.0 113.189 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -85.14 -31.97 23.0 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.353 1.061 . . . . 0.0 112.781 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.82 169.03 8.75 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 120.859 -1.15 . . . . 0.0 112.82 -173.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -64.19 -53.46 48.99 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 120.713 -1.242 . . . . 0.0 111.468 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.38 -50.36 67.7 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.183 1.393 . . . . 0.0 113.997 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -45.84 -55.04 7.13 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.915 2.086 . . . . 0.0 115.095 168.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.42 -30.43 60.05 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 120.931 -1.106 . . . . 0.0 112.979 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -54.59 -47.68 73.06 Favored 'General case' 0 C--N 1.349 0.546 0 O-C-N 119.798 -1.814 . . . . 0.0 112.729 173.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -59.51 -40.22 86.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 173.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -60.72 -20.91 62.26 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 125.836 1.654 . . . . 0.0 114.2 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.6 tp -70.53 -17.12 62.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.701 1.2 . . . . 0.0 113.663 174.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.296 91.4 p 50.93 40.89 26.22 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.363 1.865 . . . . 0.0 114.769 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.26 88.97 0.08 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.979 1.712 . . . . 0.0 114.993 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 148.2 -31.63 1.29 Allowed Glycine 0 CA--C 1.496 -1.109 0 O-C-N 120.975 -1.078 . . . . 0.0 111.096 -170.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.8 -132.7 11.02 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-O 122.423 1.013 . . . . 0.0 112.433 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 m -99.77 135.49 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 120.659 -1.495 . . . . 0.0 110.718 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.52 158.15 37.17 Favored Pre-proline 0 N--CA 1.451 -0.385 0 O-C-N 120.354 -1.466 . . . . 0.0 109.513 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.45 -5.9 17.89 Favored 'Trans proline' 0 CA--C 1.521 -0.175 0 C-N-CA 122.754 2.303 . . . . 0.0 112.848 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 mptt 61.74 51.05 4.05 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 126.481 1.912 . . . . 0.0 113.479 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.6 pt -64.11 141.69 17.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -173.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.27 26.3 0.91 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 125.305 1.442 . . . . 0.0 112.088 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -82.29 137.65 34.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.157 -1.59 . . . . 0.0 109.87 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -81.06 125.46 30.23 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 120.973 -1.079 . . . . 0.0 111.36 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.7 p -114.06 -175.22 2.63 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.517 1.151 . . . . 0.0 110.046 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -138.19 -2.95 1.8 Allowed 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 120.994 -1.066 . . . . 0.0 110.586 167.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -169.18 173.43 6.76 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.65 1.18 . . . . 0.0 109.315 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.23 -9.92 58.12 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 128.149 2.58 . . . . 0.0 111.337 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -75.0 -39.12 61.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.753 1.621 . . . . 0.0 110.962 168.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -77.89 -18.41 56.21 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.443 2.297 . . . . 0.0 112.634 -173.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.3 127.94 34.85 Favored Pre-proline 0 CA--C 1.54 0.594 0 O-C-N 120.253 -1.529 . . . . 0.0 111.55 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.76 170.09 21.12 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.649 2.233 . . . . 0.0 113.887 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.09 -96.66 0.99 Allowed Glycine 0 C--N 1.35 1.312 0 C-N-CA 124.238 0.923 . . . . 0.0 112.527 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.62 33.57 0.45 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 122.837 1.303 . . . . 0.0 109.327 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 77.3 m -91.77 136.59 33.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 119.737 -1.852 . . . . 0.0 109.965 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.488 ' H ' ' HA ' ' A' ' 1' ' ' SER . 1.6 pp -103.35 151.16 6.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 O-C-N 120.766 -1.209 . . . . 0.0 110.534 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.3 t -88.47 118.14 27.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.823 1.649 . . . . 0.0 109.154 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -79.05 172.86 13.21 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 118.952 -2.342 . . . . 0.0 110.948 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.58 -27.83 13.53 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 116.836 1.494 . . . . 0.0 116.836 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -83.82 3.49 33.38 Favored 'General case' 0 C--N 1.345 0.386 0 O-C-N 121.205 -1.174 . . . . 0.0 113.472 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.55 22.04 73.62 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 119.949 -1.719 . . . . 0.0 114.252 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -131.71 137.74 48.38 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 120.771 -1.429 . . . . 0.0 111.29 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 66.2 m -66.37 137.65 57.03 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 124.616 2.15 . . . . 0.0 114.288 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.948 0 O-C-N 120.517 -1.365 . . . . 0.0 113.928 173.176 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 N--CA 1.504 2.253 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.4 166.47 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.9 101.42 50.25 Favored Pre-proline 0 C--N 1.346 0.413 0 CA-C-O 116.936 -1.507 . . . . 0.0 110.397 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.99 168.44 23.15 Favored 'Trans proline' 0 C--N 1.329 -0.484 0 C-N-CA 123.104 2.536 . . . . 0.0 114.396 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -86.69 152.98 55.06 Favored Pre-proline 0 C--N 1.349 0.573 0 O-C-N 121.038 -1.038 . . . . 0.0 112.807 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.15 -19.23 29.92 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.145 2.563 . . . . 0.0 112.915 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.6 mt -68.62 -51.55 41.11 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-O 121.579 0.704 . . . . 0.0 110.537 169.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.87 -39.57 81.74 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 124.944 1.298 . . . . 0.0 113.391 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 tp -46.46 -42.19 15.05 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.315 1.446 . . . . 0.0 114.879 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -66.07 -36.05 82.16 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 119.595 -1.94 . . . . 0.0 113.586 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.8 tt -70.39 -50.82 34.73 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 123.927 0.891 . . . . 0.0 111.062 173.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 96.5 mt -52.65 -45.69 66.82 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 124.5 1.12 . . . . 0.0 112.412 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -59.14 -28.67 66.78 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 5.9 t -75.72 -13.18 60.3 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 124.559 1.144 . . . . 0.0 112.779 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.73 -4.3 9.37 Favored 'Isoleucine or valine' 0 C--N 1.347 0.486 0 C-N-CA 124.852 1.261 . . . . 0.0 109.987 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.58 -16.57 23.9 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 119.833 -1.792 . . . . 0.0 113.306 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.34 77.61 9.92 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.212 -1.758 . . . . 0.0 113.34 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -81.57 11.83 4.32 Favored 'General case' 0 C--N 1.344 0.351 0 O-C-N 119.747 -1.846 . . . . 0.0 115.758 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 139.94 30.21 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-O 122.132 0.968 . . . . 0.0 113.174 -174.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.05 -15.91 62.57 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.516 2.326 . . . . 0.0 114.087 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 19.6 p -138.81 126.51 22.09 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 120.318 -1.489 . . . . 0.0 110.968 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -128.34 -177.31 4.11 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-O 122.461 1.124 . . . . 0.0 110.879 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 4.2 p -90.76 176.11 6.76 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 120.041 -1.662 . . . . 0.0 110.01 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 8.5 mmt -64.75 -49.23 71.62 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 120.351 -1.468 . . . . 0.0 112.945 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -33.23 74.27 Favored 'General case' 0 C--N 1.349 0.587 0 O-C-N 120.997 -1.064 . . . . 0.0 112.605 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -57.75 -36.74 72.5 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 125.062 1.345 . . . . 0.0 114.134 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.47 -48.86 76.64 Favored 'Isoleucine or valine' 0 C--N 1.356 0.866 0 C-N-CA 123.961 0.905 . . . . 0.0 111.811 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.77 -27.33 40.46 Favored 'General case' 0 C--N 1.346 0.434 0 O-C-N 120.763 -1.211 . . . . 0.0 113.045 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -65.35 -58.84 4.89 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 125.289 1.436 . . . . 0.0 112.033 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -59.79 -41.97 92.32 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 120.992 -1.067 . . . . 0.0 112.236 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 29.6 tp -61.19 -52.45 64.74 Favored 'General case' 0 C--N 1.347 0.485 0 O-C-N 120.569 -1.332 . . . . 0.0 114.017 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.79 -45.54 94.75 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 120.602 -1.311 . . . . 0.0 113.45 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -59.05 -37.21 76.47 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 124.788 1.235 . . . . 0.0 113.157 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -59.93 -57.58 12.25 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 124.636 1.175 . . . . 0.0 112.688 173.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 3.1 mt -63.59 -41.7 93.54 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 O-C-N 119.999 -1.688 . . . . 0.0 112.209 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 52.2 ttm -56.26 -43.45 78.77 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 125.691 1.596 . . . . 0.0 112.681 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 21.6 m -82.56 -30.35 29.7 Favored 'General case' 0 C--N 1.345 0.37 0 O-C-N 119.953 -1.717 . . . . 0.0 112.521 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -75.31 -24.15 57.41 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 119.584 -1.948 . . . . 0.0 114.436 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 71.82 49.84 0.26 Allowed 'General case' 0 C--N 1.352 0.692 0 C-N-CA 125.403 1.481 . . . . 0.0 111.038 -176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 6.1 mt -107.7 17.72 22.25 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 121.054 -1.029 . . . . 0.0 111.961 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -105.83 149.54 26.41 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -77.31 154.81 32.51 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 121.254 -0.904 . . . . 0.0 108.852 172.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -71.53 -37.21 71.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 122.746 1.26 . . . . 0.0 110.794 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -88.63 -51.5 5.65 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 121.035 -1.041 . . . . 0.0 111.884 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -96.13 59.65 1.95 Allowed 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 120.338 -1.476 . . . . 0.0 113.25 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -63.29 -9.33 11.28 Favored 'General case' 0 C--N 1.346 0.436 0 O-C-N 120.098 -1.626 . . . . 0.0 115.03 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -91.07 2.38 56.36 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.293 -1.504 . . . . 0.0 113.315 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 50.1 mm -106.04 143.07 17.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 C-N-CA 125.572 1.549 . . . . 0.0 108.437 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 44.9 t -129.64 130.14 66.82 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 O-C-N 120.778 -1.201 . . . . 0.0 109.114 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -95.26 100.66 12.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.629 1.172 . . . . 0.0 110.404 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 1.2 m -101.43 1.54 38.41 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 121.118 -0.989 . . . . 0.0 112.662 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 26.4 t -65.44 131.18 45.78 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 120.828 -1.17 . . . . 0.0 110.651 173.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 4.9 t30 69.93 25.01 5.01 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.274 1.03 . . . . 0.0 113.226 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -123.26 171.5 9.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 13.8 tp -74.97 -22.19 58.71 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.781 1.632 . . . . 0.0 111.688 -171.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.04 -33.53 70.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 120.799 -1.188 . . . . 0.0 112.715 170.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.67 -38.3 96.21 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 120.065 -1.647 . . . . 0.0 113.812 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -51.91 -50.24 61.48 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.18 2.592 . . . . 0.0 112.456 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.469 HD11 HD22 ' B' ' 171' ' ' ASN . 0.9 OUTLIER -78.95 -30.76 44.77 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 120.024 -1.673 . . . . 0.0 113.865 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -75.67 -35.04 60.49 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 120.734 -1.229 . . . . 0.0 112.83 -177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 73.99 23.2 76.81 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 123.857 0.741 . . . . 0.0 113.696 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 12.3 m -135.19 152.44 76.95 Favored Pre-proline 0 N--CA 1.451 -0.408 0 O-C-N 121.176 -1.191 . . . . 0.0 108.454 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.71 -38.41 3.2 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 121.797 1.665 . . . . 0.0 111.798 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 31.1 m -144.67 164.31 31.36 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -138.06 178.48 7.09 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 77.5 p -136.78 141.64 42.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.077 -1.639 . . . . 0.0 109.626 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.23 -23.57 23.3 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 CA-C-O 122.62 1.2 . . . . 0.0 113.035 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -60.01 -27.05 66.57 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 120.666 -1.271 . . . . 0.0 113.521 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.87 56.64 1.58 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.838 1.255 . . . . 0.0 112.438 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -53.64 -38.86 64.5 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 119.684 -1.885 . . . . 0.0 114.43 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -67.45 -32.34 73.14 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.903 1.681 . . . . 0.0 113.529 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -74.72 -43.95 52.44 Favored 'General case' 0 C--N 1.348 0.53 0 C-N-CA 125.405 1.482 . . . . 0.0 110.799 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 51.3 mm -50.63 -53.38 13.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.768 1.227 . . . . 0.0 112.012 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -54.25 -43.12 70.66 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 124.243 1.017 . . . . 0.0 113.655 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -36.07 79.88 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 119.7 -1.875 . . . . 0.0 113.664 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.33 -38.38 78.16 Favored 'General case' 0 C--N 1.346 0.44 0 O-C-N 120.434 -1.416 . . . . 0.0 111.845 176.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 67.6 mt -66.54 -50.38 67.24 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 C-N-CA 124.455 1.102 . . . . 0.0 112.313 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -61.1 -14.88 27.37 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 119.735 -1.853 . . . . 0.0 114.918 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -76.31 -12.73 60.12 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.554 -1.966 . . . . 0.0 113.539 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . 0.469 HD22 HD11 ' B' ' 150' ' ' LEU . 2.1 m120 -105.24 -15.91 14.92 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 120.419 -1.426 . . . . 0.0 111.86 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 48.0 mt -111.37 162.93 14.53 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 121.92 0.867 . . . . 0.0 109.804 -174.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 8.6 p -106.92 126.68 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 O-C-N 120.453 -1.405 . . . . 0.0 108.978 173.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.348 0.534 0 C-N-CA 123.779 0.832 . . . . 0.0 110.681 -179.226 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.52 3.039 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 44.61 55.98 5.85 Favored Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.181 1.355 . . . . 0.0 114.903 -162.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -116.38 111.51 20.16 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 120.113 -1.816 . . . . 0.0 111.606 -168.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.28 -147.14 5.55 Favored Glycine 0 C--N 1.349 1.306 0 CA-C-O 122.206 0.892 . . . . 0.0 112.44 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.38 66.0 9.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 120.132 -1.805 . . . . 0.0 113.545 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.502 ' HA ' HD21 ' A' ' 18' ' ' LEU . 3.8 m -62.81 -6.26 3.55 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 pttm -89.12 -26.57 21.27 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.298 2.239 . . . . 0.0 113.635 175.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 175.16 87.22 0.08 OUTLIER Pre-proline 0 C--N 1.35 0.622 0 C-N-CA 125.074 1.35 . . . . 0.0 108.738 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.74 127.31 8.66 Favored 'Trans proline' 0 C--N 1.325 -0.702 0 C-N-CA 122.231 1.954 . . . . 0.0 111.65 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.6 t -122.38 -0.38 9.31 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-O 122.71 1.243 . . . . 0.0 110.884 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.9 t -130.39 164.2 25.23 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 124.92 1.288 . . . . 0.0 109.599 -174.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -68.26 -38.13 81.45 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 124.369 1.068 . . . . 0.0 111.105 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.7 -52.9 39.37 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 124.848 1.259 . . . . 0.0 110.803 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.84 -55.25 10.18 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.092 1.757 . . . . 0.0 114.07 169.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.57 -30.81 68.68 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.275 -1.516 . . . . 0.0 113.501 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -58.32 -41.55 84.79 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 119.937 -1.727 . . . . 0.0 112.381 171.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -65.25 -43.2 92.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.769 -1.207 . . . . 0.0 113.454 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.502 HD21 ' HA ' ' A' ' 6' ' ' SER . 3.2 mm? -53.26 -29.18 31.51 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 127.072 2.149 . . . . 0.0 115.014 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.49 -19.58 65.67 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.604 1.162 . . . . 0.0 113.94 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.268 42.2 p 54.65 35.59 24.11 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 126.871 2.068 . . . . 0.0 114.299 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.34 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.44 1.896 . . . . 0.0 115.186 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.2 -40.85 1.04 Allowed Glycine 0 CA--C 1.494 -1.225 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -170.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.91 -146.24 17.97 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 124.475 1.036 . . . . 0.0 111.684 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 m -94.53 155.24 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 O-C-N 121.09 -1.241 . . . . 0.0 110.904 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.61 155.52 80.45 Favored Pre-proline 0 N--CA 1.448 -0.559 0 O-C-N 120.601 -1.312 . . . . 0.0 107.592 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.37 6.44 3.55 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 123.113 2.542 . . . . 0.0 113.017 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt 62.63 46.25 5.54 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.705 1.602 . . . . 0.0 114.262 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 pt -59.79 139.24 19.65 Favored 'Isoleucine or valine' 0 C--N 1.348 0.531 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -173.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 mp -86.69 28.1 0.91 Allowed 'General case' 0 C--N 1.346 0.45 0 O-C-N 120.948 -1.095 . . . . 0.0 111.685 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -82.51 138.29 34.36 Favored 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 120.543 -1.348 . . . . 0.0 109.79 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -84.7 127.0 33.88 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.503 0.668 . . . . 0.0 111.019 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.9 p -119.07 -175.95 3.02 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.038 1.335 . . . . 0.0 109.388 -177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -130.67 -12.82 3.8 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 120.696 -1.252 . . . . 0.0 111.116 168.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -157.04 169.99 23.56 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 120.689 -1.257 . . . . 0.0 107.875 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.1 -31.73 71.55 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.579 1.551 . . . . 0.0 113.515 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 m -65.28 -26.64 68.17 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 120.121 -1.612 . . . . 0.0 115.058 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.84 -11.33 59.81 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.308 -0.87 . . . . 0.0 111.987 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -107.4 127.56 27.63 Favored Pre-proline 0 C--N 1.354 0.791 0 O-C-N 120.179 -1.576 . . . . 0.0 112.129 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.07 168.64 23.67 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.195 1.93 . . . . 0.0 114.175 -171.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.32 -85.57 1.13 Allowed Glycine 0 C--N 1.35 1.313 0 C-N-CA 124.626 1.108 . . . . 0.0 112.982 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -161.3 25.59 0.13 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 122.598 1.19 . . . . 0.0 110.169 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 7.1 m -89.63 148.55 23.27 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 119.181 -2.199 . . . . 0.0 109.612 -170.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 pp -115.37 147.42 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 O-C-N 119.882 -1.761 . . . . 0.0 108.821 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.06 117.14 19.08 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.989 1.316 . . . . 0.0 110.158 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -79.9 176.3 9.86 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 120.029 -1.669 . . . . 0.0 110.911 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.89 0.33 2.42 Favored Glycine 0 C--N 1.355 1.59 0 N-CA-C 117.492 1.757 . . . . 0.0 117.492 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.45 -7.49 24.23 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 120.707 -1.466 . . . . 0.0 111.925 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.35 20.18 60.93 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 120.458 -1.401 . . . . 0.0 113.707 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -130.81 145.21 51.91 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 121.133 -1.216 . . . . 0.0 110.593 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 78.8 m -75.39 147.13 40.26 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 123.51 1.624 . . . . 0.0 114.329 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.334 0 CA-C-O 116.19 -2.45 . . . . 0.0 118.186 -174.385 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 57.2 mt . . . . . 0 N--CA 1.504 2.246 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.485 HG11 HD13 ' B' ' 172' ' ' LEU . 11.7 m -136.2 166.22 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -115.84 102.14 54.04 Favored Pre-proline 0 C--N 1.345 0.391 0 CA-C-O 117.137 -1.411 . . . . 0.0 110.035 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.49 174.46 9.23 Favored 'Trans proline' 0 C--N 1.325 -0.66 0 C-N-CA 123.3 2.667 . . . . 0.0 114.086 175.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -96.2 154.64 38.73 Favored Pre-proline 0 C--N 1.35 0.617 0 O-C-N 120.914 -1.116 . . . . 0.0 111.617 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.91 -24.32 29.12 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.179 2.586 . . . . 0.0 112.7 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.8 mt -64.59 -52.94 54.94 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 118.686 0.676 . . . . 0.0 111.358 168.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 32.6 tp -58.69 -36.9 74.96 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 124.976 1.311 . . . . 0.0 113.522 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 15.6 tp -47.63 -40.3 19.26 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 125.345 1.458 . . . . 0.0 114.805 170.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -64.47 -36.82 85.44 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 119.645 -1.91 . . . . 0.0 113.723 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 tt -70.45 -50.62 36.34 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 124.037 0.935 . . . . 0.0 110.738 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 88.8 mt -53.59 -46.34 70.33 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.913 1.285 . . . . 0.0 112.287 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -58.95 -25.18 63.3 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.44 -13.57 59.02 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 125.307 1.443 . . . . 0.0 112.025 177.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.62 0.61 10.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 125.07 1.348 . . . . 0.0 109.782 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.2 -15.75 39.19 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 120.084 -1.635 . . . . 0.0 113.155 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -88.14 78.39 8.13 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 120.434 -1.627 . . . . 0.0 113.493 -172.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -85.38 8.1 20.08 Favored 'General case' 0 C--N 1.343 0.318 0 O-C-N 119.895 -1.753 . . . . 0.0 115.466 -176.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.82 149.49 27.14 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 121.339 -0.851 . . . . 0.0 112.508 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -78.74 -27.55 44.79 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.147 1.379 . . . . 0.0 112.527 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 60.4 p -121.58 140.88 51.67 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 120.808 -1.182 . . . . 0.0 112.572 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -139.43 177.31 8.02 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-O 122.439 1.114 . . . . 0.0 110.264 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.408 ' O ' HG23 ' B' ' 118' ' ' VAL . 0.7 OUTLIER -88.48 160.97 17.26 Favored 'General case' 0 C--N 1.346 0.447 0 O-C-N 120.666 -1.271 . . . . 0.0 110.872 175.208 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.98 -47.68 71.14 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.105 -1.622 . . . . 0.0 114.388 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -59.36 -52.7 64.5 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.978 0.911 . . . . 0.0 112.913 171.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.76 -46.57 50.75 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 174.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.408 HG23 ' O ' ' B' ' 114' ' ' THR . 52.1 t -51.88 -48.25 39.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 O-C-N 120.97 -1.081 . . . . 0.0 112.709 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.2 -29.84 38.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.082 -1.012 . . . . 0.0 113.288 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -56.27 -60.34 3.64 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 125.774 1.629 . . . . 0.0 112.193 172.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -59.13 -36.49 75.29 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 120.669 -1.269 . . . . 0.0 112.495 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.413 HD11 ' CD1' ' B' ' 147' ' ' LEU . 5.0 tp -62.56 -51.46 67.26 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.1 1.36 . . . . 0.0 113.902 173.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.23 -51.77 54.27 Favored Glycine 0 C--N 1.35 1.334 0 C-N-CA 125.502 1.525 . . . . 0.0 113.204 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -55.39 -39.15 69.79 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 125.216 1.406 . . . . 0.0 113.399 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -59.11 -56.3 24.02 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 121.149 -0.969 . . . . 0.0 112.74 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.71 -44.97 98.56 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 C-N-CA 124.327 1.051 . . . . 0.0 112.475 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 45.2 ttm -52.43 -44.67 65.58 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 126.268 1.827 . . . . 0.0 112.979 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 11.7 m -85.83 -23.62 27.09 Favored 'General case' 0 C--N 1.346 0.449 0 O-C-N 120.153 -1.592 . . . . 0.0 112.774 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -29.42 55.62 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 118.982 -2.324 . . . . 0.0 113.053 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? 75.15 49.27 0.09 Allowed 'General case' 0 C--N 1.351 0.659 0 C-N-CA 126.496 1.918 . . . . 0.0 110.596 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.6 23.19 12.34 Favored 'General case' 0 C--N 1.349 0.553 0 O-C-N 121.032 -1.042 . . . . 0.0 111.68 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -114.01 144.14 43.59 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.588 -1.32 . . . . 0.0 108.599 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.27 132.59 44.26 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.883 -1.136 . . . . 0.0 110.162 173.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -58.22 -47.77 82.45 Favored 'General case' 0 C--N 1.346 0.424 0 O-C-N 119.705 -1.872 . . . . 0.0 113.681 173.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -75.04 -19.49 60.01 Favored 'General case' 0 C--N 1.347 0.458 0 O-C-N 119.878 -1.764 . . . . 0.0 114.323 176.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.22 58.67 1.58 Allowed 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 119.701 -1.874 . . . . 0.0 110.231 -170.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -62.55 -7.41 4.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.453 1.901 . . . . 0.0 114.903 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -92.7 -3.82 54.22 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.015 2.526 . . . . 0.0 113.551 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 43.8 mm -106.29 139.32 28.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 0 C-N-CA 126.022 1.729 . . . . 0.0 107.643 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 39.9 t -124.7 130.17 73.47 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-O 122.406 1.098 . . . . 0.0 110.324 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.59 109.34 18.47 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.971 -1.08 . . . . 0.0 110.994 172.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 24.1 p -100.38 -14.47 18.34 Favored 'General case' 0 C--N 1.346 0.426 0 O-C-N 121.126 -0.984 . . . . 0.0 112.324 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.89 124.6 20.41 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 120.645 -1.285 . . . . 0.0 113.312 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 79.05 2.75 2.41 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 125.43 1.492 . . . . 0.0 113.554 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -112.12 167.33 10.49 Favored 'General case' 0 C--N 1.35 0.587 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 171.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 tp -64.39 -20.98 66.48 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 128.059 2.543 . . . . 0.0 112.81 -171.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' LEU . . . . . 0.413 ' CD1' HD11 ' B' ' 122' ' ' LEU . 1.1 tp -67.47 -36.55 81.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.785 1.634 . . . . 0.0 112.926 171.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.22 -48.41 31.72 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 120.923 -1.111 . . . . 0.0 112.468 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.33 -42.32 4.48 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 127.823 2.449 . . . . 0.0 114.246 169.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.75 -29.89 15.8 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 120.311 -1.493 . . . . 0.0 114.355 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.655 ' HB3' HG22 ' B' ' 153' ' ' VAL . 2.4 m-85 -74.08 -41.75 61.22 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 120.684 -1.26 . . . . 0.0 111.699 177.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 84.33 20.82 58.1 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 124.154 0.883 . . . . 0.0 113.14 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 153' ' ' VAL . . . . . 0.655 HG22 ' HB3' ' B' ' 151' ' ' PHE . 35.0 m -133.71 153.48 80.12 Favored Pre-proline 0 C--N 1.346 0.421 0 O-C-N 121.155 -1.203 . . . . 0.0 110.561 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.56 -25.18 5.7 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.046 1.83 . . . . 0.0 112.907 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 33.2 p -160.08 164.01 33.42 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 120.016 -1.678 . . . . 0.0 107.427 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -144.56 163.85 32.65 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.593 1.187 . . . . 0.0 110.7 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.57 130.27 54.36 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 120.655 -1.278 . . . . 0.0 111.034 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 48.8 t -62.79 -27.92 43.94 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 O-C-N 119.711 -1.868 . . . . 0.0 111.749 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -25.87 12.67 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 125.854 1.662 . . . . 0.0 114.868 171.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -85.2 55.52 3.53 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 119.968 -1.708 . . . . 0.0 112.185 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -48.58 -44.72 37.08 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 119.229 -2.169 . . . . 0.0 115.519 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -22.81 61.93 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 172.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -87.75 -44.13 11.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.091 1.356 . . . . 0.0 109.734 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 49.6 mm -53.98 -51.9 41.47 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 C-N-CA 125.118 1.367 . . . . 0.0 111.515 174.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -53.84 -45.96 71.07 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 171.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.87 -39.59 93.79 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 119.63 -1.918 . . . . 0.0 113.627 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 24.3 mmt -60.09 -49.25 78.4 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 120.741 -1.224 . . . . 0.0 112.58 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 45.8 mt -59.6 -51.48 72.28 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 C-N-CA 124.826 1.25 . . . . 0.0 112.524 175.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -61.39 -23.4 65.76 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 119.198 -2.189 . . . . 0.0 114.407 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -77.59 -11.87 59.91 Favored 'General case' 0 C--N 1.349 0.57 0 O-C-N 119.499 -2.001 . . . . 0.0 113.503 170.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -95.86 -26.38 15.65 Favored 'General case' 0 CA--C 1.505 -0.764 0 O-C-N 119.985 -1.697 . . . . 0.0 110.403 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.485 HD13 HG11 ' B' ' 93' ' ' VAL . 73.3 mt -103.35 174.26 5.95 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 122.023 0.916 . . . . 0.0 110.603 -174.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 97.7 t -116.59 121.66 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 99.2 t . . . . . 0 C--N 1.347 0.46 0 C-N-CA 123.792 0.837 . . . . 0.0 110.331 179.829 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.515 2.808 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 50.15 47.49 41.51 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-N 120.154 1.343 . . . . 0.0 114.874 -165.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 m -114.93 114.03 24.93 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 119.769 -2.018 . . . . 0.0 112.0 -167.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.22 -151.17 5.89 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.84 70.0 4.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.286 -1.126 . . . . 0.0 113.976 -176.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 p -69.51 -0.98 7.45 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 119.429 -2.044 . . . . 0.0 114.868 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -92.75 -34.39 13.93 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.619 1.568 . . . . 0.0 113.007 171.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -173.97 85.21 0.36 Allowed Pre-proline 0 C--N 1.347 0.471 0 CA-C-O 118.672 -0.68 . . . . 0.0 109.6 -175.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.34 118.86 4.76 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.233 1.955 . . . . 0.0 112.05 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.1 t -107.68 -25.29 11.37 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.954 1.301 . . . . 0.0 110.039 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 t -106.02 165.63 11.08 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.384 -1.447 . . . . 0.0 113.941 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -63.3 -50.44 70.07 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 119.786 -1.822 . . . . 0.0 111.77 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.36 -45.17 72.73 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 125.867 1.667 . . . . 0.0 113.061 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -56.54 -58.43 8.08 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.617 1.567 . . . . 0.0 113.888 171.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' B' ' 138' ' ' HIS . 0.1 OUTLIER -66.58 -29.52 69.59 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.321 -1.487 . . . . 0.0 113.07 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -35.63 73.81 Favored 'General case' 0 C--N 1.348 0.525 0 O-C-N 119.926 -1.734 . . . . 0.0 112.083 173.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -70.32 -44.33 68.45 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 120.532 -1.355 . . . . 0.0 112.881 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -54.32 -29.55 48.19 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 126.399 1.88 . . . . 0.0 114.862 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.488 HD22 HG13 ' B' ' 158' ' ' VAL . 21.4 tp -61.11 -30.34 70.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.511 1.124 . . . . 0.0 113.81 171.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 t 54.44 53.32 10.96 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 126.536 1.935 . . . . 0.0 113.043 -172.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.84 81.38 1.63 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 123.097 1.427 . . . . 0.0 113.561 -170.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.19 -29.92 0.47 Allowed Glycine 0 C--N 1.342 0.877 0 O-C-N 121.234 -0.916 . . . . 0.0 112.243 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.19 -149.23 18.73 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-N 117.797 0.798 . . . . 0.0 112.44 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.0 t -103.35 138.69 26.72 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 O-C-N 120.972 -1.311 . . . . 0.0 109.012 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.28 157.03 41.13 Favored Pre-proline 0 N--CA 1.447 -0.606 0 O-C-N 120.746 -1.221 . . . . 0.0 109.074 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.73 -1.09 10.27 Favored 'Trans proline' 0 C--N 1.336 -0.123 0 C-N-CA 122.73 2.286 . . . . 0.0 112.757 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt 66.98 53.76 0.81 Allowed 'General case' 0 C--N 1.35 0.609 0 C-N-CA 126.421 1.889 . . . . 0.0 112.704 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 pt -63.35 141.0 18.72 Favored 'Isoleucine or valine' 0 C--N 1.346 0.414 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.2 mt -85.65 29.9 0.67 Allowed 'General case' 0 C--N 1.348 0.503 0 C-N-CA 124.284 1.034 . . . . 0.0 111.825 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -86.32 143.34 27.93 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 120.179 -1.576 . . . . 0.0 109.386 172.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -88.48 133.95 33.99 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.861 0.839 . . . . 0.0 110.456 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.7 p -125.4 -175.88 3.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.001 0.92 . . . . 0.0 108.902 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -129.71 -13.34 4.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.346 -1.471 . . . . 0.0 111.774 167.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -161.89 176.03 11.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -74.2 -27.45 60.81 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.541 -1.349 . . . . 0.0 112.557 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.19 -28.25 67.81 Favored 'General case' 0 C--N 1.348 0.54 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 171.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -84.23 -8.24 59.11 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.347 -0.846 . . . . 0.0 110.701 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -111.29 124.19 33.29 Favored Pre-proline 0 C--N 1.355 0.816 0 O-C-N 120.091 -1.631 . . . . 0.0 111.9 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.28 169.63 22.07 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.147 1.898 . . . . 0.0 114.135 -169.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.69 -87.85 1.14 Allowed Glycine 0 C--N 1.349 1.266 0 C-N-CA 124.319 0.962 . . . . 0.0 112.246 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.39 21.53 0.29 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.992 0.901 . . . . 0.0 110.87 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 4.2 m -83.87 152.34 24.61 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 119.278 -2.139 . . . . 0.0 110.027 -168.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 pp -119.23 146.12 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 O-C-N 120.037 -1.664 . . . . 0.0 108.342 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.51 119.47 21.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.422 1.489 . . . . 0.0 109.298 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -79.53 177.34 8.94 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 119.984 -1.698 . . . . 0.0 110.565 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.34 -18.86 23.12 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 116.598 1.399 . . . . 0.0 116.598 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -82.17 -8.68 59.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.449 -1.03 . . . . 0.0 112.992 174.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.64 14.88 69.48 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 120.659 -1.276 . . . . 0.0 113.905 -175.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -127.56 148.57 50.34 Favored 'General case' 0 C--N 1.347 0.467 0 O-C-N 120.653 -1.498 . . . . 0.0 110.354 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 41.9 m -74.63 147.16 41.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 123.783 1.754 . . . . 0.0 114.35 -175.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.289 0 CA-C-O 116.689 -2.173 . . . . 0.0 117.435 -176.179 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.505 2.275 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 9.8 m -132.88 164.91 33.95 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 119.587 1.085 . . . . 0.0 108.665 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.29 100.49 53.51 Favored Pre-proline 0 C--N 1.344 0.348 0 CA-C-O 117.082 -1.437 . . . . 0.0 110.181 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.37 162.94 39.89 Favored 'Trans proline' 0 C--N 1.331 -0.358 0 C-N-CA 123.232 2.622 . . . . 0.0 114.006 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -89.11 156.28 49.07 Favored Pre-proline 0 C--N 1.347 0.492 0 O-C-N 121.344 -0.847 . . . . 0.0 112.613 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.65 -20.63 30.38 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.232 2.621 . . . . 0.0 113.3 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 81.1 mt -70.32 -61.14 1.89 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.706 0.803 . . . . 0.0 110.186 170.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 31.9 tp -50.74 -37.09 39.9 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 125.422 1.489 . . . . 0.0 114.427 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 8.3 tp -47.66 -40.71 20.6 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 169.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -64.35 -36.84 85.44 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 119.463 -2.023 . . . . 0.0 114.084 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -49.67 60.17 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 121.35 -0.844 . . . . 0.0 111.598 171.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 93.7 mt -52.18 -47.25 65.64 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 124.172 0.989 . . . . 0.0 113.124 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -52.74 -30.03 30.32 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.3 t -77.11 -20.6 55.47 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.602 1.161 . . . . 0.0 111.927 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.12 -9.72 9.49 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 C-N-CA 124.619 1.168 . . . . 0.0 110.606 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.97 -27.31 6.49 Favored Glycine 0 C--N 1.353 1.51 0 O-C-N 120.066 -1.646 . . . . 0.0 111.966 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' ALA . . . . . 0.413 ' HB1' ' CE2' ' B' ' 113' ' ' TYR . . . -78.16 74.27 4.7 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 125.82 1.648 . . . . 0.0 114.718 -171.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -84.8 17.44 2.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 119.248 -2.157 . . . . 0.0 115.158 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.43 143.8 26.54 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 123.36 1.552 . . . . 0.0 113.021 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -20.27 64.03 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 130.093 3.357 . . . . 0.0 112.396 -177.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 31.1 p -140.44 141.27 35.48 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 125.2 1.4 . . . . 0.0 109.87 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' TYR . . . . . 0.413 ' CE2' ' HB1' ' B' ' 108' ' ' ALA . 1.9 m-85 -141.51 -173.75 3.85 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.071 -1.018 . . . . 0.0 110.443 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.464 ' O ' HG23 ' B' ' 118' ' ' VAL . 4.4 p -95.68 168.73 10.49 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.526 -1.358 . . . . 0.0 110.584 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 13.7 mmt -62.48 -49.19 76.37 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.731 -1.231 . . . . 0.0 113.258 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -58.94 -45.51 90.25 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 124.677 1.191 . . . . 0.0 112.206 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -56.34 -47.54 78.59 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 114' ' ' THR . 47.2 t -52.81 -46.08 50.97 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 O-C-N 120.135 -1.603 . . . . 0.0 112.958 174.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 0.567 HD21 HD13 ' B' ' 168' ' ' ILE . 4.1 mm? -76.46 -30.79 57.46 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 120.701 -1.249 . . . . 0.0 113.233 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -62.25 -57.24 12.17 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.667 1.587 . . . . 0.0 111.588 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -59.27 -43.03 92.51 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 123.891 0.876 . . . . 0.0 112.495 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.29 -53.7 55.25 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 120.88 -1.138 . . . . 0.0 114.017 170.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.57 -40.99 99.83 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 120.523 -1.36 . . . . 0.0 113.85 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -63.11 -38.12 89.92 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 124.877 1.271 . . . . 0.0 112.718 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -56.46 -56.88 15.71 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 124.288 1.035 . . . . 0.0 112.433 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.01 -42.39 96.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 O-C-N 120.696 -1.253 . . . . 0.0 112.665 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 37.2 ttm -54.76 -41.02 69.95 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 125.911 1.684 . . . . 0.0 113.321 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 17.2 m -87.98 -28.17 21.62 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 120.162 -1.586 . . . . 0.0 112.118 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -35.12 73.63 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 119.658 -1.901 . . . . 0.0 113.562 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? 74.91 59.04 0.07 Allowed 'General case' 0 C--N 1.353 0.725 0 C-N-CA 127.033 2.133 . . . . 0.0 110.516 -169.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mt -110.42 13.79 22.73 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-O 122.065 0.936 . . . . 0.0 111.679 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -100.68 149.87 23.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.901 1.281 . . . . 0.0 108.347 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -85.14 143.42 28.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.146 -0.971 . . . . 0.0 108.548 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -64.08 -33.21 75.23 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 120.73 -1.231 . . . . 0.0 113.067 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -98.06 -35.18 10.5 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.33 -0.856 . . . . 0.0 111.953 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -111.84 63.3 0.62 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.219 1.807 . . . . 0.0 111.912 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -62.29 -9.34 7.73 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.11 1.764 . . . . 0.0 114.764 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 138' ' ' HIS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 26.2 p80 -90.07 -6.54 55.38 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.561 1.944 . . . . 0.0 113.695 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 33.1 mm -99.71 134.5 38.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 124.58 1.152 . . . . 0.0 109.273 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 19.8 t -122.74 128.39 75.25 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 O-C-N 120.757 -1.214 . . . . 0.0 109.763 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -89.2 102.72 15.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 120.97 -1.081 . . . . 0.0 109.818 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.56 -1.24 28.62 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 123.77 0.828 . . . . 0.0 111.305 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 1.4 t -71.81 139.41 48.94 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 120.623 -1.298 . . . . 0.0 109.817 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 17.6 m120 71.52 5.38 5.38 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -106.06 169.99 8.17 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 122.526 1.155 . . . . 0.0 109.884 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 13.8 tp -69.63 -21.38 63.57 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 127.193 2.197 . . . . 0.0 112.571 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.39 -32.82 64.67 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 120.565 -1.334 . . . . 0.0 111.89 170.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.57 -40.19 98.82 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 120.617 -1.302 . . . . 0.0 113.091 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.17 -43.14 70.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.688 2.395 . . . . 0.0 112.575 173.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.18 -33.29 20.84 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 119.873 -1.767 . . . . 0.0 114.135 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.578 ' HB3' HG22 ' B' ' 153' ' ' VAL . 1.8 m-85 -70.3 -41.8 72.86 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 125.713 1.605 . . . . 0.0 111.644 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.89 20.84 72.66 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 123.882 0.754 . . . . 0.0 113.178 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 153' ' ' VAL . . . . . 0.578 HG22 ' HB3' ' B' ' 151' ' ' PHE . 28.7 m -133.32 151.86 78.32 Favored Pre-proline 0 C--N 1.345 0.376 0 O-C-N 121.32 -1.106 . . . . 0.0 109.371 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.33 -25.25 11.54 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.207 1.938 . . . . 0.0 111.95 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 53.6 p -161.3 165.52 28.99 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.403 -1.436 . . . . 0.0 108.6 -175.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -143.85 168.82 19.05 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 121.074 -1.016 . . . . 0.0 108.295 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 32.6 t -115.02 140.96 48.62 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.107 -0.996 . . . . 0.0 108.907 172.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 158' ' ' VAL . . . . . 0.488 HG13 HD22 ' A' ' 19' ' ' LEU . 23.9 t -69.51 -22.19 25.22 Favored 'Isoleucine or valine' 0 C--N 1.347 0.493 0 CA-C-O 122.818 1.294 . . . . 0.0 111.564 174.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -29.62 70.72 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.163 -1.586 . . . . 0.0 112.129 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -80.46 56.98 2.71 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.754 -1.216 . . . . 0.0 112.744 175.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -52.55 -41.91 63.95 Favored 'General case' 0 C--N 1.351 0.639 0 O-C-N 119.624 -1.922 . . . . 0.0 115.555 -176.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -62.51 -33.49 74.99 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 120.54 -1.35 . . . . 0.0 113.337 173.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -78.48 -33.18 48.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.721 -1.237 . . . . 0.0 113.082 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 44.4 mm -50.13 -50.8 19.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 C-N-CA 125.633 1.573 . . . . 0.0 111.344 169.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -51.99 -52.38 50.93 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 125.218 1.407 . . . . 0.0 113.167 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.34 -42.86 82.79 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 119.996 -1.69 . . . . 0.0 115.222 173.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 11.6 mtt -62.99 -38.81 92.67 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 120.638 -1.289 . . . . 0.0 113.174 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 168' ' ' ILE . . . . . 0.567 HD13 HD21 ' B' ' 119' ' ' LEU . 44.3 mt -69.35 -54.09 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.223 -0.923 . . . . 0.0 111.927 173.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -55.53 -27.6 49.83 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 120.304 -1.497 . . . . 0.0 114.62 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -63.06 -19.53 64.48 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.898 -1.751 . . . . 0.0 115.599 171.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.0 -2.17 17.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.994 0.918 . . . . 0.0 112.169 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 92.6 mt -108.84 151.2 26.57 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 122.693 1.235 . . . . 0.0 110.199 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 16.0 t -95.98 114.29 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 O-C-N 120.315 -1.491 . . . . 0.0 108.914 173.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.35 0.601 0 C-N-CA 124.031 0.932 . . . . 0.0 111.396 179.35 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.506 ' HA ' ' H ' ' A' ' 43' ' ' ILE 0.262 87.6 p . . . . . 0 N--CA 1.532 3.626 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 55.77 53.05 44.5 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 m -107.68 113.35 26.56 Favored 'General case' 0 CA--C 1.51 -0.573 0 O-C-N 119.884 -1.951 . . . . 0.0 112.38 -173.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.48 -149.87 5.54 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.94 70.72 5.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 121.09 -1.241 . . . . 0.0 113.27 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.441 ' HA ' HD21 ' A' ' 18' ' ' LEU . 11.0 p -68.65 3.99 1.62 Allowed 'General case' 0 C--N 1.346 0.447 0 O-C-N 119.721 -1.862 . . . . 0.0 115.496 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -100.81 -39.29 7.88 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.538 1.935 . . . . 0.0 111.15 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -167.58 84.79 0.79 Allowed Pre-proline 0 N--CA 1.447 -0.583 0 O-C-N 121.402 -0.812 . . . . 0.0 109.629 -175.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.96 120.22 5.37 Favored 'Trans proline' 0 C--N 1.327 -0.599 0 C-N-CA 121.981 1.787 . . . . 0.0 112.199 -177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -107.33 -37.94 6.1 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.557 1.143 . . . . 0.0 110.109 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 m -94.04 163.67 13.38 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 120.244 -1.535 . . . . 0.0 114.841 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -60.42 -49.81 76.09 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 125.657 1.583 . . . . 0.0 111.295 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.04 -46.82 78.74 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 123.791 0.836 . . . . 0.0 113.155 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -55.09 -58.17 8.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.2 1.4 . . . . 0.0 114.422 171.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -31.98 73.25 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 120.603 -1.311 . . . . 0.0 112.947 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -57.2 -37.85 72.82 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 120.308 -1.495 . . . . 0.0 112.918 170.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -68.28 -40.54 81.79 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.369 -1.457 . . . . 0.0 112.753 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.441 HD21 ' HA ' ' A' ' 6' ' ' SER . 3.8 mm? -56.45 -29.03 61.18 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 126.382 1.873 . . . . 0.0 114.987 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.9 tp -64.98 -18.92 65.7 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 125.286 1.434 . . . . 0.0 113.676 174.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.296 59.8 p 53.85 32.02 14.28 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 126.653 1.981 . . . . 0.0 115.463 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.7 93.71 0.01 OUTLIER 'General case' 0 C--N 1.353 0.72 0 C-N-CA 126.868 2.067 . . . . 0.0 115.784 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.33 -38.03 1.26 Allowed Glycine 0 C--N 1.345 1.078 0 O-C-N 121.341 -0.85 . . . . 0.0 111.892 -169.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.68 -139.6 14.67 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 122.469 1.038 . . . . 0.0 112.528 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -97.68 145.09 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 O-C-N 120.789 -1.418 . . . . 0.0 110.452 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.35 157.7 66.78 Favored Pre-proline 0 N--CA 1.448 -0.541 0 O-C-N 120.531 -1.356 . . . . 0.0 108.168 -175.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.93 -7.82 21.32 Favored 'Trans proline' 0 CA--C 1.52 -0.188 0 C-N-CA 122.579 2.186 . . . . 0.0 112.649 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 mtmt 68.7 53.29 0.53 Allowed 'General case' 0 C--N 1.352 0.688 0 C-N-CA 126.122 1.769 . . . . 0.0 112.066 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.6 pt -64.21 142.03 17.4 Favored 'Isoleucine or valine' 0 C--N 1.347 0.486 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.34 9.94 9.77 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-O 122.545 1.164 . . . . 0.0 112.69 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -70.93 134.65 47.4 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 120.415 -1.428 . . . . 0.0 112.389 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -81.28 124.41 29.3 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 121.71 -0.619 . . . . 0.0 111.797 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.1 p -115.82 -175.86 2.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.34 1.456 . . . . 0.0 109.772 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -122.14 -32.41 3.69 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 120.528 -1.358 . . . . 0.0 110.125 163.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -138.22 176.28 8.84 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 120.613 -1.304 . . . . 0.0 112.427 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -81.03 -5.02 57.11 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 118.898 -2.376 . . . . 0.0 113.262 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.0 t -76.32 -46.76 26.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.457 2.303 . . . . 0.0 109.576 172.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -32.52 67.24 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 128.127 2.571 . . . . 0.0 113.777 177.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.76 120.3 64.9 Favored Pre-proline 0 N--CA 1.447 -0.591 0 O-C-N 120.528 -1.357 . . . . 0.0 112.776 -172.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.78 169.16 23.01 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.487 2.125 . . . . 0.0 114.108 -168.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.15 -89.67 1.1 Allowed Glycine 0 C--N 1.349 1.286 0 C-N-CA 124.195 0.903 . . . . 0.0 111.912 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.17 29.91 0.17 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.74 1.257 . . . . 0.0 109.975 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.9 m -88.66 145.26 25.77 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 119.016 -2.302 . . . . 0.0 109.415 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.506 ' H ' ' HA ' ' A' ' 1' ' ' SER . 1.3 pp -111.92 146.04 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 O-C-N 119.766 -1.834 . . . . 0.0 109.564 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -77.92 120.26 22.53 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.737 1.615 . . . . 0.0 110.041 176.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -76.41 174.78 9.83 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 119.846 -1.784 . . . . 0.0 111.077 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.89 -2.89 2.89 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 117.1 1.6 . . . . 0.0 117.1 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.21 -9.0 24.26 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.976 1.31 . . . . 0.0 112.04 172.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.56 25.43 35.83 Favored Glycine 0 C--N 1.35 1.313 0 O-C-N 120.641 -1.287 . . . . 0.0 114.26 -176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -135.93 150.29 49.25 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 120.724 -1.456 . . . . 0.0 111.465 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.9 m -85.66 116.18 23.78 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 -169.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.263 0 CA-C-O 116.063 -2.521 . . . . 0.0 116.357 175.141 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 N--CA 1.504 2.235 0 CA-C-O 118.288 -0.863 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.454 HG11 HD13 ' B' ' 172' ' ' LEU . 12.8 m -139.16 164.97 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -113.97 103.5 55.19 Favored Pre-proline 0 C--N 1.344 0.368 0 CA-C-O 116.754 -1.593 . . . . 0.0 110.271 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.56 163.93 37.16 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 122.864 2.376 . . . . 0.0 114.196 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -84.66 153.64 61.34 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.151 0.98 . . . . 0.0 113.167 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.98 -17.29 28.68 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.164 2.576 . . . . 0.0 113.34 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -71.54 -57.9 3.99 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 123.992 0.917 . . . . 0.0 109.288 169.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 28.8 tp -54.12 -38.45 65.44 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 125.678 1.591 . . . . 0.0 114.478 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 14.6 tp -46.24 -39.68 10.27 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 125.396 1.479 . . . . 0.0 114.682 168.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -69.04 -37.53 78.64 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 119.193 -2.192 . . . . 0.0 113.05 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.43 -53.32 24.43 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 126.779 2.032 . . . . 0.0 111.942 169.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 76.9 mt -49.89 -45.62 50.93 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.72 1.208 . . . . 0.0 112.513 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -17.32 63.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 174.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 20.4 t -83.02 -8.66 59.53 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 120.021 -1.674 . . . . 0.0 112.034 171.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' VAL . . . . . 0.551 HG22 ' CD1' ' B' ' 125' ' ' TYR . 2.2 t -105.34 -7.67 9.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 C-N-CA 124.766 1.226 . . . . 0.0 110.048 176.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.58 -16.91 18.87 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 120.459 -1.4 . . . . 0.0 112.558 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.45 79.84 8.85 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.401 -1.647 . . . . 0.0 113.45 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -82.58 5.76 19.88 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.804 -1.81 . . . . 0.0 115.324 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 139.14 31.56 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -174.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.51 -11.67 61.07 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.765 2.026 . . . . 0.0 114.413 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 39.9 p -138.59 137.03 36.58 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.081 1.352 . . . . 0.0 111.297 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -139.35 -172.92 3.46 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 120.798 -1.189 . . . . 0.0 110.092 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.55 ' O ' HG23 ' B' ' 118' ' ' VAL . 1.8 p -96.88 173.12 7.45 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.048 -1.657 . . . . 0.0 109.93 174.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 24.7 mtt -67.15 -43.67 81.72 Favored 'General case' 0 C--N 1.352 0.699 0 O-C-N 120.161 -1.587 . . . . 0.0 113.46 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -58.73 -51.33 70.42 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.237 1.015 . . . . 0.0 111.603 172.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -54.56 -44.1 72.63 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.55 HG23 ' O ' ' B' ' 114' ' ' THR . 86.2 t -54.72 -43.53 66.78 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 120.121 -1.612 . . . . 0.0 112.568 176.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.3 -30.91 27.18 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 120.729 -1.232 . . . . 0.0 112.344 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -59.93 -60.86 3.16 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.949 1.7 . . . . 0.0 112.123 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -56.96 -38.23 72.69 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.41 1.084 . . . . 0.0 112.286 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 32.3 tp -64.68 -51.44 62.48 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 172.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.33 -40.29 91.84 Favored Glycine 0 C--N 1.349 1.297 0 O-C-N 119.928 -1.732 . . . . 0.0 114.019 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -30.31 71.33 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 124.724 1.21 . . . . 0.0 112.177 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.551 ' CD1' HG22 ' B' ' 106' ' ' VAL . 7.9 t80 -57.55 -60.95 2.89 Favored 'General case' 0 C--N 1.357 0.91 0 O-C-N 120.833 -1.167 . . . . 0.0 111.669 171.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 45.1 mm -58.41 -40.69 79.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 O-C-N 120.584 -1.322 . . . . 0.0 113.343 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 35.7 ttm -52.55 -43.27 65.08 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 125.077 1.351 . . . . 0.0 113.867 171.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 22.3 m -87.7 -31.88 19.48 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 124.727 1.211 . . . . 0.0 112.534 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 129' ' ' LYS . . . . . 0.446 ' HD2' ' CZ ' ' B' ' 125' ' ' TYR . 5.2 mmpt? -77.54 -25.42 50.16 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 120.027 -1.671 . . . . 0.0 114.306 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.98 53.67 0.19 Allowed 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.663 1.585 . . . . 0.0 111.38 -176.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.74 19.62 18.44 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.423 1.089 . . . . 0.0 110.627 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -105.09 146.46 29.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.56 -1.338 . . . . 0.0 107.998 173.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.48 139.68 45.92 Favored 'General case' 0 C--N 1.347 0.461 0 O-C-N 120.789 -1.195 . . . . 0.0 110.043 171.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' GLU . . . . . 0.46 ' HA ' HE21 ' B' ' 137' ' ' GLN . 58.8 mt-10 -59.95 -47.16 86.92 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 120.22 -1.55 . . . . 0.0 113.177 174.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -83.09 -19.99 35.73 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.844 1.258 . . . . 0.0 113.973 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -132.83 61.92 1.66 Allowed 'General case' 0 C--N 1.352 0.707 0 O-C-N 120.589 -1.319 . . . . 0.0 109.855 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 137' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' B' ' 134' ' ' GLU . 6.4 mm-40 -64.46 -6.15 6.77 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -175.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -89.97 -8.1 52.49 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.586 1.955 . . . . 0.0 113.315 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 47.8 mm -96.44 136.49 27.13 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 124.93 1.292 . . . . 0.0 109.303 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 17.2 t -121.75 123.76 70.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 O-C-N 120.856 -1.152 . . . . 0.0 110.202 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -86.22 113.82 22.54 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.653 1.181 . . . . 0.0 109.183 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 16.0 m -115.11 1.24 13.84 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 120.623 -1.298 . . . . 0.0 111.174 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 34.1 t -73.42 126.8 31.01 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.468 -1.395 . . . . 0.0 110.21 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 75.05 23.9 1.57 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.795 1.238 . . . . 0.0 112.01 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -128.39 165.29 20.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 tp -70.83 -16.89 62.75 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 126.844 2.058 . . . . 0.0 112.143 -170.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.25 -40.95 70.69 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.511 1.524 . . . . 0.0 111.841 169.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.97 -41.81 99.69 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 120.368 -1.458 . . . . 0.0 112.895 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -53.46 -33.64 54.93 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.189 2.196 . . . . 0.0 114.403 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.79 -33.01 11.83 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 120.055 -1.653 . . . . 0.0 113.158 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -78.79 -34.01 45.8 Favored 'General case' 0 C--N 1.35 0.629 0 O-C-N 121.044 -1.035 . . . . 0.0 113.108 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 79.91 15.06 79.9 Favored Glycine 0 C--N 1.35 1.319 0 O-C-N 121.315 -0.866 . . . . 0.0 113.898 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 20.5 m -131.35 151.75 79.33 Favored Pre-proline 0 C--N 1.345 0.38 0 O-C-N 121.055 -1.262 . . . . 0.0 109.844 -174.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.48 -33.11 4.36 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.907 1.738 . . . . 0.0 112.621 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 19.3 m -150.43 161.62 42.14 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -175.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -135.34 163.82 29.14 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.456 -0.777 . . . . 0.0 109.435 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 46.0 t -110.4 129.18 55.82 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 30.6 t -61.31 -28.76 44.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 O-C-N 120.818 -1.176 . . . . 0.0 112.219 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -54.21 -29.26 45.54 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 126.075 1.75 . . . . 0.0 114.795 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.59 54.58 2.41 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 120.575 -1.328 . . . . 0.0 111.75 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -47.97 -46.2 32.2 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 119.96 -1.713 . . . . 0.0 114.428 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -58.47 -38.51 77.71 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 125.365 1.466 . . . . 0.0 114.561 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -72.96 -45.33 58.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.758 0.823 . . . . 0.0 112.038 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 18.9 mt -55.64 -50.55 66.44 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 C-N-CA 125.188 1.395 . . . . 0.0 110.342 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -51.09 -52.14 46.49 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 124.681 1.192 . . . . 0.0 114.122 171.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 1.3 p -58.49 -38.3 77.35 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 119.544 -1.972 . . . . 0.0 115.031 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -42.55 89.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.322 -0.861 . . . . 0.0 112.048 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 31.5 mt -60.67 -52.43 61.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 O-C-N 120.438 -1.413 . . . . 0.0 112.052 173.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -64.31 -4.81 4.13 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -89.22 -27.06 20.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 119.641 -1.912 . . . . 0.0 113.342 168.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -88.06 -20.44 25.74 Favored 'General case' 0 CA--C 1.509 -0.621 0 O-C-N 121.247 -0.908 . . . . 0.0 111.489 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.454 HD13 HG11 ' B' ' 93' ' ' VAL . 70.4 mt -108.1 147.24 31.5 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 125.071 1.348 . . . . 0.0 111.705 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 56.2 t -90.78 122.65 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 120.749 -1.219 . . . . 0.0 109.355 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 93.8 t . . . . . 0 C--N 1.35 0.617 0 C-N-CA 124.606 1.162 . . . . 0.0 110.38 176.467 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.518 2.931 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 45.34 60.54 4.07 Favored Glycine 0 C--N 1.355 1.631 0 CA-C-N 120.113 1.324 . . . . 0.0 113.986 -164.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.7 m -123.46 106.22 10.45 Favored 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 120.005 -1.88 . . . . 0.0 112.084 -166.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.33 -155.03 7.62 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.02 68.58 2.52 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.467 ' HA ' HD11 ' A' ' 18' ' ' LEU . 29.3 t -55.21 -27.92 49.49 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 126.113 1.765 . . . . 0.0 113.583 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -76.32 -29.51 57.34 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -178.6 87.32 0.22 Allowed Pre-proline 0 C--N 1.351 0.643 0 O-C-N 121.146 -0.971 . . . . 0.0 110.434 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -78.61 120.85 4.91 Favored 'Trans proline' 0 C--N 1.327 -0.554 0 C-N-CA 122.319 2.013 . . . . 0.0 112.854 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.9 t -120.57 6.63 10.55 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.248 1.819 . . . . 0.0 110.214 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 m -135.62 156.37 48.97 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 119.507 -1.996 . . . . 0.0 112.92 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -55.83 -45.9 78.24 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 120.352 -1.467 . . . . 0.0 112.919 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.44 94.7 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 125.216 1.406 . . . . 0.0 113.069 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -61.95 -53.91 49.08 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 120.39 -1.444 . . . . 0.0 113.317 172.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.91 -30.46 69.8 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.345 -0.847 . . . . 0.0 113.152 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.4 t90 -54.21 -45.08 72.15 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 120.097 -1.627 . . . . 0.0 113.389 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -62.34 -41.39 98.54 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 120.977 -1.077 . . . . 0.0 113.8 174.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.467 HD11 ' HA ' ' A' ' 6' ' ' SER . 2.4 mm? -55.16 -32.52 62.21 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 126.197 1.799 . . . . 0.0 114.629 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.6 tp -56.71 -28.13 60.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.376 1.471 . . . . 0.0 113.803 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p 71.04 17.91 6.04 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.54 2.336 . . . . 0.0 113.951 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.86 93.32 0.01 OUTLIER 'General case' 0 C--N 1.351 0.647 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 -164.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.86 -31.35 1.76 Allowed Glycine 0 C--N 1.345 1.077 0 O-C-N 121.034 -1.041 . . . . 0.0 111.96 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.4 -150.3 16.95 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-O 122.807 1.226 . . . . 0.0 112.407 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 t -97.27 139.89 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 120.913 -1.345 . . . . 0.0 109.458 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.16 156.48 48.51 Favored Pre-proline 0 N--CA 1.45 -0.453 0 O-C-N 120.438 -1.414 . . . . 0.0 108.64 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.69 8.33 2.35 Favored 'Trans proline' 0 N--CA 1.47 0.109 0 C-N-CA 123.058 2.505 . . . . 0.0 113.119 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? 61.45 47.32 6.8 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 125.85 1.66 . . . . 0.0 114.499 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.9 pt -60.78 140.93 17.89 Favored 'Isoleucine or valine' 0 C--N 1.349 0.576 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.5 mt -87.91 24.2 1.84 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-O 122.612 1.196 . . . . 0.0 111.743 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -80.95 138.42 36.1 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 120.428 -1.42 . . . . 0.0 110.49 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -86.85 120.92 28.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.656 -0.652 . . . . 0.0 111.524 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.3 p -109.29 -179.36 3.81 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.082 1.353 . . . . 0.0 110.109 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -119.92 -28.46 5.17 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 120.491 -1.38 . . . . 0.0 110.15 162.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -146.76 173.67 12.16 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 122.931 1.348 . . . . 0.0 113.271 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -73.65 -12.2 60.66 Favored 'General case' 0 C--N 1.346 0.435 0 O-C-N 119.842 -1.786 . . . . 0.0 113.839 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.3 p -78.16 -29.31 48.6 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 126.727 2.011 . . . . 0.0 111.79 173.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.66 -28.75 45.45 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.55 1.54 . . . . 0.0 109.728 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -94.39 119.47 66.4 Favored Pre-proline 0 N--CA 1.445 -0.685 0 O-C-N 120.953 -1.092 . . . . 0.0 113.078 -173.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.71 171.47 17.74 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.526 2.151 . . . . 0.0 114.525 -166.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.23 -84.95 1.14 Allowed Glycine 0 C--N 1.35 1.322 0 C-N-CA 124.345 0.974 . . . . 0.0 112.361 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.69 6.65 0.47 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.9 m -73.82 178.57 4.76 Favored 'General case' 0 C--N 1.347 0.496 0 O-C-N 120.353 -1.467 . . . . 0.0 112.656 -160.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 pp -141.38 149.4 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -86.88 111.68 21.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 126.338 1.855 . . . . 0.0 108.675 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -76.13 172.95 11.95 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 118.91 -2.369 . . . . 0.0 110.827 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.94 -19.36 6.93 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 117.548 1.779 . . . . 0.0 117.548 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -85.8 -8.51 58.07 Favored 'General case' 0 C--N 1.345 0.375 0 O-C-N 121.288 -1.125 . . . . 0.0 113.418 174.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.31 27.55 39.54 Favored Glycine 0 C--N 1.348 1.224 0 O-C-N 120.755 -1.216 . . . . 0.0 114.256 -175.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -137.3 146.69 44.97 Favored 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 120.942 -1.328 . . . . 0.0 110.917 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 83.1 m -78.45 135.95 37.51 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 123.747 1.736 . . . . 0.0 115.232 -170.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.347 0 CA-C-O 115.69 -2.728 . . . . 0.0 116.946 -175.097 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.451 HG11 HD13 ' B' ' 172' ' ' LEU . 15.0 m -133.21 170.28 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 119.126 0.876 . . . . 0.0 109.517 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 101.9 51.43 Favored Pre-proline 0 C--N 1.344 0.338 0 CA-C-O 116.849 -1.548 . . . . 0.0 110.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.32 164.23 35.84 Favored 'Trans proline' 0 C--N 1.326 -0.633 0 CA-C-N 123.871 2.418 . . . . 0.0 113.675 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -84.77 153.59 60.94 Favored Pre-proline 0 C--N 1.35 0.616 0 C-N-CA 123.905 0.882 . . . . 0.0 112.605 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.33 -24.27 27.24 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.312 2.675 . . . . 0.0 113.089 -172.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 mt -66.09 -54.48 25.21 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 121.365 -0.834 . . . . 0.0 110.698 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -56.82 -39.26 73.86 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 125.118 1.367 . . . . 0.0 113.663 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 15.8 tp -45.8 -40.62 9.92 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 125.37 1.468 . . . . 0.0 114.925 170.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 29.1 tttp -67.81 -34.79 77.43 Favored 'General case' 0 C--N 1.348 0.514 0 O-C-N 119.889 -1.757 . . . . 0.0 113.375 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.1 -50.25 35.63 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 124.887 1.275 . . . . 0.0 111.247 171.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.433 HD13 ' CE2' ' B' ' 113' ' ' TYR . 91.2 mt -55.17 -42.27 72.95 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 121.146 -0.972 . . . . 0.0 112.302 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.4 -26.05 67.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 175.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 4.0 t -77.93 -13.53 59.85 Favored 'General case' 0 C--N 1.344 0.369 0 O-C-N 120.958 -1.089 . . . . 0.0 112.425 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 5.2 t -97.37 -9.22 9.07 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 C-N-CA 125.154 1.382 . . . . 0.0 109.868 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.65 -20.06 10.27 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 120.465 -1.397 . . . . 0.0 112.514 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -89.28 91.52 8.79 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 120.514 -1.58 . . . . 0.0 112.215 -171.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -95.09 17.87 13.24 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 119.185 -2.197 . . . . 0.0 116.166 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -97.42 143.0 28.58 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.471 1.108 . . . . 0.0 112.937 -171.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.18 9.89 4.11 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 119.769 -1.832 . . . . 0.0 115.677 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.4 p -149.31 131.56 15.52 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 120.381 -1.45 . . . . 0.0 111.186 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' TYR . . . . . 0.433 ' CE2' HD13 ' B' ' 103' ' ' LEU . 78.6 m-85 -132.74 178.81 6.57 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-O 122.939 1.352 . . . . 0.0 110.814 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.04 163.64 14.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.658 1.583 . . . . 0.0 109.854 170.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 48.4 mtm -62.55 -48.77 78.06 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 119.012 -2.305 . . . . 0.0 113.812 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -60.91 -42.53 98.23 Favored 'General case' 0 C--N 1.349 0.562 0 O-C-N 121.274 -0.892 . . . . 0.0 113.176 173.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -50.94 -48.25 60.92 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.893 1.677 . . . . 0.0 114.804 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -52.45 -49.99 41.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 125.209 1.403 . . . . 0.0 111.884 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 0.447 HD21 HD13 ' B' ' 168' ' ' ILE . 4.5 mm? -75.01 -32.17 61.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 120.918 -1.114 . . . . 0.0 113.011 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -62.14 -57.81 10.16 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.557 1.543 . . . . 0.0 111.72 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -57.34 -44.13 84.02 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 123.977 0.911 . . . . 0.0 112.396 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.5 -54.0 50.77 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.41 -44.91 94.64 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 120.126 -1.609 . . . . 0.0 113.657 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -63.77 -32.43 73.93 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 124.139 0.976 . . . . 0.0 112.798 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -57.1 -57.91 10.51 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 120.842 -1.161 . . . . 0.0 112.262 170.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 38.1 mm -63.94 -41.41 92.41 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 O-C-N 120.392 -1.443 . . . . 0.0 112.566 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 46.9 ttm -54.56 -43.9 72.42 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 126.117 1.767 . . . . 0.0 113.705 172.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 20.5 m -86.96 -24.5 24.71 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 120.718 -1.239 . . . . 0.0 112.597 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -75.12 -26.74 59.45 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 119.702 -1.874 . . . . 0.0 113.173 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? 72.04 53.51 0.19 Allowed 'General case' 0 C--N 1.354 0.785 0 C-N-CA 126.113 1.765 . . . . 0.0 110.895 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.54 9.43 33.43 Favored 'General case' 0 C--N 1.348 0.514 0 O-C-N 121.1 -1.0 . . . . 0.0 111.848 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -93.34 146.57 23.63 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.41 160.93 31.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.842 -0.536 . . . . 0.0 110.423 173.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -76.57 -34.92 58.45 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 120.97 -1.081 . . . . 0.0 112.104 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -91.34 -44.87 8.91 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.426 -1.421 . . . . 0.0 110.929 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -107.67 57.12 0.63 Allowed 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.026 1.33 . . . . 0.0 111.721 -173.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -63.09 -11.77 22.16 Favored 'General case' 0 C--N 1.347 0.474 0 O-C-N 120.125 -1.609 . . . . 0.0 114.86 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -86.91 -4.03 59.14 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.343 1.457 . . . . 0.0 113.403 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 47.7 mm -101.55 137.13 30.34 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 C-N-CA 124.988 1.315 . . . . 0.0 108.991 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 16.7 t -123.8 123.34 66.8 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 120.85 -1.156 . . . . 0.0 110.701 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -93.33 113.92 26.22 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 121.192 -0.942 . . . . 0.0 110.101 173.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 16.5 m -115.37 20.92 14.5 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 121.191 -0.943 . . . . 0.0 110.334 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 71.3 p -74.76 140.14 43.85 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 120.11 -1.619 . . . . 0.0 109.862 171.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 3.4 t30 64.75 29.01 12.91 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -138.34 164.47 29.22 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 7.7 tp -70.8 -14.46 62.43 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-O 124.393 2.044 . . . . 0.0 113.536 -165.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.01 -35.71 69.5 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.946 1.699 . . . . 0.0 111.892 170.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.21 -43.22 99.41 Favored Glycine 0 C--N 1.348 1.201 0 O-C-N 120.096 -1.627 . . . . 0.0 113.029 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -53.15 -34.27 56.12 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 126.596 1.958 . . . . 0.0 114.731 172.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 pp -95.89 -31.24 13.23 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 119.538 -1.976 . . . . 0.0 113.402 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.481 ' HB3' HG22 ' B' ' 153' ' ' VAL . 18.5 m-85 -77.9 -42.41 33.35 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.737 1.215 . . . . 0.0 112.513 178.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 83.82 15.91 69.2 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 121.427 -0.795 . . . . 0.0 113.932 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 153' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' B' ' 151' ' ' PHE . 32.7 m -131.45 151.55 78.93 Favored Pre-proline 0 C--N 1.343 0.31 0 O-C-N 121.216 -1.167 . . . . 0.0 109.787 -174.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.18 -30.29 5.68 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.811 1.674 . . . . 0.0 112.653 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 87.2 p -154.0 169.4 23.57 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -138.74 165.61 26.54 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.204 1.002 . . . . 0.0 109.289 172.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 26.6 t -109.33 128.76 55.35 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.28 -31.84 51.39 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 O-C-N 120.623 -1.298 . . . . 0.0 111.739 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -58.75 -22.03 56.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.818 2.047 . . . . 0.0 114.463 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -82.4 58.49 4.13 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 120.404 -1.435 . . . . 0.0 112.071 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -49.17 -45.26 43.77 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.027 -1.671 . . . . 0.0 114.132 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -61.33 -33.07 73.01 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 120.64 -1.288 . . . . 0.0 114.234 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -73.95 -46.24 45.36 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 120.326 -1.484 . . . . 0.0 110.955 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 33.0 mm -50.5 -57.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.351 0.671 0 C-N-CA 125.173 1.389 . . . . 0.0 112.44 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 165' ' ' TYR . . . . . 0.55 ' HA ' HD12 ' B' ' 168' ' ' ILE . 37.5 m-85 -49.2 -46.16 45.26 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 171.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 31.9 m -62.91 -39.58 94.97 Favored 'General case' 0 C--N 1.346 0.429 0 O-C-N 120.543 -1.348 . . . . 0.0 113.379 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -44.94 88.1 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.388 -1.445 . . . . 0.0 111.752 177.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 168' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' B' ' 165' ' ' TYR . 22.0 mt -57.27 -53.11 48.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 C-N-CA 125.473 1.509 . . . . 0.0 112.291 174.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -62.74 -11.92 20.66 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.274 -1.516 . . . . 0.0 114.835 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -85.47 -11.65 53.79 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 119.394 -2.066 . . . . 0.0 113.571 169.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -105.04 -21.24 13.31 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 120.194 -1.567 . . . . 0.0 109.883 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.451 HD13 HG11 ' B' ' 93' ' ' VAL . 73.2 mt -110.92 151.67 27.64 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 126.111 1.764 . . . . 0.0 110.809 -175.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 61.0 t -96.17 119.63 44.48 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 O-C-N 120.473 -1.392 . . . . 0.0 108.954 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 56.3 t . . . . . 0 C--N 1.348 0.541 0 C-N-CA 124.166 0.986 . . . . 0.0 110.919 177.169 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.519 3.024 0 CA-C-O 116.743 -1.599 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 48.93 39.23 25.24 Favored Glycine 0 C--N 1.357 1.701 0 CA-C-N 120.23 1.377 . . . . 0.0 115.353 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.7 m -118.18 120.06 36.57 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.507 -1.584 . . . . 0.0 111.177 -167.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.05 -148.99 5.91 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.25 78.03 3.78 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 120.996 -1.297 . . . . 0.0 113.239 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.404 ' HA ' HD11 ' A' ' 18' ' ' LEU . 8.2 t -72.95 3.05 5.76 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 119.435 -2.041 . . . . 0.0 115.457 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -100.74 -44.61 5.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.614 -1.304 . . . . 0.0 110.958 173.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -150.52 85.96 5.18 Favored Pre-proline 0 N--CA 1.443 -0.798 0 O-C-N 121.552 -0.717 . . . . 0.0 109.319 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.84 108.98 2.76 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.273 1.982 . . . . 0.0 110.982 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 t -101.88 -19.89 15.1 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.041 0.936 . . . . 0.0 110.413 -174.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.3 m -120.51 164.64 16.12 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-O 122.797 1.284 . . . . 0.0 113.617 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -61.51 -49.65 75.88 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 126.316 1.846 . . . . 0.0 110.978 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.36 78.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.055 0.942 . . . . 0.0 113.511 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -68.91 -52.71 26.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 121.269 -0.895 . . . . 0.0 112.628 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -29.13 69.79 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 120.695 -1.253 . . . . 0.0 112.574 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -53.05 -38.28 62.32 Favored 'General case' 0 C--N 1.346 0.452 0 O-C-N 120.439 -1.413 . . . . 0.0 113.796 167.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -73.49 -37.23 65.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.416 -1.427 . . . . 0.0 112.726 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.404 HD11 ' HA ' ' A' ' 6' ' ' SER . 4.4 mm? -60.2 -24.02 64.47 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.992 1.317 . . . . 0.0 114.493 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.3 tp -67.84 -23.74 65.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.689 -1.257 . . . . 0.0 112.303 172.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 t 55.26 44.01 28.21 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 127.314 2.246 . . . . 0.0 112.936 -175.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.6 85.25 0.02 OUTLIER 'General case' 0 C--N 1.353 0.748 0 C-N-CA 127.17 2.188 . . . . 0.0 113.92 -172.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.452 ' HA3' ' HB1' ' A' ' 41' ' ' ALA . . . 156.73 -41.82 0.55 Allowed Glycine 0 CA--C 1.492 -1.376 0 O-C-N 121.057 -1.027 . . . . 0.0 112.807 -164.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.77 -142.62 16.09 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.6 p -94.28 135.67 27.93 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 O-C-N 120.562 -1.552 . . . . 0.0 110.445 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.1 t -129.79 145.42 56.98 Favored Pre-proline 0 C--N 1.347 0.486 0 CA-C-O 115.81 -2.043 . . . . 0.0 106.783 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -66.22 -2.36 6.88 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 124.428 3.418 . . . . 0.0 117.47 -164.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.69 52.93 0.41 Allowed 'General case' 0 C--N 1.349 0.582 0 C-N-CA 125.293 1.437 . . . . 0.0 112.48 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.3 pt -70.06 140.59 18.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.466 0 O-C-N 120.299 -1.5 . . . . 0.0 114.093 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.1 mt -88.95 33.76 0.78 Allowed 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.132 -0.98 . . . . 0.0 111.282 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -88.69 131.42 35.02 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 119.945 -1.722 . . . . 0.0 109.394 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.16 108.27 7.8 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 122.238 1.018 . . . . 0.0 111.072 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.0 p -107.3 -161.29 0.77 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.569 1.548 . . . . 0.0 111.391 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -150.45 -37.38 0.14 Allowed 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.619 -1.926 . . . . 0.0 109.47 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -133.51 174.85 9.98 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 171.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -74.15 -2.32 24.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 119.141 -2.225 . . . . 0.0 115.273 -172.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.5 m -90.15 -40.28 12.33 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 125.657 1.583 . . . . 0.0 111.934 -173.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.64 -29.8 68.36 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 123.281 1.515 . . . . 0.0 110.897 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 15.3 t -90.71 109.16 32.56 Favored Pre-proline 0 N--CA 1.443 -0.785 0 C-N-CA 125.429 1.492 . . . . 0.0 111.255 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.87 171.73 17.62 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.449 2.099 . . . . 0.0 115.294 -160.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.83 -93.26 1.58 Allowed Glycine 0 C--N 1.347 1.172 0 C-N-CA 124.271 0.939 . . . . 0.0 112.49 173.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB1' ' HA3' ' A' ' 22' ' ' GLY . . . -156.44 24.88 0.35 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 122.964 1.364 . . . . 0.0 111.096 -176.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 54.4 m -88.57 153.37 21.18 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 119.95 -1.719 . . . . 0.0 108.058 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.4 pp -119.83 154.58 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 170.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.3 m -85.11 134.51 34.19 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.1 mtt85 -82.8 168.89 16.71 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.624 -1.297 . . . . 0.0 108.356 167.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -32.8 -43.48 0.18 Allowed Glycine 0 C--N 1.353 1.508 0 N-CA-C 119.33 2.492 . . . . 0.0 119.33 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -74.07 8.43 2.09 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.92 36.38 90.94 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 119.915 -1.741 . . . . 0.0 114.191 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -135.61 147.27 48.6 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 122.08 0.943 . . . . 0.0 108.609 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.1 m -78.45 130.77 36.45 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 125.212 2.434 . . . . 0.0 113.933 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.274 0 N-CA-C 105.716 -2.954 . . . . 0.0 105.716 -177.87 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 20.7 m -120.72 167.27 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 119.496 1.044 . . . . 0.0 109.217 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -141.54 114.83 6.76 Favored Pre-proline 0 C--N 1.35 0.619 0 CA-C-O 116.694 -1.622 . . . . 0.0 108.181 170.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.73 168.12 25.54 Favored 'Trans proline' 0 C--N 1.328 -0.504 0 CA-C-N 123.822 2.401 . . . . 0.0 112.747 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -84.71 159.54 57.82 Favored Pre-proline 0 C--N 1.346 0.439 0 O-C-N 120.891 -1.13 . . . . 0.0 111.698 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -68.48 -25.16 35.56 Favored 'Trans proline' 0 CA--C 1.521 -0.159 0 C-N-CA 122.781 2.32 . . . . 0.0 114.275 -170.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.05 -42.31 99.68 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.238 0.926 . . . . 0.0 110.526 170.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 17.2 tp -72.45 -34.98 68.14 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 120.191 -1.568 . . . . 0.0 113.11 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 33.0 tp -53.3 -42.07 66.26 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.154 -1.591 . . . . 0.0 113.622 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -62.42 -30.85 71.52 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 120.47 -1.394 . . . . 0.0 113.82 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 24.0 tp -67.66 -61.37 1.92 Allowed 'General case' 0 C--N 1.35 0.619 0 C-N-CA 123.672 0.789 . . . . 0.0 110.335 172.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.29 -49.22 61.69 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 126.39 1.876 . . . . 0.0 113.305 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -14.27 61.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 120.088 -1.632 . . . . 0.0 114.871 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -85.34 -6.92 59.2 Favored 'General case' 0 C--N 1.346 0.413 0 O-C-N 120.047 -1.658 . . . . 0.0 112.234 168.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 15.2 t -94.37 -5.62 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.944 1.298 . . . . 0.0 109.061 163.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.98 -13.36 31.76 Favored Glycine 0 C--N 1.354 1.57 0 O-C-N 119.816 -1.802 . . . . 0.0 113.393 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.11 69.59 10.51 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 120.757 -1.437 . . . . 0.0 113.888 -173.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . 0.25 3.3 pm0 -78.68 76.74 5.18 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 119.61 -1.931 . . . . 0.0 110.959 165.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -151.06 124.5 8.93 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 120.815 -1.178 . . . . 0.0 109.239 168.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.89 -49.43 65.91 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 128.165 2.586 . . . . 0.0 113.475 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 22.6 p -94.48 90.22 6.13 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.139 -1.6 . . . . 0.0 114.755 -169.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -104.32 173.21 6.4 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-O 123.67 1.7 . . . . 0.0 114.522 171.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 32.7 m -96.34 159.52 14.9 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 127.281 2.233 . . . . 0.0 109.985 -173.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 2.4 mmt -53.7 -45.96 70.59 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -63.18 -50.0 72.07 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 120.583 -1.323 . . . . 0.0 112.149 170.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -54.49 -42.36 70.65 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -173.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 47.3 t -58.52 -30.91 42.28 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 O-C-N 120.927 -1.108 . . . . 0.0 111.563 175.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.2 -33.37 14.72 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.261 1.025 . . . . 0.0 112.161 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -56.89 -64.68 0.8 Allowed 'General case' 0 C--N 1.352 0.675 0 O-C-N 119.954 -1.716 . . . . 0.0 113.028 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -56.86 -39.86 75.08 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 124.278 1.031 . . . . 0.0 112.221 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 27.1 tp -63.44 -52.66 60.52 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 120.713 -1.242 . . . . 0.0 113.254 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.77 -41.31 93.73 Favored Glycine 0 C--N 1.349 1.276 0 O-C-N 120.099 -1.625 . . . . 0.0 114.022 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -56.52 -43.46 79.8 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 125.732 1.613 . . . . 0.0 112.85 173.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -54.83 -55.65 27.96 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.585 1.154 . . . . 0.0 112.459 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 3.5 mp -63.95 -43.29 97.65 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 O-C-N 120.35 -1.469 . . . . 0.0 112.215 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 45.9 ttm -57.04 -36.38 70.41 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 125.0 1.32 . . . . 0.0 113.352 175.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 26.1 m -86.06 -34.65 20.64 Favored 'General case' 0 C--N 1.344 0.344 0 O-C-N 120.394 -1.441 . . . . 0.0 112.424 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -68.34 -33.89 75.1 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 120.091 -1.631 . . . . 0.0 114.557 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 77.34 50.92 0.04 OUTLIER 'General case' 0 C--N 1.353 0.719 0 C-N-CA 126.608 1.963 . . . . 0.0 111.017 -171.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 95.1 mt -109.8 34.05 4.05 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 122.713 1.244 . . . . 0.0 110.331 169.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -110.52 148.26 32.47 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 163.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -75.48 161.97 28.74 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.277 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . 0.264 35.8 mt-10 -62.9 -47.9 81.28 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 119.995 -1.691 . . . . 0.0 111.261 172.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.21 -43.92 10.65 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.765 1.626 . . . . 0.0 108.638 -164.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -108.81 63.36 0.6 Allowed 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 125.015 1.326 . . . . 0.0 112.235 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -65.25 -7.24 12.17 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 118.898 -2.376 . . . . 0.0 114.627 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -82.69 -8.95 59.57 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.606 1.562 . . . . 0.0 113.88 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 46.4 mm -99.8 128.86 51.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 O-C-N 120.87 -1.144 . . . . 0.0 109.759 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 48.8 t -116.56 128.38 73.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.481 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -90.78 121.46 32.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 120.902 -1.123 . . . . 0.0 109.071 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 58.5 m -116.35 12.68 15.36 Favored 'General case' 0 CA--C 1.51 -0.584 0 O-C-N 121.131 -0.981 . . . . 0.0 110.837 171.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 33.0 p -71.7 131.97 43.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.112 -1.618 . . . . 0.0 108.994 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 76.55 -27.11 0.18 Allowed 'General case' 0 C--N 1.351 0.647 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -74.99 164.92 26.04 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 119.846 -1.784 . . . . 0.0 111.783 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 33.2 tp -67.94 -18.99 64.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.735 2.014 . . . . 0.0 113.013 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.24 -32.38 71.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.27 -1.519 . . . . 0.0 113.005 167.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.87 -33.25 79.29 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 120.115 -1.616 . . . . 0.0 113.813 -174.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -50.87 -57.31 8.78 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.212 2.605 . . . . 0.0 111.833 170.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 3.9 pp -76.65 -21.75 55.01 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -86.13 -37.1 19.12 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.011 -1.055 . . . . 0.0 112.222 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.12 15.48 78.67 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 121.179 -0.95 . . . . 0.0 114.337 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 29.5 m -125.42 159.38 60.48 Favored Pre-proline 0 C--N 1.344 0.343 0 O-C-N 120.99 -1.3 . . . . 0.0 110.214 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.37 -43.73 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.607 1.538 . . . . 0.0 112.653 172.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 54.6 m -151.76 167.0 29.61 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -126.02 177.69 6.2 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.728 0.775 . . . . 0.0 109.727 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 48.3 t -121.94 123.34 41.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 120.979 -1.076 . . . . 0.0 108.758 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.11 -27.43 43.14 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 O-C-N 120.437 -1.414 . . . . 0.0 112.157 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -55.04 -28.67 53.95 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.182 1.393 . . . . 0.0 114.352 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -81.83 52.12 1.87 Allowed 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.255 -1.528 . . . . 0.0 112.959 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -46.94 -45.58 20.84 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 126.741 2.017 . . . . 0.0 114.844 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -72.16 -1.66 15.84 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 126.709 2.004 . . . . 0.0 115.667 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -105.18 -38.35 6.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.443 -1.411 . . . . 0.0 109.176 167.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 30.4 mm -56.43 -52.53 51.34 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 O-C-N 120.946 -1.096 . . . . 0.0 112.727 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -53.33 -38.36 63.14 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 120.284 -1.51 . . . . 0.0 114.053 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 42.4 m -64.37 -35.9 82.38 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 125.689 1.596 . . . . 0.0 113.585 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 54.6 mtt -65.88 -47.01 76.27 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.334 -1.479 . . . . 0.0 111.281 172.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 50.9 mm -56.09 -50.31 70.93 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 C-N-CA 126.062 1.745 . . . . 0.0 113.201 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -63.38 -12.31 29.56 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 119.473 -2.017 . . . . 0.0 115.931 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -96.9 -12.51 23.38 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 119.468 -2.02 . . . . 0.0 112.839 170.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -84.07 -38.51 20.72 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 119.95 -1.719 . . . . 0.0 109.194 170.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 66.2 mt -93.53 -179.89 5.17 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.944 1.697 . . . . 0.0 113.926 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 94.6 t -111.55 128.54 68.0 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 167.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 C--N 1.349 0.56 0 O-C-N 121.19 -0.944 . . . . 0.0 110.916 176.269 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.276 91.7 p . . . . . 0 N--CA 1.531 3.593 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -5.72 74.92 0.0 OUTLIER Glycine 0 C--N 1.363 2.058 0 C-N-CA 129.423 3.392 . . . . 0.0 119.785 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.3 m -116.07 119.02 34.5 Favored 'General case' 0 CA--C 1.506 -0.746 0 O-C-N 120.978 -1.307 . . . . 0.0 108.492 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.56 -161.23 8.88 Favored Glycine 0 CA--C 1.494 -1.243 0 N-CA-C 105.967 -2.853 . . . . 0.0 105.967 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.49 79.69 0.79 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 119.048 1.424 . . . . 0.0 114.313 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 64.2 p -67.56 -16.86 64.41 Favored 'General case' 0 C--N 1.347 0.473 0 O-C-N 119.685 -1.885 . . . . 0.0 113.907 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -77.05 -31.29 56.09 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.995 1.718 . . . . 0.0 113.386 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -175.78 89.17 0.29 Allowed Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.37 137.23 18.56 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 CA-C-N 121.893 1.712 . . . . 0.0 110.232 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.8 t -127.38 -60.4 1.19 Allowed 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.3 m -68.93 170.93 8.82 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 123.674 1.702 . . . . 0.0 115.559 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -73.75 -35.76 65.07 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 119.945 -1.722 . . . . 0.0 114.489 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.87 -45.9 76.66 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 119.601 -1.937 . . . . 0.0 111.466 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -43.47 -66.98 0.31 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 129.048 2.939 . . . . 0.0 112.933 167.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.29 -6.63 53.9 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 120.383 -1.448 . . . . 0.0 114.461 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -74.09 -51.72 14.83 Favored 'General case' 0 C--N 1.346 0.416 0 O-C-N 119.193 -2.192 . . . . 0.0 110.854 165.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -61.36 -35.71 78.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.094 -1.629 . . . . 0.0 115.19 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.85 -15.42 20.89 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.8 tp -62.03 -26.21 68.11 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 120.326 -1.484 . . . . 0.0 113.214 172.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 t 60.22 49.34 7.31 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-O 123.933 1.825 . . . . 0.0 111.047 -169.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.72 89.16 0.55 Allowed 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.394 1.477 . . . . 0.0 112.629 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.515 ' HA3' ' HB1' ' A' ' 41' ' ' ALA . . . 150.11 -48.17 0.59 Allowed Glycine 0 CA--C 1.496 -1.1 0 O-C-N 121.478 -0.764 . . . . 0.0 114.996 -168.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.17 -144.8 17.03 Favored Glycine 0 C--N 1.345 1.033 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -167.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.5 p -110.94 136.81 45.85 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 O-C-N 120.658 -1.495 . . . . 0.0 111.065 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.2 m -100.04 158.54 31.86 Favored Pre-proline 0 C--N 1.35 0.624 0 O-C-N 120.182 -1.574 . . . . 0.0 110.479 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.52 11.19 1.08 Allowed 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.987 2.458 . . . . 0.0 113.118 164.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt 59.81 49.83 7.6 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 126.008 1.723 . . . . 0.0 115.296 171.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.8 pt -63.51 144.7 14.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 -171.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.6 pt? -85.13 20.22 1.98 Allowed 'General case' 0 C--N 1.347 0.471 0 O-C-N 120.679 -1.263 . . . . 0.0 113.825 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -77.28 126.67 31.3 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 119.364 -2.085 . . . . 0.0 111.21 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -78.55 100.82 7.09 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.988 0.899 . . . . 0.0 112.331 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.2 p -96.13 -175.82 3.49 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.494 1.918 . . . . 0.0 111.666 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -124.11 -41.71 2.19 Favored 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 120.16 -1.588 . . . . 0.0 112.303 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -142.0 168.31 20.04 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 103.784 -2.672 . . . . 0.0 103.784 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -68.95 -26.33 65.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 119.476 -2.015 . . . . 0.0 115.778 -167.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 m -50.93 -45.47 60.51 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 126.593 1.957 . . . . 0.0 114.801 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.85 -22.67 65.71 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 128.131 2.573 . . . . 0.0 113.961 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.6 t -103.63 106.78 53.84 Favored Pre-proline 0 C--N 1.353 0.726 0 O-C-N 119.834 -1.791 . . . . 0.0 112.489 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.11 159.37 53.4 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.804 2.336 . . . . 0.0 114.452 -162.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.7 -96.13 1.92 Allowed Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.515 ' HB1' ' HA3' ' A' ' 22' ' ' GLY . . . -161.35 40.61 0.15 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 123.088 1.423 . . . . 0.0 111.116 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.9 m -90.34 178.94 6.0 Favored 'General case' 0 N--CA 1.44 -0.939 0 O-C-N 119.847 -1.783 . . . . 0.0 109.267 -175.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.87 150.71 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 103.211 -2.885 . . . . 0.0 103.211 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.0 m -82.61 127.45 33.38 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.318 1.047 . . . . 0.0 108.368 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -78.36 172.11 14.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.917 -1.114 . . . . 0.0 108.663 170.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.5 -32.61 15.95 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 116.655 1.422 . . . . 0.0 116.655 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -70.03 -9.57 55.73 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.6 20.93 57.47 Favored Glycine 0 C--N 1.349 1.298 0 O-C-N 120.57 -1.331 . . . . 0.0 114.247 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -121.6 146.6 46.81 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 120.607 -1.526 . . . . 0.0 110.616 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.0 m -73.39 133.5 43.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -170.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.714 0 CA-C-O 117.05 -1.972 . . . . 0.0 114.955 173.865 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 94.5 mt . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 19.7 m -121.97 152.31 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 -109.79 117.87 51.34 Favored Pre-proline 0 C--N 1.352 0.679 0 CA-C-O 115.92 -1.99 . . . . 0.0 108.721 172.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.71 167.12 27.02 Favored 'Trans proline' 0 C--N 1.321 -0.897 0 C-N-CA 123.272 2.648 . . . . 0.0 113.19 166.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -78.56 159.04 75.29 Favored Pre-proline 0 C--N 1.351 0.661 0 O-C-N 120.472 -1.393 . . . . 0.0 112.81 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -65.69 -21.68 58.47 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.18 2.586 . . . . 0.0 114.681 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 94.0 mt -70.25 -46.03 65.23 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.131 0.878 . . . . 0.0 111.391 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 18.1 tp -64.68 -33.55 76.22 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 120.993 -1.067 . . . . 0.0 111.809 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 17.9 tp -55.81 -42.07 75.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -65.93 -31.69 72.75 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 119.072 -2.268 . . . . 0.0 113.42 174.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 22.2 tp -66.08 -52.78 45.66 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 121.415 -0.803 . . . . 0.0 111.637 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -54.05 -42.94 69.78 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 124.179 0.992 . . . . 0.0 112.652 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -57.46 -27.18 62.23 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 170.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 21.8 t -78.11 -16.95 57.51 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 120.412 -1.43 . . . . 0.0 112.232 173.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' VAL . . . . . 0.435 HG22 ' CD1' ' B' ' 125' ' ' TYR . 1.5 t -97.76 4.25 9.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 O-C-N 120.561 -1.337 . . . . 0.0 110.75 172.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.89 -19.39 54.2 Favored Glycine 0 C--N 1.353 1.495 0 O-C-N 119.801 -1.812 . . . . 0.0 113.357 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -76.62 75.12 3.31 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 126.212 1.805 . . . . 0.0 112.848 -174.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -89.22 1.82 55.14 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -170.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.88 160.25 30.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.649 -0.657 . . . . 0.0 110.41 172.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -74.14 -59.84 2.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 123.463 1.602 . . . . 0.0 108.822 161.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 29.9 p -71.5 98.44 1.84 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.352 1.861 . . . . 0.0 115.54 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -112.0 -179.61 3.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 123.354 1.549 . . . . 0.0 111.901 167.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 94.4 m -103.69 155.26 18.71 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.19 1.796 . . . . 0.0 108.683 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 92.7 mtp -54.8 -47.15 74.38 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 119.394 -2.066 . . . . 0.0 115.661 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -57.01 -54.33 48.0 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 120.945 -1.097 . . . . 0.0 112.464 168.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -46.77 -50.15 18.64 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 126.009 1.724 . . . . 0.0 115.079 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.7 t -52.49 -48.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 120.051 -1.655 . . . . 0.0 112.804 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.89 -24.55 44.11 Favored 'General case' 0 C--N 1.347 0.477 0 O-C-N 120.464 -1.398 . . . . 0.0 112.891 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -65.22 -62.82 1.31 Allowed 'General case' 0 C--N 1.345 0.394 0 C-N-CA 125.945 1.698 . . . . 0.0 111.105 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -53.92 -41.11 67.32 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 124.313 1.045 . . . . 0.0 111.953 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 21.5 tp -63.43 -55.54 23.46 Favored 'General case' 0 C--N 1.349 0.547 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.79 -42.21 98.61 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 119.552 -1.968 . . . . 0.0 114.345 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -63.59 -28.78 70.16 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.123 1.369 . . . . 0.0 112.303 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.435 ' CD1' HG22 ' B' ' 106' ' ' VAL . 10.5 t80 -61.96 -53.17 59.42 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.683 -1.26 . . . . 0.0 112.405 173.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 2.9 mp -62.58 -43.65 98.66 Favored 'Isoleucine or valine' 0 C--N 1.351 0.65 0 C-N-CA 124.493 1.117 . . . . 0.0 111.306 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 44.5 ttm -50.88 -43.11 59.55 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 125.234 1.413 . . . . 0.0 112.97 172.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 24.4 m -85.25 -30.2 24.01 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 120.496 -1.378 . . . . 0.0 113.334 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.0 -30.0 63.45 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 119.521 -1.987 . . . . 0.0 114.12 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? 76.02 41.53 0.23 Allowed 'General case' 0 C--N 1.352 0.681 0 C-N-CA 125.244 1.418 . . . . 0.0 110.956 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 93.6 mt -104.68 34.0 3.33 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 122.372 1.082 . . . . 0.0 110.845 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -114.96 146.04 41.61 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 165.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.6 151.98 42.04 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 121.189 -0.944 . . . . 0.0 109.264 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.98 -33.52 74.8 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 122.59 1.186 . . . . 0.0 112.004 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -109.92 -28.21 8.86 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 124.345 1.058 . . . . 0.0 112.236 -172.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -109.67 53.79 0.68 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.321 1.848 . . . . 0.0 110.936 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -55.97 -18.38 9.09 Favored 'General case' 0 C--N 1.349 0.56 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -82.84 -5.74 59.12 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.011 1.724 . . . . 0.0 114.877 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 44.1 mm -97.41 123.16 49.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 O-C-N 120.541 -1.349 . . . . 0.0 110.22 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 52.3 t -108.12 129.51 62.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.544 0 O-C-N 120.972 -1.08 . . . . 0.0 108.414 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -95.33 113.79 25.5 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.119 -0.988 . . . . 0.0 109.276 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 63.8 m -118.6 20.85 12.82 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 121.884 0.849 . . . . 0.0 109.986 171.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 34.7 p -76.66 136.65 39.15 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 120.341 -1.474 . . . . 0.0 108.228 170.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 1.2 t30 76.24 -36.06 0.27 Allowed 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -69.26 168.48 14.12 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.64 -1.287 . . . . 0.0 112.661 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 22.9 tp -70.7 -17.54 62.83 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.604 1.562 . . . . 0.0 112.778 -168.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.92 -29.38 66.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.297 -1.502 . . . . 0.0 113.896 168.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.6 -39.0 97.12 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 120.609 -1.307 . . . . 0.0 114.031 -173.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -51.37 -55.3 19.24 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 127.251 2.22 . . . . 0.0 111.816 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 pp -74.62 -27.66 60.55 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 119.867 -1.77 . . . . 0.0 115.098 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -80.81 -40.91 24.19 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 121.387 -0.82 . . . . 0.0 112.114 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.37 22.39 62.76 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 124.162 0.886 . . . . 0.0 113.65 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.74 160.97 66.28 Favored Pre-proline 0 C--N 1.343 0.304 0 O-C-N 121.231 -1.158 . . . . 0.0 108.96 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.04 -51.22 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 121.477 1.563 . . . . 0.0 112.455 170.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 66.8 m -147.93 168.2 22.87 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 119.909 1.232 . . . . 0.0 107.845 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -129.97 173.72 10.44 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.759 0.823 . . . . 0.0 108.864 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 11.4 t -113.74 129.19 56.61 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.18 -1.575 . . . . 0.0 109.859 172.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 35.1 t -60.72 -26.72 39.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.94 0 O-C-N 119.922 -1.736 . . . . 0.0 112.996 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -50.03 -25.2 3.16 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 126.449 1.9 . . . . 0.0 114.694 171.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -91.18 46.7 1.33 Allowed 'General case' 0 N--CA 1.439 -1.007 0 O-C-N 119.502 -1.999 . . . . 0.0 113.687 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -32.66 -55.36 0.36 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 128.279 2.632 . . . . 0.0 117.74 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -59.46 -28.7 67.22 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.037 1.735 . . . . 0.0 115.256 172.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -83.24 -32.57 26.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 119.646 -1.909 . . . . 0.0 112.02 172.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 37.7 mm -54.28 -54.97 17.04 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 O-C-N 120.902 -1.124 . . . . 0.0 110.789 171.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -57.39 -33.61 68.03 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 119.989 -1.694 . . . . 0.0 115.271 171.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 86.4 m -60.65 -35.42 76.17 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.237 -1.54 . . . . 0.0 112.233 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 43.1 mtt -72.85 -48.26 39.11 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.69 -1.257 . . . . 0.0 111.615 172.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 50.9 mm -57.61 -50.39 77.49 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 C-N-CA 124.668 1.187 . . . . 0.0 113.487 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -66.19 -11.08 47.45 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -79.92 -27.13 39.92 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 119.004 -2.31 . . . . 0.0 111.153 170.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -104.69 -2.61 24.74 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 124.298 1.039 . . . . 0.0 110.332 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 43.6 mt -125.93 143.12 51.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.944 2.098 . . . . 0.0 109.567 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 10.7 p -68.86 123.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 O-C-N 119.588 -1.945 . . . . 0.0 113.422 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 54.0 t . . . . . 0 C--N 1.351 0.638 0 C-N-CA 124.667 1.187 . . . . 0.0 110.718 175.58 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.511 2.582 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.71 49.31 77.58 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 119.158 0.89 . . . . 0.0 112.281 -165.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -139.66 96.31 3.06 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 121.356 -1.085 . . . . 0.0 110.046 -167.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.49 -141.1 10.62 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-O 121.882 0.712 . . . . 0.0 113.647 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.99 68.88 6.23 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-O 123.115 1.436 . . . . 0.0 111.614 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 p -69.79 -9.42 54.57 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 126.671 1.988 . . . . 0.0 114.242 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -78.0 -42.86 31.27 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.738 1.215 . . . . 0.0 112.124 171.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -166.83 89.13 0.78 Allowed Pre-proline 0 N--CA 1.448 -0.535 0 O-C-N 121.529 -0.732 . . . . 0.0 110.035 -173.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.44 115.46 2.87 Favored 'Trans proline' 0 C--N 1.329 -0.474 0 C-N-CA 122.32 2.013 . . . . 0.0 112.211 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -116.11 -31.91 5.54 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 119.109 0.868 . . . . 0.0 113.248 -170.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.8 m -105.31 176.96 4.99 Favored 'General case' 0 C--N 1.345 0.387 0 O-C-N 119.472 -2.017 . . . . 0.0 111.397 167.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -63.86 -40.42 96.51 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 119.805 -1.81 . . . . 0.0 113.408 -176.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.55 -44.45 85.24 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.571 1.948 . . . . 0.0 113.529 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -55.87 -58.99 5.54 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.033 1.333 . . . . 0.0 114.401 170.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.42 -29.98 69.33 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -37.18 52.93 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 124.933 1.293 . . . . 0.0 113.897 173.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -101.06 18.87 18.62 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 121.025 -1.047 . . . . 0.0 112.22 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.62 -29.04 13.27 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.448 1.099 . . . . 0.0 110.007 165.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.6 -29.13 69.02 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 122.423 1.106 . . . . 0.0 112.38 171.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 m 65.85 43.56 3.06 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 125.797 1.639 . . . . 0.0 112.555 174.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.61 93.49 0.01 OUTLIER 'General case' 0 C--N 1.351 0.646 0 C-N-CA 127.215 2.206 . . . . 0.0 116.778 -170.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.523 ' HA3' ' HB1' ' A' ' 41' ' ' ALA . . . 158.29 -47.34 0.44 Allowed Glycine 0 CA--C 1.491 -1.423 0 C-N-CA 119.796 -1.193 . . . . 0.0 115.019 -171.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.17 -121.14 4.32 Favored Glycine 0 CA--C 1.499 -0.933 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -171.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 p -129.65 143.47 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 O-C-N 121.055 -1.262 . . . . 0.0 108.327 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 62.8 m -104.24 162.19 20.64 Favored Pre-proline 0 C--N 1.346 0.444 0 O-C-N 120.278 -1.514 . . . . 0.0 110.45 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.1 -26.46 57.75 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.576 2.184 . . . . 0.0 112.076 168.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 79.82 78.77 0.05 OUTLIER 'General case' 0 C--N 1.354 0.768 0 C-N-CA 127.605 2.362 . . . . 0.0 110.507 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.8 pt -80.73 140.77 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 O-C-N 120.93 -1.106 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.1 pp -83.33 6.62 19.19 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 122.354 1.073 . . . . 0.0 112.394 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -63.02 132.02 50.57 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 125.112 1.365 . . . . 0.0 111.545 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -74.26 141.14 45.36 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.286 -0.884 . . . . 0.0 111.577 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.0 p -132.7 169.0 17.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 120.777 -1.202 . . . . 0.0 109.563 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -116.56 -37.25 3.74 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 120.012 -1.68 . . . . 0.0 110.683 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -141.61 -171.92 3.42 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.226 1.01 . . . . 0.0 108.622 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.42 -7.1 48.01 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 119.224 -2.172 . . . . 0.0 112.875 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 p -81.38 -40.03 24.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.719 2.008 . . . . 0.0 113.098 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.52 -28.0 68.87 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-O 122.618 1.199 . . . . 0.0 113.042 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.7 t -99.11 108.73 51.21 Favored Pre-proline 0 N--CA 1.443 -0.799 0 C-N-CA 124.107 0.963 . . . . 0.0 112.224 -164.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.77 151.55 57.57 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.113 1.875 . . . . 0.0 113.457 -168.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.09 -120.91 7.01 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.523 ' HB1' ' HA3' ' A' ' 22' ' ' GLY . . . -136.91 41.98 2.47 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.343 1.544 . . . . 0.0 110.149 176.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.1 m -107.85 112.82 25.64 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.014 -1.678 . . . . 0.0 110.736 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.8 pp -76.31 145.51 10.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 O-C-N 120.199 -1.563 . . . . 0.0 112.203 173.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.4 t -80.41 134.95 36.07 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.181 1.392 . . . . 0.0 110.063 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -86.14 167.5 14.87 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 119.56 -1.962 . . . . 0.0 110.869 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -37.34 -45.6 1.3 Allowed Glycine 0 C--N 1.356 1.664 0 C-N-CA 126.898 2.189 . . . . 0.0 118.13 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -62.75 -19.19 63.72 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.2 33.54 8.73 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 120.464 -1.398 . . . . 0.0 112.991 -172.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -139.46 142.37 37.38 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.018 -1.284 . . . . 0.0 107.631 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.95 125.18 27.0 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-O 123.397 1.57 . . . . 0.0 114.272 -173.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.343 0 O-C-N 119.946 -1.721 . . . . 0.0 113.354 -176.336 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.505 2.276 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.18 156.58 40.37 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 mtt-85 -113.73 113.0 47.76 Favored Pre-proline 0 C--N 1.348 0.516 0 CA-C-O 116.526 -1.702 . . . . 0.0 110.578 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.13 166.01 30.57 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 CA-C-N 124.355 2.591 . . . . 0.0 113.09 164.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -82.73 159.05 64.43 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.879 0.872 . . . . 0.0 112.834 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.22 -21.01 36.62 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.881 2.387 . . . . 0.0 114.734 -174.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 93.0 mt -67.37 -43.95 80.18 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 119.799 1.181 . . . . 0.0 111.112 173.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 28.7 tp -64.71 -40.45 95.38 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 124.089 0.956 . . . . 0.0 112.403 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 34.8 tp -49.41 -39.53 33.05 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.38 -32.26 72.21 Favored 'General case' 0 C--N 1.35 0.601 0 O-C-N 119.434 -2.041 . . . . 0.0 113.291 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tt -71.41 -49.88 37.5 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 121.52 -0.737 . . . . 0.0 110.442 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 96.4 mt -52.04 -44.16 64.1 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 124.658 1.183 . . . . 0.0 113.8 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -54.18 -36.15 63.09 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 120.415 -1.428 . . . . 0.0 114.321 169.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.8 t -73.92 -6.74 49.08 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.158 1.383 . . . . 0.0 112.231 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 1.6 t -108.64 7.52 9.28 Favored 'Isoleucine or valine' 0 C--N 1.35 0.616 0 C-N-CA 124.986 1.315 . . . . 0.0 110.718 167.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.82 -23.11 37.41 Favored Glycine 0 C--N 1.351 1.38 0 O-C-N 119.018 -2.301 . . . . 0.0 114.114 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.02 68.48 4.98 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.971 1.708 . . . . 0.0 112.812 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -81.67 4.92 19.99 Favored 'General case' 0 C--N 1.343 0.3 0 O-C-N 120.074 -1.641 . . . . 0.0 114.75 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -83.7 146.98 27.92 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.045 0.938 . . . . 0.0 109.629 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -70.22 -48.41 57.17 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 122.99 1.376 . . . . 0.0 111.058 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 40.7 p -84.05 110.16 18.24 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -128.4 -166.83 1.68 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.687 1.195 . . . . 0.0 110.484 168.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 50.6 p -117.99 175.47 5.66 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 119.595 -1.94 . . . . 0.0 111.362 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 46.0 mtt -57.33 -41.25 79.59 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 120.475 -1.391 . . . . 0.0 113.591 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -52.97 61.1 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.388 1.075 . . . . 0.0 110.618 174.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.73 -31.64 63.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -171.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 67.6 t -55.29 -37.01 42.39 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 O-C-N 120.065 -1.647 . . . . 0.0 111.246 171.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -89.85 -24.76 21.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.733 -1.229 . . . . 0.0 113.635 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -66.77 -56.88 8.51 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.039 -1.663 . . . . 0.0 112.916 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -61.26 -41.96 97.82 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 120.961 -1.087 . . . . 0.0 111.153 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 34.6 tp -57.88 -49.88 75.2 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 120.306 -1.497 . . . . 0.0 113.518 172.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.45 -47.92 79.86 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 120.299 -1.5 . . . . 0.0 114.321 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -58.42 -40.6 82.94 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.184 0.993 . . . . 0.0 113.618 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -58.33 -55.68 31.86 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.735 1.214 . . . . 0.0 113.633 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -68.68 -39.1 79.84 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 O-C-N 120.409 -1.432 . . . . 0.0 111.647 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 55.2 ttm -54.51 -48.33 72.05 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 122.443 1.116 . . . . 0.0 112.37 173.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 38.6 m -70.73 -29.56 65.86 Favored 'General case' 0 C--N 1.344 0.351 0 O-C-N 120.819 -1.176 . . . . 0.0 112.965 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -81.59 -23.15 37.26 Favored 'General case' 0 C--N 1.346 0.433 0 O-C-N 119.022 -2.299 . . . . 0.0 115.61 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? 72.29 49.3 0.22 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 125.343 1.457 . . . . 0.0 112.354 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 2.2 tt -95.85 -27.42 15.21 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 120.326 -1.484 . . . . 0.0 113.029 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -69.01 142.06 54.71 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.021 -1.674 . . . . 0.0 111.756 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.5 137.37 53.44 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.017 0.927 . . . . 0.0 113.302 167.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -64.32 -31.84 73.2 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 120.317 -1.489 . . . . 0.0 113.04 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -96.86 -32.82 11.89 Favored 'General case' 0 C--N 1.347 0.497 0 O-C-N 120.871 -1.143 . . . . 0.0 113.291 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.34 56.59 0.75 Allowed 'General case' 0 C--N 1.351 0.647 0 O-C-N 120.347 -1.471 . . . . 0.0 112.736 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 9.8 pm0 -60.92 5.46 0.05 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 118.655 2.835 . . . . 0.0 118.655 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -102.42 -6.54 22.86 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 119.849 -1.782 . . . . 0.0 111.704 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 49.1 mm -92.34 138.55 19.69 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 C-N-CA 125.27 1.428 . . . . 0.0 109.433 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.33 120.95 30.31 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 O-C-N 120.649 -1.282 . . . . 0.0 108.279 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -105.9 78.6 1.34 Allowed 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 120.535 -1.353 . . . . 0.0 112.795 -171.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 61.5 m -86.34 37.81 0.75 Allowed 'General case' 0 C--N 1.349 0.549 0 O-C-N 119.959 -1.713 . . . . 0.0 114.408 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 11.1 t -88.51 129.64 35.41 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 119.562 -1.961 . . . . 0.0 107.436 165.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 70.08 43.93 0.83 Allowed 'General case' 0 C--N 1.349 0.577 0 CA-C-O 122.878 1.323 . . . . 0.0 111.619 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -141.32 166.12 25.63 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 18.1 tp -83.67 -9.94 58.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.583 1.153 . . . . 0.0 112.651 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 10.1 mp -76.99 -31.23 56.34 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 119.498 -2.001 . . . . 0.0 110.658 164.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.42 -44.05 96.95 Favored Glycine 0 C--N 1.351 1.366 0 C-N-CA 125.279 1.419 . . . . 0.0 114.565 -174.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -46.08 -62.3 1.39 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.036 2.535 . . . . 0.0 112.102 169.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 4.2 pp -78.3 -18.46 55.21 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -172.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -81.22 -48.44 12.06 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.849 -1.157 . . . . 0.0 111.549 168.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.06 29.26 26.11 Favored Glycine 0 C--N 1.352 1.425 0 C-N-CA 124.829 1.204 . . . . 0.0 113.698 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.48 156.26 76.55 Favored Pre-proline 0 C--N 1.346 0.43 0 O-C-N 120.952 -1.322 . . . . 0.0 109.452 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.26 -10.33 13.65 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 CA-C-N 122.363 1.88 . . . . 0.0 112.982 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 10.0 p -178.92 171.36 1.42 Allowed 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -175.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.06 170.65 15.33 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 170.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 40.6 t -114.5 133.93 55.4 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 171.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.92 -39.9 81.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 O-C-N 121.456 -0.778 . . . . 0.0 112.276 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -54.22 -26.39 28.24 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -81.76 66.2 7.22 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 119.884 -1.76 . . . . 0.0 110.544 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -53.49 -46.23 69.93 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 125.848 1.659 . . . . 0.0 113.05 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 81.3 ttt180 -56.38 -29.45 61.46 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 127.051 2.141 . . . . 0.0 114.252 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -78.17 -42.93 30.09 Favored 'General case' 0 CA--C 1.512 -0.505 0 O-C-N 120.173 -1.579 . . . . 0.0 111.844 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 48.1 mm -56.79 -50.11 76.07 Favored 'Isoleucine or valine' 0 C--N 1.347 0.463 0 C-N-CA 124.043 0.937 . . . . 0.0 111.951 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -51.06 -43.73 61.03 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 120.742 -1.224 . . . . 0.0 113.84 168.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 52.9 m -65.45 -33.56 76.23 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 121.083 -1.011 . . . . 0.0 112.893 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -68.22 -48.51 64.97 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 118.88 -2.387 . . . . 0.0 112.697 167.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.7 -50.83 76.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 C-N-CA 124.783 1.233 . . . . 0.0 112.715 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -66.68 -12.07 56.76 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 119.232 -2.168 . . . . 0.0 115.143 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -85.93 -9.04 57.57 Favored 'General case' 0 C--N 1.351 0.663 0 O-C-N 119.596 -1.94 . . . . 0.0 112.215 169.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -96.09 -36.04 11.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 120.3 -1.5 . . . . 0.0 109.36 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 71.4 mt -92.85 161.33 14.54 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.36 1.464 . . . . 0.0 113.653 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.85 126.58 61.25 Favored 'Isoleucine or valine' 0 C--N 1.345 0.389 0 O-C-N 120.7 -1.25 . . . . 0.0 107.733 171.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 C--N 1.346 0.447 0 O-C-N 121.249 -0.907 . . . . 0.0 110.668 178.911 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.517 2.915 0 CA-C-O 117.238 -1.363 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 52.25 45.21 58.02 Favored Glycine 0 C--N 1.357 1.715 0 CA-C-N 120.18 1.354 . . . . 0.0 114.094 -170.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.2 t -152.43 134.39 14.85 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 120.691 -1.476 . . . . 0.0 109.197 -172.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.78 -137.14 3.45 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 122.368 0.982 . . . . 0.0 111.63 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.31 68.14 8.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.04 -1.859 . . . . 0.0 113.173 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 t -59.32 -13.2 7.26 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.613 1.565 . . . . 0.0 114.571 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.6 -30.17 22.02 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.81 1.644 . . . . 0.0 114.337 175.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 174.53 89.6 0.07 OUTLIER Pre-proline 0 C--N 1.35 0.626 0 C-N-CA 124.986 1.314 . . . . 0.0 108.505 -171.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.01 118.57 4.09 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.344 2.03 . . . . 0.0 112.282 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t -113.29 -4.45 13.69 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 122.588 1.185 . . . . 0.0 110.11 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t -126.21 162.62 25.01 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.069 -1.644 . . . . 0.0 113.44 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -61.62 -48.34 81.36 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 120.449 -1.407 . . . . 0.0 111.932 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.81 86.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.553 1.541 . . . . 0.0 112.786 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -63.08 -54.7 33.86 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.783 -1.198 . . . . 0.0 113.656 173.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.63 -31.19 70.17 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.734 0.778 . . . . 0.0 112.239 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -53.63 -49.6 67.52 Favored 'General case' 0 C--N 1.346 0.416 0 O-C-N 119.959 -1.713 . . . . 0.0 113.164 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -67.44 -30.16 69.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.525 -1.359 . . . . 0.0 113.862 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.97 -27.94 65.86 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 125.897 1.679 . . . . 0.0 114.295 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.7 tp -61.9 -25.33 67.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.228 1.011 . . . . 0.0 113.607 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 t 56.43 40.79 29.52 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 124.632 2.158 . . . . 0.0 112.977 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.419 ' HB1' ' HG ' ' B' ' 119' ' ' LEU . . . -64.87 92.6 0.1 Allowed 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.258 1.423 . . . . 0.0 113.526 -177.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.95 -40.66 0.8 Allowed Glycine 0 CA--C 1.496 -1.111 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -173.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.04 -144.62 16.94 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.7 m -93.79 139.84 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 120.211 -1.758 . . . . 0.0 111.102 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.62 156.66 45.87 Favored Pre-proline 0 N--CA 1.45 -0.465 0 O-C-N 120.569 -1.332 . . . . 0.0 109.347 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.59 -10.12 24.83 Favored 'Trans proline' 0 CA--C 1.519 -0.239 0 C-N-CA 122.872 2.382 . . . . 0.0 112.894 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 mptt 64.91 51.82 1.69 Allowed 'General case' 0 C--N 1.349 0.573 0 C-N-CA 126.019 1.728 . . . . 0.0 113.198 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.9 pt -64.89 143.59 15.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 mt -86.24 25.59 1.16 Allowed 'General case' 0 C--N 1.345 0.4 0 C-N-CA 124.877 1.271 . . . . 0.0 111.746 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -80.67 135.19 35.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 120.181 -1.574 . . . . 0.0 110.456 174.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -74.26 126.27 30.27 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 121.83 0.824 . . . . 0.0 111.747 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 p -118.06 -177.53 3.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 120.628 -1.295 . . . . 0.0 110.03 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 -122.05 -21.43 5.97 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 119.85 -1.781 . . . . 0.0 110.968 162.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -157.73 169.2 25.17 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 120.405 -1.434 . . . . 0.0 109.738 -176.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -52.26 -46.13 65.68 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 127.742 2.417 . . . . 0.0 111.656 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.0 m -55.59 -18.26 7.27 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 118.147 2.647 . . . . 0.0 118.147 170.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -93.87 -6.91 44.64 Favored 'General case' 0 C--N 1.345 0.388 0 O-C-N 120.46 -1.4 . . . . 0.0 111.083 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.33 127.47 26.79 Favored Pre-proline 0 C--N 1.349 0.573 0 O-C-N 120.523 -1.36 . . . . 0.0 110.327 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.47 163.33 36.37 Favored 'Trans proline' 0 C--N 1.324 -0.711 0 C-N-CA 122.067 1.845 . . . . 0.0 114.169 -169.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.86 -78.9 1.91 Allowed Glycine 0 C--N 1.348 1.207 0 O-C-N 121.349 -0.844 . . . . 0.0 113.097 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.23 24.82 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 122.377 1.084 . . . . 0.0 111.652 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.1 m -98.16 116.89 31.33 Favored 'General case' 0 C--O 1.215 -0.74 0 O-C-N 119.523 -1.986 . . . . 0.0 112.435 -162.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.57 150.06 6.75 Favored 'Isoleucine or valine' 0 C--N 1.346 0.426 0 O-C-N 118.429 -2.67 . . . . 0.0 113.665 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.29 125.32 29.19 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.804 0.842 . . . . 0.0 108.881 168.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -85.94 179.67 6.96 Favored 'General case' 0 C--N 1.345 0.412 0 O-C-N 120.032 -1.668 . . . . 0.0 110.655 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.24 -5.3 20.47 Favored Glycine 0 C--N 1.353 1.525 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -96.26 -6.15 38.64 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.201 -1.176 . . . . 0.0 112.501 170.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.59 18.28 64.29 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 121.01 -1.056 . . . . 0.0 113.787 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -128.04 146.4 50.69 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 123.083 1.42 . . . . 0.0 110.743 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 80.5 m -67.87 160.71 27.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 123.491 1.615 . . . . 0.0 113.081 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.958 0 O-C-N 119.3 -2.125 . . . . 0.0 116.846 -174.927 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 99.2 mt . . . . . 0 N--CA 1.506 2.329 0 CA-C-O 118.225 -0.893 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 15.2 m -133.47 165.44 32.14 Favored 'Isoleucine or valine' 0 C--N 1.344 0.361 0 CA-C-N 119.274 0.943 . . . . 0.0 109.271 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -114.0 101.82 54.28 Favored Pre-proline 0 C--N 1.345 0.41 0 CA-C-O 116.986 -1.483 . . . . 0.0 110.676 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.95 165.57 29.55 Favored 'Trans proline' 0 C--N 1.326 -0.609 0 C-N-CA 123.228 2.619 . . . . 0.0 114.242 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -87.16 153.2 53.94 Favored Pre-proline 0 C--N 1.351 0.653 0 O-C-N 120.967 -1.083 . . . . 0.0 111.961 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.06 -21.82 42.38 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.536 2.824 . . . . 0.0 113.436 -173.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 89.0 mt -70.14 -47.12 63.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.166 -0.959 . . . . 0.0 110.984 171.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 34.6 tp -65.17 -33.89 77.09 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 124.584 1.154 . . . . 0.0 113.062 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 14.7 tp -48.42 -41.68 29.92 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.326 1.45 . . . . 0.0 113.956 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -65.4 -36.88 85.29 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 119.844 -1.785 . . . . 0.0 114.328 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.492 HD13 HD13 ' B' ' 147' ' ' LEU . 1.1 tt -70.23 -50.22 42.09 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.656 0.782 . . . . 0.0 111.074 173.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 40.2 mt -52.16 -44.91 64.83 Favored 'General case' 0 C--N 1.35 0.617 0 C-N-CA 124.567 1.147 . . . . 0.0 112.702 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -57.4 -34.57 69.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 55.6 m -71.35 -15.49 62.39 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 124.558 1.143 . . . . 0.0 113.323 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.21 -7.38 9.62 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 124.351 1.06 . . . . 0.0 110.311 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.97 -26.47 7.9 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 120.106 -1.621 . . . . 0.0 112.36 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.41 74.47 7.28 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 126.006 1.723 . . . . 0.0 113.947 -170.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -83.57 12.03 6.3 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 -174.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -99.74 127.06 45.89 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.204 -0.935 . . . . 0.0 112.793 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.44 -9.42 0.3 Allowed 'General case' 0 C--N 1.348 0.515 0 N-CA-C 117.881 2.549 . . . . 0.0 117.881 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 67.4 p -137.11 127.04 25.77 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 119.064 -2.273 . . . . 0.0 111.158 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -129.03 -177.82 4.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 120.46 -1.4 . . . . 0.0 110.462 173.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.8 m -96.85 161.55 13.8 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.156 1.383 . . . . 0.0 108.189 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 1.1 mmm -60.04 -44.96 94.29 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 119.794 -1.816 . . . . 0.0 113.837 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -58.4 -51.87 68.0 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.136 0.974 . . . . 0.0 113.605 170.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -48.66 -49.65 36.5 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 126.504 1.921 . . . . 0.0 114.68 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 40.1 t -54.03 -46.32 65.64 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 O-C-N 120.674 -1.266 . . . . 0.0 112.355 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' LEU . . . . . 0.419 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 4.2 mm? -72.11 -38.19 69.37 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.26 1.024 . . . . 0.0 112.325 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -56.25 -59.53 4.8 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.803 1.641 . . . . 0.0 112.79 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -58.02 -41.6 83.49 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 123.903 0.881 . . . . 0.0 112.028 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 26.4 tp -63.17 -52.22 63.26 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 173.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.5 -44.89 95.98 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 119.481 -2.012 . . . . 0.0 113.092 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -60.57 -30.28 69.69 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 124.379 1.071 . . . . 0.0 113.182 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -56.74 -60.25 3.83 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 124.429 1.092 . . . . 0.0 111.613 171.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mt -59.6 -42.87 89.67 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 O-C-N 120.292 -1.505 . . . . 0.0 113.794 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -51.02 -48.24 61.48 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 124.683 1.193 . . . . 0.0 113.556 170.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 40.5 m -78.64 -39.53 36.75 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 120.351 -1.468 . . . . 0.0 112.671 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -74.74 -21.47 59.33 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 126.163 1.785 . . . . 0.0 114.538 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 69.48 50.82 0.5 Allowed 'General case' 0 C--N 1.348 0.541 0 C-N-CA 125.821 1.648 . . . . 0.0 112.394 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 51.8 mt -107.46 18.65 21.28 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 123.782 0.833 . . . . 0.0 111.751 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -105.97 150.04 26.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -81.74 141.65 33.36 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.2 -31.72 72.94 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 121.028 -1.045 . . . . 0.0 113.187 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.76 -29.02 12.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 120.743 -1.223 . . . . 0.0 112.323 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -114.88 69.04 0.71 Allowed 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.097 -1.627 . . . . 0.0 112.641 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -73.41 -2.77 23.68 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 119.896 -1.752 . . . . 0.0 113.992 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -87.15 -10.19 53.35 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.589 1.955 . . . . 0.0 113.033 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 48.3 mm -98.59 134.0 38.89 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 125.497 1.519 . . . . 0.0 109.96 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 48.0 t -117.13 126.89 74.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 O-C-N 120.905 -1.122 . . . . 0.0 111.096 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -82.93 101.6 11.15 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.501 1.12 . . . . 0.0 111.762 173.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 18.3 m -107.14 3.46 25.75 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-O 122.06 0.934 . . . . 0.0 111.69 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 79.0 p -72.91 124.32 25.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 119.744 -1.847 . . . . 0.0 110.897 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 5.3 t30 79.57 18.85 0.72 Allowed 'General case' 0 C--N 1.35 0.621 0 C-N-CA 124.612 1.165 . . . . 0.0 112.478 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -112.06 169.98 8.47 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 124.691 1.196 . . . . 0.0 108.978 172.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 146' ' ' LEU . . . . . 0.404 HD23 ' HB2' ' B' ' 102' ' ' LEU . 16.5 tp -69.97 -22.9 63.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.601 1.96 . . . . 0.0 112.657 178.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 147' ' ' LEU . . . . . 0.492 HD13 HD13 ' B' ' 102' ' ' LEU . 2.0 mp -66.46 -34.61 78.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 119.899 -1.751 . . . . 0.0 113.105 167.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.66 -37.77 92.79 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 120.554 -1.341 . . . . 0.0 114.117 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.41 -49.17 70.58 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.722 2.409 . . . . 0.0 112.845 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 1.3 pp -83.51 -28.02 28.96 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 119.35 -2.093 . . . . 0.0 113.918 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.648 ' HB3' HG22 ' B' ' 153' ' ' VAL . 9.3 m-85 -79.6 -41.02 27.99 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 125.141 1.377 . . . . 0.0 112.856 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 78.58 14.4 82.15 Favored Glycine 0 C--N 1.35 1.339 0 C-N-CA 124.189 0.899 . . . . 0.0 114.183 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 153' ' ' VAL . . . . . 0.648 HG22 ' HB3' ' B' ' 151' ' ' PHE . 33.2 m -131.15 151.27 78.61 Favored Pre-proline 0 C--N 1.345 0.403 0 O-C-N 120.828 -1.396 . . . . 0.0 110.382 -174.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.92 -26.92 10.61 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 121.965 1.777 . . . . 0.0 112.02 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 27.8 p -159.49 164.54 34.35 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 120.729 -1.232 . . . . 0.0 109.231 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -139.86 160.54 39.67 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 120.241 -1.537 . . . . 0.0 109.182 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 4.5 t -112.17 134.68 53.58 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.44 -33.7 65.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.72 -25.47 2.99 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -80.36 55.88 2.37 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.037 -1.664 . . . . 0.0 111.255 176.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -51.87 -47.39 64.52 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 119.999 -1.688 . . . . 0.0 114.235 -172.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -57.09 -38.46 73.38 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 125.842 1.657 . . . . 0.0 113.271 172.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 18.1 ttpt -66.47 -51.33 57.9 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.235 -1.541 . . . . 0.0 110.598 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 50.9 mm -50.44 -54.65 8.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 C-N-CA 125.566 1.546 . . . . 0.0 112.826 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -51.76 -46.67 64.17 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 9.9 m -59.2 -42.67 91.48 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.627 -1.296 . . . . 0.0 112.453 176.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 3.5 mtp -72.06 -22.88 61.31 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.507 -1.371 . . . . 0.0 113.577 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.45 -52.05 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 O-C-N 121.115 -0.991 . . . . 0.0 110.478 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -57.09 -24.73 56.1 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.25 -12.4 60.0 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.91 -1.744 . . . . 0.0 114.488 173.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -103.05 -13.54 16.8 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 119.945 -1.722 . . . . 0.0 111.381 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 82.6 mt -109.8 155.4 21.68 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.928 1.291 . . . . 0.0 110.541 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 38.8 t -100.58 117.79 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 O-C-N 120.1 -1.625 . . . . 0.0 108.685 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.35 0.591 0 C-N-CA 124.172 0.989 . . . . 0.0 111.022 178.787 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.526 3.336 0 N-CA-C 119.39 3.107 . . . . 0.0 119.39 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.54 15.22 65.89 Favored Glycine 0 C--N 1.355 1.588 0 N-CA-C 115.836 1.094 . . . . 0.0 115.836 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.1 t -140.24 144.04 36.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.51 -129.91 2.51 Favored Glycine 0 C--N 1.346 1.128 0 C-N-CA 125.061 1.315 . . . . 0.0 110.112 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.0 72.53 10.07 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 120.219 -1.753 . . . . 0.0 112.397 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.3 p -68.21 -15.21 63.49 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -173.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -82.39 -38.1 24.61 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.971 1.309 . . . . 0.0 111.91 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -166.79 92.36 0.75 Allowed Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.14 105.69 1.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.078 1.852 . . . . 0.0 111.398 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -103.92 -17.3 15.07 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.74 1.216 . . . . 0.0 112.187 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.4 m -109.76 173.13 6.46 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 123.566 1.65 . . . . 0.0 112.406 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -73.44 -42.23 62.23 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 119.262 -2.149 . . . . 0.0 113.733 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.43 78.46 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 120.315 -1.49 . . . . 0.0 112.878 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -59.16 -58.99 6.22 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 125.975 1.71 . . . . 0.0 113.049 169.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.97 -22.96 65.0 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 120.815 -1.178 . . . . 0.0 113.537 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -62.15 -42.04 98.87 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 119.906 -1.746 . . . . 0.0 112.415 167.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -70.3 -33.73 71.88 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 120.231 -1.543 . . . . 0.0 114.019 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.19 -25.76 61.97 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.98 -14.28 52.74 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.397 1.079 . . . . 0.0 113.431 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.347 94.4 p 56.79 25.67 10.57 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 128.047 2.539 . . . . 0.0 113.913 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.32 91.14 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 128.316 2.647 . . . . 0.0 115.817 -167.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.27 -29.9 1.9 Allowed Glycine 0 C--N 1.344 1.02 0 O-C-N 121.382 -0.824 . . . . 0.0 112.174 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.16 -160.54 17.6 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 122.81 1.228 . . . . 0.0 112.786 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.79 102.89 12.58 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 O-C-N 120.31 -1.7 . . . . 0.0 110.895 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.9 t -80.76 151.79 71.44 Favored Pre-proline 0 C--N 1.348 0.52 0 O-C-N 120.127 -1.608 . . . . 0.0 110.457 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -67.05 -8.86 23.07 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.09 2.527 . . . . 0.0 115.096 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt 70.32 51.88 0.37 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 125.454 1.502 . . . . 0.0 113.341 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.7 pt -67.89 145.66 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 122.872 1.32 . . . . 0.0 113.663 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.1 mp -91.05 28.75 1.52 Allowed 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.475 -1.391 . . . . 0.0 110.661 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -82.03 133.25 35.28 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 120.504 -1.372 . . . . 0.0 110.432 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -80.5 113.87 18.99 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 121.37 -0.832 . . . . 0.0 110.918 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.404 ' HB2' ' H ' ' A' ' 33' ' ' ARG . 1.6 p -103.91 -141.53 0.36 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.688 1.595 . . . . 0.0 110.817 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.404 ' H ' ' HB2' ' A' ' 32' ' ' CYS . 34.0 ptt180 -169.61 -39.67 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 120.676 -1.265 . . . . 0.0 107.999 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' A' ' 36' ' ' SER . 12.7 tpp85 -125.46 169.29 12.54 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 172.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -71.43 -14.81 62.27 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 119.819 -1.801 . . . . 0.0 113.814 173.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.415 ' H ' ' HG3' ' A' ' 34' ' ' ARG . 18.2 m -61.77 -48.0 82.64 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 126.522 1.929 . . . . 0.0 113.876 173.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.76 -0.56 13.6 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.888 -1.133 . . . . 0.0 113.997 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.7 t -118.7 107.99 41.8 Favored Pre-proline 0 C--N 1.353 0.726 0 O-C-N 119.955 -1.716 . . . . 0.0 111.751 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.35 170.47 19.82 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.767 2.311 . . . . 0.0 115.653 -159.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.11 -90.54 1.67 Allowed Glycine 0 C--N 1.349 1.259 0 C-N-CA 124.181 0.895 . . . . 0.0 113.035 172.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.03 16.06 0.84 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 123.079 1.419 . . . . 0.0 110.54 -177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 32.9 m -76.92 168.36 20.23 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 119.859 -1.776 . . . . 0.0 111.461 -172.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.27 148.38 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 160.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.5 t -77.26 128.38 34.23 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.099 1.759 . . . . 0.0 107.133 171.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -84.79 -179.39 7.09 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 119.973 -1.704 . . . . 0.0 109.249 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.12 -11.03 24.04 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 116.394 1.318 . . . . 0.0 116.394 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -87.06 -7.41 58.11 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 120.704 -1.468 . . . . 0.0 113.374 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.74 13.8 74.55 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 120.71 -1.244 . . . . 0.0 114.259 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -124.18 152.08 43.29 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.134 -1.215 . . . . 0.0 109.765 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 29.2 m -78.91 93.78 5.1 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -166.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.294 0 O-C-N 119.526 -1.984 . . . . 0.0 116.624 -179.694 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.504 2.267 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.8 160.88 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -116.31 117.79 38.31 Favored Pre-proline 0 C--N 1.348 0.53 0 CA-C-O 115.964 -1.97 . . . . 0.0 109.822 170.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.09 -179.28 3.78 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.092 2.528 . . . . 0.0 114.132 169.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.03 159.74 28.65 Favored Pre-proline 0 C--N 1.351 0.634 0 C-N-CA 125.485 1.514 . . . . 0.0 110.609 175.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.99 -26.83 30.86 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.907 2.405 . . . . 0.0 114.098 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.97 -55.54 24.98 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 119.556 1.071 . . . . 0.0 110.942 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 18.5 tp -59.62 -35.62 74.72 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 120.892 -1.13 . . . . 0.0 113.282 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 17.5 tp -56.44 -40.77 75.33 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 120.605 -1.309 . . . . 0.0 114.485 175.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -65.52 -32.33 73.87 Favored 'General case' 0 C--N 1.346 0.442 0 O-C-N 120.002 -1.686 . . . . 0.0 113.613 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 10.2 tt -67.94 -46.26 72.0 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.402 -0.811 . . . . 0.0 110.94 170.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -52.15 -47.62 65.35 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 121.268 -0.895 . . . . 0.0 112.83 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -58.58 -24.99 62.1 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.273 -1.517 . . . . 0.0 114.282 173.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 11.7 t -83.38 -9.64 58.92 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 120.303 -1.498 . . . . 0.0 113.753 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 4.5 t -107.76 16.83 7.05 Favored 'Isoleucine or valine' 0 C--N 1.348 0.509 0 CA-C-O 123.369 1.557 . . . . 0.0 107.903 171.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.1 -20.93 36.97 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 119.262 -2.149 . . . . 0.0 113.96 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.29 69.2 3.53 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.228 1.811 . . . . 0.0 113.473 -172.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -85.39 17.36 3.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 119.467 -2.021 . . . . 0.0 116.204 -173.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' LYS . . . . . 0.855 ' HE3' ' H ' ' B' ' 111' ' ' ASP . 0.0 OUTLIER -88.21 142.53 27.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 123.874 1.797 . . . . 0.0 110.56 170.569 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.855 ' H ' ' HE3' ' B' ' 110' ' ' LYS . 2.6 m-20 -78.38 -7.02 56.86 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 130.717 3.607 . . . . 0.0 111.656 -172.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 11.3 p -145.43 135.11 23.4 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 127.087 2.155 . . . . 0.0 109.852 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -139.52 -165.45 1.87 Allowed 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.056 -1.028 . . . . 0.0 110.055 174.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 29.1 p -94.21 -169.63 2.11 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 119.774 -1.829 . . . . 0.0 110.927 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 76.7 mtp -74.56 -53.24 9.79 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 119.367 -2.083 . . . . 0.0 112.001 169.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -58.18 -38.98 77.73 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.211 -0.93 . . . . 0.0 112.927 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.76 -44.31 97.15 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.18 -26.11 39.32 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 O-C-N 119.618 -1.926 . . . . 0.0 111.479 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.68 -27.69 17.93 Favored 'General case' 0 C--N 1.347 0.479 0 O-C-N 120.622 -1.299 . . . . 0.0 113.706 172.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -64.97 -62.53 1.5 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 126.399 1.88 . . . . 0.0 111.612 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -54.96 -36.03 64.89 Favored 'General case' 0 C--N 1.351 0.674 0 O-C-N 120.673 -1.267 . . . . 0.0 112.3 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' LEU . . . . . 0.454 HD11 HD21 ' B' ' 147' ' ' LEU . 33.2 tp -70.48 -49.2 50.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 174.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -70.44 -46.37 48.93 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 119.89 -1.756 . . . . 0.0 113.428 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -63.36 -31.29 72.4 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.201 1.4 . . . . 0.0 112.247 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -55.9 -57.85 10.33 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 124.23 1.012 . . . . 0.0 111.861 168.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 89.7 mt -64.12 -43.74 97.49 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 O-C-N 120.534 -1.354 . . . . 0.0 112.888 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 53.5 ttm -57.64 -34.2 69.07 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 125.498 1.519 . . . . 0.0 113.206 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 58.1 m -86.33 -36.27 19.37 Favored 'General case' 0 C--N 1.345 0.37 0 O-C-N 120.621 -1.299 . . . . 0.0 112.623 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -71.66 -22.26 61.7 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 126.769 2.028 . . . . 0.0 114.862 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 71.41 45.12 0.49 Allowed 'General case' 0 C--N 1.351 0.667 0 C-N-CA 125.385 1.474 . . . . 0.0 112.984 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 89.2 mt -100.29 9.32 42.88 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 121.058 -1.026 . . . . 0.0 112.319 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -94.26 141.51 28.48 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.72 -1.237 . . . . 0.0 108.667 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -78.08 147.73 34.56 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.503 1.121 . . . . 0.0 109.277 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -68.98 -31.18 69.84 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.222 1.409 . . . . 0.0 113.3 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -104.17 -24.91 13.11 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 124.813 1.245 . . . . 0.0 112.666 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -116.93 62.55 0.73 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 122.103 0.954 . . . . 0.0 110.822 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.89 -5.04 1.81 Allowed 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.106 -1.621 . . . . 0.0 115.336 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -99.81 -0.51 39.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.261 1.824 . . . . 0.0 112.917 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 51.1 mm -105.26 117.11 50.37 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 C-N-CA 125.216 1.406 . . . . 0.0 108.64 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.49 121.71 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 O-C-N 120.987 -1.071 . . . . 0.0 108.493 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -79.92 108.86 13.83 Favored 'General case' 0 C--N 1.347 0.467 0 O-C-N 120.642 -1.286 . . . . 0.0 111.598 174.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 90.6 m -124.91 24.64 7.56 Favored 'General case' 0 C--N 1.346 0.454 0 O-C-N 121.513 -0.742 . . . . 0.0 111.157 172.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 13.6 p -76.92 142.07 40.24 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 120.315 -1.491 . . . . 0.0 108.704 165.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 28.9 t30 72.97 -31.22 0.22 Allowed 'General case' 0 C--N 1.354 0.774 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -73.77 164.35 26.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.286 -1.509 . . . . 0.0 110.678 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 18.9 tp -73.54 -2.99 25.04 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-O 123.691 1.71 . . . . 0.0 114.174 -162.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 147' ' ' LEU . . . . . 0.454 HD21 HD11 ' B' ' 122' ' ' LEU . 10.0 mp -79.47 -35.9 39.56 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 119.327 -2.108 . . . . 0.0 111.353 168.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.88 -32.52 82.23 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 120.766 -1.209 . . . . 0.0 113.62 -173.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -47.56 -67.4 0.28 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.355 3.062 . . . . 0.0 112.181 166.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.95 -23.16 48.61 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -78.77 -36.19 43.39 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.139 -1.601 . . . . 0.0 111.66 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.19 19.36 77.12 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 121.266 -0.896 . . . . 0.0 114.839 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 21.9 m -130.91 156.54 79.91 Favored Pre-proline 0 C--N 1.347 0.48 0 O-C-N 120.667 -1.49 . . . . 0.0 110.813 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.01 -26.09 8.17 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 121.923 1.749 . . . . 0.0 112.733 172.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 64.9 p -162.0 165.78 26.92 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 119.701 1.137 . . . . 0.0 109.533 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -138.42 166.12 25.07 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 8.4 t -117.88 143.05 46.65 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.808 -1.182 . . . . 0.0 109.51 169.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 34.6 m -57.95 -34.65 49.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.521 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -52.87 -26.65 15.39 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.34 49.22 0.96 Allowed 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 120.458 -1.401 . . . . 0.0 111.738 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -48.4 -44.32 34.85 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 126.64 1.976 . . . . 0.0 113.333 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -57.59 -35.02 69.85 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 125.692 1.597 . . . . 0.0 114.995 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -81.75 -40.26 22.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.167 -1.583 . . . . 0.0 110.023 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 75.8 mt -59.92 -52.25 63.39 Favored 'Isoleucine or valine' 0 C--N 1.347 0.496 0 C-N-CA 123.929 0.892 . . . . 0.0 111.402 172.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -51.47 -44.04 62.31 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 120.905 -1.122 . . . . 0.0 114.007 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 86.9 m -56.71 -53.77 53.85 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 121.138 -0.976 . . . . 0.0 112.199 174.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 25.9 mmt -61.53 -34.58 75.79 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 120.561 -1.337 . . . . 0.0 114.049 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.83 -55.43 22.47 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 O-C-N 121.106 -0.996 . . . . 0.0 111.39 171.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -68.81 -18.15 64.13 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 119.414 -2.054 . . . . 0.0 115.257 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -64.48 -30.95 71.98 Favored 'General case' 0 C--N 1.349 0.562 0 O-C-N 118.515 -2.615 . . . . 0.0 112.197 165.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -96.56 -15.04 21.82 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 123.899 0.879 . . . . 0.0 113.072 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 69.5 mt -120.64 121.37 38.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.603 1.161 . . . . 0.0 112.489 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.54 119.53 13.35 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 O-C-N 120.276 -1.515 . . . . 0.0 112.399 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 C--N 1.349 0.546 0 C-N-CA 124.825 1.25 . . . . 0.0 110.601 177.46 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' SER . . . . . 0.55 ' HA ' ' H ' ' A' ' 43' ' ' ILE . 34.7 m . . . . . 0 N--CA 1.517 2.888 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.1 55.13 31.95 Favored Glycine 0 C--N 1.357 1.706 0 CA-C-O 121.705 0.614 . . . . 0.0 112.776 -166.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -124.34 105.98 9.88 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 120.315 -1.697 . . . . 0.0 111.429 -168.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.55 -152.11 7.12 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.51 72.6 4.06 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.047 -1.266 . . . . 0.0 113.184 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 p -66.45 -2.11 4.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 126.775 2.03 . . . . 0.0 115.116 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -100.58 -31.79 11.08 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 126.189 1.795 . . . . 0.0 111.474 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -171.27 87.66 0.47 Allowed Pre-proline 0 C--N 1.351 0.656 0 O-C-N 121.382 -0.824 . . . . 0.0 110.53 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.59 98.31 0.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.88 1.72 . . . . 0.0 113.189 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -85.14 -31.97 23.0 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.353 1.061 . . . . 0.0 112.781 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.82 169.03 8.75 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 120.859 -1.15 . . . . 0.0 112.82 -173.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -64.19 -53.46 48.99 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 120.713 -1.242 . . . . 0.0 111.468 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.38 -50.36 67.7 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.183 1.393 . . . . 0.0 113.997 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -45.84 -55.04 7.13 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.915 2.086 . . . . 0.0 115.095 168.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.42 -30.43 60.05 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 120.931 -1.106 . . . . 0.0 112.979 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -54.59 -47.68 73.06 Favored 'General case' 0 C--N 1.349 0.546 0 O-C-N 119.798 -1.814 . . . . 0.0 112.729 173.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -59.51 -40.22 86.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 173.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -60.72 -20.91 62.26 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 125.836 1.654 . . . . 0.0 114.2 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.6 tp -70.53 -17.12 62.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.701 1.2 . . . . 0.0 113.663 174.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.296 91.4 p 50.93 40.89 26.22 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.363 1.865 . . . . 0.0 114.769 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.26 88.97 0.08 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.979 1.712 . . . . 0.0 114.993 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 148.2 -31.63 1.29 Allowed Glycine 0 CA--C 1.496 -1.109 0 O-C-N 120.975 -1.078 . . . . 0.0 111.096 -170.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.8 -132.7 11.02 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-O 122.423 1.013 . . . . 0.0 112.433 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 m -99.77 135.49 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 120.659 -1.495 . . . . 0.0 110.718 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.52 158.15 37.17 Favored Pre-proline 0 N--CA 1.451 -0.385 0 O-C-N 120.354 -1.466 . . . . 0.0 109.513 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.45 -5.9 17.89 Favored 'Trans proline' 0 CA--C 1.521 -0.175 0 C-N-CA 122.754 2.303 . . . . 0.0 112.848 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 mptt 61.74 51.05 4.05 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 126.481 1.912 . . . . 0.0 113.479 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.6 pt -64.11 141.69 17.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -173.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.27 26.3 0.91 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 125.305 1.442 . . . . 0.0 112.088 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -82.29 137.65 34.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.157 -1.59 . . . . 0.0 109.87 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -81.06 125.46 30.23 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 120.973 -1.079 . . . . 0.0 111.36 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.7 p -114.06 -175.22 2.63 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.517 1.151 . . . . 0.0 110.046 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -138.19 -2.95 1.8 Allowed 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 120.994 -1.066 . . . . 0.0 110.586 167.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -169.18 173.43 6.76 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.65 1.18 . . . . 0.0 109.315 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.23 -9.92 58.12 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 128.149 2.58 . . . . 0.0 111.337 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -75.0 -39.12 61.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.753 1.621 . . . . 0.0 110.962 168.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -77.89 -18.41 56.21 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.443 2.297 . . . . 0.0 112.634 -173.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.3 127.94 34.85 Favored Pre-proline 0 CA--C 1.54 0.594 0 O-C-N 120.253 -1.529 . . . . 0.0 111.55 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.76 170.09 21.12 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.649 2.233 . . . . 0.0 113.887 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.09 -96.66 0.99 Allowed Glycine 0 C--N 1.35 1.312 0 C-N-CA 124.238 0.923 . . . . 0.0 112.527 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.62 33.57 0.45 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 122.837 1.303 . . . . 0.0 109.327 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 77.3 m -91.77 136.59 33.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 119.737 -1.852 . . . . 0.0 109.965 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.55 ' H ' ' HA ' ' A' ' 1' ' ' SER . 1.6 pp -103.35 151.16 6.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 O-C-N 120.766 -1.209 . . . . 0.0 110.534 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.3 t -88.47 118.14 27.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.823 1.649 . . . . 0.0 109.154 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -79.05 172.86 13.21 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 118.952 -2.342 . . . . 0.0 110.948 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.58 -27.83 13.53 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 116.836 1.494 . . . . 0.0 116.836 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -83.82 3.49 33.38 Favored 'General case' 0 C--N 1.345 0.386 0 O-C-N 121.205 -1.174 . . . . 0.0 113.472 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.55 22.04 73.62 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 119.949 -1.719 . . . . 0.0 114.252 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -131.71 137.74 48.38 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 120.771 -1.429 . . . . 0.0 111.29 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 66.2 m -66.37 137.65 57.03 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 124.616 2.15 . . . . 0.0 114.288 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.948 0 O-C-N 120.517 -1.365 . . . . 0.0 113.928 173.176 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 N--CA 1.504 2.253 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 93' ' ' VAL . . . . . 0.431 ' HB ' HD22 ' B' ' 172' ' ' LEU . 4.4 m -133.4 166.47 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' ARG . . . . . 0.401 ' HB2' HG12 ' B' ' 173' ' ' VAL . 0.0 OUTLIER -118.9 101.42 50.25 Favored Pre-proline 0 C--N 1.346 0.413 0 CA-C-O 116.936 -1.507 . . . . 0.0 110.397 -178.539 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.99 168.44 23.15 Favored 'Trans proline' 0 C--N 1.329 -0.484 0 C-N-CA 123.104 2.536 . . . . 0.0 114.396 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -86.69 152.98 55.06 Favored Pre-proline 0 C--N 1.349 0.573 0 O-C-N 121.038 -1.038 . . . . 0.0 112.807 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.15 -19.23 29.92 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.145 2.563 . . . . 0.0 112.915 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.6 mt -68.62 -51.55 41.11 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-O 121.579 0.704 . . . . 0.0 110.537 169.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.87 -39.57 81.74 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 124.944 1.298 . . . . 0.0 113.391 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 tp -46.46 -42.19 15.05 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.315 1.446 . . . . 0.0 114.879 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -66.07 -36.05 82.16 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 119.595 -1.94 . . . . 0.0 113.586 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.515 HD13 HD13 ' B' ' 147' ' ' LEU . 1.8 tt -70.39 -50.82 34.73 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 123.927 0.891 . . . . 0.0 111.062 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 96.5 mt -52.65 -45.69 66.82 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 124.5 1.12 . . . . 0.0 112.412 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -59.14 -28.67 66.78 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 5.9 t -75.72 -13.18 60.3 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 124.559 1.144 . . . . 0.0 112.779 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.73 -4.3 9.37 Favored 'Isoleucine or valine' 0 C--N 1.347 0.486 0 C-N-CA 124.852 1.261 . . . . 0.0 109.987 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.58 -16.57 23.9 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 119.833 -1.792 . . . . 0.0 113.306 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.34 77.61 9.92 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.212 -1.758 . . . . 0.0 113.34 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -81.57 11.83 4.32 Favored 'General case' 0 C--N 1.344 0.351 0 O-C-N 119.747 -1.846 . . . . 0.0 115.758 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 139.94 30.21 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-O 122.132 0.968 . . . . 0.0 113.174 -174.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.05 -15.91 62.57 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.516 2.326 . . . . 0.0 114.087 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 19.6 p -138.81 126.51 22.09 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 120.318 -1.489 . . . . 0.0 110.968 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -128.34 -177.31 4.11 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-O 122.461 1.124 . . . . 0.0 110.879 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 4.2 p -90.76 176.11 6.76 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 120.041 -1.662 . . . . 0.0 110.01 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 8.5 mmt -64.75 -49.23 71.62 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 120.351 -1.468 . . . . 0.0 112.945 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -33.23 74.27 Favored 'General case' 0 C--N 1.349 0.587 0 O-C-N 120.997 -1.064 . . . . 0.0 112.605 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -57.75 -36.74 72.5 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 125.062 1.345 . . . . 0.0 114.134 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.47 -48.86 76.64 Favored 'Isoleucine or valine' 0 C--N 1.356 0.866 0 C-N-CA 123.961 0.905 . . . . 0.0 111.811 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.77 -27.33 40.46 Favored 'General case' 0 C--N 1.346 0.434 0 O-C-N 120.763 -1.211 . . . . 0.0 113.045 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -65.35 -58.84 4.89 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 125.289 1.436 . . . . 0.0 112.033 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -59.79 -41.97 92.32 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 120.992 -1.067 . . . . 0.0 112.236 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 29.6 tp -61.19 -52.45 64.74 Favored 'General case' 0 C--N 1.347 0.485 0 O-C-N 120.569 -1.332 . . . . 0.0 114.017 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.79 -45.54 94.75 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 120.602 -1.311 . . . . 0.0 113.45 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -59.05 -37.21 76.47 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 124.788 1.235 . . . . 0.0 113.157 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -59.93 -57.58 12.25 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 124.636 1.175 . . . . 0.0 112.688 173.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 3.1 mt -63.59 -41.7 93.54 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 O-C-N 119.999 -1.688 . . . . 0.0 112.209 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 52.2 ttm -56.26 -43.45 78.77 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 125.691 1.596 . . . . 0.0 112.681 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 21.6 m -82.56 -30.35 29.7 Favored 'General case' 0 C--N 1.345 0.37 0 O-C-N 119.953 -1.717 . . . . 0.0 112.521 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -75.31 -24.15 57.41 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 119.584 -1.948 . . . . 0.0 114.436 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 71.82 49.84 0.26 Allowed 'General case' 0 C--N 1.352 0.692 0 C-N-CA 125.403 1.481 . . . . 0.0 111.038 -176.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 6.1 mt -107.7 17.72 22.25 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 121.054 -1.029 . . . . 0.0 111.961 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -105.83 149.54 26.41 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -77.31 154.81 32.51 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 121.254 -0.904 . . . . 0.0 108.852 172.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -71.53 -37.21 71.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 122.746 1.26 . . . . 0.0 110.794 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -88.63 -51.5 5.65 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 121.035 -1.041 . . . . 0.0 111.884 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -96.13 59.65 1.95 Allowed 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 120.338 -1.476 . . . . 0.0 113.25 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -63.29 -9.33 11.28 Favored 'General case' 0 C--N 1.346 0.436 0 O-C-N 120.098 -1.626 . . . . 0.0 115.03 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -91.07 2.38 56.36 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.293 -1.504 . . . . 0.0 113.315 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 50.1 mm -106.04 143.07 17.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 C-N-CA 125.572 1.549 . . . . 0.0 108.437 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 44.9 t -129.64 130.14 66.82 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 O-C-N 120.778 -1.201 . . . . 0.0 109.114 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -95.26 100.66 12.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.629 1.172 . . . . 0.0 110.404 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 1.2 m -101.43 1.54 38.41 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 121.118 -0.989 . . . . 0.0 112.662 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 26.4 t -65.44 131.18 45.78 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 120.828 -1.17 . . . . 0.0 110.651 173.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 4.9 t30 69.93 25.01 5.01 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.274 1.03 . . . . 0.0 113.226 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -123.26 171.5 9.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 13.8 tp -74.97 -22.19 58.71 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.781 1.632 . . . . 0.0 111.688 -171.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 147' ' ' LEU . . . . . 0.515 HD13 HD13 ' B' ' 102' ' ' LEU . 1.0 OUTLIER -71.04 -33.53 70.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 120.799 -1.188 . . . . 0.0 112.715 170.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.67 -38.3 96.21 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 120.065 -1.647 . . . . 0.0 113.812 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -51.91 -50.24 61.48 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.18 2.592 . . . . 0.0 112.456 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.95 -30.76 44.77 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 120.024 -1.673 . . . . 0.0 113.865 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.41 ' HB3' HG22 ' B' ' 153' ' ' VAL . 11.6 m-85 -75.67 -35.04 60.49 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 120.734 -1.229 . . . . 0.0 112.83 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 73.99 23.2 76.81 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 123.857 0.741 . . . . 0.0 113.696 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 153' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' B' ' 151' ' ' PHE . 12.3 m -135.19 152.44 76.95 Favored Pre-proline 0 N--CA 1.451 -0.408 0 O-C-N 121.176 -1.191 . . . . 0.0 108.454 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.71 -38.41 3.2 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 121.797 1.665 . . . . 0.0 111.798 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 31.1 m -144.67 164.31 31.36 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -138.06 178.48 7.09 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 77.5 p -136.78 141.64 42.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.077 -1.639 . . . . 0.0 109.626 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.23 -23.57 23.3 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 CA-C-O 122.62 1.2 . . . . 0.0 113.035 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -60.01 -27.05 66.57 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 120.666 -1.271 . . . . 0.0 113.521 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.87 56.64 1.58 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.838 1.255 . . . . 0.0 112.438 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -53.64 -38.86 64.5 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 119.684 -1.885 . . . . 0.0 114.43 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -67.45 -32.34 73.14 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.903 1.681 . . . . 0.0 113.529 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -74.72 -43.95 52.44 Favored 'General case' 0 C--N 1.348 0.53 0 C-N-CA 125.405 1.482 . . . . 0.0 110.799 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 51.3 mm -50.63 -53.38 13.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.768 1.227 . . . . 0.0 112.012 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -54.25 -43.12 70.66 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 124.243 1.017 . . . . 0.0 113.655 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -36.07 79.88 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 119.7 -1.875 . . . . 0.0 113.664 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.33 -38.38 78.16 Favored 'General case' 0 C--N 1.346 0.44 0 O-C-N 120.434 -1.416 . . . . 0.0 111.845 176.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 67.6 mt -66.54 -50.38 67.24 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 C-N-CA 124.455 1.102 . . . . 0.0 112.313 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -61.1 -14.88 27.37 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 119.735 -1.853 . . . . 0.0 114.918 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -76.31 -12.73 60.12 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.554 -1.966 . . . . 0.0 113.539 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -105.24 -15.91 14.92 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 120.419 -1.426 . . . . 0.0 111.86 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 172' ' ' LEU . . . . . 0.431 HD22 ' HB ' ' B' ' 93' ' ' VAL . 48.0 mt -111.37 162.93 14.53 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 121.92 0.867 . . . . 0.0 109.804 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 173' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' B' ' 94' ' ' ARG . 8.6 p -106.92 126.68 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 O-C-N 120.453 -1.405 . . . . 0.0 108.978 173.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.348 0.534 0 C-N-CA 123.779 0.832 . . . . 0.0 110.681 -179.226 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.52 3.039 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 44.61 55.98 5.85 Favored Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.181 1.355 . . . . 0.0 114.903 -162.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -116.38 111.51 20.16 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 120.113 -1.816 . . . . 0.0 111.606 -168.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.28 -147.14 5.55 Favored Glycine 0 C--N 1.349 1.306 0 CA-C-O 122.206 0.892 . . . . 0.0 112.44 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.38 66.0 9.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 120.132 -1.805 . . . . 0.0 113.545 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.502 ' HA ' HD21 ' A' ' 18' ' ' LEU . 3.8 m -62.81 -6.26 3.55 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 pttm -89.12 -26.57 21.27 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.298 2.239 . . . . 0.0 113.635 175.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 175.16 87.22 0.08 OUTLIER Pre-proline 0 C--N 1.35 0.622 0 C-N-CA 125.074 1.35 . . . . 0.0 108.738 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.74 127.31 8.66 Favored 'Trans proline' 0 C--N 1.325 -0.702 0 C-N-CA 122.231 1.954 . . . . 0.0 111.65 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.6 t -122.38 -0.38 9.31 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-O 122.71 1.243 . . . . 0.0 110.884 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.9 t -130.39 164.2 25.23 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 124.92 1.288 . . . . 0.0 109.599 -174.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -68.26 -38.13 81.45 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 124.369 1.068 . . . . 0.0 111.105 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.7 -52.9 39.37 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 124.848 1.259 . . . . 0.0 110.803 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.84 -55.25 10.18 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.092 1.757 . . . . 0.0 114.07 169.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.57 -30.81 68.68 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.275 -1.516 . . . . 0.0 113.501 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -58.32 -41.55 84.79 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 119.937 -1.727 . . . . 0.0 112.381 171.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -65.25 -43.2 92.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.769 -1.207 . . . . 0.0 113.454 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.502 HD21 ' HA ' ' A' ' 6' ' ' SER . 3.2 mm? -53.26 -29.18 31.51 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 127.072 2.149 . . . . 0.0 115.014 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.49 -19.58 65.67 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.604 1.162 . . . . 0.0 113.94 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.268 42.2 p 54.65 35.59 24.11 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 126.871 2.068 . . . . 0.0 114.299 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.34 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.44 1.896 . . . . 0.0 115.186 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.2 -40.85 1.04 Allowed Glycine 0 CA--C 1.494 -1.225 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -170.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.91 -146.24 17.97 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 124.475 1.036 . . . . 0.0 111.684 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 m -94.53 155.24 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 O-C-N 121.09 -1.241 . . . . 0.0 110.904 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.61 155.52 80.45 Favored Pre-proline 0 N--CA 1.448 -0.559 0 O-C-N 120.601 -1.312 . . . . 0.0 107.592 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.37 6.44 3.55 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 123.113 2.542 . . . . 0.0 113.017 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt 62.63 46.25 5.54 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.705 1.602 . . . . 0.0 114.262 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 pt -59.79 139.24 19.65 Favored 'Isoleucine or valine' 0 C--N 1.348 0.531 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -173.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 mp -86.69 28.1 0.91 Allowed 'General case' 0 C--N 1.346 0.45 0 O-C-N 120.948 -1.095 . . . . 0.0 111.685 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -82.51 138.29 34.36 Favored 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 120.543 -1.348 . . . . 0.0 109.79 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -84.7 127.0 33.88 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.503 0.668 . . . . 0.0 111.019 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.9 p -119.07 -175.95 3.02 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.038 1.335 . . . . 0.0 109.388 -177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -130.67 -12.82 3.8 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 120.696 -1.252 . . . . 0.0 111.116 168.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -157.04 169.99 23.56 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 120.689 -1.257 . . . . 0.0 107.875 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.1 -31.73 71.55 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.579 1.551 . . . . 0.0 113.515 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 m -65.28 -26.64 68.17 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 120.121 -1.612 . . . . 0.0 115.058 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.84 -11.33 59.81 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.308 -0.87 . . . . 0.0 111.987 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -107.4 127.56 27.63 Favored Pre-proline 0 C--N 1.354 0.791 0 O-C-N 120.179 -1.576 . . . . 0.0 112.129 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.07 168.64 23.67 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.195 1.93 . . . . 0.0 114.175 -171.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.32 -85.57 1.13 Allowed Glycine 0 C--N 1.35 1.313 0 C-N-CA 124.626 1.108 . . . . 0.0 112.982 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -161.3 25.59 0.13 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 122.598 1.19 . . . . 0.0 110.169 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 7.1 m -89.63 148.55 23.27 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 119.181 -2.199 . . . . 0.0 109.612 -170.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 pp -115.37 147.42 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 O-C-N 119.882 -1.761 . . . . 0.0 108.821 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.06 117.14 19.08 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.989 1.316 . . . . 0.0 110.158 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -79.9 176.3 9.86 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 120.029 -1.669 . . . . 0.0 110.911 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.89 0.33 2.42 Favored Glycine 0 C--N 1.355 1.59 0 N-CA-C 117.492 1.757 . . . . 0.0 117.492 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.45 -7.49 24.23 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 120.707 -1.466 . . . . 0.0 111.925 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.35 20.18 60.93 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 120.458 -1.401 . . . . 0.0 113.707 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -130.81 145.21 51.91 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 121.133 -1.216 . . . . 0.0 110.593 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 78.8 m -75.39 147.13 40.26 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 123.51 1.624 . . . . 0.0 114.329 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.334 0 CA-C-O 116.19 -2.45 . . . . 0.0 118.186 -174.385 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 57.2 mt . . . . . 0 N--CA 1.504 2.246 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.485 HG11 HD13 ' B' ' 172' ' ' LEU . 11.7 m -136.2 166.22 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -115.84 102.14 54.04 Favored Pre-proline 0 C--N 1.345 0.391 0 CA-C-O 117.137 -1.411 . . . . 0.0 110.035 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.49 174.46 9.23 Favored 'Trans proline' 0 C--N 1.325 -0.66 0 C-N-CA 123.3 2.667 . . . . 0.0 114.086 175.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -96.2 154.64 38.73 Favored Pre-proline 0 C--N 1.35 0.617 0 O-C-N 120.914 -1.116 . . . . 0.0 111.617 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.91 -24.32 29.12 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.179 2.586 . . . . 0.0 112.7 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.8 mt -64.59 -52.94 54.94 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 118.686 0.676 . . . . 0.0 111.358 168.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 32.6 tp -58.69 -36.9 74.96 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 124.976 1.311 . . . . 0.0 113.522 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 15.6 tp -47.63 -40.3 19.26 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 125.345 1.458 . . . . 0.0 114.805 170.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -64.47 -36.82 85.44 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 119.645 -1.91 . . . . 0.0 113.723 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 tt -70.45 -50.62 36.34 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 124.037 0.935 . . . . 0.0 110.738 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 88.8 mt -53.59 -46.34 70.33 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.913 1.285 . . . . 0.0 112.287 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -58.95 -25.18 63.3 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.44 -13.57 59.02 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 125.307 1.443 . . . . 0.0 112.025 177.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.62 0.61 10.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 125.07 1.348 . . . . 0.0 109.782 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.2 -15.75 39.19 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 120.084 -1.635 . . . . 0.0 113.155 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -88.14 78.39 8.13 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 120.434 -1.627 . . . . 0.0 113.493 -172.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -85.38 8.1 20.08 Favored 'General case' 0 C--N 1.343 0.318 0 O-C-N 119.895 -1.753 . . . . 0.0 115.466 -176.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.82 149.49 27.14 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 121.339 -0.851 . . . . 0.0 112.508 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -78.74 -27.55 44.79 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.147 1.379 . . . . 0.0 112.527 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 60.4 p -121.58 140.88 51.67 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 120.808 -1.182 . . . . 0.0 112.572 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -139.43 177.31 8.02 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-O 122.439 1.114 . . . . 0.0 110.264 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.408 ' O ' HG23 ' B' ' 118' ' ' VAL . 0.7 OUTLIER -88.48 160.97 17.26 Favored 'General case' 0 C--N 1.346 0.447 0 O-C-N 120.666 -1.271 . . . . 0.0 110.872 175.208 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.98 -47.68 71.14 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.105 -1.622 . . . . 0.0 114.388 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -59.36 -52.7 64.5 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.978 0.911 . . . . 0.0 112.913 171.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.76 -46.57 50.75 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 174.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.408 HG23 ' O ' ' B' ' 114' ' ' THR . 52.1 t -51.88 -48.25 39.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 O-C-N 120.97 -1.081 . . . . 0.0 112.709 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.2 -29.84 38.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.082 -1.012 . . . . 0.0 113.288 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -56.27 -60.34 3.64 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 125.774 1.629 . . . . 0.0 112.193 172.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -59.13 -36.49 75.29 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 120.669 -1.269 . . . . 0.0 112.495 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.413 HD11 ' CD1' ' B' ' 147' ' ' LEU . 5.0 tp -62.56 -51.46 67.26 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.1 1.36 . . . . 0.0 113.902 173.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.23 -51.77 54.27 Favored Glycine 0 C--N 1.35 1.334 0 C-N-CA 125.502 1.525 . . . . 0.0 113.204 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -55.39 -39.15 69.79 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 125.216 1.406 . . . . 0.0 113.399 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -59.11 -56.3 24.02 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 121.149 -0.969 . . . . 0.0 112.74 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.71 -44.97 98.56 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 C-N-CA 124.327 1.051 . . . . 0.0 112.475 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 45.2 ttm -52.43 -44.67 65.58 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 126.268 1.827 . . . . 0.0 112.979 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 11.7 m -85.83 -23.62 27.09 Favored 'General case' 0 C--N 1.346 0.449 0 O-C-N 120.153 -1.592 . . . . 0.0 112.774 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -29.42 55.62 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 118.982 -2.324 . . . . 0.0 113.053 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? 75.15 49.27 0.09 Allowed 'General case' 0 C--N 1.351 0.659 0 C-N-CA 126.496 1.918 . . . . 0.0 110.596 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.6 23.19 12.34 Favored 'General case' 0 C--N 1.349 0.553 0 O-C-N 121.032 -1.042 . . . . 0.0 111.68 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -114.01 144.14 43.59 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.588 -1.32 . . . . 0.0 108.599 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.27 132.59 44.26 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.883 -1.136 . . . . 0.0 110.162 173.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -58.22 -47.77 82.45 Favored 'General case' 0 C--N 1.346 0.424 0 O-C-N 119.705 -1.872 . . . . 0.0 113.681 173.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -75.04 -19.49 60.01 Favored 'General case' 0 C--N 1.347 0.458 0 O-C-N 119.878 -1.764 . . . . 0.0 114.323 176.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.22 58.67 1.58 Allowed 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 119.701 -1.874 . . . . 0.0 110.231 -170.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -62.55 -7.41 4.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.453 1.901 . . . . 0.0 114.903 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -92.7 -3.82 54.22 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.015 2.526 . . . . 0.0 113.551 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 43.8 mm -106.29 139.32 28.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 0 C-N-CA 126.022 1.729 . . . . 0.0 107.643 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 39.9 t -124.7 130.17 73.47 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-O 122.406 1.098 . . . . 0.0 110.324 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.59 109.34 18.47 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.971 -1.08 . . . . 0.0 110.994 172.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 24.1 p -100.38 -14.47 18.34 Favored 'General case' 0 C--N 1.346 0.426 0 O-C-N 121.126 -0.984 . . . . 0.0 112.324 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.89 124.6 20.41 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 120.645 -1.285 . . . . 0.0 113.312 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 79.05 2.75 2.41 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 125.43 1.492 . . . . 0.0 113.554 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -112.12 167.33 10.49 Favored 'General case' 0 C--N 1.35 0.587 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 171.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 tp -64.39 -20.98 66.48 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 128.059 2.543 . . . . 0.0 112.81 -171.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' LEU . . . . . 0.413 ' CD1' HD11 ' B' ' 122' ' ' LEU . 1.1 tp -67.47 -36.55 81.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.785 1.634 . . . . 0.0 112.926 171.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.22 -48.41 31.72 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 120.923 -1.111 . . . . 0.0 112.468 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.33 -42.32 4.48 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 127.823 2.449 . . . . 0.0 114.246 169.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.75 -29.89 15.8 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 120.311 -1.493 . . . . 0.0 114.355 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.655 ' HB3' HG22 ' B' ' 153' ' ' VAL . 2.4 m-85 -74.08 -41.75 61.22 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 120.684 -1.26 . . . . 0.0 111.699 177.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 84.33 20.82 58.1 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 124.154 0.883 . . . . 0.0 113.14 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' VAL . . . . . 0.655 HG22 ' HB3' ' B' ' 151' ' ' PHE . 35.0 m -133.71 153.48 80.12 Favored Pre-proline 0 C--N 1.346 0.421 0 O-C-N 121.155 -1.203 . . . . 0.0 110.561 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.56 -25.18 5.7 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.046 1.83 . . . . 0.0 112.907 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 33.2 p -160.08 164.01 33.42 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 120.016 -1.678 . . . . 0.0 107.427 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -144.56 163.85 32.65 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.593 1.187 . . . . 0.0 110.7 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.57 130.27 54.36 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 120.655 -1.278 . . . . 0.0 111.034 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 48.8 t -62.79 -27.92 43.94 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 O-C-N 119.711 -1.868 . . . . 0.0 111.749 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -25.87 12.67 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 125.854 1.662 . . . . 0.0 114.868 171.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -85.2 55.52 3.53 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 119.968 -1.708 . . . . 0.0 112.185 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -48.58 -44.72 37.08 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 119.229 -2.169 . . . . 0.0 115.519 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -22.81 61.93 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 172.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -87.75 -44.13 11.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.091 1.356 . . . . 0.0 109.734 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 49.6 mm -53.98 -51.9 41.47 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 C-N-CA 125.118 1.367 . . . . 0.0 111.515 174.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -53.84 -45.96 71.07 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 171.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.87 -39.59 93.79 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 119.63 -1.918 . . . . 0.0 113.627 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 24.3 mmt -60.09 -49.25 78.4 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 120.741 -1.224 . . . . 0.0 112.58 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 45.8 mt -59.6 -51.48 72.28 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 C-N-CA 124.826 1.25 . . . . 0.0 112.524 175.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -61.39 -23.4 65.76 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 119.198 -2.189 . . . . 0.0 114.407 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -77.59 -11.87 59.91 Favored 'General case' 0 C--N 1.349 0.57 0 O-C-N 119.499 -2.001 . . . . 0.0 113.503 170.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -95.86 -26.38 15.65 Favored 'General case' 0 CA--C 1.505 -0.764 0 O-C-N 119.985 -1.697 . . . . 0.0 110.403 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.485 HD13 HG11 ' B' ' 93' ' ' VAL . 73.3 mt -103.35 174.26 5.95 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 122.023 0.916 . . . . 0.0 110.603 -174.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 97.7 t -116.59 121.66 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 99.2 t . . . . . 0 C--N 1.347 0.46 0 C-N-CA 123.792 0.837 . . . . 0.0 110.331 179.829 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.515 2.808 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 50.15 47.49 41.51 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-N 120.154 1.343 . . . . 0.0 114.874 -165.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 m -114.93 114.03 24.93 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 119.769 -2.018 . . . . 0.0 112.0 -167.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.22 -151.17 5.89 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.84 70.0 4.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.286 -1.126 . . . . 0.0 113.976 -176.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 p -69.51 -0.98 7.45 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 119.429 -2.044 . . . . 0.0 114.868 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -92.75 -34.39 13.93 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.619 1.568 . . . . 0.0 113.007 171.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -173.97 85.21 0.36 Allowed Pre-proline 0 C--N 1.347 0.471 0 CA-C-O 118.672 -0.68 . . . . 0.0 109.6 -175.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.34 118.86 4.76 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.233 1.955 . . . . 0.0 112.05 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.1 t -107.68 -25.29 11.37 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.954 1.301 . . . . 0.0 110.039 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 t -106.02 165.63 11.08 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.384 -1.447 . . . . 0.0 113.941 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -63.3 -50.44 70.07 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 119.786 -1.822 . . . . 0.0 111.77 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.36 -45.17 72.73 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 125.867 1.667 . . . . 0.0 113.061 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -56.54 -58.43 8.08 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.617 1.567 . . . . 0.0 113.888 171.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' B' ' 138' ' ' HIS . 0.1 OUTLIER -66.58 -29.52 69.59 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.321 -1.487 . . . . 0.0 113.07 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -35.63 73.81 Favored 'General case' 0 C--N 1.348 0.525 0 O-C-N 119.926 -1.734 . . . . 0.0 112.083 173.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -70.32 -44.33 68.45 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 120.532 -1.355 . . . . 0.0 112.881 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -54.32 -29.55 48.19 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 126.399 1.88 . . . . 0.0 114.862 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.488 HD22 HG13 ' B' ' 158' ' ' VAL . 21.4 tp -61.11 -30.34 70.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.511 1.124 . . . . 0.0 113.81 171.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 t 54.44 53.32 10.96 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 126.536 1.935 . . . . 0.0 113.043 -172.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.84 81.38 1.63 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 123.097 1.427 . . . . 0.0 113.561 -170.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.19 -29.92 0.47 Allowed Glycine 0 C--N 1.342 0.877 0 O-C-N 121.234 -0.916 . . . . 0.0 112.243 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.19 -149.23 18.73 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-N 117.797 0.798 . . . . 0.0 112.44 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.0 t -103.35 138.69 26.72 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 O-C-N 120.972 -1.311 . . . . 0.0 109.012 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.28 157.03 41.13 Favored Pre-proline 0 N--CA 1.447 -0.606 0 O-C-N 120.746 -1.221 . . . . 0.0 109.074 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.73 -1.09 10.27 Favored 'Trans proline' 0 C--N 1.336 -0.123 0 C-N-CA 122.73 2.286 . . . . 0.0 112.757 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt 66.98 53.76 0.81 Allowed 'General case' 0 C--N 1.35 0.609 0 C-N-CA 126.421 1.889 . . . . 0.0 112.704 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 pt -63.35 141.0 18.72 Favored 'Isoleucine or valine' 0 C--N 1.346 0.414 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.2 mt -85.65 29.9 0.67 Allowed 'General case' 0 C--N 1.348 0.503 0 C-N-CA 124.284 1.034 . . . . 0.0 111.825 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -86.32 143.34 27.93 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 120.179 -1.576 . . . . 0.0 109.386 172.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -88.48 133.95 33.99 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.861 0.839 . . . . 0.0 110.456 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.7 p -125.4 -175.88 3.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.001 0.92 . . . . 0.0 108.902 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -129.71 -13.34 4.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.346 -1.471 . . . . 0.0 111.774 167.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -161.89 176.03 11.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -74.2 -27.45 60.81 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.541 -1.349 . . . . 0.0 112.557 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.19 -28.25 67.81 Favored 'General case' 0 C--N 1.348 0.54 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 171.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -84.23 -8.24 59.11 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.347 -0.846 . . . . 0.0 110.701 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -111.29 124.19 33.29 Favored Pre-proline 0 C--N 1.355 0.816 0 O-C-N 120.091 -1.631 . . . . 0.0 111.9 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.28 169.63 22.07 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.147 1.898 . . . . 0.0 114.135 -169.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.69 -87.85 1.14 Allowed Glycine 0 C--N 1.349 1.266 0 C-N-CA 124.319 0.962 . . . . 0.0 112.246 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.39 21.53 0.29 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.992 0.901 . . . . 0.0 110.87 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 4.2 m -83.87 152.34 24.61 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 119.278 -2.139 . . . . 0.0 110.027 -168.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 pp -119.23 146.12 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 O-C-N 120.037 -1.664 . . . . 0.0 108.342 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.51 119.47 21.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.422 1.489 . . . . 0.0 109.298 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -79.53 177.34 8.94 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 119.984 -1.698 . . . . 0.0 110.565 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.34 -18.86 23.12 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 116.598 1.399 . . . . 0.0 116.598 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -82.17 -8.68 59.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.449 -1.03 . . . . 0.0 112.992 174.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.64 14.88 69.48 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 120.659 -1.276 . . . . 0.0 113.905 -175.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -127.56 148.57 50.34 Favored 'General case' 0 C--N 1.347 0.467 0 O-C-N 120.653 -1.498 . . . . 0.0 110.354 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 41.9 m -74.63 147.16 41.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 123.783 1.754 . . . . 0.0 114.35 -175.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.289 0 CA-C-O 116.689 -2.173 . . . . 0.0 117.435 -176.179 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.505 2.275 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 9.8 m -132.88 164.91 33.95 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 119.587 1.085 . . . . 0.0 108.665 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.29 100.49 53.51 Favored Pre-proline 0 C--N 1.344 0.348 0 CA-C-O 117.082 -1.437 . . . . 0.0 110.181 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.37 162.94 39.89 Favored 'Trans proline' 0 C--N 1.331 -0.358 0 C-N-CA 123.232 2.622 . . . . 0.0 114.006 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -89.11 156.28 49.07 Favored Pre-proline 0 C--N 1.347 0.492 0 O-C-N 121.344 -0.847 . . . . 0.0 112.613 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.65 -20.63 30.38 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.232 2.621 . . . . 0.0 113.3 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 81.1 mt -70.32 -61.14 1.89 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.706 0.803 . . . . 0.0 110.186 170.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 31.9 tp -50.74 -37.09 39.9 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 125.422 1.489 . . . . 0.0 114.427 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 8.3 tp -47.66 -40.71 20.6 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 169.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -64.35 -36.84 85.44 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 119.463 -2.023 . . . . 0.0 114.084 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -49.67 60.17 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 121.35 -0.844 . . . . 0.0 111.598 171.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 93.7 mt -52.18 -47.25 65.64 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 124.172 0.989 . . . . 0.0 113.124 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -52.74 -30.03 30.32 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.3 t -77.11 -20.6 55.47 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.602 1.161 . . . . 0.0 111.927 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.12 -9.72 9.49 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 C-N-CA 124.619 1.168 . . . . 0.0 110.606 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.97 -27.31 6.49 Favored Glycine 0 C--N 1.353 1.51 0 O-C-N 120.066 -1.646 . . . . 0.0 111.966 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ALA . . . . . 0.413 ' HB1' ' CE2' ' B' ' 113' ' ' TYR . . . -78.16 74.27 4.7 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 125.82 1.648 . . . . 0.0 114.718 -171.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -84.8 17.44 2.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 119.248 -2.157 . . . . 0.0 115.158 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.43 143.8 26.54 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 123.36 1.552 . . . . 0.0 113.021 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -20.27 64.03 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 130.093 3.357 . . . . 0.0 112.396 -177.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 31.1 p -140.44 141.27 35.48 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 125.2 1.4 . . . . 0.0 109.87 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' TYR . . . . . 0.413 ' CE2' ' HB1' ' B' ' 108' ' ' ALA . 1.9 m-85 -141.51 -173.75 3.85 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.071 -1.018 . . . . 0.0 110.443 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.464 ' O ' HG23 ' B' ' 118' ' ' VAL . 4.4 p -95.68 168.73 10.49 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.526 -1.358 . . . . 0.0 110.584 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 13.7 mmt -62.48 -49.19 76.37 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.731 -1.231 . . . . 0.0 113.258 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -58.94 -45.51 90.25 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 124.677 1.191 . . . . 0.0 112.206 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -56.34 -47.54 78.59 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 114' ' ' THR . 47.2 t -52.81 -46.08 50.97 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 O-C-N 120.135 -1.603 . . . . 0.0 112.958 174.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.567 HD21 HD13 ' B' ' 168' ' ' ILE . 4.1 mm? -76.46 -30.79 57.46 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 120.701 -1.249 . . . . 0.0 113.233 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -62.25 -57.24 12.17 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.667 1.587 . . . . 0.0 111.588 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -59.27 -43.03 92.51 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 123.891 0.876 . . . . 0.0 112.495 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.29 -53.7 55.25 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 120.88 -1.138 . . . . 0.0 114.017 170.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.57 -40.99 99.83 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 120.523 -1.36 . . . . 0.0 113.85 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -63.11 -38.12 89.92 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 124.877 1.271 . . . . 0.0 112.718 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -56.46 -56.88 15.71 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 124.288 1.035 . . . . 0.0 112.433 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.01 -42.39 96.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 O-C-N 120.696 -1.253 . . . . 0.0 112.665 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 37.2 ttm -54.76 -41.02 69.95 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 125.911 1.684 . . . . 0.0 113.321 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 17.2 m -87.98 -28.17 21.62 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 120.162 -1.586 . . . . 0.0 112.118 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -35.12 73.63 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 119.658 -1.901 . . . . 0.0 113.562 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? 74.91 59.04 0.07 Allowed 'General case' 0 C--N 1.353 0.725 0 C-N-CA 127.033 2.133 . . . . 0.0 110.516 -169.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mt -110.42 13.79 22.73 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-O 122.065 0.936 . . . . 0.0 111.679 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -100.68 149.87 23.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.901 1.281 . . . . 0.0 108.347 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -85.14 143.42 28.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.146 -0.971 . . . . 0.0 108.548 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -64.08 -33.21 75.23 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 120.73 -1.231 . . . . 0.0 113.067 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -98.06 -35.18 10.5 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.33 -0.856 . . . . 0.0 111.953 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -111.84 63.3 0.62 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.219 1.807 . . . . 0.0 111.912 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -62.29 -9.34 7.73 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.11 1.764 . . . . 0.0 114.764 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' HIS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 26.2 p80 -90.07 -6.54 55.38 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.561 1.944 . . . . 0.0 113.695 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 33.1 mm -99.71 134.5 38.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 124.58 1.152 . . . . 0.0 109.273 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 19.8 t -122.74 128.39 75.25 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 O-C-N 120.757 -1.214 . . . . 0.0 109.763 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -89.2 102.72 15.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 120.97 -1.081 . . . . 0.0 109.818 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.56 -1.24 28.62 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 123.77 0.828 . . . . 0.0 111.305 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 1.4 t -71.81 139.41 48.94 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 120.623 -1.298 . . . . 0.0 109.817 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 17.6 m120 71.52 5.38 5.38 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -106.06 169.99 8.17 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 122.526 1.155 . . . . 0.0 109.884 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 13.8 tp -69.63 -21.38 63.57 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 127.193 2.197 . . . . 0.0 112.571 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.39 -32.82 64.67 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 120.565 -1.334 . . . . 0.0 111.89 170.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.57 -40.19 98.82 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 120.617 -1.302 . . . . 0.0 113.091 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.17 -43.14 70.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.688 2.395 . . . . 0.0 112.575 173.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.18 -33.29 20.84 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 119.873 -1.767 . . . . 0.0 114.135 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.578 ' HB3' HG22 ' B' ' 153' ' ' VAL . 1.8 m-85 -70.3 -41.8 72.86 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 125.713 1.605 . . . . 0.0 111.644 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.89 20.84 72.66 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 123.882 0.754 . . . . 0.0 113.178 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' VAL . . . . . 0.578 HG22 ' HB3' ' B' ' 151' ' ' PHE . 28.7 m -133.32 151.86 78.32 Favored Pre-proline 0 C--N 1.345 0.376 0 O-C-N 121.32 -1.106 . . . . 0.0 109.371 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.33 -25.25 11.54 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.207 1.938 . . . . 0.0 111.95 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 53.6 p -161.3 165.52 28.99 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.403 -1.436 . . . . 0.0 108.6 -175.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -143.85 168.82 19.05 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 121.074 -1.016 . . . . 0.0 108.295 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 32.6 t -115.02 140.96 48.62 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.107 -0.996 . . . . 0.0 108.907 172.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' VAL . . . . . 0.488 HG13 HD22 ' A' ' 19' ' ' LEU . 23.9 t -69.51 -22.19 25.22 Favored 'Isoleucine or valine' 0 C--N 1.347 0.493 0 CA-C-O 122.818 1.294 . . . . 0.0 111.564 174.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -29.62 70.72 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.163 -1.586 . . . . 0.0 112.129 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -80.46 56.98 2.71 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.754 -1.216 . . . . 0.0 112.744 175.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -52.55 -41.91 63.95 Favored 'General case' 0 C--N 1.351 0.639 0 O-C-N 119.624 -1.922 . . . . 0.0 115.555 -176.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -62.51 -33.49 74.99 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 120.54 -1.35 . . . . 0.0 113.337 173.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -78.48 -33.18 48.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.721 -1.237 . . . . 0.0 113.082 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 44.4 mm -50.13 -50.8 19.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 C-N-CA 125.633 1.573 . . . . 0.0 111.344 169.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -51.99 -52.38 50.93 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 125.218 1.407 . . . . 0.0 113.167 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.34 -42.86 82.79 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 119.996 -1.69 . . . . 0.0 115.222 173.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 11.6 mtt -62.99 -38.81 92.67 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 120.638 -1.289 . . . . 0.0 113.174 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 168' ' ' ILE . . . . . 0.567 HD13 HD21 ' B' ' 119' ' ' LEU . 44.3 mt -69.35 -54.09 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.223 -0.923 . . . . 0.0 111.927 173.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -55.53 -27.6 49.83 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 120.304 -1.497 . . . . 0.0 114.62 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -63.06 -19.53 64.48 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.898 -1.751 . . . . 0.0 115.599 171.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.0 -2.17 17.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.994 0.918 . . . . 0.0 112.169 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 92.6 mt -108.84 151.2 26.57 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 122.693 1.235 . . . . 0.0 110.199 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 16.0 t -95.98 114.29 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 O-C-N 120.315 -1.491 . . . . 0.0 108.914 173.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.35 0.601 0 C-N-CA 124.031 0.932 . . . . 0.0 111.396 179.35 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.506 ' HA ' ' H ' ' A' ' 43' ' ' ILE 0.262 87.6 p . . . . . 0 N--CA 1.532 3.626 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 55.77 53.05 44.5 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 m -107.68 113.35 26.56 Favored 'General case' 0 CA--C 1.51 -0.573 0 O-C-N 119.884 -1.951 . . . . 0.0 112.38 -173.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.48 -149.87 5.54 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.94 70.72 5.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 121.09 -1.241 . . . . 0.0 113.27 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.441 ' HA ' HD21 ' A' ' 18' ' ' LEU . 11.0 p -68.65 3.99 1.62 Allowed 'General case' 0 C--N 1.346 0.447 0 O-C-N 119.721 -1.862 . . . . 0.0 115.496 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -100.81 -39.29 7.88 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.538 1.935 . . . . 0.0 111.15 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -167.58 84.79 0.79 Allowed Pre-proline 0 N--CA 1.447 -0.583 0 O-C-N 121.402 -0.812 . . . . 0.0 109.629 -175.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.96 120.22 5.37 Favored 'Trans proline' 0 C--N 1.327 -0.599 0 C-N-CA 121.981 1.787 . . . . 0.0 112.199 -177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -107.33 -37.94 6.1 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.557 1.143 . . . . 0.0 110.109 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 m -94.04 163.67 13.38 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 120.244 -1.535 . . . . 0.0 114.841 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -60.42 -49.81 76.09 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 125.657 1.583 . . . . 0.0 111.295 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.04 -46.82 78.74 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 123.791 0.836 . . . . 0.0 113.155 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -55.09 -58.17 8.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.2 1.4 . . . . 0.0 114.422 171.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -31.98 73.25 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 120.603 -1.311 . . . . 0.0 112.947 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -57.2 -37.85 72.82 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 120.308 -1.495 . . . . 0.0 112.918 170.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -68.28 -40.54 81.79 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.369 -1.457 . . . . 0.0 112.753 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.441 HD21 ' HA ' ' A' ' 6' ' ' SER . 3.8 mm? -56.45 -29.03 61.18 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 126.382 1.873 . . . . 0.0 114.987 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.9 tp -64.98 -18.92 65.7 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 125.286 1.434 . . . . 0.0 113.676 174.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.296 59.8 p 53.85 32.02 14.28 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 126.653 1.981 . . . . 0.0 115.463 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.7 93.71 0.01 OUTLIER 'General case' 0 C--N 1.353 0.72 0 C-N-CA 126.868 2.067 . . . . 0.0 115.784 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.33 -38.03 1.26 Allowed Glycine 0 C--N 1.345 1.078 0 O-C-N 121.341 -0.85 . . . . 0.0 111.892 -169.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.68 -139.6 14.67 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 122.469 1.038 . . . . 0.0 112.528 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -97.68 145.09 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 O-C-N 120.789 -1.418 . . . . 0.0 110.452 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.35 157.7 66.78 Favored Pre-proline 0 N--CA 1.448 -0.541 0 O-C-N 120.531 -1.356 . . . . 0.0 108.168 -175.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.93 -7.82 21.32 Favored 'Trans proline' 0 CA--C 1.52 -0.188 0 C-N-CA 122.579 2.186 . . . . 0.0 112.649 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 mtmt 68.7 53.29 0.53 Allowed 'General case' 0 C--N 1.352 0.688 0 C-N-CA 126.122 1.769 . . . . 0.0 112.066 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.6 pt -64.21 142.03 17.4 Favored 'Isoleucine or valine' 0 C--N 1.347 0.486 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.34 9.94 9.77 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-O 122.545 1.164 . . . . 0.0 112.69 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -70.93 134.65 47.4 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 120.415 -1.428 . . . . 0.0 112.389 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -81.28 124.41 29.3 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 121.71 -0.619 . . . . 0.0 111.797 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.1 p -115.82 -175.86 2.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.34 1.456 . . . . 0.0 109.772 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -122.14 -32.41 3.69 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 120.528 -1.358 . . . . 0.0 110.125 163.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -138.22 176.28 8.84 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 120.613 -1.304 . . . . 0.0 112.427 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -81.03 -5.02 57.11 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 118.898 -2.376 . . . . 0.0 113.262 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.0 t -76.32 -46.76 26.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.457 2.303 . . . . 0.0 109.576 172.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -32.52 67.24 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 128.127 2.571 . . . . 0.0 113.777 177.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.76 120.3 64.9 Favored Pre-proline 0 N--CA 1.447 -0.591 0 O-C-N 120.528 -1.357 . . . . 0.0 112.776 -172.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.78 169.16 23.01 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.487 2.125 . . . . 0.0 114.108 -168.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.15 -89.67 1.1 Allowed Glycine 0 C--N 1.349 1.286 0 C-N-CA 124.195 0.903 . . . . 0.0 111.912 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.17 29.91 0.17 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.74 1.257 . . . . 0.0 109.975 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.9 m -88.66 145.26 25.77 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 119.016 -2.302 . . . . 0.0 109.415 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.506 ' H ' ' HA ' ' A' ' 1' ' ' SER . 1.3 pp -111.92 146.04 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 O-C-N 119.766 -1.834 . . . . 0.0 109.564 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -77.92 120.26 22.53 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.737 1.615 . . . . 0.0 110.041 176.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -76.41 174.78 9.83 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 119.846 -1.784 . . . . 0.0 111.077 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.89 -2.89 2.89 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 117.1 1.6 . . . . 0.0 117.1 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.21 -9.0 24.26 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.976 1.31 . . . . 0.0 112.04 172.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.56 25.43 35.83 Favored Glycine 0 C--N 1.35 1.313 0 O-C-N 120.641 -1.287 . . . . 0.0 114.26 -176.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -135.93 150.29 49.25 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 120.724 -1.456 . . . . 0.0 111.465 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.9 m -85.66 116.18 23.78 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 -169.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.263 0 CA-C-O 116.063 -2.521 . . . . 0.0 116.357 175.141 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 N--CA 1.504 2.235 0 CA-C-O 118.288 -0.863 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.454 HG11 HD13 ' B' ' 172' ' ' LEU . 12.8 m -139.16 164.97 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -113.97 103.5 55.19 Favored Pre-proline 0 C--N 1.344 0.368 0 CA-C-O 116.754 -1.593 . . . . 0.0 110.271 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.56 163.93 37.16 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 122.864 2.376 . . . . 0.0 114.196 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -84.66 153.64 61.34 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.151 0.98 . . . . 0.0 113.167 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.98 -17.29 28.68 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.164 2.576 . . . . 0.0 113.34 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -71.54 -57.9 3.99 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 123.992 0.917 . . . . 0.0 109.288 169.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 28.8 tp -54.12 -38.45 65.44 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 125.678 1.591 . . . . 0.0 114.478 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 14.6 tp -46.24 -39.68 10.27 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 125.396 1.479 . . . . 0.0 114.682 168.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -69.04 -37.53 78.64 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 119.193 -2.192 . . . . 0.0 113.05 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.43 -53.32 24.43 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 126.779 2.032 . . . . 0.0 111.942 169.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 76.9 mt -49.89 -45.62 50.93 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.72 1.208 . . . . 0.0 112.513 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -17.32 63.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 174.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 20.4 t -83.02 -8.66 59.53 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 120.021 -1.674 . . . . 0.0 112.034 171.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' VAL . . . . . 0.551 HG22 ' CD1' ' B' ' 125' ' ' TYR . 2.2 t -105.34 -7.67 9.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 C-N-CA 124.766 1.226 . . . . 0.0 110.048 176.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.58 -16.91 18.87 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 120.459 -1.4 . . . . 0.0 112.558 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.45 79.84 8.85 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.401 -1.647 . . . . 0.0 113.45 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -82.58 5.76 19.88 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.804 -1.81 . . . . 0.0 115.324 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 139.14 31.56 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -174.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.51 -11.67 61.07 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.765 2.026 . . . . 0.0 114.413 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 39.9 p -138.59 137.03 36.58 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.081 1.352 . . . . 0.0 111.297 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -139.35 -172.92 3.46 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 120.798 -1.189 . . . . 0.0 110.092 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.55 ' O ' HG23 ' B' ' 118' ' ' VAL . 1.8 p -96.88 173.12 7.45 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.048 -1.657 . . . . 0.0 109.93 174.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 24.7 mtt -67.15 -43.67 81.72 Favored 'General case' 0 C--N 1.352 0.699 0 O-C-N 120.161 -1.587 . . . . 0.0 113.46 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -58.73 -51.33 70.42 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.237 1.015 . . . . 0.0 111.603 172.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -54.56 -44.1 72.63 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.55 HG23 ' O ' ' B' ' 114' ' ' THR . 86.2 t -54.72 -43.53 66.78 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 120.121 -1.612 . . . . 0.0 112.568 176.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.3 -30.91 27.18 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 120.729 -1.232 . . . . 0.0 112.344 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -59.93 -60.86 3.16 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.949 1.7 . . . . 0.0 112.123 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -56.96 -38.23 72.69 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.41 1.084 . . . . 0.0 112.286 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 32.3 tp -64.68 -51.44 62.48 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 172.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.33 -40.29 91.84 Favored Glycine 0 C--N 1.349 1.297 0 O-C-N 119.928 -1.732 . . . . 0.0 114.019 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -30.31 71.33 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 124.724 1.21 . . . . 0.0 112.177 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.551 ' CD1' HG22 ' B' ' 106' ' ' VAL . 7.9 t80 -57.55 -60.95 2.89 Favored 'General case' 0 C--N 1.357 0.91 0 O-C-N 120.833 -1.167 . . . . 0.0 111.669 171.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 45.1 mm -58.41 -40.69 79.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 O-C-N 120.584 -1.322 . . . . 0.0 113.343 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 35.7 ttm -52.55 -43.27 65.08 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 125.077 1.351 . . . . 0.0 113.867 171.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 22.3 m -87.7 -31.88 19.48 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 124.727 1.211 . . . . 0.0 112.534 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' LYS . . . . . 0.446 ' HD2' ' CZ ' ' B' ' 125' ' ' TYR . 5.2 mmpt? -77.54 -25.42 50.16 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 120.027 -1.671 . . . . 0.0 114.306 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.98 53.67 0.19 Allowed 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.663 1.585 . . . . 0.0 111.38 -176.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.74 19.62 18.44 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.423 1.089 . . . . 0.0 110.627 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -105.09 146.46 29.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.56 -1.338 . . . . 0.0 107.998 173.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.48 139.68 45.92 Favored 'General case' 0 C--N 1.347 0.461 0 O-C-N 120.789 -1.195 . . . . 0.0 110.043 171.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' GLU . . . . . 0.46 ' HA ' HE21 ' B' ' 137' ' ' GLN . 58.8 mt-10 -59.95 -47.16 86.92 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 120.22 -1.55 . . . . 0.0 113.177 174.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -83.09 -19.99 35.73 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.844 1.258 . . . . 0.0 113.973 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -132.83 61.92 1.66 Allowed 'General case' 0 C--N 1.352 0.707 0 O-C-N 120.589 -1.319 . . . . 0.0 109.855 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' B' ' 134' ' ' GLU . 6.4 mm-40 -64.46 -6.15 6.77 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -175.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -89.97 -8.1 52.49 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.586 1.955 . . . . 0.0 113.315 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 47.8 mm -96.44 136.49 27.13 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 124.93 1.292 . . . . 0.0 109.303 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 17.2 t -121.75 123.76 70.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 O-C-N 120.856 -1.152 . . . . 0.0 110.202 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -86.22 113.82 22.54 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.653 1.181 . . . . 0.0 109.183 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 16.0 m -115.11 1.24 13.84 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 120.623 -1.298 . . . . 0.0 111.174 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 34.1 t -73.42 126.8 31.01 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.468 -1.395 . . . . 0.0 110.21 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 75.05 23.9 1.57 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.795 1.238 . . . . 0.0 112.01 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -128.39 165.29 20.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 tp -70.83 -16.89 62.75 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 126.844 2.058 . . . . 0.0 112.143 -170.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.25 -40.95 70.69 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.511 1.524 . . . . 0.0 111.841 169.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.97 -41.81 99.69 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 120.368 -1.458 . . . . 0.0 112.895 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -53.46 -33.64 54.93 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.189 2.196 . . . . 0.0 114.403 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.79 -33.01 11.83 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 120.055 -1.653 . . . . 0.0 113.158 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -78.79 -34.01 45.8 Favored 'General case' 0 C--N 1.35 0.629 0 O-C-N 121.044 -1.035 . . . . 0.0 113.108 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 79.91 15.06 79.9 Favored Glycine 0 C--N 1.35 1.319 0 O-C-N 121.315 -0.866 . . . . 0.0 113.898 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 20.5 m -131.35 151.75 79.33 Favored Pre-proline 0 C--N 1.345 0.38 0 O-C-N 121.055 -1.262 . . . . 0.0 109.844 -174.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.48 -33.11 4.36 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.907 1.738 . . . . 0.0 112.621 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 19.3 m -150.43 161.62 42.14 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -175.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -135.34 163.82 29.14 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.456 -0.777 . . . . 0.0 109.435 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 46.0 t -110.4 129.18 55.82 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 30.6 t -61.31 -28.76 44.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 O-C-N 120.818 -1.176 . . . . 0.0 112.219 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -54.21 -29.26 45.54 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 126.075 1.75 . . . . 0.0 114.795 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.59 54.58 2.41 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 120.575 -1.328 . . . . 0.0 111.75 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -47.97 -46.2 32.2 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 119.96 -1.713 . . . . 0.0 114.428 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -58.47 -38.51 77.71 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 125.365 1.466 . . . . 0.0 114.561 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -72.96 -45.33 58.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.758 0.823 . . . . 0.0 112.038 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 18.9 mt -55.64 -50.55 66.44 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 C-N-CA 125.188 1.395 . . . . 0.0 110.342 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -51.09 -52.14 46.49 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 124.681 1.192 . . . . 0.0 114.122 171.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 1.3 p -58.49 -38.3 77.35 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 119.544 -1.972 . . . . 0.0 115.031 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -42.55 89.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.322 -0.861 . . . . 0.0 112.048 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 31.5 mt -60.67 -52.43 61.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 O-C-N 120.438 -1.413 . . . . 0.0 112.052 173.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -64.31 -4.81 4.13 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -89.22 -27.06 20.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 119.641 -1.912 . . . . 0.0 113.342 168.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -88.06 -20.44 25.74 Favored 'General case' 0 CA--C 1.509 -0.621 0 O-C-N 121.247 -0.908 . . . . 0.0 111.489 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.454 HD13 HG11 ' B' ' 93' ' ' VAL . 70.4 mt -108.1 147.24 31.5 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 125.071 1.348 . . . . 0.0 111.705 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 56.2 t -90.78 122.65 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 120.749 -1.219 . . . . 0.0 109.355 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 93.8 t . . . . . 0 C--N 1.35 0.617 0 C-N-CA 124.606 1.162 . . . . 0.0 110.38 176.467 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.518 2.931 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 45.34 60.54 4.07 Favored Glycine 0 C--N 1.355 1.631 0 CA-C-N 120.113 1.324 . . . . 0.0 113.986 -164.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.7 m -123.46 106.22 10.45 Favored 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 120.005 -1.88 . . . . 0.0 112.084 -166.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.33 -155.03 7.62 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.02 68.58 2.52 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.467 ' HA ' HD11 ' A' ' 18' ' ' LEU . 29.3 t -55.21 -27.92 49.49 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 126.113 1.765 . . . . 0.0 113.583 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -76.32 -29.51 57.34 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -178.6 87.32 0.22 Allowed Pre-proline 0 C--N 1.351 0.643 0 O-C-N 121.146 -0.971 . . . . 0.0 110.434 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -78.61 120.85 4.91 Favored 'Trans proline' 0 C--N 1.327 -0.554 0 C-N-CA 122.319 2.013 . . . . 0.0 112.854 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.9 t -120.57 6.63 10.55 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.248 1.819 . . . . 0.0 110.214 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 m -135.62 156.37 48.97 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 119.507 -1.996 . . . . 0.0 112.92 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -55.83 -45.9 78.24 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 120.352 -1.467 . . . . 0.0 112.919 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.44 94.7 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 125.216 1.406 . . . . 0.0 113.069 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -61.95 -53.91 49.08 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 120.39 -1.444 . . . . 0.0 113.317 172.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.91 -30.46 69.8 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.345 -0.847 . . . . 0.0 113.152 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.4 t90 -54.21 -45.08 72.15 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 120.097 -1.627 . . . . 0.0 113.389 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -62.34 -41.39 98.54 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 120.977 -1.077 . . . . 0.0 113.8 174.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.467 HD11 ' HA ' ' A' ' 6' ' ' SER . 2.4 mm? -55.16 -32.52 62.21 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 126.197 1.799 . . . . 0.0 114.629 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.6 tp -56.71 -28.13 60.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.376 1.471 . . . . 0.0 113.803 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p 71.04 17.91 6.04 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.54 2.336 . . . . 0.0 113.951 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.86 93.32 0.01 OUTLIER 'General case' 0 C--N 1.351 0.647 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 -164.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.86 -31.35 1.76 Allowed Glycine 0 C--N 1.345 1.077 0 O-C-N 121.034 -1.041 . . . . 0.0 111.96 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.4 -150.3 16.95 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-O 122.807 1.226 . . . . 0.0 112.407 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 t -97.27 139.89 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 120.913 -1.345 . . . . 0.0 109.458 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.16 156.48 48.51 Favored Pre-proline 0 N--CA 1.45 -0.453 0 O-C-N 120.438 -1.414 . . . . 0.0 108.64 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.69 8.33 2.35 Favored 'Trans proline' 0 N--CA 1.47 0.109 0 C-N-CA 123.058 2.505 . . . . 0.0 113.119 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? 61.45 47.32 6.8 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 125.85 1.66 . . . . 0.0 114.499 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.9 pt -60.78 140.93 17.89 Favored 'Isoleucine or valine' 0 C--N 1.349 0.576 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.5 mt -87.91 24.2 1.84 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-O 122.612 1.196 . . . . 0.0 111.743 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -80.95 138.42 36.1 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 120.428 -1.42 . . . . 0.0 110.49 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -86.85 120.92 28.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.656 -0.652 . . . . 0.0 111.524 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.3 p -109.29 -179.36 3.81 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.082 1.353 . . . . 0.0 110.109 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -119.92 -28.46 5.17 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 120.491 -1.38 . . . . 0.0 110.15 162.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -146.76 173.67 12.16 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 122.931 1.348 . . . . 0.0 113.271 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -73.65 -12.2 60.66 Favored 'General case' 0 C--N 1.346 0.435 0 O-C-N 119.842 -1.786 . . . . 0.0 113.839 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.3 p -78.16 -29.31 48.6 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 126.727 2.011 . . . . 0.0 111.79 173.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.66 -28.75 45.45 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.55 1.54 . . . . 0.0 109.728 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -94.39 119.47 66.4 Favored Pre-proline 0 N--CA 1.445 -0.685 0 O-C-N 120.953 -1.092 . . . . 0.0 113.078 -173.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.71 171.47 17.74 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.526 2.151 . . . . 0.0 114.525 -166.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.23 -84.95 1.14 Allowed Glycine 0 C--N 1.35 1.322 0 C-N-CA 124.345 0.974 . . . . 0.0 112.361 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.69 6.65 0.47 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.9 m -73.82 178.57 4.76 Favored 'General case' 0 C--N 1.347 0.496 0 O-C-N 120.353 -1.467 . . . . 0.0 112.656 -160.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 pp -141.38 149.4 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -86.88 111.68 21.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 126.338 1.855 . . . . 0.0 108.675 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -76.13 172.95 11.95 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 118.91 -2.369 . . . . 0.0 110.827 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.94 -19.36 6.93 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 117.548 1.779 . . . . 0.0 117.548 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -85.8 -8.51 58.07 Favored 'General case' 0 C--N 1.345 0.375 0 O-C-N 121.288 -1.125 . . . . 0.0 113.418 174.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.31 27.55 39.54 Favored Glycine 0 C--N 1.348 1.224 0 O-C-N 120.755 -1.216 . . . . 0.0 114.256 -175.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -137.3 146.69 44.97 Favored 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 120.942 -1.328 . . . . 0.0 110.917 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 83.1 m -78.45 135.95 37.51 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 123.747 1.736 . . . . 0.0 115.232 -170.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.347 0 CA-C-O 115.69 -2.728 . . . . 0.0 116.946 -175.097 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.451 HG11 HD13 ' B' ' 172' ' ' LEU . 15.0 m -133.21 170.28 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 119.126 0.876 . . . . 0.0 109.517 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 101.9 51.43 Favored Pre-proline 0 C--N 1.344 0.338 0 CA-C-O 116.849 -1.548 . . . . 0.0 110.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.32 164.23 35.84 Favored 'Trans proline' 0 C--N 1.326 -0.633 0 CA-C-N 123.871 2.418 . . . . 0.0 113.675 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -84.77 153.59 60.94 Favored Pre-proline 0 C--N 1.35 0.616 0 C-N-CA 123.905 0.882 . . . . 0.0 112.605 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.33 -24.27 27.24 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.312 2.675 . . . . 0.0 113.089 -172.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 mt -66.09 -54.48 25.21 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 121.365 -0.834 . . . . 0.0 110.698 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -56.82 -39.26 73.86 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 125.118 1.367 . . . . 0.0 113.663 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 15.8 tp -45.8 -40.62 9.92 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 125.37 1.468 . . . . 0.0 114.925 170.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 29.1 tttp -67.81 -34.79 77.43 Favored 'General case' 0 C--N 1.348 0.514 0 O-C-N 119.889 -1.757 . . . . 0.0 113.375 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.1 -50.25 35.63 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 124.887 1.275 . . . . 0.0 111.247 171.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.433 HD13 ' CE2' ' B' ' 113' ' ' TYR . 91.2 mt -55.17 -42.27 72.95 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 121.146 -0.972 . . . . 0.0 112.302 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.4 -26.05 67.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 175.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 4.0 t -77.93 -13.53 59.85 Favored 'General case' 0 C--N 1.344 0.369 0 O-C-N 120.958 -1.089 . . . . 0.0 112.425 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 5.2 t -97.37 -9.22 9.07 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 C-N-CA 125.154 1.382 . . . . 0.0 109.868 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.65 -20.06 10.27 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 120.465 -1.397 . . . . 0.0 112.514 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -89.28 91.52 8.79 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 120.514 -1.58 . . . . 0.0 112.215 -171.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -95.09 17.87 13.24 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 119.185 -2.197 . . . . 0.0 116.166 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -97.42 143.0 28.58 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.471 1.108 . . . . 0.0 112.937 -171.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.18 9.89 4.11 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 119.769 -1.832 . . . . 0.0 115.677 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.4 p -149.31 131.56 15.52 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 120.381 -1.45 . . . . 0.0 111.186 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' TYR . . . . . 0.433 ' CE2' HD13 ' B' ' 103' ' ' LEU . 78.6 m-85 -132.74 178.81 6.57 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-O 122.939 1.352 . . . . 0.0 110.814 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.04 163.64 14.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.658 1.583 . . . . 0.0 109.854 170.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 48.4 mtm -62.55 -48.77 78.06 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 119.012 -2.305 . . . . 0.0 113.812 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -60.91 -42.53 98.23 Favored 'General case' 0 C--N 1.349 0.562 0 O-C-N 121.274 -0.892 . . . . 0.0 113.176 173.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -50.94 -48.25 60.92 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.893 1.677 . . . . 0.0 114.804 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -52.45 -49.99 41.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 125.209 1.403 . . . . 0.0 111.884 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.447 HD21 HD13 ' B' ' 168' ' ' ILE . 4.5 mm? -75.01 -32.17 61.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 120.918 -1.114 . . . . 0.0 113.011 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -62.14 -57.81 10.16 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.557 1.543 . . . . 0.0 111.72 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -57.34 -44.13 84.02 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 123.977 0.911 . . . . 0.0 112.396 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.5 -54.0 50.77 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.41 -44.91 94.64 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 120.126 -1.609 . . . . 0.0 113.657 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -63.77 -32.43 73.93 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 124.139 0.976 . . . . 0.0 112.798 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -57.1 -57.91 10.51 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 120.842 -1.161 . . . . 0.0 112.262 170.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 38.1 mm -63.94 -41.41 92.41 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 O-C-N 120.392 -1.443 . . . . 0.0 112.566 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 46.9 ttm -54.56 -43.9 72.42 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 126.117 1.767 . . . . 0.0 113.705 172.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 20.5 m -86.96 -24.5 24.71 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 120.718 -1.239 . . . . 0.0 112.597 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -75.12 -26.74 59.45 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 119.702 -1.874 . . . . 0.0 113.173 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? 72.04 53.51 0.19 Allowed 'General case' 0 C--N 1.354 0.785 0 C-N-CA 126.113 1.765 . . . . 0.0 110.895 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.54 9.43 33.43 Favored 'General case' 0 C--N 1.348 0.514 0 O-C-N 121.1 -1.0 . . . . 0.0 111.848 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -93.34 146.57 23.63 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.41 160.93 31.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.842 -0.536 . . . . 0.0 110.423 173.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -76.57 -34.92 58.45 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 120.97 -1.081 . . . . 0.0 112.104 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -91.34 -44.87 8.91 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.426 -1.421 . . . . 0.0 110.929 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 -107.67 57.12 0.63 Allowed 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.026 1.33 . . . . 0.0 111.721 -173.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -63.09 -11.77 22.16 Favored 'General case' 0 C--N 1.347 0.474 0 O-C-N 120.125 -1.609 . . . . 0.0 114.86 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -86.91 -4.03 59.14 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.343 1.457 . . . . 0.0 113.403 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 47.7 mm -101.55 137.13 30.34 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 C-N-CA 124.988 1.315 . . . . 0.0 108.991 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 16.7 t -123.8 123.34 66.8 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 120.85 -1.156 . . . . 0.0 110.701 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -93.33 113.92 26.22 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 121.192 -0.942 . . . . 0.0 110.101 173.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 16.5 m -115.37 20.92 14.5 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 121.191 -0.943 . . . . 0.0 110.334 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 71.3 p -74.76 140.14 43.85 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 120.11 -1.619 . . . . 0.0 109.862 171.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 3.4 t30 64.75 29.01 12.91 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -138.34 164.47 29.22 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 7.7 tp -70.8 -14.46 62.43 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-O 124.393 2.044 . . . . 0.0 113.536 -165.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.01 -35.71 69.5 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.946 1.699 . . . . 0.0 111.892 170.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.21 -43.22 99.41 Favored Glycine 0 C--N 1.348 1.201 0 O-C-N 120.096 -1.627 . . . . 0.0 113.029 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -53.15 -34.27 56.12 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 126.596 1.958 . . . . 0.0 114.731 172.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 pp -95.89 -31.24 13.23 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 119.538 -1.976 . . . . 0.0 113.402 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.481 ' HB3' HG22 ' B' ' 153' ' ' VAL . 18.5 m-85 -77.9 -42.41 33.35 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.737 1.215 . . . . 0.0 112.513 178.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 83.82 15.91 69.2 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 121.427 -0.795 . . . . 0.0 113.932 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' B' ' 151' ' ' PHE . 32.7 m -131.45 151.55 78.93 Favored Pre-proline 0 C--N 1.343 0.31 0 O-C-N 121.216 -1.167 . . . . 0.0 109.787 -174.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.18 -30.29 5.68 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.811 1.674 . . . . 0.0 112.653 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 87.2 p -154.0 169.4 23.57 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -138.74 165.61 26.54 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.204 1.002 . . . . 0.0 109.289 172.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 26.6 t -109.33 128.76 55.35 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.28 -31.84 51.39 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 O-C-N 120.623 -1.298 . . . . 0.0 111.739 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -58.75 -22.03 56.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.818 2.047 . . . . 0.0 114.463 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -82.4 58.49 4.13 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 120.404 -1.435 . . . . 0.0 112.071 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -49.17 -45.26 43.77 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.027 -1.671 . . . . 0.0 114.132 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -61.33 -33.07 73.01 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 120.64 -1.288 . . . . 0.0 114.234 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -73.95 -46.24 45.36 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 120.326 -1.484 . . . . 0.0 110.955 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 33.0 mm -50.5 -57.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.351 0.671 0 C-N-CA 125.173 1.389 . . . . 0.0 112.44 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.55 ' HA ' HD12 ' B' ' 168' ' ' ILE . 37.5 m-85 -49.2 -46.16 45.26 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 171.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 31.9 m -62.91 -39.58 94.97 Favored 'General case' 0 C--N 1.346 0.429 0 O-C-N 120.543 -1.348 . . . . 0.0 113.379 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -44.94 88.1 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.388 -1.445 . . . . 0.0 111.752 177.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 168' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' B' ' 165' ' ' TYR . 22.0 mt -57.27 -53.11 48.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 C-N-CA 125.473 1.509 . . . . 0.0 112.291 174.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -62.74 -11.92 20.66 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.274 -1.516 . . . . 0.0 114.835 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -85.47 -11.65 53.79 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 119.394 -2.066 . . . . 0.0 113.571 169.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -105.04 -21.24 13.31 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 120.194 -1.567 . . . . 0.0 109.883 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.451 HD13 HG11 ' B' ' 93' ' ' VAL . 73.2 mt -110.92 151.67 27.64 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 126.111 1.764 . . . . 0.0 110.809 -175.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 61.0 t -96.17 119.63 44.48 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 O-C-N 120.473 -1.392 . . . . 0.0 108.954 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 56.3 t . . . . . 0 C--N 1.348 0.541 0 C-N-CA 124.166 0.986 . . . . 0.0 110.919 177.169 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.519 3.024 0 CA-C-O 116.743 -1.599 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 48.93 39.23 25.24 Favored Glycine 0 C--N 1.357 1.701 0 CA-C-N 120.23 1.377 . . . . 0.0 115.353 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.7 m -118.18 120.06 36.57 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.507 -1.584 . . . . 0.0 111.177 -167.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.05 -148.99 5.91 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.25 78.03 3.78 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 120.996 -1.297 . . . . 0.0 113.239 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.404 ' HA ' HD11 ' A' ' 18' ' ' LEU . 8.2 t -72.95 3.05 5.76 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 119.435 -2.041 . . . . 0.0 115.457 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -100.74 -44.61 5.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.614 -1.304 . . . . 0.0 110.958 173.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -150.52 85.96 5.18 Favored Pre-proline 0 N--CA 1.443 -0.798 0 O-C-N 121.552 -0.717 . . . . 0.0 109.319 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.84 108.98 2.76 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.273 1.982 . . . . 0.0 110.982 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 t -101.88 -19.89 15.1 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.041 0.936 . . . . 0.0 110.413 -174.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.3 m -120.51 164.64 16.12 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-O 122.797 1.284 . . . . 0.0 113.617 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -61.51 -49.65 75.88 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 126.316 1.846 . . . . 0.0 110.978 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.36 78.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.055 0.942 . . . . 0.0 113.511 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -68.91 -52.71 26.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 121.269 -0.895 . . . . 0.0 112.628 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -29.13 69.79 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 120.695 -1.253 . . . . 0.0 112.574 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -53.05 -38.28 62.32 Favored 'General case' 0 C--N 1.346 0.452 0 O-C-N 120.439 -1.413 . . . . 0.0 113.796 167.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -73.49 -37.23 65.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.416 -1.427 . . . . 0.0 112.726 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.404 HD11 ' HA ' ' A' ' 6' ' ' SER . 4.4 mm? -60.2 -24.02 64.47 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.992 1.317 . . . . 0.0 114.493 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.3 tp -67.84 -23.74 65.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.689 -1.257 . . . . 0.0 112.303 172.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 t 55.26 44.01 28.21 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 127.314 2.246 . . . . 0.0 112.936 -175.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.6 85.25 0.02 OUTLIER 'General case' 0 C--N 1.353 0.748 0 C-N-CA 127.17 2.188 . . . . 0.0 113.92 -172.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.452 ' HA3' ' HB1' ' A' ' 41' ' ' ALA . . . 156.73 -41.82 0.55 Allowed Glycine 0 CA--C 1.492 -1.376 0 O-C-N 121.057 -1.027 . . . . 0.0 112.807 -164.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.77 -142.62 16.09 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.6 p -94.28 135.67 27.93 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 O-C-N 120.562 -1.552 . . . . 0.0 110.445 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.1 t -129.79 145.42 56.98 Favored Pre-proline 0 C--N 1.347 0.486 0 CA-C-O 115.81 -2.043 . . . . 0.0 106.783 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -66.22 -2.36 6.88 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 124.428 3.418 . . . . 0.0 117.47 -164.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.69 52.93 0.41 Allowed 'General case' 0 C--N 1.349 0.582 0 C-N-CA 125.293 1.437 . . . . 0.0 112.48 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.3 pt -70.06 140.59 18.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.466 0 O-C-N 120.299 -1.5 . . . . 0.0 114.093 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.1 mt -88.95 33.76 0.78 Allowed 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.132 -0.98 . . . . 0.0 111.282 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -88.69 131.42 35.02 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 119.945 -1.722 . . . . 0.0 109.394 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.16 108.27 7.8 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 122.238 1.018 . . . . 0.0 111.072 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.0 p -107.3 -161.29 0.77 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.569 1.548 . . . . 0.0 111.391 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -150.45 -37.38 0.14 Allowed 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.619 -1.926 . . . . 0.0 109.47 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -133.51 174.85 9.98 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 171.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -74.15 -2.32 24.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 119.141 -2.225 . . . . 0.0 115.273 -172.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.5 m -90.15 -40.28 12.33 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 125.657 1.583 . . . . 0.0 111.934 -173.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.64 -29.8 68.36 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 123.281 1.515 . . . . 0.0 110.897 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 15.3 t -90.71 109.16 32.56 Favored Pre-proline 0 N--CA 1.443 -0.785 0 C-N-CA 125.429 1.492 . . . . 0.0 111.255 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.87 171.73 17.62 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.449 2.099 . . . . 0.0 115.294 -160.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.83 -93.26 1.58 Allowed Glycine 0 C--N 1.347 1.172 0 C-N-CA 124.271 0.939 . . . . 0.0 112.49 173.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB1' ' HA3' ' A' ' 22' ' ' GLY . . . -156.44 24.88 0.35 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 122.964 1.364 . . . . 0.0 111.096 -176.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 54.4 m -88.57 153.37 21.18 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 119.95 -1.719 . . . . 0.0 108.058 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.4 pp -119.83 154.58 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 170.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.3 m -85.11 134.51 34.19 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.1 mtt85 -82.8 168.89 16.71 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.624 -1.297 . . . . 0.0 108.356 167.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -32.8 -43.48 0.18 Allowed Glycine 0 C--N 1.353 1.508 0 N-CA-C 119.33 2.492 . . . . 0.0 119.33 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -74.07 8.43 2.09 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.92 36.38 90.94 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 119.915 -1.741 . . . . 0.0 114.191 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -135.61 147.27 48.6 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 122.08 0.943 . . . . 0.0 108.609 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.1 m -78.45 130.77 36.45 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 125.212 2.434 . . . . 0.0 113.933 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.274 0 N-CA-C 105.716 -2.954 . . . . 0.0 105.716 -177.87 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 20.7 m -120.72 167.27 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 119.496 1.044 . . . . 0.0 109.217 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -141.54 114.83 6.76 Favored Pre-proline 0 C--N 1.35 0.619 0 CA-C-O 116.694 -1.622 . . . . 0.0 108.181 170.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.73 168.12 25.54 Favored 'Trans proline' 0 C--N 1.328 -0.504 0 CA-C-N 123.822 2.401 . . . . 0.0 112.747 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -84.71 159.54 57.82 Favored Pre-proline 0 C--N 1.346 0.439 0 O-C-N 120.891 -1.13 . . . . 0.0 111.698 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -68.48 -25.16 35.56 Favored 'Trans proline' 0 CA--C 1.521 -0.159 0 C-N-CA 122.781 2.32 . . . . 0.0 114.275 -170.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.05 -42.31 99.68 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.238 0.926 . . . . 0.0 110.526 170.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 17.2 tp -72.45 -34.98 68.14 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 120.191 -1.568 . . . . 0.0 113.11 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 33.0 tp -53.3 -42.07 66.26 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.154 -1.591 . . . . 0.0 113.622 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -62.42 -30.85 71.52 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 120.47 -1.394 . . . . 0.0 113.82 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 24.0 tp -67.66 -61.37 1.92 Allowed 'General case' 0 C--N 1.35 0.619 0 C-N-CA 123.672 0.789 . . . . 0.0 110.335 172.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.29 -49.22 61.69 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 126.39 1.876 . . . . 0.0 113.305 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -14.27 61.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 120.088 -1.632 . . . . 0.0 114.871 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -85.34 -6.92 59.2 Favored 'General case' 0 C--N 1.346 0.413 0 O-C-N 120.047 -1.658 . . . . 0.0 112.234 168.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 15.2 t -94.37 -5.62 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.944 1.298 . . . . 0.0 109.061 163.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.98 -13.36 31.76 Favored Glycine 0 C--N 1.354 1.57 0 O-C-N 119.816 -1.802 . . . . 0.0 113.393 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.11 69.59 10.51 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 120.757 -1.437 . . . . 0.0 113.888 -173.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . 0.25 3.3 pm0 -78.68 76.74 5.18 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 119.61 -1.931 . . . . 0.0 110.959 165.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -151.06 124.5 8.93 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 120.815 -1.178 . . . . 0.0 109.239 168.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.89 -49.43 65.91 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 128.165 2.586 . . . . 0.0 113.475 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 22.6 p -94.48 90.22 6.13 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.139 -1.6 . . . . 0.0 114.755 -169.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -104.32 173.21 6.4 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-O 123.67 1.7 . . . . 0.0 114.522 171.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 32.7 m -96.34 159.52 14.9 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 127.281 2.233 . . . . 0.0 109.985 -173.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 2.4 mmt -53.7 -45.96 70.59 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -63.18 -50.0 72.07 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 120.583 -1.323 . . . . 0.0 112.149 170.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -54.49 -42.36 70.65 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -173.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 47.3 t -58.52 -30.91 42.28 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 O-C-N 120.927 -1.108 . . . . 0.0 111.563 175.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.2 -33.37 14.72 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.261 1.025 . . . . 0.0 112.161 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -56.89 -64.68 0.8 Allowed 'General case' 0 C--N 1.352 0.675 0 O-C-N 119.954 -1.716 . . . . 0.0 113.028 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -56.86 -39.86 75.08 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 124.278 1.031 . . . . 0.0 112.221 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 27.1 tp -63.44 -52.66 60.52 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 120.713 -1.242 . . . . 0.0 113.254 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.77 -41.31 93.73 Favored Glycine 0 C--N 1.349 1.276 0 O-C-N 120.099 -1.625 . . . . 0.0 114.022 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -56.52 -43.46 79.8 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 125.732 1.613 . . . . 0.0 112.85 173.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -54.83 -55.65 27.96 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.585 1.154 . . . . 0.0 112.459 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 3.5 mp -63.95 -43.29 97.65 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 O-C-N 120.35 -1.469 . . . . 0.0 112.215 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 45.9 ttm -57.04 -36.38 70.41 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 125.0 1.32 . . . . 0.0 113.352 175.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 26.1 m -86.06 -34.65 20.64 Favored 'General case' 0 C--N 1.344 0.344 0 O-C-N 120.394 -1.441 . . . . 0.0 112.424 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -68.34 -33.89 75.1 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 120.091 -1.631 . . . . 0.0 114.557 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 77.34 50.92 0.04 OUTLIER 'General case' 0 C--N 1.353 0.719 0 C-N-CA 126.608 1.963 . . . . 0.0 111.017 -171.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 95.1 mt -109.8 34.05 4.05 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 122.713 1.244 . . . . 0.0 110.331 169.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -110.52 148.26 32.47 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 163.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -75.48 161.97 28.74 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.277 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . 0.264 35.8 mt-10 -62.9 -47.9 81.28 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 119.995 -1.691 . . . . 0.0 111.261 172.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.21 -43.92 10.65 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.765 1.626 . . . . 0.0 108.638 -164.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -108.81 63.36 0.6 Allowed 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 125.015 1.326 . . . . 0.0 112.235 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -65.25 -7.24 12.17 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 118.898 -2.376 . . . . 0.0 114.627 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -82.69 -8.95 59.57 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.606 1.562 . . . . 0.0 113.88 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 46.4 mm -99.8 128.86 51.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 O-C-N 120.87 -1.144 . . . . 0.0 109.759 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 48.8 t -116.56 128.38 73.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.481 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -90.78 121.46 32.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 120.902 -1.123 . . . . 0.0 109.071 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 58.5 m -116.35 12.68 15.36 Favored 'General case' 0 CA--C 1.51 -0.584 0 O-C-N 121.131 -0.981 . . . . 0.0 110.837 171.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 33.0 p -71.7 131.97 43.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.112 -1.618 . . . . 0.0 108.994 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 76.55 -27.11 0.18 Allowed 'General case' 0 C--N 1.351 0.647 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -74.99 164.92 26.04 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 119.846 -1.784 . . . . 0.0 111.783 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 33.2 tp -67.94 -18.99 64.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.735 2.014 . . . . 0.0 113.013 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.24 -32.38 71.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.27 -1.519 . . . . 0.0 113.005 167.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.87 -33.25 79.29 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 120.115 -1.616 . . . . 0.0 113.813 -174.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -50.87 -57.31 8.78 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.212 2.605 . . . . 0.0 111.833 170.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 3.9 pp -76.65 -21.75 55.01 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -86.13 -37.1 19.12 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.011 -1.055 . . . . 0.0 112.222 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.12 15.48 78.67 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 121.179 -0.95 . . . . 0.0 114.337 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 29.5 m -125.42 159.38 60.48 Favored Pre-proline 0 C--N 1.344 0.343 0 O-C-N 120.99 -1.3 . . . . 0.0 110.214 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.37 -43.73 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.607 1.538 . . . . 0.0 112.653 172.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 54.6 m -151.76 167.0 29.61 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -126.02 177.69 6.2 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.728 0.775 . . . . 0.0 109.727 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 48.3 t -121.94 123.34 41.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 120.979 -1.076 . . . . 0.0 108.758 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.11 -27.43 43.14 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 O-C-N 120.437 -1.414 . . . . 0.0 112.157 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -55.04 -28.67 53.95 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.182 1.393 . . . . 0.0 114.352 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -81.83 52.12 1.87 Allowed 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.255 -1.528 . . . . 0.0 112.959 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -46.94 -45.58 20.84 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 126.741 2.017 . . . . 0.0 114.844 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -72.16 -1.66 15.84 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 126.709 2.004 . . . . 0.0 115.667 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -105.18 -38.35 6.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.443 -1.411 . . . . 0.0 109.176 167.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 30.4 mm -56.43 -52.53 51.34 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 O-C-N 120.946 -1.096 . . . . 0.0 112.727 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -53.33 -38.36 63.14 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 120.284 -1.51 . . . . 0.0 114.053 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 42.4 m -64.37 -35.9 82.38 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 125.689 1.596 . . . . 0.0 113.585 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 54.6 mtt -65.88 -47.01 76.27 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.334 -1.479 . . . . 0.0 111.281 172.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 50.9 mm -56.09 -50.31 70.93 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 C-N-CA 126.062 1.745 . . . . 0.0 113.201 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -63.38 -12.31 29.56 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 119.473 -2.017 . . . . 0.0 115.931 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -96.9 -12.51 23.38 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 119.468 -2.02 . . . . 0.0 112.839 170.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -84.07 -38.51 20.72 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 119.95 -1.719 . . . . 0.0 109.194 170.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 66.2 mt -93.53 -179.89 5.17 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.944 1.697 . . . . 0.0 113.926 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 94.6 t -111.55 128.54 68.0 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 167.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 C--N 1.349 0.56 0 O-C-N 121.19 -0.944 . . . . 0.0 110.916 176.269 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.276 91.7 p . . . . . 0 N--CA 1.531 3.593 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -5.72 74.92 0.0 OUTLIER Glycine 0 C--N 1.363 2.058 0 C-N-CA 129.423 3.392 . . . . 0.0 119.785 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.3 m -116.07 119.02 34.5 Favored 'General case' 0 CA--C 1.506 -0.746 0 O-C-N 120.978 -1.307 . . . . 0.0 108.492 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.56 -161.23 8.88 Favored Glycine 0 CA--C 1.494 -1.243 0 N-CA-C 105.967 -2.853 . . . . 0.0 105.967 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.49 79.69 0.79 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 119.048 1.424 . . . . 0.0 114.313 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 64.2 p -67.56 -16.86 64.41 Favored 'General case' 0 C--N 1.347 0.473 0 O-C-N 119.685 -1.885 . . . . 0.0 113.907 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -77.05 -31.29 56.09 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.995 1.718 . . . . 0.0 113.386 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -175.78 89.17 0.29 Allowed Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.37 137.23 18.56 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 CA-C-N 121.893 1.712 . . . . 0.0 110.232 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.8 t -127.38 -60.4 1.19 Allowed 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.3 m -68.93 170.93 8.82 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 123.674 1.702 . . . . 0.0 115.559 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -73.75 -35.76 65.07 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 119.945 -1.722 . . . . 0.0 114.489 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.87 -45.9 76.66 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 119.601 -1.937 . . . . 0.0 111.466 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -43.47 -66.98 0.31 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 129.048 2.939 . . . . 0.0 112.933 167.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.29 -6.63 53.9 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 120.383 -1.448 . . . . 0.0 114.461 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -74.09 -51.72 14.83 Favored 'General case' 0 C--N 1.346 0.416 0 O-C-N 119.193 -2.192 . . . . 0.0 110.854 165.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -61.36 -35.71 78.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.094 -1.629 . . . . 0.0 115.19 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.85 -15.42 20.89 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.8 tp -62.03 -26.21 68.11 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 120.326 -1.484 . . . . 0.0 113.214 172.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 t 60.22 49.34 7.31 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-O 123.933 1.825 . . . . 0.0 111.047 -169.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.72 89.16 0.55 Allowed 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.394 1.477 . . . . 0.0 112.629 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.515 ' HA3' ' HB1' ' A' ' 41' ' ' ALA . . . 150.11 -48.17 0.59 Allowed Glycine 0 CA--C 1.496 -1.1 0 O-C-N 121.478 -0.764 . . . . 0.0 114.996 -168.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.17 -144.8 17.03 Favored Glycine 0 C--N 1.345 1.033 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -167.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.5 p -110.94 136.81 45.85 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 O-C-N 120.658 -1.495 . . . . 0.0 111.065 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.2 m -100.04 158.54 31.86 Favored Pre-proline 0 C--N 1.35 0.624 0 O-C-N 120.182 -1.574 . . . . 0.0 110.479 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.52 11.19 1.08 Allowed 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.987 2.458 . . . . 0.0 113.118 164.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt 59.81 49.83 7.6 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 126.008 1.723 . . . . 0.0 115.296 171.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.8 pt -63.51 144.7 14.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 -171.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.6 pt? -85.13 20.22 1.98 Allowed 'General case' 0 C--N 1.347 0.471 0 O-C-N 120.679 -1.263 . . . . 0.0 113.825 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -77.28 126.67 31.3 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 119.364 -2.085 . . . . 0.0 111.21 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -78.55 100.82 7.09 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.988 0.899 . . . . 0.0 112.331 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.2 p -96.13 -175.82 3.49 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.494 1.918 . . . . 0.0 111.666 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -124.11 -41.71 2.19 Favored 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 120.16 -1.588 . . . . 0.0 112.303 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -142.0 168.31 20.04 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 103.784 -2.672 . . . . 0.0 103.784 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -68.95 -26.33 65.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 119.476 -2.015 . . . . 0.0 115.778 -167.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 m -50.93 -45.47 60.51 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 126.593 1.957 . . . . 0.0 114.801 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.85 -22.67 65.71 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 128.131 2.573 . . . . 0.0 113.961 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.6 t -103.63 106.78 53.84 Favored Pre-proline 0 C--N 1.353 0.726 0 O-C-N 119.834 -1.791 . . . . 0.0 112.489 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.11 159.37 53.4 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.804 2.336 . . . . 0.0 114.452 -162.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.7 -96.13 1.92 Allowed Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.515 ' HB1' ' HA3' ' A' ' 22' ' ' GLY . . . -161.35 40.61 0.15 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 123.088 1.423 . . . . 0.0 111.116 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.9 m -90.34 178.94 6.0 Favored 'General case' 0 N--CA 1.44 -0.939 0 O-C-N 119.847 -1.783 . . . . 0.0 109.267 -175.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.87 150.71 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 103.211 -2.885 . . . . 0.0 103.211 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.0 m -82.61 127.45 33.38 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.318 1.047 . . . . 0.0 108.368 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -78.36 172.11 14.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.917 -1.114 . . . . 0.0 108.663 170.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.5 -32.61 15.95 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 116.655 1.422 . . . . 0.0 116.655 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -70.03 -9.57 55.73 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.6 20.93 57.47 Favored Glycine 0 C--N 1.349 1.298 0 O-C-N 120.57 -1.331 . . . . 0.0 114.247 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -121.6 146.6 46.81 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 120.607 -1.526 . . . . 0.0 110.616 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.0 m -73.39 133.5 43.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -170.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.714 0 CA-C-O 117.05 -1.972 . . . . 0.0 114.955 173.865 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 94.5 mt . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 19.7 m -121.97 152.31 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 -109.79 117.87 51.34 Favored Pre-proline 0 C--N 1.352 0.679 0 CA-C-O 115.92 -1.99 . . . . 0.0 108.721 172.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.71 167.12 27.02 Favored 'Trans proline' 0 C--N 1.321 -0.897 0 C-N-CA 123.272 2.648 . . . . 0.0 113.19 166.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -78.56 159.04 75.29 Favored Pre-proline 0 C--N 1.351 0.661 0 O-C-N 120.472 -1.393 . . . . 0.0 112.81 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -65.69 -21.68 58.47 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.18 2.586 . . . . 0.0 114.681 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 94.0 mt -70.25 -46.03 65.23 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.131 0.878 . . . . 0.0 111.391 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 18.1 tp -64.68 -33.55 76.22 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 120.993 -1.067 . . . . 0.0 111.809 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 17.9 tp -55.81 -42.07 75.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -65.93 -31.69 72.75 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 119.072 -2.268 . . . . 0.0 113.42 174.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 22.2 tp -66.08 -52.78 45.66 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 121.415 -0.803 . . . . 0.0 111.637 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -54.05 -42.94 69.78 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 124.179 0.992 . . . . 0.0 112.652 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -57.46 -27.18 62.23 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 170.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 21.8 t -78.11 -16.95 57.51 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 120.412 -1.43 . . . . 0.0 112.232 173.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' VAL . . . . . 0.435 HG22 ' CD1' ' B' ' 125' ' ' TYR . 1.5 t -97.76 4.25 9.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 O-C-N 120.561 -1.337 . . . . 0.0 110.75 172.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.89 -19.39 54.2 Favored Glycine 0 C--N 1.353 1.495 0 O-C-N 119.801 -1.812 . . . . 0.0 113.357 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -76.62 75.12 3.31 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 126.212 1.805 . . . . 0.0 112.848 -174.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -89.22 1.82 55.14 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -170.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.88 160.25 30.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.649 -0.657 . . . . 0.0 110.41 172.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -74.14 -59.84 2.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 123.463 1.602 . . . . 0.0 108.822 161.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 29.9 p -71.5 98.44 1.84 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.352 1.861 . . . . 0.0 115.54 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -112.0 -179.61 3.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 123.354 1.549 . . . . 0.0 111.901 167.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 94.4 m -103.69 155.26 18.71 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.19 1.796 . . . . 0.0 108.683 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 92.7 mtp -54.8 -47.15 74.38 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 119.394 -2.066 . . . . 0.0 115.661 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -57.01 -54.33 48.0 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 120.945 -1.097 . . . . 0.0 112.464 168.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -46.77 -50.15 18.64 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 126.009 1.724 . . . . 0.0 115.079 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.7 t -52.49 -48.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 120.051 -1.655 . . . . 0.0 112.804 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.89 -24.55 44.11 Favored 'General case' 0 C--N 1.347 0.477 0 O-C-N 120.464 -1.398 . . . . 0.0 112.891 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -65.22 -62.82 1.31 Allowed 'General case' 0 C--N 1.345 0.394 0 C-N-CA 125.945 1.698 . . . . 0.0 111.105 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -53.92 -41.11 67.32 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 124.313 1.045 . . . . 0.0 111.953 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 21.5 tp -63.43 -55.54 23.46 Favored 'General case' 0 C--N 1.349 0.547 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.79 -42.21 98.61 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 119.552 -1.968 . . . . 0.0 114.345 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -63.59 -28.78 70.16 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.123 1.369 . . . . 0.0 112.303 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.435 ' CD1' HG22 ' B' ' 106' ' ' VAL . 10.5 t80 -61.96 -53.17 59.42 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.683 -1.26 . . . . 0.0 112.405 173.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 2.9 mp -62.58 -43.65 98.66 Favored 'Isoleucine or valine' 0 C--N 1.351 0.65 0 C-N-CA 124.493 1.117 . . . . 0.0 111.306 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 44.5 ttm -50.88 -43.11 59.55 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 125.234 1.413 . . . . 0.0 112.97 172.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 24.4 m -85.25 -30.2 24.01 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 120.496 -1.378 . . . . 0.0 113.334 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.0 -30.0 63.45 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 119.521 -1.987 . . . . 0.0 114.12 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? 76.02 41.53 0.23 Allowed 'General case' 0 C--N 1.352 0.681 0 C-N-CA 125.244 1.418 . . . . 0.0 110.956 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 93.6 mt -104.68 34.0 3.33 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 122.372 1.082 . . . . 0.0 110.845 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -114.96 146.04 41.61 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 165.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.6 151.98 42.04 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 121.189 -0.944 . . . . 0.0 109.264 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.98 -33.52 74.8 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 122.59 1.186 . . . . 0.0 112.004 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -109.92 -28.21 8.86 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 124.345 1.058 . . . . 0.0 112.236 -172.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -109.67 53.79 0.68 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.321 1.848 . . . . 0.0 110.936 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -55.97 -18.38 9.09 Favored 'General case' 0 C--N 1.349 0.56 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -82.84 -5.74 59.12 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.011 1.724 . . . . 0.0 114.877 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 44.1 mm -97.41 123.16 49.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 O-C-N 120.541 -1.349 . . . . 0.0 110.22 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 52.3 t -108.12 129.51 62.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.544 0 O-C-N 120.972 -1.08 . . . . 0.0 108.414 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -95.33 113.79 25.5 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.119 -0.988 . . . . 0.0 109.276 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 63.8 m -118.6 20.85 12.82 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 121.884 0.849 . . . . 0.0 109.986 171.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 34.7 p -76.66 136.65 39.15 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 120.341 -1.474 . . . . 0.0 108.228 170.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 1.2 t30 76.24 -36.06 0.27 Allowed 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -69.26 168.48 14.12 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.64 -1.287 . . . . 0.0 112.661 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 22.9 tp -70.7 -17.54 62.83 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.604 1.562 . . . . 0.0 112.778 -168.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.92 -29.38 66.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.297 -1.502 . . . . 0.0 113.896 168.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.6 -39.0 97.12 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 120.609 -1.307 . . . . 0.0 114.031 -173.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -51.37 -55.3 19.24 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 127.251 2.22 . . . . 0.0 111.816 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 pp -74.62 -27.66 60.55 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 119.867 -1.77 . . . . 0.0 115.098 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -80.81 -40.91 24.19 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 121.387 -0.82 . . . . 0.0 112.114 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.37 22.39 62.76 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 124.162 0.886 . . . . 0.0 113.65 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.74 160.97 66.28 Favored Pre-proline 0 C--N 1.343 0.304 0 O-C-N 121.231 -1.158 . . . . 0.0 108.96 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.04 -51.22 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 121.477 1.563 . . . . 0.0 112.455 170.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 66.8 m -147.93 168.2 22.87 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 119.909 1.232 . . . . 0.0 107.845 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -129.97 173.72 10.44 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.759 0.823 . . . . 0.0 108.864 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 11.4 t -113.74 129.19 56.61 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.18 -1.575 . . . . 0.0 109.859 172.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 35.1 t -60.72 -26.72 39.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.94 0 O-C-N 119.922 -1.736 . . . . 0.0 112.996 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -50.03 -25.2 3.16 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 126.449 1.9 . . . . 0.0 114.694 171.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -91.18 46.7 1.33 Allowed 'General case' 0 N--CA 1.439 -1.007 0 O-C-N 119.502 -1.999 . . . . 0.0 113.687 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -32.66 -55.36 0.36 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 128.279 2.632 . . . . 0.0 117.74 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -59.46 -28.7 67.22 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.037 1.735 . . . . 0.0 115.256 172.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -83.24 -32.57 26.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 119.646 -1.909 . . . . 0.0 112.02 172.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 37.7 mm -54.28 -54.97 17.04 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 O-C-N 120.902 -1.124 . . . . 0.0 110.789 171.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -57.39 -33.61 68.03 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 119.989 -1.694 . . . . 0.0 115.271 171.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 86.4 m -60.65 -35.42 76.17 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.237 -1.54 . . . . 0.0 112.233 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 43.1 mtt -72.85 -48.26 39.11 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.69 -1.257 . . . . 0.0 111.615 172.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 50.9 mm -57.61 -50.39 77.49 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 C-N-CA 124.668 1.187 . . . . 0.0 113.487 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -66.19 -11.08 47.45 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -79.92 -27.13 39.92 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 119.004 -2.31 . . . . 0.0 111.153 170.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -104.69 -2.61 24.74 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 124.298 1.039 . . . . 0.0 110.332 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 43.6 mt -125.93 143.12 51.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.944 2.098 . . . . 0.0 109.567 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 10.7 p -68.86 123.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 O-C-N 119.588 -1.945 . . . . 0.0 113.422 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 54.0 t . . . . . 0 C--N 1.351 0.638 0 C-N-CA 124.667 1.187 . . . . 0.0 110.718 175.58 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.511 2.582 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.71 49.31 77.58 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 119.158 0.89 . . . . 0.0 112.281 -165.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -139.66 96.31 3.06 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 121.356 -1.085 . . . . 0.0 110.046 -167.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.49 -141.1 10.62 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-O 121.882 0.712 . . . . 0.0 113.647 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.99 68.88 6.23 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-O 123.115 1.436 . . . . 0.0 111.614 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 p -69.79 -9.42 54.57 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 126.671 1.988 . . . . 0.0 114.242 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -78.0 -42.86 31.27 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.738 1.215 . . . . 0.0 112.124 171.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -166.83 89.13 0.78 Allowed Pre-proline 0 N--CA 1.448 -0.535 0 O-C-N 121.529 -0.732 . . . . 0.0 110.035 -173.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.44 115.46 2.87 Favored 'Trans proline' 0 C--N 1.329 -0.474 0 C-N-CA 122.32 2.013 . . . . 0.0 112.211 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -116.11 -31.91 5.54 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 119.109 0.868 . . . . 0.0 113.248 -170.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.8 m -105.31 176.96 4.99 Favored 'General case' 0 C--N 1.345 0.387 0 O-C-N 119.472 -2.017 . . . . 0.0 111.397 167.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -63.86 -40.42 96.51 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 119.805 -1.81 . . . . 0.0 113.408 -176.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.55 -44.45 85.24 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.571 1.948 . . . . 0.0 113.529 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -55.87 -58.99 5.54 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.033 1.333 . . . . 0.0 114.401 170.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.42 -29.98 69.33 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -37.18 52.93 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 124.933 1.293 . . . . 0.0 113.897 173.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -101.06 18.87 18.62 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 121.025 -1.047 . . . . 0.0 112.22 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.62 -29.04 13.27 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.448 1.099 . . . . 0.0 110.007 165.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.6 -29.13 69.02 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 122.423 1.106 . . . . 0.0 112.38 171.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 m 65.85 43.56 3.06 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 125.797 1.639 . . . . 0.0 112.555 174.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.61 93.49 0.01 OUTLIER 'General case' 0 C--N 1.351 0.646 0 C-N-CA 127.215 2.206 . . . . 0.0 116.778 -170.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.523 ' HA3' ' HB1' ' A' ' 41' ' ' ALA . . . 158.29 -47.34 0.44 Allowed Glycine 0 CA--C 1.491 -1.423 0 C-N-CA 119.796 -1.193 . . . . 0.0 115.019 -171.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.17 -121.14 4.32 Favored Glycine 0 CA--C 1.499 -0.933 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -171.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 p -129.65 143.47 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 O-C-N 121.055 -1.262 . . . . 0.0 108.327 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 62.8 m -104.24 162.19 20.64 Favored Pre-proline 0 C--N 1.346 0.444 0 O-C-N 120.278 -1.514 . . . . 0.0 110.45 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.1 -26.46 57.75 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.576 2.184 . . . . 0.0 112.076 168.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 79.82 78.77 0.05 OUTLIER 'General case' 0 C--N 1.354 0.768 0 C-N-CA 127.605 2.362 . . . . 0.0 110.507 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.8 pt -80.73 140.77 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 O-C-N 120.93 -1.106 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.1 pp -83.33 6.62 19.19 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 122.354 1.073 . . . . 0.0 112.394 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -63.02 132.02 50.57 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 125.112 1.365 . . . . 0.0 111.545 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -74.26 141.14 45.36 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.286 -0.884 . . . . 0.0 111.577 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.0 p -132.7 169.0 17.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 120.777 -1.202 . . . . 0.0 109.563 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -116.56 -37.25 3.74 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 120.012 -1.68 . . . . 0.0 110.683 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -141.61 -171.92 3.42 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.226 1.01 . . . . 0.0 108.622 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.42 -7.1 48.01 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 119.224 -2.172 . . . . 0.0 112.875 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 p -81.38 -40.03 24.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.719 2.008 . . . . 0.0 113.098 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.52 -28.0 68.87 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-O 122.618 1.199 . . . . 0.0 113.042 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.7 t -99.11 108.73 51.21 Favored Pre-proline 0 N--CA 1.443 -0.799 0 C-N-CA 124.107 0.963 . . . . 0.0 112.224 -164.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.77 151.55 57.57 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.113 1.875 . . . . 0.0 113.457 -168.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.09 -120.91 7.01 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.523 ' HB1' ' HA3' ' A' ' 22' ' ' GLY . . . -136.91 41.98 2.47 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.343 1.544 . . . . 0.0 110.149 176.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.1 m -107.85 112.82 25.64 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.014 -1.678 . . . . 0.0 110.736 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.8 pp -76.31 145.51 10.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 O-C-N 120.199 -1.563 . . . . 0.0 112.203 173.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.4 t -80.41 134.95 36.07 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.181 1.392 . . . . 0.0 110.063 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -86.14 167.5 14.87 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 119.56 -1.962 . . . . 0.0 110.869 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -37.34 -45.6 1.3 Allowed Glycine 0 C--N 1.356 1.664 0 C-N-CA 126.898 2.189 . . . . 0.0 118.13 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -62.75 -19.19 63.72 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.2 33.54 8.73 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 120.464 -1.398 . . . . 0.0 112.991 -172.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -139.46 142.37 37.38 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.018 -1.284 . . . . 0.0 107.631 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.95 125.18 27.0 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-O 123.397 1.57 . . . . 0.0 114.272 -173.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.343 0 O-C-N 119.946 -1.721 . . . . 0.0 113.354 -176.336 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.505 2.276 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.18 156.58 40.37 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 mtt-85 -113.73 113.0 47.76 Favored Pre-proline 0 C--N 1.348 0.516 0 CA-C-O 116.526 -1.702 . . . . 0.0 110.578 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.13 166.01 30.57 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 CA-C-N 124.355 2.591 . . . . 0.0 113.09 164.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -82.73 159.05 64.43 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.879 0.872 . . . . 0.0 112.834 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.22 -21.01 36.62 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.881 2.387 . . . . 0.0 114.734 -174.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 93.0 mt -67.37 -43.95 80.18 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 119.799 1.181 . . . . 0.0 111.112 173.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 28.7 tp -64.71 -40.45 95.38 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 124.089 0.956 . . . . 0.0 112.403 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 34.8 tp -49.41 -39.53 33.05 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.38 -32.26 72.21 Favored 'General case' 0 C--N 1.35 0.601 0 O-C-N 119.434 -2.041 . . . . 0.0 113.291 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tt -71.41 -49.88 37.5 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 121.52 -0.737 . . . . 0.0 110.442 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 96.4 mt -52.04 -44.16 64.1 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 124.658 1.183 . . . . 0.0 113.8 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -54.18 -36.15 63.09 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 120.415 -1.428 . . . . 0.0 114.321 169.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.8 t -73.92 -6.74 49.08 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.158 1.383 . . . . 0.0 112.231 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 1.6 t -108.64 7.52 9.28 Favored 'Isoleucine or valine' 0 C--N 1.35 0.616 0 C-N-CA 124.986 1.315 . . . . 0.0 110.718 167.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.82 -23.11 37.41 Favored Glycine 0 C--N 1.351 1.38 0 O-C-N 119.018 -2.301 . . . . 0.0 114.114 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.02 68.48 4.98 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.971 1.708 . . . . 0.0 112.812 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -81.67 4.92 19.99 Favored 'General case' 0 C--N 1.343 0.3 0 O-C-N 120.074 -1.641 . . . . 0.0 114.75 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -83.7 146.98 27.92 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.045 0.938 . . . . 0.0 109.629 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -70.22 -48.41 57.17 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 122.99 1.376 . . . . 0.0 111.058 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 40.7 p -84.05 110.16 18.24 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -128.4 -166.83 1.68 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.687 1.195 . . . . 0.0 110.484 168.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 50.6 p -117.99 175.47 5.66 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 119.595 -1.94 . . . . 0.0 111.362 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 46.0 mtt -57.33 -41.25 79.59 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 120.475 -1.391 . . . . 0.0 113.591 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -52.97 61.1 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.388 1.075 . . . . 0.0 110.618 174.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.73 -31.64 63.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -171.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 67.6 t -55.29 -37.01 42.39 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 O-C-N 120.065 -1.647 . . . . 0.0 111.246 171.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -89.85 -24.76 21.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.733 -1.229 . . . . 0.0 113.635 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -66.77 -56.88 8.51 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.039 -1.663 . . . . 0.0 112.916 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -61.26 -41.96 97.82 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 120.961 -1.087 . . . . 0.0 111.153 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 34.6 tp -57.88 -49.88 75.2 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 120.306 -1.497 . . . . 0.0 113.518 172.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.45 -47.92 79.86 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 120.299 -1.5 . . . . 0.0 114.321 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -58.42 -40.6 82.94 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.184 0.993 . . . . 0.0 113.618 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -58.33 -55.68 31.86 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.735 1.214 . . . . 0.0 113.633 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -68.68 -39.1 79.84 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 O-C-N 120.409 -1.432 . . . . 0.0 111.647 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 55.2 ttm -54.51 -48.33 72.05 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 122.443 1.116 . . . . 0.0 112.37 173.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 38.6 m -70.73 -29.56 65.86 Favored 'General case' 0 C--N 1.344 0.351 0 O-C-N 120.819 -1.176 . . . . 0.0 112.965 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -81.59 -23.15 37.26 Favored 'General case' 0 C--N 1.346 0.433 0 O-C-N 119.022 -2.299 . . . . 0.0 115.61 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? 72.29 49.3 0.22 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 125.343 1.457 . . . . 0.0 112.354 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 2.2 tt -95.85 -27.42 15.21 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 120.326 -1.484 . . . . 0.0 113.029 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -69.01 142.06 54.71 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.021 -1.674 . . . . 0.0 111.756 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.5 137.37 53.44 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.017 0.927 . . . . 0.0 113.302 167.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -64.32 -31.84 73.2 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 120.317 -1.489 . . . . 0.0 113.04 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -96.86 -32.82 11.89 Favored 'General case' 0 C--N 1.347 0.497 0 O-C-N 120.871 -1.143 . . . . 0.0 113.291 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.34 56.59 0.75 Allowed 'General case' 0 C--N 1.351 0.647 0 O-C-N 120.347 -1.471 . . . . 0.0 112.736 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 9.8 pm0 -60.92 5.46 0.05 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 118.655 2.835 . . . . 0.0 118.655 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -102.42 -6.54 22.86 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 119.849 -1.782 . . . . 0.0 111.704 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 49.1 mm -92.34 138.55 19.69 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 C-N-CA 125.27 1.428 . . . . 0.0 109.433 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.33 120.95 30.31 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 O-C-N 120.649 -1.282 . . . . 0.0 108.279 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -105.9 78.6 1.34 Allowed 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 120.535 -1.353 . . . . 0.0 112.795 -171.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 61.5 m -86.34 37.81 0.75 Allowed 'General case' 0 C--N 1.349 0.549 0 O-C-N 119.959 -1.713 . . . . 0.0 114.408 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 11.1 t -88.51 129.64 35.41 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 119.562 -1.961 . . . . 0.0 107.436 165.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 70.08 43.93 0.83 Allowed 'General case' 0 C--N 1.349 0.577 0 CA-C-O 122.878 1.323 . . . . 0.0 111.619 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -141.32 166.12 25.63 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 18.1 tp -83.67 -9.94 58.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.583 1.153 . . . . 0.0 112.651 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 10.1 mp -76.99 -31.23 56.34 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 119.498 -2.001 . . . . 0.0 110.658 164.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.42 -44.05 96.95 Favored Glycine 0 C--N 1.351 1.366 0 C-N-CA 125.279 1.419 . . . . 0.0 114.565 -174.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -46.08 -62.3 1.39 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.036 2.535 . . . . 0.0 112.102 169.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 4.2 pp -78.3 -18.46 55.21 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -172.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -81.22 -48.44 12.06 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.849 -1.157 . . . . 0.0 111.549 168.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.06 29.26 26.11 Favored Glycine 0 C--N 1.352 1.425 0 C-N-CA 124.829 1.204 . . . . 0.0 113.698 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.48 156.26 76.55 Favored Pre-proline 0 C--N 1.346 0.43 0 O-C-N 120.952 -1.322 . . . . 0.0 109.452 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.26 -10.33 13.65 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 CA-C-N 122.363 1.88 . . . . 0.0 112.982 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 10.0 p -178.92 171.36 1.42 Allowed 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -175.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.06 170.65 15.33 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 170.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 40.6 t -114.5 133.93 55.4 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 171.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.92 -39.9 81.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 O-C-N 121.456 -0.778 . . . . 0.0 112.276 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -54.22 -26.39 28.24 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -81.76 66.2 7.22 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 119.884 -1.76 . . . . 0.0 110.544 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -53.49 -46.23 69.93 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 125.848 1.659 . . . . 0.0 113.05 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 81.3 ttt180 -56.38 -29.45 61.46 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 127.051 2.141 . . . . 0.0 114.252 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -78.17 -42.93 30.09 Favored 'General case' 0 CA--C 1.512 -0.505 0 O-C-N 120.173 -1.579 . . . . 0.0 111.844 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 48.1 mm -56.79 -50.11 76.07 Favored 'Isoleucine or valine' 0 C--N 1.347 0.463 0 C-N-CA 124.043 0.937 . . . . 0.0 111.951 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -51.06 -43.73 61.03 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 120.742 -1.224 . . . . 0.0 113.84 168.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 52.9 m -65.45 -33.56 76.23 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 121.083 -1.011 . . . . 0.0 112.893 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -68.22 -48.51 64.97 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 118.88 -2.387 . . . . 0.0 112.697 167.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.7 -50.83 76.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 C-N-CA 124.783 1.233 . . . . 0.0 112.715 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -66.68 -12.07 56.76 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 119.232 -2.168 . . . . 0.0 115.143 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -85.93 -9.04 57.57 Favored 'General case' 0 C--N 1.351 0.663 0 O-C-N 119.596 -1.94 . . . . 0.0 112.215 169.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -96.09 -36.04 11.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 120.3 -1.5 . . . . 0.0 109.36 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 71.4 mt -92.85 161.33 14.54 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.36 1.464 . . . . 0.0 113.653 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.85 126.58 61.25 Favored 'Isoleucine or valine' 0 C--N 1.345 0.389 0 O-C-N 120.7 -1.25 . . . . 0.0 107.733 171.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 C--N 1.346 0.447 0 O-C-N 121.249 -0.907 . . . . 0.0 110.668 178.911 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.517 2.915 0 CA-C-O 117.238 -1.363 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 52.25 45.21 58.02 Favored Glycine 0 C--N 1.357 1.715 0 CA-C-N 120.18 1.354 . . . . 0.0 114.094 -170.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.2 t -152.43 134.39 14.85 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 120.691 -1.476 . . . . 0.0 109.197 -172.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.78 -137.14 3.45 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 122.368 0.982 . . . . 0.0 111.63 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.31 68.14 8.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.04 -1.859 . . . . 0.0 113.173 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 t -59.32 -13.2 7.26 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.613 1.565 . . . . 0.0 114.571 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.6 -30.17 22.02 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.81 1.644 . . . . 0.0 114.337 175.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 174.53 89.6 0.07 OUTLIER Pre-proline 0 C--N 1.35 0.626 0 C-N-CA 124.986 1.314 . . . . 0.0 108.505 -171.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.01 118.57 4.09 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.344 2.03 . . . . 0.0 112.282 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t -113.29 -4.45 13.69 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 122.588 1.185 . . . . 0.0 110.11 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t -126.21 162.62 25.01 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.069 -1.644 . . . . 0.0 113.44 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -61.62 -48.34 81.36 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 120.449 -1.407 . . . . 0.0 111.932 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.81 86.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.553 1.541 . . . . 0.0 112.786 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -63.08 -54.7 33.86 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.783 -1.198 . . . . 0.0 113.656 173.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.63 -31.19 70.17 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.734 0.778 . . . . 0.0 112.239 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -53.63 -49.6 67.52 Favored 'General case' 0 C--N 1.346 0.416 0 O-C-N 119.959 -1.713 . . . . 0.0 113.164 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -67.44 -30.16 69.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.525 -1.359 . . . . 0.0 113.862 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.97 -27.94 65.86 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 125.897 1.679 . . . . 0.0 114.295 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.7 tp -61.9 -25.33 67.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.228 1.011 . . . . 0.0 113.607 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 t 56.43 40.79 29.52 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 124.632 2.158 . . . . 0.0 112.977 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.419 ' HB1' ' HG ' ' B' ' 119' ' ' LEU . . . -64.87 92.6 0.1 Allowed 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.258 1.423 . . . . 0.0 113.526 -177.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.95 -40.66 0.8 Allowed Glycine 0 CA--C 1.496 -1.111 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -173.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.04 -144.62 16.94 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.7 m -93.79 139.84 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 120.211 -1.758 . . . . 0.0 111.102 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.62 156.66 45.87 Favored Pre-proline 0 N--CA 1.45 -0.465 0 O-C-N 120.569 -1.332 . . . . 0.0 109.347 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.59 -10.12 24.83 Favored 'Trans proline' 0 CA--C 1.519 -0.239 0 C-N-CA 122.872 2.382 . . . . 0.0 112.894 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 mptt 64.91 51.82 1.69 Allowed 'General case' 0 C--N 1.349 0.573 0 C-N-CA 126.019 1.728 . . . . 0.0 113.198 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.9 pt -64.89 143.59 15.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 mt -86.24 25.59 1.16 Allowed 'General case' 0 C--N 1.345 0.4 0 C-N-CA 124.877 1.271 . . . . 0.0 111.746 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -80.67 135.19 35.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 120.181 -1.574 . . . . 0.0 110.456 174.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -74.26 126.27 30.27 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 121.83 0.824 . . . . 0.0 111.747 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 p -118.06 -177.53 3.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 120.628 -1.295 . . . . 0.0 110.03 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 -122.05 -21.43 5.97 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 119.85 -1.781 . . . . 0.0 110.968 162.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -157.73 169.2 25.17 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 120.405 -1.434 . . . . 0.0 109.738 -176.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -52.26 -46.13 65.68 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 127.742 2.417 . . . . 0.0 111.656 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.0 m -55.59 -18.26 7.27 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 118.147 2.647 . . . . 0.0 118.147 170.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -93.87 -6.91 44.64 Favored 'General case' 0 C--N 1.345 0.388 0 O-C-N 120.46 -1.4 . . . . 0.0 111.083 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.33 127.47 26.79 Favored Pre-proline 0 C--N 1.349 0.573 0 O-C-N 120.523 -1.36 . . . . 0.0 110.327 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.47 163.33 36.37 Favored 'Trans proline' 0 C--N 1.324 -0.711 0 C-N-CA 122.067 1.845 . . . . 0.0 114.169 -169.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.86 -78.9 1.91 Allowed Glycine 0 C--N 1.348 1.207 0 O-C-N 121.349 -0.844 . . . . 0.0 113.097 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.23 24.82 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 122.377 1.084 . . . . 0.0 111.652 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.1 m -98.16 116.89 31.33 Favored 'General case' 0 C--O 1.215 -0.74 0 O-C-N 119.523 -1.986 . . . . 0.0 112.435 -162.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.57 150.06 6.75 Favored 'Isoleucine or valine' 0 C--N 1.346 0.426 0 O-C-N 118.429 -2.67 . . . . 0.0 113.665 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.29 125.32 29.19 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.804 0.842 . . . . 0.0 108.881 168.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -85.94 179.67 6.96 Favored 'General case' 0 C--N 1.345 0.412 0 O-C-N 120.032 -1.668 . . . . 0.0 110.655 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.24 -5.3 20.47 Favored Glycine 0 C--N 1.353 1.525 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -96.26 -6.15 38.64 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.201 -1.176 . . . . 0.0 112.501 170.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.59 18.28 64.29 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 121.01 -1.056 . . . . 0.0 113.787 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -128.04 146.4 50.69 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 123.083 1.42 . . . . 0.0 110.743 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 80.5 m -67.87 160.71 27.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 123.491 1.615 . . . . 0.0 113.081 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.958 0 O-C-N 119.3 -2.125 . . . . 0.0 116.846 -174.927 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 99.2 mt . . . . . 0 N--CA 1.506 2.329 0 CA-C-O 118.225 -0.893 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 15.2 m -133.47 165.44 32.14 Favored 'Isoleucine or valine' 0 C--N 1.344 0.361 0 CA-C-N 119.274 0.943 . . . . 0.0 109.271 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -114.0 101.82 54.28 Favored Pre-proline 0 C--N 1.345 0.41 0 CA-C-O 116.986 -1.483 . . . . 0.0 110.676 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.95 165.57 29.55 Favored 'Trans proline' 0 C--N 1.326 -0.609 0 C-N-CA 123.228 2.619 . . . . 0.0 114.242 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -87.16 153.2 53.94 Favored Pre-proline 0 C--N 1.351 0.653 0 O-C-N 120.967 -1.083 . . . . 0.0 111.961 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.06 -21.82 42.38 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.536 2.824 . . . . 0.0 113.436 -173.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 89.0 mt -70.14 -47.12 63.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.166 -0.959 . . . . 0.0 110.984 171.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 34.6 tp -65.17 -33.89 77.09 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 124.584 1.154 . . . . 0.0 113.062 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 14.7 tp -48.42 -41.68 29.92 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.326 1.45 . . . . 0.0 113.956 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -65.4 -36.88 85.29 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 119.844 -1.785 . . . . 0.0 114.328 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.492 HD13 HD13 ' B' ' 147' ' ' LEU . 1.1 tt -70.23 -50.22 42.09 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.656 0.782 . . . . 0.0 111.074 173.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 40.2 mt -52.16 -44.91 64.83 Favored 'General case' 0 C--N 1.35 0.617 0 C-N-CA 124.567 1.147 . . . . 0.0 112.702 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -57.4 -34.57 69.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 55.6 m -71.35 -15.49 62.39 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 124.558 1.143 . . . . 0.0 113.323 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.21 -7.38 9.62 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 124.351 1.06 . . . . 0.0 110.311 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.97 -26.47 7.9 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 120.106 -1.621 . . . . 0.0 112.36 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.41 74.47 7.28 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 126.006 1.723 . . . . 0.0 113.947 -170.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -83.57 12.03 6.3 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 -174.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -99.74 127.06 45.89 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.204 -0.935 . . . . 0.0 112.793 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.44 -9.42 0.3 Allowed 'General case' 0 C--N 1.348 0.515 0 N-CA-C 117.881 2.549 . . . . 0.0 117.881 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 67.4 p -137.11 127.04 25.77 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 119.064 -2.273 . . . . 0.0 111.158 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -129.03 -177.82 4.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 120.46 -1.4 . . . . 0.0 110.462 173.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.8 m -96.85 161.55 13.8 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.156 1.383 . . . . 0.0 108.189 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 1.1 mmm -60.04 -44.96 94.29 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 119.794 -1.816 . . . . 0.0 113.837 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -58.4 -51.87 68.0 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.136 0.974 . . . . 0.0 113.605 170.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -48.66 -49.65 36.5 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 126.504 1.921 . . . . 0.0 114.68 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 40.1 t -54.03 -46.32 65.64 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 O-C-N 120.674 -1.266 . . . . 0.0 112.355 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' LEU . . . . . 0.419 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 4.2 mm? -72.11 -38.19 69.37 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.26 1.024 . . . . 0.0 112.325 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -56.25 -59.53 4.8 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.803 1.641 . . . . 0.0 112.79 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -58.02 -41.6 83.49 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 123.903 0.881 . . . . 0.0 112.028 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 26.4 tp -63.17 -52.22 63.26 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 173.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.5 -44.89 95.98 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 119.481 -2.012 . . . . 0.0 113.092 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -60.57 -30.28 69.69 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 124.379 1.071 . . . . 0.0 113.182 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -56.74 -60.25 3.83 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 124.429 1.092 . . . . 0.0 111.613 171.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mt -59.6 -42.87 89.67 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 O-C-N 120.292 -1.505 . . . . 0.0 113.794 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -51.02 -48.24 61.48 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 124.683 1.193 . . . . 0.0 113.556 170.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 40.5 m -78.64 -39.53 36.75 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 120.351 -1.468 . . . . 0.0 112.671 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -74.74 -21.47 59.33 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 126.163 1.785 . . . . 0.0 114.538 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 69.48 50.82 0.5 Allowed 'General case' 0 C--N 1.348 0.541 0 C-N-CA 125.821 1.648 . . . . 0.0 112.394 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 51.8 mt -107.46 18.65 21.28 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 123.782 0.833 . . . . 0.0 111.751 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -105.97 150.04 26.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -81.74 141.65 33.36 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.2 -31.72 72.94 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 121.028 -1.045 . . . . 0.0 113.187 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.76 -29.02 12.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 120.743 -1.223 . . . . 0.0 112.323 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -114.88 69.04 0.71 Allowed 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.097 -1.627 . . . . 0.0 112.641 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -73.41 -2.77 23.68 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 119.896 -1.752 . . . . 0.0 113.992 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -87.15 -10.19 53.35 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.589 1.955 . . . . 0.0 113.033 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 48.3 mm -98.59 134.0 38.89 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 125.497 1.519 . . . . 0.0 109.96 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 48.0 t -117.13 126.89 74.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 O-C-N 120.905 -1.122 . . . . 0.0 111.096 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -82.93 101.6 11.15 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.501 1.12 . . . . 0.0 111.762 173.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 18.3 m -107.14 3.46 25.75 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-O 122.06 0.934 . . . . 0.0 111.69 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 79.0 p -72.91 124.32 25.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 119.744 -1.847 . . . . 0.0 110.897 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 5.3 t30 79.57 18.85 0.72 Allowed 'General case' 0 C--N 1.35 0.621 0 C-N-CA 124.612 1.165 . . . . 0.0 112.478 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -112.06 169.98 8.47 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 124.691 1.196 . . . . 0.0 108.978 172.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' LEU . . . . . 0.404 HD23 ' HB2' ' B' ' 102' ' ' LEU . 16.5 tp -69.97 -22.9 63.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.601 1.96 . . . . 0.0 112.657 178.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 147' ' ' LEU . . . . . 0.492 HD13 HD13 ' B' ' 102' ' ' LEU . 2.0 mp -66.46 -34.61 78.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 119.899 -1.751 . . . . 0.0 113.105 167.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.66 -37.77 92.79 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 120.554 -1.341 . . . . 0.0 114.117 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.41 -49.17 70.58 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.722 2.409 . . . . 0.0 112.845 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 1.3 pp -83.51 -28.02 28.96 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 119.35 -2.093 . . . . 0.0 113.918 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.648 ' HB3' HG22 ' B' ' 153' ' ' VAL . 9.3 m-85 -79.6 -41.02 27.99 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 125.141 1.377 . . . . 0.0 112.856 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 78.58 14.4 82.15 Favored Glycine 0 C--N 1.35 1.339 0 C-N-CA 124.189 0.899 . . . . 0.0 114.183 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' VAL . . . . . 0.648 HG22 ' HB3' ' B' ' 151' ' ' PHE . 33.2 m -131.15 151.27 78.61 Favored Pre-proline 0 C--N 1.345 0.403 0 O-C-N 120.828 -1.396 . . . . 0.0 110.382 -174.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.92 -26.92 10.61 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 121.965 1.777 . . . . 0.0 112.02 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 27.8 p -159.49 164.54 34.35 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 120.729 -1.232 . . . . 0.0 109.231 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -139.86 160.54 39.67 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 120.241 -1.537 . . . . 0.0 109.182 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 4.5 t -112.17 134.68 53.58 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.44 -33.7 65.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.72 -25.47 2.99 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -80.36 55.88 2.37 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.037 -1.664 . . . . 0.0 111.255 176.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -51.87 -47.39 64.52 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 119.999 -1.688 . . . . 0.0 114.235 -172.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -57.09 -38.46 73.38 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 125.842 1.657 . . . . 0.0 113.271 172.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 18.1 ttpt -66.47 -51.33 57.9 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.235 -1.541 . . . . 0.0 110.598 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 50.9 mm -50.44 -54.65 8.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 C-N-CA 125.566 1.546 . . . . 0.0 112.826 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -51.76 -46.67 64.17 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 9.9 m -59.2 -42.67 91.48 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.627 -1.296 . . . . 0.0 112.453 176.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 3.5 mtp -72.06 -22.88 61.31 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.507 -1.371 . . . . 0.0 113.577 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.45 -52.05 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 O-C-N 121.115 -0.991 . . . . 0.0 110.478 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -57.09 -24.73 56.1 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.25 -12.4 60.0 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.91 -1.744 . . . . 0.0 114.488 173.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -103.05 -13.54 16.8 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 119.945 -1.722 . . . . 0.0 111.381 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 82.6 mt -109.8 155.4 21.68 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.928 1.291 . . . . 0.0 110.541 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 38.8 t -100.58 117.79 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 O-C-N 120.1 -1.625 . . . . 0.0 108.685 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.35 0.591 0 C-N-CA 124.172 0.989 . . . . 0.0 111.022 178.787 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.526 3.336 0 N-CA-C 119.39 3.107 . . . . 0.0 119.39 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.54 15.22 65.89 Favored Glycine 0 C--N 1.355 1.588 0 N-CA-C 115.836 1.094 . . . . 0.0 115.836 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.1 t -140.24 144.04 36.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.51 -129.91 2.51 Favored Glycine 0 C--N 1.346 1.128 0 C-N-CA 125.061 1.315 . . . . 0.0 110.112 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.0 72.53 10.07 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 120.219 -1.753 . . . . 0.0 112.397 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.3 p -68.21 -15.21 63.49 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -173.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -82.39 -38.1 24.61 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.971 1.309 . . . . 0.0 111.91 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -166.79 92.36 0.75 Allowed Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.14 105.69 1.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.078 1.852 . . . . 0.0 111.398 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -103.92 -17.3 15.07 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.74 1.216 . . . . 0.0 112.187 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.4 m -109.76 173.13 6.46 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 123.566 1.65 . . . . 0.0 112.406 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -73.44 -42.23 62.23 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 119.262 -2.149 . . . . 0.0 113.733 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.43 78.46 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 120.315 -1.49 . . . . 0.0 112.878 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -59.16 -58.99 6.22 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 125.975 1.71 . . . . 0.0 113.049 169.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.97 -22.96 65.0 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 120.815 -1.178 . . . . 0.0 113.537 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -62.15 -42.04 98.87 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 119.906 -1.746 . . . . 0.0 112.415 167.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -70.3 -33.73 71.88 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 120.231 -1.543 . . . . 0.0 114.019 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.19 -25.76 61.97 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.98 -14.28 52.74 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.397 1.079 . . . . 0.0 113.431 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.347 94.4 p 56.79 25.67 10.57 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 128.047 2.539 . . . . 0.0 113.913 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.32 91.14 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 128.316 2.647 . . . . 0.0 115.817 -167.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.27 -29.9 1.9 Allowed Glycine 0 C--N 1.344 1.02 0 O-C-N 121.382 -0.824 . . . . 0.0 112.174 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.16 -160.54 17.6 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 122.81 1.228 . . . . 0.0 112.786 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.79 102.89 12.58 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 O-C-N 120.31 -1.7 . . . . 0.0 110.895 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.9 t -80.76 151.79 71.44 Favored Pre-proline 0 C--N 1.348 0.52 0 O-C-N 120.127 -1.608 . . . . 0.0 110.457 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -67.05 -8.86 23.07 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.09 2.527 . . . . 0.0 115.096 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt 70.32 51.88 0.37 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 125.454 1.502 . . . . 0.0 113.341 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.7 pt -67.89 145.66 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 122.872 1.32 . . . . 0.0 113.663 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.1 mp -91.05 28.75 1.52 Allowed 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.475 -1.391 . . . . 0.0 110.661 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -82.03 133.25 35.28 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 120.504 -1.372 . . . . 0.0 110.432 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -80.5 113.87 18.99 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 121.37 -0.832 . . . . 0.0 110.918 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.404 ' HB2' ' H ' ' A' ' 33' ' ' ARG . 1.6 p -103.91 -141.53 0.36 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.688 1.595 . . . . 0.0 110.817 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.404 ' H ' ' HB2' ' A' ' 32' ' ' CYS . 34.0 ptt180 -169.61 -39.67 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 120.676 -1.265 . . . . 0.0 107.999 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' A' ' 36' ' ' SER . 12.7 tpp85 -125.46 169.29 12.54 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 172.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -71.43 -14.81 62.27 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 119.819 -1.801 . . . . 0.0 113.814 173.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.415 ' H ' ' HG3' ' A' ' 34' ' ' ARG . 18.2 m -61.77 -48.0 82.64 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 126.522 1.929 . . . . 0.0 113.876 173.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.76 -0.56 13.6 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.888 -1.133 . . . . 0.0 113.997 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.7 t -118.7 107.99 41.8 Favored Pre-proline 0 C--N 1.353 0.726 0 O-C-N 119.955 -1.716 . . . . 0.0 111.751 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.35 170.47 19.82 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.767 2.311 . . . . 0.0 115.653 -159.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.11 -90.54 1.67 Allowed Glycine 0 C--N 1.349 1.259 0 C-N-CA 124.181 0.895 . . . . 0.0 113.035 172.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.03 16.06 0.84 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 123.079 1.419 . . . . 0.0 110.54 -177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 32.9 m -76.92 168.36 20.23 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 119.859 -1.776 . . . . 0.0 111.461 -172.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.27 148.38 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 160.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.5 t -77.26 128.38 34.23 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.099 1.759 . . . . 0.0 107.133 171.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -84.79 -179.39 7.09 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 119.973 -1.704 . . . . 0.0 109.249 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.12 -11.03 24.04 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 116.394 1.318 . . . . 0.0 116.394 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -87.06 -7.41 58.11 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 120.704 -1.468 . . . . 0.0 113.374 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.74 13.8 74.55 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 120.71 -1.244 . . . . 0.0 114.259 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -124.18 152.08 43.29 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.134 -1.215 . . . . 0.0 109.765 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 29.2 m -78.91 93.78 5.1 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -166.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.294 0 O-C-N 119.526 -1.984 . . . . 0.0 116.624 -179.694 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.504 2.267 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.8 160.88 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -116.31 117.79 38.31 Favored Pre-proline 0 C--N 1.348 0.53 0 CA-C-O 115.964 -1.97 . . . . 0.0 109.822 170.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.09 -179.28 3.78 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.092 2.528 . . . . 0.0 114.132 169.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.03 159.74 28.65 Favored Pre-proline 0 C--N 1.351 0.634 0 C-N-CA 125.485 1.514 . . . . 0.0 110.609 175.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.99 -26.83 30.86 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.907 2.405 . . . . 0.0 114.098 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.97 -55.54 24.98 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 119.556 1.071 . . . . 0.0 110.942 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 18.5 tp -59.62 -35.62 74.72 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 120.892 -1.13 . . . . 0.0 113.282 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 17.5 tp -56.44 -40.77 75.33 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 120.605 -1.309 . . . . 0.0 114.485 175.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -65.52 -32.33 73.87 Favored 'General case' 0 C--N 1.346 0.442 0 O-C-N 120.002 -1.686 . . . . 0.0 113.613 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 10.2 tt -67.94 -46.26 72.0 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.402 -0.811 . . . . 0.0 110.94 170.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -52.15 -47.62 65.35 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 121.268 -0.895 . . . . 0.0 112.83 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -58.58 -24.99 62.1 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.273 -1.517 . . . . 0.0 114.282 173.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 11.7 t -83.38 -9.64 58.92 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 120.303 -1.498 . . . . 0.0 113.753 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 4.5 t -107.76 16.83 7.05 Favored 'Isoleucine or valine' 0 C--N 1.348 0.509 0 CA-C-O 123.369 1.557 . . . . 0.0 107.903 171.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.1 -20.93 36.97 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 119.262 -2.149 . . . . 0.0 113.96 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.29 69.2 3.53 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.228 1.811 . . . . 0.0 113.473 -172.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -85.39 17.36 3.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 119.467 -2.021 . . . . 0.0 116.204 -173.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' LYS . . . . . 0.855 ' HE3' ' H ' ' B' ' 111' ' ' ASP . 0.0 OUTLIER -88.21 142.53 27.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 123.874 1.797 . . . . 0.0 110.56 170.569 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.855 ' H ' ' HE3' ' B' ' 110' ' ' LYS . 2.6 m-20 -78.38 -7.02 56.86 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 130.717 3.607 . . . . 0.0 111.656 -172.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 11.3 p -145.43 135.11 23.4 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 127.087 2.155 . . . . 0.0 109.852 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -139.52 -165.45 1.87 Allowed 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.056 -1.028 . . . . 0.0 110.055 174.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 29.1 p -94.21 -169.63 2.11 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 119.774 -1.829 . . . . 0.0 110.927 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 76.7 mtp -74.56 -53.24 9.79 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 119.367 -2.083 . . . . 0.0 112.001 169.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -58.18 -38.98 77.73 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.211 -0.93 . . . . 0.0 112.927 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.76 -44.31 97.15 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.18 -26.11 39.32 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 O-C-N 119.618 -1.926 . . . . 0.0 111.479 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.68 -27.69 17.93 Favored 'General case' 0 C--N 1.347 0.479 0 O-C-N 120.622 -1.299 . . . . 0.0 113.706 172.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -64.97 -62.53 1.5 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 126.399 1.88 . . . . 0.0 111.612 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -54.96 -36.03 64.89 Favored 'General case' 0 C--N 1.351 0.674 0 O-C-N 120.673 -1.267 . . . . 0.0 112.3 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.454 HD11 HD21 ' B' ' 147' ' ' LEU . 33.2 tp -70.48 -49.2 50.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 174.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -70.44 -46.37 48.93 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 119.89 -1.756 . . . . 0.0 113.428 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -63.36 -31.29 72.4 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.201 1.4 . . . . 0.0 112.247 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -55.9 -57.85 10.33 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 124.23 1.012 . . . . 0.0 111.861 168.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 89.7 mt -64.12 -43.74 97.49 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 O-C-N 120.534 -1.354 . . . . 0.0 112.888 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 53.5 ttm -57.64 -34.2 69.07 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 125.498 1.519 . . . . 0.0 113.206 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 58.1 m -86.33 -36.27 19.37 Favored 'General case' 0 C--N 1.345 0.37 0 O-C-N 120.621 -1.299 . . . . 0.0 112.623 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -71.66 -22.26 61.7 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 126.769 2.028 . . . . 0.0 114.862 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 71.41 45.12 0.49 Allowed 'General case' 0 C--N 1.351 0.667 0 C-N-CA 125.385 1.474 . . . . 0.0 112.984 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 89.2 mt -100.29 9.32 42.88 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 121.058 -1.026 . . . . 0.0 112.319 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -94.26 141.51 28.48 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.72 -1.237 . . . . 0.0 108.667 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -78.08 147.73 34.56 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.503 1.121 . . . . 0.0 109.277 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -68.98 -31.18 69.84 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.222 1.409 . . . . 0.0 113.3 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -104.17 -24.91 13.11 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 124.813 1.245 . . . . 0.0 112.666 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -116.93 62.55 0.73 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 122.103 0.954 . . . . 0.0 110.822 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.89 -5.04 1.81 Allowed 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.106 -1.621 . . . . 0.0 115.336 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -99.81 -0.51 39.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.261 1.824 . . . . 0.0 112.917 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 51.1 mm -105.26 117.11 50.37 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 C-N-CA 125.216 1.406 . . . . 0.0 108.64 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.49 121.71 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 O-C-N 120.987 -1.071 . . . . 0.0 108.493 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -79.92 108.86 13.83 Favored 'General case' 0 C--N 1.347 0.467 0 O-C-N 120.642 -1.286 . . . . 0.0 111.598 174.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 90.6 m -124.91 24.64 7.56 Favored 'General case' 0 C--N 1.346 0.454 0 O-C-N 121.513 -0.742 . . . . 0.0 111.157 172.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 13.6 p -76.92 142.07 40.24 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 120.315 -1.491 . . . . 0.0 108.704 165.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 28.9 t30 72.97 -31.22 0.22 Allowed 'General case' 0 C--N 1.354 0.774 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -73.77 164.35 26.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.286 -1.509 . . . . 0.0 110.678 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 18.9 tp -73.54 -2.99 25.04 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-O 123.691 1.71 . . . . 0.0 114.174 -162.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' LEU . . . . . 0.454 HD21 HD11 ' B' ' 122' ' ' LEU . 10.0 mp -79.47 -35.9 39.56 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 119.327 -2.108 . . . . 0.0 111.353 168.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.88 -32.52 82.23 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 120.766 -1.209 . . . . 0.0 113.62 -173.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -47.56 -67.4 0.28 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.355 3.062 . . . . 0.0 112.181 166.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.95 -23.16 48.61 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -78.77 -36.19 43.39 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.139 -1.601 . . . . 0.0 111.66 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.19 19.36 77.12 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 121.266 -0.896 . . . . 0.0 114.839 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 21.9 m -130.91 156.54 79.91 Favored Pre-proline 0 C--N 1.347 0.48 0 O-C-N 120.667 -1.49 . . . . 0.0 110.813 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.01 -26.09 8.17 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 121.923 1.749 . . . . 0.0 112.733 172.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 64.9 p -162.0 165.78 26.92 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 119.701 1.137 . . . . 0.0 109.533 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -138.42 166.12 25.07 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 8.4 t -117.88 143.05 46.65 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.808 -1.182 . . . . 0.0 109.51 169.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 34.6 m -57.95 -34.65 49.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.521 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -52.87 -26.65 15.39 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.34 49.22 0.96 Allowed 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 120.458 -1.401 . . . . 0.0 111.738 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -48.4 -44.32 34.85 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 126.64 1.976 . . . . 0.0 113.333 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -57.59 -35.02 69.85 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 125.692 1.597 . . . . 0.0 114.995 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -81.75 -40.26 22.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.167 -1.583 . . . . 0.0 110.023 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 75.8 mt -59.92 -52.25 63.39 Favored 'Isoleucine or valine' 0 C--N 1.347 0.496 0 C-N-CA 123.929 0.892 . . . . 0.0 111.402 172.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -51.47 -44.04 62.31 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 120.905 -1.122 . . . . 0.0 114.007 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 86.9 m -56.71 -53.77 53.85 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 121.138 -0.976 . . . . 0.0 112.199 174.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 25.9 mmt -61.53 -34.58 75.79 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 120.561 -1.337 . . . . 0.0 114.049 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.83 -55.43 22.47 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 O-C-N 121.106 -0.996 . . . . 0.0 111.39 171.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -68.81 -18.15 64.13 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 119.414 -2.054 . . . . 0.0 115.257 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -64.48 -30.95 71.98 Favored 'General case' 0 C--N 1.349 0.562 0 O-C-N 118.515 -2.615 . . . . 0.0 112.197 165.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -96.56 -15.04 21.82 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 123.899 0.879 . . . . 0.0 113.072 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 69.5 mt -120.64 121.37 38.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.603 1.161 . . . . 0.0 112.489 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.54 119.53 13.35 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 O-C-N 120.276 -1.515 . . . . 0.0 112.399 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 C--N 1.349 0.546 0 C-N-CA 124.825 1.25 . . . . 0.0 110.601 177.46 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.55 ' HA ' ' H ' ' A' ' 43' ' ' ILE . 34.7 m . . . . . 0 N--CA 1.517 2.888 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.1 55.13 31.95 Favored Glycine 0 C--N 1.357 1.706 0 CA-C-O 121.705 0.614 . . . . 0.0 112.776 -166.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -124.34 105.98 9.88 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 120.315 -1.697 . . . . 0.0 111.429 -168.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.55 -152.11 7.12 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.51 72.6 4.06 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.047 -1.266 . . . . 0.0 113.184 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 p -66.45 -2.11 4.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 126.775 2.03 . . . . 0.0 115.116 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -100.58 -31.79 11.08 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 126.189 1.795 . . . . 0.0 111.474 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -171.27 87.66 0.47 Allowed Pre-proline 0 C--N 1.351 0.656 0 O-C-N 121.382 -0.824 . . . . 0.0 110.53 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.59 98.31 0.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.88 1.72 . . . . 0.0 113.189 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -85.14 -31.97 23.0 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.353 1.061 . . . . 0.0 112.781 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.82 169.03 8.75 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 120.859 -1.15 . . . . 0.0 112.82 -173.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -64.19 -53.46 48.99 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 120.713 -1.242 . . . . 0.0 111.468 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.38 -50.36 67.7 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.183 1.393 . . . . 0.0 113.997 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -45.84 -55.04 7.13 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.915 2.086 . . . . 0.0 115.095 168.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.42 -30.43 60.05 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 120.931 -1.106 . . . . 0.0 112.979 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -54.59 -47.68 73.06 Favored 'General case' 0 C--N 1.349 0.546 0 O-C-N 119.798 -1.814 . . . . 0.0 112.729 173.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -59.51 -40.22 86.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 173.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -60.72 -20.91 62.26 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 125.836 1.654 . . . . 0.0 114.2 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.6 tp -70.53 -17.12 62.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.701 1.2 . . . . 0.0 113.663 174.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.296 91.4 p 50.93 40.89 26.22 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.363 1.865 . . . . 0.0 114.769 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.26 88.97 0.08 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.979 1.712 . . . . 0.0 114.993 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 148.2 -31.63 1.29 Allowed Glycine 0 CA--C 1.496 -1.109 0 O-C-N 120.975 -1.078 . . . . 0.0 111.096 -170.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.8 -132.7 11.02 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-O 122.423 1.013 . . . . 0.0 112.433 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 m -99.77 135.49 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 120.659 -1.495 . . . . 0.0 110.718 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.52 158.15 37.17 Favored Pre-proline 0 N--CA 1.451 -0.385 0 O-C-N 120.354 -1.466 . . . . 0.0 109.513 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.45 -5.9 17.89 Favored 'Trans proline' 0 CA--C 1.521 -0.175 0 C-N-CA 122.754 2.303 . . . . 0.0 112.848 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 mptt 61.74 51.05 4.05 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 126.481 1.912 . . . . 0.0 113.479 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.6 pt -64.11 141.69 17.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -173.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.27 26.3 0.91 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 125.305 1.442 . . . . 0.0 112.088 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -82.29 137.65 34.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.157 -1.59 . . . . 0.0 109.87 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -81.06 125.46 30.23 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 120.973 -1.079 . . . . 0.0 111.36 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.7 p -114.06 -175.22 2.63 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.517 1.151 . . . . 0.0 110.046 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -138.19 -2.95 1.8 Allowed 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 120.994 -1.066 . . . . 0.0 110.586 167.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -169.18 173.43 6.76 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.65 1.18 . . . . 0.0 109.315 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.23 -9.92 58.12 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 128.149 2.58 . . . . 0.0 111.337 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -75.0 -39.12 61.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.753 1.621 . . . . 0.0 110.962 168.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -77.89 -18.41 56.21 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.443 2.297 . . . . 0.0 112.634 -173.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.3 127.94 34.85 Favored Pre-proline 0 CA--C 1.54 0.594 0 O-C-N 120.253 -1.529 . . . . 0.0 111.55 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.76 170.09 21.12 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.649 2.233 . . . . 0.0 113.887 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.09 -96.66 0.99 Allowed Glycine 0 C--N 1.35 1.312 0 C-N-CA 124.238 0.923 . . . . 0.0 112.527 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.62 33.57 0.45 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 122.837 1.303 . . . . 0.0 109.327 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 77.3 m -91.77 136.59 33.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 119.737 -1.852 . . . . 0.0 109.965 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.55 ' H ' ' HA ' ' A' ' 1' ' ' SER . 1.6 pp -103.35 151.16 6.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 O-C-N 120.766 -1.209 . . . . 0.0 110.534 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.3 t -88.47 118.14 27.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.823 1.649 . . . . 0.0 109.154 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -79.05 172.86 13.21 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 118.952 -2.342 . . . . 0.0 110.948 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.58 -27.83 13.53 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 116.836 1.494 . . . . 0.0 116.836 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -83.82 3.49 33.38 Favored 'General case' 0 C--N 1.345 0.386 0 O-C-N 121.205 -1.174 . . . . 0.0 113.472 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.55 22.04 73.62 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 119.949 -1.719 . . . . 0.0 114.252 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -131.71 137.74 48.38 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 120.771 -1.429 . . . . 0.0 111.29 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 66.2 m -66.37 137.65 57.03 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 124.616 2.15 . . . . 0.0 114.288 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.948 0 O-C-N 120.517 -1.365 . . . . 0.0 113.928 173.176 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 N--CA 1.504 2.253 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.431 ' HB ' HD22 ' B' ' 172' ' ' LEU . 4.4 m -133.4 166.47 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' ARG . . . . . 0.401 ' HB2' HG12 ' B' ' 173' ' ' VAL . 0.0 OUTLIER -118.9 101.42 50.25 Favored Pre-proline 0 C--N 1.346 0.413 0 CA-C-O 116.936 -1.507 . . . . 0.0 110.397 -178.539 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.99 168.44 23.15 Favored 'Trans proline' 0 C--N 1.329 -0.484 0 C-N-CA 123.104 2.536 . . . . 0.0 114.396 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -86.69 152.98 55.06 Favored Pre-proline 0 C--N 1.349 0.573 0 O-C-N 121.038 -1.038 . . . . 0.0 112.807 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.15 -19.23 29.92 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.145 2.563 . . . . 0.0 112.915 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.6 mt -68.62 -51.55 41.11 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-O 121.579 0.704 . . . . 0.0 110.537 169.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.87 -39.57 81.74 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 124.944 1.298 . . . . 0.0 113.391 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 tp -46.46 -42.19 15.05 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.315 1.446 . . . . 0.0 114.879 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -66.07 -36.05 82.16 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 119.595 -1.94 . . . . 0.0 113.586 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.515 HD13 HD13 ' B' ' 147' ' ' LEU . 1.8 tt -70.39 -50.82 34.73 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 123.927 0.891 . . . . 0.0 111.062 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 96.5 mt -52.65 -45.69 66.82 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 124.5 1.12 . . . . 0.0 112.412 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -59.14 -28.67 66.78 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 5.9 t -75.72 -13.18 60.3 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 124.559 1.144 . . . . 0.0 112.779 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.73 -4.3 9.37 Favored 'Isoleucine or valine' 0 C--N 1.347 0.486 0 C-N-CA 124.852 1.261 . . . . 0.0 109.987 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.58 -16.57 23.9 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 119.833 -1.792 . . . . 0.0 113.306 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.34 77.61 9.92 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.212 -1.758 . . . . 0.0 113.34 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -81.57 11.83 4.32 Favored 'General case' 0 C--N 1.344 0.351 0 O-C-N 119.747 -1.846 . . . . 0.0 115.758 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 139.94 30.21 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-O 122.132 0.968 . . . . 0.0 113.174 -174.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.05 -15.91 62.57 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.516 2.326 . . . . 0.0 114.087 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 19.6 p -138.81 126.51 22.09 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 120.318 -1.489 . . . . 0.0 110.968 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -128.34 -177.31 4.11 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-O 122.461 1.124 . . . . 0.0 110.879 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 4.2 p -90.76 176.11 6.76 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 120.041 -1.662 . . . . 0.0 110.01 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 8.5 mmt -64.75 -49.23 71.62 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 120.351 -1.468 . . . . 0.0 112.945 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -33.23 74.27 Favored 'General case' 0 C--N 1.349 0.587 0 O-C-N 120.997 -1.064 . . . . 0.0 112.605 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -57.75 -36.74 72.5 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 125.062 1.345 . . . . 0.0 114.134 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.47 -48.86 76.64 Favored 'Isoleucine or valine' 0 C--N 1.356 0.866 0 C-N-CA 123.961 0.905 . . . . 0.0 111.811 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.77 -27.33 40.46 Favored 'General case' 0 C--N 1.346 0.434 0 O-C-N 120.763 -1.211 . . . . 0.0 113.045 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -65.35 -58.84 4.89 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 125.289 1.436 . . . . 0.0 112.033 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -59.79 -41.97 92.32 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 120.992 -1.067 . . . . 0.0 112.236 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 29.6 tp -61.19 -52.45 64.74 Favored 'General case' 0 C--N 1.347 0.485 0 O-C-N 120.569 -1.332 . . . . 0.0 114.017 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.79 -45.54 94.75 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 120.602 -1.311 . . . . 0.0 113.45 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -59.05 -37.21 76.47 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 124.788 1.235 . . . . 0.0 113.157 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -59.93 -57.58 12.25 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 124.636 1.175 . . . . 0.0 112.688 173.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 3.1 mt -63.59 -41.7 93.54 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 O-C-N 119.999 -1.688 . . . . 0.0 112.209 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 52.2 ttm -56.26 -43.45 78.77 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 125.691 1.596 . . . . 0.0 112.681 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 21.6 m -82.56 -30.35 29.7 Favored 'General case' 0 C--N 1.345 0.37 0 O-C-N 119.953 -1.717 . . . . 0.0 112.521 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -75.31 -24.15 57.41 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 119.584 -1.948 . . . . 0.0 114.436 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 71.82 49.84 0.26 Allowed 'General case' 0 C--N 1.352 0.692 0 C-N-CA 125.403 1.481 . . . . 0.0 111.038 -176.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 6.1 mt -107.7 17.72 22.25 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 121.054 -1.029 . . . . 0.0 111.961 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -105.83 149.54 26.41 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -77.31 154.81 32.51 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 121.254 -0.904 . . . . 0.0 108.852 172.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -71.53 -37.21 71.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 122.746 1.26 . . . . 0.0 110.794 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -88.63 -51.5 5.65 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 121.035 -1.041 . . . . 0.0 111.884 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -96.13 59.65 1.95 Allowed 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 120.338 -1.476 . . . . 0.0 113.25 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -63.29 -9.33 11.28 Favored 'General case' 0 C--N 1.346 0.436 0 O-C-N 120.098 -1.626 . . . . 0.0 115.03 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -91.07 2.38 56.36 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.293 -1.504 . . . . 0.0 113.315 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 50.1 mm -106.04 143.07 17.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 C-N-CA 125.572 1.549 . . . . 0.0 108.437 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 44.9 t -129.64 130.14 66.82 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 O-C-N 120.778 -1.201 . . . . 0.0 109.114 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -95.26 100.66 12.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.629 1.172 . . . . 0.0 110.404 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 1.2 m -101.43 1.54 38.41 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 121.118 -0.989 . . . . 0.0 112.662 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 26.4 t -65.44 131.18 45.78 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 120.828 -1.17 . . . . 0.0 110.651 173.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 4.9 t30 69.93 25.01 5.01 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.274 1.03 . . . . 0.0 113.226 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -123.26 171.5 9.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 13.8 tp -74.97 -22.19 58.71 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.781 1.632 . . . . 0.0 111.688 -171.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' LEU . . . . . 0.515 HD13 HD13 ' B' ' 102' ' ' LEU . 1.0 OUTLIER -71.04 -33.53 70.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 120.799 -1.188 . . . . 0.0 112.715 170.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.67 -38.3 96.21 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 120.065 -1.647 . . . . 0.0 113.812 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -51.91 -50.24 61.48 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.18 2.592 . . . . 0.0 112.456 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.95 -30.76 44.77 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 120.024 -1.673 . . . . 0.0 113.865 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.41 ' HB3' HG22 ' B' ' 153' ' ' VAL . 11.6 m-85 -75.67 -35.04 60.49 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 120.734 -1.229 . . . . 0.0 112.83 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 73.99 23.2 76.81 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 123.857 0.741 . . . . 0.0 113.696 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' B' ' 151' ' ' PHE . 12.3 m -135.19 152.44 76.95 Favored Pre-proline 0 N--CA 1.451 -0.408 0 O-C-N 121.176 -1.191 . . . . 0.0 108.454 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.71 -38.41 3.2 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 121.797 1.665 . . . . 0.0 111.798 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 31.1 m -144.67 164.31 31.36 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -138.06 178.48 7.09 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 77.5 p -136.78 141.64 42.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.077 -1.639 . . . . 0.0 109.626 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.23 -23.57 23.3 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 CA-C-O 122.62 1.2 . . . . 0.0 113.035 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -60.01 -27.05 66.57 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 120.666 -1.271 . . . . 0.0 113.521 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.87 56.64 1.58 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.838 1.255 . . . . 0.0 112.438 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -53.64 -38.86 64.5 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 119.684 -1.885 . . . . 0.0 114.43 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -67.45 -32.34 73.14 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.903 1.681 . . . . 0.0 113.529 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -74.72 -43.95 52.44 Favored 'General case' 0 C--N 1.348 0.53 0 C-N-CA 125.405 1.482 . . . . 0.0 110.799 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 51.3 mm -50.63 -53.38 13.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.768 1.227 . . . . 0.0 112.012 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -54.25 -43.12 70.66 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 124.243 1.017 . . . . 0.0 113.655 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -36.07 79.88 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 119.7 -1.875 . . . . 0.0 113.664 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.33 -38.38 78.16 Favored 'General case' 0 C--N 1.346 0.44 0 O-C-N 120.434 -1.416 . . . . 0.0 111.845 176.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 67.6 mt -66.54 -50.38 67.24 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 C-N-CA 124.455 1.102 . . . . 0.0 112.313 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -61.1 -14.88 27.37 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 119.735 -1.853 . . . . 0.0 114.918 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -76.31 -12.73 60.12 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.554 -1.966 . . . . 0.0 113.539 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 43.7 m-20 -105.24 -15.91 14.92 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 120.419 -1.426 . . . . 0.0 111.86 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' LEU . . . . . 0.431 HD22 ' HB ' ' B' ' 93' ' ' VAL . 48.0 mt -111.37 162.93 14.53 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 121.92 0.867 . . . . 0.0 109.804 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 173' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' B' ' 94' ' ' ARG . 8.6 p -106.92 126.68 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 O-C-N 120.453 -1.405 . . . . 0.0 108.978 173.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.348 0.534 0 C-N-CA 123.779 0.832 . . . . 0.0 110.681 -179.226 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.52 3.039 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 44.61 55.98 5.85 Favored Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.181 1.355 . . . . 0.0 114.903 -162.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -116.38 111.51 20.16 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 120.113 -1.816 . . . . 0.0 111.606 -168.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.28 -147.14 5.55 Favored Glycine 0 C--N 1.349 1.306 0 CA-C-O 122.206 0.892 . . . . 0.0 112.44 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.38 66.0 9.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 120.132 -1.805 . . . . 0.0 113.545 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.502 ' HA ' HD21 ' A' ' 18' ' ' LEU . 3.8 m -62.81 -6.26 3.55 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 pttm -89.12 -26.57 21.27 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.298 2.239 . . . . 0.0 113.635 175.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 175.16 87.22 0.08 OUTLIER Pre-proline 0 C--N 1.35 0.622 0 C-N-CA 125.074 1.35 . . . . 0.0 108.738 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.74 127.31 8.66 Favored 'Trans proline' 0 C--N 1.325 -0.702 0 C-N-CA 122.231 1.954 . . . . 0.0 111.65 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.6 t -122.38 -0.38 9.31 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-O 122.71 1.243 . . . . 0.0 110.884 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.9 t -130.39 164.2 25.23 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 124.92 1.288 . . . . 0.0 109.599 -174.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -68.26 -38.13 81.45 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 124.369 1.068 . . . . 0.0 111.105 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.7 -52.9 39.37 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 124.848 1.259 . . . . 0.0 110.803 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.84 -55.25 10.18 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.092 1.757 . . . . 0.0 114.07 169.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.57 -30.81 68.68 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.275 -1.516 . . . . 0.0 113.501 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -58.32 -41.55 84.79 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 119.937 -1.727 . . . . 0.0 112.381 171.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -65.25 -43.2 92.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.769 -1.207 . . . . 0.0 113.454 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.502 HD21 ' HA ' ' A' ' 6' ' ' SER . 3.2 mm? -53.26 -29.18 31.51 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 127.072 2.149 . . . . 0.0 115.014 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.49 -19.58 65.67 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.604 1.162 . . . . 0.0 113.94 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.268 42.2 p 54.65 35.59 24.11 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 126.871 2.068 . . . . 0.0 114.299 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.34 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.44 1.896 . . . . 0.0 115.186 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.2 -40.85 1.04 Allowed Glycine 0 CA--C 1.494 -1.225 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -170.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.91 -146.24 17.97 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 124.475 1.036 . . . . 0.0 111.684 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 m -94.53 155.24 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 O-C-N 121.09 -1.241 . . . . 0.0 110.904 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.61 155.52 80.45 Favored Pre-proline 0 N--CA 1.448 -0.559 0 O-C-N 120.601 -1.312 . . . . 0.0 107.592 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.37 6.44 3.55 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 123.113 2.542 . . . . 0.0 113.017 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt 62.63 46.25 5.54 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.705 1.602 . . . . 0.0 114.262 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 pt -59.79 139.24 19.65 Favored 'Isoleucine or valine' 0 C--N 1.348 0.531 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -173.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 mp -86.69 28.1 0.91 Allowed 'General case' 0 C--N 1.346 0.45 0 O-C-N 120.948 -1.095 . . . . 0.0 111.685 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -82.51 138.29 34.36 Favored 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 120.543 -1.348 . . . . 0.0 109.79 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -84.7 127.0 33.88 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.503 0.668 . . . . 0.0 111.019 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.9 p -119.07 -175.95 3.02 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.038 1.335 . . . . 0.0 109.388 -177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -130.67 -12.82 3.8 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 120.696 -1.252 . . . . 0.0 111.116 168.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -157.04 169.99 23.56 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 120.689 -1.257 . . . . 0.0 107.875 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.1 -31.73 71.55 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.579 1.551 . . . . 0.0 113.515 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 m -65.28 -26.64 68.17 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 120.121 -1.612 . . . . 0.0 115.058 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.84 -11.33 59.81 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.308 -0.87 . . . . 0.0 111.987 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -107.4 127.56 27.63 Favored Pre-proline 0 C--N 1.354 0.791 0 O-C-N 120.179 -1.576 . . . . 0.0 112.129 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.07 168.64 23.67 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.195 1.93 . . . . 0.0 114.175 -171.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.32 -85.57 1.13 Allowed Glycine 0 C--N 1.35 1.313 0 C-N-CA 124.626 1.108 . . . . 0.0 112.982 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -161.3 25.59 0.13 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 122.598 1.19 . . . . 0.0 110.169 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 7.1 m -89.63 148.55 23.27 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 119.181 -2.199 . . . . 0.0 109.612 -170.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 pp -115.37 147.42 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 O-C-N 119.882 -1.761 . . . . 0.0 108.821 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.06 117.14 19.08 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.989 1.316 . . . . 0.0 110.158 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -79.9 176.3 9.86 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 120.029 -1.669 . . . . 0.0 110.911 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.89 0.33 2.42 Favored Glycine 0 C--N 1.355 1.59 0 N-CA-C 117.492 1.757 . . . . 0.0 117.492 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.45 -7.49 24.23 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 120.707 -1.466 . . . . 0.0 111.925 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.35 20.18 60.93 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 120.458 -1.401 . . . . 0.0 113.707 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -130.81 145.21 51.91 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 121.133 -1.216 . . . . 0.0 110.593 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 78.8 m -75.39 147.13 40.26 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 123.51 1.624 . . . . 0.0 114.329 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.334 0 CA-C-O 116.19 -2.45 . . . . 0.0 118.186 -174.385 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 57.2 mt . . . . . 0 N--CA 1.504 2.246 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.485 HG11 HD13 ' B' ' 172' ' ' LEU . 11.7 m -136.2 166.22 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -115.84 102.14 54.04 Favored Pre-proline 0 C--N 1.345 0.391 0 CA-C-O 117.137 -1.411 . . . . 0.0 110.035 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.49 174.46 9.23 Favored 'Trans proline' 0 C--N 1.325 -0.66 0 C-N-CA 123.3 2.667 . . . . 0.0 114.086 175.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -96.2 154.64 38.73 Favored Pre-proline 0 C--N 1.35 0.617 0 O-C-N 120.914 -1.116 . . . . 0.0 111.617 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.91 -24.32 29.12 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.179 2.586 . . . . 0.0 112.7 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.8 mt -64.59 -52.94 54.94 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 118.686 0.676 . . . . 0.0 111.358 168.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 32.6 tp -58.69 -36.9 74.96 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 124.976 1.311 . . . . 0.0 113.522 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 15.6 tp -47.63 -40.3 19.26 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 125.345 1.458 . . . . 0.0 114.805 170.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -64.47 -36.82 85.44 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 119.645 -1.91 . . . . 0.0 113.723 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 tt -70.45 -50.62 36.34 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 124.037 0.935 . . . . 0.0 110.738 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 88.8 mt -53.59 -46.34 70.33 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.913 1.285 . . . . 0.0 112.287 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -58.95 -25.18 63.3 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.44 -13.57 59.02 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 125.307 1.443 . . . . 0.0 112.025 177.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.62 0.61 10.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 125.07 1.348 . . . . 0.0 109.782 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.2 -15.75 39.19 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 120.084 -1.635 . . . . 0.0 113.155 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -88.14 78.39 8.13 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 120.434 -1.627 . . . . 0.0 113.493 -172.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -85.38 8.1 20.08 Favored 'General case' 0 C--N 1.343 0.318 0 O-C-N 119.895 -1.753 . . . . 0.0 115.466 -176.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.82 149.49 27.14 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 121.339 -0.851 . . . . 0.0 112.508 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -78.74 -27.55 44.79 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.147 1.379 . . . . 0.0 112.527 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 60.4 p -121.58 140.88 51.67 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 120.808 -1.182 . . . . 0.0 112.572 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -139.43 177.31 8.02 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-O 122.439 1.114 . . . . 0.0 110.264 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.408 ' O ' HG23 ' B' ' 118' ' ' VAL . 0.7 OUTLIER -88.48 160.97 17.26 Favored 'General case' 0 C--N 1.346 0.447 0 O-C-N 120.666 -1.271 . . . . 0.0 110.872 175.208 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.98 -47.68 71.14 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.105 -1.622 . . . . 0.0 114.388 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -59.36 -52.7 64.5 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.978 0.911 . . . . 0.0 112.913 171.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.76 -46.57 50.75 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 174.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.408 HG23 ' O ' ' B' ' 114' ' ' THR . 52.1 t -51.88 -48.25 39.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 O-C-N 120.97 -1.081 . . . . 0.0 112.709 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.2 -29.84 38.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.082 -1.012 . . . . 0.0 113.288 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -56.27 -60.34 3.64 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 125.774 1.629 . . . . 0.0 112.193 172.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -59.13 -36.49 75.29 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 120.669 -1.269 . . . . 0.0 112.495 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.413 HD11 ' CD1' ' B' ' 147' ' ' LEU . 5.0 tp -62.56 -51.46 67.26 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.1 1.36 . . . . 0.0 113.902 173.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.23 -51.77 54.27 Favored Glycine 0 C--N 1.35 1.334 0 C-N-CA 125.502 1.525 . . . . 0.0 113.204 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -55.39 -39.15 69.79 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 125.216 1.406 . . . . 0.0 113.399 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -59.11 -56.3 24.02 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 121.149 -0.969 . . . . 0.0 112.74 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.71 -44.97 98.56 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 C-N-CA 124.327 1.051 . . . . 0.0 112.475 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 45.2 ttm -52.43 -44.67 65.58 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 126.268 1.827 . . . . 0.0 112.979 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 11.7 m -85.83 -23.62 27.09 Favored 'General case' 0 C--N 1.346 0.449 0 O-C-N 120.153 -1.592 . . . . 0.0 112.774 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -29.42 55.62 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 118.982 -2.324 . . . . 0.0 113.053 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? 75.15 49.27 0.09 Allowed 'General case' 0 C--N 1.351 0.659 0 C-N-CA 126.496 1.918 . . . . 0.0 110.596 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.6 23.19 12.34 Favored 'General case' 0 C--N 1.349 0.553 0 O-C-N 121.032 -1.042 . . . . 0.0 111.68 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -114.01 144.14 43.59 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.588 -1.32 . . . . 0.0 108.599 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.27 132.59 44.26 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.883 -1.136 . . . . 0.0 110.162 173.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -58.22 -47.77 82.45 Favored 'General case' 0 C--N 1.346 0.424 0 O-C-N 119.705 -1.872 . . . . 0.0 113.681 173.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -75.04 -19.49 60.01 Favored 'General case' 0 C--N 1.347 0.458 0 O-C-N 119.878 -1.764 . . . . 0.0 114.323 176.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.22 58.67 1.58 Allowed 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 119.701 -1.874 . . . . 0.0 110.231 -170.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -62.55 -7.41 4.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.453 1.901 . . . . 0.0 114.903 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -92.7 -3.82 54.22 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.015 2.526 . . . . 0.0 113.551 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 43.8 mm -106.29 139.32 28.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 0 C-N-CA 126.022 1.729 . . . . 0.0 107.643 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 39.9 t -124.7 130.17 73.47 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-O 122.406 1.098 . . . . 0.0 110.324 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.59 109.34 18.47 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.971 -1.08 . . . . 0.0 110.994 172.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 24.1 p -100.38 -14.47 18.34 Favored 'General case' 0 C--N 1.346 0.426 0 O-C-N 121.126 -0.984 . . . . 0.0 112.324 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.89 124.6 20.41 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 120.645 -1.285 . . . . 0.0 113.312 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 79.05 2.75 2.41 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 125.43 1.492 . . . . 0.0 113.554 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -112.12 167.33 10.49 Favored 'General case' 0 C--N 1.35 0.587 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 171.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 tp -64.39 -20.98 66.48 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 128.059 2.543 . . . . 0.0 112.81 -171.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' LEU . . . . . 0.413 ' CD1' HD11 ' B' ' 122' ' ' LEU . 1.1 tp -67.47 -36.55 81.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.785 1.634 . . . . 0.0 112.926 171.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.22 -48.41 31.72 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 120.923 -1.111 . . . . 0.0 112.468 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.33 -42.32 4.48 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 127.823 2.449 . . . . 0.0 114.246 169.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.75 -29.89 15.8 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 120.311 -1.493 . . . . 0.0 114.355 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.655 ' HB3' HG22 ' B' ' 153' ' ' VAL . 2.4 m-85 -74.08 -41.75 61.22 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 120.684 -1.26 . . . . 0.0 111.699 177.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 84.33 20.82 58.1 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 124.154 0.883 . . . . 0.0 113.14 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . 0.655 HG22 ' HB3' ' B' ' 151' ' ' PHE . 35.0 m -133.71 153.48 80.12 Favored Pre-proline 0 C--N 1.346 0.421 0 O-C-N 121.155 -1.203 . . . . 0.0 110.561 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.56 -25.18 5.7 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.046 1.83 . . . . 0.0 112.907 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 33.2 p -160.08 164.01 33.42 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 120.016 -1.678 . . . . 0.0 107.427 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -144.56 163.85 32.65 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.593 1.187 . . . . 0.0 110.7 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.57 130.27 54.36 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 120.655 -1.278 . . . . 0.0 111.034 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 48.8 t -62.79 -27.92 43.94 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 O-C-N 119.711 -1.868 . . . . 0.0 111.749 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -25.87 12.67 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 125.854 1.662 . . . . 0.0 114.868 171.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -85.2 55.52 3.53 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 119.968 -1.708 . . . . 0.0 112.185 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -48.58 -44.72 37.08 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 119.229 -2.169 . . . . 0.0 115.519 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -22.81 61.93 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 172.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -87.75 -44.13 11.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.091 1.356 . . . . 0.0 109.734 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 49.6 mm -53.98 -51.9 41.47 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 C-N-CA 125.118 1.367 . . . . 0.0 111.515 174.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -53.84 -45.96 71.07 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 171.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.87 -39.59 93.79 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 119.63 -1.918 . . . . 0.0 113.627 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 24.3 mmt -60.09 -49.25 78.4 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 120.741 -1.224 . . . . 0.0 112.58 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 45.8 mt -59.6 -51.48 72.28 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 C-N-CA 124.826 1.25 . . . . 0.0 112.524 175.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -61.39 -23.4 65.76 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 119.198 -2.189 . . . . 0.0 114.407 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -77.59 -11.87 59.91 Favored 'General case' 0 C--N 1.349 0.57 0 O-C-N 119.499 -2.001 . . . . 0.0 113.503 170.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -95.86 -26.38 15.65 Favored 'General case' 0 CA--C 1.505 -0.764 0 O-C-N 119.985 -1.697 . . . . 0.0 110.403 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.485 HD13 HG11 ' B' ' 93' ' ' VAL . 73.3 mt -103.35 174.26 5.95 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 122.023 0.916 . . . . 0.0 110.603 -174.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 97.7 t -116.59 121.66 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 99.2 t . . . . . 0 C--N 1.347 0.46 0 C-N-CA 123.792 0.837 . . . . 0.0 110.331 179.829 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.515 2.808 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 50.15 47.49 41.51 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-N 120.154 1.343 . . . . 0.0 114.874 -165.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 m -114.93 114.03 24.93 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 119.769 -2.018 . . . . 0.0 112.0 -167.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.22 -151.17 5.89 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.84 70.0 4.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.286 -1.126 . . . . 0.0 113.976 -176.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 p -69.51 -0.98 7.45 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 119.429 -2.044 . . . . 0.0 114.868 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -92.75 -34.39 13.93 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.619 1.568 . . . . 0.0 113.007 171.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -173.97 85.21 0.36 Allowed Pre-proline 0 C--N 1.347 0.471 0 CA-C-O 118.672 -0.68 . . . . 0.0 109.6 -175.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.34 118.86 4.76 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.233 1.955 . . . . 0.0 112.05 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.1 t -107.68 -25.29 11.37 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.954 1.301 . . . . 0.0 110.039 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 t -106.02 165.63 11.08 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.384 -1.447 . . . . 0.0 113.941 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -63.3 -50.44 70.07 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 119.786 -1.822 . . . . 0.0 111.77 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.36 -45.17 72.73 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 125.867 1.667 . . . . 0.0 113.061 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -56.54 -58.43 8.08 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.617 1.567 . . . . 0.0 113.888 171.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' B' ' 138' ' ' HIS . 0.1 OUTLIER -66.58 -29.52 69.59 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.321 -1.487 . . . . 0.0 113.07 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -35.63 73.81 Favored 'General case' 0 C--N 1.348 0.525 0 O-C-N 119.926 -1.734 . . . . 0.0 112.083 173.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -70.32 -44.33 68.45 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 120.532 -1.355 . . . . 0.0 112.881 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -54.32 -29.55 48.19 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 126.399 1.88 . . . . 0.0 114.862 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.488 HD22 HG13 ' B' ' 158' ' ' VAL . 21.4 tp -61.11 -30.34 70.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.511 1.124 . . . . 0.0 113.81 171.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 t 54.44 53.32 10.96 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 126.536 1.935 . . . . 0.0 113.043 -172.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.84 81.38 1.63 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 123.097 1.427 . . . . 0.0 113.561 -170.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.19 -29.92 0.47 Allowed Glycine 0 C--N 1.342 0.877 0 O-C-N 121.234 -0.916 . . . . 0.0 112.243 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.19 -149.23 18.73 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-N 117.797 0.798 . . . . 0.0 112.44 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.0 t -103.35 138.69 26.72 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 O-C-N 120.972 -1.311 . . . . 0.0 109.012 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.28 157.03 41.13 Favored Pre-proline 0 N--CA 1.447 -0.606 0 O-C-N 120.746 -1.221 . . . . 0.0 109.074 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.73 -1.09 10.27 Favored 'Trans proline' 0 C--N 1.336 -0.123 0 C-N-CA 122.73 2.286 . . . . 0.0 112.757 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt 66.98 53.76 0.81 Allowed 'General case' 0 C--N 1.35 0.609 0 C-N-CA 126.421 1.889 . . . . 0.0 112.704 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 pt -63.35 141.0 18.72 Favored 'Isoleucine or valine' 0 C--N 1.346 0.414 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.2 mt -85.65 29.9 0.67 Allowed 'General case' 0 C--N 1.348 0.503 0 C-N-CA 124.284 1.034 . . . . 0.0 111.825 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -86.32 143.34 27.93 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 120.179 -1.576 . . . . 0.0 109.386 172.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -88.48 133.95 33.99 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.861 0.839 . . . . 0.0 110.456 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.7 p -125.4 -175.88 3.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.001 0.92 . . . . 0.0 108.902 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -129.71 -13.34 4.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.346 -1.471 . . . . 0.0 111.774 167.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -161.89 176.03 11.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -74.2 -27.45 60.81 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.541 -1.349 . . . . 0.0 112.557 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.19 -28.25 67.81 Favored 'General case' 0 C--N 1.348 0.54 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 171.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -84.23 -8.24 59.11 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.347 -0.846 . . . . 0.0 110.701 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -111.29 124.19 33.29 Favored Pre-proline 0 C--N 1.355 0.816 0 O-C-N 120.091 -1.631 . . . . 0.0 111.9 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.28 169.63 22.07 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.147 1.898 . . . . 0.0 114.135 -169.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.69 -87.85 1.14 Allowed Glycine 0 C--N 1.349 1.266 0 C-N-CA 124.319 0.962 . . . . 0.0 112.246 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.39 21.53 0.29 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.992 0.901 . . . . 0.0 110.87 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 4.2 m -83.87 152.34 24.61 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 119.278 -2.139 . . . . 0.0 110.027 -168.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 pp -119.23 146.12 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 O-C-N 120.037 -1.664 . . . . 0.0 108.342 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.51 119.47 21.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.422 1.489 . . . . 0.0 109.298 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -79.53 177.34 8.94 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 119.984 -1.698 . . . . 0.0 110.565 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.34 -18.86 23.12 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 116.598 1.399 . . . . 0.0 116.598 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -82.17 -8.68 59.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.449 -1.03 . . . . 0.0 112.992 174.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.64 14.88 69.48 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 120.659 -1.276 . . . . 0.0 113.905 -175.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -127.56 148.57 50.34 Favored 'General case' 0 C--N 1.347 0.467 0 O-C-N 120.653 -1.498 . . . . 0.0 110.354 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 41.9 m -74.63 147.16 41.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 123.783 1.754 . . . . 0.0 114.35 -175.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.289 0 CA-C-O 116.689 -2.173 . . . . 0.0 117.435 -176.179 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.505 2.275 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 9.8 m -132.88 164.91 33.95 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 119.587 1.085 . . . . 0.0 108.665 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.29 100.49 53.51 Favored Pre-proline 0 C--N 1.344 0.348 0 CA-C-O 117.082 -1.437 . . . . 0.0 110.181 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.37 162.94 39.89 Favored 'Trans proline' 0 C--N 1.331 -0.358 0 C-N-CA 123.232 2.622 . . . . 0.0 114.006 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -89.11 156.28 49.07 Favored Pre-proline 0 C--N 1.347 0.492 0 O-C-N 121.344 -0.847 . . . . 0.0 112.613 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.65 -20.63 30.38 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.232 2.621 . . . . 0.0 113.3 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 81.1 mt -70.32 -61.14 1.89 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.706 0.803 . . . . 0.0 110.186 170.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 31.9 tp -50.74 -37.09 39.9 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 125.422 1.489 . . . . 0.0 114.427 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 8.3 tp -47.66 -40.71 20.6 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 169.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -64.35 -36.84 85.44 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 119.463 -2.023 . . . . 0.0 114.084 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -49.67 60.17 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 121.35 -0.844 . . . . 0.0 111.598 171.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 93.7 mt -52.18 -47.25 65.64 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 124.172 0.989 . . . . 0.0 113.124 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -52.74 -30.03 30.32 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.3 t -77.11 -20.6 55.47 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.602 1.161 . . . . 0.0 111.927 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.12 -9.72 9.49 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 C-N-CA 124.619 1.168 . . . . 0.0 110.606 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.97 -27.31 6.49 Favored Glycine 0 C--N 1.353 1.51 0 O-C-N 120.066 -1.646 . . . . 0.0 111.966 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . 0.413 ' HB1' ' CE2' ' B' ' 113' ' ' TYR . . . -78.16 74.27 4.7 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 125.82 1.648 . . . . 0.0 114.718 -171.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -84.8 17.44 2.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 119.248 -2.157 . . . . 0.0 115.158 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.43 143.8 26.54 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 123.36 1.552 . . . . 0.0 113.021 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -20.27 64.03 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 130.093 3.357 . . . . 0.0 112.396 -177.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 31.1 p -140.44 141.27 35.48 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 125.2 1.4 . . . . 0.0 109.87 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . 0.413 ' CE2' ' HB1' ' B' ' 108' ' ' ALA . 1.9 m-85 -141.51 -173.75 3.85 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.071 -1.018 . . . . 0.0 110.443 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.464 ' O ' HG23 ' B' ' 118' ' ' VAL . 4.4 p -95.68 168.73 10.49 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.526 -1.358 . . . . 0.0 110.584 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 13.7 mmt -62.48 -49.19 76.37 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.731 -1.231 . . . . 0.0 113.258 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -58.94 -45.51 90.25 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 124.677 1.191 . . . . 0.0 112.206 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -56.34 -47.54 78.59 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 114' ' ' THR . 47.2 t -52.81 -46.08 50.97 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 O-C-N 120.135 -1.603 . . . . 0.0 112.958 174.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 0.567 HD21 HD13 ' B' ' 168' ' ' ILE . 4.1 mm? -76.46 -30.79 57.46 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 120.701 -1.249 . . . . 0.0 113.233 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -62.25 -57.24 12.17 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.667 1.587 . . . . 0.0 111.588 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -59.27 -43.03 92.51 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 123.891 0.876 . . . . 0.0 112.495 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.29 -53.7 55.25 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 120.88 -1.138 . . . . 0.0 114.017 170.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.57 -40.99 99.83 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 120.523 -1.36 . . . . 0.0 113.85 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -63.11 -38.12 89.92 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 124.877 1.271 . . . . 0.0 112.718 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -56.46 -56.88 15.71 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 124.288 1.035 . . . . 0.0 112.433 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.01 -42.39 96.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 O-C-N 120.696 -1.253 . . . . 0.0 112.665 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 37.2 ttm -54.76 -41.02 69.95 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 125.911 1.684 . . . . 0.0 113.321 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 17.2 m -87.98 -28.17 21.62 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 120.162 -1.586 . . . . 0.0 112.118 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -35.12 73.63 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 119.658 -1.901 . . . . 0.0 113.562 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? 74.91 59.04 0.07 Allowed 'General case' 0 C--N 1.353 0.725 0 C-N-CA 127.033 2.133 . . . . 0.0 110.516 -169.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mt -110.42 13.79 22.73 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-O 122.065 0.936 . . . . 0.0 111.679 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -100.68 149.87 23.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.901 1.281 . . . . 0.0 108.347 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -85.14 143.42 28.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.146 -0.971 . . . . 0.0 108.548 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -64.08 -33.21 75.23 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 120.73 -1.231 . . . . 0.0 113.067 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -98.06 -35.18 10.5 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.33 -0.856 . . . . 0.0 111.953 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -111.84 63.3 0.62 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.219 1.807 . . . . 0.0 111.912 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -62.29 -9.34 7.73 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.11 1.764 . . . . 0.0 114.764 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' HIS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 26.2 p80 -90.07 -6.54 55.38 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.561 1.944 . . . . 0.0 113.695 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 33.1 mm -99.71 134.5 38.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 124.58 1.152 . . . . 0.0 109.273 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 19.8 t -122.74 128.39 75.25 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 O-C-N 120.757 -1.214 . . . . 0.0 109.763 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -89.2 102.72 15.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 120.97 -1.081 . . . . 0.0 109.818 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.56 -1.24 28.62 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 123.77 0.828 . . . . 0.0 111.305 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 1.4 t -71.81 139.41 48.94 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 120.623 -1.298 . . . . 0.0 109.817 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 17.6 m120 71.52 5.38 5.38 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -106.06 169.99 8.17 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 122.526 1.155 . . . . 0.0 109.884 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 13.8 tp -69.63 -21.38 63.57 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 127.193 2.197 . . . . 0.0 112.571 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.39 -32.82 64.67 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 120.565 -1.334 . . . . 0.0 111.89 170.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.57 -40.19 98.82 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 120.617 -1.302 . . . . 0.0 113.091 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.17 -43.14 70.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.688 2.395 . . . . 0.0 112.575 173.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.18 -33.29 20.84 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 119.873 -1.767 . . . . 0.0 114.135 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.578 ' HB3' HG22 ' B' ' 153' ' ' VAL . 1.8 m-85 -70.3 -41.8 72.86 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 125.713 1.605 . . . . 0.0 111.644 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.89 20.84 72.66 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 123.882 0.754 . . . . 0.0 113.178 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . 0.578 HG22 ' HB3' ' B' ' 151' ' ' PHE . 28.7 m -133.32 151.86 78.32 Favored Pre-proline 0 C--N 1.345 0.376 0 O-C-N 121.32 -1.106 . . . . 0.0 109.371 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.33 -25.25 11.54 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.207 1.938 . . . . 0.0 111.95 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 53.6 p -161.3 165.52 28.99 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.403 -1.436 . . . . 0.0 108.6 -175.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -143.85 168.82 19.05 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 121.074 -1.016 . . . . 0.0 108.295 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 32.6 t -115.02 140.96 48.62 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.107 -0.996 . . . . 0.0 108.907 172.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . 0.488 HG13 HD22 ' A' ' 19' ' ' LEU . 23.9 t -69.51 -22.19 25.22 Favored 'Isoleucine or valine' 0 C--N 1.347 0.493 0 CA-C-O 122.818 1.294 . . . . 0.0 111.564 174.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -29.62 70.72 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.163 -1.586 . . . . 0.0 112.129 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -80.46 56.98 2.71 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.754 -1.216 . . . . 0.0 112.744 175.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -52.55 -41.91 63.95 Favored 'General case' 0 C--N 1.351 0.639 0 O-C-N 119.624 -1.922 . . . . 0.0 115.555 -176.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -62.51 -33.49 74.99 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 120.54 -1.35 . . . . 0.0 113.337 173.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -78.48 -33.18 48.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.721 -1.237 . . . . 0.0 113.082 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 44.4 mm -50.13 -50.8 19.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 C-N-CA 125.633 1.573 . . . . 0.0 111.344 169.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -51.99 -52.38 50.93 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 125.218 1.407 . . . . 0.0 113.167 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.34 -42.86 82.79 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 119.996 -1.69 . . . . 0.0 115.222 173.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 11.6 mtt -62.99 -38.81 92.67 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 120.638 -1.289 . . . . 0.0 113.174 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' ILE . . . . . 0.567 HD13 HD21 ' B' ' 119' ' ' LEU . 44.3 mt -69.35 -54.09 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.223 -0.923 . . . . 0.0 111.927 173.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -55.53 -27.6 49.83 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 120.304 -1.497 . . . . 0.0 114.62 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -63.06 -19.53 64.48 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.898 -1.751 . . . . 0.0 115.599 171.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.0 -2.17 17.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.994 0.918 . . . . 0.0 112.169 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 92.6 mt -108.84 151.2 26.57 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 122.693 1.235 . . . . 0.0 110.199 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 16.0 t -95.98 114.29 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 O-C-N 120.315 -1.491 . . . . 0.0 108.914 173.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.35 0.601 0 C-N-CA 124.031 0.932 . . . . 0.0 111.396 179.35 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.506 ' HA ' ' H ' ' A' ' 43' ' ' ILE 0.262 87.6 p . . . . . 0 N--CA 1.532 3.626 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 55.77 53.05 44.5 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 m -107.68 113.35 26.56 Favored 'General case' 0 CA--C 1.51 -0.573 0 O-C-N 119.884 -1.951 . . . . 0.0 112.38 -173.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.48 -149.87 5.54 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.94 70.72 5.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 121.09 -1.241 . . . . 0.0 113.27 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.441 ' HA ' HD21 ' A' ' 18' ' ' LEU . 11.0 p -68.65 3.99 1.62 Allowed 'General case' 0 C--N 1.346 0.447 0 O-C-N 119.721 -1.862 . . . . 0.0 115.496 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -100.81 -39.29 7.88 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.538 1.935 . . . . 0.0 111.15 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -167.58 84.79 0.79 Allowed Pre-proline 0 N--CA 1.447 -0.583 0 O-C-N 121.402 -0.812 . . . . 0.0 109.629 -175.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.96 120.22 5.37 Favored 'Trans proline' 0 C--N 1.327 -0.599 0 C-N-CA 121.981 1.787 . . . . 0.0 112.199 -177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -107.33 -37.94 6.1 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.557 1.143 . . . . 0.0 110.109 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 m -94.04 163.67 13.38 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 120.244 -1.535 . . . . 0.0 114.841 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -60.42 -49.81 76.09 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 125.657 1.583 . . . . 0.0 111.295 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.04 -46.82 78.74 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 123.791 0.836 . . . . 0.0 113.155 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -55.09 -58.17 8.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.2 1.4 . . . . 0.0 114.422 171.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -31.98 73.25 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 120.603 -1.311 . . . . 0.0 112.947 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -57.2 -37.85 72.82 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 120.308 -1.495 . . . . 0.0 112.918 170.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -68.28 -40.54 81.79 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.369 -1.457 . . . . 0.0 112.753 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.441 HD21 ' HA ' ' A' ' 6' ' ' SER . 3.8 mm? -56.45 -29.03 61.18 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 126.382 1.873 . . . . 0.0 114.987 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.9 tp -64.98 -18.92 65.7 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 125.286 1.434 . . . . 0.0 113.676 174.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.296 59.8 p 53.85 32.02 14.28 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 126.653 1.981 . . . . 0.0 115.463 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.7 93.71 0.01 OUTLIER 'General case' 0 C--N 1.353 0.72 0 C-N-CA 126.868 2.067 . . . . 0.0 115.784 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.33 -38.03 1.26 Allowed Glycine 0 C--N 1.345 1.078 0 O-C-N 121.341 -0.85 . . . . 0.0 111.892 -169.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.68 -139.6 14.67 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 122.469 1.038 . . . . 0.0 112.528 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -97.68 145.09 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 O-C-N 120.789 -1.418 . . . . 0.0 110.452 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.35 157.7 66.78 Favored Pre-proline 0 N--CA 1.448 -0.541 0 O-C-N 120.531 -1.356 . . . . 0.0 108.168 -175.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.93 -7.82 21.32 Favored 'Trans proline' 0 CA--C 1.52 -0.188 0 C-N-CA 122.579 2.186 . . . . 0.0 112.649 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 mtmt 68.7 53.29 0.53 Allowed 'General case' 0 C--N 1.352 0.688 0 C-N-CA 126.122 1.769 . . . . 0.0 112.066 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.6 pt -64.21 142.03 17.4 Favored 'Isoleucine or valine' 0 C--N 1.347 0.486 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.34 9.94 9.77 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-O 122.545 1.164 . . . . 0.0 112.69 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -70.93 134.65 47.4 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 120.415 -1.428 . . . . 0.0 112.389 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -81.28 124.41 29.3 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 121.71 -0.619 . . . . 0.0 111.797 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.1 p -115.82 -175.86 2.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.34 1.456 . . . . 0.0 109.772 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -122.14 -32.41 3.69 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 120.528 -1.358 . . . . 0.0 110.125 163.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -138.22 176.28 8.84 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 120.613 -1.304 . . . . 0.0 112.427 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -81.03 -5.02 57.11 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 118.898 -2.376 . . . . 0.0 113.262 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.0 t -76.32 -46.76 26.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.457 2.303 . . . . 0.0 109.576 172.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -32.52 67.24 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 128.127 2.571 . . . . 0.0 113.777 177.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.76 120.3 64.9 Favored Pre-proline 0 N--CA 1.447 -0.591 0 O-C-N 120.528 -1.357 . . . . 0.0 112.776 -172.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.78 169.16 23.01 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.487 2.125 . . . . 0.0 114.108 -168.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.15 -89.67 1.1 Allowed Glycine 0 C--N 1.349 1.286 0 C-N-CA 124.195 0.903 . . . . 0.0 111.912 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.17 29.91 0.17 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.74 1.257 . . . . 0.0 109.975 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.9 m -88.66 145.26 25.77 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 119.016 -2.302 . . . . 0.0 109.415 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.506 ' H ' ' HA ' ' A' ' 1' ' ' SER . 1.3 pp -111.92 146.04 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 O-C-N 119.766 -1.834 . . . . 0.0 109.564 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -77.92 120.26 22.53 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.737 1.615 . . . . 0.0 110.041 176.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -76.41 174.78 9.83 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 119.846 -1.784 . . . . 0.0 111.077 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.89 -2.89 2.89 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 117.1 1.6 . . . . 0.0 117.1 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.21 -9.0 24.26 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.976 1.31 . . . . 0.0 112.04 172.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.56 25.43 35.83 Favored Glycine 0 C--N 1.35 1.313 0 O-C-N 120.641 -1.287 . . . . 0.0 114.26 -176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -135.93 150.29 49.25 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 120.724 -1.456 . . . . 0.0 111.465 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.9 m -85.66 116.18 23.78 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 -169.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.263 0 CA-C-O 116.063 -2.521 . . . . 0.0 116.357 175.141 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 N--CA 1.504 2.235 0 CA-C-O 118.288 -0.863 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.454 HG11 HD13 ' B' ' 172' ' ' LEU . 12.8 m -139.16 164.97 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -113.97 103.5 55.19 Favored Pre-proline 0 C--N 1.344 0.368 0 CA-C-O 116.754 -1.593 . . . . 0.0 110.271 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.56 163.93 37.16 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 122.864 2.376 . . . . 0.0 114.196 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -84.66 153.64 61.34 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.151 0.98 . . . . 0.0 113.167 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.98 -17.29 28.68 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.164 2.576 . . . . 0.0 113.34 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -71.54 -57.9 3.99 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 123.992 0.917 . . . . 0.0 109.288 169.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 28.8 tp -54.12 -38.45 65.44 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 125.678 1.591 . . . . 0.0 114.478 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 14.6 tp -46.24 -39.68 10.27 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 125.396 1.479 . . . . 0.0 114.682 168.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -69.04 -37.53 78.64 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 119.193 -2.192 . . . . 0.0 113.05 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.43 -53.32 24.43 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 126.779 2.032 . . . . 0.0 111.942 169.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 76.9 mt -49.89 -45.62 50.93 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.72 1.208 . . . . 0.0 112.513 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -17.32 63.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 174.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 20.4 t -83.02 -8.66 59.53 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 120.021 -1.674 . . . . 0.0 112.034 171.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . 0.551 HG22 ' CD1' ' B' ' 125' ' ' TYR . 2.2 t -105.34 -7.67 9.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 C-N-CA 124.766 1.226 . . . . 0.0 110.048 176.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.58 -16.91 18.87 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 120.459 -1.4 . . . . 0.0 112.558 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.45 79.84 8.85 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.401 -1.647 . . . . 0.0 113.45 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -82.58 5.76 19.88 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.804 -1.81 . . . . 0.0 115.324 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 139.14 31.56 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -174.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.51 -11.67 61.07 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.765 2.026 . . . . 0.0 114.413 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 39.9 p -138.59 137.03 36.58 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.081 1.352 . . . . 0.0 111.297 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -139.35 -172.92 3.46 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 120.798 -1.189 . . . . 0.0 110.092 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.55 ' O ' HG23 ' B' ' 118' ' ' VAL . 1.8 p -96.88 173.12 7.45 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.048 -1.657 . . . . 0.0 109.93 174.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 24.7 mtt -67.15 -43.67 81.72 Favored 'General case' 0 C--N 1.352 0.699 0 O-C-N 120.161 -1.587 . . . . 0.0 113.46 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -58.73 -51.33 70.42 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.237 1.015 . . . . 0.0 111.603 172.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -54.56 -44.1 72.63 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.55 HG23 ' O ' ' B' ' 114' ' ' THR . 86.2 t -54.72 -43.53 66.78 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 120.121 -1.612 . . . . 0.0 112.568 176.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.3 -30.91 27.18 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 120.729 -1.232 . . . . 0.0 112.344 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -59.93 -60.86 3.16 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.949 1.7 . . . . 0.0 112.123 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -56.96 -38.23 72.69 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.41 1.084 . . . . 0.0 112.286 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 32.3 tp -64.68 -51.44 62.48 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 172.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.33 -40.29 91.84 Favored Glycine 0 C--N 1.349 1.297 0 O-C-N 119.928 -1.732 . . . . 0.0 114.019 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -30.31 71.33 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 124.724 1.21 . . . . 0.0 112.177 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.551 ' CD1' HG22 ' B' ' 106' ' ' VAL . 7.9 t80 -57.55 -60.95 2.89 Favored 'General case' 0 C--N 1.357 0.91 0 O-C-N 120.833 -1.167 . . . . 0.0 111.669 171.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 45.1 mm -58.41 -40.69 79.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 O-C-N 120.584 -1.322 . . . . 0.0 113.343 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 35.7 ttm -52.55 -43.27 65.08 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 125.077 1.351 . . . . 0.0 113.867 171.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 22.3 m -87.7 -31.88 19.48 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 124.727 1.211 . . . . 0.0 112.534 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . 0.446 ' HD2' ' CZ ' ' B' ' 125' ' ' TYR . 5.2 mmpt? -77.54 -25.42 50.16 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 120.027 -1.671 . . . . 0.0 114.306 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.98 53.67 0.19 Allowed 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.663 1.585 . . . . 0.0 111.38 -176.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.74 19.62 18.44 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.423 1.089 . . . . 0.0 110.627 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -105.09 146.46 29.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.56 -1.338 . . . . 0.0 107.998 173.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.48 139.68 45.92 Favored 'General case' 0 C--N 1.347 0.461 0 O-C-N 120.789 -1.195 . . . . 0.0 110.043 171.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . 0.46 ' HA ' HE21 ' B' ' 137' ' ' GLN . 58.8 mt-10 -59.95 -47.16 86.92 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 120.22 -1.55 . . . . 0.0 113.177 174.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -83.09 -19.99 35.73 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.844 1.258 . . . . 0.0 113.973 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -132.83 61.92 1.66 Allowed 'General case' 0 C--N 1.352 0.707 0 O-C-N 120.589 -1.319 . . . . 0.0 109.855 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' B' ' 134' ' ' GLU . 6.4 mm-40 -64.46 -6.15 6.77 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -175.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -89.97 -8.1 52.49 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.586 1.955 . . . . 0.0 113.315 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 47.8 mm -96.44 136.49 27.13 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 124.93 1.292 . . . . 0.0 109.303 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 17.2 t -121.75 123.76 70.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 O-C-N 120.856 -1.152 . . . . 0.0 110.202 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -86.22 113.82 22.54 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.653 1.181 . . . . 0.0 109.183 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 16.0 m -115.11 1.24 13.84 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 120.623 -1.298 . . . . 0.0 111.174 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 34.1 t -73.42 126.8 31.01 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.468 -1.395 . . . . 0.0 110.21 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 75.05 23.9 1.57 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.795 1.238 . . . . 0.0 112.01 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -128.39 165.29 20.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 tp -70.83 -16.89 62.75 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 126.844 2.058 . . . . 0.0 112.143 -170.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.25 -40.95 70.69 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.511 1.524 . . . . 0.0 111.841 169.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.97 -41.81 99.69 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 120.368 -1.458 . . . . 0.0 112.895 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -53.46 -33.64 54.93 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.189 2.196 . . . . 0.0 114.403 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.79 -33.01 11.83 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 120.055 -1.653 . . . . 0.0 113.158 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -78.79 -34.01 45.8 Favored 'General case' 0 C--N 1.35 0.629 0 O-C-N 121.044 -1.035 . . . . 0.0 113.108 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 79.91 15.06 79.9 Favored Glycine 0 C--N 1.35 1.319 0 O-C-N 121.315 -0.866 . . . . 0.0 113.898 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 20.5 m -131.35 151.75 79.33 Favored Pre-proline 0 C--N 1.345 0.38 0 O-C-N 121.055 -1.262 . . . . 0.0 109.844 -174.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.48 -33.11 4.36 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.907 1.738 . . . . 0.0 112.621 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 19.3 m -150.43 161.62 42.14 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -175.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -135.34 163.82 29.14 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.456 -0.777 . . . . 0.0 109.435 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 46.0 t -110.4 129.18 55.82 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 30.6 t -61.31 -28.76 44.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 O-C-N 120.818 -1.176 . . . . 0.0 112.219 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -54.21 -29.26 45.54 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 126.075 1.75 . . . . 0.0 114.795 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.59 54.58 2.41 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 120.575 -1.328 . . . . 0.0 111.75 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -47.97 -46.2 32.2 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 119.96 -1.713 . . . . 0.0 114.428 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -58.47 -38.51 77.71 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 125.365 1.466 . . . . 0.0 114.561 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -72.96 -45.33 58.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.758 0.823 . . . . 0.0 112.038 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 18.9 mt -55.64 -50.55 66.44 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 C-N-CA 125.188 1.395 . . . . 0.0 110.342 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -51.09 -52.14 46.49 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 124.681 1.192 . . . . 0.0 114.122 171.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 1.3 p -58.49 -38.3 77.35 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 119.544 -1.972 . . . . 0.0 115.031 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -42.55 89.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.322 -0.861 . . . . 0.0 112.048 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 31.5 mt -60.67 -52.43 61.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 O-C-N 120.438 -1.413 . . . . 0.0 112.052 173.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -64.31 -4.81 4.13 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -89.22 -27.06 20.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 119.641 -1.912 . . . . 0.0 113.342 168.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -88.06 -20.44 25.74 Favored 'General case' 0 CA--C 1.509 -0.621 0 O-C-N 121.247 -0.908 . . . . 0.0 111.489 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.454 HD13 HG11 ' B' ' 93' ' ' VAL . 70.4 mt -108.1 147.24 31.5 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 125.071 1.348 . . . . 0.0 111.705 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 56.2 t -90.78 122.65 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 120.749 -1.219 . . . . 0.0 109.355 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 93.8 t . . . . . 0 C--N 1.35 0.617 0 C-N-CA 124.606 1.162 . . . . 0.0 110.38 176.467 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.518 2.931 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 45.34 60.54 4.07 Favored Glycine 0 C--N 1.355 1.631 0 CA-C-N 120.113 1.324 . . . . 0.0 113.986 -164.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.7 m -123.46 106.22 10.45 Favored 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 120.005 -1.88 . . . . 0.0 112.084 -166.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.33 -155.03 7.62 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.02 68.58 2.52 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.467 ' HA ' HD11 ' A' ' 18' ' ' LEU . 29.3 t -55.21 -27.92 49.49 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 126.113 1.765 . . . . 0.0 113.583 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -76.32 -29.51 57.34 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -178.6 87.32 0.22 Allowed Pre-proline 0 C--N 1.351 0.643 0 O-C-N 121.146 -0.971 . . . . 0.0 110.434 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -78.61 120.85 4.91 Favored 'Trans proline' 0 C--N 1.327 -0.554 0 C-N-CA 122.319 2.013 . . . . 0.0 112.854 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.9 t -120.57 6.63 10.55 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.248 1.819 . . . . 0.0 110.214 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 m -135.62 156.37 48.97 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 119.507 -1.996 . . . . 0.0 112.92 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -55.83 -45.9 78.24 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 120.352 -1.467 . . . . 0.0 112.919 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.44 94.7 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 125.216 1.406 . . . . 0.0 113.069 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -61.95 -53.91 49.08 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 120.39 -1.444 . . . . 0.0 113.317 172.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.91 -30.46 69.8 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.345 -0.847 . . . . 0.0 113.152 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.4 t90 -54.21 -45.08 72.15 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 120.097 -1.627 . . . . 0.0 113.389 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -62.34 -41.39 98.54 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 120.977 -1.077 . . . . 0.0 113.8 174.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.467 HD11 ' HA ' ' A' ' 6' ' ' SER . 2.4 mm? -55.16 -32.52 62.21 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 126.197 1.799 . . . . 0.0 114.629 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.6 tp -56.71 -28.13 60.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.376 1.471 . . . . 0.0 113.803 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p 71.04 17.91 6.04 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.54 2.336 . . . . 0.0 113.951 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.86 93.32 0.01 OUTLIER 'General case' 0 C--N 1.351 0.647 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 -164.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.86 -31.35 1.76 Allowed Glycine 0 C--N 1.345 1.077 0 O-C-N 121.034 -1.041 . . . . 0.0 111.96 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.4 -150.3 16.95 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-O 122.807 1.226 . . . . 0.0 112.407 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 t -97.27 139.89 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 120.913 -1.345 . . . . 0.0 109.458 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.16 156.48 48.51 Favored Pre-proline 0 N--CA 1.45 -0.453 0 O-C-N 120.438 -1.414 . . . . 0.0 108.64 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.69 8.33 2.35 Favored 'Trans proline' 0 N--CA 1.47 0.109 0 C-N-CA 123.058 2.505 . . . . 0.0 113.119 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? 61.45 47.32 6.8 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 125.85 1.66 . . . . 0.0 114.499 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.9 pt -60.78 140.93 17.89 Favored 'Isoleucine or valine' 0 C--N 1.349 0.576 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.5 mt -87.91 24.2 1.84 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-O 122.612 1.196 . . . . 0.0 111.743 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -80.95 138.42 36.1 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 120.428 -1.42 . . . . 0.0 110.49 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -86.85 120.92 28.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.656 -0.652 . . . . 0.0 111.524 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.3 p -109.29 -179.36 3.81 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.082 1.353 . . . . 0.0 110.109 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -119.92 -28.46 5.17 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 120.491 -1.38 . . . . 0.0 110.15 162.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -146.76 173.67 12.16 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 122.931 1.348 . . . . 0.0 113.271 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -73.65 -12.2 60.66 Favored 'General case' 0 C--N 1.346 0.435 0 O-C-N 119.842 -1.786 . . . . 0.0 113.839 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.3 p -78.16 -29.31 48.6 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 126.727 2.011 . . . . 0.0 111.79 173.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.66 -28.75 45.45 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.55 1.54 . . . . 0.0 109.728 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -94.39 119.47 66.4 Favored Pre-proline 0 N--CA 1.445 -0.685 0 O-C-N 120.953 -1.092 . . . . 0.0 113.078 -173.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.71 171.47 17.74 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.526 2.151 . . . . 0.0 114.525 -166.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.23 -84.95 1.14 Allowed Glycine 0 C--N 1.35 1.322 0 C-N-CA 124.345 0.974 . . . . 0.0 112.361 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.69 6.65 0.47 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.9 m -73.82 178.57 4.76 Favored 'General case' 0 C--N 1.347 0.496 0 O-C-N 120.353 -1.467 . . . . 0.0 112.656 -160.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 pp -141.38 149.4 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -86.88 111.68 21.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 126.338 1.855 . . . . 0.0 108.675 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -76.13 172.95 11.95 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 118.91 -2.369 . . . . 0.0 110.827 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.94 -19.36 6.93 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 117.548 1.779 . . . . 0.0 117.548 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -85.8 -8.51 58.07 Favored 'General case' 0 C--N 1.345 0.375 0 O-C-N 121.288 -1.125 . . . . 0.0 113.418 174.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.31 27.55 39.54 Favored Glycine 0 C--N 1.348 1.224 0 O-C-N 120.755 -1.216 . . . . 0.0 114.256 -175.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -137.3 146.69 44.97 Favored 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 120.942 -1.328 . . . . 0.0 110.917 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 83.1 m -78.45 135.95 37.51 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 123.747 1.736 . . . . 0.0 115.232 -170.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.347 0 CA-C-O 115.69 -2.728 . . . . 0.0 116.946 -175.097 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.451 HG11 HD13 ' B' ' 172' ' ' LEU . 15.0 m -133.21 170.28 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 119.126 0.876 . . . . 0.0 109.517 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 101.9 51.43 Favored Pre-proline 0 C--N 1.344 0.338 0 CA-C-O 116.849 -1.548 . . . . 0.0 110.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.32 164.23 35.84 Favored 'Trans proline' 0 C--N 1.326 -0.633 0 CA-C-N 123.871 2.418 . . . . 0.0 113.675 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -84.77 153.59 60.94 Favored Pre-proline 0 C--N 1.35 0.616 0 C-N-CA 123.905 0.882 . . . . 0.0 112.605 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.33 -24.27 27.24 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.312 2.675 . . . . 0.0 113.089 -172.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 mt -66.09 -54.48 25.21 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 121.365 -0.834 . . . . 0.0 110.698 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -56.82 -39.26 73.86 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 125.118 1.367 . . . . 0.0 113.663 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 15.8 tp -45.8 -40.62 9.92 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 125.37 1.468 . . . . 0.0 114.925 170.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 29.1 tttp -67.81 -34.79 77.43 Favored 'General case' 0 C--N 1.348 0.514 0 O-C-N 119.889 -1.757 . . . . 0.0 113.375 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.1 -50.25 35.63 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 124.887 1.275 . . . . 0.0 111.247 171.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.433 HD13 ' CE2' ' B' ' 113' ' ' TYR . 91.2 mt -55.17 -42.27 72.95 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 121.146 -0.972 . . . . 0.0 112.302 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.4 -26.05 67.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 175.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 4.0 t -77.93 -13.53 59.85 Favored 'General case' 0 C--N 1.344 0.369 0 O-C-N 120.958 -1.089 . . . . 0.0 112.425 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 5.2 t -97.37 -9.22 9.07 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 C-N-CA 125.154 1.382 . . . . 0.0 109.868 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.65 -20.06 10.27 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 120.465 -1.397 . . . . 0.0 112.514 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -89.28 91.52 8.79 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 120.514 -1.58 . . . . 0.0 112.215 -171.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -95.09 17.87 13.24 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 119.185 -2.197 . . . . 0.0 116.166 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -97.42 143.0 28.58 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.471 1.108 . . . . 0.0 112.937 -171.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.18 9.89 4.11 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 119.769 -1.832 . . . . 0.0 115.677 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.4 p -149.31 131.56 15.52 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 120.381 -1.45 . . . . 0.0 111.186 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . 0.433 ' CE2' HD13 ' B' ' 103' ' ' LEU . 78.6 m-85 -132.74 178.81 6.57 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-O 122.939 1.352 . . . . 0.0 110.814 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.04 163.64 14.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.658 1.583 . . . . 0.0 109.854 170.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 48.4 mtm -62.55 -48.77 78.06 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 119.012 -2.305 . . . . 0.0 113.812 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -60.91 -42.53 98.23 Favored 'General case' 0 C--N 1.349 0.562 0 O-C-N 121.274 -0.892 . . . . 0.0 113.176 173.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -50.94 -48.25 60.92 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.893 1.677 . . . . 0.0 114.804 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -52.45 -49.99 41.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 125.209 1.403 . . . . 0.0 111.884 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 0.447 HD21 HD13 ' B' ' 168' ' ' ILE . 4.5 mm? -75.01 -32.17 61.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 120.918 -1.114 . . . . 0.0 113.011 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -62.14 -57.81 10.16 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.557 1.543 . . . . 0.0 111.72 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -57.34 -44.13 84.02 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 123.977 0.911 . . . . 0.0 112.396 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.5 -54.0 50.77 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.41 -44.91 94.64 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 120.126 -1.609 . . . . 0.0 113.657 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -63.77 -32.43 73.93 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 124.139 0.976 . . . . 0.0 112.798 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -57.1 -57.91 10.51 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 120.842 -1.161 . . . . 0.0 112.262 170.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 38.1 mm -63.94 -41.41 92.41 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 O-C-N 120.392 -1.443 . . . . 0.0 112.566 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 46.9 ttm -54.56 -43.9 72.42 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 126.117 1.767 . . . . 0.0 113.705 172.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 20.5 m -86.96 -24.5 24.71 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 120.718 -1.239 . . . . 0.0 112.597 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -75.12 -26.74 59.45 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 119.702 -1.874 . . . . 0.0 113.173 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? 72.04 53.51 0.19 Allowed 'General case' 0 C--N 1.354 0.785 0 C-N-CA 126.113 1.765 . . . . 0.0 110.895 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.54 9.43 33.43 Favored 'General case' 0 C--N 1.348 0.514 0 O-C-N 121.1 -1.0 . . . . 0.0 111.848 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -93.34 146.57 23.63 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.41 160.93 31.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.842 -0.536 . . . . 0.0 110.423 173.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -76.57 -34.92 58.45 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 120.97 -1.081 . . . . 0.0 112.104 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -91.34 -44.87 8.91 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.426 -1.421 . . . . 0.0 110.929 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -107.67 57.12 0.63 Allowed 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.026 1.33 . . . . 0.0 111.721 -173.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -63.09 -11.77 22.16 Favored 'General case' 0 C--N 1.347 0.474 0 O-C-N 120.125 -1.609 . . . . 0.0 114.86 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -86.91 -4.03 59.14 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.343 1.457 . . . . 0.0 113.403 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 47.7 mm -101.55 137.13 30.34 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 C-N-CA 124.988 1.315 . . . . 0.0 108.991 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 16.7 t -123.8 123.34 66.8 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 120.85 -1.156 . . . . 0.0 110.701 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -93.33 113.92 26.22 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 121.192 -0.942 . . . . 0.0 110.101 173.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 16.5 m -115.37 20.92 14.5 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 121.191 -0.943 . . . . 0.0 110.334 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 71.3 p -74.76 140.14 43.85 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 120.11 -1.619 . . . . 0.0 109.862 171.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 3.4 t30 64.75 29.01 12.91 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -138.34 164.47 29.22 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 7.7 tp -70.8 -14.46 62.43 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-O 124.393 2.044 . . . . 0.0 113.536 -165.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.01 -35.71 69.5 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.946 1.699 . . . . 0.0 111.892 170.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.21 -43.22 99.41 Favored Glycine 0 C--N 1.348 1.201 0 O-C-N 120.096 -1.627 . . . . 0.0 113.029 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -53.15 -34.27 56.12 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 126.596 1.958 . . . . 0.0 114.731 172.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 pp -95.89 -31.24 13.23 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 119.538 -1.976 . . . . 0.0 113.402 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.481 ' HB3' HG22 ' B' ' 153' ' ' VAL . 18.5 m-85 -77.9 -42.41 33.35 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.737 1.215 . . . . 0.0 112.513 178.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 83.82 15.91 69.2 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 121.427 -0.795 . . . . 0.0 113.932 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' B' ' 151' ' ' PHE . 32.7 m -131.45 151.55 78.93 Favored Pre-proline 0 C--N 1.343 0.31 0 O-C-N 121.216 -1.167 . . . . 0.0 109.787 -174.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.18 -30.29 5.68 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.811 1.674 . . . . 0.0 112.653 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 87.2 p -154.0 169.4 23.57 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -138.74 165.61 26.54 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.204 1.002 . . . . 0.0 109.289 172.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 26.6 t -109.33 128.76 55.35 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.28 -31.84 51.39 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 O-C-N 120.623 -1.298 . . . . 0.0 111.739 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -58.75 -22.03 56.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.818 2.047 . . . . 0.0 114.463 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -82.4 58.49 4.13 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 120.404 -1.435 . . . . 0.0 112.071 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -49.17 -45.26 43.77 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.027 -1.671 . . . . 0.0 114.132 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -61.33 -33.07 73.01 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 120.64 -1.288 . . . . 0.0 114.234 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -73.95 -46.24 45.36 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 120.326 -1.484 . . . . 0.0 110.955 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 33.0 mm -50.5 -57.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.351 0.671 0 C-N-CA 125.173 1.389 . . . . 0.0 112.44 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . 0.55 ' HA ' HD12 ' B' ' 168' ' ' ILE . 37.5 m-85 -49.2 -46.16 45.26 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 171.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 31.9 m -62.91 -39.58 94.97 Favored 'General case' 0 C--N 1.346 0.429 0 O-C-N 120.543 -1.348 . . . . 0.0 113.379 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -44.94 88.1 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.388 -1.445 . . . . 0.0 111.752 177.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' B' ' 165' ' ' TYR . 22.0 mt -57.27 -53.11 48.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 C-N-CA 125.473 1.509 . . . . 0.0 112.291 174.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -62.74 -11.92 20.66 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.274 -1.516 . . . . 0.0 114.835 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -85.47 -11.65 53.79 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 119.394 -2.066 . . . . 0.0 113.571 169.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -105.04 -21.24 13.31 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 120.194 -1.567 . . . . 0.0 109.883 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.451 HD13 HG11 ' B' ' 93' ' ' VAL . 73.2 mt -110.92 151.67 27.64 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 126.111 1.764 . . . . 0.0 110.809 -175.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 61.0 t -96.17 119.63 44.48 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 O-C-N 120.473 -1.392 . . . . 0.0 108.954 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 56.3 t . . . . . 0 C--N 1.348 0.541 0 C-N-CA 124.166 0.986 . . . . 0.0 110.919 177.169 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.519 3.024 0 CA-C-O 116.743 -1.599 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 48.93 39.23 25.24 Favored Glycine 0 C--N 1.357 1.701 0 CA-C-N 120.23 1.377 . . . . 0.0 115.353 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.7 m -118.18 120.06 36.57 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.507 -1.584 . . . . 0.0 111.177 -167.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.05 -148.99 5.91 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.25 78.03 3.78 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 120.996 -1.297 . . . . 0.0 113.239 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.404 ' HA ' HD11 ' A' ' 18' ' ' LEU . 8.2 t -72.95 3.05 5.76 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 119.435 -2.041 . . . . 0.0 115.457 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -100.74 -44.61 5.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.614 -1.304 . . . . 0.0 110.958 173.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -150.52 85.96 5.18 Favored Pre-proline 0 N--CA 1.443 -0.798 0 O-C-N 121.552 -0.717 . . . . 0.0 109.319 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.84 108.98 2.76 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.273 1.982 . . . . 0.0 110.982 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 t -101.88 -19.89 15.1 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.041 0.936 . . . . 0.0 110.413 -174.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.3 m -120.51 164.64 16.12 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-O 122.797 1.284 . . . . 0.0 113.617 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -61.51 -49.65 75.88 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 126.316 1.846 . . . . 0.0 110.978 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.36 78.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.055 0.942 . . . . 0.0 113.511 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -68.91 -52.71 26.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 121.269 -0.895 . . . . 0.0 112.628 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -29.13 69.79 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 120.695 -1.253 . . . . 0.0 112.574 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -53.05 -38.28 62.32 Favored 'General case' 0 C--N 1.346 0.452 0 O-C-N 120.439 -1.413 . . . . 0.0 113.796 167.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -73.49 -37.23 65.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.416 -1.427 . . . . 0.0 112.726 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.404 HD11 ' HA ' ' A' ' 6' ' ' SER . 4.4 mm? -60.2 -24.02 64.47 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.992 1.317 . . . . 0.0 114.493 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.3 tp -67.84 -23.74 65.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.689 -1.257 . . . . 0.0 112.303 172.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 t 55.26 44.01 28.21 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 127.314 2.246 . . . . 0.0 112.936 -175.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.6 85.25 0.02 OUTLIER 'General case' 0 C--N 1.353 0.748 0 C-N-CA 127.17 2.188 . . . . 0.0 113.92 -172.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.452 ' HA3' ' HB1' ' A' ' 41' ' ' ALA . . . 156.73 -41.82 0.55 Allowed Glycine 0 CA--C 1.492 -1.376 0 O-C-N 121.057 -1.027 . . . . 0.0 112.807 -164.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.77 -142.62 16.09 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.6 p -94.28 135.67 27.93 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 O-C-N 120.562 -1.552 . . . . 0.0 110.445 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.1 t -129.79 145.42 56.98 Favored Pre-proline 0 C--N 1.347 0.486 0 CA-C-O 115.81 -2.043 . . . . 0.0 106.783 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -66.22 -2.36 6.88 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 124.428 3.418 . . . . 0.0 117.47 -164.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.69 52.93 0.41 Allowed 'General case' 0 C--N 1.349 0.582 0 C-N-CA 125.293 1.437 . . . . 0.0 112.48 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.3 pt -70.06 140.59 18.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.466 0 O-C-N 120.299 -1.5 . . . . 0.0 114.093 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.1 mt -88.95 33.76 0.78 Allowed 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.132 -0.98 . . . . 0.0 111.282 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -88.69 131.42 35.02 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 119.945 -1.722 . . . . 0.0 109.394 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.16 108.27 7.8 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 122.238 1.018 . . . . 0.0 111.072 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.0 p -107.3 -161.29 0.77 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.569 1.548 . . . . 0.0 111.391 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -150.45 -37.38 0.14 Allowed 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.619 -1.926 . . . . 0.0 109.47 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -133.51 174.85 9.98 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 171.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -74.15 -2.32 24.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 119.141 -2.225 . . . . 0.0 115.273 -172.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.5 m -90.15 -40.28 12.33 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 125.657 1.583 . . . . 0.0 111.934 -173.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.64 -29.8 68.36 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 123.281 1.515 . . . . 0.0 110.897 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 15.3 t -90.71 109.16 32.56 Favored Pre-proline 0 N--CA 1.443 -0.785 0 C-N-CA 125.429 1.492 . . . . 0.0 111.255 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.87 171.73 17.62 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.449 2.099 . . . . 0.0 115.294 -160.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.83 -93.26 1.58 Allowed Glycine 0 C--N 1.347 1.172 0 C-N-CA 124.271 0.939 . . . . 0.0 112.49 173.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB1' ' HA3' ' A' ' 22' ' ' GLY . . . -156.44 24.88 0.35 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 122.964 1.364 . . . . 0.0 111.096 -176.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 54.4 m -88.57 153.37 21.18 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 119.95 -1.719 . . . . 0.0 108.058 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.4 pp -119.83 154.58 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 170.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.3 m -85.11 134.51 34.19 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.1 mtt85 -82.8 168.89 16.71 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.624 -1.297 . . . . 0.0 108.356 167.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -32.8 -43.48 0.18 Allowed Glycine 0 C--N 1.353 1.508 0 N-CA-C 119.33 2.492 . . . . 0.0 119.33 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -74.07 8.43 2.09 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.92 36.38 90.94 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 119.915 -1.741 . . . . 0.0 114.191 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -135.61 147.27 48.6 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 122.08 0.943 . . . . 0.0 108.609 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.1 m -78.45 130.77 36.45 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 125.212 2.434 . . . . 0.0 113.933 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.274 0 N-CA-C 105.716 -2.954 . . . . 0.0 105.716 -177.87 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 20.7 m -120.72 167.27 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 119.496 1.044 . . . . 0.0 109.217 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -141.54 114.83 6.76 Favored Pre-proline 0 C--N 1.35 0.619 0 CA-C-O 116.694 -1.622 . . . . 0.0 108.181 170.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.73 168.12 25.54 Favored 'Trans proline' 0 C--N 1.328 -0.504 0 CA-C-N 123.822 2.401 . . . . 0.0 112.747 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -84.71 159.54 57.82 Favored Pre-proline 0 C--N 1.346 0.439 0 O-C-N 120.891 -1.13 . . . . 0.0 111.698 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -68.48 -25.16 35.56 Favored 'Trans proline' 0 CA--C 1.521 -0.159 0 C-N-CA 122.781 2.32 . . . . 0.0 114.275 -170.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.05 -42.31 99.68 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.238 0.926 . . . . 0.0 110.526 170.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 17.2 tp -72.45 -34.98 68.14 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 120.191 -1.568 . . . . 0.0 113.11 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 33.0 tp -53.3 -42.07 66.26 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.154 -1.591 . . . . 0.0 113.622 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -62.42 -30.85 71.52 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 120.47 -1.394 . . . . 0.0 113.82 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 24.0 tp -67.66 -61.37 1.92 Allowed 'General case' 0 C--N 1.35 0.619 0 C-N-CA 123.672 0.789 . . . . 0.0 110.335 172.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.29 -49.22 61.69 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 126.39 1.876 . . . . 0.0 113.305 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -14.27 61.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 120.088 -1.632 . . . . 0.0 114.871 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -85.34 -6.92 59.2 Favored 'General case' 0 C--N 1.346 0.413 0 O-C-N 120.047 -1.658 . . . . 0.0 112.234 168.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 15.2 t -94.37 -5.62 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.944 1.298 . . . . 0.0 109.061 163.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.98 -13.36 31.76 Favored Glycine 0 C--N 1.354 1.57 0 O-C-N 119.816 -1.802 . . . . 0.0 113.393 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.11 69.59 10.51 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 120.757 -1.437 . . . . 0.0 113.888 -173.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . 0.25 3.3 pm0 -78.68 76.74 5.18 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 119.61 -1.931 . . . . 0.0 110.959 165.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -151.06 124.5 8.93 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 120.815 -1.178 . . . . 0.0 109.239 168.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.89 -49.43 65.91 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 128.165 2.586 . . . . 0.0 113.475 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 22.6 p -94.48 90.22 6.13 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.139 -1.6 . . . . 0.0 114.755 -169.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -104.32 173.21 6.4 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-O 123.67 1.7 . . . . 0.0 114.522 171.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 32.7 m -96.34 159.52 14.9 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 127.281 2.233 . . . . 0.0 109.985 -173.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 2.4 mmt -53.7 -45.96 70.59 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -63.18 -50.0 72.07 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 120.583 -1.323 . . . . 0.0 112.149 170.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -54.49 -42.36 70.65 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -173.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 47.3 t -58.52 -30.91 42.28 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 O-C-N 120.927 -1.108 . . . . 0.0 111.563 175.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.2 -33.37 14.72 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.261 1.025 . . . . 0.0 112.161 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -56.89 -64.68 0.8 Allowed 'General case' 0 C--N 1.352 0.675 0 O-C-N 119.954 -1.716 . . . . 0.0 113.028 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -56.86 -39.86 75.08 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 124.278 1.031 . . . . 0.0 112.221 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 27.1 tp -63.44 -52.66 60.52 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 120.713 -1.242 . . . . 0.0 113.254 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.77 -41.31 93.73 Favored Glycine 0 C--N 1.349 1.276 0 O-C-N 120.099 -1.625 . . . . 0.0 114.022 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -56.52 -43.46 79.8 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 125.732 1.613 . . . . 0.0 112.85 173.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -54.83 -55.65 27.96 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.585 1.154 . . . . 0.0 112.459 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 3.5 mp -63.95 -43.29 97.65 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 O-C-N 120.35 -1.469 . . . . 0.0 112.215 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 45.9 ttm -57.04 -36.38 70.41 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 125.0 1.32 . . . . 0.0 113.352 175.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 26.1 m -86.06 -34.65 20.64 Favored 'General case' 0 C--N 1.344 0.344 0 O-C-N 120.394 -1.441 . . . . 0.0 112.424 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -68.34 -33.89 75.1 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 120.091 -1.631 . . . . 0.0 114.557 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 77.34 50.92 0.04 OUTLIER 'General case' 0 C--N 1.353 0.719 0 C-N-CA 126.608 1.963 . . . . 0.0 111.017 -171.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 95.1 mt -109.8 34.05 4.05 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 122.713 1.244 . . . . 0.0 110.331 169.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -110.52 148.26 32.47 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 163.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -75.48 161.97 28.74 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.277 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . 0.264 35.8 mt-10 -62.9 -47.9 81.28 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 119.995 -1.691 . . . . 0.0 111.261 172.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.21 -43.92 10.65 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.765 1.626 . . . . 0.0 108.638 -164.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -108.81 63.36 0.6 Allowed 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 125.015 1.326 . . . . 0.0 112.235 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -65.25 -7.24 12.17 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 118.898 -2.376 . . . . 0.0 114.627 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -82.69 -8.95 59.57 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.606 1.562 . . . . 0.0 113.88 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 46.4 mm -99.8 128.86 51.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 O-C-N 120.87 -1.144 . . . . 0.0 109.759 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 48.8 t -116.56 128.38 73.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.481 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -90.78 121.46 32.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 120.902 -1.123 . . . . 0.0 109.071 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 58.5 m -116.35 12.68 15.36 Favored 'General case' 0 CA--C 1.51 -0.584 0 O-C-N 121.131 -0.981 . . . . 0.0 110.837 171.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 33.0 p -71.7 131.97 43.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.112 -1.618 . . . . 0.0 108.994 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 76.55 -27.11 0.18 Allowed 'General case' 0 C--N 1.351 0.647 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -74.99 164.92 26.04 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 119.846 -1.784 . . . . 0.0 111.783 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 33.2 tp -67.94 -18.99 64.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.735 2.014 . . . . 0.0 113.013 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.24 -32.38 71.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.27 -1.519 . . . . 0.0 113.005 167.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.87 -33.25 79.29 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 120.115 -1.616 . . . . 0.0 113.813 -174.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -50.87 -57.31 8.78 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.212 2.605 . . . . 0.0 111.833 170.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 3.9 pp -76.65 -21.75 55.01 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -86.13 -37.1 19.12 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.011 -1.055 . . . . 0.0 112.222 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.12 15.48 78.67 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 121.179 -0.95 . . . . 0.0 114.337 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 29.5 m -125.42 159.38 60.48 Favored Pre-proline 0 C--N 1.344 0.343 0 O-C-N 120.99 -1.3 . . . . 0.0 110.214 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.37 -43.73 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.607 1.538 . . . . 0.0 112.653 172.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 54.6 m -151.76 167.0 29.61 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -126.02 177.69 6.2 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.728 0.775 . . . . 0.0 109.727 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 48.3 t -121.94 123.34 41.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 120.979 -1.076 . . . . 0.0 108.758 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.11 -27.43 43.14 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 O-C-N 120.437 -1.414 . . . . 0.0 112.157 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -55.04 -28.67 53.95 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.182 1.393 . . . . 0.0 114.352 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -81.83 52.12 1.87 Allowed 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.255 -1.528 . . . . 0.0 112.959 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -46.94 -45.58 20.84 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 126.741 2.017 . . . . 0.0 114.844 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -72.16 -1.66 15.84 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 126.709 2.004 . . . . 0.0 115.667 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -105.18 -38.35 6.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.443 -1.411 . . . . 0.0 109.176 167.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 30.4 mm -56.43 -52.53 51.34 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 O-C-N 120.946 -1.096 . . . . 0.0 112.727 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -53.33 -38.36 63.14 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 120.284 -1.51 . . . . 0.0 114.053 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 42.4 m -64.37 -35.9 82.38 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 125.689 1.596 . . . . 0.0 113.585 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 54.6 mtt -65.88 -47.01 76.27 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.334 -1.479 . . . . 0.0 111.281 172.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 50.9 mm -56.09 -50.31 70.93 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 C-N-CA 126.062 1.745 . . . . 0.0 113.201 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -63.38 -12.31 29.56 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 119.473 -2.017 . . . . 0.0 115.931 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -96.9 -12.51 23.38 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 119.468 -2.02 . . . . 0.0 112.839 170.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -84.07 -38.51 20.72 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 119.95 -1.719 . . . . 0.0 109.194 170.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 66.2 mt -93.53 -179.89 5.17 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.944 1.697 . . . . 0.0 113.926 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 94.6 t -111.55 128.54 68.0 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 167.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 C--N 1.349 0.56 0 O-C-N 121.19 -0.944 . . . . 0.0 110.916 176.269 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.276 91.7 p . . . . . 0 N--CA 1.531 3.593 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -5.72 74.92 0.0 OUTLIER Glycine 0 C--N 1.363 2.058 0 C-N-CA 129.423 3.392 . . . . 0.0 119.785 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.3 m -116.07 119.02 34.5 Favored 'General case' 0 CA--C 1.506 -0.746 0 O-C-N 120.978 -1.307 . . . . 0.0 108.492 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.56 -161.23 8.88 Favored Glycine 0 CA--C 1.494 -1.243 0 N-CA-C 105.967 -2.853 . . . . 0.0 105.967 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.49 79.69 0.79 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 119.048 1.424 . . . . 0.0 114.313 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 64.2 p -67.56 -16.86 64.41 Favored 'General case' 0 C--N 1.347 0.473 0 O-C-N 119.685 -1.885 . . . . 0.0 113.907 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -77.05 -31.29 56.09 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.995 1.718 . . . . 0.0 113.386 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -175.78 89.17 0.29 Allowed Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.37 137.23 18.56 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 CA-C-N 121.893 1.712 . . . . 0.0 110.232 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.8 t -127.38 -60.4 1.19 Allowed 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.3 m -68.93 170.93 8.82 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 123.674 1.702 . . . . 0.0 115.559 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -73.75 -35.76 65.07 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 119.945 -1.722 . . . . 0.0 114.489 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.87 -45.9 76.66 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 119.601 -1.937 . . . . 0.0 111.466 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -43.47 -66.98 0.31 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 129.048 2.939 . . . . 0.0 112.933 167.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.29 -6.63 53.9 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 120.383 -1.448 . . . . 0.0 114.461 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -74.09 -51.72 14.83 Favored 'General case' 0 C--N 1.346 0.416 0 O-C-N 119.193 -2.192 . . . . 0.0 110.854 165.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -61.36 -35.71 78.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.094 -1.629 . . . . 0.0 115.19 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.85 -15.42 20.89 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.8 tp -62.03 -26.21 68.11 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 120.326 -1.484 . . . . 0.0 113.214 172.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 t 60.22 49.34 7.31 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-O 123.933 1.825 . . . . 0.0 111.047 -169.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.72 89.16 0.55 Allowed 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.394 1.477 . . . . 0.0 112.629 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.515 ' HA3' ' HB1' ' A' ' 41' ' ' ALA . . . 150.11 -48.17 0.59 Allowed Glycine 0 CA--C 1.496 -1.1 0 O-C-N 121.478 -0.764 . . . . 0.0 114.996 -168.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.17 -144.8 17.03 Favored Glycine 0 C--N 1.345 1.033 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -167.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.5 p -110.94 136.81 45.85 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 O-C-N 120.658 -1.495 . . . . 0.0 111.065 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.2 m -100.04 158.54 31.86 Favored Pre-proline 0 C--N 1.35 0.624 0 O-C-N 120.182 -1.574 . . . . 0.0 110.479 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.52 11.19 1.08 Allowed 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.987 2.458 . . . . 0.0 113.118 164.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt 59.81 49.83 7.6 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 126.008 1.723 . . . . 0.0 115.296 171.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.8 pt -63.51 144.7 14.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 -171.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.6 pt? -85.13 20.22 1.98 Allowed 'General case' 0 C--N 1.347 0.471 0 O-C-N 120.679 -1.263 . . . . 0.0 113.825 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -77.28 126.67 31.3 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 119.364 -2.085 . . . . 0.0 111.21 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -78.55 100.82 7.09 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.988 0.899 . . . . 0.0 112.331 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.2 p -96.13 -175.82 3.49 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.494 1.918 . . . . 0.0 111.666 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -124.11 -41.71 2.19 Favored 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 120.16 -1.588 . . . . 0.0 112.303 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -142.0 168.31 20.04 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 103.784 -2.672 . . . . 0.0 103.784 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -68.95 -26.33 65.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 119.476 -2.015 . . . . 0.0 115.778 -167.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 m -50.93 -45.47 60.51 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 126.593 1.957 . . . . 0.0 114.801 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.85 -22.67 65.71 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 128.131 2.573 . . . . 0.0 113.961 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.6 t -103.63 106.78 53.84 Favored Pre-proline 0 C--N 1.353 0.726 0 O-C-N 119.834 -1.791 . . . . 0.0 112.489 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.11 159.37 53.4 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.804 2.336 . . . . 0.0 114.452 -162.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.7 -96.13 1.92 Allowed Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.515 ' HB1' ' HA3' ' A' ' 22' ' ' GLY . . . -161.35 40.61 0.15 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 123.088 1.423 . . . . 0.0 111.116 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.9 m -90.34 178.94 6.0 Favored 'General case' 0 N--CA 1.44 -0.939 0 O-C-N 119.847 -1.783 . . . . 0.0 109.267 -175.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.87 150.71 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 103.211 -2.885 . . . . 0.0 103.211 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.0 m -82.61 127.45 33.38 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.318 1.047 . . . . 0.0 108.368 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -78.36 172.11 14.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.917 -1.114 . . . . 0.0 108.663 170.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.5 -32.61 15.95 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 116.655 1.422 . . . . 0.0 116.655 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -70.03 -9.57 55.73 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.6 20.93 57.47 Favored Glycine 0 C--N 1.349 1.298 0 O-C-N 120.57 -1.331 . . . . 0.0 114.247 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -121.6 146.6 46.81 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 120.607 -1.526 . . . . 0.0 110.616 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.0 m -73.39 133.5 43.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -170.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.714 0 CA-C-O 117.05 -1.972 . . . . 0.0 114.955 173.865 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 94.5 mt . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 19.7 m -121.97 152.31 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 -109.79 117.87 51.34 Favored Pre-proline 0 C--N 1.352 0.679 0 CA-C-O 115.92 -1.99 . . . . 0.0 108.721 172.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.71 167.12 27.02 Favored 'Trans proline' 0 C--N 1.321 -0.897 0 C-N-CA 123.272 2.648 . . . . 0.0 113.19 166.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -78.56 159.04 75.29 Favored Pre-proline 0 C--N 1.351 0.661 0 O-C-N 120.472 -1.393 . . . . 0.0 112.81 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -65.69 -21.68 58.47 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.18 2.586 . . . . 0.0 114.681 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 94.0 mt -70.25 -46.03 65.23 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.131 0.878 . . . . 0.0 111.391 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 18.1 tp -64.68 -33.55 76.22 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 120.993 -1.067 . . . . 0.0 111.809 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 17.9 tp -55.81 -42.07 75.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -65.93 -31.69 72.75 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 119.072 -2.268 . . . . 0.0 113.42 174.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 22.2 tp -66.08 -52.78 45.66 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 121.415 -0.803 . . . . 0.0 111.637 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -54.05 -42.94 69.78 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 124.179 0.992 . . . . 0.0 112.652 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -57.46 -27.18 62.23 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 170.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 21.8 t -78.11 -16.95 57.51 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 120.412 -1.43 . . . . 0.0 112.232 173.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . 0.435 HG22 ' CD1' ' B' ' 125' ' ' TYR . 1.5 t -97.76 4.25 9.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 O-C-N 120.561 -1.337 . . . . 0.0 110.75 172.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.89 -19.39 54.2 Favored Glycine 0 C--N 1.353 1.495 0 O-C-N 119.801 -1.812 . . . . 0.0 113.357 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -76.62 75.12 3.31 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 126.212 1.805 . . . . 0.0 112.848 -174.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -89.22 1.82 55.14 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -170.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.88 160.25 30.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.649 -0.657 . . . . 0.0 110.41 172.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -74.14 -59.84 2.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 123.463 1.602 . . . . 0.0 108.822 161.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 29.9 p -71.5 98.44 1.84 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.352 1.861 . . . . 0.0 115.54 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -112.0 -179.61 3.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 123.354 1.549 . . . . 0.0 111.901 167.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 94.4 m -103.69 155.26 18.71 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.19 1.796 . . . . 0.0 108.683 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 92.7 mtp -54.8 -47.15 74.38 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 119.394 -2.066 . . . . 0.0 115.661 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -57.01 -54.33 48.0 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 120.945 -1.097 . . . . 0.0 112.464 168.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -46.77 -50.15 18.64 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 126.009 1.724 . . . . 0.0 115.079 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.7 t -52.49 -48.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 120.051 -1.655 . . . . 0.0 112.804 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.89 -24.55 44.11 Favored 'General case' 0 C--N 1.347 0.477 0 O-C-N 120.464 -1.398 . . . . 0.0 112.891 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -65.22 -62.82 1.31 Allowed 'General case' 0 C--N 1.345 0.394 0 C-N-CA 125.945 1.698 . . . . 0.0 111.105 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -53.92 -41.11 67.32 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 124.313 1.045 . . . . 0.0 111.953 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 21.5 tp -63.43 -55.54 23.46 Favored 'General case' 0 C--N 1.349 0.547 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.79 -42.21 98.61 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 119.552 -1.968 . . . . 0.0 114.345 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -63.59 -28.78 70.16 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.123 1.369 . . . . 0.0 112.303 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.435 ' CD1' HG22 ' B' ' 106' ' ' VAL . 10.5 t80 -61.96 -53.17 59.42 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.683 -1.26 . . . . 0.0 112.405 173.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 2.9 mp -62.58 -43.65 98.66 Favored 'Isoleucine or valine' 0 C--N 1.351 0.65 0 C-N-CA 124.493 1.117 . . . . 0.0 111.306 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 44.5 ttm -50.88 -43.11 59.55 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 125.234 1.413 . . . . 0.0 112.97 172.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 24.4 m -85.25 -30.2 24.01 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 120.496 -1.378 . . . . 0.0 113.334 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.0 -30.0 63.45 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 119.521 -1.987 . . . . 0.0 114.12 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? 76.02 41.53 0.23 Allowed 'General case' 0 C--N 1.352 0.681 0 C-N-CA 125.244 1.418 . . . . 0.0 110.956 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 93.6 mt -104.68 34.0 3.33 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 122.372 1.082 . . . . 0.0 110.845 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -114.96 146.04 41.61 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 165.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.6 151.98 42.04 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 121.189 -0.944 . . . . 0.0 109.264 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.98 -33.52 74.8 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 122.59 1.186 . . . . 0.0 112.004 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -109.92 -28.21 8.86 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 124.345 1.058 . . . . 0.0 112.236 -172.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -109.67 53.79 0.68 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.321 1.848 . . . . 0.0 110.936 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -55.97 -18.38 9.09 Favored 'General case' 0 C--N 1.349 0.56 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -82.84 -5.74 59.12 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.011 1.724 . . . . 0.0 114.877 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 44.1 mm -97.41 123.16 49.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 O-C-N 120.541 -1.349 . . . . 0.0 110.22 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 52.3 t -108.12 129.51 62.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.544 0 O-C-N 120.972 -1.08 . . . . 0.0 108.414 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -95.33 113.79 25.5 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.119 -0.988 . . . . 0.0 109.276 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 63.8 m -118.6 20.85 12.82 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 121.884 0.849 . . . . 0.0 109.986 171.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 34.7 p -76.66 136.65 39.15 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 120.341 -1.474 . . . . 0.0 108.228 170.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 1.2 t30 76.24 -36.06 0.27 Allowed 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -69.26 168.48 14.12 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.64 -1.287 . . . . 0.0 112.661 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 22.9 tp -70.7 -17.54 62.83 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.604 1.562 . . . . 0.0 112.778 -168.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.92 -29.38 66.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.297 -1.502 . . . . 0.0 113.896 168.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.6 -39.0 97.12 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 120.609 -1.307 . . . . 0.0 114.031 -173.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -51.37 -55.3 19.24 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 127.251 2.22 . . . . 0.0 111.816 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 pp -74.62 -27.66 60.55 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 119.867 -1.77 . . . . 0.0 115.098 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -80.81 -40.91 24.19 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 121.387 -0.82 . . . . 0.0 112.114 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.37 22.39 62.76 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 124.162 0.886 . . . . 0.0 113.65 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.74 160.97 66.28 Favored Pre-proline 0 C--N 1.343 0.304 0 O-C-N 121.231 -1.158 . . . . 0.0 108.96 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.04 -51.22 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 121.477 1.563 . . . . 0.0 112.455 170.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 66.8 m -147.93 168.2 22.87 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 119.909 1.232 . . . . 0.0 107.845 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -129.97 173.72 10.44 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.759 0.823 . . . . 0.0 108.864 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 11.4 t -113.74 129.19 56.61 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.18 -1.575 . . . . 0.0 109.859 172.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 35.1 t -60.72 -26.72 39.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.94 0 O-C-N 119.922 -1.736 . . . . 0.0 112.996 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -50.03 -25.2 3.16 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 126.449 1.9 . . . . 0.0 114.694 171.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -91.18 46.7 1.33 Allowed 'General case' 0 N--CA 1.439 -1.007 0 O-C-N 119.502 -1.999 . . . . 0.0 113.687 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -32.66 -55.36 0.36 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 128.279 2.632 . . . . 0.0 117.74 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -59.46 -28.7 67.22 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.037 1.735 . . . . 0.0 115.256 172.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -83.24 -32.57 26.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 119.646 -1.909 . . . . 0.0 112.02 172.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 37.7 mm -54.28 -54.97 17.04 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 O-C-N 120.902 -1.124 . . . . 0.0 110.789 171.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -57.39 -33.61 68.03 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 119.989 -1.694 . . . . 0.0 115.271 171.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 86.4 m -60.65 -35.42 76.17 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.237 -1.54 . . . . 0.0 112.233 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 43.1 mtt -72.85 -48.26 39.11 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.69 -1.257 . . . . 0.0 111.615 172.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 50.9 mm -57.61 -50.39 77.49 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 C-N-CA 124.668 1.187 . . . . 0.0 113.487 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -66.19 -11.08 47.45 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -79.92 -27.13 39.92 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 119.004 -2.31 . . . . 0.0 111.153 170.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -104.69 -2.61 24.74 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 124.298 1.039 . . . . 0.0 110.332 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 43.6 mt -125.93 143.12 51.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.944 2.098 . . . . 0.0 109.567 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 10.7 p -68.86 123.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 O-C-N 119.588 -1.945 . . . . 0.0 113.422 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 54.0 t . . . . . 0 C--N 1.351 0.638 0 C-N-CA 124.667 1.187 . . . . 0.0 110.718 175.58 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.511 2.582 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.71 49.31 77.58 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 119.158 0.89 . . . . 0.0 112.281 -165.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -139.66 96.31 3.06 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 121.356 -1.085 . . . . 0.0 110.046 -167.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.49 -141.1 10.62 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-O 121.882 0.712 . . . . 0.0 113.647 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.99 68.88 6.23 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-O 123.115 1.436 . . . . 0.0 111.614 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 p -69.79 -9.42 54.57 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 126.671 1.988 . . . . 0.0 114.242 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -78.0 -42.86 31.27 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.738 1.215 . . . . 0.0 112.124 171.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -166.83 89.13 0.78 Allowed Pre-proline 0 N--CA 1.448 -0.535 0 O-C-N 121.529 -0.732 . . . . 0.0 110.035 -173.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.44 115.46 2.87 Favored 'Trans proline' 0 C--N 1.329 -0.474 0 C-N-CA 122.32 2.013 . . . . 0.0 112.211 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -116.11 -31.91 5.54 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 119.109 0.868 . . . . 0.0 113.248 -170.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.8 m -105.31 176.96 4.99 Favored 'General case' 0 C--N 1.345 0.387 0 O-C-N 119.472 -2.017 . . . . 0.0 111.397 167.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -63.86 -40.42 96.51 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 119.805 -1.81 . . . . 0.0 113.408 -176.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.55 -44.45 85.24 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.571 1.948 . . . . 0.0 113.529 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -55.87 -58.99 5.54 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.033 1.333 . . . . 0.0 114.401 170.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.42 -29.98 69.33 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -37.18 52.93 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 124.933 1.293 . . . . 0.0 113.897 173.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -101.06 18.87 18.62 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 121.025 -1.047 . . . . 0.0 112.22 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.62 -29.04 13.27 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.448 1.099 . . . . 0.0 110.007 165.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.6 -29.13 69.02 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 122.423 1.106 . . . . 0.0 112.38 171.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 m 65.85 43.56 3.06 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 125.797 1.639 . . . . 0.0 112.555 174.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.61 93.49 0.01 OUTLIER 'General case' 0 C--N 1.351 0.646 0 C-N-CA 127.215 2.206 . . . . 0.0 116.778 -170.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.523 ' HA3' ' HB1' ' A' ' 41' ' ' ALA . . . 158.29 -47.34 0.44 Allowed Glycine 0 CA--C 1.491 -1.423 0 C-N-CA 119.796 -1.193 . . . . 0.0 115.019 -171.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.17 -121.14 4.32 Favored Glycine 0 CA--C 1.499 -0.933 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -171.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 p -129.65 143.47 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 O-C-N 121.055 -1.262 . . . . 0.0 108.327 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 62.8 m -104.24 162.19 20.64 Favored Pre-proline 0 C--N 1.346 0.444 0 O-C-N 120.278 -1.514 . . . . 0.0 110.45 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.1 -26.46 57.75 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.576 2.184 . . . . 0.0 112.076 168.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 79.82 78.77 0.05 OUTLIER 'General case' 0 C--N 1.354 0.768 0 C-N-CA 127.605 2.362 . . . . 0.0 110.507 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.8 pt -80.73 140.77 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 O-C-N 120.93 -1.106 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.1 pp -83.33 6.62 19.19 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 122.354 1.073 . . . . 0.0 112.394 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -63.02 132.02 50.57 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 125.112 1.365 . . . . 0.0 111.545 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -74.26 141.14 45.36 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.286 -0.884 . . . . 0.0 111.577 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.0 p -132.7 169.0 17.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 120.777 -1.202 . . . . 0.0 109.563 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -116.56 -37.25 3.74 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 120.012 -1.68 . . . . 0.0 110.683 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -141.61 -171.92 3.42 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.226 1.01 . . . . 0.0 108.622 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.42 -7.1 48.01 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 119.224 -2.172 . . . . 0.0 112.875 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 p -81.38 -40.03 24.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.719 2.008 . . . . 0.0 113.098 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.52 -28.0 68.87 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-O 122.618 1.199 . . . . 0.0 113.042 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.7 t -99.11 108.73 51.21 Favored Pre-proline 0 N--CA 1.443 -0.799 0 C-N-CA 124.107 0.963 . . . . 0.0 112.224 -164.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.77 151.55 57.57 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.113 1.875 . . . . 0.0 113.457 -168.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.09 -120.91 7.01 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.523 ' HB1' ' HA3' ' A' ' 22' ' ' GLY . . . -136.91 41.98 2.47 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.343 1.544 . . . . 0.0 110.149 176.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.1 m -107.85 112.82 25.64 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.014 -1.678 . . . . 0.0 110.736 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.8 pp -76.31 145.51 10.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 O-C-N 120.199 -1.563 . . . . 0.0 112.203 173.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.4 t -80.41 134.95 36.07 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.181 1.392 . . . . 0.0 110.063 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -86.14 167.5 14.87 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 119.56 -1.962 . . . . 0.0 110.869 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -37.34 -45.6 1.3 Allowed Glycine 0 C--N 1.356 1.664 0 C-N-CA 126.898 2.189 . . . . 0.0 118.13 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -62.75 -19.19 63.72 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.2 33.54 8.73 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 120.464 -1.398 . . . . 0.0 112.991 -172.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -139.46 142.37 37.38 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.018 -1.284 . . . . 0.0 107.631 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.95 125.18 27.0 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-O 123.397 1.57 . . . . 0.0 114.272 -173.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.343 0 O-C-N 119.946 -1.721 . . . . 0.0 113.354 -176.336 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.505 2.276 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.18 156.58 40.37 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 mtt-85 -113.73 113.0 47.76 Favored Pre-proline 0 C--N 1.348 0.516 0 CA-C-O 116.526 -1.702 . . . . 0.0 110.578 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.13 166.01 30.57 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 CA-C-N 124.355 2.591 . . . . 0.0 113.09 164.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -82.73 159.05 64.43 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.879 0.872 . . . . 0.0 112.834 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.22 -21.01 36.62 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.881 2.387 . . . . 0.0 114.734 -174.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 93.0 mt -67.37 -43.95 80.18 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 119.799 1.181 . . . . 0.0 111.112 173.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 28.7 tp -64.71 -40.45 95.38 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 124.089 0.956 . . . . 0.0 112.403 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 34.8 tp -49.41 -39.53 33.05 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.38 -32.26 72.21 Favored 'General case' 0 C--N 1.35 0.601 0 O-C-N 119.434 -2.041 . . . . 0.0 113.291 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tt -71.41 -49.88 37.5 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 121.52 -0.737 . . . . 0.0 110.442 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 96.4 mt -52.04 -44.16 64.1 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 124.658 1.183 . . . . 0.0 113.8 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -54.18 -36.15 63.09 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 120.415 -1.428 . . . . 0.0 114.321 169.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.8 t -73.92 -6.74 49.08 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.158 1.383 . . . . 0.0 112.231 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 1.6 t -108.64 7.52 9.28 Favored 'Isoleucine or valine' 0 C--N 1.35 0.616 0 C-N-CA 124.986 1.315 . . . . 0.0 110.718 167.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.82 -23.11 37.41 Favored Glycine 0 C--N 1.351 1.38 0 O-C-N 119.018 -2.301 . . . . 0.0 114.114 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.02 68.48 4.98 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.971 1.708 . . . . 0.0 112.812 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -81.67 4.92 19.99 Favored 'General case' 0 C--N 1.343 0.3 0 O-C-N 120.074 -1.641 . . . . 0.0 114.75 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -83.7 146.98 27.92 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.045 0.938 . . . . 0.0 109.629 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -70.22 -48.41 57.17 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 122.99 1.376 . . . . 0.0 111.058 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 40.7 p -84.05 110.16 18.24 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -128.4 -166.83 1.68 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.687 1.195 . . . . 0.0 110.484 168.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 50.6 p -117.99 175.47 5.66 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 119.595 -1.94 . . . . 0.0 111.362 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 46.0 mtt -57.33 -41.25 79.59 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 120.475 -1.391 . . . . 0.0 113.591 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -52.97 61.1 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.388 1.075 . . . . 0.0 110.618 174.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.73 -31.64 63.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -171.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 67.6 t -55.29 -37.01 42.39 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 O-C-N 120.065 -1.647 . . . . 0.0 111.246 171.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -89.85 -24.76 21.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.733 -1.229 . . . . 0.0 113.635 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -66.77 -56.88 8.51 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.039 -1.663 . . . . 0.0 112.916 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -61.26 -41.96 97.82 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 120.961 -1.087 . . . . 0.0 111.153 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 34.6 tp -57.88 -49.88 75.2 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 120.306 -1.497 . . . . 0.0 113.518 172.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.45 -47.92 79.86 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 120.299 -1.5 . . . . 0.0 114.321 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -58.42 -40.6 82.94 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.184 0.993 . . . . 0.0 113.618 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -58.33 -55.68 31.86 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.735 1.214 . . . . 0.0 113.633 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -68.68 -39.1 79.84 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 O-C-N 120.409 -1.432 . . . . 0.0 111.647 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 55.2 ttm -54.51 -48.33 72.05 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 122.443 1.116 . . . . 0.0 112.37 173.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 38.6 m -70.73 -29.56 65.86 Favored 'General case' 0 C--N 1.344 0.351 0 O-C-N 120.819 -1.176 . . . . 0.0 112.965 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -81.59 -23.15 37.26 Favored 'General case' 0 C--N 1.346 0.433 0 O-C-N 119.022 -2.299 . . . . 0.0 115.61 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? 72.29 49.3 0.22 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 125.343 1.457 . . . . 0.0 112.354 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 2.2 tt -95.85 -27.42 15.21 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 120.326 -1.484 . . . . 0.0 113.029 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -69.01 142.06 54.71 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.021 -1.674 . . . . 0.0 111.756 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.5 137.37 53.44 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.017 0.927 . . . . 0.0 113.302 167.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -64.32 -31.84 73.2 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 120.317 -1.489 . . . . 0.0 113.04 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -96.86 -32.82 11.89 Favored 'General case' 0 C--N 1.347 0.497 0 O-C-N 120.871 -1.143 . . . . 0.0 113.291 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.34 56.59 0.75 Allowed 'General case' 0 C--N 1.351 0.647 0 O-C-N 120.347 -1.471 . . . . 0.0 112.736 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 9.8 pm0 -60.92 5.46 0.05 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 118.655 2.835 . . . . 0.0 118.655 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -102.42 -6.54 22.86 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 119.849 -1.782 . . . . 0.0 111.704 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 49.1 mm -92.34 138.55 19.69 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 C-N-CA 125.27 1.428 . . . . 0.0 109.433 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.33 120.95 30.31 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 O-C-N 120.649 -1.282 . . . . 0.0 108.279 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -105.9 78.6 1.34 Allowed 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 120.535 -1.353 . . . . 0.0 112.795 -171.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 61.5 m -86.34 37.81 0.75 Allowed 'General case' 0 C--N 1.349 0.549 0 O-C-N 119.959 -1.713 . . . . 0.0 114.408 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 11.1 t -88.51 129.64 35.41 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 119.562 -1.961 . . . . 0.0 107.436 165.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 70.08 43.93 0.83 Allowed 'General case' 0 C--N 1.349 0.577 0 CA-C-O 122.878 1.323 . . . . 0.0 111.619 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -141.32 166.12 25.63 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 18.1 tp -83.67 -9.94 58.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.583 1.153 . . . . 0.0 112.651 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 10.1 mp -76.99 -31.23 56.34 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 119.498 -2.001 . . . . 0.0 110.658 164.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.42 -44.05 96.95 Favored Glycine 0 C--N 1.351 1.366 0 C-N-CA 125.279 1.419 . . . . 0.0 114.565 -174.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -46.08 -62.3 1.39 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.036 2.535 . . . . 0.0 112.102 169.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 4.2 pp -78.3 -18.46 55.21 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -172.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -81.22 -48.44 12.06 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.849 -1.157 . . . . 0.0 111.549 168.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.06 29.26 26.11 Favored Glycine 0 C--N 1.352 1.425 0 C-N-CA 124.829 1.204 . . . . 0.0 113.698 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.48 156.26 76.55 Favored Pre-proline 0 C--N 1.346 0.43 0 O-C-N 120.952 -1.322 . . . . 0.0 109.452 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.26 -10.33 13.65 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 CA-C-N 122.363 1.88 . . . . 0.0 112.982 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 10.0 p -178.92 171.36 1.42 Allowed 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -175.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.06 170.65 15.33 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 170.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 40.6 t -114.5 133.93 55.4 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 171.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.92 -39.9 81.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 O-C-N 121.456 -0.778 . . . . 0.0 112.276 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -54.22 -26.39 28.24 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -81.76 66.2 7.22 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 119.884 -1.76 . . . . 0.0 110.544 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -53.49 -46.23 69.93 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 125.848 1.659 . . . . 0.0 113.05 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 81.3 ttt180 -56.38 -29.45 61.46 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 127.051 2.141 . . . . 0.0 114.252 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -78.17 -42.93 30.09 Favored 'General case' 0 CA--C 1.512 -0.505 0 O-C-N 120.173 -1.579 . . . . 0.0 111.844 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 48.1 mm -56.79 -50.11 76.07 Favored 'Isoleucine or valine' 0 C--N 1.347 0.463 0 C-N-CA 124.043 0.937 . . . . 0.0 111.951 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -51.06 -43.73 61.03 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 120.742 -1.224 . . . . 0.0 113.84 168.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 52.9 m -65.45 -33.56 76.23 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 121.083 -1.011 . . . . 0.0 112.893 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -68.22 -48.51 64.97 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 118.88 -2.387 . . . . 0.0 112.697 167.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.7 -50.83 76.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 C-N-CA 124.783 1.233 . . . . 0.0 112.715 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -66.68 -12.07 56.76 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 119.232 -2.168 . . . . 0.0 115.143 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -85.93 -9.04 57.57 Favored 'General case' 0 C--N 1.351 0.663 0 O-C-N 119.596 -1.94 . . . . 0.0 112.215 169.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -96.09 -36.04 11.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 120.3 -1.5 . . . . 0.0 109.36 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 71.4 mt -92.85 161.33 14.54 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.36 1.464 . . . . 0.0 113.653 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.85 126.58 61.25 Favored 'Isoleucine or valine' 0 C--N 1.345 0.389 0 O-C-N 120.7 -1.25 . . . . 0.0 107.733 171.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 C--N 1.346 0.447 0 O-C-N 121.249 -0.907 . . . . 0.0 110.668 178.911 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.517 2.915 0 CA-C-O 117.238 -1.363 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 52.25 45.21 58.02 Favored Glycine 0 C--N 1.357 1.715 0 CA-C-N 120.18 1.354 . . . . 0.0 114.094 -170.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.2 t -152.43 134.39 14.85 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 120.691 -1.476 . . . . 0.0 109.197 -172.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.78 -137.14 3.45 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 122.368 0.982 . . . . 0.0 111.63 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.31 68.14 8.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.04 -1.859 . . . . 0.0 113.173 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 t -59.32 -13.2 7.26 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.613 1.565 . . . . 0.0 114.571 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.6 -30.17 22.02 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.81 1.644 . . . . 0.0 114.337 175.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 174.53 89.6 0.07 OUTLIER Pre-proline 0 C--N 1.35 0.626 0 C-N-CA 124.986 1.314 . . . . 0.0 108.505 -171.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.01 118.57 4.09 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.344 2.03 . . . . 0.0 112.282 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t -113.29 -4.45 13.69 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 122.588 1.185 . . . . 0.0 110.11 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t -126.21 162.62 25.01 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.069 -1.644 . . . . 0.0 113.44 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -61.62 -48.34 81.36 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 120.449 -1.407 . . . . 0.0 111.932 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.81 86.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.553 1.541 . . . . 0.0 112.786 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -63.08 -54.7 33.86 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.783 -1.198 . . . . 0.0 113.656 173.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.63 -31.19 70.17 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.734 0.778 . . . . 0.0 112.239 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -53.63 -49.6 67.52 Favored 'General case' 0 C--N 1.346 0.416 0 O-C-N 119.959 -1.713 . . . . 0.0 113.164 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -67.44 -30.16 69.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.525 -1.359 . . . . 0.0 113.862 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.97 -27.94 65.86 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 125.897 1.679 . . . . 0.0 114.295 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.7 tp -61.9 -25.33 67.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.228 1.011 . . . . 0.0 113.607 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 t 56.43 40.79 29.52 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 124.632 2.158 . . . . 0.0 112.977 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.419 ' HB1' ' HG ' ' B' ' 119' ' ' LEU . . . -64.87 92.6 0.1 Allowed 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.258 1.423 . . . . 0.0 113.526 -177.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.95 -40.66 0.8 Allowed Glycine 0 CA--C 1.496 -1.111 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -173.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.04 -144.62 16.94 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.7 m -93.79 139.84 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 120.211 -1.758 . . . . 0.0 111.102 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.62 156.66 45.87 Favored Pre-proline 0 N--CA 1.45 -0.465 0 O-C-N 120.569 -1.332 . . . . 0.0 109.347 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.59 -10.12 24.83 Favored 'Trans proline' 0 CA--C 1.519 -0.239 0 C-N-CA 122.872 2.382 . . . . 0.0 112.894 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 mptt 64.91 51.82 1.69 Allowed 'General case' 0 C--N 1.349 0.573 0 C-N-CA 126.019 1.728 . . . . 0.0 113.198 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.9 pt -64.89 143.59 15.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 mt -86.24 25.59 1.16 Allowed 'General case' 0 C--N 1.345 0.4 0 C-N-CA 124.877 1.271 . . . . 0.0 111.746 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -80.67 135.19 35.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 120.181 -1.574 . . . . 0.0 110.456 174.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -74.26 126.27 30.27 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 121.83 0.824 . . . . 0.0 111.747 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 p -118.06 -177.53 3.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 120.628 -1.295 . . . . 0.0 110.03 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 -122.05 -21.43 5.97 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 119.85 -1.781 . . . . 0.0 110.968 162.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -157.73 169.2 25.17 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 120.405 -1.434 . . . . 0.0 109.738 -176.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -52.26 -46.13 65.68 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 127.742 2.417 . . . . 0.0 111.656 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.0 m -55.59 -18.26 7.27 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 118.147 2.647 . . . . 0.0 118.147 170.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -93.87 -6.91 44.64 Favored 'General case' 0 C--N 1.345 0.388 0 O-C-N 120.46 -1.4 . . . . 0.0 111.083 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.33 127.47 26.79 Favored Pre-proline 0 C--N 1.349 0.573 0 O-C-N 120.523 -1.36 . . . . 0.0 110.327 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.47 163.33 36.37 Favored 'Trans proline' 0 C--N 1.324 -0.711 0 C-N-CA 122.067 1.845 . . . . 0.0 114.169 -169.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.86 -78.9 1.91 Allowed Glycine 0 C--N 1.348 1.207 0 O-C-N 121.349 -0.844 . . . . 0.0 113.097 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.23 24.82 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 122.377 1.084 . . . . 0.0 111.652 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.1 m -98.16 116.89 31.33 Favored 'General case' 0 C--O 1.215 -0.74 0 O-C-N 119.523 -1.986 . . . . 0.0 112.435 -162.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.57 150.06 6.75 Favored 'Isoleucine or valine' 0 C--N 1.346 0.426 0 O-C-N 118.429 -2.67 . . . . 0.0 113.665 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.29 125.32 29.19 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.804 0.842 . . . . 0.0 108.881 168.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -85.94 179.67 6.96 Favored 'General case' 0 C--N 1.345 0.412 0 O-C-N 120.032 -1.668 . . . . 0.0 110.655 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.24 -5.3 20.47 Favored Glycine 0 C--N 1.353 1.525 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -96.26 -6.15 38.64 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.201 -1.176 . . . . 0.0 112.501 170.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.59 18.28 64.29 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 121.01 -1.056 . . . . 0.0 113.787 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -128.04 146.4 50.69 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 123.083 1.42 . . . . 0.0 110.743 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 80.5 m -67.87 160.71 27.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 123.491 1.615 . . . . 0.0 113.081 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.958 0 O-C-N 119.3 -2.125 . . . . 0.0 116.846 -174.927 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 99.2 mt . . . . . 0 N--CA 1.506 2.329 0 CA-C-O 118.225 -0.893 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 15.2 m -133.47 165.44 32.14 Favored 'Isoleucine or valine' 0 C--N 1.344 0.361 0 CA-C-N 119.274 0.943 . . . . 0.0 109.271 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -114.0 101.82 54.28 Favored Pre-proline 0 C--N 1.345 0.41 0 CA-C-O 116.986 -1.483 . . . . 0.0 110.676 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.95 165.57 29.55 Favored 'Trans proline' 0 C--N 1.326 -0.609 0 C-N-CA 123.228 2.619 . . . . 0.0 114.242 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -87.16 153.2 53.94 Favored Pre-proline 0 C--N 1.351 0.653 0 O-C-N 120.967 -1.083 . . . . 0.0 111.961 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.06 -21.82 42.38 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.536 2.824 . . . . 0.0 113.436 -173.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 89.0 mt -70.14 -47.12 63.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.166 -0.959 . . . . 0.0 110.984 171.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 34.6 tp -65.17 -33.89 77.09 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 124.584 1.154 . . . . 0.0 113.062 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 14.7 tp -48.42 -41.68 29.92 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.326 1.45 . . . . 0.0 113.956 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -65.4 -36.88 85.29 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 119.844 -1.785 . . . . 0.0 114.328 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.492 HD13 HD13 ' B' ' 147' ' ' LEU . 1.1 tt -70.23 -50.22 42.09 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.656 0.782 . . . . 0.0 111.074 173.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 40.2 mt -52.16 -44.91 64.83 Favored 'General case' 0 C--N 1.35 0.617 0 C-N-CA 124.567 1.147 . . . . 0.0 112.702 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -57.4 -34.57 69.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 55.6 m -71.35 -15.49 62.39 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 124.558 1.143 . . . . 0.0 113.323 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.21 -7.38 9.62 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 124.351 1.06 . . . . 0.0 110.311 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.97 -26.47 7.9 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 120.106 -1.621 . . . . 0.0 112.36 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.41 74.47 7.28 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 126.006 1.723 . . . . 0.0 113.947 -170.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -83.57 12.03 6.3 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 -174.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -99.74 127.06 45.89 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.204 -0.935 . . . . 0.0 112.793 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.44 -9.42 0.3 Allowed 'General case' 0 C--N 1.348 0.515 0 N-CA-C 117.881 2.549 . . . . 0.0 117.881 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 67.4 p -137.11 127.04 25.77 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 119.064 -2.273 . . . . 0.0 111.158 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -129.03 -177.82 4.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 120.46 -1.4 . . . . 0.0 110.462 173.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.8 m -96.85 161.55 13.8 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.156 1.383 . . . . 0.0 108.189 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 1.1 mmm -60.04 -44.96 94.29 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 119.794 -1.816 . . . . 0.0 113.837 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -58.4 -51.87 68.0 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.136 0.974 . . . . 0.0 113.605 170.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -48.66 -49.65 36.5 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 126.504 1.921 . . . . 0.0 114.68 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 40.1 t -54.03 -46.32 65.64 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 O-C-N 120.674 -1.266 . . . . 0.0 112.355 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . 0.419 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 4.2 mm? -72.11 -38.19 69.37 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.26 1.024 . . . . 0.0 112.325 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -56.25 -59.53 4.8 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.803 1.641 . . . . 0.0 112.79 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -58.02 -41.6 83.49 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 123.903 0.881 . . . . 0.0 112.028 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 26.4 tp -63.17 -52.22 63.26 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 173.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.5 -44.89 95.98 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 119.481 -2.012 . . . . 0.0 113.092 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -60.57 -30.28 69.69 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 124.379 1.071 . . . . 0.0 113.182 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -56.74 -60.25 3.83 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 124.429 1.092 . . . . 0.0 111.613 171.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mt -59.6 -42.87 89.67 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 O-C-N 120.292 -1.505 . . . . 0.0 113.794 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -51.02 -48.24 61.48 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 124.683 1.193 . . . . 0.0 113.556 170.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 40.5 m -78.64 -39.53 36.75 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 120.351 -1.468 . . . . 0.0 112.671 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -74.74 -21.47 59.33 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 126.163 1.785 . . . . 0.0 114.538 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 69.48 50.82 0.5 Allowed 'General case' 0 C--N 1.348 0.541 0 C-N-CA 125.821 1.648 . . . . 0.0 112.394 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 51.8 mt -107.46 18.65 21.28 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 123.782 0.833 . . . . 0.0 111.751 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -105.97 150.04 26.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -81.74 141.65 33.36 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.2 -31.72 72.94 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 121.028 -1.045 . . . . 0.0 113.187 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.76 -29.02 12.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 120.743 -1.223 . . . . 0.0 112.323 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -114.88 69.04 0.71 Allowed 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.097 -1.627 . . . . 0.0 112.641 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -73.41 -2.77 23.68 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 119.896 -1.752 . . . . 0.0 113.992 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -87.15 -10.19 53.35 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.589 1.955 . . . . 0.0 113.033 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 48.3 mm -98.59 134.0 38.89 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 125.497 1.519 . . . . 0.0 109.96 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 48.0 t -117.13 126.89 74.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 O-C-N 120.905 -1.122 . . . . 0.0 111.096 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -82.93 101.6 11.15 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.501 1.12 . . . . 0.0 111.762 173.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 18.3 m -107.14 3.46 25.75 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-O 122.06 0.934 . . . . 0.0 111.69 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 79.0 p -72.91 124.32 25.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 119.744 -1.847 . . . . 0.0 110.897 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 5.3 t30 79.57 18.85 0.72 Allowed 'General case' 0 C--N 1.35 0.621 0 C-N-CA 124.612 1.165 . . . . 0.0 112.478 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -112.06 169.98 8.47 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 124.691 1.196 . . . . 0.0 108.978 172.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . 0.404 HD23 ' HB2' ' B' ' 102' ' ' LEU . 16.5 tp -69.97 -22.9 63.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.601 1.96 . . . . 0.0 112.657 178.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' LEU . . . . . 0.492 HD13 HD13 ' B' ' 102' ' ' LEU . 2.0 mp -66.46 -34.61 78.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 119.899 -1.751 . . . . 0.0 113.105 167.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.66 -37.77 92.79 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 120.554 -1.341 . . . . 0.0 114.117 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.41 -49.17 70.58 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.722 2.409 . . . . 0.0 112.845 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 1.3 pp -83.51 -28.02 28.96 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 119.35 -2.093 . . . . 0.0 113.918 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.648 ' HB3' HG22 ' B' ' 153' ' ' VAL . 9.3 m-85 -79.6 -41.02 27.99 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 125.141 1.377 . . . . 0.0 112.856 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 78.58 14.4 82.15 Favored Glycine 0 C--N 1.35 1.339 0 C-N-CA 124.189 0.899 . . . . 0.0 114.183 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . 0.648 HG22 ' HB3' ' B' ' 151' ' ' PHE . 33.2 m -131.15 151.27 78.61 Favored Pre-proline 0 C--N 1.345 0.403 0 O-C-N 120.828 -1.396 . . . . 0.0 110.382 -174.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.92 -26.92 10.61 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 121.965 1.777 . . . . 0.0 112.02 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 27.8 p -159.49 164.54 34.35 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 120.729 -1.232 . . . . 0.0 109.231 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -139.86 160.54 39.67 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 120.241 -1.537 . . . . 0.0 109.182 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 4.5 t -112.17 134.68 53.58 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.44 -33.7 65.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.72 -25.47 2.99 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -80.36 55.88 2.37 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.037 -1.664 . . . . 0.0 111.255 176.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -51.87 -47.39 64.52 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 119.999 -1.688 . . . . 0.0 114.235 -172.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -57.09 -38.46 73.38 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 125.842 1.657 . . . . 0.0 113.271 172.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 18.1 ttpt -66.47 -51.33 57.9 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.235 -1.541 . . . . 0.0 110.598 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 50.9 mm -50.44 -54.65 8.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 C-N-CA 125.566 1.546 . . . . 0.0 112.826 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -51.76 -46.67 64.17 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 9.9 m -59.2 -42.67 91.48 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.627 -1.296 . . . . 0.0 112.453 176.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 3.5 mtp -72.06 -22.88 61.31 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.507 -1.371 . . . . 0.0 113.577 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.45 -52.05 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 O-C-N 121.115 -0.991 . . . . 0.0 110.478 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -57.09 -24.73 56.1 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.25 -12.4 60.0 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.91 -1.744 . . . . 0.0 114.488 173.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -103.05 -13.54 16.8 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 119.945 -1.722 . . . . 0.0 111.381 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 82.6 mt -109.8 155.4 21.68 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.928 1.291 . . . . 0.0 110.541 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 38.8 t -100.58 117.79 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 O-C-N 120.1 -1.625 . . . . 0.0 108.685 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.35 0.591 0 C-N-CA 124.172 0.989 . . . . 0.0 111.022 178.787 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.526 3.336 0 N-CA-C 119.39 3.107 . . . . 0.0 119.39 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.54 15.22 65.89 Favored Glycine 0 C--N 1.355 1.588 0 N-CA-C 115.836 1.094 . . . . 0.0 115.836 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.1 t -140.24 144.04 36.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.51 -129.91 2.51 Favored Glycine 0 C--N 1.346 1.128 0 C-N-CA 125.061 1.315 . . . . 0.0 110.112 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.0 72.53 10.07 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 120.219 -1.753 . . . . 0.0 112.397 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.3 p -68.21 -15.21 63.49 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -173.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -82.39 -38.1 24.61 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.971 1.309 . . . . 0.0 111.91 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -166.79 92.36 0.75 Allowed Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.14 105.69 1.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.078 1.852 . . . . 0.0 111.398 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -103.92 -17.3 15.07 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.74 1.216 . . . . 0.0 112.187 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.4 m -109.76 173.13 6.46 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 123.566 1.65 . . . . 0.0 112.406 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -73.44 -42.23 62.23 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 119.262 -2.149 . . . . 0.0 113.733 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.43 78.46 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 120.315 -1.49 . . . . 0.0 112.878 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -59.16 -58.99 6.22 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 125.975 1.71 . . . . 0.0 113.049 169.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.97 -22.96 65.0 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 120.815 -1.178 . . . . 0.0 113.537 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -62.15 -42.04 98.87 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 119.906 -1.746 . . . . 0.0 112.415 167.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -70.3 -33.73 71.88 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 120.231 -1.543 . . . . 0.0 114.019 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.19 -25.76 61.97 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.98 -14.28 52.74 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.397 1.079 . . . . 0.0 113.431 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.347 94.4 p 56.79 25.67 10.57 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 128.047 2.539 . . . . 0.0 113.913 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.32 91.14 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 128.316 2.647 . . . . 0.0 115.817 -167.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.27 -29.9 1.9 Allowed Glycine 0 C--N 1.344 1.02 0 O-C-N 121.382 -0.824 . . . . 0.0 112.174 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.16 -160.54 17.6 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 122.81 1.228 . . . . 0.0 112.786 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.79 102.89 12.58 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 O-C-N 120.31 -1.7 . . . . 0.0 110.895 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.9 t -80.76 151.79 71.44 Favored Pre-proline 0 C--N 1.348 0.52 0 O-C-N 120.127 -1.608 . . . . 0.0 110.457 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -67.05 -8.86 23.07 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.09 2.527 . . . . 0.0 115.096 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt 70.32 51.88 0.37 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 125.454 1.502 . . . . 0.0 113.341 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.7 pt -67.89 145.66 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 122.872 1.32 . . . . 0.0 113.663 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.1 mp -91.05 28.75 1.52 Allowed 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.475 -1.391 . . . . 0.0 110.661 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -82.03 133.25 35.28 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 120.504 -1.372 . . . . 0.0 110.432 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -80.5 113.87 18.99 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 121.37 -0.832 . . . . 0.0 110.918 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.404 ' HB2' ' H ' ' A' ' 33' ' ' ARG . 1.6 p -103.91 -141.53 0.36 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.688 1.595 . . . . 0.0 110.817 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.404 ' H ' ' HB2' ' A' ' 32' ' ' CYS . 34.0 ptt180 -169.61 -39.67 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 120.676 -1.265 . . . . 0.0 107.999 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' A' ' 36' ' ' SER . 12.7 tpp85 -125.46 169.29 12.54 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 172.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -71.43 -14.81 62.27 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 119.819 -1.801 . . . . 0.0 113.814 173.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.415 ' H ' ' HG3' ' A' ' 34' ' ' ARG . 18.2 m -61.77 -48.0 82.64 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 126.522 1.929 . . . . 0.0 113.876 173.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.76 -0.56 13.6 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.888 -1.133 . . . . 0.0 113.997 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.7 t -118.7 107.99 41.8 Favored Pre-proline 0 C--N 1.353 0.726 0 O-C-N 119.955 -1.716 . . . . 0.0 111.751 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.35 170.47 19.82 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.767 2.311 . . . . 0.0 115.653 -159.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.11 -90.54 1.67 Allowed Glycine 0 C--N 1.349 1.259 0 C-N-CA 124.181 0.895 . . . . 0.0 113.035 172.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.03 16.06 0.84 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 123.079 1.419 . . . . 0.0 110.54 -177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 32.9 m -76.92 168.36 20.23 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 119.859 -1.776 . . . . 0.0 111.461 -172.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.27 148.38 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 160.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.5 t -77.26 128.38 34.23 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.099 1.759 . . . . 0.0 107.133 171.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -84.79 -179.39 7.09 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 119.973 -1.704 . . . . 0.0 109.249 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.12 -11.03 24.04 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 116.394 1.318 . . . . 0.0 116.394 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -87.06 -7.41 58.11 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 120.704 -1.468 . . . . 0.0 113.374 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.74 13.8 74.55 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 120.71 -1.244 . . . . 0.0 114.259 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -124.18 152.08 43.29 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.134 -1.215 . . . . 0.0 109.765 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 29.2 m -78.91 93.78 5.1 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -166.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.294 0 O-C-N 119.526 -1.984 . . . . 0.0 116.624 -179.694 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.504 2.267 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.8 160.88 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -116.31 117.79 38.31 Favored Pre-proline 0 C--N 1.348 0.53 0 CA-C-O 115.964 -1.97 . . . . 0.0 109.822 170.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.09 -179.28 3.78 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.092 2.528 . . . . 0.0 114.132 169.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.03 159.74 28.65 Favored Pre-proline 0 C--N 1.351 0.634 0 C-N-CA 125.485 1.514 . . . . 0.0 110.609 175.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.99 -26.83 30.86 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.907 2.405 . . . . 0.0 114.098 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.97 -55.54 24.98 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 119.556 1.071 . . . . 0.0 110.942 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 18.5 tp -59.62 -35.62 74.72 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 120.892 -1.13 . . . . 0.0 113.282 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 17.5 tp -56.44 -40.77 75.33 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 120.605 -1.309 . . . . 0.0 114.485 175.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -65.52 -32.33 73.87 Favored 'General case' 0 C--N 1.346 0.442 0 O-C-N 120.002 -1.686 . . . . 0.0 113.613 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 10.2 tt -67.94 -46.26 72.0 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.402 -0.811 . . . . 0.0 110.94 170.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -52.15 -47.62 65.35 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 121.268 -0.895 . . . . 0.0 112.83 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -58.58 -24.99 62.1 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.273 -1.517 . . . . 0.0 114.282 173.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 11.7 t -83.38 -9.64 58.92 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 120.303 -1.498 . . . . 0.0 113.753 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 4.5 t -107.76 16.83 7.05 Favored 'Isoleucine or valine' 0 C--N 1.348 0.509 0 CA-C-O 123.369 1.557 . . . . 0.0 107.903 171.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.1 -20.93 36.97 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 119.262 -2.149 . . . . 0.0 113.96 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.29 69.2 3.53 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.228 1.811 . . . . 0.0 113.473 -172.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -85.39 17.36 3.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 119.467 -2.021 . . . . 0.0 116.204 -173.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . 0.855 ' HE3' ' H ' ' B' ' 111' ' ' ASP . 0.0 OUTLIER -88.21 142.53 27.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 123.874 1.797 . . . . 0.0 110.56 170.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.855 ' H ' ' HE3' ' B' ' 110' ' ' LYS . 2.6 m-20 -78.38 -7.02 56.86 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 130.717 3.607 . . . . 0.0 111.656 -172.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 11.3 p -145.43 135.11 23.4 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 127.087 2.155 . . . . 0.0 109.852 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -139.52 -165.45 1.87 Allowed 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.056 -1.028 . . . . 0.0 110.055 174.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 29.1 p -94.21 -169.63 2.11 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 119.774 -1.829 . . . . 0.0 110.927 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 76.7 mtp -74.56 -53.24 9.79 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 119.367 -2.083 . . . . 0.0 112.001 169.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -58.18 -38.98 77.73 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.211 -0.93 . . . . 0.0 112.927 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.76 -44.31 97.15 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.18 -26.11 39.32 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 O-C-N 119.618 -1.926 . . . . 0.0 111.479 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.68 -27.69 17.93 Favored 'General case' 0 C--N 1.347 0.479 0 O-C-N 120.622 -1.299 . . . . 0.0 113.706 172.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -64.97 -62.53 1.5 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 126.399 1.88 . . . . 0.0 111.612 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -54.96 -36.03 64.89 Favored 'General case' 0 C--N 1.351 0.674 0 O-C-N 120.673 -1.267 . . . . 0.0 112.3 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . 0.454 HD11 HD21 ' B' ' 147' ' ' LEU . 33.2 tp -70.48 -49.2 50.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 174.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -70.44 -46.37 48.93 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 119.89 -1.756 . . . . 0.0 113.428 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -63.36 -31.29 72.4 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.201 1.4 . . . . 0.0 112.247 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -55.9 -57.85 10.33 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 124.23 1.012 . . . . 0.0 111.861 168.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 89.7 mt -64.12 -43.74 97.49 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 O-C-N 120.534 -1.354 . . . . 0.0 112.888 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 53.5 ttm -57.64 -34.2 69.07 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 125.498 1.519 . . . . 0.0 113.206 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 58.1 m -86.33 -36.27 19.37 Favored 'General case' 0 C--N 1.345 0.37 0 O-C-N 120.621 -1.299 . . . . 0.0 112.623 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -71.66 -22.26 61.7 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 126.769 2.028 . . . . 0.0 114.862 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 71.41 45.12 0.49 Allowed 'General case' 0 C--N 1.351 0.667 0 C-N-CA 125.385 1.474 . . . . 0.0 112.984 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 89.2 mt -100.29 9.32 42.88 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 121.058 -1.026 . . . . 0.0 112.319 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -94.26 141.51 28.48 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.72 -1.237 . . . . 0.0 108.667 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -78.08 147.73 34.56 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.503 1.121 . . . . 0.0 109.277 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -68.98 -31.18 69.84 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.222 1.409 . . . . 0.0 113.3 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -104.17 -24.91 13.11 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 124.813 1.245 . . . . 0.0 112.666 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -116.93 62.55 0.73 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 122.103 0.954 . . . . 0.0 110.822 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.89 -5.04 1.81 Allowed 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.106 -1.621 . . . . 0.0 115.336 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -99.81 -0.51 39.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.261 1.824 . . . . 0.0 112.917 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 51.1 mm -105.26 117.11 50.37 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 C-N-CA 125.216 1.406 . . . . 0.0 108.64 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.49 121.71 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 O-C-N 120.987 -1.071 . . . . 0.0 108.493 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -79.92 108.86 13.83 Favored 'General case' 0 C--N 1.347 0.467 0 O-C-N 120.642 -1.286 . . . . 0.0 111.598 174.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 90.6 m -124.91 24.64 7.56 Favored 'General case' 0 C--N 1.346 0.454 0 O-C-N 121.513 -0.742 . . . . 0.0 111.157 172.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 13.6 p -76.92 142.07 40.24 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 120.315 -1.491 . . . . 0.0 108.704 165.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 28.9 t30 72.97 -31.22 0.22 Allowed 'General case' 0 C--N 1.354 0.774 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -73.77 164.35 26.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.286 -1.509 . . . . 0.0 110.678 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 18.9 tp -73.54 -2.99 25.04 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-O 123.691 1.71 . . . . 0.0 114.174 -162.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' LEU . . . . . 0.454 HD21 HD11 ' B' ' 122' ' ' LEU . 10.0 mp -79.47 -35.9 39.56 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 119.327 -2.108 . . . . 0.0 111.353 168.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.88 -32.52 82.23 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 120.766 -1.209 . . . . 0.0 113.62 -173.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -47.56 -67.4 0.28 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.355 3.062 . . . . 0.0 112.181 166.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.95 -23.16 48.61 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -78.77 -36.19 43.39 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.139 -1.601 . . . . 0.0 111.66 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.19 19.36 77.12 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 121.266 -0.896 . . . . 0.0 114.839 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 21.9 m -130.91 156.54 79.91 Favored Pre-proline 0 C--N 1.347 0.48 0 O-C-N 120.667 -1.49 . . . . 0.0 110.813 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.01 -26.09 8.17 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 121.923 1.749 . . . . 0.0 112.733 172.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 64.9 p -162.0 165.78 26.92 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 119.701 1.137 . . . . 0.0 109.533 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -138.42 166.12 25.07 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 8.4 t -117.88 143.05 46.65 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.808 -1.182 . . . . 0.0 109.51 169.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 34.6 m -57.95 -34.65 49.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.521 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -52.87 -26.65 15.39 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.34 49.22 0.96 Allowed 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 120.458 -1.401 . . . . 0.0 111.738 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -48.4 -44.32 34.85 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 126.64 1.976 . . . . 0.0 113.333 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -57.59 -35.02 69.85 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 125.692 1.597 . . . . 0.0 114.995 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -81.75 -40.26 22.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.167 -1.583 . . . . 0.0 110.023 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 75.8 mt -59.92 -52.25 63.39 Favored 'Isoleucine or valine' 0 C--N 1.347 0.496 0 C-N-CA 123.929 0.892 . . . . 0.0 111.402 172.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -51.47 -44.04 62.31 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 120.905 -1.122 . . . . 0.0 114.007 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 86.9 m -56.71 -53.77 53.85 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 121.138 -0.976 . . . . 0.0 112.199 174.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 25.9 mmt -61.53 -34.58 75.79 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 120.561 -1.337 . . . . 0.0 114.049 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.83 -55.43 22.47 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 O-C-N 121.106 -0.996 . . . . 0.0 111.39 171.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -68.81 -18.15 64.13 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 119.414 -2.054 . . . . 0.0 115.257 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -64.48 -30.95 71.98 Favored 'General case' 0 C--N 1.349 0.562 0 O-C-N 118.515 -2.615 . . . . 0.0 112.197 165.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -96.56 -15.04 21.82 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 123.899 0.879 . . . . 0.0 113.072 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 69.5 mt -120.64 121.37 38.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.603 1.161 . . . . 0.0 112.489 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.54 119.53 13.35 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 O-C-N 120.276 -1.515 . . . . 0.0 112.399 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 C--N 1.349 0.546 0 C-N-CA 124.825 1.25 . . . . 0.0 110.601 177.46 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . 0.55 ' HA ' ' H ' ' A' ' 43' ' ' ILE . 34.7 m . . . . . 0 N--CA 1.517 2.888 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.1 55.13 31.95 Favored Glycine 0 C--N 1.357 1.706 0 CA-C-O 121.705 0.614 . . . . 0.0 112.776 -166.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -124.34 105.98 9.88 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 120.315 -1.697 . . . . 0.0 111.429 -168.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.55 -152.11 7.12 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.51 72.6 4.06 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.047 -1.266 . . . . 0.0 113.184 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 p -66.45 -2.11 4.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 126.775 2.03 . . . . 0.0 115.116 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -100.58 -31.79 11.08 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 126.189 1.795 . . . . 0.0 111.474 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -171.27 87.66 0.47 Allowed Pre-proline 0 C--N 1.351 0.656 0 O-C-N 121.382 -0.824 . . . . 0.0 110.53 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.59 98.31 0.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.88 1.72 . . . . 0.0 113.189 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -85.14 -31.97 23.0 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.353 1.061 . . . . 0.0 112.781 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.82 169.03 8.75 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 120.859 -1.15 . . . . 0.0 112.82 -173.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -64.19 -53.46 48.99 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 120.713 -1.242 . . . . 0.0 111.468 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.38 -50.36 67.7 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.183 1.393 . . . . 0.0 113.997 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -45.84 -55.04 7.13 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.915 2.086 . . . . 0.0 115.095 168.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.42 -30.43 60.05 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 120.931 -1.106 . . . . 0.0 112.979 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -54.59 -47.68 73.06 Favored 'General case' 0 C--N 1.349 0.546 0 O-C-N 119.798 -1.814 . . . . 0.0 112.729 173.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -59.51 -40.22 86.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 173.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -60.72 -20.91 62.26 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 125.836 1.654 . . . . 0.0 114.2 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.6 tp -70.53 -17.12 62.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.701 1.2 . . . . 0.0 113.663 174.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.296 91.4 p 50.93 40.89 26.22 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.363 1.865 . . . . 0.0 114.769 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.26 88.97 0.08 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.979 1.712 . . . . 0.0 114.993 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 148.2 -31.63 1.29 Allowed Glycine 0 CA--C 1.496 -1.109 0 O-C-N 120.975 -1.078 . . . . 0.0 111.096 -170.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.8 -132.7 11.02 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-O 122.423 1.013 . . . . 0.0 112.433 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 m -99.77 135.49 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 120.659 -1.495 . . . . 0.0 110.718 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.52 158.15 37.17 Favored Pre-proline 0 N--CA 1.451 -0.385 0 O-C-N 120.354 -1.466 . . . . 0.0 109.513 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.45 -5.9 17.89 Favored 'Trans proline' 0 CA--C 1.521 -0.175 0 C-N-CA 122.754 2.303 . . . . 0.0 112.848 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 mptt 61.74 51.05 4.05 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 126.481 1.912 . . . . 0.0 113.479 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.6 pt -64.11 141.69 17.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -173.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.27 26.3 0.91 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 125.305 1.442 . . . . 0.0 112.088 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -82.29 137.65 34.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.157 -1.59 . . . . 0.0 109.87 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -81.06 125.46 30.23 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 120.973 -1.079 . . . . 0.0 111.36 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.7 p -114.06 -175.22 2.63 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.517 1.151 . . . . 0.0 110.046 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -138.19 -2.95 1.8 Allowed 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 120.994 -1.066 . . . . 0.0 110.586 167.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -169.18 173.43 6.76 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.65 1.18 . . . . 0.0 109.315 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.23 -9.92 58.12 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 128.149 2.58 . . . . 0.0 111.337 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -75.0 -39.12 61.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.753 1.621 . . . . 0.0 110.962 168.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -77.89 -18.41 56.21 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.443 2.297 . . . . 0.0 112.634 -173.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.3 127.94 34.85 Favored Pre-proline 0 CA--C 1.54 0.594 0 O-C-N 120.253 -1.529 . . . . 0.0 111.55 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.76 170.09 21.12 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.649 2.233 . . . . 0.0 113.887 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.09 -96.66 0.99 Allowed Glycine 0 C--N 1.35 1.312 0 C-N-CA 124.238 0.923 . . . . 0.0 112.527 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.62 33.57 0.45 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 122.837 1.303 . . . . 0.0 109.327 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 77.3 m -91.77 136.59 33.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 119.737 -1.852 . . . . 0.0 109.965 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.55 ' H ' ' HA ' ' A' ' 1' ' ' SER . 1.6 pp -103.35 151.16 6.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 O-C-N 120.766 -1.209 . . . . 0.0 110.534 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.3 t -88.47 118.14 27.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.823 1.649 . . . . 0.0 109.154 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -79.05 172.86 13.21 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 118.952 -2.342 . . . . 0.0 110.948 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.58 -27.83 13.53 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 116.836 1.494 . . . . 0.0 116.836 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -83.82 3.49 33.38 Favored 'General case' 0 C--N 1.345 0.386 0 O-C-N 121.205 -1.174 . . . . 0.0 113.472 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.55 22.04 73.62 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 119.949 -1.719 . . . . 0.0 114.252 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -131.71 137.74 48.38 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 120.771 -1.429 . . . . 0.0 111.29 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 66.2 m -66.37 137.65 57.03 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 124.616 2.15 . . . . 0.0 114.288 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.948 0 O-C-N 120.517 -1.365 . . . . 0.0 113.928 173.176 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 N--CA 1.504 2.253 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' VAL . . . . . 0.431 ' HB ' HD22 ' B' ' 172' ' ' LEU . 4.4 m -133.4 166.47 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' ARG . . . . . 0.401 ' HB2' HG12 ' B' ' 173' ' ' VAL . 0.0 OUTLIER -118.9 101.42 50.25 Favored Pre-proline 0 C--N 1.346 0.413 0 CA-C-O 116.936 -1.507 . . . . 0.0 110.397 -178.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.99 168.44 23.15 Favored 'Trans proline' 0 C--N 1.329 -0.484 0 C-N-CA 123.104 2.536 . . . . 0.0 114.396 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -86.69 152.98 55.06 Favored Pre-proline 0 C--N 1.349 0.573 0 O-C-N 121.038 -1.038 . . . . 0.0 112.807 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.15 -19.23 29.92 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.145 2.563 . . . . 0.0 112.915 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.6 mt -68.62 -51.55 41.11 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-O 121.579 0.704 . . . . 0.0 110.537 169.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.87 -39.57 81.74 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 124.944 1.298 . . . . 0.0 113.391 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 tp -46.46 -42.19 15.05 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.315 1.446 . . . . 0.0 114.879 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -66.07 -36.05 82.16 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 119.595 -1.94 . . . . 0.0 113.586 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.515 HD13 HD13 ' B' ' 147' ' ' LEU . 1.8 tt -70.39 -50.82 34.73 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 123.927 0.891 . . . . 0.0 111.062 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 96.5 mt -52.65 -45.69 66.82 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 124.5 1.12 . . . . 0.0 112.412 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -59.14 -28.67 66.78 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 5.9 t -75.72 -13.18 60.3 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 124.559 1.144 . . . . 0.0 112.779 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.73 -4.3 9.37 Favored 'Isoleucine or valine' 0 C--N 1.347 0.486 0 C-N-CA 124.852 1.261 . . . . 0.0 109.987 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.58 -16.57 23.9 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 119.833 -1.792 . . . . 0.0 113.306 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.34 77.61 9.92 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.212 -1.758 . . . . 0.0 113.34 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -81.57 11.83 4.32 Favored 'General case' 0 C--N 1.344 0.351 0 O-C-N 119.747 -1.846 . . . . 0.0 115.758 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 139.94 30.21 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-O 122.132 0.968 . . . . 0.0 113.174 -174.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.05 -15.91 62.57 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.516 2.326 . . . . 0.0 114.087 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 19.6 p -138.81 126.51 22.09 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 120.318 -1.489 . . . . 0.0 110.968 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -128.34 -177.31 4.11 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-O 122.461 1.124 . . . . 0.0 110.879 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 4.2 p -90.76 176.11 6.76 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 120.041 -1.662 . . . . 0.0 110.01 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 8.5 mmt -64.75 -49.23 71.62 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 120.351 -1.468 . . . . 0.0 112.945 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -33.23 74.27 Favored 'General case' 0 C--N 1.349 0.587 0 O-C-N 120.997 -1.064 . . . . 0.0 112.605 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -57.75 -36.74 72.5 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 125.062 1.345 . . . . 0.0 114.134 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.47 -48.86 76.64 Favored 'Isoleucine or valine' 0 C--N 1.356 0.866 0 C-N-CA 123.961 0.905 . . . . 0.0 111.811 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.77 -27.33 40.46 Favored 'General case' 0 C--N 1.346 0.434 0 O-C-N 120.763 -1.211 . . . . 0.0 113.045 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -65.35 -58.84 4.89 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 125.289 1.436 . . . . 0.0 112.033 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -59.79 -41.97 92.32 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 120.992 -1.067 . . . . 0.0 112.236 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 29.6 tp -61.19 -52.45 64.74 Favored 'General case' 0 C--N 1.347 0.485 0 O-C-N 120.569 -1.332 . . . . 0.0 114.017 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.79 -45.54 94.75 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 120.602 -1.311 . . . . 0.0 113.45 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -59.05 -37.21 76.47 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 124.788 1.235 . . . . 0.0 113.157 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -59.93 -57.58 12.25 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 124.636 1.175 . . . . 0.0 112.688 173.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 3.1 mt -63.59 -41.7 93.54 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 O-C-N 119.999 -1.688 . . . . 0.0 112.209 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 52.2 ttm -56.26 -43.45 78.77 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 125.691 1.596 . . . . 0.0 112.681 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 21.6 m -82.56 -30.35 29.7 Favored 'General case' 0 C--N 1.345 0.37 0 O-C-N 119.953 -1.717 . . . . 0.0 112.521 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -75.31 -24.15 57.41 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 119.584 -1.948 . . . . 0.0 114.436 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 71.82 49.84 0.26 Allowed 'General case' 0 C--N 1.352 0.692 0 C-N-CA 125.403 1.481 . . . . 0.0 111.038 -176.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 6.1 mt -107.7 17.72 22.25 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 121.054 -1.029 . . . . 0.0 111.961 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -105.83 149.54 26.41 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -77.31 154.81 32.51 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 121.254 -0.904 . . . . 0.0 108.852 172.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -71.53 -37.21 71.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 122.746 1.26 . . . . 0.0 110.794 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -88.63 -51.5 5.65 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 121.035 -1.041 . . . . 0.0 111.884 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -96.13 59.65 1.95 Allowed 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 120.338 -1.476 . . . . 0.0 113.25 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -63.29 -9.33 11.28 Favored 'General case' 0 C--N 1.346 0.436 0 O-C-N 120.098 -1.626 . . . . 0.0 115.03 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -91.07 2.38 56.36 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.293 -1.504 . . . . 0.0 113.315 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 50.1 mm -106.04 143.07 17.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 C-N-CA 125.572 1.549 . . . . 0.0 108.437 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 44.9 t -129.64 130.14 66.82 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 O-C-N 120.778 -1.201 . . . . 0.0 109.114 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -95.26 100.66 12.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.629 1.172 . . . . 0.0 110.404 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 1.2 m -101.43 1.54 38.41 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 121.118 -0.989 . . . . 0.0 112.662 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 26.4 t -65.44 131.18 45.78 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 120.828 -1.17 . . . . 0.0 110.651 173.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 4.9 t30 69.93 25.01 5.01 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.274 1.03 . . . . 0.0 113.226 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -123.26 171.5 9.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 13.8 tp -74.97 -22.19 58.71 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.781 1.632 . . . . 0.0 111.688 -171.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' LEU . . . . . 0.515 HD13 HD13 ' B' ' 102' ' ' LEU . 1.0 OUTLIER -71.04 -33.53 70.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 120.799 -1.188 . . . . 0.0 112.715 170.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.67 -38.3 96.21 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 120.065 -1.647 . . . . 0.0 113.812 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -51.91 -50.24 61.48 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.18 2.592 . . . . 0.0 112.456 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' LEU . . . . . 0.419 HD13 HD21 ' B' ' 171' ' ' ASN . 0.9 OUTLIER -78.95 -30.76 44.77 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 120.024 -1.673 . . . . 0.0 113.865 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.41 ' HB3' HG22 ' B' ' 153' ' ' VAL . 11.6 m-85 -75.67 -35.04 60.49 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 120.734 -1.229 . . . . 0.0 112.83 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 73.99 23.2 76.81 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 123.857 0.741 . . . . 0.0 113.696 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' B' ' 151' ' ' PHE . 12.3 m -135.19 152.44 76.95 Favored Pre-proline 0 N--CA 1.451 -0.408 0 O-C-N 121.176 -1.191 . . . . 0.0 108.454 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.71 -38.41 3.2 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 121.797 1.665 . . . . 0.0 111.798 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 31.1 m -144.67 164.31 31.36 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -138.06 178.48 7.09 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 77.5 p -136.78 141.64 42.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.077 -1.639 . . . . 0.0 109.626 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.23 -23.57 23.3 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 CA-C-O 122.62 1.2 . . . . 0.0 113.035 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -60.01 -27.05 66.57 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 120.666 -1.271 . . . . 0.0 113.521 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.87 56.64 1.58 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.838 1.255 . . . . 0.0 112.438 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -53.64 -38.86 64.5 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 119.684 -1.885 . . . . 0.0 114.43 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -67.45 -32.34 73.14 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.903 1.681 . . . . 0.0 113.529 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -74.72 -43.95 52.44 Favored 'General case' 0 C--N 1.348 0.53 0 C-N-CA 125.405 1.482 . . . . 0.0 110.799 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 51.3 mm -50.63 -53.38 13.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.768 1.227 . . . . 0.0 112.012 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -54.25 -43.12 70.66 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 124.243 1.017 . . . . 0.0 113.655 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -36.07 79.88 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 119.7 -1.875 . . . . 0.0 113.664 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.33 -38.38 78.16 Favored 'General case' 0 C--N 1.346 0.44 0 O-C-N 120.434 -1.416 . . . . 0.0 111.845 176.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 67.6 mt -66.54 -50.38 67.24 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 C-N-CA 124.455 1.102 . . . . 0.0 112.313 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -61.1 -14.88 27.37 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 119.735 -1.853 . . . . 0.0 114.918 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -76.31 -12.73 60.12 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.554 -1.966 . . . . 0.0 113.539 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . 0.419 HD21 HD13 ' B' ' 150' ' ' LEU . 2.1 m120 -105.24 -15.91 14.92 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 120.419 -1.426 . . . . 0.0 111.86 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' LEU . . . . . 0.431 HD22 ' HB ' ' B' ' 93' ' ' VAL . 48.0 mt -111.37 162.93 14.53 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 121.92 0.867 . . . . 0.0 109.804 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' B' ' 94' ' ' ARG . 8.6 p -106.92 126.68 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 O-C-N 120.453 -1.405 . . . . 0.0 108.978 173.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.348 0.534 0 C-N-CA 123.779 0.832 . . . . 0.0 110.681 -179.226 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.52 3.039 0 N-CA-C 104.169 -2.53 . . . . 0.0 104.169 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 44.61 55.98 5.85 Favored Glycine 0 C--N 1.355 1.62 0 CA-C-N 120.181 1.355 . . . . 0.0 114.903 -162.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -116.38 111.51 20.16 Favored 'General case' 0 CA--C 1.506 -0.72 0 O-C-N 120.113 -1.816 . . . . 0.0 111.606 -168.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.28 -147.14 5.55 Favored Glycine 0 C--N 1.349 1.306 0 CA-C-O 122.206 0.892 . . . . 0.0 112.44 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -84.38 66.0 9.18 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 120.132 -1.805 . . . . 0.0 113.545 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.502 ' HA ' HD21 ' A' ' 18' ' ' LEU . 3.8 m -62.81 -6.26 3.55 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.8 pttm -89.12 -26.57 21.27 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.298 2.239 . . . . 0.0 113.635 175.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 175.16 87.22 0.08 OUTLIER Pre-proline 0 C--N 1.35 0.622 0 C-N-CA 125.074 1.35 . . . . 0.0 108.738 -172.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.74 127.31 8.66 Favored 'Trans proline' 0 C--N 1.325 -0.702 0 C-N-CA 122.231 1.954 . . . . 0.0 111.65 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.6 t -122.38 -0.38 9.31 Favored 'General case' 0 C--N 1.347 0.498 0 CA-C-O 122.71 1.243 . . . . 0.0 110.884 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.9 t -130.39 164.2 25.23 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 124.92 1.288 . . . . 0.0 109.599 -174.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -68.26 -38.13 81.45 Favored 'General case' 0 C--N 1.348 0.534 0 C-N-CA 124.369 1.068 . . . . 0.0 111.105 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.7 -52.9 39.37 Favored 'General case' 0 C--N 1.35 0.604 0 C-N-CA 124.848 1.259 . . . . 0.0 110.803 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.84 -55.25 10.18 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.092 1.757 . . . . 0.0 114.07 169.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -69.57 -30.81 68.68 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.275 -1.516 . . . . 0.0 113.501 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 30.4 t90 -58.32 -41.55 84.79 Favored 'General case' 0 C--N 1.35 0.596 0 O-C-N 119.937 -1.727 . . . . 0.0 112.381 171.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -65.25 -43.2 92.08 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 120.769 -1.207 . . . . 0.0 113.454 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.502 HD21 ' HA ' ' A' ' 6' ' ' SER . 3.2 mm? -53.26 -29.18 31.51 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 127.072 2.149 . . . . 0.0 115.014 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.1 tp -64.49 -19.58 65.67 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.604 1.162 . . . . 0.0 113.94 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.268 42.2 p 54.65 35.59 24.11 Favored 'General case' 0 C--N 1.351 0.644 0 C-N-CA 126.871 2.068 . . . . 0.0 114.299 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.34 94.59 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 126.44 1.896 . . . . 0.0 115.186 -170.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 146.2 -40.85 1.04 Allowed Glycine 0 CA--C 1.494 -1.225 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -170.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 111.91 -146.24 17.97 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 124.475 1.036 . . . . 0.0 111.684 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.9 m -94.53 155.24 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 O-C-N 121.09 -1.241 . . . . 0.0 110.904 177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -133.61 155.52 80.45 Favored Pre-proline 0 N--CA 1.448 -0.559 0 O-C-N 120.601 -1.312 . . . . 0.0 107.592 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -75.37 6.44 3.55 Favored 'Trans proline' 0 C--N 1.333 -0.247 0 C-N-CA 123.113 2.542 . . . . 0.0 113.017 -177.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt 62.63 46.25 5.54 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.705 1.602 . . . . 0.0 114.262 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 pt -59.79 139.24 19.65 Favored 'Isoleucine or valine' 0 C--N 1.348 0.531 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -173.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 3.5 mp -86.69 28.1 0.91 Allowed 'General case' 0 C--N 1.346 0.45 0 O-C-N 120.948 -1.095 . . . . 0.0 111.685 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -82.51 138.29 34.36 Favored 'General case' 0 N--CA 1.441 -0.875 0 O-C-N 120.543 -1.348 . . . . 0.0 109.79 173.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -84.7 127.0 33.88 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.503 0.668 . . . . 0.0 111.019 178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.9 p -119.07 -175.95 3.02 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.038 1.335 . . . . 0.0 109.388 -177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -130.67 -12.82 3.8 Favored 'General case' 0 N--CA 1.451 -0.387 0 O-C-N 120.696 -1.252 . . . . 0.0 111.116 168.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -157.04 169.99 23.56 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 120.689 -1.257 . . . . 0.0 107.875 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.1 -31.73 71.55 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.579 1.551 . . . . 0.0 113.515 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.7 m -65.28 -26.64 68.17 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 120.121 -1.612 . . . . 0.0 115.058 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -76.84 -11.33 59.81 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.308 -0.87 . . . . 0.0 111.987 176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -107.4 127.56 27.63 Favored Pre-proline 0 C--N 1.354 0.791 0 O-C-N 120.179 -1.576 . . . . 0.0 112.129 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.07 168.64 23.67 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.195 1.93 . . . . 0.0 114.175 -171.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.32 -85.57 1.13 Allowed Glycine 0 C--N 1.35 1.313 0 C-N-CA 124.626 1.108 . . . . 0.0 112.982 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -161.3 25.59 0.13 Allowed 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 122.598 1.19 . . . . 0.0 110.169 177.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 7.1 m -89.63 148.55 23.27 Favored 'General case' 0 N--CA 1.445 -0.717 0 O-C-N 119.181 -2.199 . . . . 0.0 109.612 -170.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 pp -115.37 147.42 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.926 0 O-C-N 119.882 -1.761 . . . . 0.0 108.821 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.06 117.14 19.08 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.989 1.316 . . . . 0.0 110.158 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 78.7 mtm180 -79.9 176.3 9.86 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 120.029 -1.669 . . . . 0.0 110.911 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.89 0.33 2.42 Favored Glycine 0 C--N 1.355 1.59 0 N-CA-C 117.492 1.757 . . . . 0.0 117.492 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -100.45 -7.49 24.23 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 120.707 -1.466 . . . . 0.0 111.925 170.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.35 20.18 60.93 Favored Glycine 0 C--N 1.348 1.208 0 O-C-N 120.458 -1.401 . . . . 0.0 113.707 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -130.81 145.21 51.91 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 121.133 -1.216 . . . . 0.0 110.593 -178.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 78.8 m -75.39 147.13 40.26 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 123.51 1.624 . . . . 0.0 114.329 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.334 0 CA-C-O 116.19 -2.45 . . . . 0.0 118.186 -174.385 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 57.2 mt . . . . . 0 N--CA 1.504 2.246 0 CA-C-O 118.752 -0.642 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.485 HG11 HD13 ' B' ' 172' ' ' LEU . 11.7 m -136.2 166.22 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -115.84 102.14 54.04 Favored Pre-proline 0 C--N 1.345 0.391 0 CA-C-O 117.137 -1.411 . . . . 0.0 110.035 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.49 174.46 9.23 Favored 'Trans proline' 0 C--N 1.325 -0.66 0 C-N-CA 123.3 2.667 . . . . 0.0 114.086 175.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -96.2 154.64 38.73 Favored Pre-proline 0 C--N 1.35 0.617 0 O-C-N 120.914 -1.116 . . . . 0.0 111.617 -177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.91 -24.32 29.12 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.179 2.586 . . . . 0.0 112.7 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.8 mt -64.59 -52.94 54.94 Favored 'General case' 0 C--N 1.347 0.485 0 CA-C-N 118.686 0.676 . . . . 0.0 111.358 168.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 32.6 tp -58.69 -36.9 74.96 Favored 'General case' 0 C--N 1.348 0.5 0 C-N-CA 124.976 1.311 . . . . 0.0 113.522 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 15.6 tp -47.63 -40.3 19.26 Favored 'General case' 0 C--N 1.352 0.682 0 C-N-CA 125.345 1.458 . . . . 0.0 114.805 170.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -64.47 -36.82 85.44 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 119.645 -1.91 . . . . 0.0 113.723 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.7 tt -70.45 -50.62 36.34 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 124.037 0.935 . . . . 0.0 110.738 173.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 88.8 mt -53.59 -46.34 70.33 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.913 1.285 . . . . 0.0 112.287 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -58.95 -25.18 63.3 Favored 'General case' 0 C--N 1.346 0.453 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 176.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.44 -13.57 59.02 Favored 'General case' 0 C--N 1.345 0.392 0 C-N-CA 125.307 1.443 . . . . 0.0 112.025 177.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.5 t -101.62 0.61 10.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 125.07 1.348 . . . . 0.0 109.782 173.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 107.2 -15.75 39.19 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 120.084 -1.635 . . . . 0.0 113.155 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -88.14 78.39 8.13 Favored 'General case' 0 N--CA 1.442 -0.831 0 O-C-N 120.434 -1.627 . . . . 0.0 113.493 -172.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -85.38 8.1 20.08 Favored 'General case' 0 C--N 1.343 0.318 0 O-C-N 119.895 -1.753 . . . . 0.0 115.466 -176.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.82 149.49 27.14 Favored 'General case' 0 C--N 1.346 0.437 0 O-C-N 121.339 -0.851 . . . . 0.0 112.508 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -78.74 -27.55 44.79 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 125.147 1.379 . . . . 0.0 112.527 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 60.4 p -121.58 140.88 51.67 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 120.808 -1.182 . . . . 0.0 112.572 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -139.43 177.31 8.02 Favored 'General case' 0 C--N 1.347 0.496 0 CA-C-O 122.439 1.114 . . . . 0.0 110.264 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.408 ' O ' HG23 ' B' ' 118' ' ' VAL . 0.7 OUTLIER -88.48 160.97 17.26 Favored 'General case' 0 C--N 1.346 0.447 0 O-C-N 120.666 -1.271 . . . . 0.0 110.872 175.208 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -53.98 -47.68 71.14 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.105 -1.622 . . . . 0.0 114.388 178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -59.36 -52.7 64.5 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 123.978 0.911 . . . . 0.0 112.913 171.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.76 -46.57 50.75 Favored 'General case' 0 C--N 1.352 0.689 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 174.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.408 HG23 ' O ' ' B' ' 114' ' ' THR . 52.1 t -51.88 -48.25 39.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 O-C-N 120.97 -1.081 . . . . 0.0 112.709 177.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -80.2 -29.84 38.66 Favored 'General case' 0 N--CA 1.451 -0.383 0 O-C-N 121.082 -1.012 . . . . 0.0 113.288 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 93.7 t80 -56.27 -60.34 3.64 Favored 'General case' 0 C--N 1.346 0.456 0 C-N-CA 125.774 1.629 . . . . 0.0 112.193 172.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -59.13 -36.49 75.29 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 120.669 -1.269 . . . . 0.0 112.495 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.413 HD11 ' CD1' ' B' ' 147' ' ' LEU . 5.0 tp -62.56 -51.46 67.26 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.1 1.36 . . . . 0.0 113.902 173.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.23 -51.77 54.27 Favored Glycine 0 C--N 1.35 1.334 0 C-N-CA 125.502 1.525 . . . . 0.0 113.204 178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -55.39 -39.15 69.79 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 125.216 1.406 . . . . 0.0 113.399 174.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -59.11 -56.3 24.02 Favored 'General case' 0 C--N 1.35 0.621 0 O-C-N 121.149 -0.969 . . . . 0.0 112.74 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.71 -44.97 98.56 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 C-N-CA 124.327 1.051 . . . . 0.0 112.475 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 45.2 ttm -52.43 -44.67 65.58 Favored 'General case' 0 C--N 1.348 0.511 0 C-N-CA 126.268 1.827 . . . . 0.0 112.979 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 11.7 m -85.83 -23.62 27.09 Favored 'General case' 0 C--N 1.346 0.449 0 O-C-N 120.153 -1.592 . . . . 0.0 112.774 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -29.42 55.62 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 118.982 -2.324 . . . . 0.0 113.053 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? 75.15 49.27 0.09 Allowed 'General case' 0 C--N 1.351 0.659 0 C-N-CA 126.496 1.918 . . . . 0.0 110.596 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 4.5 mt -102.6 23.19 12.34 Favored 'General case' 0 C--N 1.349 0.553 0 O-C-N 121.032 -1.042 . . . . 0.0 111.68 -179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -114.01 144.14 43.59 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 120.588 -1.32 . . . . 0.0 108.599 178.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -72.27 132.59 44.26 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 120.883 -1.136 . . . . 0.0 110.162 173.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -58.22 -47.77 82.45 Favored 'General case' 0 C--N 1.346 0.424 0 O-C-N 119.705 -1.872 . . . . 0.0 113.681 173.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -75.04 -19.49 60.01 Favored 'General case' 0 C--N 1.347 0.458 0 O-C-N 119.878 -1.764 . . . . 0.0 114.323 176.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.22 58.67 1.58 Allowed 'General case' 0 CA--C 1.512 -0.515 0 O-C-N 119.701 -1.874 . . . . 0.0 110.231 -170.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -62.55 -7.41 4.62 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.453 1.901 . . . . 0.0 114.903 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 1.7 m170 -92.7 -3.82 54.22 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.015 2.526 . . . . 0.0 113.551 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 43.8 mm -106.29 139.32 28.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.419 0 C-N-CA 126.022 1.729 . . . . 0.0 107.643 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 39.9 t -124.7 130.17 73.47 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 CA-C-O 122.406 1.098 . . . . 0.0 110.324 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.59 109.34 18.47 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 120.971 -1.08 . . . . 0.0 110.994 172.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 24.1 p -100.38 -14.47 18.34 Favored 'General case' 0 C--N 1.346 0.426 0 O-C-N 121.126 -0.984 . . . . 0.0 112.324 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.89 124.6 20.41 Favored 'General case' 0 C--N 1.35 0.627 0 O-C-N 120.645 -1.285 . . . . 0.0 113.312 178.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 79.05 2.75 2.41 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 125.43 1.492 . . . . 0.0 113.554 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -112.12 167.33 10.49 Favored 'General case' 0 C--N 1.35 0.587 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 171.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 tp -64.39 -20.98 66.48 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 128.059 2.543 . . . . 0.0 112.81 -171.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' LEU . . . . . 0.413 ' CD1' HD11 ' B' ' 122' ' ' LEU . 1.1 tp -67.47 -36.55 81.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 C-N-CA 125.785 1.634 . . . . 0.0 112.926 171.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -71.22 -48.41 31.72 Favored Glycine 0 C--N 1.349 1.264 0 O-C-N 120.923 -1.111 . . . . 0.0 112.468 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.33 -42.32 4.48 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 127.823 2.449 . . . . 0.0 114.246 169.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.75 -29.89 15.8 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 120.311 -1.493 . . . . 0.0 114.355 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.655 ' HB3' HG22 ' B' ' 153' ' ' VAL . 2.4 m-85 -74.08 -41.75 61.22 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 120.684 -1.26 . . . . 0.0 111.699 177.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 84.33 20.82 58.1 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 124.154 0.883 . . . . 0.0 113.14 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . 0.655 HG22 ' HB3' ' B' ' 151' ' ' PHE . 35.0 m -133.71 153.48 80.12 Favored Pre-proline 0 C--N 1.346 0.421 0 O-C-N 121.155 -1.203 . . . . 0.0 110.561 -177.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.56 -25.18 5.7 Favored 'Trans proline' 0 N--CA 1.464 -0.229 0 C-N-CA 122.046 1.83 . . . . 0.0 112.907 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 33.2 p -160.08 164.01 33.42 Favored 'General case' 0 CA--C 1.503 -0.841 0 O-C-N 120.016 -1.678 . . . . 0.0 107.427 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -144.56 163.85 32.65 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 122.593 1.187 . . . . 0.0 110.7 176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.57 130.27 54.36 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 120.655 -1.278 . . . . 0.0 111.034 175.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 48.8 t -62.79 -27.92 43.94 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 O-C-N 119.711 -1.868 . . . . 0.0 111.749 175.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -25.87 12.67 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 125.854 1.662 . . . . 0.0 114.868 171.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -85.2 55.52 3.53 Favored 'General case' 0 N--CA 1.44 -0.968 0 O-C-N 119.968 -1.708 . . . . 0.0 112.185 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 78.1 m-70 -48.58 -44.72 37.08 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 119.229 -2.169 . . . . 0.0 115.519 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -22.81 61.93 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 172.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -87.75 -44.13 11.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.091 1.356 . . . . 0.0 109.734 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 49.6 mm -53.98 -51.9 41.47 Favored 'Isoleucine or valine' 0 C--N 1.35 0.61 0 C-N-CA 125.118 1.367 . . . . 0.0 111.515 174.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -53.84 -45.96 71.07 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 171.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.87 -39.59 93.79 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 119.63 -1.918 . . . . 0.0 113.627 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 24.3 mmt -60.09 -49.25 78.4 Favored 'General case' 0 C--N 1.345 0.382 0 O-C-N 120.741 -1.224 . . . . 0.0 112.58 173.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 45.8 mt -59.6 -51.48 72.28 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 C-N-CA 124.826 1.25 . . . . 0.0 112.524 175.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -61.39 -23.4 65.76 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 119.198 -2.189 . . . . 0.0 114.407 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 5.3 mmm180 -77.59 -11.87 59.91 Favored 'General case' 0 C--N 1.349 0.57 0 O-C-N 119.499 -2.001 . . . . 0.0 113.503 170.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -95.86 -26.38 15.65 Favored 'General case' 0 CA--C 1.505 -0.764 0 O-C-N 119.985 -1.697 . . . . 0.0 110.403 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.485 HD13 HG11 ' B' ' 93' ' ' VAL . 73.3 mt -103.35 174.26 5.95 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 122.023 0.916 . . . . 0.0 110.603 -174.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 97.7 t -116.59 121.66 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 N-CA-C 105.665 -1.976 . . . . 0.0 105.665 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 99.2 t . . . . . 0 C--N 1.347 0.46 0 C-N-CA 123.792 0.837 . . . . 0.0 110.331 179.829 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.3 p . . . . . 0 N--CA 1.515 2.808 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 50.15 47.49 41.51 Favored Glycine 0 C--N 1.354 1.577 0 CA-C-N 120.154 1.343 . . . . 0.0 114.874 -165.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.6 m -114.93 114.03 24.93 Favored 'General case' 0 CA--C 1.507 -0.699 0 O-C-N 119.769 -2.018 . . . . 0.0 112.0 -167.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.22 -151.17 5.89 Favored Glycine 0 C--N 1.348 1.213 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.84 70.0 4.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 121.286 -1.126 . . . . 0.0 113.976 -176.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.0 p -69.51 -0.98 7.45 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 119.429 -2.044 . . . . 0.0 114.868 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 4.9 mtpm? -92.75 -34.39 13.93 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.619 1.568 . . . . 0.0 113.007 171.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -173.97 85.21 0.36 Allowed Pre-proline 0 C--N 1.347 0.471 0 CA-C-O 118.672 -0.68 . . . . 0.0 109.6 -175.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.34 118.86 4.76 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.233 1.955 . . . . 0.0 112.05 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.1 t -107.68 -25.29 11.37 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 124.954 1.301 . . . . 0.0 110.039 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 t -106.02 165.63 11.08 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.384 -1.447 . . . . 0.0 113.941 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.3 p90 -63.3 -50.44 70.07 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 119.786 -1.822 . . . . 0.0 111.77 175.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.36 -45.17 72.73 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 125.867 1.667 . . . . 0.0 113.061 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -56.54 -58.43 8.08 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 125.617 1.567 . . . . 0.0 113.888 171.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' B' ' 138' ' ' HIS . 0.1 OUTLIER -66.58 -29.52 69.59 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 120.321 -1.487 . . . . 0.0 113.07 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -35.63 73.81 Favored 'General case' 0 C--N 1.348 0.525 0 O-C-N 119.926 -1.734 . . . . 0.0 112.083 173.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -70.32 -44.33 68.45 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 120.532 -1.355 . . . . 0.0 112.881 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -54.32 -29.55 48.19 Favored 'General case' 0 C--N 1.353 0.721 0 C-N-CA 126.399 1.88 . . . . 0.0 114.862 178.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.488 HD22 HG13 ' B' ' 158' ' ' VAL . 21.4 tp -61.11 -30.34 70.3 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.511 1.124 . . . . 0.0 113.81 171.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 t 54.44 53.32 10.96 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 126.536 1.935 . . . . 0.0 113.043 -172.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.84 81.38 1.63 Allowed 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 123.097 1.427 . . . . 0.0 113.561 -170.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.19 -29.92 0.47 Allowed Glycine 0 C--N 1.342 0.877 0 O-C-N 121.234 -0.916 . . . . 0.0 112.243 -176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 117.19 -149.23 18.73 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-N 117.797 0.798 . . . . 0.0 112.44 175.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.0 t -103.35 138.69 26.72 Favored 'Isoleucine or valine' 0 C--N 1.344 0.344 0 O-C-N 120.972 -1.311 . . . . 0.0 109.012 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -112.28 157.03 41.13 Favored Pre-proline 0 N--CA 1.447 -0.606 0 O-C-N 120.746 -1.221 . . . . 0.0 109.074 -178.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.73 -1.09 10.27 Favored 'Trans proline' 0 C--N 1.336 -0.123 0 C-N-CA 122.73 2.286 . . . . 0.0 112.757 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.2 mtmt 66.98 53.76 0.81 Allowed 'General case' 0 C--N 1.35 0.609 0 C-N-CA 126.421 1.889 . . . . 0.0 112.704 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 pt -63.35 141.0 18.72 Favored 'Isoleucine or valine' 0 C--N 1.346 0.414 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 -175.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.2 mt -85.65 29.9 0.67 Allowed 'General case' 0 C--N 1.348 0.503 0 C-N-CA 124.284 1.034 . . . . 0.0 111.825 174.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -86.32 143.34 27.93 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 120.179 -1.576 . . . . 0.0 109.386 172.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -88.48 133.95 33.99 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.861 0.839 . . . . 0.0 110.456 178.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.7 p -125.4 -175.88 3.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.001 0.92 . . . . 0.0 108.902 -173.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.7 ttp85 -129.71 -13.34 4.22 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.346 -1.471 . . . . 0.0 111.774 167.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.6 ptt180 -161.89 176.03 11.25 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -74.2 -27.45 60.81 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 120.541 -1.349 . . . . 0.0 112.557 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.19 -28.25 67.81 Favored 'General case' 0 C--N 1.348 0.54 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 171.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -84.23 -8.24 59.11 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.347 -0.846 . . . . 0.0 110.701 -177.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -111.29 124.19 33.29 Favored Pre-proline 0 C--N 1.355 0.816 0 O-C-N 120.091 -1.631 . . . . 0.0 111.9 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.28 169.63 22.07 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.147 1.898 . . . . 0.0 114.135 -169.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.69 -87.85 1.14 Allowed Glycine 0 C--N 1.349 1.266 0 C-N-CA 124.319 0.962 . . . . 0.0 112.246 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.39 21.53 0.29 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.992 0.901 . . . . 0.0 110.87 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 4.2 m -83.87 152.34 24.61 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 119.278 -2.139 . . . . 0.0 110.027 -168.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 pp -119.23 146.12 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 O-C-N 120.037 -1.664 . . . . 0.0 108.342 177.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -77.51 119.47 21.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.422 1.489 . . . . 0.0 109.298 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -79.53 177.34 8.94 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 119.984 -1.698 . . . . 0.0 110.565 178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.34 -18.86 23.12 Favored Glycine 0 C--N 1.355 1.626 0 N-CA-C 116.598 1.399 . . . . 0.0 116.598 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 44.4 m-20 -82.17 -8.68 59.66 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.449 -1.03 . . . . 0.0 112.992 174.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.64 14.88 69.48 Favored Glycine 0 C--N 1.351 1.377 0 O-C-N 120.659 -1.276 . . . . 0.0 113.905 -175.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -127.56 148.57 50.34 Favored 'General case' 0 C--N 1.347 0.467 0 O-C-N 120.653 -1.498 . . . . 0.0 110.354 -176.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 41.9 m -74.63 147.16 41.84 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 123.783 1.754 . . . . 0.0 114.35 -175.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.289 0 CA-C-O 116.689 -2.173 . . . . 0.0 117.435 -176.179 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.505 2.275 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 9.8 m -132.88 164.91 33.95 Favored 'Isoleucine or valine' 0 C--N 1.345 0.378 0 CA-C-N 119.587 1.085 . . . . 0.0 108.665 173.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.29 100.49 53.51 Favored Pre-proline 0 C--N 1.344 0.348 0 CA-C-O 117.082 -1.437 . . . . 0.0 110.181 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.37 162.94 39.89 Favored 'Trans proline' 0 C--N 1.331 -0.358 0 C-N-CA 123.232 2.622 . . . . 0.0 114.006 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -89.11 156.28 49.07 Favored Pre-proline 0 C--N 1.347 0.492 0 O-C-N 121.344 -0.847 . . . . 0.0 112.613 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -70.65 -20.63 30.38 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.232 2.621 . . . . 0.0 113.3 -170.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 81.1 mt -70.32 -61.14 1.89 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 123.706 0.803 . . . . 0.0 110.186 170.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 31.9 tp -50.74 -37.09 39.9 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 125.422 1.489 . . . . 0.0 114.427 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 8.3 tp -47.66 -40.71 20.6 Favored 'General case' 0 C--N 1.352 0.675 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 169.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -64.35 -36.84 85.44 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 119.463 -2.023 . . . . 0.0 114.084 176.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -49.67 60.17 Favored 'General case' 0 C--N 1.347 0.488 0 O-C-N 121.35 -0.844 . . . . 0.0 111.598 171.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 93.7 mt -52.18 -47.25 65.64 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 124.172 0.989 . . . . 0.0 113.124 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -52.74 -30.03 30.32 Favored 'General case' 0 C--N 1.348 0.506 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 171.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 1.3 t -77.11 -20.6 55.47 Favored 'General case' 0 C--N 1.345 0.381 0 C-N-CA 124.602 1.161 . . . . 0.0 111.927 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.12 -9.72 9.49 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 C-N-CA 124.619 1.168 . . . . 0.0 110.606 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 120.97 -27.31 6.49 Favored Glycine 0 C--N 1.353 1.51 0 O-C-N 120.066 -1.646 . . . . 0.0 111.966 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . 0.413 ' HB1' ' CE2' ' B' ' 113' ' ' TYR . . . -78.16 74.27 4.7 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 125.82 1.648 . . . . 0.0 114.718 -171.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -84.8 17.44 2.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 119.248 -2.157 . . . . 0.0 115.158 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.43 143.8 26.54 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 123.36 1.552 . . . . 0.0 113.021 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -20.27 64.03 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 130.093 3.357 . . . . 0.0 112.396 -177.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 31.1 p -140.44 141.27 35.48 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 125.2 1.4 . . . . 0.0 109.87 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . 0.413 ' CE2' ' HB1' ' B' ' 108' ' ' ALA . 1.9 m-85 -141.51 -173.75 3.85 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.071 -1.018 . . . . 0.0 110.443 177.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.464 ' O ' HG23 ' B' ' 118' ' ' VAL . 4.4 p -95.68 168.73 10.49 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.526 -1.358 . . . . 0.0 110.584 175.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 13.7 mmt -62.48 -49.19 76.37 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.731 -1.231 . . . . 0.0 113.258 177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -58.94 -45.51 90.25 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 124.677 1.191 . . . . 0.0 112.206 175.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -56.34 -47.54 78.59 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 114' ' ' THR . 47.2 t -52.81 -46.08 50.97 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 O-C-N 120.135 -1.603 . . . . 0.0 112.958 174.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.567 HD21 HD13 ' B' ' 168' ' ' ILE . 4.1 mm? -76.46 -30.79 57.46 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 120.701 -1.249 . . . . 0.0 113.233 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -62.25 -57.24 12.17 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.667 1.587 . . . . 0.0 111.588 175.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -59.27 -43.03 92.51 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 123.891 0.876 . . . . 0.0 112.495 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.29 -53.7 55.25 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 120.88 -1.138 . . . . 0.0 114.017 170.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -62.57 -40.99 99.83 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 120.523 -1.36 . . . . 0.0 113.85 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -63.11 -38.12 89.92 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 124.877 1.271 . . . . 0.0 112.718 173.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -56.46 -56.88 15.71 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 124.288 1.035 . . . . 0.0 112.433 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.01 -42.39 96.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 O-C-N 120.696 -1.253 . . . . 0.0 112.665 178.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 37.2 ttm -54.76 -41.02 69.95 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 125.911 1.684 . . . . 0.0 113.321 174.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 17.2 m -87.98 -28.17 21.62 Favored 'General case' 0 C--N 1.344 0.357 0 O-C-N 120.162 -1.586 . . . . 0.0 112.118 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.23 -35.12 73.63 Favored 'General case' 0 C--N 1.347 0.469 0 O-C-N 119.658 -1.901 . . . . 0.0 113.562 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? 74.91 59.04 0.07 Allowed 'General case' 0 C--N 1.353 0.725 0 C-N-CA 127.033 2.133 . . . . 0.0 110.516 -169.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 mt -110.42 13.79 22.73 Favored 'General case' 0 C--N 1.35 0.587 0 CA-C-O 122.065 0.936 . . . . 0.0 111.679 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -100.68 149.87 23.33 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.901 1.281 . . . . 0.0 108.347 173.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -85.14 143.42 28.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 121.146 -0.971 . . . . 0.0 108.548 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -64.08 -33.21 75.23 Favored 'General case' 0 C--N 1.348 0.524 0 O-C-N 120.73 -1.231 . . . . 0.0 113.067 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -98.06 -35.18 10.5 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 121.33 -0.856 . . . . 0.0 111.953 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -111.84 63.3 0.62 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.219 1.807 . . . . 0.0 111.912 176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -62.29 -9.34 7.73 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.11 1.764 . . . . 0.0 114.764 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' HIS . . . . . 0.426 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 26.2 p80 -90.07 -6.54 55.38 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.561 1.944 . . . . 0.0 113.695 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 33.1 mm -99.71 134.5 38.81 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 124.58 1.152 . . . . 0.0 109.273 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 19.8 t -122.74 128.39 75.25 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 O-C-N 120.757 -1.214 . . . . 0.0 109.763 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -89.2 102.72 15.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 120.97 -1.081 . . . . 0.0 109.818 175.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.56 -1.24 28.62 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 123.77 0.828 . . . . 0.0 111.305 175.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 1.4 t -71.81 139.41 48.94 Favored 'General case' 0 CA--C 1.506 -0.722 0 O-C-N 120.623 -1.298 . . . . 0.0 109.817 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 17.6 m120 71.52 5.38 5.38 Favored 'General case' 0 C--N 1.346 0.434 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -106.06 169.99 8.17 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 122.526 1.155 . . . . 0.0 109.884 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 13.8 tp -69.63 -21.38 63.57 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 127.193 2.197 . . . . 0.0 112.571 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -73.39 -32.82 64.67 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 120.565 -1.334 . . . . 0.0 111.89 170.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.57 -40.19 98.82 Favored Glycine 0 C--N 1.35 1.328 0 O-C-N 120.617 -1.302 . . . . 0.0 113.091 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.17 -43.14 70.38 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 127.688 2.395 . . . . 0.0 112.575 173.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.18 -33.29 20.84 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 119.873 -1.767 . . . . 0.0 114.135 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.578 ' HB3' HG22 ' B' ' 153' ' ' VAL . 1.8 m-85 -70.3 -41.8 72.86 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 125.713 1.605 . . . . 0.0 111.644 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.89 20.84 72.66 Favored Glycine 0 C--N 1.349 1.289 0 C-N-CA 123.882 0.754 . . . . 0.0 113.178 -178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . 0.578 HG22 ' HB3' ' B' ' 151' ' ' PHE . 28.7 m -133.32 151.86 78.32 Favored Pre-proline 0 C--N 1.345 0.376 0 O-C-N 121.32 -1.106 . . . . 0.0 109.371 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -75.33 -25.25 11.54 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.207 1.938 . . . . 0.0 111.95 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 53.6 p -161.3 165.52 28.99 Favored 'General case' 0 CA--C 1.504 -0.81 0 O-C-N 120.403 -1.436 . . . . 0.0 108.6 -175.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -143.85 168.82 19.05 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 121.074 -1.016 . . . . 0.0 108.295 177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 32.6 t -115.02 140.96 48.62 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.107 -0.996 . . . . 0.0 108.907 172.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . 0.488 HG13 HD22 ' A' ' 19' ' ' LEU . 23.9 t -69.51 -22.19 25.22 Favored 'Isoleucine or valine' 0 C--N 1.347 0.493 0 CA-C-O 122.818 1.294 . . . . 0.0 111.564 174.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.22 -29.62 70.72 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 120.163 -1.586 . . . . 0.0 112.129 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -80.46 56.98 2.71 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.754 -1.216 . . . . 0.0 112.744 175.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 19.4 p80 -52.55 -41.91 63.95 Favored 'General case' 0 C--N 1.351 0.639 0 O-C-N 119.624 -1.922 . . . . 0.0 115.555 -176.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -62.51 -33.49 74.99 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 120.54 -1.35 . . . . 0.0 113.337 173.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -78.48 -33.18 48.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.721 -1.237 . . . . 0.0 113.082 -176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 44.4 mm -50.13 -50.8 19.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 C-N-CA 125.633 1.573 . . . . 0.0 111.344 169.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -51.99 -52.38 50.93 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 125.218 1.407 . . . . 0.0 113.167 173.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -57.34 -42.86 82.79 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 119.996 -1.69 . . . . 0.0 115.222 173.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 11.6 mtt -62.99 -38.81 92.67 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 120.638 -1.289 . . . . 0.0 113.174 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' ILE . . . . . 0.567 HD13 HD21 ' B' ' 119' ' ' LEU . 44.3 mt -69.35 -54.09 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 O-C-N 121.223 -0.923 . . . . 0.0 111.927 173.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -55.53 -27.6 49.83 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 120.304 -1.497 . . . . 0.0 114.62 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 17.5 mmm180 -63.06 -19.53 64.48 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.898 -1.751 . . . . 0.0 115.599 171.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.0 -2.17 17.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.994 0.918 . . . . 0.0 112.169 178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 92.6 mt -108.84 151.2 26.57 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-O 122.693 1.235 . . . . 0.0 110.199 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 16.0 t -95.98 114.29 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 O-C-N 120.315 -1.491 . . . . 0.0 108.914 173.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.35 0.601 0 C-N-CA 124.031 0.932 . . . . 0.0 111.396 179.35 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.506 ' HA ' ' H ' ' A' ' 43' ' ' ILE 0.262 87.6 p . . . . . 0 N--CA 1.532 3.626 0 N-CA-C 117.146 2.276 . . . . 0.0 117.146 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 55.77 53.05 44.5 Favored Glycine 0 C--N 1.356 1.683 0 N-CA-C 115.239 0.856 . . . . 0.0 115.239 -173.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.0 m -107.68 113.35 26.56 Favored 'General case' 0 CA--C 1.51 -0.573 0 O-C-N 119.884 -1.951 . . . . 0.0 112.38 -173.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.48 -149.87 5.54 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.94 70.72 5.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 121.09 -1.241 . . . . 0.0 113.27 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.441 ' HA ' HD21 ' A' ' 18' ' ' LEU . 11.0 p -68.65 3.99 1.62 Allowed 'General case' 0 C--N 1.346 0.447 0 O-C-N 119.721 -1.862 . . . . 0.0 115.496 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -100.81 -39.29 7.88 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 126.538 1.935 . . . . 0.0 111.15 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -167.58 84.79 0.79 Allowed Pre-proline 0 N--CA 1.447 -0.583 0 O-C-N 121.402 -0.812 . . . . 0.0 109.629 -175.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.96 120.22 5.37 Favored 'Trans proline' 0 C--N 1.327 -0.599 0 C-N-CA 121.981 1.787 . . . . 0.0 112.199 -177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -107.33 -37.94 6.1 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.557 1.143 . . . . 0.0 110.109 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.0 m -94.04 163.67 13.38 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 120.244 -1.535 . . . . 0.0 114.841 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -60.42 -49.81 76.09 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 125.657 1.583 . . . . 0.0 111.295 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.04 -46.82 78.74 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 123.791 0.836 . . . . 0.0 113.155 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 89.8 mt-10 -55.09 -58.17 8.74 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.2 1.4 . . . . 0.0 114.422 171.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.8 -31.98 73.25 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 120.603 -1.311 . . . . 0.0 112.947 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.1 t90 -57.2 -37.85 72.82 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 120.308 -1.495 . . . . 0.0 112.918 170.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -68.28 -40.54 81.79 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.369 -1.457 . . . . 0.0 112.753 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.441 HD21 ' HA ' ' A' ' 6' ' ' SER . 3.8 mm? -56.45 -29.03 61.18 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 126.382 1.873 . . . . 0.0 114.987 177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.9 tp -64.98 -18.92 65.7 Favored 'General case' 0 C--N 1.348 0.505 0 C-N-CA 125.286 1.434 . . . . 0.0 113.676 174.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.296 59.8 p 53.85 32.02 14.28 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 126.653 1.981 . . . . 0.0 115.463 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.7 93.71 0.01 OUTLIER 'General case' 0 C--N 1.353 0.72 0 C-N-CA 126.868 2.067 . . . . 0.0 115.784 -173.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 145.33 -38.03 1.26 Allowed Glycine 0 C--N 1.345 1.078 0 O-C-N 121.341 -0.85 . . . . 0.0 111.892 -169.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 104.68 -139.6 14.67 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-O 122.469 1.038 . . . . 0.0 112.528 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 15.6 m -97.68 145.09 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 O-C-N 120.789 -1.418 . . . . 0.0 110.452 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.35 157.7 66.78 Favored Pre-proline 0 N--CA 1.448 -0.541 0 O-C-N 120.531 -1.356 . . . . 0.0 108.168 -175.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.93 -7.82 21.32 Favored 'Trans proline' 0 CA--C 1.52 -0.188 0 C-N-CA 122.579 2.186 . . . . 0.0 112.649 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.1 mtmt 68.7 53.29 0.53 Allowed 'General case' 0 C--N 1.352 0.688 0 C-N-CA 126.122 1.769 . . . . 0.0 112.066 178.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.6 pt -64.21 142.03 17.4 Favored 'Isoleucine or valine' 0 C--N 1.347 0.486 0 N-CA-C 113.917 1.08 . . . . 0.0 113.917 -175.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.1 pp -83.34 9.94 9.77 Favored 'General case' 0 C--N 1.348 0.526 0 CA-C-O 122.545 1.164 . . . . 0.0 112.69 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -70.93 134.65 47.4 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 120.415 -1.428 . . . . 0.0 112.389 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -81.28 124.41 29.3 Favored 'General case' 0 N--CA 1.442 -0.847 0 O-C-N 121.71 -0.619 . . . . 0.0 111.797 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.1 p -115.82 -175.86 2.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.34 1.456 . . . . 0.0 109.772 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -122.14 -32.41 3.69 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 120.528 -1.358 . . . . 0.0 110.125 163.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.5 ttm180 -138.22 176.28 8.84 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 120.613 -1.304 . . . . 0.0 112.427 178.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -81.03 -5.02 57.11 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 118.898 -2.376 . . . . 0.0 113.262 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.0 t -76.32 -46.76 26.18 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 127.457 2.303 . . . . 0.0 109.576 172.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.58 -32.52 67.24 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 128.127 2.571 . . . . 0.0 113.777 177.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.76 120.3 64.9 Favored Pre-proline 0 N--CA 1.447 -0.591 0 O-C-N 120.528 -1.357 . . . . 0.0 112.776 -172.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -73.78 169.16 23.01 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.487 2.125 . . . . 0.0 114.108 -168.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.15 -89.67 1.1 Allowed Glycine 0 C--N 1.349 1.286 0 C-N-CA 124.195 0.903 . . . . 0.0 111.912 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.17 29.91 0.17 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.74 1.257 . . . . 0.0 109.975 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 18.9 m -88.66 145.26 25.77 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 119.016 -2.302 . . . . 0.0 109.415 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.506 ' H ' ' HA ' ' A' ' 1' ' ' SER . 1.3 pp -111.92 146.04 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 O-C-N 119.766 -1.834 . . . . 0.0 109.564 178.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -77.92 120.26 22.53 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 125.737 1.615 . . . . 0.0 110.041 176.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.7 mtm180 -76.41 174.78 9.83 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 119.846 -1.784 . . . . 0.0 111.077 177.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.89 -2.89 2.89 Favored Glycine 0 C--N 1.354 1.54 0 N-CA-C 117.1 1.6 . . . . 0.0 117.1 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -99.21 -9.0 24.26 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.976 1.31 . . . . 0.0 112.04 172.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.56 25.43 35.83 Favored Glycine 0 C--N 1.35 1.313 0 O-C-N 120.641 -1.287 . . . . 0.0 114.26 -176.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -135.93 150.29 49.25 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 120.724 -1.456 . . . . 0.0 111.465 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 28.9 m -85.66 116.18 23.78 Favored 'General case' 0 C--N 1.347 0.459 0 N-CA-C 117.261 2.319 . . . . 0.0 117.261 -169.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.263 0 CA-C-O 116.063 -2.521 . . . . 0.0 116.357 175.141 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 N--CA 1.504 2.235 0 CA-C-O 118.288 -0.863 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.454 HG11 HD13 ' B' ' 172' ' ' LEU . 12.8 m -139.16 164.97 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 176.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -113.97 103.5 55.19 Favored Pre-proline 0 C--N 1.344 0.368 0 CA-C-O 116.754 -1.593 . . . . 0.0 110.271 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.56 163.93 37.16 Favored 'Trans proline' 0 C--N 1.324 -0.758 0 C-N-CA 122.864 2.376 . . . . 0.0 114.196 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 6.1 mttt -84.66 153.64 61.34 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.151 0.98 . . . . 0.0 113.167 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.98 -17.29 28.68 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.164 2.576 . . . . 0.0 113.34 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -71.54 -57.9 3.99 Favored 'General case' 0 C--N 1.345 0.388 0 C-N-CA 123.992 0.917 . . . . 0.0 109.288 169.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 28.8 tp -54.12 -38.45 65.44 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 125.678 1.591 . . . . 0.0 114.478 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 14.6 tp -46.24 -39.68 10.27 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 125.396 1.479 . . . . 0.0 114.682 168.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -69.04 -37.53 78.64 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 119.193 -2.192 . . . . 0.0 113.05 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.43 -53.32 24.43 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 126.779 2.032 . . . . 0.0 111.942 169.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 76.9 mt -49.89 -45.62 50.93 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 124.72 1.208 . . . . 0.0 112.513 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -17.32 63.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 174.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 20.4 t -83.02 -8.66 59.53 Favored 'General case' 0 C--N 1.347 0.489 0 O-C-N 120.021 -1.674 . . . . 0.0 112.034 171.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . 0.551 HG22 ' CD1' ' B' ' 125' ' ' TYR . 2.2 t -105.34 -7.67 9.92 Favored 'Isoleucine or valine' 0 C--N 1.347 0.472 0 C-N-CA 124.766 1.226 . . . . 0.0 110.048 176.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 114.58 -16.91 18.87 Favored Glycine 0 C--N 1.351 1.415 0 O-C-N 120.459 -1.4 . . . . 0.0 112.558 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.45 79.84 8.85 Favored 'General case' 0 N--CA 1.444 -0.748 0 O-C-N 120.401 -1.647 . . . . 0.0 113.45 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -82.58 5.76 19.88 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.804 -1.81 . . . . 0.0 115.324 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 139.14 31.56 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -174.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.51 -11.67 61.07 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 126.765 2.026 . . . . 0.0 114.413 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 39.9 p -138.59 137.03 36.58 Favored 'General case' 0 C--N 1.348 0.542 0 C-N-CA 125.081 1.352 . . . . 0.0 111.297 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -139.35 -172.92 3.46 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 120.798 -1.189 . . . . 0.0 110.092 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.55 ' O ' HG23 ' B' ' 118' ' ' VAL . 1.8 p -96.88 173.12 7.45 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 120.048 -1.657 . . . . 0.0 109.93 174.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 24.7 mtt -67.15 -43.67 81.72 Favored 'General case' 0 C--N 1.352 0.699 0 O-C-N 120.161 -1.587 . . . . 0.0 113.46 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -58.73 -51.33 70.42 Favored 'General case' 0 C--N 1.353 0.744 0 C-N-CA 124.237 1.015 . . . . 0.0 111.603 172.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -54.56 -44.1 72.63 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.55 HG23 ' O ' ' B' ' 114' ' ' THR . 86.2 t -54.72 -43.53 66.78 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 120.121 -1.612 . . . . 0.0 112.568 176.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.3 -30.91 27.18 Favored 'General case' 0 C--N 1.346 0.415 0 O-C-N 120.729 -1.232 . . . . 0.0 112.344 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -59.93 -60.86 3.16 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.949 1.7 . . . . 0.0 112.123 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -56.96 -38.23 72.69 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.41 1.084 . . . . 0.0 112.286 178.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 32.3 tp -64.68 -51.44 62.48 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 172.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.33 -40.29 91.84 Favored Glycine 0 C--N 1.349 1.297 0 O-C-N 119.928 -1.732 . . . . 0.0 114.019 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -30.31 71.33 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 124.724 1.21 . . . . 0.0 112.177 174.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.551 ' CD1' HG22 ' B' ' 106' ' ' VAL . 7.9 t80 -57.55 -60.95 2.89 Favored 'General case' 0 C--N 1.357 0.91 0 O-C-N 120.833 -1.167 . . . . 0.0 111.669 171.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 45.1 mm -58.41 -40.69 79.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.527 0 O-C-N 120.584 -1.322 . . . . 0.0 113.343 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 35.7 ttm -52.55 -43.27 65.08 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 125.077 1.351 . . . . 0.0 113.867 171.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 22.3 m -87.7 -31.88 19.48 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 124.727 1.211 . . . . 0.0 112.534 -176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . 0.446 ' HD2' ' CZ ' ' B' ' 125' ' ' TYR . 5.2 mmpt? -77.54 -25.42 50.16 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 120.027 -1.671 . . . . 0.0 114.306 -178.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.98 53.67 0.19 Allowed 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.663 1.585 . . . . 0.0 111.38 -176.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 2.6 mt -110.74 19.62 18.44 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.423 1.089 . . . . 0.0 110.627 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -105.09 146.46 29.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.56 -1.338 . . . . 0.0 107.998 173.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -73.48 139.68 45.92 Favored 'General case' 0 C--N 1.347 0.461 0 O-C-N 120.789 -1.195 . . . . 0.0 110.043 171.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . 0.46 ' HA ' HE21 ' B' ' 137' ' ' GLN . 58.8 mt-10 -59.95 -47.16 86.92 Favored 'General case' 0 C--N 1.349 0.544 0 O-C-N 120.22 -1.55 . . . . 0.0 113.177 174.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 6.8 ptmt -83.09 -19.99 35.73 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.844 1.258 . . . . 0.0 113.973 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -132.83 61.92 1.66 Allowed 'General case' 0 C--N 1.352 0.707 0 O-C-N 120.589 -1.319 . . . . 0.0 109.855 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' B' ' 134' ' ' GLU . 6.4 mm-40 -64.46 -6.15 6.77 Favored 'General case' 0 C--N 1.345 0.404 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 -175.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -89.97 -8.1 52.49 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.586 1.955 . . . . 0.0 113.315 175.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 47.8 mm -96.44 136.49 27.13 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 124.93 1.292 . . . . 0.0 109.303 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 17.2 t -121.75 123.76 70.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.573 0 O-C-N 120.856 -1.152 . . . . 0.0 110.202 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -86.22 113.82 22.54 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.653 1.181 . . . . 0.0 109.183 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 16.0 m -115.11 1.24 13.84 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 120.623 -1.298 . . . . 0.0 111.174 176.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 34.1 t -73.42 126.8 31.01 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 120.468 -1.395 . . . . 0.0 110.21 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 75.05 23.9 1.57 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.795 1.238 . . . . 0.0 112.01 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -128.39 165.29 20.9 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 tp -70.83 -16.89 62.75 Favored 'General case' 0 C--N 1.344 0.348 0 C-N-CA 126.844 2.058 . . . . 0.0 112.143 -170.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -71.25 -40.95 70.69 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.511 1.524 . . . . 0.0 111.841 169.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.97 -41.81 99.69 Favored Glycine 0 C--N 1.347 1.193 0 O-C-N 120.368 -1.458 . . . . 0.0 112.895 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -53.46 -33.64 54.93 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.189 2.196 . . . . 0.0 114.403 173.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -96.79 -33.01 11.83 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 120.055 -1.653 . . . . 0.0 113.158 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -78.79 -34.01 45.8 Favored 'General case' 0 C--N 1.35 0.629 0 O-C-N 121.044 -1.035 . . . . 0.0 113.108 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 79.91 15.06 79.9 Favored Glycine 0 C--N 1.35 1.319 0 O-C-N 121.315 -0.866 . . . . 0.0 113.898 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 20.5 m -131.35 151.75 79.33 Favored Pre-proline 0 C--N 1.345 0.38 0 O-C-N 121.055 -1.262 . . . . 0.0 109.844 -174.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.48 -33.11 4.36 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.907 1.738 . . . . 0.0 112.621 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 19.3 m -150.43 161.62 42.14 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 -175.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -135.34 163.82 29.14 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.456 -0.777 . . . . 0.0 109.435 170.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 46.0 t -110.4 129.18 55.82 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 30.6 t -61.31 -28.76 44.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 O-C-N 120.818 -1.176 . . . . 0.0 112.219 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 16.4 tptm -54.21 -29.26 45.54 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 126.075 1.75 . . . . 0.0 114.795 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -81.59 54.58 2.41 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 120.575 -1.328 . . . . 0.0 111.75 177.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 16.1 m170 -47.97 -46.2 32.2 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 119.96 -1.713 . . . . 0.0 114.428 -175.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -58.47 -38.51 77.71 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 125.365 1.466 . . . . 0.0 114.561 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -72.96 -45.33 58.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 123.758 0.823 . . . . 0.0 112.038 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 18.9 mt -55.64 -50.55 66.44 Favored 'Isoleucine or valine' 0 C--N 1.348 0.513 0 C-N-CA 125.188 1.395 . . . . 0.0 110.342 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -51.09 -52.14 46.49 Favored 'General case' 0 C--N 1.352 0.677 0 C-N-CA 124.681 1.192 . . . . 0.0 114.122 171.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 1.3 p -58.49 -38.3 77.35 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 119.544 -1.972 . . . . 0.0 115.031 173.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -42.55 89.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.322 -0.861 . . . . 0.0 112.048 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 31.5 mt -60.67 -52.43 61.61 Favored 'Isoleucine or valine' 0 C--N 1.346 0.432 0 O-C-N 120.438 -1.413 . . . . 0.0 112.052 173.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -64.31 -4.81 4.13 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 177.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -89.22 -27.06 20.89 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 119.641 -1.912 . . . . 0.0 113.342 168.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -88.06 -20.44 25.74 Favored 'General case' 0 CA--C 1.509 -0.621 0 O-C-N 121.247 -0.908 . . . . 0.0 111.489 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.454 HD13 HG11 ' B' ' 93' ' ' VAL . 70.4 mt -108.1 147.24 31.5 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 125.071 1.348 . . . . 0.0 111.705 -174.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 56.2 t -90.78 122.65 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 O-C-N 120.749 -1.219 . . . . 0.0 109.355 174.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 93.8 t . . . . . 0 C--N 1.35 0.617 0 C-N-CA 124.606 1.162 . . . . 0.0 110.38 176.467 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.518 2.931 0 N-CA-C 104.631 -2.359 . . . . 0.0 104.631 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 45.34 60.54 4.07 Favored Glycine 0 C--N 1.355 1.631 0 CA-C-N 120.113 1.324 . . . . 0.0 113.986 -164.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.7 m -123.46 106.22 10.45 Favored 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 120.005 -1.88 . . . . 0.0 112.084 -166.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.33 -155.03 7.62 Favored Glycine 0 C--N 1.347 1.168 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.02 68.58 2.52 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -176.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.467 ' HA ' HD11 ' A' ' 18' ' ' LEU . 29.3 t -55.21 -27.92 49.49 Favored 'General case' 0 C--N 1.347 0.491 0 C-N-CA 126.113 1.765 . . . . 0.0 113.583 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -76.32 -29.51 57.34 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 115.286 1.587 . . . . 0.0 115.286 177.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -178.6 87.32 0.22 Allowed Pre-proline 0 C--N 1.351 0.643 0 O-C-N 121.146 -0.971 . . . . 0.0 110.434 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -78.61 120.85 4.91 Favored 'Trans proline' 0 C--N 1.327 -0.554 0 C-N-CA 122.319 2.013 . . . . 0.0 112.854 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.9 t -120.57 6.63 10.55 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 126.248 1.819 . . . . 0.0 110.214 -176.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 m -135.62 156.37 48.97 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 119.507 -1.996 . . . . 0.0 112.92 172.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -55.83 -45.9 78.24 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 120.352 -1.467 . . . . 0.0 112.919 175.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.11 -39.44 94.7 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 125.216 1.406 . . . . 0.0 113.069 178.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -61.95 -53.91 49.08 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 120.39 -1.444 . . . . 0.0 113.317 172.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.91 -30.46 69.8 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.345 -0.847 . . . . 0.0 113.152 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 41.4 t90 -54.21 -45.08 72.15 Favored 'General case' 0 C--N 1.349 0.558 0 O-C-N 120.097 -1.627 . . . . 0.0 113.389 171.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -62.34 -41.39 98.54 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 120.977 -1.077 . . . . 0.0 113.8 174.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.467 HD11 ' HA ' ' A' ' 6' ' ' SER . 2.4 mm? -55.16 -32.52 62.21 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 126.197 1.799 . . . . 0.0 114.629 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.6 tp -56.71 -28.13 60.38 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.376 1.471 . . . . 0.0 113.803 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.9 p 71.04 17.91 6.04 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.54 2.336 . . . . 0.0 113.951 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.86 93.32 0.01 OUTLIER 'General case' 0 C--N 1.351 0.647 0 N-CA-C 116.88 2.178 . . . . 0.0 116.88 -164.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.86 -31.35 1.76 Allowed Glycine 0 C--N 1.345 1.077 0 O-C-N 121.034 -1.041 . . . . 0.0 111.96 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 105.4 -150.3 16.95 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-O 122.807 1.226 . . . . 0.0 112.407 178.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.0 t -97.27 139.89 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 120.913 -1.345 . . . . 0.0 109.458 -175.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.16 156.48 48.51 Favored Pre-proline 0 N--CA 1.45 -0.453 0 O-C-N 120.438 -1.414 . . . . 0.0 108.64 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.69 8.33 2.35 Favored 'Trans proline' 0 N--CA 1.47 0.109 0 C-N-CA 123.058 2.505 . . . . 0.0 113.119 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? 61.45 47.32 6.8 Favored 'General case' 0 C--N 1.348 0.519 0 C-N-CA 125.85 1.66 . . . . 0.0 114.499 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.9 pt -60.78 140.93 17.89 Favored 'Isoleucine or valine' 0 C--N 1.349 0.576 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -174.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 74.5 mt -87.91 24.2 1.84 Allowed 'General case' 0 C--N 1.346 0.429 0 CA-C-O 122.612 1.196 . . . . 0.0 111.743 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -80.95 138.42 36.1 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 120.428 -1.42 . . . . 0.0 110.49 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -86.85 120.92 28.64 Favored 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 121.656 -0.652 . . . . 0.0 111.524 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.3 p -109.29 -179.36 3.81 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.082 1.353 . . . . 0.0 110.109 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -119.92 -28.46 5.17 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 120.491 -1.38 . . . . 0.0 110.15 162.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -146.76 173.67 12.16 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 122.931 1.348 . . . . 0.0 113.271 178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -73.65 -12.2 60.66 Favored 'General case' 0 C--N 1.346 0.435 0 O-C-N 119.842 -1.786 . . . . 0.0 113.839 -176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.3 p -78.16 -29.31 48.6 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 126.727 2.011 . . . . 0.0 111.79 173.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.66 -28.75 45.45 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.55 1.54 . . . . 0.0 109.728 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -94.39 119.47 66.4 Favored Pre-proline 0 N--CA 1.445 -0.685 0 O-C-N 120.953 -1.092 . . . . 0.0 113.078 -173.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.71 171.47 17.74 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.526 2.151 . . . . 0.0 114.525 -166.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.23 -84.95 1.14 Allowed Glycine 0 C--N 1.35 1.322 0 C-N-CA 124.345 0.974 . . . . 0.0 112.361 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.69 6.65 0.47 Allowed 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 177.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 3.9 m -73.82 178.57 4.76 Favored 'General case' 0 C--N 1.347 0.496 0 O-C-N 120.353 -1.467 . . . . 0.0 112.656 -160.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.3 pp -141.38 149.4 20.4 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 178.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 t -86.88 111.68 21.03 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 126.338 1.855 . . . . 0.0 108.675 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -76.13 172.95 11.95 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 118.91 -2.369 . . . . 0.0 110.827 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -52.94 -19.36 6.93 Favored Glycine 0 C--N 1.354 1.548 0 N-CA-C 117.548 1.779 . . . . 0.0 117.548 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 -85.8 -8.51 58.07 Favored 'General case' 0 C--N 1.345 0.375 0 O-C-N 121.288 -1.125 . . . . 0.0 113.418 174.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.31 27.55 39.54 Favored Glycine 0 C--N 1.348 1.224 0 O-C-N 120.755 -1.216 . . . . 0.0 114.256 -175.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -137.3 146.69 44.97 Favored 'General case' 0 CA--C 1.512 -0.507 0 O-C-N 120.942 -1.328 . . . . 0.0 110.917 -177.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 83.1 m -78.45 135.95 37.51 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 123.747 1.736 . . . . 0.0 115.232 -170.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.347 0 CA-C-O 115.69 -2.728 . . . . 0.0 116.946 -175.097 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 81.4 mt . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 118.481 -0.771 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.451 HG11 HD13 ' B' ' 172' ' ' LEU . 15.0 m -133.21 170.28 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 119.126 0.876 . . . . 0.0 109.517 176.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.99 101.9 51.43 Favored Pre-proline 0 C--N 1.344 0.338 0 CA-C-O 116.849 -1.548 . . . . 0.0 110.04 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -70.32 164.23 35.84 Favored 'Trans proline' 0 C--N 1.326 -0.633 0 CA-C-N 123.871 2.418 . . . . 0.0 113.675 178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 46.6 mttt -84.77 153.59 60.94 Favored Pre-proline 0 C--N 1.35 0.616 0 C-N-CA 123.905 0.882 . . . . 0.0 112.605 178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.33 -24.27 27.24 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.312 2.675 . . . . 0.0 113.089 -172.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 5.9 mt -66.09 -54.48 25.21 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 121.365 -0.834 . . . . 0.0 110.698 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 tp -56.82 -39.26 73.86 Favored 'General case' 0 C--N 1.347 0.481 0 C-N-CA 125.118 1.367 . . . . 0.0 113.663 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 15.8 tp -45.8 -40.62 9.92 Favored 'General case' 0 C--N 1.352 0.711 0 C-N-CA 125.37 1.468 . . . . 0.0 114.925 170.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 29.1 tttp -67.81 -34.79 77.43 Favored 'General case' 0 C--N 1.348 0.514 0 O-C-N 119.889 -1.757 . . . . 0.0 113.375 179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.1 -50.25 35.63 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 124.887 1.275 . . . . 0.0 111.247 171.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.433 HD13 ' CE2' ' B' ' 113' ' ' TYR . 91.2 mt -55.17 -42.27 72.95 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 121.146 -0.972 . . . . 0.0 112.302 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.4 -26.05 67.6 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 175.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 4.0 t -77.93 -13.53 59.85 Favored 'General case' 0 C--N 1.344 0.369 0 O-C-N 120.958 -1.089 . . . . 0.0 112.425 176.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 5.2 t -97.37 -9.22 9.07 Favored 'Isoleucine or valine' 0 C--N 1.349 0.563 0 C-N-CA 125.154 1.382 . . . . 0.0 109.868 174.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 118.65 -20.06 10.27 Favored Glycine 0 C--N 1.353 1.474 0 O-C-N 120.465 -1.397 . . . . 0.0 112.514 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -89.28 91.52 8.79 Favored 'General case' 0 N--CA 1.441 -0.906 0 O-C-N 120.514 -1.58 . . . . 0.0 112.215 -171.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -95.09 17.87 13.24 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 119.185 -2.197 . . . . 0.0 116.166 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -97.42 143.0 28.58 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.471 1.108 . . . . 0.0 112.937 -171.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -79.18 9.89 4.11 Favored 'General case' 0 C--O 1.235 0.338 0 O-C-N 119.769 -1.832 . . . . 0.0 115.677 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 1.4 p -149.31 131.56 15.52 Favored 'General case' 0 CA--C 1.511 -0.554 0 O-C-N 120.381 -1.45 . . . . 0.0 111.186 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . 0.433 ' CE2' HD13 ' B' ' 103' ' ' LEU . 78.6 m-85 -132.74 178.81 6.57 Favored 'General case' 0 C--N 1.347 0.497 0 CA-C-O 122.939 1.352 . . . . 0.0 110.814 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.04 163.64 14.24 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.658 1.583 . . . . 0.0 109.854 170.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 48.4 mtm -62.55 -48.77 78.06 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 119.012 -2.305 . . . . 0.0 113.812 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -60.91 -42.53 98.23 Favored 'General case' 0 C--N 1.349 0.562 0 O-C-N 121.274 -0.892 . . . . 0.0 113.176 173.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -50.94 -48.25 60.92 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.893 1.677 . . . . 0.0 114.804 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.9 t -52.45 -49.99 41.03 Favored 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 125.209 1.403 . . . . 0.0 111.884 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.447 HD21 HD13 ' B' ' 168' ' ' ILE . 4.5 mm? -75.01 -32.17 61.57 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 120.918 -1.114 . . . . 0.0 113.011 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -62.14 -57.81 10.16 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.557 1.543 . . . . 0.0 111.72 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -57.34 -44.13 84.02 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 123.977 0.911 . . . . 0.0 112.396 176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 45.8 tp -60.5 -54.0 50.77 Favored 'General case' 0 C--N 1.349 0.548 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 172.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -64.41 -44.91 94.64 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 120.126 -1.609 . . . . 0.0 113.657 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -63.77 -32.43 73.93 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 124.139 0.976 . . . . 0.0 112.798 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -57.1 -57.91 10.51 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 120.842 -1.161 . . . . 0.0 112.262 170.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 38.1 mm -63.94 -41.41 92.41 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 O-C-N 120.392 -1.443 . . . . 0.0 112.566 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 46.9 ttm -54.56 -43.9 72.42 Favored 'General case' 0 C--N 1.349 0.554 0 C-N-CA 126.117 1.767 . . . . 0.0 113.705 172.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 20.5 m -86.96 -24.5 24.71 Favored 'General case' 0 C--N 1.344 0.346 0 O-C-N 120.718 -1.239 . . . . 0.0 112.597 -178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -75.12 -26.74 59.45 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 119.702 -1.874 . . . . 0.0 113.173 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? 72.04 53.51 0.19 Allowed 'General case' 0 C--N 1.354 0.785 0 C-N-CA 126.113 1.765 . . . . 0.0 110.895 -175.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.54 9.43 33.43 Favored 'General case' 0 C--N 1.348 0.514 0 O-C-N 121.1 -1.0 . . . . 0.0 111.848 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -93.34 146.57 23.63 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -73.41 160.93 31.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 121.842 -0.536 . . . . 0.0 110.423 173.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -76.57 -34.92 58.45 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 120.97 -1.081 . . . . 0.0 112.104 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -91.34 -44.87 8.91 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 120.426 -1.421 . . . . 0.0 110.929 178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -107.67 57.12 0.63 Allowed 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 125.026 1.33 . . . . 0.0 111.721 -173.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -63.09 -11.77 22.16 Favored 'General case' 0 C--N 1.347 0.474 0 O-C-N 120.125 -1.609 . . . . 0.0 114.86 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -86.91 -4.03 59.14 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.343 1.457 . . . . 0.0 113.403 176.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 47.7 mm -101.55 137.13 30.34 Favored 'Isoleucine or valine' 0 C--N 1.347 0.495 0 C-N-CA 124.988 1.315 . . . . 0.0 108.991 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 16.7 t -123.8 123.34 66.8 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 120.85 -1.156 . . . . 0.0 110.701 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -93.33 113.92 26.22 Favored 'General case' 0 N--CA 1.444 -0.725 0 O-C-N 121.192 -0.942 . . . . 0.0 110.101 173.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 16.5 m -115.37 20.92 14.5 Favored 'General case' 0 C--N 1.346 0.432 0 O-C-N 121.191 -0.943 . . . . 0.0 110.334 172.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 71.3 p -74.76 140.14 43.85 Favored 'General case' 0 C--N 1.347 0.499 0 O-C-N 120.11 -1.619 . . . . 0.0 109.862 171.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 3.4 t30 64.75 29.01 12.91 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -138.34 164.47 29.22 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 176.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 7.7 tp -70.8 -14.46 62.43 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-O 124.393 2.044 . . . . 0.0 113.536 -165.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.01 -35.71 69.5 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.946 1.699 . . . . 0.0 111.892 170.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.21 -43.22 99.41 Favored Glycine 0 C--N 1.348 1.201 0 O-C-N 120.096 -1.627 . . . . 0.0 113.029 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -53.15 -34.27 56.12 Favored 'General case' 0 C--N 1.347 0.474 0 C-N-CA 126.596 1.958 . . . . 0.0 114.731 172.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 pp -95.89 -31.24 13.23 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 119.538 -1.976 . . . . 0.0 113.402 -178.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.481 ' HB3' HG22 ' B' ' 153' ' ' VAL . 18.5 m-85 -77.9 -42.41 33.35 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 124.737 1.215 . . . . 0.0 112.513 178.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 83.82 15.91 69.2 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 121.427 -0.795 . . . . 0.0 113.932 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . 0.481 HG22 ' HB3' ' B' ' 151' ' ' PHE . 32.7 m -131.45 151.55 78.93 Favored Pre-proline 0 C--N 1.343 0.31 0 O-C-N 121.216 -1.167 . . . . 0.0 109.787 -174.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.18 -30.29 5.68 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 121.811 1.674 . . . . 0.0 112.653 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 87.2 p -154.0 169.4 23.57 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -138.74 165.61 26.54 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.204 1.002 . . . . 0.0 109.289 172.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 26.6 t -109.33 128.76 55.35 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 174.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 40.6 t -61.28 -31.84 51.39 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 O-C-N 120.623 -1.298 . . . . 0.0 111.739 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 7.3 ttpt -58.75 -22.03 56.86 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 126.818 2.047 . . . . 0.0 114.463 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -82.4 58.49 4.13 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 120.404 -1.435 . . . . 0.0 112.071 174.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -49.17 -45.26 43.77 Favored 'General case' 0 C--N 1.353 0.72 0 O-C-N 120.027 -1.671 . . . . 0.0 114.132 -176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -61.33 -33.07 73.01 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 120.64 -1.288 . . . . 0.0 114.234 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 13.8 ttmm -73.95 -46.24 45.36 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 120.326 -1.484 . . . . 0.0 110.955 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 33.0 mm -50.5 -57.13 2.79 Favored 'Isoleucine or valine' 0 C--N 1.351 0.671 0 C-N-CA 125.173 1.389 . . . . 0.0 112.44 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.55 ' HA ' HD12 ' B' ' 168' ' ' ILE . 37.5 m-85 -49.2 -46.16 45.26 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 171.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 31.9 m -62.91 -39.58 94.97 Favored 'General case' 0 C--N 1.346 0.429 0 O-C-N 120.543 -1.348 . . . . 0.0 113.379 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.85 -44.94 88.1 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.388 -1.445 . . . . 0.0 111.752 177.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' B' ' 165' ' ' TYR . 22.0 mt -57.27 -53.11 48.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.478 0 C-N-CA 125.473 1.509 . . . . 0.0 112.291 174.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -62.74 -11.92 20.66 Favored 'General case' 0 C--N 1.351 0.64 0 O-C-N 120.274 -1.516 . . . . 0.0 114.835 176.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -85.47 -11.65 53.79 Favored 'General case' 0 C--N 1.35 0.592 0 O-C-N 119.394 -2.066 . . . . 0.0 113.571 169.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -105.04 -21.24 13.31 Favored 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 120.194 -1.567 . . . . 0.0 109.883 -177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.451 HD13 HG11 ' B' ' 93' ' ' VAL . 73.2 mt -110.92 151.67 27.64 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 126.111 1.764 . . . . 0.0 110.809 -175.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 61.0 t -96.17 119.63 44.48 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 O-C-N 120.473 -1.392 . . . . 0.0 108.954 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 56.3 t . . . . . 0 C--N 1.348 0.541 0 C-N-CA 124.166 0.986 . . . . 0.0 110.919 177.169 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.519 3.024 0 CA-C-O 116.743 -1.599 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 48.93 39.23 25.24 Favored Glycine 0 C--N 1.357 1.701 0 CA-C-N 120.23 1.377 . . . . 0.0 115.353 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.7 m -118.18 120.06 36.57 Favored 'General case' 0 CA--C 1.506 -0.748 0 O-C-N 120.507 -1.584 . . . . 0.0 111.177 -167.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.05 -148.99 5.91 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.25 78.03 3.78 Favored 'General case' 0 N--CA 1.445 -0.682 0 O-C-N 120.996 -1.297 . . . . 0.0 113.239 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.404 ' HA ' HD11 ' A' ' 18' ' ' LEU . 8.2 t -72.95 3.05 5.76 Favored 'General case' 0 C--N 1.347 0.48 0 O-C-N 119.435 -2.041 . . . . 0.0 115.457 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -100.74 -44.61 5.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 120.614 -1.304 . . . . 0.0 110.958 173.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -150.52 85.96 5.18 Favored Pre-proline 0 N--CA 1.443 -0.798 0 O-C-N 121.552 -0.717 . . . . 0.0 109.319 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.84 108.98 2.76 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 122.273 1.982 . . . . 0.0 110.982 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.7 t -101.88 -19.89 15.1 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.041 0.936 . . . . 0.0 110.413 -174.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.3 m -120.51 164.64 16.12 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-O 122.797 1.284 . . . . 0.0 113.617 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -61.51 -49.65 75.88 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 126.316 1.846 . . . . 0.0 110.978 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.36 78.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.055 0.942 . . . . 0.0 113.511 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 62.4 mt-10 -68.91 -52.71 26.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 121.269 -0.895 . . . . 0.0 112.628 172.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -29.13 69.79 Favored 'General case' 0 C--N 1.351 0.656 0 O-C-N 120.695 -1.253 . . . . 0.0 112.574 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -53.05 -38.28 62.32 Favored 'General case' 0 C--N 1.346 0.452 0 O-C-N 120.439 -1.413 . . . . 0.0 113.796 167.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -73.49 -37.23 65.79 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 120.416 -1.427 . . . . 0.0 112.726 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.404 HD11 ' HA ' ' A' ' 6' ' ' SER . 4.4 mm? -60.2 -24.02 64.47 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 124.992 1.317 . . . . 0.0 114.493 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.3 tp -67.84 -23.74 65.2 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.689 -1.257 . . . . 0.0 112.303 172.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 t 55.26 44.01 28.21 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 127.314 2.246 . . . . 0.0 112.936 -175.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.6 85.25 0.02 OUTLIER 'General case' 0 C--N 1.353 0.748 0 C-N-CA 127.17 2.188 . . . . 0.0 113.92 -172.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.452 ' HA3' ' HB1' ' A' ' 41' ' ' ALA . . . 156.73 -41.82 0.55 Allowed Glycine 0 CA--C 1.492 -1.376 0 O-C-N 121.057 -1.027 . . . . 0.0 112.807 -164.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.77 -142.62 16.09 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -171.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.6 p -94.28 135.67 27.93 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 O-C-N 120.562 -1.552 . . . . 0.0 110.445 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.1 t -129.79 145.42 56.98 Favored Pre-proline 0 C--N 1.347 0.486 0 CA-C-O 115.81 -2.043 . . . . 0.0 106.783 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -66.22 -2.36 6.88 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 124.428 3.418 . . . . 0.0 117.47 -164.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.69 52.93 0.41 Allowed 'General case' 0 C--N 1.349 0.582 0 C-N-CA 125.293 1.437 . . . . 0.0 112.48 178.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.3 pt -70.06 140.59 18.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.466 0 O-C-N 120.299 -1.5 . . . . 0.0 114.093 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 79.1 mt -88.95 33.76 0.78 Allowed 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.132 -0.98 . . . . 0.0 111.282 176.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -88.69 131.42 35.02 Favored 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 119.945 -1.722 . . . . 0.0 109.394 177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.16 108.27 7.8 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 122.238 1.018 . . . . 0.0 111.072 -178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.0 p -107.3 -161.29 0.77 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.569 1.548 . . . . 0.0 111.391 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -150.45 -37.38 0.14 Allowed 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.619 -1.926 . . . . 0.0 109.47 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -133.51 174.85 9.98 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 171.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -74.15 -2.32 24.12 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 119.141 -2.225 . . . . 0.0 115.273 -172.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.5 m -90.15 -40.28 12.33 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 125.657 1.583 . . . . 0.0 111.934 -173.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.64 -29.8 68.36 Favored 'General case' 0 C--N 1.349 0.583 0 CA-C-O 123.281 1.515 . . . . 0.0 110.897 -178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 15.3 t -90.71 109.16 32.56 Favored Pre-proline 0 N--CA 1.443 -0.785 0 C-N-CA 125.429 1.492 . . . . 0.0 111.255 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -75.87 171.73 17.62 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.449 2.099 . . . . 0.0 115.294 -160.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 81.83 -93.26 1.58 Allowed Glycine 0 C--N 1.347 1.172 0 C-N-CA 124.271 0.939 . . . . 0.0 112.49 173.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB1' ' HA3' ' A' ' 22' ' ' GLY . . . -156.44 24.88 0.35 Allowed 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 122.964 1.364 . . . . 0.0 111.096 -176.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 54.4 m -88.57 153.37 21.18 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 119.95 -1.719 . . . . 0.0 108.058 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.4 pp -119.83 154.58 22.67 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.692 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 170.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.3 m -85.11 134.51 34.19 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 23.1 mtt85 -82.8 168.89 16.71 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.624 -1.297 . . . . 0.0 108.356 167.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -32.8 -43.48 0.18 Allowed Glycine 0 C--N 1.353 1.508 0 N-CA-C 119.33 2.492 . . . . 0.0 119.33 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -74.07 8.43 2.09 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 178.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 66.92 36.38 90.94 Favored Glycine 0 C--N 1.35 1.31 0 O-C-N 119.915 -1.741 . . . . 0.0 114.191 178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -135.61 147.27 48.6 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-O 122.08 0.943 . . . . 0.0 108.609 176.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.1 m -78.45 130.77 36.45 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-O 125.212 2.434 . . . . 0.0 113.933 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.274 0 N-CA-C 105.716 -2.954 . . . . 0.0 105.716 -177.87 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 79.3 mt . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 118.114 -0.946 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 20.7 m -120.72 167.27 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 119.496 1.044 . . . . 0.0 109.217 -177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -141.54 114.83 6.76 Favored Pre-proline 0 C--N 1.35 0.619 0 CA-C-O 116.694 -1.622 . . . . 0.0 108.181 170.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -74.73 168.12 25.54 Favored 'Trans proline' 0 C--N 1.328 -0.504 0 CA-C-N 123.822 2.401 . . . . 0.0 112.747 175.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -84.71 159.54 57.82 Favored Pre-proline 0 C--N 1.346 0.439 0 O-C-N 120.891 -1.13 . . . . 0.0 111.698 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -68.48 -25.16 35.56 Favored 'Trans proline' 0 CA--C 1.521 -0.159 0 C-N-CA 122.781 2.32 . . . . 0.0 114.275 -170.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.05 -42.31 99.68 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-N 119.238 0.926 . . . . 0.0 110.526 170.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 17.2 tp -72.45 -34.98 68.14 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 120.191 -1.568 . . . . 0.0 113.11 176.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 33.0 tp -53.3 -42.07 66.26 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 120.154 -1.591 . . . . 0.0 113.622 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -62.42 -30.85 71.52 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 120.47 -1.394 . . . . 0.0 113.82 176.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 24.0 tp -67.66 -61.37 1.92 Allowed 'General case' 0 C--N 1.35 0.619 0 C-N-CA 123.672 0.789 . . . . 0.0 110.335 172.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 79.5 mt -51.29 -49.22 61.69 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 126.39 1.876 . . . . 0.0 113.305 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -14.27 61.51 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 120.088 -1.632 . . . . 0.0 114.871 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.5 m -85.34 -6.92 59.2 Favored 'General case' 0 C--N 1.346 0.413 0 O-C-N 120.047 -1.658 . . . . 0.0 112.234 168.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 15.2 t -94.37 -5.62 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 124.944 1.298 . . . . 0.0 109.061 163.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.98 -13.36 31.76 Favored Glycine 0 C--N 1.354 1.57 0 O-C-N 119.816 -1.802 . . . . 0.0 113.393 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -86.11 69.59 10.51 Favored 'General case' 0 N--CA 1.442 -0.875 0 O-C-N 120.757 -1.437 . . . . 0.0 113.888 -173.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . 0.25 3.3 pm0 -78.68 76.74 5.18 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 119.61 -1.931 . . . . 0.0 110.959 165.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -151.06 124.5 8.93 Favored 'General case' 0 N--CA 1.438 -1.074 0 O-C-N 120.815 -1.178 . . . . 0.0 109.239 168.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.89 -49.43 65.91 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 128.165 2.586 . . . . 0.0 113.475 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 22.6 p -94.48 90.22 6.13 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 120.139 -1.6 . . . . 0.0 114.755 -169.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -104.32 173.21 6.4 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-O 123.67 1.7 . . . . 0.0 114.522 171.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 32.7 m -96.34 159.52 14.9 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 127.281 2.233 . . . . 0.0 109.985 -173.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 2.4 mmt -53.7 -45.96 70.59 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 115.64 1.719 . . . . 0.0 115.64 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -63.18 -50.0 72.07 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 120.583 -1.323 . . . . 0.0 112.149 170.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -54.49 -42.36 70.65 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 117.264 2.32 . . . . 0.0 117.264 -173.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 47.3 t -58.52 -30.91 42.28 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 O-C-N 120.927 -1.108 . . . . 0.0 111.563 175.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -92.2 -33.37 14.72 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.261 1.025 . . . . 0.0 112.161 174.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -56.89 -64.68 0.8 Allowed 'General case' 0 C--N 1.352 0.675 0 O-C-N 119.954 -1.716 . . . . 0.0 113.028 177.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -56.86 -39.86 75.08 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 124.278 1.031 . . . . 0.0 112.221 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 27.1 tp -63.44 -52.66 60.52 Favored 'General case' 0 C--N 1.349 0.551 0 O-C-N 120.713 -1.242 . . . . 0.0 113.254 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.77 -41.31 93.73 Favored Glycine 0 C--N 1.349 1.276 0 O-C-N 120.099 -1.625 . . . . 0.0 114.022 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -56.52 -43.46 79.8 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 125.732 1.613 . . . . 0.0 112.85 173.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -54.83 -55.65 27.96 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.585 1.154 . . . . 0.0 112.459 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 3.5 mp -63.95 -43.29 97.65 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 O-C-N 120.35 -1.469 . . . . 0.0 112.215 178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 45.9 ttm -57.04 -36.38 70.41 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 125.0 1.32 . . . . 0.0 113.352 175.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 26.1 m -86.06 -34.65 20.64 Favored 'General case' 0 C--N 1.344 0.344 0 O-C-N 120.394 -1.441 . . . . 0.0 112.424 178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -68.34 -33.89 75.1 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 120.091 -1.631 . . . . 0.0 114.557 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 77.34 50.92 0.04 OUTLIER 'General case' 0 C--N 1.353 0.719 0 C-N-CA 126.608 1.963 . . . . 0.0 111.017 -171.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 95.1 mt -109.8 34.05 4.05 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-O 122.713 1.244 . . . . 0.0 110.331 169.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -110.52 148.26 32.47 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 163.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -75.48 161.97 28.74 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 121.221 -0.925 . . . . 0.0 109.277 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . 0.264 35.8 mt-10 -62.9 -47.9 81.28 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 119.995 -1.691 . . . . 0.0 111.261 172.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.21 -43.92 10.65 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 125.765 1.626 . . . . 0.0 108.638 -164.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -108.81 63.36 0.6 Allowed 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 125.015 1.326 . . . . 0.0 112.235 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -65.25 -7.24 12.17 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 118.898 -2.376 . . . . 0.0 114.627 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -82.69 -8.95 59.57 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.606 1.562 . . . . 0.0 113.88 174.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 46.4 mm -99.8 128.86 51.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 O-C-N 120.87 -1.144 . . . . 0.0 109.759 175.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 48.8 t -116.56 128.38 73.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.481 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -90.78 121.46 32.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 120.902 -1.123 . . . . 0.0 109.071 176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 58.5 m -116.35 12.68 15.36 Favored 'General case' 0 CA--C 1.51 -0.584 0 O-C-N 121.131 -0.981 . . . . 0.0 110.837 171.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 33.0 p -71.7 131.97 43.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.112 -1.618 . . . . 0.0 108.994 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 76.55 -27.11 0.18 Allowed 'General case' 0 C--N 1.351 0.647 0 N-CA-C 114.274 1.213 . . . . 0.0 114.274 -177.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -74.99 164.92 26.04 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 119.846 -1.784 . . . . 0.0 111.783 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 33.2 tp -67.94 -18.99 64.93 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 126.735 2.014 . . . . 0.0 113.013 -174.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -69.24 -32.38 71.56 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.27 -1.519 . . . . 0.0 113.005 167.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.87 -33.25 79.29 Favored Glycine 0 C--N 1.35 1.359 0 O-C-N 120.115 -1.616 . . . . 0.0 113.813 -174.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -50.87 -57.31 8.78 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 128.212 2.605 . . . . 0.0 111.833 170.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 3.9 pp -76.65 -21.75 55.01 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -86.13 -37.1 19.12 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.011 -1.055 . . . . 0.0 112.222 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.12 15.48 78.67 Favored Glycine 0 C--N 1.35 1.342 0 O-C-N 121.179 -0.95 . . . . 0.0 114.337 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 29.5 m -125.42 159.38 60.48 Favored Pre-proline 0 C--N 1.344 0.343 0 O-C-N 120.99 -1.3 . . . . 0.0 110.214 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.37 -43.73 0.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.607 1.538 . . . . 0.0 112.653 172.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 54.6 m -151.76 167.0 29.61 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -126.02 177.69 6.2 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.728 0.775 . . . . 0.0 109.727 174.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 48.3 t -121.94 123.34 41.45 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 120.979 -1.076 . . . . 0.0 108.758 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.11 -27.43 43.14 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 O-C-N 120.437 -1.414 . . . . 0.0 112.157 -176.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -55.04 -28.67 53.95 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 125.182 1.393 . . . . 0.0 114.352 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -81.83 52.12 1.87 Allowed 'General case' 0 N--CA 1.444 -0.731 0 O-C-N 120.255 -1.528 . . . . 0.0 112.959 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -46.94 -45.58 20.84 Favored 'General case' 0 C--N 1.348 0.538 0 C-N-CA 126.741 2.017 . . . . 0.0 114.844 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -72.16 -1.66 15.84 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 126.709 2.004 . . . . 0.0 115.667 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -105.18 -38.35 6.58 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.443 -1.411 . . . . 0.0 109.176 167.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 30.4 mm -56.43 -52.53 51.34 Favored 'Isoleucine or valine' 0 C--N 1.351 0.637 0 O-C-N 120.946 -1.096 . . . . 0.0 112.727 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -53.33 -38.36 63.14 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 120.284 -1.51 . . . . 0.0 114.053 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 42.4 m -64.37 -35.9 82.38 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 125.689 1.596 . . . . 0.0 113.585 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 54.6 mtt -65.88 -47.01 76.27 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.334 -1.479 . . . . 0.0 111.281 172.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 50.9 mm -56.09 -50.31 70.93 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 C-N-CA 126.062 1.745 . . . . 0.0 113.201 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -63.38 -12.31 29.56 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 119.473 -2.017 . . . . 0.0 115.931 178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -96.9 -12.51 23.38 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 119.468 -2.02 . . . . 0.0 112.839 170.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -84.07 -38.51 20.72 Favored 'General case' 0 N--CA 1.445 -0.713 0 O-C-N 119.95 -1.719 . . . . 0.0 109.194 170.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 66.2 mt -93.53 -179.89 5.17 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.944 1.697 . . . . 0.0 113.926 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 94.6 t -111.55 128.54 68.0 Favored 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 167.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 C--N 1.349 0.56 0 O-C-N 121.19 -0.944 . . . . 0.0 110.916 176.269 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.276 91.7 p . . . . . 0 N--CA 1.531 3.593 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -5.72 74.92 0.0 OUTLIER Glycine 0 C--N 1.363 2.058 0 C-N-CA 129.423 3.392 . . . . 0.0 119.785 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.3 m -116.07 119.02 34.5 Favored 'General case' 0 CA--C 1.506 -0.746 0 O-C-N 120.978 -1.307 . . . . 0.0 108.492 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.56 -161.23 8.88 Favored Glycine 0 CA--C 1.494 -1.243 0 N-CA-C 105.967 -2.853 . . . . 0.0 105.967 174.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.49 79.69 0.79 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 119.048 1.424 . . . . 0.0 114.313 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 64.2 p -67.56 -16.86 64.41 Favored 'General case' 0 C--N 1.347 0.473 0 O-C-N 119.685 -1.885 . . . . 0.0 113.907 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -77.05 -31.29 56.09 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 125.995 1.718 . . . . 0.0 113.386 176.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -175.78 89.17 0.29 Allowed Pre-proline 0 N--CA 1.445 -0.714 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.37 137.23 18.56 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 CA-C-N 121.893 1.712 . . . . 0.0 110.232 176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.8 t -127.38 -60.4 1.19 Allowed 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 177.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.3 m -68.93 170.93 8.82 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 123.674 1.702 . . . . 0.0 115.559 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -73.75 -35.76 65.07 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 119.945 -1.722 . . . . 0.0 114.489 -176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.87 -45.9 76.66 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 119.601 -1.937 . . . . 0.0 111.466 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -43.47 -66.98 0.31 Allowed 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 129.048 2.939 . . . . 0.0 112.933 167.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -77.29 -6.63 53.9 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 120.383 -1.448 . . . . 0.0 114.461 -179.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 56.4 t-105 -74.09 -51.72 14.83 Favored 'General case' 0 C--N 1.346 0.416 0 O-C-N 119.193 -2.192 . . . . 0.0 110.854 165.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 52.5 m-20 -61.36 -35.71 78.22 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 120.094 -1.629 . . . . 0.0 115.19 -176.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.85 -15.42 20.89 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.8 tp -62.03 -26.21 68.11 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 120.326 -1.484 . . . . 0.0 113.214 172.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 t 60.22 49.34 7.31 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-O 123.933 1.825 . . . . 0.0 111.047 -169.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.72 89.16 0.55 Allowed 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 125.394 1.477 . . . . 0.0 112.629 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.515 ' HA3' ' HB1' ' A' ' 41' ' ' ALA . . . 150.11 -48.17 0.59 Allowed Glycine 0 CA--C 1.496 -1.1 0 O-C-N 121.478 -0.764 . . . . 0.0 114.996 -168.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.17 -144.8 17.03 Favored Glycine 0 C--N 1.345 1.033 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 -167.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.5 p -110.94 136.81 45.85 Favored 'Isoleucine or valine' 0 C--N 1.343 0.306 0 O-C-N 120.658 -1.495 . . . . 0.0 111.065 -176.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.2 m -100.04 158.54 31.86 Favored Pre-proline 0 C--N 1.35 0.624 0 O-C-N 120.182 -1.574 . . . . 0.0 110.479 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.52 11.19 1.08 Allowed 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.987 2.458 . . . . 0.0 113.118 164.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt 59.81 49.83 7.6 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 126.008 1.723 . . . . 0.0 115.296 171.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.8 pt -63.51 144.7 14.35 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 -171.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 29' ' ' LEU . 2.6 pt? -85.13 20.22 1.98 Allowed 'General case' 0 C--N 1.347 0.471 0 O-C-N 120.679 -1.263 . . . . 0.0 113.825 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.3 tt0 -77.28 126.67 31.3 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 119.364 -2.085 . . . . 0.0 111.21 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -78.55 100.82 7.09 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.988 0.899 . . . . 0.0 112.331 -178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.2 p -96.13 -175.82 3.49 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 126.494 1.918 . . . . 0.0 111.666 -177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -124.11 -41.71 2.19 Favored 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 120.16 -1.588 . . . . 0.0 112.303 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 -142.0 168.31 20.04 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 103.784 -2.672 . . . . 0.0 103.784 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -68.95 -26.33 65.0 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 119.476 -2.015 . . . . 0.0 115.778 -167.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.6 m -50.93 -45.47 60.51 Favored 'General case' 0 C--N 1.347 0.476 0 C-N-CA 126.593 1.957 . . . . 0.0 114.801 173.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.85 -22.67 65.71 Favored 'General case' 0 N--CA 1.441 -0.899 0 C-N-CA 128.131 2.573 . . . . 0.0 113.961 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.6 t -103.63 106.78 53.84 Favored Pre-proline 0 C--N 1.353 0.726 0 O-C-N 119.834 -1.791 . . . . 0.0 112.489 -174.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.11 159.37 53.4 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.804 2.336 . . . . 0.0 114.452 -162.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.7 -96.13 1.92 Allowed Glycine 0 CA--C 1.494 -1.235 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.515 ' HB1' ' HA3' ' A' ' 22' ' ' GLY . . . -161.35 40.61 0.15 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 123.088 1.423 . . . . 0.0 111.116 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.9 m -90.34 178.94 6.0 Favored 'General case' 0 N--CA 1.44 -0.939 0 O-C-N 119.847 -1.783 . . . . 0.0 109.267 -175.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.5 pp -138.87 150.71 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 103.211 -2.885 . . . . 0.0 103.211 168.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.0 m -82.61 127.45 33.38 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.318 1.047 . . . . 0.0 108.368 173.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -78.36 172.11 14.1 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.917 -1.114 . . . . 0.0 108.663 170.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.5 -32.61 15.95 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 116.655 1.422 . . . . 0.0 116.655 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -70.03 -9.57 55.73 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 173.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 84.6 20.93 57.47 Favored Glycine 0 C--N 1.349 1.298 0 O-C-N 120.57 -1.331 . . . . 0.0 114.247 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -121.6 146.6 46.81 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 120.607 -1.526 . . . . 0.0 110.616 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 58.0 m -73.39 133.5 43.79 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -170.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.714 0 CA-C-O 117.05 -1.972 . . . . 0.0 114.955 173.865 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 94.5 mt . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 118.64 -0.695 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 19.7 m -121.97 152.31 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 -109.79 117.87 51.34 Favored Pre-proline 0 C--N 1.352 0.679 0 CA-C-O 115.92 -1.99 . . . . 0.0 108.721 172.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -75.71 167.12 27.02 Favored 'Trans proline' 0 C--N 1.321 -0.897 0 C-N-CA 123.272 2.648 . . . . 0.0 113.19 166.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -78.56 159.04 75.29 Favored Pre-proline 0 C--N 1.351 0.661 0 O-C-N 120.472 -1.393 . . . . 0.0 112.81 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -65.69 -21.68 58.47 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.18 2.586 . . . . 0.0 114.681 -178.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 94.0 mt -70.25 -46.03 65.23 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.131 0.878 . . . . 0.0 111.391 171.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 18.1 tp -64.68 -33.55 76.22 Favored 'General case' 0 C--N 1.351 0.631 0 O-C-N 120.993 -1.067 . . . . 0.0 111.809 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 17.9 tp -55.81 -42.07 75.12 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 114.9 1.444 . . . . 0.0 114.9 174.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -65.93 -31.69 72.75 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 119.072 -2.268 . . . . 0.0 113.42 174.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 22.2 tp -66.08 -52.78 45.66 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 121.415 -0.803 . . . . 0.0 111.637 170.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 96.1 mt -54.05 -42.94 69.78 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 124.179 0.992 . . . . 0.0 112.652 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -57.46 -27.18 62.23 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 170.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 21.8 t -78.11 -16.95 57.51 Favored 'General case' 0 C--N 1.349 0.56 0 O-C-N 120.412 -1.43 . . . . 0.0 112.232 173.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . 0.435 HG22 ' CD1' ' B' ' 125' ' ' TYR . 1.5 t -97.76 4.25 9.78 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 O-C-N 120.561 -1.337 . . . . 0.0 110.75 172.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 94.89 -19.39 54.2 Favored Glycine 0 C--N 1.353 1.495 0 O-C-N 119.801 -1.812 . . . . 0.0 113.357 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -76.62 75.12 3.31 Favored 'General case' 0 N--CA 1.44 -0.964 0 C-N-CA 126.212 1.805 . . . . 0.0 112.848 -174.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -89.22 1.82 55.14 Favored 'General case' 0 C--N 1.346 0.422 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 -170.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -75.88 160.25 30.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 121.649 -0.657 . . . . 0.0 110.41 172.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -74.14 -59.84 2.54 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 123.463 1.602 . . . . 0.0 108.822 161.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 29.9 p -71.5 98.44 1.84 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.352 1.861 . . . . 0.0 115.54 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -112.0 -179.61 3.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 123.354 1.549 . . . . 0.0 111.901 167.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 94.4 m -103.69 155.26 18.71 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 126.19 1.796 . . . . 0.0 108.683 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 92.7 mtp -54.8 -47.15 74.38 Favored 'General case' 0 C--N 1.351 0.643 0 O-C-N 119.394 -2.066 . . . . 0.0 115.661 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -57.01 -54.33 48.0 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 120.945 -1.097 . . . . 0.0 112.464 168.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -46.77 -50.15 18.64 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 126.009 1.724 . . . . 0.0 115.079 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 92.7 t -52.49 -48.83 45.94 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 120.051 -1.655 . . . . 0.0 112.804 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.89 -24.55 44.11 Favored 'General case' 0 C--N 1.347 0.477 0 O-C-N 120.464 -1.398 . . . . 0.0 112.891 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -65.22 -62.82 1.31 Allowed 'General case' 0 C--N 1.345 0.394 0 C-N-CA 125.945 1.698 . . . . 0.0 111.105 173.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -53.92 -41.11 67.32 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 124.313 1.045 . . . . 0.0 111.953 176.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 21.5 tp -63.43 -55.54 23.46 Favored 'General case' 0 C--N 1.349 0.547 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 172.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.79 -42.21 98.61 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 119.552 -1.968 . . . . 0.0 114.345 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -63.59 -28.78 70.16 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.123 1.369 . . . . 0.0 112.303 176.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.435 ' CD1' HG22 ' B' ' 106' ' ' VAL . 10.5 t80 -61.96 -53.17 59.42 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.683 -1.26 . . . . 0.0 112.405 173.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 2.9 mp -62.58 -43.65 98.66 Favored 'Isoleucine or valine' 0 C--N 1.351 0.65 0 C-N-CA 124.493 1.117 . . . . 0.0 111.306 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 44.5 ttm -50.88 -43.11 59.55 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 125.234 1.413 . . . . 0.0 112.97 172.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 24.4 m -85.25 -30.2 24.01 Favored 'General case' 0 C--N 1.343 0.323 0 O-C-N 120.496 -1.378 . . . . 0.0 113.334 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.0 -30.0 63.45 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 119.521 -1.987 . . . . 0.0 114.12 178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? 76.02 41.53 0.23 Allowed 'General case' 0 C--N 1.352 0.681 0 C-N-CA 125.244 1.418 . . . . 0.0 110.956 -174.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 93.6 mt -104.68 34.0 3.33 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 122.372 1.082 . . . . 0.0 110.845 174.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -114.96 146.04 41.61 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 165.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -72.6 151.98 42.04 Favored 'General case' 0 C--N 1.346 0.438 0 O-C-N 121.189 -0.944 . . . . 0.0 109.264 173.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -67.98 -33.52 74.8 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 122.59 1.186 . . . . 0.0 112.004 -178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -109.92 -28.21 8.86 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 124.345 1.058 . . . . 0.0 112.236 -172.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -109.67 53.79 0.68 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.321 1.848 . . . . 0.0 110.936 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -55.97 -18.38 9.09 Favored 'General case' 0 C--N 1.349 0.56 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -82.84 -5.74 59.12 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 126.011 1.724 . . . . 0.0 114.877 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 44.1 mm -97.41 123.16 49.65 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 O-C-N 120.541 -1.349 . . . . 0.0 110.22 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 52.3 t -108.12 129.51 62.23 Favored 'Isoleucine or valine' 0 C--N 1.349 0.544 0 O-C-N 120.972 -1.08 . . . . 0.0 108.414 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -95.33 113.79 25.5 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 121.119 -0.988 . . . . 0.0 109.276 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 63.8 m -118.6 20.85 12.82 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 121.884 0.849 . . . . 0.0 109.986 171.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 34.7 p -76.66 136.65 39.15 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 120.341 -1.474 . . . . 0.0 108.228 170.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 1.2 t30 76.24 -36.06 0.27 Allowed 'General case' 0 C--N 1.35 0.616 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -69.26 168.48 14.12 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 120.64 -1.287 . . . . 0.0 112.661 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 22.9 tp -70.7 -17.54 62.83 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 125.604 1.562 . . . . 0.0 112.778 -168.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.92 -29.38 66.53 Favored 'General case' 0 N--CA 1.449 -0.523 0 O-C-N 120.297 -1.502 . . . . 0.0 113.896 168.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -63.6 -39.0 97.12 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 120.609 -1.307 . . . . 0.0 114.031 -173.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -51.37 -55.3 19.24 Favored 'General case' 0 C--N 1.346 0.428 0 C-N-CA 127.251 2.22 . . . . 0.0 111.816 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 pp -74.62 -27.66 60.55 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 119.867 -1.77 . . . . 0.0 115.098 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -80.81 -40.91 24.19 Favored 'General case' 0 C--N 1.348 0.539 0 O-C-N 121.387 -0.82 . . . . 0.0 112.114 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 80.37 22.39 62.76 Favored Glycine 0 C--N 1.35 1.336 0 C-N-CA 124.162 0.886 . . . . 0.0 113.65 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 27.7 m -132.74 160.97 66.28 Favored Pre-proline 0 C--N 1.343 0.304 0 O-C-N 121.231 -1.158 . . . . 0.0 108.96 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -71.04 -51.22 0.29 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 121.477 1.563 . . . . 0.0 112.455 170.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 66.8 m -147.93 168.2 22.87 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 119.909 1.232 . . . . 0.0 107.845 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -129.97 173.72 10.44 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 123.759 0.823 . . . . 0.0 108.864 174.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 11.4 t -113.74 129.19 56.61 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 120.18 -1.575 . . . . 0.0 109.859 172.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 35.1 t -60.72 -26.72 39.02 Favored 'Isoleucine or valine' 0 C--N 1.358 0.94 0 O-C-N 119.922 -1.736 . . . . 0.0 112.996 -177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -50.03 -25.2 3.16 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 126.449 1.9 . . . . 0.0 114.694 171.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -91.18 46.7 1.33 Allowed 'General case' 0 N--CA 1.439 -1.007 0 O-C-N 119.502 -1.999 . . . . 0.0 113.687 -176.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -32.66 -55.36 0.36 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 128.279 2.632 . . . . 0.0 117.74 176.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 24.8 ptt180 -59.46 -28.7 67.22 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.037 1.735 . . . . 0.0 115.256 172.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -83.24 -32.57 26.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 119.646 -1.909 . . . . 0.0 112.02 172.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 37.7 mm -54.28 -54.97 17.04 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 O-C-N 120.902 -1.124 . . . . 0.0 110.789 171.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -57.39 -33.61 68.03 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 119.989 -1.694 . . . . 0.0 115.271 171.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 86.4 m -60.65 -35.42 76.17 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 120.237 -1.54 . . . . 0.0 112.233 174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 43.1 mtt -72.85 -48.26 39.11 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 120.69 -1.257 . . . . 0.0 111.615 172.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 50.9 mm -57.61 -50.39 77.49 Favored 'Isoleucine or valine' 0 C--N 1.349 0.547 0 C-N-CA 124.668 1.187 . . . . 0.0 113.487 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -66.19 -11.08 47.45 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 -177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 86.5 mtt180 -79.92 -27.13 39.92 Favored 'General case' 0 C--N 1.346 0.422 0 O-C-N 119.004 -2.31 . . . . 0.0 111.153 170.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -104.69 -2.61 24.74 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 124.298 1.039 . . . . 0.0 110.332 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 43.6 mt -125.93 143.12 51.22 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.944 2.098 . . . . 0.0 109.567 174.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 10.7 p -68.86 123.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.348 0.51 0 O-C-N 119.588 -1.945 . . . . 0.0 113.422 173.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 54.0 t . . . . . 0 C--N 1.351 0.638 0 C-N-CA 124.667 1.187 . . . . 0.0 110.718 175.58 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.511 2.582 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.71 49.31 77.58 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 119.158 0.89 . . . . 0.0 112.281 -165.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -139.66 96.31 3.06 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 121.356 -1.085 . . . . 0.0 110.046 -167.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -93.49 -141.1 10.62 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-O 121.882 0.712 . . . . 0.0 113.647 178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.99 68.88 6.23 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-O 123.115 1.436 . . . . 0.0 111.614 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 p -69.79 -9.42 54.57 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 126.671 1.988 . . . . 0.0 114.242 -176.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -78.0 -42.86 31.27 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.738 1.215 . . . . 0.0 112.124 171.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -166.83 89.13 0.78 Allowed Pre-proline 0 N--CA 1.448 -0.535 0 O-C-N 121.529 -0.732 . . . . 0.0 110.035 -173.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -81.44 115.46 2.87 Favored 'Trans proline' 0 C--N 1.329 -0.474 0 C-N-CA 122.32 2.013 . . . . 0.0 112.211 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -116.11 -31.91 5.54 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 119.109 0.868 . . . . 0.0 113.248 -170.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.8 m -105.31 176.96 4.99 Favored 'General case' 0 C--N 1.345 0.387 0 O-C-N 119.472 -2.017 . . . . 0.0 111.397 167.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -63.86 -40.42 96.51 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 119.805 -1.81 . . . . 0.0 113.408 -176.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.55 -44.45 85.24 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.571 1.948 . . . . 0.0 113.529 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -55.87 -58.99 5.54 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 125.033 1.333 . . . . 0.0 114.401 170.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.42 -29.98 69.33 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -52.06 -37.18 52.93 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 124.933 1.293 . . . . 0.0 113.897 173.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -101.06 18.87 18.62 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 121.025 -1.047 . . . . 0.0 112.22 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.62 -29.04 13.27 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.448 1.099 . . . . 0.0 110.007 165.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.2 tp -60.6 -29.13 69.02 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 122.423 1.106 . . . . 0.0 112.38 171.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.3 m 65.85 43.56 3.06 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 125.797 1.639 . . . . 0.0 112.555 174.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.61 93.49 0.01 OUTLIER 'General case' 0 C--N 1.351 0.646 0 C-N-CA 127.215 2.206 . . . . 0.0 116.778 -170.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.523 ' HA3' ' HB1' ' A' ' 41' ' ' ALA . . . 158.29 -47.34 0.44 Allowed Glycine 0 CA--C 1.491 -1.423 0 C-N-CA 119.796 -1.193 . . . . 0.0 115.019 -171.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 124.17 -121.14 4.32 Favored Glycine 0 CA--C 1.499 -0.933 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -171.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.8 p -129.65 143.47 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 O-C-N 121.055 -1.262 . . . . 0.0 108.327 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 62.8 m -104.24 162.19 20.64 Favored Pre-proline 0 C--N 1.346 0.444 0 O-C-N 120.278 -1.514 . . . . 0.0 110.45 176.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.1 -26.46 57.75 Favored 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 122.576 2.184 . . . . 0.0 112.076 168.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt 79.82 78.77 0.05 OUTLIER 'General case' 0 C--N 1.354 0.768 0 C-N-CA 127.605 2.362 . . . . 0.0 110.507 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.8 pt -80.73 140.77 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 O-C-N 120.93 -1.106 . . . . 0.0 110.786 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.1 pp -83.33 6.62 19.19 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 122.354 1.073 . . . . 0.0 112.394 176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -63.02 132.02 50.57 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 125.112 1.365 . . . . 0.0 111.545 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.3 ppt_? -74.26 141.14 45.36 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 121.286 -0.884 . . . . 0.0 111.577 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 6.0 p -132.7 169.0 17.3 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 120.777 -1.202 . . . . 0.0 109.563 -174.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -116.56 -37.25 3.74 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 120.012 -1.68 . . . . 0.0 110.683 173.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -141.61 -171.92 3.42 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 124.226 1.01 . . . . 0.0 108.622 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.42 -7.1 48.01 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 119.224 -2.172 . . . . 0.0 112.875 176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 15.4 p -81.38 -40.03 24.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 126.719 2.008 . . . . 0.0 113.098 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.52 -28.0 68.87 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-O 122.618 1.199 . . . . 0.0 113.042 178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.7 t -99.11 108.73 51.21 Favored Pre-proline 0 N--CA 1.443 -0.799 0 C-N-CA 124.107 0.963 . . . . 0.0 112.224 -164.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.77 151.55 57.57 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.113 1.875 . . . . 0.0 113.457 -168.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.09 -120.91 7.01 Favored Glycine 0 C--N 1.346 1.099 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.523 ' HB1' ' HA3' ' A' ' 22' ' ' GLY . . . -136.91 41.98 2.47 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.343 1.544 . . . . 0.0 110.149 176.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 8.1 m -107.85 112.82 25.64 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.014 -1.678 . . . . 0.0 110.736 -168.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.8 pp -76.31 145.51 10.33 Favored 'Isoleucine or valine' 0 C--O 1.242 0.662 0 O-C-N 120.199 -1.563 . . . . 0.0 112.203 173.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 6.4 t -80.41 134.95 36.07 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.181 1.392 . . . . 0.0 110.063 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -86.14 167.5 14.87 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 119.56 -1.962 . . . . 0.0 110.869 176.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -37.34 -45.6 1.3 Allowed Glycine 0 C--N 1.356 1.664 0 C-N-CA 126.898 2.189 . . . . 0.0 118.13 175.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -62.75 -19.19 63.72 Favored 'General case' 0 C--N 1.349 0.564 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 175.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 90.2 33.54 8.73 Favored Glycine 0 C--N 1.347 1.179 0 O-C-N 120.464 -1.398 . . . . 0.0 112.991 -172.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -139.46 142.37 37.38 Favored 'General case' 0 C--O 1.237 0.423 0 O-C-N 121.018 -1.284 . . . . 0.0 107.631 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.95 125.18 27.0 Favored 'General case' 0 C--N 1.347 0.46 0 CA-C-O 123.397 1.57 . . . . 0.0 114.272 -173.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.343 0 O-C-N 119.946 -1.721 . . . . 0.0 113.354 -176.336 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 N--CA 1.505 2.276 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.41 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 26.8 m -128.18 156.58 40.37 Favored 'Isoleucine or valine' 0 C--N 1.345 0.384 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 13.0 mtt-85 -113.73 113.0 47.76 Favored Pre-proline 0 C--N 1.348 0.516 0 CA-C-O 116.526 -1.702 . . . . 0.0 110.578 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.13 166.01 30.57 Favored 'Trans proline' 0 C--N 1.323 -0.808 0 CA-C-N 124.355 2.591 . . . . 0.0 113.09 164.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -82.73 159.05 64.43 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 123.879 0.872 . . . . 0.0 112.834 176.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.22 -21.01 36.62 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.881 2.387 . . . . 0.0 114.734 -174.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 93.0 mt -67.37 -43.95 80.18 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 119.799 1.181 . . . . 0.0 111.112 173.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 28.7 tp -64.71 -40.45 95.38 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 124.089 0.956 . . . . 0.0 112.403 175.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 34.8 tp -49.41 -39.53 33.05 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -68.38 -32.26 72.21 Favored 'General case' 0 C--N 1.35 0.601 0 O-C-N 119.434 -2.041 . . . . 0.0 113.291 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 3.4 tt -71.41 -49.88 37.5 Favored 'General case' 0 C--N 1.348 0.505 0 O-C-N 121.52 -0.737 . . . . 0.0 110.442 170.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 96.4 mt -52.04 -44.16 64.1 Favored 'General case' 0 C--N 1.348 0.506 0 C-N-CA 124.658 1.183 . . . . 0.0 113.8 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -54.18 -36.15 63.09 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 120.415 -1.428 . . . . 0.0 114.321 169.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 3.8 t -73.92 -6.74 49.08 Favored 'General case' 0 C--N 1.342 0.268 0 C-N-CA 125.158 1.383 . . . . 0.0 112.231 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 1.6 t -108.64 7.52 9.28 Favored 'Isoleucine or valine' 0 C--N 1.35 0.616 0 C-N-CA 124.986 1.315 . . . . 0.0 110.718 167.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.82 -23.11 37.41 Favored Glycine 0 C--N 1.351 1.38 0 O-C-N 119.018 -2.301 . . . . 0.0 114.114 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -79.02 68.48 4.98 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 125.971 1.708 . . . . 0.0 112.812 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -81.67 4.92 19.99 Favored 'General case' 0 C--N 1.343 0.3 0 O-C-N 120.074 -1.641 . . . . 0.0 114.75 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 1.3 tppp? -83.7 146.98 27.92 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.045 0.938 . . . . 0.0 109.629 175.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -70.22 -48.41 57.17 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-O 122.99 1.376 . . . . 0.0 111.058 169.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 40.7 p -84.05 110.16 18.24 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -175.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -128.4 -166.83 1.68 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.687 1.195 . . . . 0.0 110.484 168.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 50.6 p -117.99 175.47 5.66 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 119.595 -1.94 . . . . 0.0 111.362 -175.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 46.0 mtt -57.33 -41.25 79.59 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 120.475 -1.391 . . . . 0.0 113.591 172.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.8 -52.97 61.1 Favored 'General case' 0 C--N 1.349 0.564 0 C-N-CA 124.388 1.075 . . . . 0.0 110.618 174.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -73.73 -31.64 63.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 -171.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 67.6 t -55.29 -37.01 42.39 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 O-C-N 120.065 -1.647 . . . . 0.0 111.246 171.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -89.85 -24.76 21.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 120.733 -1.229 . . . . 0.0 113.635 175.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -66.77 -56.88 8.51 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 120.039 -1.663 . . . . 0.0 112.916 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -61.26 -41.96 97.82 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 120.961 -1.087 . . . . 0.0 111.153 175.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 34.6 tp -57.88 -49.88 75.2 Favored 'General case' 0 C--N 1.347 0.491 0 O-C-N 120.306 -1.497 . . . . 0.0 113.518 172.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -56.45 -47.92 79.86 Favored Glycine 0 C--N 1.347 1.177 0 O-C-N 120.299 -1.5 . . . . 0.0 114.321 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -58.42 -40.6 82.94 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.184 0.993 . . . . 0.0 113.618 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -58.33 -55.68 31.86 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 124.735 1.214 . . . . 0.0 113.633 176.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 4.3 mp -68.68 -39.1 79.84 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 O-C-N 120.409 -1.432 . . . . 0.0 111.647 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 55.2 ttm -54.51 -48.33 72.05 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-O 122.443 1.116 . . . . 0.0 112.37 173.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 38.6 m -70.73 -29.56 65.86 Favored 'General case' 0 C--N 1.344 0.351 0 O-C-N 120.819 -1.176 . . . . 0.0 112.965 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -81.59 -23.15 37.26 Favored 'General case' 0 C--N 1.346 0.433 0 O-C-N 119.022 -2.299 . . . . 0.0 115.61 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? 72.29 49.3 0.22 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 125.343 1.457 . . . . 0.0 112.354 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 2.2 tt -95.85 -27.42 15.21 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 120.326 -1.484 . . . . 0.0 113.029 -177.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -69.01 142.06 54.71 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 120.021 -1.674 . . . . 0.0 111.756 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.5 137.37 53.44 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.017 0.927 . . . . 0.0 113.302 167.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -64.32 -31.84 73.2 Favored 'General case' 0 C--N 1.35 0.594 0 O-C-N 120.317 -1.489 . . . . 0.0 113.04 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -96.86 -32.82 11.89 Favored 'General case' 0 C--N 1.347 0.497 0 O-C-N 120.871 -1.143 . . . . 0.0 113.291 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.34 56.59 0.75 Allowed 'General case' 0 C--N 1.351 0.647 0 O-C-N 120.347 -1.471 . . . . 0.0 112.736 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 9.8 pm0 -60.92 5.46 0.05 Allowed 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 118.655 2.835 . . . . 0.0 118.655 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 44.6 p-80 -102.42 -6.54 22.86 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 119.849 -1.782 . . . . 0.0 111.704 175.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 49.1 mm -92.34 138.55 19.69 Favored 'Isoleucine or valine' 0 C--N 1.345 0.404 0 C-N-CA 125.27 1.428 . . . . 0.0 109.433 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 41.2 t -135.33 120.95 30.31 Favored 'Isoleucine or valine' 0 C--N 1.35 0.609 0 O-C-N 120.649 -1.282 . . . . 0.0 108.279 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -105.9 78.6 1.34 Allowed 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 120.535 -1.353 . . . . 0.0 112.795 -171.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 61.5 m -86.34 37.81 0.75 Allowed 'General case' 0 C--N 1.349 0.549 0 O-C-N 119.959 -1.713 . . . . 0.0 114.408 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 11.1 t -88.51 129.64 35.41 Favored 'General case' 0 CA--C 1.507 -0.687 0 O-C-N 119.562 -1.961 . . . . 0.0 107.436 165.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 70.08 43.93 0.83 Allowed 'General case' 0 C--N 1.349 0.577 0 CA-C-O 122.878 1.323 . . . . 0.0 111.619 -178.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -141.32 166.12 25.63 Favored 'General case' 0 N--CA 1.438 -1.07 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 18.1 tp -83.67 -9.94 58.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.583 1.153 . . . . 0.0 112.651 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' LEU . . . . . . . . . . . . . 10.1 mp -76.99 -31.23 56.34 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 119.498 -2.001 . . . . 0.0 110.658 164.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.42 -44.05 96.95 Favored Glycine 0 C--N 1.351 1.366 0 C-N-CA 125.279 1.419 . . . . 0.0 114.565 -174.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -46.08 -62.3 1.39 Allowed 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 128.036 2.535 . . . . 0.0 112.102 169.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 4.2 pp -78.3 -18.46 55.21 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -172.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -81.22 -48.44 12.06 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.849 -1.157 . . . . 0.0 111.549 168.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 86.06 29.26 26.11 Favored Glycine 0 C--N 1.352 1.425 0 C-N-CA 124.829 1.204 . . . . 0.0 113.698 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 33.0 m -136.48 156.26 76.55 Favored Pre-proline 0 C--N 1.346 0.43 0 O-C-N 120.952 -1.322 . . . . 0.0 109.452 -176.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -80.26 -10.33 13.65 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 CA-C-N 122.363 1.88 . . . . 0.0 112.982 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 10.0 p -178.92 171.36 1.42 Allowed 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 -175.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.06 170.65 15.33 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 170.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 40.6 t -114.5 133.93 55.4 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 106.135 -1.802 . . . . 0.0 106.135 171.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 58.2 t -59.92 -39.9 81.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 O-C-N 121.456 -0.778 . . . . 0.0 112.276 -175.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -54.22 -26.39 28.24 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 -175.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -81.76 66.2 7.22 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 119.884 -1.76 . . . . 0.0 110.544 176.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -53.49 -46.23 69.93 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 125.848 1.659 . . . . 0.0 113.05 -174.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 81.3 ttt180 -56.38 -29.45 61.46 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 127.051 2.141 . . . . 0.0 114.252 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -78.17 -42.93 30.09 Favored 'General case' 0 CA--C 1.512 -0.505 0 O-C-N 120.173 -1.579 . . . . 0.0 111.844 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 48.1 mm -56.79 -50.11 76.07 Favored 'Isoleucine or valine' 0 C--N 1.347 0.463 0 C-N-CA 124.043 0.937 . . . . 0.0 111.951 176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 -51.06 -43.73 61.03 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 120.742 -1.224 . . . . 0.0 113.84 168.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 52.9 m -65.45 -33.56 76.23 Favored 'General case' 0 C--N 1.345 0.374 0 O-C-N 121.083 -1.011 . . . . 0.0 112.893 178.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -68.22 -48.51 64.97 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 118.88 -2.387 . . . . 0.0 112.697 167.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 81.2 mt -57.7 -50.83 76.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.449 0 C-N-CA 124.783 1.233 . . . . 0.0 112.715 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -66.68 -12.07 56.76 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 119.232 -2.168 . . . . 0.0 115.143 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -85.93 -9.04 57.57 Favored 'General case' 0 C--N 1.351 0.663 0 O-C-N 119.596 -1.94 . . . . 0.0 112.215 169.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -96.09 -36.04 11.14 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 120.3 -1.5 . . . . 0.0 109.36 174.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 71.4 mt -92.85 161.33 14.54 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 125.36 1.464 . . . . 0.0 113.653 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 46.3 t -105.85 126.58 61.25 Favored 'Isoleucine or valine' 0 C--N 1.345 0.389 0 O-C-N 120.7 -1.25 . . . . 0.0 107.733 171.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 C--N 1.346 0.447 0 O-C-N 121.249 -0.907 . . . . 0.0 110.668 178.911 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.517 2.915 0 CA-C-O 117.238 -1.363 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 52.25 45.21 58.02 Favored Glycine 0 C--N 1.357 1.715 0 CA-C-N 120.18 1.354 . . . . 0.0 114.094 -170.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.2 t -152.43 134.39 14.85 Favored 'General case' 0 CA--C 1.508 -0.666 0 O-C-N 120.691 -1.476 . . . . 0.0 109.197 -172.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.78 -137.14 3.45 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 122.368 0.982 . . . . 0.0 111.63 -173.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.31 68.14 8.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 120.04 -1.859 . . . . 0.0 113.173 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 t -59.32 -13.2 7.26 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 125.613 1.565 . . . . 0.0 114.571 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.6 -30.17 22.02 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.81 1.644 . . . . 0.0 114.337 175.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 174.53 89.6 0.07 OUTLIER Pre-proline 0 C--N 1.35 0.626 0 C-N-CA 124.986 1.314 . . . . 0.0 108.505 -171.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.01 118.57 4.09 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.344 2.03 . . . . 0.0 112.282 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t -113.29 -4.45 13.69 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 122.588 1.185 . . . . 0.0 110.11 -177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.2 t -126.21 162.62 25.01 Favored 'General case' 0 C--N 1.348 0.513 0 O-C-N 120.069 -1.644 . . . . 0.0 113.44 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -61.62 -48.34 81.36 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 120.449 -1.407 . . . . 0.0 111.932 177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.81 86.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 125.553 1.541 . . . . 0.0 112.786 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -63.08 -54.7 33.86 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.783 -1.198 . . . . 0.0 113.656 173.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.63 -31.19 70.17 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 121.734 0.778 . . . . 0.0 112.239 179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 60.0 t-105 -53.63 -49.6 67.52 Favored 'General case' 0 C--N 1.346 0.416 0 O-C-N 119.959 -1.713 . . . . 0.0 113.164 169.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -67.44 -30.16 69.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 120.525 -1.359 . . . . 0.0 113.862 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.97 -27.94 65.86 Favored 'General case' 0 C--N 1.353 0.742 0 C-N-CA 125.897 1.679 . . . . 0.0 114.295 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.7 tp -61.9 -25.33 67.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.228 1.011 . . . . 0.0 113.607 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.6 t 56.43 40.79 29.52 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 124.632 2.158 . . . . 0.0 112.977 -175.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.419 ' HB1' ' HG ' ' B' ' 119' ' ' LEU . . . -64.87 92.6 0.1 Allowed 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.258 1.423 . . . . 0.0 113.526 -177.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.95 -40.66 0.8 Allowed Glycine 0 CA--C 1.496 -1.111 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -173.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 110.04 -144.62 16.94 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -176.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.7 m -93.79 139.84 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 120.211 -1.758 . . . . 0.0 111.102 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.62 156.66 45.87 Favored Pre-proline 0 N--CA 1.45 -0.465 0 O-C-N 120.569 -1.332 . . . . 0.0 109.347 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -72.59 -10.12 24.83 Favored 'Trans proline' 0 CA--C 1.519 -0.239 0 C-N-CA 122.872 2.382 . . . . 0.0 112.894 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 mptt 64.91 51.82 1.69 Allowed 'General case' 0 C--N 1.349 0.573 0 C-N-CA 126.019 1.728 . . . . 0.0 113.198 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.9 pt -64.89 143.59 15.62 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -174.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 mt -86.24 25.59 1.16 Allowed 'General case' 0 C--N 1.345 0.4 0 C-N-CA 124.877 1.271 . . . . 0.0 111.746 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -80.67 135.19 35.98 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 120.181 -1.574 . . . . 0.0 110.456 174.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -74.26 126.27 30.27 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 121.83 0.824 . . . . 0.0 111.747 175.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.7 p -118.06 -177.53 3.29 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 120.628 -1.295 . . . . 0.0 110.03 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.3 ttm-85 -122.05 -21.43 5.97 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 119.85 -1.781 . . . . 0.0 110.968 162.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.7 ptt180 -157.73 169.2 25.17 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 120.405 -1.434 . . . . 0.0 109.738 -176.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -52.26 -46.13 65.68 Favored 'General case' 0 C--N 1.354 0.793 0 C-N-CA 127.742 2.417 . . . . 0.0 111.656 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.0 m -55.59 -18.26 7.27 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 118.147 2.647 . . . . 0.0 118.147 170.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -93.87 -6.91 44.64 Favored 'General case' 0 C--N 1.345 0.388 0 O-C-N 120.46 -1.4 . . . . 0.0 111.083 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.33 127.47 26.79 Favored Pre-proline 0 C--N 1.349 0.573 0 O-C-N 120.523 -1.36 . . . . 0.0 110.327 -176.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.47 163.33 36.37 Favored 'Trans proline' 0 C--N 1.324 -0.711 0 C-N-CA 122.067 1.845 . . . . 0.0 114.169 -169.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.86 -78.9 1.91 Allowed Glycine 0 C--N 1.348 1.207 0 O-C-N 121.349 -0.844 . . . . 0.0 113.097 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.23 24.82 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 122.377 1.084 . . . . 0.0 111.652 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 62.1 m -98.16 116.89 31.33 Favored 'General case' 0 C--O 1.215 -0.74 0 O-C-N 119.523 -1.986 . . . . 0.0 112.435 -162.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.57 150.06 6.75 Favored 'Isoleucine or valine' 0 C--N 1.346 0.426 0 O-C-N 118.429 -2.67 . . . . 0.0 113.665 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.29 125.32 29.19 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.804 0.842 . . . . 0.0 108.881 168.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -85.94 179.67 6.96 Favored 'General case' 0 C--N 1.345 0.412 0 O-C-N 120.032 -1.668 . . . . 0.0 110.655 178.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.24 -5.3 20.47 Favored Glycine 0 C--N 1.353 1.525 0 N-CA-C 116.804 1.482 . . . . 0.0 116.804 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -96.26 -6.15 38.64 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 121.201 -1.176 . . . . 0.0 112.501 170.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.59 18.28 64.29 Favored Glycine 0 C--N 1.348 1.216 0 O-C-N 121.01 -1.056 . . . . 0.0 113.787 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -128.04 146.4 50.69 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 123.083 1.42 . . . . 0.0 110.743 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 80.5 m -67.87 160.71 27.88 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-O 123.491 1.615 . . . . 0.0 113.081 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.343 0.958 0 O-C-N 119.3 -2.125 . . . . 0.0 116.846 -174.927 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 99.2 mt . . . . . 0 N--CA 1.506 2.329 0 CA-C-O 118.225 -0.893 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 15.2 m -133.47 165.44 32.14 Favored 'Isoleucine or valine' 0 C--N 1.344 0.361 0 CA-C-N 119.274 0.943 . . . . 0.0 109.271 177.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -114.0 101.82 54.28 Favored Pre-proline 0 C--N 1.345 0.41 0 CA-C-O 116.986 -1.483 . . . . 0.0 110.676 178.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.95 165.57 29.55 Favored 'Trans proline' 0 C--N 1.326 -0.609 0 C-N-CA 123.228 2.619 . . . . 0.0 114.242 176.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 1.9 mtpt -87.16 153.2 53.94 Favored Pre-proline 0 C--N 1.351 0.653 0 O-C-N 120.967 -1.083 . . . . 0.0 111.961 177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.06 -21.82 42.38 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.536 2.824 . . . . 0.0 113.436 -173.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 89.0 mt -70.14 -47.12 63.06 Favored 'General case' 0 N--CA 1.452 -0.348 0 O-C-N 121.166 -0.959 . . . . 0.0 110.984 171.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 34.6 tp -65.17 -33.89 77.09 Favored 'General case' 0 C--N 1.347 0.463 0 C-N-CA 124.584 1.154 . . . . 0.0 113.062 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 14.7 tp -48.42 -41.68 29.92 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 125.326 1.45 . . . . 0.0 113.956 169.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -65.4 -36.88 85.29 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 119.844 -1.785 . . . . 0.0 114.328 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.492 HD13 HD13 ' B' ' 147' ' ' LEU . 1.1 tt -70.23 -50.22 42.09 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.656 0.782 . . . . 0.0 111.074 173.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 40.2 mt -52.16 -44.91 64.83 Favored 'General case' 0 C--N 1.35 0.617 0 C-N-CA 124.567 1.147 . . . . 0.0 112.702 176.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 3.8 ttmt -57.4 -34.57 69.02 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 115.219 1.563 . . . . 0.0 115.219 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 55.6 m -71.35 -15.49 62.39 Favored 'General case' 0 C--N 1.347 0.48 0 C-N-CA 124.558 1.143 . . . . 0.0 113.323 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.7 t -96.21 -7.38 9.62 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 124.351 1.06 . . . . 0.0 110.311 173.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.97 -26.47 7.9 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 120.106 -1.621 . . . . 0.0 112.36 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -80.41 74.47 7.28 Favored 'General case' 0 N--CA 1.441 -0.891 0 C-N-CA 126.006 1.723 . . . . 0.0 113.947 -170.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -83.57 12.03 6.3 Favored 'General case' 0 C--N 1.343 0.291 0 N-CA-C 116.18 1.919 . . . . 0.0 116.18 -174.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 14.8 ttpp -99.74 127.06 45.89 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 121.204 -0.935 . . . . 0.0 112.793 -169.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.44 -9.42 0.3 Allowed 'General case' 0 C--N 1.348 0.515 0 N-CA-C 117.881 2.549 . . . . 0.0 117.881 177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 67.4 p -137.11 127.04 25.77 Favored 'General case' 0 CA--C 1.508 -0.643 0 O-C-N 119.064 -2.273 . . . . 0.0 111.158 175.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -129.03 -177.82 4.38 Favored 'General case' 0 N--CA 1.452 -0.358 0 O-C-N 120.46 -1.4 . . . . 0.0 110.462 173.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 2.8 m -96.85 161.55 13.8 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.156 1.383 . . . . 0.0 108.189 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 1.1 mmm -60.04 -44.96 94.29 Favored 'General case' 0 C--N 1.35 0.6 0 O-C-N 119.794 -1.816 . . . . 0.0 113.837 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -58.4 -51.87 68.0 Favored 'General case' 0 C--N 1.348 0.522 0 C-N-CA 124.136 0.974 . . . . 0.0 113.605 170.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -48.66 -49.65 36.5 Favored 'General case' 0 C--N 1.35 0.628 0 C-N-CA 126.504 1.921 . . . . 0.0 114.68 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 40.1 t -54.03 -46.32 65.64 Favored 'Isoleucine or valine' 0 C--N 1.355 0.842 0 O-C-N 120.674 -1.266 . . . . 0.0 112.355 176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . 0.419 ' HG ' ' HB1' ' A' ' 21' ' ' ALA . 4.2 mm? -72.11 -38.19 69.37 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 124.26 1.024 . . . . 0.0 112.325 176.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -56.25 -59.53 4.8 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 125.803 1.641 . . . . 0.0 112.79 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -58.02 -41.6 83.49 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 123.903 0.881 . . . . 0.0 112.028 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 26.4 tp -63.17 -52.22 63.26 Favored 'General case' 0 C--N 1.346 0.441 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 173.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -63.5 -44.89 95.98 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 119.481 -2.012 . . . . 0.0 113.092 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -60.57 -30.28 69.69 Favored 'General case' 0 C--N 1.346 0.445 0 C-N-CA 124.379 1.071 . . . . 0.0 113.182 176.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -56.74 -60.25 3.83 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 124.429 1.092 . . . . 0.0 111.613 171.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 4.8 mt -59.6 -42.87 89.67 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 O-C-N 120.292 -1.505 . . . . 0.0 113.794 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 1.7 mpp? -51.02 -48.24 61.48 Favored 'General case' 0 C--N 1.352 0.701 0 C-N-CA 124.683 1.193 . . . . 0.0 113.556 170.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 40.5 m -78.64 -39.53 36.75 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 120.351 -1.468 . . . . 0.0 112.671 -177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -74.74 -21.47 59.33 Favored 'General case' 0 C--N 1.349 0.58 0 C-N-CA 126.163 1.785 . . . . 0.0 114.538 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 69.48 50.82 0.5 Allowed 'General case' 0 C--N 1.348 0.541 0 C-N-CA 125.821 1.648 . . . . 0.0 112.394 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 51.8 mt -107.46 18.65 21.28 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 123.782 0.833 . . . . 0.0 111.751 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -105.97 150.04 26.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 173.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -81.74 141.65 33.36 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.2 -31.72 72.94 Favored 'General case' 0 C--N 1.346 0.428 0 O-C-N 121.028 -1.045 . . . . 0.0 113.187 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.76 -29.02 12.13 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 120.743 -1.223 . . . . 0.0 112.323 -177.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -114.88 69.04 0.71 Allowed 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.097 -1.627 . . . . 0.0 112.641 174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -73.41 -2.77 23.68 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 119.896 -1.752 . . . . 0.0 113.992 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -87.15 -10.19 53.35 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.589 1.955 . . . . 0.0 113.033 176.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 48.3 mm -98.59 134.0 38.89 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 C-N-CA 125.497 1.519 . . . . 0.0 109.96 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 48.0 t -117.13 126.89 74.74 Favored 'Isoleucine or valine' 0 C--N 1.35 0.617 0 O-C-N 120.905 -1.122 . . . . 0.0 111.096 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -82.93 101.6 11.15 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.501 1.12 . . . . 0.0 111.762 173.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 18.3 m -107.14 3.46 25.75 Favored 'General case' 0 C--N 1.35 0.618 0 CA-C-O 122.06 0.934 . . . . 0.0 111.69 173.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 79.0 p -72.91 124.32 25.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 119.744 -1.847 . . . . 0.0 110.897 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 5.3 t30 79.57 18.85 0.72 Allowed 'General case' 0 C--N 1.35 0.621 0 C-N-CA 124.612 1.165 . . . . 0.0 112.478 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -112.06 169.98 8.47 Favored 'General case' 0 C--N 1.351 0.639 0 C-N-CA 124.691 1.196 . . . . 0.0 108.978 172.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . 0.404 HD23 ' HB2' ' B' ' 102' ' ' LEU . 16.5 tp -69.97 -22.9 63.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.601 1.96 . . . . 0.0 112.657 178.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' LEU . . . . . 0.492 HD13 HD13 ' B' ' 102' ' ' LEU . 2.0 mp -66.46 -34.61 78.33 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 119.899 -1.751 . . . . 0.0 113.105 167.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -59.66 -37.77 92.79 Favored Glycine 0 C--N 1.348 1.226 0 O-C-N 120.554 -1.341 . . . . 0.0 114.117 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.41 -49.17 70.58 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.722 2.409 . . . . 0.0 112.845 173.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 1.3 pp -83.51 -28.02 28.96 Favored 'General case' 0 C--N 1.349 0.576 0 O-C-N 119.35 -2.093 . . . . 0.0 113.918 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.648 ' HB3' HG22 ' B' ' 153' ' ' VAL . 9.3 m-85 -79.6 -41.02 27.99 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 125.141 1.377 . . . . 0.0 112.856 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 78.58 14.4 82.15 Favored Glycine 0 C--N 1.35 1.339 0 C-N-CA 124.189 0.899 . . . . 0.0 114.183 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . 0.648 HG22 ' HB3' ' B' ' 151' ' ' PHE . 33.2 m -131.15 151.27 78.61 Favored Pre-proline 0 C--N 1.345 0.403 0 O-C-N 120.828 -1.396 . . . . 0.0 110.382 -174.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.92 -26.92 10.61 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 121.965 1.777 . . . . 0.0 112.02 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 27.8 p -159.49 164.54 34.35 Favored 'General case' 0 CA--C 1.503 -0.828 0 O-C-N 120.729 -1.232 . . . . 0.0 109.231 -174.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -139.86 160.54 39.67 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 120.241 -1.537 . . . . 0.0 109.182 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 4.5 t -112.17 134.68 53.58 Favored 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.44 -33.7 65.47 Favored 'Isoleucine or valine' 0 C--N 1.347 0.488 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.72 -25.47 2.99 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -80.36 55.88 2.37 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 120.037 -1.664 . . . . 0.0 111.255 176.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 86.4 m-70 -51.87 -47.39 64.52 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 119.999 -1.688 . . . . 0.0 114.235 -172.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -57.09 -38.46 73.38 Favored 'General case' 0 C--N 1.347 0.495 0 C-N-CA 125.842 1.657 . . . . 0.0 113.271 172.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 18.1 ttpt -66.47 -51.33 57.9 Favored 'General case' 0 C--N 1.35 0.602 0 O-C-N 120.235 -1.541 . . . . 0.0 110.598 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 50.9 mm -50.44 -54.65 8.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 C-N-CA 125.566 1.546 . . . . 0.0 112.826 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -51.76 -46.67 64.17 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 171.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 9.9 m -59.2 -42.67 91.48 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.627 -1.296 . . . . 0.0 112.453 176.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 3.5 mtp -72.06 -22.88 61.31 Favored 'General case' 0 C--N 1.348 0.537 0 O-C-N 120.507 -1.371 . . . . 0.0 113.577 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.45 -52.05 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 O-C-N 121.115 -0.991 . . . . 0.0 110.478 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -57.09 -24.73 56.1 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 114.945 1.461 . . . . 0.0 114.945 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.25 -12.4 60.0 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.91 -1.744 . . . . 0.0 114.488 173.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -103.05 -13.54 16.8 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 119.945 -1.722 . . . . 0.0 111.381 176.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 82.6 mt -109.8 155.4 21.68 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.928 1.291 . . . . 0.0 110.541 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 38.8 t -100.58 117.79 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 O-C-N 120.1 -1.625 . . . . 0.0 108.685 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.35 0.591 0 C-N-CA 124.172 0.989 . . . . 0.0 111.022 178.787 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.526 3.336 0 N-CA-C 119.39 3.107 . . . . 0.0 119.39 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.54 15.22 65.89 Favored Glycine 0 C--N 1.355 1.588 0 N-CA-C 115.836 1.094 . . . . 0.0 115.836 175.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.1 t -140.24 144.04 36.29 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -141.51 -129.91 2.51 Favored Glycine 0 C--N 1.346 1.128 0 C-N-CA 125.061 1.315 . . . . 0.0 110.112 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.0 72.53 10.07 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 120.219 -1.753 . . . . 0.0 112.397 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.3 p -68.21 -15.21 63.49 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -173.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -82.39 -38.1 24.61 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 124.971 1.309 . . . . 0.0 111.91 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -166.79 92.36 0.75 Allowed Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.14 105.69 1.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.078 1.852 . . . . 0.0 111.398 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -103.92 -17.3 15.07 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 124.74 1.216 . . . . 0.0 112.187 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.4 m -109.76 173.13 6.46 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 123.566 1.65 . . . . 0.0 112.406 169.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -73.44 -42.23 62.23 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 119.262 -2.149 . . . . 0.0 113.733 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.97 -35.43 78.46 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 120.315 -1.49 . . . . 0.0 112.878 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -59.16 -58.99 6.22 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 125.975 1.71 . . . . 0.0 113.049 169.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.97 -22.96 65.0 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 120.815 -1.178 . . . . 0.0 113.537 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 26.2 t90 -62.15 -42.04 98.87 Favored 'General case' 0 C--N 1.348 0.508 0 O-C-N 119.906 -1.746 . . . . 0.0 112.415 167.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -70.3 -33.73 71.88 Favored 'General case' 0 C--N 1.346 0.448 0 O-C-N 120.231 -1.543 . . . . 0.0 114.019 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.19 -25.76 61.97 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 177.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.1 tp -63.98 -14.28 52.74 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.397 1.079 . . . . 0.0 113.431 175.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.347 94.4 p 56.79 25.67 10.57 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 128.047 2.539 . . . . 0.0 113.913 -178.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.32 91.14 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 128.316 2.647 . . . . 0.0 115.817 -167.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 144.27 -29.9 1.9 Allowed Glycine 0 C--N 1.344 1.02 0 O-C-N 121.382 -0.824 . . . . 0.0 112.174 -173.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 102.16 -160.54 17.6 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-O 122.81 1.228 . . . . 0.0 112.786 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.9 t -86.79 102.89 12.58 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 O-C-N 120.31 -1.7 . . . . 0.0 110.895 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 5.9 t -80.76 151.79 71.44 Favored Pre-proline 0 C--N 1.348 0.52 0 O-C-N 120.127 -1.608 . . . . 0.0 110.457 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -67.05 -8.86 23.07 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 123.09 2.527 . . . . 0.0 115.096 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt 70.32 51.88 0.37 Allowed 'General case' 0 C--N 1.35 0.615 0 C-N-CA 125.454 1.502 . . . . 0.0 113.341 174.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.7 pt -67.89 145.66 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 122.872 1.32 . . . . 0.0 113.663 -177.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.1 mp -91.05 28.75 1.52 Allowed 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 120.475 -1.391 . . . . 0.0 110.661 -177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -82.03 133.25 35.28 Favored 'General case' 0 N--CA 1.442 -0.864 0 O-C-N 120.504 -1.372 . . . . 0.0 110.432 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -80.5 113.87 18.99 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 121.37 -0.832 . . . . 0.0 110.918 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.404 ' HB2' ' H ' ' A' ' 33' ' ' ARG . 1.6 p -103.91 -141.53 0.36 Allowed 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.688 1.595 . . . . 0.0 110.817 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.404 ' H ' ' HB2' ' A' ' 32' ' ' CYS . 34.0 ptt180 -169.61 -39.67 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 120.676 -1.265 . . . . 0.0 107.999 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.415 ' HG3' ' H ' ' A' ' 36' ' ' SER . 12.7 tpp85 -125.46 169.29 12.54 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 172.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -71.43 -14.81 62.27 Favored 'General case' 0 N--CA 1.442 -0.835 0 O-C-N 119.819 -1.801 . . . . 0.0 113.814 173.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.415 ' H ' ' HG3' ' A' ' 34' ' ' ARG . 18.2 m -61.77 -48.0 82.64 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 126.522 1.929 . . . . 0.0 113.876 173.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.76 -0.56 13.6 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.888 -1.133 . . . . 0.0 113.997 -174.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.7 t -118.7 107.99 41.8 Favored Pre-proline 0 C--N 1.353 0.726 0 O-C-N 119.955 -1.716 . . . . 0.0 111.751 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.35 170.47 19.82 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.767 2.311 . . . . 0.0 115.653 -159.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.11 -90.54 1.67 Allowed Glycine 0 C--N 1.349 1.259 0 C-N-CA 124.181 0.895 . . . . 0.0 113.035 172.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.03 16.06 0.84 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 123.079 1.419 . . . . 0.0 110.54 -177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 32.9 m -76.92 168.36 20.23 Favored 'General case' 0 N--CA 1.437 -1.107 0 O-C-N 119.859 -1.776 . . . . 0.0 111.461 -172.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.27 148.38 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.089 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 160.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.5 t -77.26 128.38 34.23 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 126.099 1.759 . . . . 0.0 107.133 171.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -84.79 -179.39 7.09 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 119.973 -1.704 . . . . 0.0 109.249 175.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.12 -11.03 24.04 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 116.394 1.318 . . . . 0.0 116.394 174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 40.6 p-10 -87.06 -7.41 58.11 Favored 'General case' 0 C--N 1.351 0.648 0 O-C-N 120.704 -1.468 . . . . 0.0 113.374 170.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.74 13.8 74.55 Favored Glycine 0 C--N 1.346 1.123 0 O-C-N 120.71 -1.244 . . . . 0.0 114.259 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -124.18 152.08 43.29 Favored 'General case' 0 C--O 1.237 0.429 0 O-C-N 121.134 -1.215 . . . . 0.0 109.765 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 29.2 m -78.91 93.78 5.1 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 115.594 1.701 . . . . 0.0 115.594 -166.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.294 0 O-C-N 119.526 -1.984 . . . . 0.0 116.624 -179.694 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.504 2.267 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.444 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 29.3 m -120.8 160.88 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 42.5 mtt180 -116.31 117.79 38.31 Favored Pre-proline 0 C--N 1.348 0.53 0 CA-C-O 115.964 -1.97 . . . . 0.0 109.822 170.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.09 -179.28 3.78 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.092 2.528 . . . . 0.0 114.132 169.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -101.03 159.74 28.65 Favored Pre-proline 0 C--N 1.351 0.634 0 C-N-CA 125.485 1.514 . . . . 0.0 110.609 175.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -68.99 -26.83 30.86 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.907 2.405 . . . . 0.0 114.098 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 93.6 mt -62.97 -55.54 24.98 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-N 119.556 1.071 . . . . 0.0 110.942 172.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 18.5 tp -59.62 -35.62 74.72 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 120.892 -1.13 . . . . 0.0 113.282 174.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 17.5 tp -56.44 -40.77 75.33 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 120.605 -1.309 . . . . 0.0 114.485 175.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -65.52 -32.33 73.87 Favored 'General case' 0 C--N 1.346 0.442 0 O-C-N 120.002 -1.686 . . . . 0.0 113.613 177.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . . . . . . . . . 10.2 tt -67.94 -46.26 72.0 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.402 -0.811 . . . . 0.0 110.94 170.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 95.5 mt -52.15 -47.62 65.35 Favored 'General case' 0 C--N 1.35 0.591 0 O-C-N 121.268 -0.895 . . . . 0.0 112.83 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 19.3 mttt -58.58 -24.99 62.1 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.273 -1.517 . . . . 0.0 114.282 173.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 11.7 t -83.38 -9.64 58.92 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 120.303 -1.498 . . . . 0.0 113.753 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 4.5 t -107.76 16.83 7.05 Favored 'Isoleucine or valine' 0 C--N 1.348 0.509 0 CA-C-O 123.369 1.557 . . . . 0.0 107.903 171.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.1 -20.93 36.97 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 119.262 -2.149 . . . . 0.0 113.96 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -77.29 69.2 3.53 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 126.228 1.811 . . . . 0.0 113.473 -172.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -85.39 17.36 3.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 119.467 -2.021 . . . . 0.0 116.204 -173.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . 0.855 ' HE3' ' H ' ' B' ' 111' ' ' ASP . 0.0 OUTLIER -88.21 142.53 27.68 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 123.874 1.797 . . . . 0.0 110.56 170.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.855 ' H ' ' HE3' ' B' ' 110' ' ' LYS . 2.6 m-20 -78.38 -7.02 56.86 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 130.717 3.607 . . . . 0.0 111.656 -172.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 11.3 p -145.43 135.11 23.4 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 127.087 2.155 . . . . 0.0 109.852 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -139.52 -165.45 1.87 Allowed 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.056 -1.028 . . . . 0.0 110.055 174.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 29.1 p -94.21 -169.63 2.11 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 119.774 -1.829 . . . . 0.0 110.927 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 76.7 mtp -74.56 -53.24 9.79 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 119.367 -2.083 . . . . 0.0 112.001 169.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -58.18 -38.98 77.73 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.211 -0.93 . . . . 0.0 112.927 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -61.76 -44.31 97.15 Favored 'General case' 0 C--N 1.348 0.51 0 N-CA-C 115.67 1.73 . . . . 0.0 115.67 177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.18 -26.11 39.32 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 O-C-N 119.618 -1.926 . . . . 0.0 111.479 177.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -91.68 -27.69 17.93 Favored 'General case' 0 C--N 1.347 0.479 0 O-C-N 120.622 -1.299 . . . . 0.0 113.706 172.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -64.97 -62.53 1.5 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 126.399 1.88 . . . . 0.0 111.612 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -54.96 -36.03 64.89 Favored 'General case' 0 C--N 1.351 0.674 0 O-C-N 120.673 -1.267 . . . . 0.0 112.3 177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.454 HD11 HD21 ' B' ' 147' ' ' LEU . 33.2 tp -70.48 -49.2 50.98 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 114.972 1.471 . . . . 0.0 114.972 174.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -70.44 -46.37 48.93 Favored Glycine 0 C--N 1.346 1.095 0 O-C-N 119.89 -1.756 . . . . 0.0 113.428 -176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 5.7 mp0 -63.36 -31.29 72.4 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.201 1.4 . . . . 0.0 112.247 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -55.9 -57.85 10.33 Favored 'General case' 0 C--N 1.353 0.738 0 C-N-CA 124.23 1.012 . . . . 0.0 111.861 168.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 89.7 mt -64.12 -43.74 97.49 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 O-C-N 120.534 -1.354 . . . . 0.0 112.888 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 53.5 ttm -57.64 -34.2 69.07 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 125.498 1.519 . . . . 0.0 113.206 174.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 58.1 m -86.33 -36.27 19.37 Favored 'General case' 0 C--N 1.345 0.37 0 O-C-N 120.621 -1.299 . . . . 0.0 112.623 176.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -71.66 -22.26 61.7 Favored 'General case' 0 C--N 1.352 0.679 0 C-N-CA 126.769 2.028 . . . . 0.0 114.862 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 71.41 45.12 0.49 Allowed 'General case' 0 C--N 1.351 0.667 0 C-N-CA 125.385 1.474 . . . . 0.0 112.984 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 89.2 mt -100.29 9.32 42.88 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 121.058 -1.026 . . . . 0.0 112.319 172.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -94.26 141.51 28.48 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 120.72 -1.237 . . . . 0.0 108.667 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -78.08 147.73 34.56 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.503 1.121 . . . . 0.0 109.277 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -68.98 -31.18 69.84 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.222 1.409 . . . . 0.0 113.3 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 22.2 mmtp -104.17 -24.91 13.11 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 124.813 1.245 . . . . 0.0 112.666 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -116.93 62.55 0.73 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 122.103 0.954 . . . . 0.0 110.822 -177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.89 -5.04 1.81 Allowed 'General case' 0 C--N 1.353 0.727 0 O-C-N 120.106 -1.621 . . . . 0.0 115.336 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 23.8 p80 -99.81 -0.51 39.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.261 1.824 . . . . 0.0 112.917 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 51.1 mm -105.26 117.11 50.37 Favored 'Isoleucine or valine' 0 C--N 1.347 0.482 0 C-N-CA 125.216 1.406 . . . . 0.0 108.64 176.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 49.0 t -111.49 121.71 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 O-C-N 120.987 -1.071 . . . . 0.0 108.493 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -79.92 108.86 13.83 Favored 'General case' 0 C--N 1.347 0.467 0 O-C-N 120.642 -1.286 . . . . 0.0 111.598 174.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 90.6 m -124.91 24.64 7.56 Favored 'General case' 0 C--N 1.346 0.454 0 O-C-N 121.513 -0.742 . . . . 0.0 111.157 172.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 13.6 p -76.92 142.07 40.24 Favored 'General case' 0 CA--C 1.515 -0.38 0 O-C-N 120.315 -1.491 . . . . 0.0 108.704 165.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 28.9 t30 72.97 -31.22 0.22 Allowed 'General case' 0 C--N 1.354 0.774 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -73.77 164.35 26.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 120.286 -1.509 . . . . 0.0 110.678 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 18.9 tp -73.54 -2.99 25.04 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-O 123.691 1.71 . . . . 0.0 114.174 -162.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' LEU . . . . . 0.454 HD21 HD11 ' B' ' 122' ' ' LEU . 10.0 mp -79.47 -35.9 39.56 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 119.327 -2.108 . . . . 0.0 111.353 168.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -61.88 -32.52 82.23 Favored Glycine 0 C--N 1.349 1.268 0 O-C-N 120.766 -1.209 . . . . 0.0 113.62 -173.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -47.56 -67.4 0.28 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 129.355 3.062 . . . . 0.0 112.181 166.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.95 -23.16 48.61 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -78.77 -36.19 43.39 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 120.139 -1.601 . . . . 0.0 111.66 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 77.19 19.36 77.12 Favored Glycine 0 C--N 1.351 1.386 0 O-C-N 121.266 -0.896 . . . . 0.0 114.839 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . . . . . . . . . 21.9 m -130.91 156.54 79.91 Favored Pre-proline 0 C--N 1.347 0.48 0 O-C-N 120.667 -1.49 . . . . 0.0 110.813 -175.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.01 -26.09 8.17 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 121.923 1.749 . . . . 0.0 112.733 172.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 64.9 p -162.0 165.78 26.92 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 119.701 1.137 . . . . 0.0 109.533 -175.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -138.42 166.12 25.07 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 8.4 t -117.88 143.05 46.65 Favored 'General case' 0 CA--C 1.506 -0.718 0 O-C-N 120.808 -1.182 . . . . 0.0 109.51 169.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 34.6 m -57.95 -34.65 49.24 Favored 'Isoleucine or valine' 0 C--N 1.348 0.521 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -52.87 -26.65 15.39 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 176.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.34 49.22 0.96 Allowed 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 120.458 -1.401 . . . . 0.0 111.738 174.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 23.7 m170 -48.4 -44.32 34.85 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 126.64 1.976 . . . . 0.0 113.333 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -57.59 -35.02 69.85 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 125.692 1.597 . . . . 0.0 114.995 174.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -81.75 -40.26 22.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 120.167 -1.583 . . . . 0.0 110.023 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 75.8 mt -59.92 -52.25 63.39 Favored 'Isoleucine or valine' 0 C--N 1.347 0.496 0 C-N-CA 123.929 0.892 . . . . 0.0 111.402 172.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -51.47 -44.04 62.31 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 120.905 -1.122 . . . . 0.0 114.007 169.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 86.9 m -56.71 -53.77 53.85 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 121.138 -0.976 . . . . 0.0 112.199 174.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 25.9 mmt -61.53 -34.58 75.79 Favored 'General case' 0 C--N 1.347 0.459 0 O-C-N 120.561 -1.337 . . . . 0.0 114.049 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 72.9 mt -63.83 -55.43 22.47 Favored 'Isoleucine or valine' 0 C--N 1.344 0.335 0 O-C-N 121.106 -0.996 . . . . 0.0 111.39 171.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -68.81 -18.15 64.13 Favored 'General case' 0 C--N 1.35 0.628 0 O-C-N 119.414 -2.054 . . . . 0.0 115.257 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -64.48 -30.95 71.98 Favored 'General case' 0 C--N 1.349 0.562 0 O-C-N 118.515 -2.615 . . . . 0.0 112.197 165.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 36.2 m-80 -96.56 -15.04 21.82 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 123.899 0.879 . . . . 0.0 113.072 -178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . . . . . . . . . 69.5 mt -120.64 121.37 38.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.603 1.161 . . . . 0.0 112.489 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.54 119.53 13.35 Favored 'Isoleucine or valine' 0 C--N 1.348 0.505 0 O-C-N 120.276 -1.515 . . . . 0.0 112.399 174.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 C--N 1.349 0.546 0 C-N-CA 124.825 1.25 . . . . 0.0 110.601 177.46 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.55 ' HA ' ' H ' ' A' ' 43' ' ' ILE . 34.7 m . . . . . 0 N--CA 1.517 2.888 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.1 55.13 31.95 Favored Glycine 0 C--N 1.357 1.706 0 CA-C-O 121.705 0.614 . . . . 0.0 112.776 -166.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.9 m -124.34 105.98 9.88 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 120.315 -1.697 . . . . 0.0 111.429 -168.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -131.55 -152.11 7.12 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.51 72.6 4.06 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 121.047 -1.266 . . . . 0.0 113.184 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 p -66.45 -2.11 4.27 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 126.775 2.03 . . . . 0.0 115.116 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -100.58 -31.79 11.08 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 126.189 1.795 . . . . 0.0 111.474 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -171.27 87.66 0.47 Allowed Pre-proline 0 C--N 1.351 0.656 0 O-C-N 121.382 -0.824 . . . . 0.0 110.53 -176.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -81.59 98.31 0.99 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 121.88 1.72 . . . . 0.0 113.189 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -85.14 -31.97 23.0 Favored 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.353 1.061 . . . . 0.0 112.781 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.82 169.03 8.75 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 120.859 -1.15 . . . . 0.0 112.82 -173.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.4 t80 -64.19 -53.46 48.99 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 120.713 -1.242 . . . . 0.0 111.468 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.38 -50.36 67.7 Favored 'General case' 0 C--N 1.349 0.553 0 C-N-CA 125.183 1.393 . . . . 0.0 113.997 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -45.84 -55.04 7.13 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.915 2.086 . . . . 0.0 115.095 168.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -75.42 -30.43 60.05 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 120.931 -1.106 . . . . 0.0 112.979 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . . . . . . . . . 27.6 t90 -54.59 -47.68 73.06 Favored 'General case' 0 C--N 1.349 0.546 0 O-C-N 119.798 -1.814 . . . . 0.0 112.729 173.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -59.51 -40.22 86.38 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 173.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -60.72 -20.91 62.26 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 125.836 1.654 . . . . 0.0 114.2 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.6 tp -70.53 -17.12 62.94 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.701 1.2 . . . . 0.0 113.663 174.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.296 91.4 p 50.93 40.89 26.22 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.363 1.865 . . . . 0.0 114.769 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.26 88.97 0.08 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.979 1.712 . . . . 0.0 114.993 -172.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 148.2 -31.63 1.29 Allowed Glycine 0 CA--C 1.496 -1.109 0 O-C-N 120.975 -1.078 . . . . 0.0 111.096 -170.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 99.8 -132.7 11.02 Favored Glycine 0 C--N 1.346 1.103 0 CA-C-O 122.423 1.013 . . . . 0.0 112.433 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.0 m -99.77 135.49 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 O-C-N 120.659 -1.495 . . . . 0.0 110.718 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.52 158.15 37.17 Favored Pre-proline 0 N--CA 1.451 -0.385 0 O-C-N 120.354 -1.466 . . . . 0.0 109.513 -178.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.45 -5.9 17.89 Favored 'Trans proline' 0 CA--C 1.521 -0.175 0 C-N-CA 122.754 2.303 . . . . 0.0 112.848 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 mptt 61.74 51.05 4.05 Favored 'General case' 0 C--N 1.35 0.593 0 C-N-CA 126.481 1.912 . . . . 0.0 113.479 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.6 pt -64.11 141.69 17.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -173.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.3 mt -85.27 26.3 0.91 Allowed 'General case' 0 C--N 1.344 0.36 0 C-N-CA 125.305 1.442 . . . . 0.0 112.088 176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -82.29 137.65 34.77 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.157 -1.59 . . . . 0.0 109.87 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -81.06 125.46 30.23 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 120.973 -1.079 . . . . 0.0 111.36 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 5.7 p -114.06 -175.22 2.63 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 122.517 1.151 . . . . 0.0 110.046 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -138.19 -2.95 1.8 Allowed 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 120.994 -1.066 . . . . 0.0 110.586 167.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -169.18 173.43 6.76 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.65 1.18 . . . . 0.0 109.315 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.23 -9.92 58.12 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 128.149 2.58 . . . . 0.0 111.337 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 16.5 m -75.0 -39.12 61.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.753 1.621 . . . . 0.0 110.962 168.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -77.89 -18.41 56.21 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 127.443 2.297 . . . . 0.0 112.634 -173.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.3 127.94 34.85 Favored Pre-proline 0 CA--C 1.54 0.594 0 O-C-N 120.253 -1.529 . . . . 0.0 111.55 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -74.76 170.09 21.12 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.649 2.233 . . . . 0.0 113.887 -172.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.09 -96.66 0.99 Allowed Glycine 0 C--N 1.35 1.312 0 C-N-CA 124.238 0.923 . . . . 0.0 112.527 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.62 33.57 0.45 Allowed 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 122.837 1.303 . . . . 0.0 109.327 176.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 77.3 m -91.77 136.59 33.03 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 119.737 -1.852 . . . . 0.0 109.965 -172.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.55 ' H ' ' HA ' ' A' ' 1' ' ' SER . 1.6 pp -103.35 151.16 6.46 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 O-C-N 120.766 -1.209 . . . . 0.0 110.534 178.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.3 t -88.47 118.14 27.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.823 1.649 . . . . 0.0 109.154 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -79.05 172.86 13.21 Favored 'General case' 0 C--N 1.347 0.483 0 O-C-N 118.952 -2.342 . . . . 0.0 110.948 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.58 -27.83 13.53 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 116.836 1.494 . . . . 0.0 116.836 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 -83.82 3.49 33.38 Favored 'General case' 0 C--N 1.345 0.386 0 O-C-N 121.205 -1.174 . . . . 0.0 113.472 176.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 76.55 22.04 73.62 Favored Glycine 0 C--N 1.349 1.277 0 O-C-N 119.949 -1.719 . . . . 0.0 114.252 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -131.71 137.74 48.38 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 120.771 -1.429 . . . . 0.0 111.29 -176.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 66.2 m -66.37 137.65 57.03 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 124.616 2.15 . . . . 0.0 114.288 -176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.948 0 O-C-N 120.517 -1.365 . . . . 0.0 113.928 173.176 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 N--CA 1.504 2.253 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.431 ' HB ' HD22 ' B' ' 172' ' ' LEU . 4.4 m -133.4 166.47 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . 0.401 ' HB2' HG12 ' B' ' 173' ' ' VAL . 0.0 OUTLIER -118.9 101.42 50.25 Favored Pre-proline 0 C--N 1.346 0.413 0 CA-C-O 116.936 -1.507 . . . . 0.0 110.397 -178.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.99 168.44 23.15 Favored 'Trans proline' 0 C--N 1.329 -0.484 0 C-N-CA 123.104 2.536 . . . . 0.0 114.396 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -86.69 152.98 55.06 Favored Pre-proline 0 C--N 1.349 0.573 0 O-C-N 121.038 -1.038 . . . . 0.0 112.807 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.15 -19.23 29.92 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.145 2.563 . . . . 0.0 112.915 -173.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 7.6 mt -68.62 -51.55 41.11 Favored 'General case' 0 C--N 1.347 0.481 0 CA-C-O 121.579 0.704 . . . . 0.0 110.537 169.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' LEU . . . . . . . . . . . . . 20.2 tp -58.87 -39.57 81.74 Favored 'General case' 0 C--N 1.348 0.524 0 C-N-CA 124.944 1.298 . . . . 0.0 113.391 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 tp -46.46 -42.19 15.05 Favored 'General case' 0 C--N 1.35 0.616 0 C-N-CA 125.315 1.446 . . . . 0.0 114.879 171.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -66.07 -36.05 82.16 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 119.595 -1.94 . . . . 0.0 113.586 176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.515 HD13 HD13 ' B' ' 147' ' ' LEU . 1.8 tt -70.39 -50.82 34.73 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 123.927 0.891 . . . . 0.0 111.062 173.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 96.5 mt -52.65 -45.69 66.82 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 124.5 1.12 . . . . 0.0 112.412 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -59.14 -28.67 66.78 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' SER . . . . . . . . . . . . . 5.9 t -75.72 -13.18 60.3 Favored 'General case' 0 C--N 1.346 0.432 0 C-N-CA 124.559 1.144 . . . . 0.0 112.779 176.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' VAL . . . . . . . . . . . . . 2.8 t -102.73 -4.3 9.37 Favored 'Isoleucine or valine' 0 C--N 1.347 0.486 0 C-N-CA 124.852 1.261 . . . . 0.0 109.987 174.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' GLY . . . . . . . . . . . . . . . 112.58 -16.57 23.9 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 119.833 -1.792 . . . . 0.0 113.306 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -85.34 77.61 9.92 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 120.212 -1.758 . . . . 0.0 113.34 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -81.57 11.83 4.32 Favored 'General case' 0 C--N 1.344 0.351 0 O-C-N 119.747 -1.846 . . . . 0.0 115.758 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.62 139.94 30.21 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-O 122.132 0.968 . . . . 0.0 113.174 -174.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.05 -15.91 62.57 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 127.516 2.326 . . . . 0.0 114.087 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 19.6 p -138.81 126.51 22.09 Favored 'General case' 0 CA--C 1.512 -0.496 0 O-C-N 120.318 -1.489 . . . . 0.0 110.968 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -128.34 -177.31 4.11 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-O 122.461 1.124 . . . . 0.0 110.879 175.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 4.2 p -90.76 176.11 6.76 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 120.041 -1.662 . . . . 0.0 110.01 175.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' MET . . . . . . . . . . . . . 8.5 mmt -64.75 -49.23 71.62 Favored 'General case' 0 C--N 1.35 0.615 0 O-C-N 120.351 -1.468 . . . . 0.0 112.945 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -33.23 74.27 Favored 'General case' 0 C--N 1.349 0.587 0 O-C-N 120.997 -1.064 . . . . 0.0 112.605 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -57.75 -36.74 72.5 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 125.062 1.345 . . . . 0.0 114.134 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.47 -48.86 76.64 Favored 'Isoleucine or valine' 0 C--N 1.356 0.866 0 C-N-CA 123.961 0.905 . . . . 0.0 111.811 174.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.77 -27.33 40.46 Favored 'General case' 0 C--N 1.346 0.434 0 O-C-N 120.763 -1.211 . . . . 0.0 113.045 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -65.35 -58.84 4.89 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 125.289 1.436 . . . . 0.0 112.033 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -59.79 -41.97 92.32 Favored 'General case' 0 C--N 1.35 0.61 0 O-C-N 120.992 -1.067 . . . . 0.0 112.236 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 29.6 tp -61.19 -52.45 64.74 Favored 'General case' 0 C--N 1.347 0.485 0 O-C-N 120.569 -1.332 . . . . 0.0 114.017 174.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' GLY . . . . . . . . . . . . . . . -58.79 -45.54 94.75 Favored Glycine 0 C--N 1.35 1.314 0 O-C-N 120.602 -1.311 . . . . 0.0 113.45 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -59.05 -37.21 76.47 Favored 'General case' 0 C--N 1.347 0.46 0 C-N-CA 124.788 1.235 . . . . 0.0 113.157 175.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -59.93 -57.58 12.25 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 124.636 1.175 . . . . 0.0 112.688 173.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 3.1 mt -63.59 -41.7 93.54 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 O-C-N 119.999 -1.688 . . . . 0.0 112.209 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' MET . . . . . . . . . . . . . 52.2 ttm -56.26 -43.45 78.77 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 125.691 1.596 . . . . 0.0 112.681 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' THR . . . . . . . . . . . . . 21.6 m -82.56 -30.35 29.7 Favored 'General case' 0 C--N 1.345 0.37 0 O-C-N 119.953 -1.717 . . . . 0.0 112.521 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -75.31 -24.15 57.41 Favored 'General case' 0 C--N 1.345 0.406 0 O-C-N 119.584 -1.948 . . . . 0.0 114.436 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 71.82 49.84 0.26 Allowed 'General case' 0 C--N 1.352 0.692 0 C-N-CA 125.403 1.481 . . . . 0.0 111.038 -176.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' LEU . . . . . . . . . . . . . 6.1 mt -107.7 17.72 22.25 Favored 'General case' 0 C--N 1.349 0.574 0 O-C-N 121.054 -1.029 . . . . 0.0 111.961 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -105.83 149.54 26.41 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 173.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -77.31 154.81 32.51 Favored 'General case' 0 C--N 1.35 0.616 0 O-C-N 121.254 -0.904 . . . . 0.0 108.852 172.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -71.53 -37.21 71.18 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 122.746 1.26 . . . . 0.0 110.794 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -88.63 -51.5 5.65 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 121.035 -1.041 . . . . 0.0 111.884 175.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -96.13 59.65 1.95 Allowed 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 120.338 -1.476 . . . . 0.0 113.25 -178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -63.29 -9.33 11.28 Favored 'General case' 0 C--N 1.346 0.436 0 O-C-N 120.098 -1.626 . . . . 0.0 115.03 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -91.07 2.38 56.36 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.293 -1.504 . . . . 0.0 113.315 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 50.1 mm -106.04 143.07 17.63 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 C-N-CA 125.572 1.549 . . . . 0.0 108.437 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' VAL . . . . . . . . . . . . . 44.9 t -129.64 130.14 66.82 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 O-C-N 120.778 -1.201 . . . . 0.0 109.114 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -95.26 100.66 12.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 124.629 1.172 . . . . 0.0 110.404 -177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' CYS . . . . . . . . . . . . . 1.2 m -101.43 1.54 38.41 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 121.118 -0.989 . . . . 0.0 112.662 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' SER . . . . . . . . . . . . . 26.4 t -65.44 131.18 45.78 Favored 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 120.828 -1.17 . . . . 0.0 110.651 173.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 4.9 t30 69.93 25.01 5.01 Favored 'General case' 0 C--N 1.349 0.578 0 C-N-CA 124.274 1.03 . . . . 0.0 113.226 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -123.26 171.5 9.33 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 171.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 13.8 tp -74.97 -22.19 58.71 Favored 'General case' 0 C--N 1.344 0.357 0 C-N-CA 125.781 1.632 . . . . 0.0 111.688 -171.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' LEU . . . . . 0.515 HD13 HD13 ' B' ' 102' ' ' LEU . 1.0 OUTLIER -71.04 -33.53 70.41 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 120.799 -1.188 . . . . 0.0 112.715 170.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -62.67 -38.3 96.21 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 120.065 -1.647 . . . . 0.0 113.812 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -51.91 -50.24 61.48 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.18 2.592 . . . . 0.0 112.456 173.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.419 HD13 HD21 ' B' ' 171' ' ' ASN . 0.9 OUTLIER -78.95 -30.76 44.77 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 120.024 -1.673 . . . . 0.0 113.865 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.41 ' HB3' HG22 ' B' ' 153' ' ' VAL . 11.6 m-85 -75.67 -35.04 60.49 Favored 'General case' 0 C--N 1.35 0.625 0 O-C-N 120.734 -1.229 . . . . 0.0 112.83 -177.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' GLY . . . . . . . . . . . . . . . 73.99 23.2 76.81 Favored Glycine 0 C--N 1.35 1.311 0 C-N-CA 123.857 0.741 . . . . 0.0 113.696 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' VAL . . . . . 0.41 HG22 ' HB3' ' B' ' 151' ' ' PHE . 12.3 m -135.19 152.44 76.95 Favored Pre-proline 0 N--CA 1.451 -0.408 0 O-C-N 121.176 -1.191 . . . . 0.0 108.454 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -72.71 -38.41 3.2 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 121.797 1.665 . . . . 0.0 111.798 178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 31.1 m -144.67 164.31 31.36 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 -175.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -138.06 178.48 7.09 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' SER . . . . . . . . . . . . . 77.5 p -136.78 141.64 42.96 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.077 -1.639 . . . . 0.0 109.626 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.23 -23.57 23.3 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 CA-C-O 122.62 1.2 . . . . 0.0 113.035 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' LYS . . . . . . . . . . . . . 1.5 ptpm? -60.01 -27.05 66.57 Favored 'General case' 0 C--N 1.347 0.475 0 O-C-N 120.666 -1.271 . . . . 0.0 113.521 175.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -77.87 56.64 1.58 Allowed 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.838 1.255 . . . . 0.0 112.438 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -53.64 -38.86 64.5 Favored 'General case' 0 C--N 1.345 0.404 0 O-C-N 119.684 -1.885 . . . . 0.0 114.43 -175.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -67.45 -32.34 73.14 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.903 1.681 . . . . 0.0 113.529 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' LYS . . . . . . . . . . . . . 17.0 tttm -74.72 -43.95 52.44 Favored 'General case' 0 C--N 1.348 0.53 0 C-N-CA 125.405 1.482 . . . . 0.0 110.799 175.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' ILE . . . . . . . . . . . . . 51.3 mm -50.63 -53.38 13.21 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 124.768 1.227 . . . . 0.0 112.012 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -54.25 -43.12 70.66 Favored 'General case' 0 C--N 1.348 0.52 0 C-N-CA 124.243 1.017 . . . . 0.0 113.655 173.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -36.07 79.88 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 119.7 -1.875 . . . . 0.0 113.664 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -69.33 -38.38 78.16 Favored 'General case' 0 C--N 1.346 0.44 0 O-C-N 120.434 -1.416 . . . . 0.0 111.845 176.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' ILE . . . . . . . . . . . . . 67.6 mt -66.54 -50.38 67.24 Favored 'Isoleucine or valine' 0 C--N 1.347 0.476 0 C-N-CA 124.455 1.102 . . . . 0.0 112.313 173.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -61.1 -14.88 27.37 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 119.735 -1.853 . . . . 0.0 114.918 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -76.31 -12.73 60.12 Favored 'General case' 0 C--N 1.346 0.414 0 O-C-N 119.554 -1.966 . . . . 0.0 113.539 169.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . 0.419 HD21 HD13 ' B' ' 150' ' ' LEU . 2.1 m120 -105.24 -15.91 14.92 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 120.419 -1.426 . . . . 0.0 111.86 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' LEU . . . . . 0.431 HD22 ' HB ' ' B' ' 93' ' ' VAL . 48.0 mt -111.37 162.93 14.53 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 121.92 0.867 . . . . 0.0 109.804 -174.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' B' ' 94' ' ' ARG . 8.6 p -106.92 126.68 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 O-C-N 120.453 -1.405 . . . . 0.0 108.978 173.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 49.1 t . . . . . 0 C--N 1.348 0.534 0 C-N-CA 123.779 0.832 . . . . 0.0 110.681 -179.226 . . . . . . . . 0 0 . 1 stop_ save_